Citrus Sinensis ID: 018656
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 352 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.775 | 0.7 | 0.439 | 2e-61 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.701 | 0.269 | 0.371 | 5e-42 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.727 | 0.221 | 0.379 | 7e-42 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.718 | 0.190 | 0.384 | 3e-40 | |
| Q54I36 | 1338 | Dual specificity protein | no | no | 0.758 | 0.199 | 0.371 | 3e-39 | |
| Q16584 | 847 | Mitogen-activated protein | yes | no | 0.687 | 0.285 | 0.348 | 4e-38 | |
| Q80XI6 | 850 | Mitogen-activated protein | yes | no | 0.687 | 0.284 | 0.344 | 4e-38 | |
| Q66HA1 | 850 | Mitogen-activated protein | yes | no | 0.687 | 0.284 | 0.344 | 4e-38 | |
| Q54L00 | 650 | Probable LIM domain-conta | no | no | 0.690 | 0.373 | 0.372 | 1e-37 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.681 | 0.206 | 0.348 | 2e-37 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 236 bits (603), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 128/291 (43%), Positives = 176/291 (60%), Gaps = 18/291 (6%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIV----HKGETPEEIAKKESRFAR 73
+W D LF+G + GAH+++Y G YK + VA+K+V HK ET AK E +F
Sbjct: 78 EWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETR---AKLEQQFKS 134
Query: 74 EVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
EVA+LSR+ H N+V+FI ACK+P V I+TE +S G LR YL P L + + AL
Sbjct: 135 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLAL 194
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM 192
DI+R ME LHS G+IHRDLK NLLL ++++ +K+ADFG + E+ GTYRWM
Sbjct: 195 DISRGMEYLHSQGVIHRDLKSNNLLLNDEMR-VKVADFGTSCLETQCREAKGNMGTYRWM 253
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252
APE+ ++K Y KVD YSF IVLWEL LPF+GM+ +QAA+A A KN RP
Sbjct: 254 APEMI--------KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERP 305
Query: 253 S-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 302
+ L+ ++ CW E+P+ RP+F+ I+ +L Y + P+ H
Sbjct: 306 PLPASCQPALAHLIKRCWSENPSKRPDFSNIVAVLEKYDECVKEGLPLTSH 356
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (435), Expect = 5e-42, Method: Compositional matrix adjust.
Identities = 97/261 (37%), Positives = 154/261 (59%), Gaps = 14/261 (5%)
Query: 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
+ ++GEG VY+G ++ +VAIK + E +E F +E+ +LSR++H N+V
Sbjct: 664 ISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEE--FRKELTILSRLRHPNIV 721
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+ AC P + +TE L GG+L L + + + +++ + A+ IA+ M LH G+
Sbjct: 722 LLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQLYKKLAIQIAQGMNYLHLSGV 780
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
IHRD+K NLLL E + +K+ DFGL++ +S + MT G+ WM+PEL GE
Sbjct: 781 IHRDIKSLNLLLDEHMN-VKICDFGLSKLKSKSTEMTKSIGSPIWMSPELL------MGE 833
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV-PEELSIIL 265
Y KVD Y+F I+LWEL +LP+ G+ ++Q A A K++RP N P +LS ++
Sbjct: 834 D--YTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLI 891
Query: 266 TSCWKEDPNARPNFTQIIQML 286
+CW +DP RP+FT+I+ +L
Sbjct: 892 QACWHQDPLKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 171 bits (433), Expect = 7e-42, Method: Composition-based stats.
Identities = 107/282 (37%), Positives = 157/282 (55%), Gaps = 26/282 (9%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ +++ID + ++GEGA ++V+EG +K VAIK + E+ + RF REV
Sbjct: 843 EREYIIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGDEEQF---KERFIREV 899
Query: 76 AMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDV----CVAIGFA 131
L + H+N+V FIGAC +P I+TE ++GG+L L N V + + A
Sbjct: 900 QNLKKGNHQNIVMFIGACYKPA-CIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMA 958
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-- 189
D+A + LHS I+HRDL +N+LL E L IK++DFGL+RE+S MT G
Sbjct: 959 TDMALGLLHLHSITIVHRDLTSQNILLDE-LGNIKISDFGLSREKSREGSMTMTNGGICN 1017
Query: 190 -RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248
RW PEL + HY+ KVD Y F++V+WE+L ++PF + QA+ A+
Sbjct: 1018 PRWRPPELTKNL-------GHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYA 1070
Query: 249 NVRPSAENVPE----ELSIILTSCWKEDPNARPNFTQIIQML 286
+RP +PE EL ++LT CW+ DPN RP FT I+ L
Sbjct: 1071 GLRPP---IPEYCDPELKLLLTQCWEADPNDRPPFTYIVNKL 1109
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 166 bits (419), Expect = 3e-40, Method: Composition-based stats.
Identities = 108/281 (38%), Positives = 155/281 (55%), Gaps = 28/281 (9%)
Query: 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVH--KGETPEEIAKKESRFAREVAM 77
+I+ + + IG+G +KV +G +K + VA+K ++ K + EE+ ++ F EV +
Sbjct: 1067 MINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQE---FKAEVEL 1123
Query: 78 LSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR------CLDVCVAIGFA 131
L +QH NLV G P M IV E L G L + L++ +P LD + + A
Sbjct: 1124 LGSLQHPNLVTCYGYSLNP-MCIVMEFLPSGNLFE-LIHSKPSEQQQSIKLDSTLILAIA 1181
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
DIAR M+ LH+ IIHRDLK NLL+ + IK+AD G+ARE S T+ MT GT W
Sbjct: 1182 FDIARGMQHLHTRNIIHRDLKSSNLLMDKHF-NIKIADLGIARETSFTQTMTT-IGTVAW 1239
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251
APE+ LR + YN K D YS+AIVL+ELL + P++G+ + A A K +R
Sbjct: 1240 TAPEI-----LRH---ESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLR 1291
Query: 252 PS-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291
P +N ++ CW EDPN RP+F +I NYL+
Sbjct: 1292 PELPDNCDPNWKKLVVWCWSEDPNKRPSFEEIT----NYLT 1328
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 162 bits (411), Expect = 3e-39, Method: Compositional matrix adjust.
Identities = 107/288 (37%), Positives = 161/288 (55%), Gaps = 21/288 (7%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
++ + RF E L K I + + ++G G+ A V+ G + VAIKI+
Sbjct: 1033 LQKKERFNEITEF-LRGKKEIKFDEVAIVEKVGAGSFANVFLGIWNGYKVAIKILKN--- 1088
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
E I+ E +F +EV+ L + H N+V F+GAC +P I TE L GG+L +L+++
Sbjct: 1089 -ESISNDE-KFIKEVSSLIKSHHPNVVTFMGACIDPP-CIFTEYLQGGSLYD-VLHIQKI 1144
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
L+ + D++ ME LHS ++HRDL +N+LL E K IK+ADFGLA +L++
Sbjct: 1145 KLNPLMMYKMIHDLSLGMEHLHSIQMLHRDLTSKNILLDE-FKNIKIADFGLAT--TLSD 1201
Query: 181 MMTAETGTY-RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
MT T RW +PEL + YN KVD YSF +V++E+ K+PFEG+
Sbjct: 1202 DMTLSGITNPRWRSPELTKGLV--------YNEKVDVYSFGLVVYEIYTGKIPFEGLDGT 1253
Query: 240 QAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+A AAF+N RP+ + P L ++T CW DP+ RP+FT+I+ L
Sbjct: 1254 ASAAKAAFENYRPAIPPDCPVSLRKLITKCWASDPSQRPSFTEILTEL 1301
|
Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q16584|M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (401), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 93/267 (34%), Positives = 141/267 (52%), Gaps = 25/267 (9%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IG G KVY G ++ + VA+K + + E+I+ +E + + + H N++
Sbjct: 123 IGIGGFGKVYRGSWRGELVAVKAARQ-DPDEDISVTAESVRQEARLFAMLAHPNIIALKA 181
Query: 92 AC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---II 147
C +EP + +V E +GG L + L R + V + +A+ IAR M LH +I
Sbjct: 182 VCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPVI 238
Query: 148 HRDLKPENLLL-----TEDL--KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
HRDLK N+LL ++D+ KT+K+ DFGLARE T M+A GTY WMAPE+
Sbjct: 239 HRDLKSNNILLLQPIESDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKAS 297
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 259
T +G D +SF ++LWELL ++P+ G+ L AY A + P PE
Sbjct: 298 TFSKGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCPE 349
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQML 286
+ ++ CW +DP+ RP+F I+Q L
Sbjct: 350 PFAQLMADCWAQDPHRRPDFASILQQL 376
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q80XI6|M3K11_MOUSE Mitogen-activated protein kinase kinase kinase 11 OS=Mus musculus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (401), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 92/267 (34%), Positives = 139/267 (52%), Gaps = 25/267 (9%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IG G KVY G ++ + VA+K + + E+I+ +E + + + H N++
Sbjct: 124 IGIGGFGKVYRGSWRGELVAVKAARQ-DPDEDISVTAESVRQEARLFAMLAHPNIIALKA 182
Query: 92 AC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---II 147
C +EP + +V E +GG L + L R + V + +A+ IAR M LH +I
Sbjct: 183 VCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPVI 239
Query: 148 HRDLKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
HRDLK N+LL + + KT+K+ DFGLARE T M+A GTY WMAPE+
Sbjct: 240 HRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKAS 298
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 259
T +G D +SF ++LWELL ++P+ G+ L AY A + P PE
Sbjct: 299 TFSKGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCPE 350
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQML 286
+ ++ CW +DP+ RP+F I+Q L
Sbjct: 351 PFAQLMADCWAQDPHRRPDFASILQQL 377
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q66HA1|M3K11_RAT Mitogen-activated protein kinase kinase kinase 11 OS=Rattus norvegicus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (401), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 92/267 (34%), Positives = 139/267 (52%), Gaps = 25/267 (9%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IG G KVY G ++ + VA+K + + E+I+ +E + + + H N++
Sbjct: 124 IGIGGFGKVYRGSWRGELVAVKAARQ-DPDEDISVTAESVRQEARLFAMLAHPNIIALKA 182
Query: 92 AC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---II 147
C +EP + +V E +GG L + L R + V + +A+ IAR M LH +I
Sbjct: 183 VCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPVI 239
Query: 148 HRDLKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
HRDLK N+LL + + KT+K+ DFGLARE T M+A GTY WMAPE+
Sbjct: 240 HRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKAS 298
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 259
T +G D +SF ++LWELL ++P+ G+ L AY A + P PE
Sbjct: 299 TFSKGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCPE 350
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQML 286
+ ++ CW +DP+ RP+F I+Q L
Sbjct: 351 PFAQLMADCWAQDPHRRPDFASILQQL 377
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54L00|LIMKA_DICDI Probable LIM domain-containing serine/threonine-protein kinase DDB_G0287001 OS=Dictyostelium discoideum GN=DDB_G0287001 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (397), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 98/263 (37%), Positives = 142/263 (53%), Gaps = 20/263 (7%)
Query: 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNL 86
G I GA KVY+G YK + VAIK+ + E F REV ++S + H N
Sbjct: 389 GDVIASGASGKVYKGIYKGRDVAIKVY----SSENFCFNIEEFDREVTIMSLIDSDHPNF 444
Query: 87 VKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+F GA K+ + V+EL+ G+LR LL+ + + L + A DIA AM+ LHS
Sbjct: 445 TRFYGANKQNKKYLFHVSELVKSGSLRDLLLD-KEKPLAYFTQLSIASDIANAMKHLHSI 503
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
G+IHRDLK N+L+TED T K+ DFG +R L + MT GT +M+PEL+
Sbjct: 504 GVIHRDLKSLNVLITEDF-TAKVIDFGTSRNVDLAKQMTLNLGTSCYMSPELF------- 555
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSI 263
+ Y+ D Y+F IVLWE++ K P+E +++ A K RP+ + P E S
Sbjct: 556 -KGNGYDETCDVYAFGIVLWEIIARKEPYENINSWSIPVLVA-KGERPTIPADCPSEYSK 613
Query: 264 ILTSCWKEDPNARPNFTQIIQML 286
++ +CW + P RP+F +I L
Sbjct: 614 LIKACWTDKPKKRPSFKEICDTL 636
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (395), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 93/267 (34%), Positives = 139/267 (52%), Gaps = 27/267 (10%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHK-GETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90
IG G KV+ G Y + VAIKI H+ GE +++ + +E + ++H N+
Sbjct: 148 IGSGGFCKVHRGYYDGEEVAIKIAHQTGE--DDMQRMRDNVLQEAKLFWALKHENIAALR 205
Query: 91 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---II 147
G C + +V E GG+L + L P V + +A+ IAR M LH+ II
Sbjct: 206 GVCLNTKLCLVMEYARGGSLNRILAGKIP----PDVLVNWAIQIARGMNYLHNEAPMSII 261
Query: 148 HRDLKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
HRDLK N+L+ E + KT+K+ DFGLARE T+ M+A GTY WM PE+ S
Sbjct: 262 HRDLKSSNVLIYEAIEGNHLQQKTLKITDFGLAREMYNTQRMSA-AGTYAWMPPEVISVS 320
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 259
T Y+ D +S+ ++LWEL+ + P++G L AY A + P + PE
Sbjct: 321 T--------YSKFSDVWSYGVLLWELITGETPYKGFDPLSVAYGVAVNTLTLPIPKTCPE 372
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQML 286
++ SCW+ DP+ RP F +I++ L
Sbjct: 373 TWGALMKSCWQTDPHKRPGFKEILKQL 399
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 352 | ||||||
| 255540509 | 351 | protein kinase atn1, putative [Ricinus c | 0.997 | 1.0 | 0.889 | 0.0 | |
| 449440628 | 353 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.997 | 0.872 | 0.0 | |
| 225456892 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 1.0 | 0.863 | 0.0 | |
| 356516635 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 1.0 | 0.857 | 1e-180 | |
| 224140853 | 351 | predicted protein [Populus trichocarpa] | 0.997 | 1.0 | 0.849 | 1e-180 | |
| 363808050 | 352 | uncharacterized protein LOC100804884 [Gl | 1.0 | 1.0 | 0.846 | 1e-178 | |
| 224055579 | 351 | predicted protein [Populus trichocarpa] | 0.997 | 1.0 | 0.838 | 1e-177 | |
| 225452312 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 1.0 | 0.832 | 1e-176 | |
| 357461809 | 352 | Serine/threonine protein kinase TNNI3K [ | 1.0 | 1.0 | 0.835 | 1e-176 | |
| 255560936 | 353 | protein kinase atn1, putative [Ricinus c | 1.0 | 0.997 | 0.830 | 1e-175 |
| >gi|255540509|ref|XP_002511319.1| protein kinase atn1, putative [Ricinus communis] gi|223550434|gb|EEF51921.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1696), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/352 (88%), Positives = 331/352 (94%), Gaps = 1/352 (0%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
MES +RFY DE+KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVA+KIVHKGET
Sbjct: 1 MESGNRFYSPDEVKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAVKIVHKGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEI+K+E+RFAREVAMLSRVQH+NLVKF+GACKEPVMVIVTELLSGGTLRKYLLNMRPR
Sbjct: 61 PEEISKREARFAREVAMLSRVQHKNLVKFVGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CL+ VAIGFALDIARAMECLHSHGIIHRDLKPENLLLT D KT+KLADFGLAREESLTE
Sbjct: 121 CLETRVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+YSFAIVLWELLHNKLPFEGMSNLQ
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQ 240
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
AAYAAAFKNVRPSAE++PEELSIILTSCWKEDPN RPNF+QII MLLN+L+ IAPPEP I
Sbjct: 241 AAYAAAFKNVRPSAEDLPEELSIILTSCWKEDPNTRPNFSQIIHMLLNHLAVIAPPEPAI 300
Query: 301 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 352
PHRIF SENT LPPESPGTSSLM V D GETPKAKM ++PK LFFCF CY
Sbjct: 301 PHRIFTSENTFLPPESPGTSSLMAVH-DTGETPKAKMENQPKGLFFCFKQCY 351
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440628|ref|XP_004138086.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449524138|ref|XP_004169080.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 649 bits (1674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 308/353 (87%), Positives = 329/353 (93%), Gaps = 1/353 (0%)
Query: 1 MESRSRFYLA-DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGE 59
ME+ SRFY A DE +L+AKWL+DPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGE
Sbjct: 1 MEAGSRFYSATDEFRLEAKWLVDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGE 60
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRP 119
T +E+AKKE+RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLNMRP
Sbjct: 61 TVDEVAKKEARFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRP 120
Query: 120 RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179
RCLD VA+GFALDIARAMECLHSHGIIHRDLKPENLLLT D KT+KLADFGLAREESLT
Sbjct: 121 RCLDTRVAVGFALDIARAMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLT 180
Query: 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+YSFAIVLWELLHNKLPFEGMSNL
Sbjct: 181 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNL 240
Query: 240 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM 299
QAAYAAAFKNVRPSAEN+PEEL+IILTSCW+ED NARPNF+QIIQMLLNYL I+PPEP+
Sbjct: 241 QAAYAAAFKNVRPSAENLPEELAIILTSCWQEDANARPNFSQIIQMLLNYLYTISPPEPV 300
Query: 300 IPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 352
IP RIF SENT+ PPESPGTSSLM VRDD G+TPKAKM + P+ FFC N CY
Sbjct: 301 IPSRIFTSENTVFPPESPGTSSLMAVRDDSGDTPKAKMENNPRGCFFCSNDCY 353
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456892|ref|XP_002280504.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|147839295|emb|CAN63533.1| hypothetical protein VITISV_011081 [Vitis vinifera] gi|297733702|emb|CBI14949.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1670), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 304/352 (86%), Positives = 324/352 (92%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
MES +RFY DE LD KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ VAIKIVH+GET
Sbjct: 1 MESGNRFYSVDEFHLDPKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQNVAIKIVHRGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEI K+E+RFAREV+MLSRVQH+NL KFIG CKEPVMVIVTELL GGTLRKYLLNMRPR
Sbjct: 61 PEEITKREARFAREVSMLSRVQHKNLAKFIGVCKEPVMVIVTELLLGGTLRKYLLNMRPR 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD +A+GFALDIARAMECLHSHGIIHRDLKPENL+LT D KT+KL DFGLAREESLTE
Sbjct: 121 CLDARIAVGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLVDFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MMTAETGTYRWMAPELYSTVTLR GEKKHYN+KVD+YSFAIVLWELLHNKLPFEGMSNLQ
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNNKVDAYSFAIVLWELLHNKLPFEGMSNLQ 240
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
AAYAAAFKNVRPSAEN+PEEL+IILTSCWKEDPNARPNF+QI+QMLL+YLS I+PPEP I
Sbjct: 241 AAYAAAFKNVRPSAENLPEELAIILTSCWKEDPNARPNFSQIVQMLLHYLSTISPPEPAI 300
Query: 301 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 352
P R+F SENTILPPESPGTSSLM VRDD GETPK KM +KPK FFCFN CY
Sbjct: 301 PSRVFASENTILPPESPGTSSLMAVRDDSGETPKVKMENKPKGFFFCFNQCY 352
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516635|ref|XP_003526999.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 638 bits (1646), Expect = e-180, Method: Compositional matrix adjust.
Identities = 302/352 (85%), Positives = 323/352 (91%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
MES FY DE +LD KWLIDPKHLFVGP+IGEGAHAKVYEGKYKNQTVAIKIVHKGET
Sbjct: 1 MESGDMFYSVDEFRLDPKWLIDPKHLFVGPQIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
E+IAK+E RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYL +MRP+
Sbjct: 61 TEDIAKREGRFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLFSMRPK 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD VAIGFALDIARAMECLHSHGIIHRDLKP+NLLLTED KT+KLADFGLAREESLTE
Sbjct: 121 CLDRHVAIGFALDIARAMECLHSHGIIHRDLKPDNLLLTEDQKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+YSFAIVLWELLHNK+PFEGMSNLQ
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELLHNKVPFEGMSNLQ 240
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
AAYAAAFKNVRPSAEN+PEEL++ILTSCW+EDPNARPNFTQIIQMLLNYL +APPEPMI
Sbjct: 241 AAYAAAFKNVRPSAENLPEELAVILTSCWQEDPNARPNFTQIIQMLLNYLYTVAPPEPMI 300
Query: 301 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 352
P RIF+SENT+LPPESPGTSSLM RDD G+TP+AK KP CF+ CY
Sbjct: 301 PSRIFSSENTVLPPESPGTSSLMAKRDDTGDTPRAKDEIKPNGFLCCFSQCY 352
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224140853|ref|XP_002323793.1| predicted protein [Populus trichocarpa] gi|222866795|gb|EEF03926.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1639), Expect = e-180, Method: Compositional matrix adjust.
Identities = 299/352 (84%), Positives = 328/352 (93%), Gaps = 1/352 (0%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S + FY ++E LDAKWLIDPK LFVGP+IGEGAHAKVYEGKYKNQ VAIKIVH GET
Sbjct: 1 MGSSNGFY-SEEFDLDAKWLIDPKLLFVGPKIGEGAHAKVYEGKYKNQIVAIKIVHGGET 59
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+E+RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLNMRPR
Sbjct: 60 PEEIAKREARFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPR 119
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD+ +A+GFALDIARAMECLHSHGIIHRDLKPENL+LT D KT+KLADFGLAREESLTE
Sbjct: 120 CLDMRLAVGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 179
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MMTAETGTYRWMAPELYSTVTLR GEKKHYNHKVD+YSFAIVLWEL+HNKLPFEGMSNLQ
Sbjct: 180 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQ 239
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
AAYAAAFKNVRPSAEN+PE+L++I+TSCWKEDPNARPNF+QIIQMLL+YLS I+ P+P+I
Sbjct: 240 AAYAAAFKNVRPSAENLPEDLALIVTSCWKEDPNARPNFSQIIQMLLHYLSTISAPKPVI 299
Query: 301 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 352
P RIF SEN +LPPESPGTSSLM VRDD+GETP+ ++ DKPKS FFCFN CY
Sbjct: 300 PARIFTSENAVLPPESPGTSSLMAVRDDLGETPRTQIEDKPKSFFFCFNQCY 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363808050|ref|NP_001241956.1| uncharacterized protein LOC100804884 [Glycine max] gi|255636187|gb|ACU18435.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 631 bits (1627), Expect = e-178, Method: Compositional matrix adjust.
Identities = 298/352 (84%), Positives = 319/352 (90%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
MES RFY DE +LD KWLIDP HLFVGP+IGEGAHAKVYEGKYKNQTVA KIVHKGET
Sbjct: 1 MESGGRFYSVDEFRLDPKWLIDPNHLFVGPQIGEGAHAKVYEGKYKNQTVAFKIVHKGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
E+IAK+E RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLL+MRP+
Sbjct: 61 TEDIAKREGRFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLSMRPK 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD VAIG+ALDIARAMECLHSHGIIHRDLKP+NLLLTED KT+KL DFGLAREESLTE
Sbjct: 121 CLDRHVAIGYALDIARAMECLHSHGIIHRDLKPDNLLLTEDQKTVKLVDFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+YSFAIVLWELLHNK+PFEGMSNLQ
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELLHNKVPFEGMSNLQ 240
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
AAYAAAFKNVRPSAEN+PEEL++ILTSCW+ED NARPNFTQIIQMLLNYL +APPEPM
Sbjct: 241 AAYAAAFKNVRPSAENLPEELAVILTSCWQEDSNARPNFTQIIQMLLNYLYTVAPPEPMT 300
Query: 301 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 352
P RIFNSENT+LPPESPGTSSLM RD G+TP+AK KP CF+ CY
Sbjct: 301 PSRIFNSENTVLPPESPGTSSLMAKRDGTGDTPRAKDEIKPNGFLCCFSQCY 352
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055579|ref|XP_002298549.1| predicted protein [Populus trichocarpa] gi|222845807|gb|EEE83354.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1618), Expect = e-177, Method: Compositional matrix adjust.
Identities = 295/352 (83%), Positives = 322/352 (91%), Gaps = 1/352 (0%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S + FY + E LDAKWL+DPK LFVGP+IGEGAHAKVYEGKYKNQ VAIKIVH GET
Sbjct: 1 MGSSNVFY-SGEFNLDAKWLVDPKLLFVGPKIGEGAHAKVYEGKYKNQNVAIKIVHGGET 59
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+++RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLNMRPR
Sbjct: 60 PEEIAKRQARFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPR 119
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CL++ VA GFALDIARAMECLHSHGIIHRDLKPENL+LT D KT+KLADFGLAREESLTE
Sbjct: 120 CLEMRVAFGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 179
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MMTAETGTYRWMAPELYSTVTLR GEKKHYNHKVD+YSFAIVLWEL+HNKLPFEGMSNLQ
Sbjct: 180 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQ 239
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
AAYAAAFKNVRPSAEN+PE+L++I+TSCWKEDPNARPNF+QIIQMLL+YLS I+ PEP I
Sbjct: 240 AAYAAAFKNVRPSAENLPEDLALIVTSCWKEDPNARPNFSQIIQMLLHYLSTISAPEPAI 299
Query: 301 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 352
P RIF SEN + PPESPGTSSLM VRDD GETP+ ++ DKP+ FFCFN CY
Sbjct: 300 PARIFTSENAVFPPESPGTSSLMAVRDDSGETPRTQIEDKPRGFFFCFNQCY 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452312|ref|XP_002272486.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|296087594|emb|CBI34850.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1611), Expect = e-176, Method: Compositional matrix adjust.
Identities = 293/352 (83%), Positives = 320/352 (90%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S + FY ++E LDAKWL+DPK LFVGPRIGEGAHAKVYEGKYKNQ VAIKIVH+GET
Sbjct: 1 MGSGNGFYESEEFNLDAKWLVDPKLLFVGPRIGEGAHAKVYEGKYKNQNVAIKIVHRGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+E RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLN+RPR
Sbjct: 61 PEEIAKREGRFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNLRPR 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD VA+GFALDIARAMECLHSHGIIHRDLKPENL+LT D KT+KLADFGLAREESLTE
Sbjct: 121 CLDTKVAVGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MMTAETGTYRWMAPELYSTVTLR GEKKHYNHKVD+YSFAIVLWEL+HNKLPFEGMSNLQ
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELVHNKLPFEGMSNLQ 240
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
AAYAAAFKN+RPSAE++PE+L++I+TSCWKEDPN RPNF+QIIQMLL+YLS I+PPEPM+
Sbjct: 241 AAYAAAFKNMRPSAEDLPEDLALIVTSCWKEDPNTRPNFSQIIQMLLHYLSTISPPEPMV 300
Query: 301 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 352
P R+F SEN +LPPESPGTSSLM VRD GETPK M P+ F CFN CY
Sbjct: 301 PPRVFTSENAVLPPESPGTSSLMAVRDGSGETPKTSMETNPRGCFSCFNHCY 352
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461809|ref|XP_003601186.1| Serine/threonine protein kinase TNNI3K [Medicago truncatula] gi|355490234|gb|AES71437.1| Serine/threonine protein kinase TNNI3K [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1611), Expect = e-176, Method: Compositional matrix adjust.
Identities = 294/352 (83%), Positives = 317/352 (90%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
MES RFY DE LD KWL+DPKHL+VGPRIGEGAHAKVYEGKYKNQ VAIKIVHKGET
Sbjct: 1 MESGGRFYSVDEFNLDPKWLVDPKHLYVGPRIGEGAHAKVYEGKYKNQIVAIKIVHKGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
EEIAK+E RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRP+
Sbjct: 61 TEEIAKREDRFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPK 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD VAIGFALDI+RAMECLHSHGIIHRDLKP+NLLLTED T+KLADFGLAREESLTE
Sbjct: 121 CLDTHVAIGFALDISRAMECLHSHGIIHRDLKPDNLLLTEDHGTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+YSFAIV WELLHNK+PFEGMSNLQ
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVFWELLHNKVPFEGMSNLQ 240
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
AAYAAAFKNVRP+A+++PEEL++ILTSCW+ED NARPNFTQIIQMLLNYL ++PP P I
Sbjct: 241 AAYAAAFKNVRPNADHLPEELAVILTSCWQEDANARPNFTQIIQMLLNYLYTVSPPTPAI 300
Query: 301 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 352
P RIF SENT+LPPESPGTSSLM RDD G+TP+ K KP CF+ CY
Sbjct: 301 PSRIFTSENTLLPPESPGTSSLMAKRDDTGDTPRVKDEIKPNGFLCCFSQCY 352
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560936|ref|XP_002521481.1| protein kinase atn1, putative [Ricinus communis] gi|223539380|gb|EEF40971.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 622 bits (1603), Expect = e-175, Method: Compositional matrix adjust.
Identities = 293/353 (83%), Positives = 323/353 (91%), Gaps = 1/353 (0%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S + + E LDAKWLIDPK L VGP+IGEGAHAKVYEGKYKN+ VAIK+VH+GET
Sbjct: 1 MGSTDNGFYSGEFNLDAKWLIDPKLLLVGPKIGEGAHAKVYEGKYKNRIVAIKVVHRGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+E+RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLN+RPR
Sbjct: 61 PEEIAKREARFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNLRPR 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
L++ VAIGFALDIARAMECLHSHGIIHRDLKPENL+LT D KT+KLADFGLAREESLTE
Sbjct: 121 SLELHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MMTAETGTYRWMAPELYSTVTLR GEKKHYNHKVD+YSFAIVLWEL+HNKLPFEGMSNLQ
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQ 240
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
AAYAAAFKNVRPSA+++PEE+++I+TSCW+EDPNARPNFTQIIQMLL +LS I+PPEP+I
Sbjct: 241 AAYAAAFKNVRPSADDLPEEMAMIVTSCWQEDPNARPNFTQIIQMLLRFLSTISPPEPVI 300
Query: 301 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGD-KPKSLFFCFNLCY 352
P RIF SEN +LPPESPGTSSLM VRDD GETPK+KM D KP+ FFCFN CY
Sbjct: 301 PARIFTSENAVLPPESPGTSSLMAVRDDSGETPKSKMEDNKPRGFFFCFNQCY 353
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 352 | ||||||
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.963 | 0.979 | 0.828 | 2e-152 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.988 | 0.985 | 0.754 | 2.9e-142 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.982 | 0.971 | 0.75 | 2.1e-141 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.838 | 0.885 | 0.663 | 7.5e-105 | |
| TAIR|locus:2173674 | 405 | AT5G66710 [Arabidopsis thalian | 0.911 | 0.792 | 0.501 | 2.1e-77 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.764 | 0.713 | 0.496 | 1.2e-67 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.735 | 0.630 | 0.461 | 6.4e-60 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.735 | 0.628 | 0.450 | 8.4e-58 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.730 | 0.489 | 0.402 | 3.8e-53 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.724 | 0.443 | 0.440 | 2.1e-52 |
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1487 (528.5 bits), Expect = 2.0e-152, P = 2.0e-152
Identities = 281/339 (82%), Positives = 304/339 (89%)
Query: 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAR 73
+++ KW IDP+ LFVGP+IGEGAHAKVYEGKYKNQTVAIKIVH+GETPEEIAK++SRF R
Sbjct: 8 RMEPKWQIDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGETPEEIAKRDSRFLR 67
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
EV MLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLN+RP CL+ VAIGFALD
Sbjct: 68 EVEMLSRVQHKNLVKFIGACKEPVMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALD 127
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
IAR MECLHSHGIIHRDLKPENLLLT D KT+KLADFGLAREESLTEMMTAETGTYRWMA
Sbjct: 128 IARGMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 187
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253
PELYSTVTLR GEKKHYNHKVD+YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS
Sbjct: 188 PELYSTVTLRLGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 247
Query: 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILP 313
AE++PEEL I+TSCW EDPNARPNFT II++LLNYLS + P IP RI S+NT+LP
Sbjct: 248 AESLPEELGDIVTSCWNEDPNARPNFTHIIELLLNYLSKVGSPISAIPQRILASKNTLLP 307
Query: 314 PESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 352
P+SPGTSSLM D+ GETPKAK DK K LFFCFN CY
Sbjct: 308 PDSPGTSSLMAKLDECGETPKAKSEDKRKGLFFCFNQCY 346
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1391 (494.7 bits), Expect = 2.9e-142, P = 2.9e-142
Identities = 265/351 (75%), Positives = 309/351 (88%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S + FY + +LD KW++DP+HLFVGP+IGEGAHAK+YEGKYKN+TVAIKIV +GE+
Sbjct: 1 MGSVTGFYSNEVFELDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGES 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+ESRFAREV+MLSRVQH+NLVKFIGACKEP+MVIVTELL GGTLRKYL+++RP
Sbjct: 61 PEEIAKRESRFAREVSMLSRVQHKNLVKFIGACKEPIMVIVTELLLGGTLRKYLVSLRPG 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
LD+ VA+G+ALDIARAMECLHSHG+IHRDLKPE+L+LT D KT+KLADFGLAREESLTE
Sbjct: 121 SLDIRVAVGYALDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MMTAETGTYRWMAPELYSTVTLR GEKKHYNHKVD+YSFAIVLWEL+HNKLPFEGMSNLQ
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQ 240
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
AAYAAAFKNVRPSA+++P++L++I+TSCWKEDPN RPNFT+IIQMLL LS I+ E +
Sbjct: 241 AAYAAAFKNVRPSADDLPKDLAMIVTSCWKEDPNDRPNFTEIIQMLLRCLSTISSTELVP 300
Query: 301 P--HRIFNSENTILPPESPGTSSLMTVRD-DIGETPKAKMGDKPKSLFFCF 348
P R+F+SENT+LPPESPGT SLMTVRD D T ++ + FF F
Sbjct: 301 PAIKRVFSSENTVLPPESPGTCSLMTVRDKDQIPTDANSAQNEVRGSFFFF 351
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1383 (491.9 bits), Expect = 2.1e-141, P = 2.1e-141
Identities = 264/352 (75%), Positives = 311/352 (88%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S S FY +E +LD KWL+DP+HLFVGP+IGEGAHAKVYEGKY+NQTVAIKI+ +GE+
Sbjct: 1 MGSASGFYSNEEFELDPKWLVDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGES 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+++RFARE+AMLS+VQH+NLVKFIGACKEP+MVIVTELL GGTLRKYL+++RP+
Sbjct: 61 PEEIAKRDNRFAREIAMLSKVQHKNLVKFIGACKEPMMVIVTELLLGGTLRKYLVSLRPK 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
LD+ +A+GFALDIARAMECLHSHGIIHRDLKPENL+L+ D KT+KLADFGLAREESLTE
Sbjct: 121 RLDIRLAVGFALDIARAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD+YSFAIVLWEL+ NKLPFEGMSNLQ
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELILNKLPFEGMSNLQ 240
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
AAYAAAFKN+RPSAE++P +L +I+TSCWKEDPN RPNFT+IIQMLL YL+ ++ P+ +
Sbjct: 241 AAYAAAFKNLRPSAEDLPGDLEMIVTSCWKEDPNERPNFTEIIQMLLRYLTTVSAPQIIP 300
Query: 301 P--HRIFNSENTILPPESPGTSSLMTVRD-DIG-ETPK-AKMGDKP-KSLFF 346
P R+F+SEN +L PESPGT SLM+VRD D+ +T A +K K FF
Sbjct: 301 PPNRRVFSSENIVLSPESPGTCSLMSVRDGDVSRQTVNTADSSEKQTKGSFF 352
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
Identities = 197/297 (66%), Positives = 241/297 (81%)
Query: 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFARE 74
++ L+DPK LF+G +IGEGAH KVY+G+Y Q VAIK+V++G P++ + ESRF RE
Sbjct: 7 IEESLLVDPKLLFIGSKIGEGAHGKVYQGRYGRQIVAIKVVNRGSKPDQQSSLESRFVRE 66
Query: 75 VAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
V M+SRVQH NLVKFIGACK+P+MVIVTELL G +LRKYL ++RP+ L + +A+ FALDI
Sbjct: 67 VNMMSRVQHHNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDI 126
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAP 194
ARA+ CLH++GIIHRDLKP+NLLLTE+ K++KLADFGLAREES+TEMMTAETGTYRWMAP
Sbjct: 127 ARALHCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAP 186
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-S 253
ELYSTVTLRQGEKKHYN+KVD YSF IVLWELL N++PFEGMSNLQAAYAAAFK RP
Sbjct: 187 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPVM 246
Query: 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM-IPHRIFNSEN 309
E + L+ I+ SCW EDPN RP+F+QII++L +L + PP P +P N N
Sbjct: 247 PEGISPSLAFIVQSCWVEDPNMRPSFSQIIRLLNEFLLTLTPPPPQPLPETATNRTN 303
|
|
| TAIR|locus:2173674 AT5G66710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 779 (279.3 bits), Expect = 2.1e-77, P = 2.1e-77
Identities = 166/331 (50%), Positives = 224/331 (67%)
Query: 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAR 73
++ + L+D K + +G IGEG+ + VY G ++ V++KI T ++ +F R
Sbjct: 60 INTELLVDVKDISIGDFIGEGSSSTVYRGLFRRVVPVSVKIFQPKRTSALSIEQRKKFQR 119
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
EV +LS+ +H N+V+FIGAC EP ++I+TEL+ G TL+K++L++RP+ LD+ ++I FALD
Sbjct: 120 EVLLLSKFRHENIVRFIGACIEPKLMIITELMEGNTLQKFMLSVRPKPLDLKLSISFALD 179
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
IAR ME L+++GIIHRDLKP N+LLT D K +KLADFGLAREE+ MT E GTYRWMA
Sbjct: 180 IARGMEFLNANGIIHRDLKPSNMLLTGDQKHVKLADFGLAREET-KGFMTFEAGTYRWMA 238
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253
PEL+S TL GEKKHY+HKVD YSFAIV WELL NK PF+G +N+ AYAA+ KN RPS
Sbjct: 239 PELFSYDTLEIGEKKHYDHKVDVYSFAIVFWELLTNKTPFKGKNNIFVAYAAS-KNQRPS 297
Query: 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILP 313
EN+PE + IL SCW E+P+ARP F +I L N L +++ NS+ I
Sbjct: 298 VENLPEGVVSILQSCWAENPDARPEFKEITYSLTNLLRSLSSDTDATSS---NSKANIAT 354
Query: 314 PESPGTSSLMTVRDDIGETPKAKMGDKPKSL 344
+S TSSL+ R + + P KM K K L
Sbjct: 355 EDS--TSSLVQERV-VCDCPGLKMS-KTKKL 381
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 687 (246.9 bits), Expect = 1.2e-67, P = 1.2e-67
Identities = 135/272 (49%), Positives = 186/272 (68%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESR 70
+ + + L++PK + G IGEG ++ VY+G+ KN VA+KIV G+T + + +
Sbjct: 34 DFNISRELLLNPKDIMRGEMIGEGGNSIVYKGRLKNIVPVAVKIVQPGKTSAVSIQDKQQ 93
Query: 71 FAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
F +EV +LS ++H N+V+F+GAC EP ++IVTEL+ GGTL++++LN RP LD+ V++ F
Sbjct: 94 FQKEVLVLSSMKHENIVRFVGACIEPQLMIVTELVRGGTLQRFMLNSRPSPLDLKVSLSF 153
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
ALDI+RAME LHS GIIHRDL P N+L+T D+K +KLADFGLARE++L M T E GTYR
Sbjct: 154 ALDISRAMEYLHSKGIIHRDLNPRNVLVTGDMKHVKLADFGLAREKTLGGM-TCEAGTYR 212
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250
WMAPE+ S LR GEKKHY+ K+D YSFA++ W LL NK PF + ++ Y +
Sbjct: 213 WMAPEVCSREPLRIGEKKHYDQKIDVYSFALIFWSLLTNKTPFSEIPSISIPYFVN-QGK 271
Query: 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQI 282
RPS N+P+E+ IL CW D R F I
Sbjct: 272 RPSLSNIPDEVVPILECCWAADSKTRLEFKDI 303
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 6.4e-60, P = 6.4e-60
Identities = 126/273 (46%), Positives = 182/273 (66%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGE-TPEEIAKKESRFAREVA 76
+W ID + L +GP +GA K+Y+G Y + VAIKI+ + E +PE+ E +F +EV+
Sbjct: 122 EWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQFQQEVS 181
Query: 77 MLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
ML+ ++H N+V+FIGAC++P V IVTE GG++R++L + R + + +A+ ALD+A
Sbjct: 182 MLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 241
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
R M +H IHRDLK +NLL++ D K+IK+ADFG+AR E TE MT ETGTYRWMAPE
Sbjct: 242 RGMAYVHGRNFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 300
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 255
+ + + YN KVD YSF IVLWEL+ LPF+ M+ +QAA+A + VRP+
Sbjct: 301 MI--------QHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVP 352
Query: 256 N--VPEELSIILTSCWKEDPNARPNFTQIIQML 286
N +P LS I+T CW +P RP F +++++L
Sbjct: 353 NDCLPV-LSDIMTRCWDANPEVRPCFVEVVKLL 384
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 8.4e-58, P = 8.4e-58
Identities = 123/273 (45%), Positives = 178/273 (65%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET-PEEIAKKESRFAREVA 76
+W ID + L +GP +GA K+Y G Y + VAIK++ + ++ PE+ E +F +EV+
Sbjct: 123 EWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQFQQEVS 182
Query: 77 MLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
ML+ ++H N+V+FIGAC +P V IVTE GG++R++L + R + + +A+ ALD+A
Sbjct: 183 MLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVA 242
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
R M +H IHRDLK +NLL++ D ++IK+ADFG+AR E TE MT ETGTYRWMAPE
Sbjct: 243 RGMAYVHERNFIHRDLKSDNLLISAD-RSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 301
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 253
+ + + Y KVD YSF IVLWEL+ LPF+ M+ +QAA+A + VRP+
Sbjct: 302 MI--------QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVP 353
Query: 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
A+ +P L I+T CW DP RP F +I+ +L
Sbjct: 354 ADCLPV-LGEIMTRCWDADPEVRPCFAEIVNLL 385
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 3.8e-53, P = 3.8e-53
Identities = 109/271 (40%), Positives = 171/271 (63%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI---AKKESRFAREVAM 77
+D LF G + G ++++Y GKY+++ VA+K++ + + A+ E +F +EV +
Sbjct: 202 VDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQFTKEVTL 261
Query: 78 LSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
LSR+ H N++KF+GA K+P V ++T+ L G+LR +L R L + I FA+DIAR
Sbjct: 262 LSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIAR 321
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
ME +HS IIHRDLKPEN+L+ E+ +K+ADFG+A EE +M+ + GTYRWMAPE+
Sbjct: 322 GMEYIHSRRIIHRDLKPENVLIDEEFH-LKIADFGIACEEEYCDMLADDPGTYRWMAPEM 380
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE- 255
++K + K D YSF +VLWE++ +P+E M+ +QAA+A KN+RP+
Sbjct: 381 I--------KRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPG 432
Query: 256 NVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+ P + ++ CW P+ RP F QI+++L
Sbjct: 433 DCPVAMKALIEQCWSVAPDKRPEFWQIVKVL 463
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 2.1e-52, P = 2.1e-52
Identities = 119/270 (44%), Positives = 174/270 (64%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
W I+ KHL G +I G++ +Y+G Y +Q VAIK++ K E + +KE FA+EV ++
Sbjct: 283 WEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVL-KPERLDSDLEKE--FAQEVFIM 339
Query: 79 SRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+V+H+N+V+FIGAC K P + IVTE + GG++ YL + + + A+DI +
Sbjct: 340 RKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYL-HKQKGVFKLPTLFKVAIDICKG 398
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 197
M LH + IIHRDLK NLL+ E+ + +K+ADFG+AR ++ T +MTAETGTYRWMAPE+
Sbjct: 399 MSYLHQNNIIHRDLKAANLLMDEN-EVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVI 457
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-EN 256
E K Y+HK D +S+ IVLWELL KLP+E M+ LQAA K +RP+ +N
Sbjct: 458 --------EHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKN 509
Query: 257 VPEELSIILTSCWKEDPNARPNFTQIIQML 286
+L+ +L W+ D RP+F++II+ L
Sbjct: 510 THPKLAELLERLWEHDSTQRPDFSEIIEQL 539
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00015979001 | SubName- Full=Putative uncharacterized protein (Chromosome chr17 scaffold_12, whole genome shotgun sequence); (352 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 352 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-74 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-73 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-69 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-68 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-65 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-61 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-46 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-45 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-44 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-42 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-41 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-41 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-40 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-39 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-38 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-38 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-38 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-38 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-38 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-37 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-36 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-36 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-36 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-36 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-35 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-34 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-34 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-33 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-33 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-33 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-32 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-32 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-32 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-32 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-32 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-32 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-31 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-31 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-31 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-30 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-30 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-29 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-28 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-28 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-28 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-28 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-28 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-28 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-28 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-27 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-27 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-27 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-26 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-26 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-24 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-23 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-23 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-22 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-21 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-20 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-19 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-18 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-18 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-18 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-17 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-16 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-16 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-15 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-11 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 5e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-09 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 8e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-05 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.004 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 4e-74
Identities = 94/266 (35%), Positives = 145/266 (54%), Gaps = 25/266 (9%)
Query: 32 IGEGAHAKVYEGKYKN------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEGA +VY+G K VA+K + + + ++I + F RE ++ ++ H N
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE----FLREARIMRKLDHPN 62
Query: 86 LVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
+VK +G C +EP+M IV E + GG L YL RP+ L + + FAL IAR ME L S
Sbjct: 63 IVKLLGVCTEEEPLM-IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG--TYRWMAPELYSTVT 201
IHRDL N L+ E+ +K++DFGL+R+ + + G RWMAPE +
Sbjct: 122 KNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE-----S 175
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260
L++G+ + K D +SF ++LWE+ + P+ GMSN + P N P E
Sbjct: 176 LKEGK---FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPE 232
Query: 261 LSIILTSCWKEDPNARPNFTQIIQML 286
L ++ CW EDP RP F++++++L
Sbjct: 233 LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 1e-73
Identities = 92/267 (34%), Positives = 144/267 (53%), Gaps = 28/267 (10%)
Query: 32 IGEGAHAKVYEGKYKN------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEGA +VY+GK K VA+K + + + ++I + F RE ++ ++ H N
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE----FLREARIMRKLDHPN 62
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--IGFALDIARAMECLH 142
+VK +G C +E + IV E + GG L YL RP+ + ++ + FAL IAR ME L
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGMEYLE 119
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG--TYRWMAPELYSTV 200
S IHRDL N L+ E+ +K++DFGL+R+ + G RWMAPE
Sbjct: 120 SKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE----- 173
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259
+L++G+ + K D +SF ++LWE+ + P+ GMSN + P N P
Sbjct: 174 SLKEGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP 230
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQML 286
EL ++ CW EDP RP F++++++L
Sbjct: 231 ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 7e-69
Identities = 89/268 (33%), Positives = 139/268 (51%), Gaps = 29/268 (10%)
Query: 32 IGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEGA +VY+G K VA+K + +G + EE + F E +++ ++ H N
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE----FLEEASIMKKLSHPN 62
Query: 86 LVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
+V+ +G C EP+ IVTE + GG L +L L + + AL IA+ ME L S
Sbjct: 63 IVRLLGVCTQGEPLY-IVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTV 200
+HRDL N L+TE+L +K++DFGL+R+ + G +WMAPE
Sbjct: 121 KNFVHRDLAARNCLVTENL-VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES---- 175
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSA-ENVP 258
L+ G+ + K D +SF ++LWE+ + P+ GMSN + R EN P
Sbjct: 176 -LKDGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-LELLEDGYRLPRPENCP 230
Query: 259 EELSIILTSCWKEDPNARPNFTQIIQML 286
+EL ++ CW DP RP F+++++ L
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 214 bits (548), Expect = 2e-68
Identities = 87/260 (33%), Positives = 127/260 (48%), Gaps = 21/260 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG+ KVY + K + VAIK++ K ++I K R RE+ +L +++H N+V+
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKK----KKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 90 IGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
++ + +V E GG L L L A + I A+E LHS GI+H
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 208
RDLKPEN+LL ED +KLADFGLAR+ E +T GT +MAPE+ K
Sbjct: 121 RDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL--------GK 171
Query: 209 HYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRPSAENVPEELSIIL 265
Y VD +S ++L+ELL K PF G L + K P ++ E ++
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI 231
Query: 266 TSCWKEDPNARPNFTQIIQM 285
+DP R + +Q
Sbjct: 232 RKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 1e-65
Identities = 90/275 (32%), Positives = 144/275 (52%), Gaps = 36/275 (13%)
Query: 32 IGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+GEGA +VY+GK K VA+K + + + EE F +E ++ ++ H N+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD----FLKEARVMKKLGHPNV 58
Query: 87 VKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRP-------RCLDVCVAIGFALDIARA 137
V+ +G C +EP+ +V E + GG L YL RP L + + FA+ IA+
Sbjct: 59 VRLLGVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAP 194
ME L S +HRDL N L+ ED +K++DFGL+R+ + +TG RWMAP
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQ--AAYAAAFKNVR 251
E +L+ G + K D +SF ++LWE+ P+ G+SN + ++ +
Sbjct: 177 E-----SLKDG---IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK 228
Query: 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
P E P+EL ++ SCW+ DP RP F+++++ L
Sbjct: 229 P--EYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 5e-61
Identities = 79/259 (30%), Positives = 120/259 (46%), Gaps = 48/259 (18%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG VY + K + VAIKI+ K E+ + RE+ +L ++ H N+VK
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56
Query: 90 IGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
G + E + +V E GG+L+ L L + L I +E LHS+GIIH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 149 RDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
RDLKPEN+LL D +KLADFGL++ S ++ GT +MAPE+ K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL-------GK 168
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 267
+Y+ K D +S ++L+EL EL ++
Sbjct: 169 GYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRK 196
Query: 268 CWKEDPNARPNFTQIIQML 286
++DP RP+ +I++ L
Sbjct: 197 MLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 1e-60
Identities = 96/268 (35%), Positives = 142/268 (52%), Gaps = 25/268 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ ++G G+ VY+ K+K + VA+KI+ K E +KK+ RE+ +L R+ H N
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK---RSEKSKKDQTARREIRILRRLSHPN 59
Query: 86 LVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V+ I A ++ + +V E GG L YL R L A AL I R +E LHS+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLR 203
GIIHRDLKPEN+LL E+ +K+ADFGLA++ + +T GT +MAPE+ L
Sbjct: 118 GIIHRDLKPENILLDENG-VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV-----LL 171
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-------N 256
G Y KVD +S ++L+ELL K PF G N+ + + P E +
Sbjct: 172 GG--NGYGPKVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSS 228
Query: 257 VPEELSIILTSCWKEDPNARPNFTQIIQ 284
EE ++ C +DP+ RP +I+Q
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-46
Identities = 81/266 (30%), Positives = 124/266 (46%), Gaps = 24/266 (9%)
Query: 29 GPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
G +G G+ VY K+ + +A+K V E + ++ RE+ +LS +QH N+
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSV---ELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 87 VKFIGAC--KEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
V++ G+ +E + I E +SGG+L LL + L V + I + LHS
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGK-LPEPVIRKYTRQILEGLAYLHS 119
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYSTV 200
+GI+HRD+K N+L+ D +KLADFG A+ E GT WMAPE+
Sbjct: 120 NGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV---- 174
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA-YAAAFKNVRPS-AENVP 258
+R E Y D +S + E+ K P+ + N AA Y P E++
Sbjct: 175 -IRGEE---YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLS 230
Query: 259 EELSIILTSCWKEDPNARPNFTQIIQ 284
EE L C + DP RP +++Q
Sbjct: 231 EEAKDFLRKCLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 91/277 (32%), Positives = 143/277 (51%), Gaps = 33/277 (11%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
W I+ K L +G IG+G V G Y+ Q VA+K + ++ + F E +++
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCL------KDDSTAAQAFLAEASVM 54
Query: 79 SRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA---IGFALD 133
+ ++H NLV+ +G P+ IVTE ++ G+L YL R R V +GFALD
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALD 110
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RW 191
+ ME L +HRDL N+L++EDL K++DFGLA+E S + ++G +W
Sbjct: 111 VCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ----DSGKLPVKW 165
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNV 250
APE LR +K ++ K D +SF I+LWE+ ++P+ + L+ K
Sbjct: 166 TAPE-----ALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPHVEKGY 216
Query: 251 R-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
R + E P E+ ++ CW+ DP RP F Q+ + L
Sbjct: 217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 7e-44
Identities = 91/280 (32%), Positives = 141/280 (50%), Gaps = 37/280 (13%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLS 79
IDP L +G G V+ GK++ + VAIK++ +G E+ F E ++
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED------DFIEEAKVMM 54
Query: 80 RVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPR-----CLDVCVAIGFALD 133
++ H NLV+ G C K+ + IVTE ++ G L YL + + LD+C D
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC------SD 108
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ AME L S+G IHRDL N L+ ED +K++DFGLAR L + T+ GT +
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLAR-YVLDDQYTSSQGTKFPVK 166
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAA--YAAAF 247
W PE++ ++ K D +SF +++WE+ K+P+E SN + +A +
Sbjct: 167 WAPPEVFD--------YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY 218
Query: 248 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287
+ RP P E+ I+ SCW E P RP F +++ L
Sbjct: 219 RLYRPKL--APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 92/264 (34%), Positives = 131/264 (49%), Gaps = 24/264 (9%)
Query: 31 RIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+IG+G VY+G K T VA+K P+ K F +E +L + H N+VK
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK----FLQEAEILKQYDHPNIVKL 57
Query: 90 IGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
IG C K+P+ IV EL+ GG+L +L + R L V + +LD A ME L S I
Sbjct: 58 IGVCVQKQPIY-IVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT----YRWMAPELYSTVTLR 203
HRDL N L+ E+ +K++DFG++REE + T G +W APE L
Sbjct: 116 HRDLAARNCLVGEN-NVLKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAPE-----ALN 168
Query: 204 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 262
G Y + D +S+ I+LWE P+ GMSN Q P+ + PEE+
Sbjct: 169 YGR---YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIY 225
Query: 263 IILTSCWKEDPNARPNFTQIIQML 286
++ CW DP RP+F++I L
Sbjct: 226 RLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 9e-42
Identities = 84/262 (32%), Positives = 139/262 (53%), Gaps = 26/262 (9%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG+G +VY+ ++K + VAIK++ E +K+ + E+ +L + +H N+VK
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVI-----KLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 89 FIGA--CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-ALDIARAMECLHSHG 145
+ G+ K+ + IV E SGG+L+ LL + L I + ++ + +E LHS+G
Sbjct: 62 YYGSYLKKDELW-IVMEFCSGGSLKD-LLKSTNQTLTES-QIAYVCKELLKGLEYLHSNG 118
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 205
IIHRD+K N+LLT D + +KL DFGL+ + S T+ GT WMAPE+ +
Sbjct: 119 IIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN------- 170
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---SAENVPEELS 262
K Y++K D +S I EL K P+ + ++A + A N P + E +E
Sbjct: 171 -GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-TNGPPGLRNPEKWSDEFK 228
Query: 263 IILTSCWKEDPNARPNFTQIIQ 284
L C +++P RP Q+++
Sbjct: 229 DFLKKCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-41
Identities = 87/264 (32%), Positives = 135/264 (51%), Gaps = 23/264 (8%)
Query: 23 PKHLF-VGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLSR 80
P+ F + ++G G +V+EG +KN+ VAIKI+ + K+ F +EV L R
Sbjct: 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS-----DDLLKQQDFQKEVQALKR 58
Query: 81 VQHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
++H++L+ C EPV I+TEL+ G+L +L + + L V I A +A M
Sbjct: 59 LRHKHLISLFAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT-YRWMAPELY 197
L IHRDL N+L+ EDL K+ADFGLAR ++++ Y+W APE
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAE 255
S ++ K D +SF I+L+E+ + ++P+ GM+N Y R P
Sbjct: 177 S--------HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQITAGYRMPCPA 227
Query: 256 NVPEELSIILTSCWKEDPNARPNF 279
P+E+ I+ CW +P RP+F
Sbjct: 228 KCPQEIYKIMLECWAAEPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 9e-41
Identities = 86/272 (31%), Positives = 143/272 (52%), Gaps = 25/272 (9%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
WL++ + L +G IGEG V +G+Y Q VA+K + T + F E A++
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA-------FLEETAVM 53
Query: 79 SRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
+++ H+NLV+ +G + IV EL+S G L +L + V + F+LD+A M
Sbjct: 54 TKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPEL 196
E L S ++HRDL N+L++ED K++DFGLAR S M + +W APE
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGS----MGVDNSKLPVKWTAPE- 167
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSA 254
L+ + ++ K D +S+ ++LWE+ + + P+ MS L+ K R
Sbjct: 168 ----ALKHKK---FSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEPP 219
Query: 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
E P ++ +++TSCW+ +P RP+F ++ + L
Sbjct: 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 8e-40
Identities = 88/271 (32%), Positives = 138/271 (50%), Gaps = 30/271 (11%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGE-TPEEIAKKESRFAREVA 76
W ID + + ++G G +V+EG + N T VA+K + G P++ F E
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD-------FLAEAQ 53
Query: 77 MLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
++ +++H L++ C +EP+ IVTEL+ G+L +YL R L + I A +
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWM 192
A M L + IHRDL N+L+ E+ K+ADFGLAR +E + E +W
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 193 APE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKN 249
APE LY+ ++ K D +SF I+L E++ + ++P+ GM+N + +
Sbjct: 172 APEAALYNRFSI----------KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QG 220
Query: 250 VR-PSAENVPEELSIILTSCWKEDPNARPNF 279
R P P+EL I+ CWKEDP+ RP F
Sbjct: 221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 81/291 (27%), Positives = 138/291 (47%), Gaps = 35/291 (12%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRF 71
W + + + + +G+G+ VYEG K VAIK V++ + E + F
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE----F 56
Query: 72 AREVAMLSRVQHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV--- 126
E +++ ++V+ +G +P +V++ EL++ G L+ YL + RP +
Sbjct: 57 LNEASVMKEFNCHHVVRLLGVVSTGQPTLVVM-ELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 127 -----AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
I A +IA M L + +HRDL N ++ EDL T+K+ DFG+ R+ T+
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDY 174
Query: 182 MTAETGTY---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS 237
RWMAPE +L+ G + K D +SF +VLWE+ + P++G+S
Sbjct: 175 YRKGGKGLLPVRWMAPE-----SLKDG---VFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226
Query: 238 NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288
N + EN P++L ++ CW+ +P RP F +I+ L +
Sbjct: 227 NEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-38
Identities = 93/309 (30%), Positives = 147/309 (47%), Gaps = 56/309 (18%)
Query: 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIA 65
L LD +W + L +G +GEGA +V + + + TVA+K++ T +++
Sbjct: 1 LPLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL- 59
Query: 66 KKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPR-- 120
S E+ M+ + +H+N++ +G C + P+ V+V E + G LR +L RP
Sbjct: 60 ---SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGE 115
Query: 121 --CLDVCVAIG----------FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168
D FA +AR ME L S IHRDL N+L+TED +K+A
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKIA 174
Query: 169 DFGLAREESLTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224
DFGLAR+ + T +WMAPE L+ V Y H+ D +SF ++LW
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLLW 225
Query: 225 ELL------HNKLPFEGM-SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 277
E+ + +P E + L+ Y + +P N +EL ++ CW E P+ RP
Sbjct: 226 EIFTLGGSPYPGIPVEELFKLLKEGY----RMEKPQ--NCTQELYHLMRDCWHEVPSQRP 279
Query: 278 NFTQIIQML 286
F Q+++ L
Sbjct: 280 TFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 78/267 (29%), Positives = 129/267 (48%), Gaps = 32/267 (11%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVH-KGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG+G+ KVY K + +K + + +E ++++ EV +L ++ H N++K
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE--REDAL--NEVKILKKLNHPNIIK 63
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRC--------LDVCVAIGFALDIARAME 139
+ + +E + IV E GG L + + + LD V + AL
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK------ 117
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYS 198
LHS I+HRD+KP+N+ LT + +KL DFG+++ S ++ GT +++PEL
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC- 175
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258
+ K YN+K D +S VL+EL K PFEG + L+ A P
Sbjct: 176 -------QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYS 228
Query: 259 EELSIILTSCWKEDPNARPNFTQIIQM 285
EL +++S ++DP RP+ QI+Q
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 85/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEG-----KYKNQTVAIKIVHKGETPEEIAKKESRFAREV 75
IDP ++ + IG G +V G K VAIK + G + K+ F E
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD----KQRLDFLTEA 56
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+++ + H N+++ G PVM I+TE + G+L K+L + V +G
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVM-IITEYMENGSLDKFLRENDGK-FTVGQLVGMLRG 114
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---- 189
IA M+ L +HRDL N+L+ +L K++DFGL+R +E TY
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDSE------ATYTTKG 167
Query: 190 -----RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAY 243
RW APE + R + D +SF IV+WE++ + + P+ MSN Q
Sbjct: 168 GKIPIRWTAPE---AIAYR-----KFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVI 218
Query: 244 AAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290
A R P + P L ++ CW++D N RP F+QI+ L +
Sbjct: 219 KAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-38
Identities = 79/277 (28%), Positives = 123/277 (44%), Gaps = 39/277 (14%)
Query: 31 RIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G G V +G Y K VA+K + E IA + F RE ++++++ H
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK----QEHIAAGKKEFLREASVMAQLDHPC 57
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--IGFALDIARAMECLHS 143
+V+ IG CK +++V EL G L KYL R ++ V+ A +A M L S
Sbjct: 58 IVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES 113
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL---TEMMTAETG---TYRWMAPEL- 196
+HRDL N+LL K++DFG++R +L ++ A T +W APE
Sbjct: 114 KHFVHRDLAARNVLLVNR-HQAKISDFGMSR--ALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 197 -YSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PS 253
Y ++ K D +S+ + LWE + P+ M + A R P
Sbjct: 171 NYGK----------FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGERLPR 219
Query: 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290
E P+E+ I+ SCWK P RP F+++
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 6e-38
Identities = 89/273 (32%), Positives = 136/273 (49%), Gaps = 34/273 (12%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGE-TPEEIAKKESRFAREVA 76
W I + L + ++G G +V+ G + T VA+K + G +PE F +E
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-------FLQEAQ 53
Query: 77 MLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
++ +++H LV+ C +EP+ IVTE +S G+L +L + + L + + A I
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI 112
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRW 191
A M L S IHRDL N+L+ E+L K+ADFGLAR E TA G +W
Sbjct: 113 AEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDEY-TAREGAKFPIKW 170
Query: 192 MAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQ--AAYAAA 246
APE Y T+ K D +SF I+L E++ + ++P+ GM+N +
Sbjct: 171 TAPEAANYGRFTI----------KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220
Query: 247 FKNVRPSAENVPEELSIILTSCWKEDPNARPNF 279
++ RP N PEEL ++ CW +DP RP F
Sbjct: 221 YRMPRPP--NCPEELYDLMLQCWDKDPEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 93/268 (34%), Positives = 135/268 (50%), Gaps = 29/268 (10%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
RIG G +V+ G+ + N VA+K + P+ AK F +E +L + H N+V+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK----FLQEARILKQYSHPNIVR 57
Query: 89 FIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
IG C K+P+ IV EL+ GG +L PR L V I + A ME L S
Sbjct: 58 LIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKHC 115
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR-----WMAPELYSTVT 201
IHRDL N L+TE +K++DFG++REE + + A TG + W APE
Sbjct: 116 IHRDLAARNCLVTEK-NVLKISDFGMSREEE--DGVYASTGGMKQIPVKWTAPE-----A 167
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 259
L G Y+ + D +SF I+LWE +P+ +SN Q A + VR P E P+
Sbjct: 168 LNYGR---YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPD 223
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQMLL 287
+ ++ CW+ DP RP+F+ + Q L
Sbjct: 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 137 bits (344), Expect = 4e-37
Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 24/272 (8%)
Query: 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNL 86
+ ++GEG+ +VY + + VA+K++ K + K+ RF RE+ +L+ + H N+
Sbjct: 4 ILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNI 60
Query: 87 VKFIGACKEP-VMVIVTELLSGGTLRKYL-LNMRPRCLDVCVAIGFALDIARAMECLHSH 144
VK ++ + +V E + GG+L L R L A+ I A+E LHS
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLARE-------ESLTEMMTAETGTYRWMAPELY 197
GIIHRD+KPEN+LL D + +KL DFGLA+ S+ + + GT +MAPE+
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV- 179
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257
L + + D +S I L+ELL PFEG N A + ++
Sbjct: 180 ----LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 258 PEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289
LS + +++ LL
Sbjct: 236 ASPLS------PSNPELISKAASDLLKKLLAK 261
|
Length = 384 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 85/278 (30%), Positives = 132/278 (47%), Gaps = 41/278 (14%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQ-TVAIKIVHKGETPEEIAKKESRFAREVAMLS 79
IDPK L +G G V GK++ Q VAIK++ +G E+ F E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED------EFIEEAKVMM 54
Query: 80 RVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPR-----CLDVCVAIGFALD 133
++ H LV+ G C K+ + IVTE +S G L YL R L++C D
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------D 108
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ M L S IHRDL N L+ + +K++DFGL+R L + T+ G+ R
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSR-YVLDDEYTSSVGSKFPVR 166
Query: 191 WMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA--YAA 245
W PE LYS ++ K D ++F +++WE+ K+P+E +N + +
Sbjct: 167 WSPPEVLLYSK----------FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
Query: 246 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQII 283
+ RP + E++ I+ SCW E RP F Q++
Sbjct: 217 GLRLYRPHLAS--EKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 78/287 (27%), Positives = 138/287 (48%), Gaps = 30/287 (10%)
Query: 10 ADELKLDAKWLI---DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE 63
+ELK K ++ DP+ L+ +IGEGA +VY+ + + VAIK + +
Sbjct: 1 EEELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK---- 56
Query: 64 IAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCL 122
+ + E+ ++ +H N+V + + + +V E + GG+L ++ +
Sbjct: 57 --QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRM 113
Query: 123 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180
+ ++ + +E LHS +IHRD+K +N+LL++D ++KLADFG A + LT+
Sbjct: 114 NEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQ--LTKEK 170
Query: 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
+ GT WMAPE+ +K Y KVD +S I+ E+ + P+ L
Sbjct: 171 SKRNSVVGTPYWMAPEVIK--------RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL 222
Query: 240 QAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+A + K + P + E E L C +DP RP+ +++Q
Sbjct: 223 RALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 79/263 (30%), Positives = 123/263 (46%), Gaps = 22/263 (8%)
Query: 32 IGEGAHAKVYEGKYKNQ-----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
IGEG VY+G Y + VA+K +P + +E +F +E ++ + H ++
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP---SVRE-KFLQEAYIMRQFDHPHI 69
Query: 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
VK IG E + IV EL G LR YL + LD+ I ++ ++ A+ L S
Sbjct: 70 VKLIGVITENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLESKRF 128
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTVTLRQ 204
+HRD+ N+L++ +KL DFGL+R A G +WMAPE ++ R+
Sbjct: 129 VHRDIAARNVLVS-SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE---SINFRR 184
Query: 205 GEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 263
+ D + F + +WE+L PF+G+ N P N P L
Sbjct: 185 -----FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239
Query: 264 ILTSCWKEDPNARPNFTQIIQML 286
++T CW DP+ RP FT++ L
Sbjct: 240 LMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-36
Identities = 83/284 (29%), Positives = 144/284 (50%), Gaps = 37/284 (13%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA 76
W ++ + + ++G G + +VYEG +K + TVA+K T +E + F +E A
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK------TLKEDTMEVEEFLKEAA 54
Query: 77 MLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
++ ++H NLV+ +G C +EP I+TE ++ G L YL + ++ V + A I+
Sbjct: 55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT------- 188
AME L IHRDL N L+ E+ +K+ADFGL+R +MT +T T
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSR------LMTGDTYTAHAGAKF 167
Query: 189 -YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL-LHNKLPFEG--MSNLQAAYA 244
+W APE + ++ K D ++F ++LWE+ + P+ G +S +
Sbjct: 168 PIKWTAPESLAYNK--------FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
Query: 245 AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288
++ RP E P ++ ++ +CW+ +P+ RP+F +I Q
Sbjct: 220 KGYRMERP--EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 86/280 (30%), Positives = 139/280 (49%), Gaps = 36/280 (12%)
Query: 32 IGEGAHAKVYEGKYKN--------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH 83
+G GA +VYEG + VA+K + KG T +E + F +E ++S H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE----FLKEAHLMSNFNH 58
Query: 84 RNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIAR 136
N+VK +G C EP +I+ EL+ GG L YL + R P L + + LD+A+
Sbjct: 59 PNIVKLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDL----KTIKLADFGLAREESLTEMMTAETG---TY 189
L IHRDL N L++E + +K+ DFGLAR+ ++ E
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 190 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK 248
RWMAPE +L G+ + + D +SF +++WE+L + P+ ++N +
Sbjct: 178 RWMAPE-----SLLDGK---FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229
Query: 249 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288
EN P+++ ++T+CW +DP+ RP F +I ++L N
Sbjct: 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 72/277 (25%), Positives = 119/277 (42%), Gaps = 42/277 (15%)
Query: 31 RIGEGAHAKVYEGKYKNQT-----VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
++G+G+ V G++ VA+K + ++++ F +E A++ + H N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCL----KSDKLSDIMDDFLKEAAIMHSLDHEN 57
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLD---VCVAIGFALDIARAMECLH 142
L++ G +++VTEL G+L L +R L + +A+ IA M L
Sbjct: 58 LIRLYGVVLTHPLMMVTELAPLGSL---LDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR----------WM 192
S IHRDL N+LL D +K+ DFGL R E Y W
Sbjct: 115 SKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDH------YVMEEHLKVPFAWC 167
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR 251
APE T T ++H D + F + LWE+ + + P+ G+S Q + R
Sbjct: 168 APESLRTRT--------FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER 219
Query: 252 -PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287
E P+++ ++ CW +P RP F + + L
Sbjct: 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 83/251 (33%), Positives = 125/251 (49%), Gaps = 22/251 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G+G+ KV + K + A+K++ K + I +KE E +LSR+ H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK---IIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 89 FIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + + +V E GG L +L + A +A +I A+E LHS GII
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
+RDLKPEN+LL D IKL DFGLA+E S +E T GT ++APE V L +G
Sbjct: 116 YRDLKPENILLDAD-GHIKLTDFGLAKELS-SEGSRTNTFCGTPEYLAPE----VLLGKG 169
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 265
Y VD +S ++L+E+L K PF + + Y K+ E + E ++
Sbjct: 170 ----YGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPLRFPEFLSPEARDLI 224
Query: 266 TSCWKEDPNAR 276
+ ++DP R
Sbjct: 225 SGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 7e-34
Identities = 87/279 (31%), Positives = 128/279 (45%), Gaps = 43/279 (15%)
Query: 32 IGEGAHAKVYEG-------KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+GEGA KVY+G + +VAIK + + P K + F +E ++S +QH
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP----KVQQEFRQEAELMSDLQHP 68
Query: 85 NLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIG 129
N+V +G C KE ++ E L+ G L ++L+ P LD +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAET 186
A+ IA ME L SH +HRDL N L+ E L T+K++DFGL+R+ + +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 187 GTYRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAY 243
RWM PE LY T D +SF +VLWE+ L P+ G SN +
Sbjct: 188 LPVRWMPPEAILYGKFTTES----------DIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237
Query: 244 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 282
+ + P E+ P + ++ CW E P RP F I
Sbjct: 238 MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 84/282 (29%), Positives = 138/282 (48%), Gaps = 43/282 (15%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
W ++ K L + IG+G V G Y+ VA+K + T + F E +++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-------FLAEASVM 53
Query: 79 SRVQHRNLVKFIGACKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
++++H NLV+ +G E + IVTE ++ G+L YL + L + F+LD+
Sbjct: 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAP 194
AME L ++ +HRDL N+L++ED K++DFGL +E S T+ +TG +W AP
Sbjct: 114 AMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ----DTGKLPVKWTAP 168
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 253
E LR+ K ++ K D +SF I+LWE+ ++P+ + K+V P
Sbjct: 169 E-----ALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRI---------PLKDVVPR 211
Query: 254 AEN---------VPEELSIILTSCWKEDPNARPNFTQIIQML 286
E P + ++ CW D RP+F Q+ + L
Sbjct: 212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-33
Identities = 87/283 (30%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 32 IGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+GEGA KV+ G+ + + VA+K + K + A+K+ F RE +L+ QH
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASND-ARKD--FEREAELLTNFQHE 68
Query: 85 NLVKFIGACKE---PVMVIVTELLSGGTLRKYL----------LNMRPRC--LDVCVAIG 129
N+VKF G C E P+MV E + G L K+L + L + +
Sbjct: 69 NIVKFYGVCTEGDPPIMVF--EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
A+ IA M L S +HRDL N L+ DL +K+ DFG++R+ T+ T
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 190 ---RWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAY 243
RWM PE +Y T D +SF +VLWE+ + K P+ G+SN +
Sbjct: 186 LPIRWMPPESIMYRKFTTES----------DVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235
Query: 244 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+ P E+ I+ CWK DP R N I + L
Sbjct: 236 CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-33
Identities = 78/274 (28%), Positives = 132/274 (48%), Gaps = 27/274 (9%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQ-TVAIKIVHKGETPEEIAKKESRFAREVAMLS 79
I+P L +G G V+ GK++ Q VAIK +++G A E F E ++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG------AMSEEDFIEEAKVMM 54
Query: 80 RVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
++ H LV+ G C ++ + IVTE + G L YL + + L + + D+ M
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGM 113
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE 195
E L + IHRDL N L++ +K++DFG+ R L + T+ +G +W PE
Sbjct: 114 EYLERNSFIHRDLAARNCLVS-STGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPE 171
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQA--AYAAAFKNVRP 252
+++ Y+ K D +SF +++WE+ K+PFE SN + + F+ RP
Sbjct: 172 VFNF--------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP 223
Query: 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+ ++ SCW E P RP F ++++ +
Sbjct: 224 KL--ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 6e-33
Identities = 86/277 (31%), Positives = 134/277 (48%), Gaps = 26/277 (9%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAM 77
W + + L + ++G G +V+ G Y T VAIK + +G E F E +
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA------FLAEANL 54
Query: 78 LSRVQHRNLVK-FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+ ++QH LV+ + +EP+ I+TE + G+L +L L + I A IA
Sbjct: 55 MKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAP 194
M + IHRDL+ N+L++E L K+ADFGLAR E E + +W AP
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172
Query: 195 EL--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR 251
E Y T T+ K D +SF I+L E++ + ++P+ GM+N +
Sbjct: 173 EAINYGTFTI----------KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM 222
Query: 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288
P +N PEEL ++ CWKE P RP F + ++ +L
Sbjct: 223 PRPDNCPEELYELMRLCWKEKPEERPTF-EYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 89/290 (30%), Positives = 136/290 (46%), Gaps = 29/290 (10%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYE----GKYKNQTVAIKIVHKGETPEEIAKK 67
+L D KW +L G +G GA KV E G K+ +K+ K P + +
Sbjct: 23 QLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSD-AVMKVAVKMLKPTAHSSE 81
Query: 68 ESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
E+ ++S + H N+V +GAC P++VI TE G L +L R L +
Sbjct: 82 REALMSELKIMSHLGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRKRESFLTL 140
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184
+ F+ +A+ M L S IHRDL N+LLT K +K+ DFGLAR+
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLARDIMNDSNYVV 199
Query: 185 ETGTY---RWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGM--- 236
+ +WMAPE +++ V Y + D +S+ I+LWE+ P+ GM
Sbjct: 200 KGNARLPVKWMAPESIFNCV---------YTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250
Query: 237 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
S ++ +P E+ P E+ I+ +CW DP RP F QI+Q++
Sbjct: 251 SKFYKLIKEGYRMAQP--EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 69/277 (24%), Positives = 131/277 (47%), Gaps = 38/277 (13%)
Query: 32 IGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+G G +V+ K K V +K + K T +E + E F RE+ M ++ H+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK--TKDENLQSE--FRRELDMFRKLSHK 68
Query: 85 NLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDV---------CVAIGFALD 133
N+V+ +G C EP ++ E G L+++L + + + VA+
Sbjct: 69 NVVRLLGLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL--CTQ 125
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE--MMTAETGTYRW 191
IA M+ L + +HRDL N L++ + +K++ L+++ +E + RW
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQRE-VKVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNV 250
+APE +++ + ++ K D +SF +++WE+ +LPF G+S+ + +
Sbjct: 185 LAPE-----AVQEDD---FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236
Query: 251 R-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
P E P L ++T CW +P RP+F++++ L
Sbjct: 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 2e-32
Identities = 85/278 (30%), Positives = 135/278 (48%), Gaps = 24/278 (8%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAM 77
W I + + + ++G G +V+ G Y N T VA+K + G + F E +
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA------FLEEANL 54
Query: 78 LSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+ +QH LV+ KE + I+TE ++ G+L +L + + + I F+ IA
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAP 194
M + IHRDL+ N+L++E L K+ADFGLAR E E + +W AP
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173
Query: 195 EL--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR 251
E + + T+ K D +SF I+L+E++ + K+P+ GMSN A
Sbjct: 174 EAINFGSFTI----------KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM 223
Query: 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289
P EN P+EL I+ +CWKE RP F + +L ++
Sbjct: 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-32
Identities = 83/260 (31%), Positives = 135/260 (51%), Gaps = 27/260 (10%)
Query: 32 IGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90
+G+G +V++G K++T VA+K K + P+E+ + +F E +L + H N+VK I
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTC-KEDLPQEL---KIKFLSEARILKQYDHPNIVKLI 58
Query: 91 GAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
G C ++P+ IV EL+ GG +L + L + FALD A M L S IH
Sbjct: 59 GVCTQRQPIY-IVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG----TYRWMAPELYSTVTLRQ 204
RDL N L+ E+ +K++DFG++R+E + + + +G +W APE L
Sbjct: 117 RDLAARNCLVGEN-NVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTAPE-----ALNY 168
Query: 205 GEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELS 262
G Y+ + D +S+ I+LWE P+ GM+N QA K R S + P+++
Sbjct: 169 GR---YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVY 224
Query: 263 IILTSCWKEDPNARPNFTQI 282
++ CW P RP F+++
Sbjct: 225 KVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 94/313 (30%), Positives = 147/313 (46%), Gaps = 50/313 (15%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVY---------EGKYKNQTVAIKIVHKGETPE 62
EL D +W + L +G +GEG +V E + VA+K++ T +
Sbjct: 6 ELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK 65
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRP 119
++ S E+ M+ + +H+N++ +GAC + P+ VIV E S G LR+YL RP
Sbjct: 66 DL----SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRP 120
Query: 120 RCLDVCV--------------AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
++ C + A +AR ME L S IHRDL N+L+TED +
Sbjct: 121 PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVM 179
Query: 166 KLADFGLAREESLTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAI 221
K+ADFGLAR+ + T +WMAPE L+ + Y H+ D +SF +
Sbjct: 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGV 230
Query: 222 VLWELLH-NKLPFEG--MSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 278
+LWE+ P+ G + L + +PS N EL +++ CW P+ RP
Sbjct: 231 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS--NCTNELYMMMRDCWHAVPSQRPT 288
Query: 279 FTQIIQMLLNYLS 291
F Q+++ L L+
Sbjct: 289 FKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLS 79
I P L + IG G V+ G + + VAIK + +G EE F E ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE------DFIEEAQVMM 54
Query: 80 RVQHRNLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
++ H LV+ G C E + +V E + G L YL R + +G LD+ M
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGM 113
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE 195
L S +IHRDL N L+ E+ + +K++DFG+ R L + T+ TGT +W +PE
Sbjct: 114 AYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE 171
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAA--YAAAFKNVRP 252
++S Y+ K D +SF +++WE+ K P+E SN + A F+ +P
Sbjct: 172 VFSF--------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP 223
Query: 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+ + ++ CWKE P RP+F+ ++ L
Sbjct: 224 RL--ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 7e-32
Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 20/251 (7%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRVQHRNLVK 88
IG+GA KV + + + A+K ++K + + K R E +L + H LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC---VEKGSVRNVLNERRILQELNHPFLVN 64
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ E M +V +LL GG LR +L + +I A+E LHS GII
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK--FSEEQVKFWICEIVLALEYLHSKGII 122
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
HRD+KP+N+LL E + + DF +A + + + T+ +GT +MAPE+
Sbjct: 123 HRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-------- 173
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFK-NVRPSAENVPEELSIIL 265
+ Y+ VD +S + +E L K P+ G S ++ A + E +
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233
Query: 266 TSCWKEDPNAR 276
+ DP R
Sbjct: 234 NKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 3e-31
Identities = 101/345 (29%), Positives = 159/345 (46%), Gaps = 57/345 (16%)
Query: 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVY---------EGKYKNQTVAIKIVHKGETPEE 63
L D KW + L +G +GEG +V + K TVA+K++ T ++
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD 60
Query: 64 IAKKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPR 120
+ S E+ M+ + +H+N++ +GAC + P+ V+V E S G LR+YL RP
Sbjct: 61 L----SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPP 115
Query: 121 CLDVCV--------------AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
+D + A +AR ME L S IHRDL N+L+TED +K
Sbjct: 116 GMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED-NVMK 174
Query: 167 LADFGLAREESLTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIV 222
+ADFGLAR+ + T +WMAPE L+ V Y H+ D +SF ++
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVL 225
Query: 223 LWELLH-NKLPFEGM--SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF 279
LWE+ P+ G+ L + +P+ N EL +I+ CW P+ RP F
Sbjct: 226 LWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA--NCTHELYMIMRECWHAVPSQRPTF 283
Query: 280 TQIIQMLLNYLSAIAPPEPM---IPHRIFNSENTILPPESPGTSS 321
Q+++ L L+ + E + +P ++ P+SP + S
Sbjct: 284 KQLVEDLDRVLTVTSTDEYLDLSVPFEQYSPGC----PDSPSSCS 324
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 39/289 (13%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ + + +G GA +VYEG Y+ + + + E+ E + ES F E
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEA 60
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPR-----CLDVCVAI 128
++S+ H+N+V+ IG + P I+ EL++GG L+ +L RPR L + +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 129 GFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREESLTE------ 180
A D+A+ + L + IHRD+ N LLT + K+ADFG+AR+
Sbjct: 120 FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS 237
M+ +WM PE + + K D +SF ++LWE+ +P+ G +
Sbjct: 180 RAMLPI-----KWMPPEAFLDGI--------FTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
Query: 238 NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
N + + P + I+T CW+ P RPNF I++ +
Sbjct: 227 NQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 73/286 (25%), Positives = 126/286 (44%), Gaps = 54/286 (18%)
Query: 32 IGEGAHAKVYEGKYKNQT------VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEG KV +Y VA+K + E+ S F RE+ +L + H N
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQ---HRSDFEREIEILRTLDHEN 67
Query: 86 LVKFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+VK+ G C++P + ++ E L G+LR YL R + +++ + F+ I + M+ L
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLG 126
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY----------RWM 192
S IHRDL N+L+ + +K++DFGLA+ ++ + Y W
Sbjct: 127 SQRYIHRDLAARNILVESE-DLVKISDFGLAK------VLPEDKDYYYVKEPGESPIFWY 179
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL----HNKLP---FEGMSNLQAAYAA 245
APE T ++ D +SF + L+EL ++ P F M +
Sbjct: 180 APECLRTSK--------FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI 231
Query: 246 AFKNVR--------PSAENVPEELSIILTSCWKEDPNARPNFTQII 283
+ + P + P+E+ ++ CW+ +P RP+F +I
Sbjct: 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 94/318 (29%), Positives = 147/318 (46%), Gaps = 56/318 (17%)
Query: 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY---------KNQTVAIKIVHKGETPEE 63
L LD KW L +G +GEG +V + + TVA+K++ T ++
Sbjct: 1 LPLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD 60
Query: 64 IAKKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPR 120
+A S E+ ++ + +H+N++ +G C + P+ VIV E + G LR++L RP
Sbjct: 61 LADLIS----EMELMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPP 115
Query: 121 CLDVCVAI--------------GFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
D I A +AR ME L S IHRDL N+L+TED +K
Sbjct: 116 GPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED-NVMK 174
Query: 167 LADFGLAREESLTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIV 222
+ADFGLAR + + +WMAPE L+ V Y H+ D +SF I+
Sbjct: 175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGIL 225
Query: 223 LWELL------HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 276
+WE+ + +P E + L + +PS N EL +++ CW P R
Sbjct: 226 MWEIFTLGGSPYPGIPVEELFKL---LREGHRMDKPS--NCTHELYMLMRECWHAVPTQR 280
Query: 277 PNFTQIIQMLLNYLSAIA 294
P F Q+++ L L+A++
Sbjct: 281 PTFKQLVEALDKVLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 79/290 (27%), Positives = 134/290 (46%), Gaps = 51/290 (17%)
Query: 32 IGEGAHAKVYEGK------YKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
IG+GA +V++ + Y+ T VA+K++ + + A ++ F RE A+++ H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS----ADMQADFQREAALMAEFDHP 68
Query: 85 NLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRC------------------LDV 124
N+VK +G C +P M ++ E ++ G L ++L + PR L +
Sbjct: 69 NIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 125 CVAI--GFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM 182
A +A M L +HRDL N L+ E++ +K+ADFGL+R +
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYY 186
Query: 183 TAETGTY---RWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGM 236
A RWM PE Y+ T D +++ +VLWE+ + P+ GM
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTES----------DVWAYGVVLWEIFSYGMQPYYGM 236
Query: 237 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
++ + Y NV +N P EL ++ CW + P+ RP+F I ++L
Sbjct: 237 AHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-30
Identities = 85/279 (30%), Positives = 132/279 (47%), Gaps = 27/279 (9%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGE-TPEEIAKKESRFAREVA 76
W I + L + ++G G +V+ G + T VA+K + G +PE F E
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-------FLEEAQ 53
Query: 77 MLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
++ +++H LV+ E + IVTE +S G+L +L + R L + + A +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMA 193
M + IHRDL+ N+L+ + L K+ADFGLAR E TA G +W A
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNE-YTARQGAKFPIKWTA 171
Query: 194 PE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNV 250
PE LY T+ K D +SF I+L EL+ ++P+ GM+N +
Sbjct: 172 PEAALYGRFTI----------KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
Query: 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289
P ++ P L ++ CWK+DP RP F + L +Y
Sbjct: 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 83/277 (29%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAM 77
W I + L + ++G+G +V+ G + T VAIK + G E F +E +
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA------FLQEAQI 54
Query: 78 LSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ +++H LV E + IVTE + G+L +L + L + + A IA
Sbjct: 55 MKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADG 114
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE 195
M + IHRDL+ N+L+ ++L K+ADFGLAR E + + +W APE
Sbjct: 115 MAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 196 --LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRP 252
LY T+ K D +SF I+L EL+ ++P+ GM N + P
Sbjct: 174 AALYGRFTI----------KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP 223
Query: 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289
+ PE L ++ CWK+DP+ RP F I L +Y
Sbjct: 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 79/267 (29%), Positives = 127/267 (47%), Gaps = 28/267 (10%)
Query: 29 GPRIGEGAHAKVYEG--KYKNQTVAIK---IVHKGETPEEIAKKESRFAREVAMLSRVQH 83
G +G G+ VYEG A+K + G+T +E K+ +E+A+LS++QH
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQ---LEQEIALLSKLQH 61
Query: 84 RNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
N+V+++G + E + I EL+ GG+L K L V + I +E LH
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLH 119
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 202
+HRD+K N+L+ + +KLADFG+A++ + G+ WMAPE V
Sbjct: 120 DRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE----VIA 174
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEEL 261
+QG Y D +S + E+ K P+ S L+ AA FK R +P+ L
Sbjct: 175 QQGG---YGLAADIWSLGCTVLEMATGKPPW---SQLE-GVAAVFKIGRSKELPPIPDHL 227
Query: 262 SI----ILTSCWKEDPNARPNFTQIIQ 284
S + C + DP+ RP ++++
Sbjct: 228 SDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 80/259 (30%), Positives = 127/259 (49%), Gaps = 26/259 (10%)
Query: 28 VGPRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G IG GA VY+G VAIK + + EE K +E+ +L ++H N
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALK---SIMQEIDLLKNLKHPN 60
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+VK+IG+ + + I+ E G+LR+ ++ + VA+ + + + + LH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAV-YVYQVLQGLAYLHEQ 118
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLR 203
G+IHRD+K N+L T+D +KLADFG+A + +++ + GT WMAPE V
Sbjct: 119 GVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE----VIEM 173
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR----PSAENVPE 259
G + D +S + ELL P+ +L AA F+ V+ P E +
Sbjct: 174 SG----ASTASDIWSLGCTVIELLTGNPPY---YDLNPM-AALFRIVQDDHPPLPEGISP 225
Query: 260 ELSIILTSCWKEDPNARPN 278
EL L C+++DPN RP
Sbjct: 226 ELKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 73/271 (26%), Positives = 131/271 (48%), Gaps = 42/271 (15%)
Query: 32 IGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G GA VY+G + + VAIK++ + +P+ A KE E +++ V H +
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK--ANKE--ILDEAYVMASVDHPH 70
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
+V+ +G C + ++T+L+ G L Y+ N + + + + + IA+ M L
Sbjct: 71 VVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMSYLEEKR 129
Query: 146 IIHRDLKPENLLLTEDLKT---IKLADFGLARE-ESLTEMMTAETGTY--RWMAPELYST 199
++HRDL N+L +KT +K+ DFGLA+ + + AE G +WMA E
Sbjct: 130 LVHRDLAARNVL----VKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE---- 181
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258
++ Y HK D +S+ + +WEL+ P+EG+ A ++ E +P
Sbjct: 182 -SILHRI---YTHKSDVWSYGVTVWELMTFGAKPYEGIP------AVEIPDLLEKGERLP 231
Query: 259 E------ELSIILTSCWKEDPNARPNFTQII 283
+ ++ ++L CW D +RP F ++I
Sbjct: 232 QPPICTIDVYMVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 75/269 (27%), Positives = 125/269 (46%), Gaps = 38/269 (14%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ VY+ ++K + A+K +H E + RE+ L + +VK
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE----FRKQLLRELKTLRSCESPYVVKC 64
Query: 90 IGA-CKEPVMVIVTELLSGGTL---RKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-H 144
GA KE + IV E + GG+L K + + L A I + ++ LH+
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTKR 119
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTVTL 202
IIHRD+KP NLL+ +K+ADFG+++ E +L + T GT +M+PE
Sbjct: 120 HIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE------- 170
Query: 203 R-QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------RPSAE 255
R QGE Y++ D +S + L E K PF Q ++ + + AE
Sbjct: 171 RIQGE--SYSYAADIWSLGLTLLECALGKFPFL--PPGQPSFFELMQAICDGPPPSLPAE 226
Query: 256 NVPEELSIILTSCWKEDPNARPNFTQIIQ 284
E +++C ++DP RP+ +++Q
Sbjct: 227 EFSPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 85/281 (30%), Positives = 127/281 (45%), Gaps = 50/281 (17%)
Query: 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRF-----------AREVAM 77
G +IG G KVY A+ + +T E +A KE R A E+ +
Sbjct: 5 GNKIGGGTFGKVY--------TAVNL----DTGELMAVKEIRIQDNDPKTIKEIADEMKV 52
Query: 78 LSRVQHRNLVKFIGA--CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
L ++H NLVK+ G +E V I E SGGTL + L + R LD V + L +
Sbjct: 53 LELLKHPNLVKYYGVEVHREKVY-IFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLL 109
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA-----REESLTEMMTAETGTYR 190
+ LHSHGI+HRD+KP N+ L IKL DFG A ++ E + + GT
Sbjct: 110 EGLAYLHSHGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFKN 249
+MAPE+ G+ K + D +S V+ E+ K P+ + N Q + +
Sbjct: 169 YMAPEVI-----TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH 223
Query: 250 VRPSAENVPEELSI------ILTSCWKEDPNARPNFTQIIQ 284
+P P+ L + L C + DP RP ++++Q
Sbjct: 224 -KPPI---PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 84/295 (28%), Positives = 138/295 (46%), Gaps = 55/295 (18%)
Query: 26 LFVGPRIGEGAHAKVYE-------GKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
L +G +GEG KV + G+ TVA+K++ + + E+ S F +L
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN----LL 57
Query: 79 SRVQHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRP----------------- 119
+V H +++K GAC P+++IV E G+LR +L R
Sbjct: 58 KQVNHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 120 -----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
R L + I FA I+R M+ L ++HRDL N+L+ E + +K++DFGL+R
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG-RKMKISDFGLSR 175
Query: 175 ---EESLTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-N 229
EE + +WMA E L+ + Y + D +SF ++LWE++
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLLWEIVTLG 226
Query: 230 KLPFEGMS--NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 282
P+ G++ L ++ RP EN EE+ ++ +CWK++P+ RP F I
Sbjct: 227 GNPYPGIAPERLFNLLKTGYRMERP--ENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 80/262 (30%), Positives = 129/262 (49%), Gaps = 27/262 (10%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG+G+ +VY+ K NQ VAIK++ E +EI +E+ LS+ + + K
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED----IQQEIQFLSQCRSPYITK 63
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGI 146
+ G+ K + I+ E GG+ L +P LD I F L ++ +E LH G
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDE-TYIAFILREVLLGLEYLHEEGK 119
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQ 204
IHRD+K N+LL+E+ +KLADFG++ + + T M T GT WMAPE+ ++Q
Sbjct: 120 IHRDIKAANILLSEE-GDVKLADFGVSGQLTST-MSKRNTFVGTPFWMAPEV-----IKQ 172
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE--NVPEELS 262
Y+ K D +S I EL + P + ++ + KN PS E +
Sbjct: 173 SG---YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFK 228
Query: 263 IILTSCWKEDPNARPNFTQIIQ 284
++ C +DP RP+ ++++
Sbjct: 229 DFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 81/279 (29%), Positives = 129/279 (46%), Gaps = 23/279 (8%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAM 77
W I + L + ++G+G +V+ G + T VAIK + G E F +E +
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA------FLQEAQV 54
Query: 78 LSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ +++H LV+ E + IVTE +S G+L +L + L + + A IA
Sbjct: 55 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 114
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE 195
M + +HRDL+ N+L+ E+L K+ADFGLAR E + + +W APE
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 196 --LYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL-LHNKLPFEGMSNLQAAYAAAFKNVRP 252
LY T+ K D +SF I+L EL ++P+ GM N + P
Sbjct: 174 AALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 223
Query: 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291
PE L ++ CW+++P RP F + L +Y +
Sbjct: 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 51/301 (16%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFARE 74
I + + + EG +++ G K + V +K V + ++ +E
Sbjct: 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVT----LLLQE 58
Query: 75 VAMLSRVQHRNLVKFIGACKE---PVMVIVTELLSGGTLRKYLLNMR------PRCLDVC 125
+L + H+N++ + C E P V+ ++ G L+ +L R P+ L
Sbjct: 59 SCLLYGLSHQNILPILHVCIEDGEPPFVLYP-YMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 126 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE------ESLT 179
+ A+ IA M LH G+IH+D+ N ++ E+L+ +K+ D L+R+ L
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ-VKITDNALSRDLFPMDYHCLG 176
Query: 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL------HNKL-P 232
+ E +WMA E +L K Y+ D +SF ++LWEL+ + ++ P
Sbjct: 177 D---NENRPVKWMALE-----SL---VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225
Query: 233 FEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
FE + L+ Y A N P+EL ++ CW DP RP+F+Q++Q L ++ +
Sbjct: 226 FEMAAYLKDGYRLAQPI------NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279
Query: 293 I 293
+
Sbjct: 280 L 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 1e-28
Identities = 78/277 (28%), Positives = 132/277 (47%), Gaps = 39/277 (14%)
Query: 32 IGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GE A K+Y+G Q VAIK + P++ + F +E ++++ + H N
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE----FQQEASLMAELHHPN 68
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRC---------------LDVCVAIG 129
+V +G +E + ++ E L+ G L ++L+ P LD +
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
A+ IA ME L SH +H+DL N+L+ E L +K++D GL+RE + + +
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-VKISDLGLSREIYSADYYRVQPKSL 187
Query: 190 ---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAYAA 245
RWM PE + G+ ++ D +SF +VLWE+ L P+ G SN +
Sbjct: 188 LPIRWMPPE-----AIMYGK---FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239
Query: 246 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 282
+ + P +E+ P + ++T CW+E P+ RP F I
Sbjct: 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 91/308 (29%), Positives = 145/308 (47%), Gaps = 50/308 (16%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVY---------EGKYKNQTVAIKIVHKGETPE 62
EL D +W L +G +GEG +V + + TVA+K++ T +
Sbjct: 3 ELPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK 62
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRP 119
++ S E+ M+ + +H+N++ +GAC + P+ VIV E S G LR+YL RP
Sbjct: 63 DL----SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRP 117
Query: 120 RCLDVCVAIGFALD--------------IARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
++ I D +AR ME L S IHRDL N+L+TE+ +
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN-NVM 176
Query: 166 KLADFGLAREESLTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAI 221
K+ADFGLAR+ + + T +WMAPE L+ V Y H+ D +SF +
Sbjct: 177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGV 227
Query: 222 VLWELLH-NKLPFEGM--SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 278
++WE+ P+ G+ L + +P+ N EL +++ CW P+ RP
Sbjct: 228 LMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA--NCTNELYMMMRDCWHAIPSHRPT 285
Query: 279 FTQIIQML 286
F Q+++ L
Sbjct: 286 FKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 73/255 (28%), Positives = 127/255 (49%), Gaps = 11/255 (4%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IGEG+ K+Y K K+ + I T + +KE+ +EV +L++++H N+V F
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHPNIVTFFA 66
Query: 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRD 150
+ +E + IV E GG L K + R + + + I+ ++ +H I+HRD
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 151 LKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 209
+K +N+ L+++ KL DFG+AR+ E+ GT +++PE+ + +
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC--------QNRP 178
Query: 210 YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCW 269
YN+K D +S VL+EL K PFEG + Q P + N +L +++ +
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238
Query: 270 KEDPNARPNFTQIIQ 284
K P RP+ T I++
Sbjct: 239 KVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 81/274 (29%), Positives = 118/274 (43%), Gaps = 52/274 (18%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK- 88
I +GA+ +V+ K K AIK++ K + + + R++ LS+ Q +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL 58
Query: 89 ---FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
F G + +V E L GG L L N+ LD VA + +I A+E LHS+G
Sbjct: 59 YYSFQGKKN---LYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG 113
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE---------TGTYRWMAPEL 196
IIHRDLKP+N+L+ + +KL DFGL++ + + GT ++APE
Sbjct: 114 IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE- 171
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 256
V L QG ++ VD +S +L+E L PF G E
Sbjct: 172 ---VILGQG----HSKTVDWWSLGCILYEFLVGIPPFHG-------------------ET 205
Query: 257 VPEELSIILTS--CWKEDPNARPNFTQIIQMLLN 288
E IL W ED +I LL
Sbjct: 206 PEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 82/284 (28%), Positives = 128/284 (45%), Gaps = 30/284 (10%)
Query: 26 LFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKE-SRFAREVAMLSRVQH 83
L +G +GEG V EG+ + +K+ K + E F E A + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 84 RNLVKFIGACKE-------PVMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFAL 132
N++K IG C E P +++ + G L +LL R P L + + F +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAETGTY 189
DIA ME L + IHRDL N +L ED+ T+ +ADFGL+++
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 190 RWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 247
+W+A E L V Y K D ++F + +WE+ + P+ G+ N + Y
Sbjct: 180 KWIAIESLADRV---------YTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-IYDYLR 229
Query: 248 KNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290
R E+ +EL ++ SCW+ DP RP FT++ ++L N L
Sbjct: 230 HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 80/269 (29%), Positives = 126/269 (46%), Gaps = 36/269 (13%)
Query: 32 IGEGAHAKVYEGKYKNQTV--AIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+GA KVY+ ++K + A KI+ EE+ F E+ +LS +H N+V
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EEL----EDFMVEIDILSECKHPNIVGL 67
Query: 90 IGA-CKEPVMVIVTELLSGGTLRKYLLNM---------RPRCLDVCVAIGFALDIARAME 139
A E + I+ E GG L +L + R C + A+ F
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF--------- 118
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYS 198
LHSH +IHRDLK N+LLT D +KLADFG+ A+ +S + GT WMAPE+ +
Sbjct: 119 -LHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV- 257
T + Y++K D +S I L EL + P ++ ++ K+ P+ +
Sbjct: 177 CETFKD---NPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEPPTLDQPS 232
Query: 258 --PEELSIILTSCWKEDPNARPNFTQIIQ 284
+ L SC +DP+ RP ++++
Sbjct: 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 82/263 (31%), Positives = 128/263 (48%), Gaps = 31/263 (11%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG++ VY+ +K Q VAIK+V E +EI K E+++L + +VK+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK-------EISILKQCDSPYIVKY 63
Query: 90 IGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGII 147
G+ K + IV E G++ ++ + + L I L + +E LHS+ I
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTE-EEIAAILYQTLKGLEYLHSNKKI 121
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
HRD+K N+LL E+ KLADFG++ + + T M T GT WMAPE V G
Sbjct: 122 HRDIKAGNILLNEE-GQAKLADFGVSGQLTDT-MAKRNTVIGTPFWMAPE----VIQEIG 175
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE----EL 261
YN+K D +S I E+ K P+ + ++A + N P + PE E
Sbjct: 176 ----YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--MIPNKPPPTLSDPEKWSPEF 229
Query: 262 SIILTSCWKEDPNARPNFTQIIQ 284
+ + C +DP RP+ Q++Q
Sbjct: 230 NDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 83/277 (29%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAM 77
W I + L + ++G G +V+ Y T VA+K + G + F E +
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------SMSVEAFLAEANV 54
Query: 78 LSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ +QH LVK + + I+TE ++ G+L +L + + I F+ IA
Sbjct: 55 MKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 114
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE 195
M + IHRDL+ N+L++ L K+ADFGLAR E E + +W APE
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 196 L--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRP 252
+ + T+ K D +SF I+L E++ + ++P+ GMSN + A P
Sbjct: 174 AINFGSFTI----------KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223
Query: 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289
EN PEEL I+ CWK P RP F I +L ++
Sbjct: 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ RIGEGAH V++ K + +TVA+K V I + RE+ L QH
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ---ALREIKALQACQHPY 60
Query: 86 LVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+VK + V+V E + L + L + R L + + + + +H++
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPE-LYSTVT 201
GI+HRDLKP NLL++ D +K+ADFGLAR E + + + T + APE LY
Sbjct: 119 GIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG--- 174
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+ Y+ VD ++ + ELL+ F G
Sbjct: 175 -----ARKYDPGVDLWAVGCIFAELLNGSPLFPG 203
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 74/257 (28%), Positives = 122/257 (47%), Gaps = 18/257 (7%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G GA V+ K + V IK + E++ K E A+ E +L + H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQI----PVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ ++ ++IV E GGTL +Y+ LD + F + I A+ +H+ I+
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
HRDLK +N+LL + +K+ DFG+++ S GT +++PEL E
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC--------EG 175
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILT 266
K YN K D ++ VL+EL K FE +NL A P ++ +L ++
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234
Query: 267 SCWKEDPNARPNFTQII 283
S DP+ RP +QI+
Sbjct: 235 SMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 76/256 (29%), Positives = 125/256 (48%), Gaps = 29/256 (11%)
Query: 32 IGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH---RNL 86
IG GA+ VY GK+ + VA+KI++ +TP++ S REVA+LS+++ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINL-DTPDD---DVSDIQREVALLSQLRQSQPPNI 64
Query: 87 VKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLD---VCVAIGFALDIARAMECLH 142
K+ G+ K P + I+ E GG++R M+ + + V I L A++ +H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTL---MKAGPIAEKYISVIIREVL---VALKYIH 118
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVT 201
G+IHRD+K N+L+T +KL DFG+A + + GT WMAPE+ +
Sbjct: 119 KVGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT--- 174
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY-AAAFKNVRPSAENVPEE 260
E K+Y+ K D +S I ++E+ P+ + +A K R +
Sbjct: 175 ----EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKL 230
Query: 261 LSIILTSCWKEDPNAR 276
L + +C E+P R
Sbjct: 231 LREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 78/296 (26%), Positives = 139/296 (46%), Gaps = 49/296 (16%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRF 71
W + + + + +G+G+ VYEG ++ VA+K V++ + E F
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE----RIEF 56
Query: 72 AREVAMLSRVQHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLD------ 123
E +++ ++V+ +G +P +V++ EL++ G L+ YL ++RP +
Sbjct: 57 LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPP 115
Query: 124 --VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
+ I A +IA M L++ +HRDL N ++ D T+K+ DFG+ R+
Sbjct: 116 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTRD------ 168
Query: 182 MTAETGTYR----------WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NK 230
ET YR WMAPE +L+ G + D +SF +VLWE+ +
Sbjct: 169 -IYETDYYRKGGKGLLPVRWMAPE-----SLKDGVFTTSS---DMWSFGVVLWEITSLAE 219
Query: 231 LPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
P++G+SN Q +N PE ++ ++ CW+ +P RP F +I+ +L
Sbjct: 220 QPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 74/283 (26%), Positives = 116/283 (40%), Gaps = 55/283 (19%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHR 84
G IGEG+ + V K K N+ AIKI+ K + +E KK E +L+R+ H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE--KKVKYVKIEKEVLTRLNGHP 62
Query: 85 NLVKFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
++K ++ V+ E G L +Y+ LD +A +I A+E
Sbjct: 63 GIIKLYYTFQDEENLYFVL----EYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALE 116
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET------------- 186
LHS GIIHRDLKPEN+LL +D IK+ DFG A+ +
Sbjct: 117 YLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 187 --------GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 238
GT +++PEL + +K D ++ +++++L K PF G +
Sbjct: 176 RRRFASFVGTAEYVSPELLN--------EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227
Query: 239 LQAAYAAAFKNVRPSA----ENVPEELSIILTSCWKEDPNARP 277
F+ + N P + ++ DP R
Sbjct: 228 YL-----TFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 86/299 (28%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+ + K + VAIK + E I K RE+ +L + H N++K
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPK---TALREIKLLKELNHPNIIK 62
Query: 89 FIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + + +V E + L K L+ R R L + + + + + HSHGI+
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYK-LIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWM-APELYSTVTLRQG 205
HRDLKPENLL+ + +KLADFGLAR S T T RW APEL + +
Sbjct: 121 HRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPEL--LLGDKG- 175
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 265
Y+ VD +S + ELL + F G S + ++L I
Sbjct: 176 ----YSTPVDIWSVGCIFAELLSRRPLFPGKSEI-------------------DQLFKIF 212
Query: 266 TSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMT 324
+ DP P FT + NY + M ++F P SP L++
Sbjct: 213 RTLGTPDPEVWPKFT---SLARNYKFSFPKKAGMPLPKLF-------PNASPQALDLLS 261
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 78/262 (29%), Positives = 125/262 (47%), Gaps = 20/262 (7%)
Query: 32 IGEGAH--AKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
+G+GA A +Y + V K V+ E KE R A E+ +LS +QH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE----KERRDALNEIVILSLLQHPNIIA 63
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + ++I E +GGTL ++ + + + + + + I A+ +H GI+
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
HRD+K N+ LT+ IKL DFG+++ +E AET GT +M+PEL QG
Sbjct: 124 HRDIKTLNIFLTKA-GLIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELC------QG 175
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 265
K YN K D ++ VL+ELL K F+ + L N P EL ++
Sbjct: 176 VK--YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV 233
Query: 266 TSCWKEDPNARPNFTQIIQMLL 287
S ++DP RP +++ L
Sbjct: 234 HSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-27
Identities = 83/281 (29%), Positives = 131/281 (46%), Gaps = 31/281 (11%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREV 75
ID + + IG G +V G+ K VAIK + G T K+ F E
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT----EKQRRDFLSEA 56
Query: 76 AMLSRVQHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+++ + H N++ G + PVM I+TE + G L +L V +G
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVM-IITEFMENGALDSFL-RQNDGQFTVIQLVGMLRG 114
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETG--- 187
IA M+ L +HRDL N+L+ +L K++DFGL+R +++ T+ G
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173
Query: 188 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAA 246
RW APE + R+ + D +S+ IV+WE++ + + P+ MSN Q A
Sbjct: 174 PIRWTAPE---AIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAI 224
Query: 247 FKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
++ R P + P L ++ CW++D NARP F QI+ L
Sbjct: 225 EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 6e-27
Identities = 82/282 (29%), Positives = 134/282 (47%), Gaps = 28/282 (9%)
Query: 20 LIDPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA 76
L DP +F + IGEG + KVY+ ++K Q VAIKI+ E EE K+E R+ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 77 MLSRVQHRNLVKFIGA-------CKEPVMVIVTELLSGGT---LRKYLLNMRPRCLDVCV 126
H N+ F GA + + +V EL GG+ L K L R + +
Sbjct: 61 -----NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AE 185
A + R + LH + +IHRD+K +N+LLT++ + +KL DFG++ + T
Sbjct: 116 AY-ILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTF 173
Query: 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 245
GT WMAPE+ + + Y+ + D +S I EL K P M ++A +
Sbjct: 174 IGTPYWMAPEV---IACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230
Query: 246 AFKNVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+N P S EN ++ + ++ C ++ RP ++++
Sbjct: 231 P-RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 71/215 (33%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 31 RIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
++GEG + VY+ K + VA+K + + + EE + RE+++L ++H N+VK
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTA--LREISLLKELKHPNIVK 62
Query: 89 FIG-ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ E + +V E L+KYL + RP L + + R + HSH I+
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-MTAETGT--YRWMAPELYSTVTLRQ 204
HRDLKP+N+L+ D +KLADFGLAR + T E T YR APE+
Sbjct: 121 HRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYR--APEIL------L 171
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
G KHY+ VD +S + E++ K F G S +
Sbjct: 172 GS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 79/277 (28%), Positives = 121/277 (43%), Gaps = 58/277 (20%)
Query: 32 IGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA A VY N+ VAIK + + + E R +EV +S+ H N+VK+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV--DELR--KEVQAMSQCNHPNVVKY 64
Query: 90 IGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGII 147
+ + +V LSGG+L + + PR I L ++ + +E LHS+G I
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET-------GTYRWMAPELYSTV 200
HRD+K N+LL ED ++K+ADFG++ SL + GT WMAPE+
Sbjct: 125 HRDIKAGNILLGED-GSVKIADFGVS--ASLADGGDRTRKVRKTFVGTPCWMAPEVME-- 179
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG-------MSNLQAA----------- 242
+ Y+ K D +SF I EL P+ M LQ
Sbjct: 180 -----QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 243 -YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPN 278
Y+ +F+ +++ C ++DP+ RP
Sbjct: 235 KYSKSFRK--------------MISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 86/280 (30%), Positives = 132/280 (47%), Gaps = 31/280 (11%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT-----VAIKIVHKGETPEEIAKKESRFAREV 75
ID + + IG G +V G+ K VAIK + G T K+ F E
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT----EKQRRDFLSEA 56
Query: 76 AMLSRVQHRNLVKFIGA---CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+++ + H N++ G K PVM IVTE + G+L +L + V +G
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSK-PVM-IVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLR 113
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGT-- 188
IA M+ L G +HRDL N+L+ +L K++DFGL+R E+ T G
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 247
RW APE + R+ + D +S+ IV+WE++ + + P+ MSN Q A
Sbjct: 173 IRWTAPE---AIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIE 223
Query: 248 KNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+ R P+ + P L ++ CW++D N RP F QI+ +L
Sbjct: 224 EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-26
Identities = 84/293 (28%), Positives = 140/293 (47%), Gaps = 49/293 (16%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRF 71
W + + + + +G+G+ VYEG K VAIK V++ + E F
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE----RIEF 56
Query: 72 AREVAMLSRVQHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCV--- 126
E +++ ++V+ +G + P +VI+ EL++ G L+ YL ++RP + V
Sbjct: 57 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 127 -----AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
I A +IA M L+++ +HRDL N ++ ED T+K+ DFG+ R+
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRD------ 168
Query: 182 MTAETGTYR----------WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NK 230
ET YR WM+PE +L+ G Y+ D +SF +VLWE+ +
Sbjct: 169 -IYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYS---DVWSFGVVLWEIATLAE 219
Query: 231 LPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQII 283
P++GMSN Q + +N P+ L ++ CW+ +P RP+F +II
Sbjct: 220 QPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-26
Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 32 IGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
IG+G VY G + A+K +++ EE+ + F +E ++ H N+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ----FLKEGIIMKDFSHPNV 58
Query: 87 VKFIGAC--KEPVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLH 142
+ +G C E ++V + G LR ++ + P D+ IGF L +A+ ME L
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYLA 115
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT-----YRWMAPELY 197
S +HRDL N +L E T+K+ADFGLAR+ E + T +WMA E
Sbjct: 116 SKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAEN 256
T + K D +SF ++LWEL+ P + + R E
Sbjct: 175 QTQK--------FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY 226
Query: 257 VPEELSIILTSCWKEDPNARPNFTQII 283
P+ L ++ SCW P RP F++++
Sbjct: 227 CPDPLYEVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-26
Identities = 78/277 (28%), Positives = 124/277 (44%), Gaps = 25/277 (9%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREV 75
I P H+ IG G +V+ G K VAIK + G T K+ F E
Sbjct: 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT----EKQRQDFLSEA 57
Query: 76 AMLSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
+++ + H N+++ G K +I+TE + G L KYL + +G I
Sbjct: 58 SIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGI 116
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETG---TYR 190
A M+ L +HRDL N+L+ +L+ K++DFGL+R E E +G R
Sbjct: 117 AAGMKYLSDMNYVHRDLAARNILVNSNLEC-KVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKN 249
W APE + + + D +SF IV+WE++ + P+ MSN + A
Sbjct: 176 WTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227
Query: 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
P+ + P + ++ CW++D RP F I+ +L
Sbjct: 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 75/313 (23%), Positives = 131/313 (41%), Gaps = 69/313 (22%)
Query: 24 KHLFVGPRIGEGAHAKVY----------------EGKYKNQT--VAIKIVHKGETPEEIA 65
+ L ++GEG +V+ E + VA+K++ + A
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN--A 62
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYL---------L 115
+++ F +EV +LSR+ N+ + +G C +P + ++ E + G L ++L L
Sbjct: 63 RED--FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 116 NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175
+ L + A IA M L S +HRDL N L+ ++ TIK+ADFG++R
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY-TIKIADFGMSRN 179
Query: 176 ESLTEMMTAETGTY-----------RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224
+ Y RWMA E ++ G+ + K D ++F + LW
Sbjct: 180 --------LYSSDYYRVQGRAPLPIRWMAWE-----SVLLGK---FTTKSDVWAFGVTLW 223
Query: 225 EL--LHNKLPFEGMSNLQAAYAAAFKNVR-------PSAENVPEELSIILTSCWKEDPNA 275
E+ L + P+E +++ Q A P N P+++ ++ CW+ D
Sbjct: 224 EILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEED 283
Query: 276 RPNFTQIIQMLLN 288
RP F +I L
Sbjct: 284 RPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 87/271 (32%), Positives = 127/271 (46%), Gaps = 24/271 (8%)
Query: 22 DPKHLFVGPR-IGEGAHAKVY--EGKYKNQTVAIK-IVHKGETPEEIAKKESRFAREVAM 77
DP+ LF R IG G+ VY N+ VAIK + + G+ E K +EV
Sbjct: 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE---KWQDIIKEVRF 68
Query: 78 LSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
L +++H N +++ G C +E +V E G ++ +P AI
Sbjct: 69 LQQLRHPNTIEYKG-CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI--CHGAL 125
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
+ + LHSH IHRD+K N+LLTE T+KLADFG A SL + GT WMAPE
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSA---SLVSPANSFVGTPYWMAPE 181
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 255
V L E Y+ KVD +S I EL K P M+ + A Y A +N P+
Sbjct: 182 ----VILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLS 235
Query: 256 NV--PEELSIILTSCWKEDPNARPNFTQIIQ 284
+ + + SC ++ P RP+ ++++
Sbjct: 236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 67/262 (25%), Positives = 117/262 (44%), Gaps = 26/262 (9%)
Query: 32 IGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK- 88
+G+G++ VY+ K NQ A+K V G + ++E E+ +L+ V H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ--KEREDAV-NEIRILASVNHPNIISY 64
Query: 89 ---FIGACKEPVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHS 143
F+ K + IV E G L K + + + + + + R ++ LH
Sbjct: 65 KEAFLDGNK---LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWMAPELYSTVTL 202
I+HRDLK N+LL + +K+ D G+++ L + M + GT +MAPE++
Sbjct: 122 QKILHRDLKSANILLVAN-DLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWK---- 174
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 262
+ Y++K D +S +L+E+ PFE S Y P ++L
Sbjct: 175 ----GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230
Query: 263 IILTSCWKEDPNARPNFTQIIQ 284
+ S + P RPN +I+
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 65/270 (24%), Positives = 112/270 (41%), Gaps = 37/270 (13%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G G V + ++ + +A+K + + RE+ +L + +V F
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ----KQILRELDILHKCNSPYIVGF 64
Query: 90 IGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHS-HGI 146
GA + I E + GG+L K L ++ R + I A + + + LH H I
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGLTYLHEKHKI 122
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWMAPELYSTVTLR-Q 204
IHRD+KP N+L+ IKL DFG++ + L + GT +MAPE R Q
Sbjct: 123 IHRDVKPSNILVNS-RGQIKLCDFGVSGQ--LVNSLAKTFVGTSSYMAPE-------RIQ 172
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV---------RPSAE 255
G Y+ K D +S + L EL + P+ F+ + R +
Sbjct: 173 GN--DYSVKSDIWSLGLSLIELATGRFPY---PPENDPPDGIFELLQYIVNEPPPRLPSG 227
Query: 256 NVPEELSIILTSCWKEDPNARPNFTQIIQM 285
+ + C +DP RP++ ++++
Sbjct: 228 KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-24
Identities = 76/274 (27%), Positives = 123/274 (44%), Gaps = 41/274 (14%)
Query: 29 GPRIGEGAHAKVY------EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ 82
G +G+GA +VY G+ +A+K V E K+ + E+ +L +Q
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGR----ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 83 HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
H +V++ G ++ + I E + GG+++ L L V + I +E L
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYL 120
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE----ESLTEMMTAETGTYRWMAPELY 197
HS+ I+HRD+K N +L + +KL DFG ++ S M + TGT WM+PE+
Sbjct: 121 HSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP---FEGMSNLQAAYAAAFK-NVRPS 253
S GE Y K D +S + E+L K P FE M AA FK +P+
Sbjct: 180 S------GEG--YGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPT 224
Query: 254 AENVPEELSII----LTSCWKEDPNARPNFTQII 283
+P +S L + E+ RP+ +++
Sbjct: 225 NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 5e-24
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIA--KKESRFAREVAMLSRVQHRNLV 87
+G G+ +V ++K + A+KI+ K +I K+ E +L ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSK----AKIVKLKQVEHVLNEKRILQSIRHPFLV 64
Query: 88 KFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
G+ ++ + +V E + GG L +L + VA +A + A+E LHS I
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVTLRQG 205
++RDLKPENLLL D IK+ DFG A R + T + GT ++APE + L +G
Sbjct: 123 VYRDLKPENLLLDSD-GYIKITDFGFAKRVKGRTYTL---CGTPEYLAPE----IILSKG 174
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPF 233
Y VD ++ I+++E+L PF
Sbjct: 175 ----YGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-24
Identities = 75/268 (27%), Positives = 129/268 (48%), Gaps = 34/268 (12%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAR----EVAMLSRVQHRNLV 87
+G+G + VY + + V I I +EI +++SR+ + E+A+ S ++HRN+V
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAI-------KEIPERDSRYVQPLHEEIALHSYLKHRNIV 68
Query: 88 KFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-ALDIARAMECLHSHG 145
+++G+ E I E + GG+L L + D I F I ++ LH +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFG----LAREESLTEMMTAETGTYRWMAPELYSTVT 201
I+HRD+K +N+L+ +K++DFG LA TE TGT ++MAPE+
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYMAPEV----- 180
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA-YAAAFKNVRPSAENVPEE 260
+ +G + Y D +S + E+ K PF + QAA + + P +PE
Sbjct: 181 IDKGPRG-YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP---EIPES 236
Query: 261 LSI----ILTSCWKEDPNARPNFTQIIQ 284
LS + C++ DP+ R + ++Q
Sbjct: 237 LSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 7e-24
Identities = 80/281 (28%), Positives = 129/281 (45%), Gaps = 31/281 (11%)
Query: 32 IGEGAHAKVYEGKYKN----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
+GEGA KV+ + N Q + V + + A+K+ F RE +L+ +QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--FHREAELLTNLQHEHIV 70
Query: 88 KFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRC-----------LDVCVAIGFALDIA 135
KF G C E +++V E + G L K+L P L + A IA
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWM 192
M L S +HRDL N L+ E+L +K+ DFG++R+ T+ T RWM
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR 251
PE ++ R+ + + D +S +VLWE+ + K P+ +SN + V
Sbjct: 190 PPE---SIMYRK-----FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241
Query: 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
P+E+ ++ CW+ +P+ R N +I +L N A
Sbjct: 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-23
Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 43/279 (15%)
Query: 32 IGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+GE KVY+G + Q VAIK + + E +E F E M SR+QH
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL---KDKAEGPLRE-EFKHEAMMRSRLQHP 68
Query: 85 NLVKFIG-ACKEPVMVIVTELLSGGTLRKYLLNMRPR--------------CLDVCVAIG 129
N+V +G KE + ++ S L ++L+ P L+ +
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAET 186
IA ME L SH ++H+DL N+L+ + L +K++D GL RE ++M
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL-NVKISDLGLFREVYAADYYKLMGNSL 187
Query: 187 GTYRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAY 243
RWM+PE +Y ++ D +S+ +VLWE+ L P+ G SN
Sbjct: 188 LPIRWMSPEAIMYGKFSIDS----------DIWSYGVVLWEVFSYGLQPYCGYSNQDVIE 237
Query: 244 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 282
+ V P ++ P + ++ CW E P+ RP F I
Sbjct: 238 MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 68/272 (25%), Positives = 122/272 (44%), Gaps = 29/272 (10%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG+G+ V + + K+ + + K + G E K++ + EV +L ++H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE---KEKQQLVSEVNILRELKHPNIVR 63
Query: 89 FIGACKEP---VMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAM-ECLH 142
+ + + IV E GG L + + + + ++ + A+ EC H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC-H 122
Query: 143 -----SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPE 195
+ ++HRDLKP N+ L + +KL DFGLA+ + A+T GT +M+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPE 180
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 255
+ Y+ K D +S +++EL PF + LQ A R
Sbjct: 181 QLN--------HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPY 232
Query: 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287
EL+ ++ S DP+ RP+ +++Q+ L
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-23
Identities = 77/288 (26%), Positives = 125/288 (43%), Gaps = 48/288 (16%)
Query: 32 IGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEG KV Y + VA+K + + + S + +E+ +L + H N
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQN----TSGWKKEINILKTLYHEN 67
Query: 86 LVKFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECL 141
+VK+ G C E + ++ E + G+LR YL P+ L++ + FA I M L
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPEL 196
HS IHRDL N+LL D + +K+ DFGLA+ E ++ + W A E
Sbjct: 124 HSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-WYAVEC 181
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-------FEGMSNLQAAYAAAFKN 249
E K + D +SF + L+ELL + FE M + +
Sbjct: 182 LK-------ENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233
Query: 250 VR--------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289
+ P +N P+E+ I++ +CW+ + RP F +I +L
Sbjct: 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 80/281 (28%), Positives = 135/281 (48%), Gaps = 40/281 (14%)
Query: 32 IGEGAHAKVYEGKYKNQT-------VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+GEGA KV+ + N + VA+K + + P A+K+ F RE +L+ +QH
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKD--FQREAELLTNLQHE 67
Query: 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKY----------LLNMRPRC----LDVCVAIG 129
++VKF G C + +++V E + G L K+ L++ +PR L + +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
A IA M L S +HRDL N L+ +L +K+ DFG++R+ T+ T
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 190 ---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAA 245
RWM PE ++ R+ + + D +SF ++LWE+ + K P+ +SN +
Sbjct: 187 LPIRWMPPE---SIMYRK-----FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238
Query: 246 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
V P+E+ I+ CW+ +P R N +I ++L
Sbjct: 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 39/270 (14%)
Query: 32 IGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+GEGA KV+ + N VA+K + + E A+++ F RE +L+ +QH+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQD--FQREAELLTVLQHQ 67
Query: 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRC-------------LDVCVAIGF 130
++V+F G C E +++V E + G L ++L + P L + +
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY- 189
A IA M L S +HRDL N L+ + L +K+ DFG++R+ T+ T
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 190 --RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAA 246
RWM PE ++ R+ + + D +SF +VLWE+ + K P+ +SN +A
Sbjct: 187 PIRWMPPE---SILYRK-----FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 247 FKNVRPSAENVPEELSIILTSCWKEDPNAR 276
P E+ I+ CW+ +P R
Sbjct: 239 QGRELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 5e-23
Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 53/293 (18%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+GEGA+ V + + K + VAIK + E E++ K REV +L +++H N+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA---LREVKVLRQLRHENIVN 64
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + + + +V E + L LL P L + + +A+ HSH II
Sbjct: 65 LKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII 122
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWM-APELYSTVTLR 203
HRD+KPEN+L++E +KL DFG AR +L + Y RW APEL T
Sbjct: 123 HRDIKPENILVSESG-VLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLVGDT-- 177
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY--------------AAAFKN 249
+Y VD ++ ++ ELL + F G S++ Y N
Sbjct: 178 -----NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 250 VRPSAENVPEELSII-----------------LTSCWKEDPNARPNFTQIIQM 285
R + PE L +C + DP R +++Q
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-23
Identities = 63/259 (24%), Positives = 115/259 (44%), Gaps = 18/259 (6%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG+G+ V++ K + A+K + + + ++ E +L+++ +++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQI---DLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + + + IV E G L K L R R L F + I + LHS I+
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
HRD+K NL L +K+ D G+A+ S A T GT +++PEL
Sbjct: 124 HRDIKSLNLFLDAYDN-VKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELC-------- 173
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 265
E K YN K D ++ +VL+E K PF+ + P ++ ++L+ ++
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLI 233
Query: 266 TSCWKEDPNARPNFTQIIQ 284
C +D RP+ Q+++
Sbjct: 234 DQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 5e-23
Identities = 82/265 (30%), Positives = 134/265 (50%), Gaps = 30/265 (11%)
Query: 31 RIGEGAHAKVYEGKYKN---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
+IGEG+ K K K Q V +I +P+E ++ESR +EVA+LS ++H N+V
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE--REESR--KEVAVLSNMKHPNIV 62
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
++ + +E + IV + GG L K + R + + + I A++ +H I
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQG 205
+HRD+K +N+ LT+D TIKL DFG+AR S E+ GT +++PE+
Sbjct: 123 LHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC-------- 173
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG--MSNLQAAYAAAFKNVRPSAENVP----E 259
E + YN+K D ++ VL+E+ K FE M NL K +R S V
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIRGSYPPVSSHYSY 227
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQ 284
+L +++ +K +P RP+ I++
Sbjct: 228 DLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 6e-23
Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 38/282 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGE--TPEEIAKKESRFAREVAMLSR 80
+G +G+G V E + K+ Q VA+K++ K + + +I F RE A +
Sbjct: 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDI----EEFLREAACMKE 57
Query: 81 VQHRNLVKFIGAC-------KEPVMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIG 129
H N++K IG + P+ +++ + G L +LL R P L + +
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAET 186
F +DIA ME L S IHRDL N +L E++ T+ +ADFGL+++ A
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 187 GTYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYA 244
+W+A E L V Y D ++F + +WE++ + P+ G+ N +
Sbjct: 177 LPVKWLALESLADNV---------YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY 227
Query: 245 AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
N + E++ ++ CW +P RP+F + L
Sbjct: 228 LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-23
Identities = 70/279 (25%), Positives = 127/279 (45%), Gaps = 39/279 (13%)
Query: 29 GPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAR--------EVAML 78
G IG+G + +VY + +A+K V E P IA + + E+ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQV---ELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 79 SRVQHRNLVKFIG-ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ H N+V+++G E + I E + GG++ L + + F +
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQVLEG 120
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE----SLTEMMTAETGTYRWMA 193
+ LHS GI+HRDLK +NLL+ D K++DFG++++ + M+ + G+ WMA
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMA 178
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253
PE+ + + Y+ KVD +S V+ E+ + P+ + A + K P
Sbjct: 179 PEVIHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP 232
Query: 254 AENVPEELSIILTS--------CWKEDPNARPNFTQIIQ 284
+P ++S+ L+ C+ +P+ RP +++Q
Sbjct: 233 ---IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-23
Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 44/287 (15%)
Query: 32 IGEGAHAKVYEGKYKNQ----TVAIKIVHKGETPEEIAKKESR-FAREVAMLSRV-QHRN 85
IGEG +V K AIK++ E ++ + R FA E+ +L ++ H N
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK-----EFASENDHRDFAGELEVLCKLGHHPN 64
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGF 130
++ +GAC+ + I E G L +L R D A + F
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
A D+A M+ L IHRDL N+L+ E+L + K+ADFGL+R E + T R
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS-KIADFGLSRGEEVYVKKTMGRLPVR 183
Query: 191 WMAPEL--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS--NLQAAYAA 245
WMA E YS Y K D +SF ++LWE++ P+ GM+ L
Sbjct: 184 WMAIESLNYSV----------YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233
Query: 246 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
++ +P N +E+ ++ CW++ P RP F QI L L A
Sbjct: 234 GYRMEKP--RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 9e-23
Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 36/277 (12%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRV-QHRNLVKF 89
IGEG +V + + K + + K E +K + R FA E+ +L ++ H N++
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG--------------FALDI 134
+GAC+ + + E G L +L R D AI FA D+
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAP 194
AR M+ L IHRDL N+L+ E+ K+ADFGL+R + + T RWMA
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 192
Query: 195 EL--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS--NLQAAYAAAFKN 249
E YS Y D +S+ ++LWE++ P+ GM+ L ++
Sbjct: 193 ESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 242
Query: 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+P N +E+ ++ CW+E P RP+F QI+ L
Sbjct: 243 EKPL--NCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-22
Identities = 81/270 (30%), Positives = 120/270 (44%), Gaps = 37/270 (13%)
Query: 31 RIGEGAHAKVYEGKYKNQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRN 85
IGEGA+ VY+ + N VA+K V + E I RE+A+L +++ H N
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFEHPN 62
Query: 86 LVKFIGAC------KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
+V+ + C +E + +V E + L YL L + R ++
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPE 195
LHSH I+HRDLKP+N+L+T D +K+ADFGLAR E +LT ++ T YR APE
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYSFEMALTSVVV--TLWYR--APE 176
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSA 254
V L+ Y VD +S + EL + F G S F + PS
Sbjct: 177 ----VLLQS----SYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSE 227
Query: 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
E P +S+ +S +F +
Sbjct: 228 EEWPRNVSLPRSSF---PSYTPRSFKSFVP 254
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-22
Identities = 76/258 (29%), Positives = 116/258 (44%), Gaps = 40/258 (15%)
Query: 50 VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC---KEPVMVIVTELLS 106
VA+K + T E + F RE+ +L +QH N+VK+ G C + +V E L
Sbjct: 36 VAVKKLQHS-TAEHLRD----FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
G+LR YL R R D + +A I + ME L S +HRDL N+L+ E +K
Sbjct: 91 YGSLRDYLQKHRERL-DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV-ESENRVK 148
Query: 167 LADFGLAR-----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAI 221
+ DFGL + +E E+ + W APE + E K ++ D +SF +
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIF-WYAPESLT-------ESK-FSVASDVWSFGV 199
Query: 222 VLWELL----HNKLP----FEGMSNLQAAYAAAF-------KNVR-PSAENVPEELSIIL 265
VL+EL + P M N + + N R P+ P E+ I+
Sbjct: 200 VLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIM 259
Query: 266 TSCWKEDPNARPNFTQII 283
CW DP+ RP+F+++
Sbjct: 260 KECWNNDPSQRPSFSELA 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 78/298 (26%), Positives = 130/298 (43%), Gaps = 67/298 (22%)
Query: 31 RIGEGAHAKV---YEGKYKNQTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRN 85
+IGEG+ V + Q VA+K + ++ K++ R EV ++ QH N
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQ-VAVKKM-------DLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 86 LVKFIGACKEPVMV-----IVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARA 137
+V+ + +V +V E L GG L + + R + VC+A+ +A
Sbjct: 78 IVEMYSS----YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAV------LKA 127
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG--------LAREESLTEMMTAETGTY 189
+ LH+ G+IHRD+K +++LLT D +KL+DFG + R +SL GT
Sbjct: 128 LSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSL-------VGTP 179
Query: 190 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH------NKLPFEGMSNLQAAY 243
WMAPE+ S + Y +VD +S I++ E++ N+ P + M ++
Sbjct: 180 YWMAPEVIS--------RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL 231
Query: 244 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 301
KN V L L DP R +++ +L+ PP ++P
Sbjct: 232 PPKLKN----LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH--PFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-22
Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 37/287 (12%)
Query: 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKE-SRFAREVAMLSRVQHR 84
L +G +GEG V EG+ +K+ K + E F E + H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 85 NLVKFIGACKE-------PVMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALD 133
N+++ IG C + P V++ + G L +LL R P+ L + + F D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA---------REESLTEMMTA 184
IA ME L S IHRDL N +L E++ + +ADFGL+ R+ + +M
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKM--- 176
Query: 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL-LHNKLPFEGMSNLQAAY 243
+W+A E + + Y K D +SF + +WE+ + P+ G+ N +
Sbjct: 177 ---PVKWIAIESLA--------DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225
Query: 244 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290
N + + L +++SCW +P RP+F + L L
Sbjct: 226 YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-22
Identities = 72/219 (32%), Positives = 107/219 (48%), Gaps = 22/219 (10%)
Query: 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA--REVAMLSRVQHR 84
G ++GEG +A VY+ + K + VAIK + GE + AK F RE+ +L ++H
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQELKHP 62
Query: 85 NLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
N++ + + + +V E + L K + + + + L R +E LHS
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIK-SYMLMTLRGLEYLHS 120
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWM-APEL-YSTV 200
+ I+HRDLKP NLL+ D +KLADFGLAR S MT + T RW APEL +
Sbjct: 121 NWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAPELLFGA- 177
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
+HY VD +S + ELL G S++
Sbjct: 178 -------RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 79/274 (28%), Positives = 128/274 (46%), Gaps = 35/274 (12%)
Query: 29 GPRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESR-------FAREVAMLS 79
G IG G+ VY G + +A+K V E P A + R ARE+A+L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQV---ELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 80 RVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
+QH N+V+++G+ + I E + GG++ LLN + V F I + +
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVR-NFVRQILKGL 119
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR-------- 190
LH+ GIIHRD+K N+L+ ++ IK++DFG++++ + T T R
Sbjct: 120 NYLHNRGIIHRDIKGANILV-DNKGGIKISDFGISKKLEANSLSTK-TNGARPSLQGSVF 177
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250
WMAPE+ ++ Y K D +S ++ E+L K PF + LQA + +N
Sbjct: 178 WMAPEVV--------KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENA 228
Query: 251 RPS-AENVPEELSIILTSCWKEDPNARPNFTQII 283
P N+ E L ++ D N RP +++
Sbjct: 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-22
Identities = 77/269 (28%), Positives = 131/269 (48%), Gaps = 23/269 (8%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF RIG+G+ +VY+G + VAIKI+ E +EI + +E+ +L
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
S+ + ++ G+ K + I+ E L GG+ L +P L+ +I +
Sbjct: 57 SQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKG 113
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-TAETGTYRWMAPEL 196
++ LHS IHRD+K N+LL+E +KLADFG+A + + T++ GT WMAPE+
Sbjct: 114 LDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE- 255
++ Y+ K D +S I EL + P + ++ + KN P+ E
Sbjct: 173 I--------KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEG 223
Query: 256 NVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ + +C +DP RP ++++
Sbjct: 224 QYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 73/264 (27%), Positives = 128/264 (48%), Gaps = 22/264 (8%)
Query: 31 RIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG+G + VY+ + VA+K V E + AK +E+ +L ++ H N++K
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--AKARQDCLKEIDLLKQLDHPNVIK 66
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHG 145
++ + + + IV EL G L + + + + R + + + + A+E +HS
Sbjct: 67 YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 203
I+HRD+KP N+ +T +KL D GL R S ++ A + GT +M+PE
Sbjct: 127 IMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI------ 178
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG-MSNLQAAYAAAFKNVRP--SAENVPEE 260
+ YN K D +S +L+E+ + PF G NL + K P A++ EE
Sbjct: 179 --HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236
Query: 261 LSIILTSCWKEDPNARPNFTQIIQ 284
L +++ C DP RP+ + ++Q
Sbjct: 237 LRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-21
Identities = 76/271 (28%), Positives = 128/271 (47%), Gaps = 29/271 (10%)
Query: 29 GPRIGEGAHAKVYEG-KYKNQTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRVQHRNL 86
G +G+GA+ VY G + Q +A+K V + A+KE EV +L ++H N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 87 VKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
V+++G C + + I E + GG++ L P L V + I + LH++
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNC 122
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLARE-------ESLTEMMTAETGTYRWMAPELYS 198
++HRD+K N++L + IKL DFG AR + + M+ + GT WMAPE+ +
Sbjct: 123 VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA-AAFKNVRPSAENV 257
+ Y K D +S ++E+ K P M L A + A + + P +
Sbjct: 182 --------ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR---L 230
Query: 258 PEELSI----ILTSCWKEDPNARPNFTQIIQ 284
P+ S +TSC D + RP+ Q+++
Sbjct: 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 98/362 (27%), Positives = 150/362 (41%), Gaps = 105/362 (29%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYE------GKYKNQ-TVAIKIVHKGETPEEI 64
+L + KW +L G +G GA KV E GK N VA+K++ +E
Sbjct: 26 QLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE- 84
Query: 65 AKKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTL----------- 110
+E+ + E+ +LS + QH+N+V +GAC PV+VI TE G L
Sbjct: 85 --REALMS-ELKILSHLGQHKNIVNLLGACTHGGPVLVI-TEYCCYGDLLNFLRKKAETF 140
Query: 111 -----------------------RKYL--------------LNMRP-------------- 119
+KY+ + MRP
Sbjct: 141 LNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDE 200
Query: 120 ------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
LD+ + F+ +A+ M+ L S IHRD+ N+LLT D + K+ DFGLA
Sbjct: 201 EDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLA 259
Query: 174 REESLTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 228
R+ + + G R WMAPE ++ V Y + D +S+ I+LWE+
Sbjct: 260 RD-IMNDSNYVVKGNARLPVKWMAPESIFDCV---------YTVQSDVWSYGILLWEIFS 309
Query: 229 -NKLPFEGM---SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
K P+ G+ S ++ RP + P E+ I+ CW +P RP F+QI Q
Sbjct: 310 LGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367
Query: 285 ML 286
++
Sbjct: 368 LI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 78/269 (28%), Positives = 134/269 (49%), Gaps = 23/269 (8%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF +IG+G+ +V++G + VAIKI+ E +EI + +E+ +L
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
S+ + K+ G+ K+ + I+ E L GG+ L P LD +I +
Sbjct: 57 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKG 113
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
++ LHS IHRD+K N+LL+E +KLADFG+A + + T++ GT WMAPE+
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE- 255
++ Y+ K D +S I EL + P + ++ + KN P+ E
Sbjct: 173 I--------KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEG 223
Query: 256 NVPEELSIILTSCWKEDPNARPNFTQIIQ 284
N + L + +C ++P+ RP ++++
Sbjct: 224 NYSKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-21
Identities = 86/277 (31%), Positives = 136/277 (49%), Gaps = 38/277 (13%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA VY Q VAIK ++ + P KKE E+ ++
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP----KKE-LIINEILVM 70
Query: 79 SRVQHRNLVKFIGA---CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
+H N+V ++ + E + +V E L+GG+L + C+D +
Sbjct: 71 RENKHPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECL 125
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG----LAREESLTEMMTAETGTYRW 191
+A+E LHS+ +IHRD+K +N+LL D ++KL DFG + E+S M GT W
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYW 181
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251
MAPE+ + +K Y KVD +S I+ E++ + P+ + L+A Y A N
Sbjct: 182 MAPEVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGT 232
Query: 252 PSAENVPEELSII----LTSCWKEDPNARPNFTQIIQ 284
P +N PE+LS I L C + D R + +++Q
Sbjct: 233 PELQN-PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 80/271 (29%), Positives = 130/271 (47%), Gaps = 38/271 (14%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIV--HKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
RIG G + VY+ + + VAIK++ G+ E I + E++ML +H N+
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ-------EISMLKECRHPNI 62
Query: 87 VKFIGA-CKEPVMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIAR----AMEC 140
V + G+ + + IV E GG+L+ Y + P ++ +A + R +
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAY-----VCRETLKGLAY 116
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELY 197
LH G IHRD+K N+LLTED +KLADFG++ + LT + GT WMAPE+
Sbjct: 117 LHETGKIHRDIKGANILLTED-GDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPEVA 173
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257
+ V + G Y+ K D ++ I EL + P + ++A + + N P
Sbjct: 174 A-VERKGG----YDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKD 228
Query: 258 PEELSII----LTSCWKEDPNARPNFTQIIQ 284
E+ S + + C +DP RP T+++Q
Sbjct: 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 83/273 (30%), Positives = 130/273 (47%), Gaps = 22/273 (8%)
Query: 22 DPKHLFVGPR-IGEGAHAKVYEGK--YKNQTVAIK-IVHKGETPEEIAKKESRFAREVAM 77
DP+ LF R IG G+ VY + N+ VAIK + + G+ E K +EV
Sbjct: 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE---KWQDIIKEVKF 78
Query: 78 LSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
L R++H N +++ G +E +V E G LL + + L +
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGALQ 136
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+ LHSH +IHRD+K N+LLTE +KLADFG A S+ + GT WMAPE+
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSA---SIASPANSFVGTPYWMAPEV 192
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 256
+ + +G+ Y+ KVD +S I EL K P M+ + A Y A +N P+ ++
Sbjct: 193 --ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPTLQS 246
Query: 257 V--PEELSIILTSCWKEDPNARPNFTQIIQMLL 287
+ + SC ++ P RP ++++ +
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 2e-21
Identities = 77/300 (25%), Positives = 118/300 (39%), Gaps = 70/300 (23%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIK-IVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNL 86
++G+G VY + K + VAIK + K + EE REV L ++ H N+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-----LREVKSLRKLNEHPNI 60
Query: 87 VKFIGACKEPVMV-----IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
VK KE V E + G L + + + + + V I + + +
Sbjct: 61 VKL----KEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ES---LTEMMTAETGTYRWMAPELY 197
H HG HRDLKPENLL++ +K+ADFGLARE S T+ ++ T YR APE
Sbjct: 116 HKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVS--TRWYR--APE-- 168
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS-------------------- 237
+ LR Y+ VD ++ ++ EL + F G S
Sbjct: 169 --ILLRST---SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223
Query: 238 ------------NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285
+ + P+A E ++ + DP RP +Q +Q
Sbjct: 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNA---SPEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 4e-21
Identities = 68/267 (25%), Positives = 126/267 (47%), Gaps = 36/267 (13%)
Query: 32 IGEGAHAKVY------EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G GA VY EG+ VAIKI+++ P K F E +++ + H +
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP----KANVEFMDEALIMASMDHPH 70
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
LV+ +G C P + +VT+L+ G L Y+ + + + + + + IA+ M L
Sbjct: 71 LVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEERR 129
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTY--RWMAPELYSTVTL 202
++HRDL N+L+ +K+ DFGLAR E + A+ G +WMA E
Sbjct: 130 LVHRDLAARNVLVKSP-NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI----- 183
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE-- 259
+ + H+ D +S+ + +WEL+ P++G+ + ++ E +P+
Sbjct: 184 ---HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------IPDLLEKGERLPQPP 234
Query: 260 ----ELSIILTSCWKEDPNARPNFTQI 282
++ +++ CW D ++RP F ++
Sbjct: 235 ICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-21
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 31 RIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+ + N+T+A+K + + E + S RE+++L +QH N+V+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVP---STAIREISLLKEMQHGNIVR 65
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYL-----LNMRPRCLDVCVAIGFALDIARAMECLH 142
E + +V E L L+K++ PR + + I R + H
Sbjct: 66 LQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKT-----YLYQILRGIAYCH 119
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVT 201
SH ++HRDLKP+NLL+ +KLADFGLAR + T E T + APE+
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG-- 177
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
+HY+ VD +S + E+++ K F G S +
Sbjct: 178 -----SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 7e-21
Identities = 81/289 (28%), Positives = 137/289 (47%), Gaps = 30/289 (10%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA VY Q VAI+ ++ + P K+ E+ ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVM 71
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
++ N+V ++ + + +V E L+GG+L + C+D + +A
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 128
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
+E LHS+ +IHRD+K +N+LL D ++KL DFG + + + + GT WMAPE+
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 256
+ +K Y KVD +S I+ E++ + P+ + L+A Y A N P +N
Sbjct: 188 VT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQN 238
Query: 257 VPEELSII----LTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 301
PE+LS I L C D R + +++Q +L P + P
Sbjct: 239 -PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH--QFLKIAKPLSSLTP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-21
Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 44/277 (15%)
Query: 32 IGEGAHAKVYEGKYKNQ----TVAIKIVHKGETPEEIAKKESR-FAREVAMLSRV-QHRN 85
IGEG +V + + K AIK + E +K + R FA E+ +L ++ H N
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDHRDFAGELEVLCKLGHHPN 57
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGF 130
++ +GAC+ + + E G L +L R D A + F
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
A D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R + + T R
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVR 176
Query: 191 WMAPEL--YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS--NLQAAYAA 245
WMA E YS Y D +S+ ++LWE++ P+ GM+ L
Sbjct: 177 WMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226
Query: 246 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 282
++ +P N +E+ ++ CW+E P RP+F QI
Sbjct: 227 GYRLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 68/279 (24%), Positives = 129/279 (46%), Gaps = 58/279 (20%)
Query: 32 IGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G GA VY+G + + VAIK + + +P+ A KE E +++ V + +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKE--ILDEAYVMASVDNPH 70
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMEC 140
+ + +G C + ++T+L+ G L Y+ + L+ CV IA+ M
Sbjct: 71 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNY 124
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---------RW 191
L ++HRDL N+L+ + + +K+ DFGLA+ ++ A+ Y +W
Sbjct: 125 LEERRLVHRDLAARNVLV-KTPQHVKITDFGLAK------LLGADEKEYHAEGGKVPIKW 177
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNV 250
MA L + Y H+ D +S+ + +WEL+ P++G+ A+ ++
Sbjct: 178 MA--------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------ASEISSI 223
Query: 251 RPSAENVPE------ELSIILTSCWKEDPNARPNFTQII 283
E +P+ ++ +I+ CW D ++RP F ++I
Sbjct: 224 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 76/268 (28%), Positives = 126/268 (47%), Gaps = 21/268 (7%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF RIG+G+ +V++G Q VAIKI+ E +EI + +E+ +L
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
S+ + K+ G+ K + I+ E L GG+ L R D +I +
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKG 113
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
++ LHS IHRD+K N+LL+E +KLADFG+A + + T++ GT WMAPE+
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 256
++ Y+ K D +S I EL + P M ++ + N
Sbjct: 173 I--------QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE 224
Query: 257 VPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ + +C +DP+ RP ++++
Sbjct: 225 FSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 81/270 (30%), Positives = 129/270 (47%), Gaps = 22/270 (8%)
Query: 22 DPKHLFVG-PRIGEGAHAKVY--EGKYKNQTVAIK-IVHKGETPEEIAKKESRFAREVAM 77
DP+ +FVG IG G+ VY + N+ VA+K + + G+ E K +EV
Sbjct: 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE---KWQDIIKEVKF 74
Query: 78 LSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
L +++H N +++ G KE +V E G LL + + L +
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGALQ 132
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+ LHSH +IHRD+K N+LLTE +KLADFG A S + + GT WMAPE+
Sbjct: 133 GLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSA---SKSSPANSFVGTPYWMAPEV 188
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 256
+ + +G+ Y+ KVD +S I EL K P M+ + A Y A +N P+ ++
Sbjct: 189 --ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLQS 242
Query: 257 --VPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ + C ++ P RP ++++
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-20
Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 20/242 (8%)
Query: 50 VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA-CKEPVMVIVTELLSGG 108
VAI + G + K+ F E L + H N+V+ G + M+IVTE +S G
Sbjct: 36 VAIHTLRAGCS----DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG 91
Query: 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168
L +L + L +G +A M+ L G +H+ L +L+ DL K++
Sbjct: 92 ALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKIS 149
Query: 169 DFGLAREESLTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226
F +E+ + T +G W APE ++ H++ D +SF IV+WE+
Sbjct: 150 GFRRLQEDKSEAIYTTMSGKSPVLWAAPE-----AIQYH---HFSSASDVWSFGIVMWEV 201
Query: 227 L-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ + + P+ MS Q A R P+ N P L ++ CW+++ RP F+QI
Sbjct: 202 MSYGERPYWDMSG-QDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260
Query: 285 ML 286
+L
Sbjct: 261 IL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-20
Identities = 59/172 (34%), Positives = 83/172 (48%), Gaps = 18/172 (10%)
Query: 122 LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
LD + F+ +A+ M L S IHRDL N+LLT + K+ DFGLAR+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIR-NDS 268
Query: 182 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEG 235
G R WMAPE +++ V Y + D +S+ I+LWE+ P+ G
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCV---------YTFESDVWSYGILLWEIFSLGSSPYPG 319
Query: 236 MSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
M Y + R S E P E+ I+ SCW DP RP F QI+Q++
Sbjct: 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-20
Identities = 85/290 (29%), Positives = 141/290 (48%), Gaps = 38/290 (13%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA V+ Q VAIK ++ + P K+ E+ ++
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-----KKELIINEILVM 70
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+++ N+V F+ + + +V E L+GG+L + C+D + +A
Sbjct: 71 KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQA 127
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG----LAREESLTEMMTAETGTYRWMA 193
+E LH++ +IHRD+K +N+LL D ++KL DFG + E+S M GT WMA
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMA 183
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253
PE+ + +K Y KVD +S I+ E++ + P+ + L+A Y A N P
Sbjct: 184 PEVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPE 234
Query: 254 AENVPEELSII----LTSCWKEDPNARPNFTQIIQ----MLLNYLSAIAP 295
+N PE+LS I L C + D R + +++Q L LS++ P
Sbjct: 235 LQN-PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 6e-20
Identities = 84/290 (28%), Positives = 140/290 (48%), Gaps = 38/290 (13%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA VY Q VAIK ++ + P K+ E+ ++
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-----KKELIINEILVM 70
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
++ N+V ++ + + +V E L+GG+L + C+D + +A
Sbjct: 71 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 127
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG----LAREESLTEMMTAETGTYRWMA 193
++ LHS+ +IHRD+K +N+LL D ++KL DFG + E+S M GT WMA
Sbjct: 128 LDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMA 183
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253
PE+ + +K Y KVD +S I+ E++ + P+ + L+A Y A N P
Sbjct: 184 PEVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPE 234
Query: 254 AENVPEELSII----LTSCWKEDPNARPNFTQIIQ----MLLNYLSAIAP 295
+N PE LS + L C + D + R + +++Q L LS++ P
Sbjct: 235 LQN-PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-20
Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 43/279 (15%)
Query: 29 GPRIGEGAHAKVYEGK-YKNQTV-AIKIV--------HKGETPEEIAKKESRFAREVAML 78
G ++G GA + Y+ + K T+ A+K V + E E + K E+ ++
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRK-------EIRLM 57
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+R+ H ++++ +GA C++ + E ++GG++ L V I + + R
Sbjct: 58 ARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRG 115
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-----TGTYRWM 192
+ LH + IIHRD+K NLL+ + +++ADFG A + E GT +M
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSN-LQAAYAAAFKN 249
APE+ LR GE+ Y D +S V+ E+ K P+ E SN L + A
Sbjct: 176 APEV-----LR-GEQ--YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 250 VRPSAENVPEELSI----ILTSCWKEDPNARPNFTQIIQ 284
PS +PE LS + C + P RP ++++
Sbjct: 228 TAPS---IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 7e-20
Identities = 69/224 (30%), Positives = 99/224 (44%), Gaps = 32/224 (14%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA+ V K + VAIK + AK R RE+ +L ++H N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK---RILREIKLLRHLRHENIIGL 64
Query: 90 IGACKEPV------MVIVTELLSGGT-LRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+ + P + IVTEL+ T L K + + +P D F I R ++ LH
Sbjct: 65 LDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQY--FLYQILRGLKYLH 120
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGT--YRWMAPEL 196
S +IHRDLKP N+L+ + +K+ DFGLAR +E +T T YR APEL
Sbjct: 121 SANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR--APEL 177
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
Y +D +S + ELL K F G +
Sbjct: 178 L-------LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-20
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKK--ESRFAREVAMLSRVQHRNLV 87
+G+G +V + K + A K + K + + K+ E E +L +V R +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDK----KRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 88 KFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
A + + +V L++GG L+ ++ N+ AI +A I +E LH I
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
++RDLKPEN+LL +D ++++D GLA E + + GT +MAPE+ +
Sbjct: 117 VYRDLKPENVLL-DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--------Q 167
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPF 233
+ Y+ VD ++ L+E++ + PF
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 8e-20
Identities = 72/212 (33%), Positives = 112/212 (52%), Gaps = 17/212 (8%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+G+ K Q VA+K + + E+ EE S RE+++L +QH N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEE--GVPSTAIREISLLKELQHPNIVC 63
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGI 146
+E + ++ E LS L+KYL ++ + +D + + I + + HS +
Sbjct: 64 LQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQG 205
+HRDLKP+NLL+ ++ IKLADFGLAR + + T E T + APE V L G
Sbjct: 123 LHRDLKPQNLLI-DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE----VLL--G 175
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237
+ Y+ VD +S + E+ K F G S
Sbjct: 176 SPR-YSTPVDIWSIGTIFAEMATKKPLFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-20
Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 26/275 (9%)
Query: 22 DPKHLFVGPR-IGEGAHAKVYEGK--YKNQTVAIK-IVHKGETPEEIAKKESRFAREVAM 77
DP+ LF R IG G+ VY + ++ VAIK + + G+ E K +EV
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRF 68
Query: 78 LSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
L +++H N +++ G +E +V E G LL + + L +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+ LHSH +IHRD+K N+LL+E +KL DFG A S+ GT WMAPE+
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSA---SIMAPANXFVGTPYWMAPEV 182
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SA 254
+ + +G+ Y+ KVD +S I EL K P M+ + A Y A +N P +
Sbjct: 183 --ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPALQS 236
Query: 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289
+ E + SC ++ P RP ++LL +
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKH 267
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 83/287 (28%), Positives = 130/287 (45%), Gaps = 47/287 (16%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG++ V + K+K Q VAIK + E + + K RE+ ML +++H NLV
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA---MREIRMLKQLRHENLVNL 65
Query: 90 IGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
I + + + +V E + L L P LD + I R +E HSH IIH
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123
Query: 149 RDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
RD+KPEN+L+++ +KL DFG AR + E+ T T + APEL G+
Sbjct: 124 RDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV------GDT 176
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY-------------------AAAFK 248
K Y VD ++ ++ E+L + F G S++ Y F
Sbjct: 177 K-YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235
Query: 249 NVR-PSAENV-PEE-----LSII----LTSCWKEDPNARPNFTQIIQ 284
+R P + + P E LS + C + DP+ RP+ +Q++
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
R+GEGA V + + KN A+K + P+ + K+ RE+ + + +VK
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQ---ILRELEINKSCKSPYIVK 63
Query: 89 FIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVC--VAIGFALDIARAMECLHS 143
+ GA + + I E GG+L ++ R + V A + + + LHS
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 203
IIHRD+KP N+LLT +KL DFG++ E + T TGT +MAPE
Sbjct: 124 RKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNSLAGTF-TGTSFYMAPERI------ 175
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234
QG K Y+ D +S + L E+ N+ PF
Sbjct: 176 QG--KPYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 70/210 (33%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK- 88
+G GA V + Q VAIK + K + +AK R RE+ +L ++H N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK---RTYRELKLLKHLRHENIISL 74
Query: 89 ---FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
FI ++ + VTELL GT LL RP L+ F I R ++ +HS G
Sbjct: 75 SDIFISPLED--IYFVTELL--GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVHSAG 128
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 205
++HRDLKP N+L+ E+ +K+ DFGLAR + MT T + APE+ T
Sbjct: 129 VVHRDLKPSNILINENCD-LKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTW----- 180
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+ Y+ +VD +S + E+L K F G
Sbjct: 181 --QKYDVEVDIWSAGCIFAEMLEGKPLFPG 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 70/242 (28%), Positives = 117/242 (48%), Gaps = 24/242 (9%)
Query: 15 LDAKWLIDPKHLF-VGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRF 71
+D L DP +F + +G G + +VY+G++ Q AIK++ E EE K E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE--- 62
Query: 72 AREVAMLSRV-QHRNLVKFIGAC--KEPV-----MVIVTELLSGGTLRKYLLNMRPRCL- 122
+ ML + HRN+ + GA K P + +V E G++ + N + L
Sbjct: 63 ---INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 123 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL-AREESLTEM 181
+ +A +I R + LH+H +IHRD+K +N+LLTE+ + +KL DFG+ A+ +
Sbjct: 120 EDWIAY-ICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRTVGR 177
Query: 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 241
GT WMAPE+ + + Y+++ D +S I E+ P M ++A
Sbjct: 178 RNTFIGTPYWMAPEV---IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234
Query: 242 AY 243
+
Sbjct: 235 LF 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIA-KKESRFAREVAMLSRVQHRNLVK 88
+G G +V+ + + A+K++ PE I K+E E +L V H +++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVM---AIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + ++ E + GG L YL N + +A +I A+E LHS I+
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKEIV 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
+RDLKPEN+LL ++ IKL DFG A++ L + GT ++APE+ +
Sbjct: 124 YRDLKPENILLDKE-GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVI--------QS 172
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEG 235
K +N VD ++ I+++E+L PF
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 20/173 (11%)
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
I ++ +AR ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 176 ISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 233
Query: 188 TYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 241
R WMAPE ++ V Y + D +SF ++LWE+ P+ G+ +
Sbjct: 234 DARLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QIDE 283
Query: 242 AYAAAFKN-VRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
+ K R A E E+ I+ CW +P RP F++++++L + L
Sbjct: 284 EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 7e-19
Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 27/280 (9%)
Query: 20 LIDPKHLF-VGPRIGEGAHAKVYEGKY--KNQTVAIKIVH-KGETPEEIAKKESRFAREV 75
L DP +F + +G G + +VY+G++ Q AIK++ G+ EEI + E+
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-------EI 53
Query: 76 AMLSRV-QHRNLVKFIGAC--KEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
ML + HRN+ + GA K P + +V E G++ + N + L
Sbjct: 54 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 113
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL-AREESLTEMMTAET 186
+I R + LH H +IHRD+K +N+LLTE+ + +KL DFG+ A+ +
Sbjct: 114 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRTVGRRNTFI 172
Query: 187 GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA 246
GT WMAPE+ + + Y+ K D +S I E+ P M ++A +
Sbjct: 173 GTPYWMAPEV---IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 229
Query: 247 FKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+N P ++ ++ + SC ++ + RP Q+++
Sbjct: 230 -RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 8e-19
Identities = 82/328 (25%), Positives = 133/328 (40%), Gaps = 69/328 (21%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEE-------IAKKESRFARE----VAML 78
+G+G+ KV E K ++ A+K++ K ++ K+ A + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 79 SRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
S Q ++ + F V E ++GG L ++ R D A +A +I +
Sbjct: 63 SCFQTKDRLFF-----------VMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGL 109
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
+ LH GII+RDLK +N+LL + IK+ADFG+ + E + +T T GT ++APE+
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEI 167
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 256
+ Y VD ++ ++L+E+L + PFEG + + VR
Sbjct: 168 L------SYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR----- 214
Query: 257 VPEELSI----ILTSCWKEDPNAR--------------PNFTQIIQMLLNYLSAIAPPEP 298
P LS IL S ++P R P F +I L P +P
Sbjct: 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKP 274
Query: 299 MIPHRI--------FNSENTILPPESPG 318
I R F E +L P
Sbjct: 275 KIKGRFDVSNFDDEFTKEKPVLTPPDEA 302
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK- 88
+G+G+ KV E K N+ AIK + K E+ + + R V L+ +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 89 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
F + + V E L+GG L ++ + D A +A +I ++ LH GII+
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEK 207
RDLK +N+LL +D IK+ADFG+ +E E + GT ++APE+ +G+K
Sbjct: 120 RDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL------KGQK 172
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEG 235
YN VD +SF ++L+E+L + PF G
Sbjct: 173 --YNESVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 66/267 (24%), Positives = 118/267 (44%), Gaps = 23/267 (8%)
Query: 32 IGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
+G G V +G YK +TVA+KI+ K + + K E RE ++ ++ + +V
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDE--LLREANVMQQLDNPYIV 59
Query: 88 KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ IG C+ ++V EL G L K+L + + + ++ M+ L +
Sbjct: 60 RMIGICEAESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLR 203
HRDL N+LL K++DFGL++ +E+ + T +W APE +
Sbjct: 118 HRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK-- 174
Query: 204 QGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 262
++ K D +SF +++WE + + P++GM + + P E+
Sbjct: 175 ------FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMY 228
Query: 263 IILTSCWKEDPNARPNFTQIIQMLLNY 289
++ CW + RP F + L NY
Sbjct: 229 DLMKLCWTYGVDERPGFAVVELRLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 69/212 (32%), Positives = 107/212 (50%), Gaps = 23/212 (10%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+G+G+ KV+ G Q A+K++ K + R E +L+ V H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFI 60
Query: 87 VKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSH 144
VK A + E + ++ + L GG L + + + F L ++A A++ LHS
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLR 203
GII+RDLKPEN+LL E+ IKL DFGL++E E GT +MAPE V R
Sbjct: 118 GIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE----VVNR 172
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+G + D +SF ++++E+L LPF+G
Sbjct: 173 RG----HTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 61/180 (33%), Positives = 91/180 (50%), Gaps = 21/180 (11%)
Query: 70 RFAREVAMLSRVQHRNLVKFIGACKEPV------MVIVTELLSGGTLRKYLLNMRPRCLD 123
R RE+ ML +H N++ + + P + +VTEL+ L K +++ +P D
Sbjct: 45 RVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSD 103
Query: 124 -VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180
V V F I R ++ LHS GI+HRD+KP NLL+ + +K+ DFGLAR E E
Sbjct: 104 HVKV---FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESK 159
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
MT E T + APE+ +HY VD +S + ELL ++ F+ S +Q
Sbjct: 160 HMTQEVVTQYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 56/171 (32%), Positives = 89/171 (52%), Gaps = 20/171 (11%)
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
I ++ +AR ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 177 ICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 234
Query: 188 TYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 241
+ R WMAPE ++ V Y + D +SF ++LWE+ P+ G+ +
Sbjct: 235 SARLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QINE 284
Query: 242 AYAAAFKN-VRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290
+ K+ R A EN E+ I+ +CW+ DP RP F+ ++++L + L
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 16/213 (7%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+ + K + VA+K + E + S RE+++L + H N+VK
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHPNIVK 63
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ E + +V E L L+K++ + + + + + + + HSH ++
Sbjct: 64 LLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGE 206
HRDLKP+NLL+ + IKLADFGLAR + T E T + APE+
Sbjct: 123 HRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC------ 175
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
K+Y+ VD +S + E++ + F G S +
Sbjct: 176 -KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LV 87
+IGEG + KVY+ + KN + VA+K E I RE+++L + +V
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP---PTALREISLLQMLSESIYIV 64
Query: 88 KFIGA------CKEPVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAM 138
+ + +P + +V E L L+K++ + R L F + + +
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELY 197
H HG++HRDLKP+NLL+ + +K+AD GL R S+ + T E T + APE+
Sbjct: 124 AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVL 183
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
T HY+ VD +S + E+ + F G S LQ
Sbjct: 184 LGST-------HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 4e-18
Identities = 78/278 (28%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 21 IDPKHLF-VGPRIGEGAHAKVYEGKYKNQTV--AIKIVHKGETPEEIAKKESRFAREVAM 77
+DP ++ + +G+GA KVY+ K K A K++ ET E ++ + E+ +
Sbjct: 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSE--EELEDYMVEIEI 62
Query: 78 LSRVQHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNM-----RPRCLDVCVAIGFA 131
L+ H +VK +GA + + I+ E GG + +L + P+ +C
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC------ 116
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYR 190
+ A++ LHS IIHRDLK N+LLT D IKLADFG++ + T + + GT
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPY 175
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250
WMAPE+ T++ Y++K D +S I L E+ + P ++ ++ A
Sbjct: 176 WMAPEVVMCETMKDTP---YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA--KS 230
Query: 251 RPSAENVPEELSI----ILTSCWKEDPNARPNFTQIIQ 284
P + P + S+ L + + P RP+ Q+++
Sbjct: 231 EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 31/175 (17%)
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
+ F +AR ME L S +HRDL N+LL + K +K+ DFGLAR+ ++
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGS 298
Query: 188 TY---RWMAPE-----LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM-- 236
T+ +WMAPE LY+T++ D +S+ I+LWE+ P+ GM
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLS-------------DVWSYGILLWEIFSLGGTPYPGMIV 345
Query: 237 -SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF---TQIIQMLL 287
S + ++ +P ++ +E+ I+ CW +P RP+F + I++ LL
Sbjct: 346 DSTFYNKIKSGYRMAKP--DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-18
Identities = 68/264 (25%), Positives = 128/264 (48%), Gaps = 16/264 (6%)
Query: 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQH 83
+ FV +G+G++ +V +++T + V K +++E + A +E +LS+++H
Sbjct: 2 YCFVRV-VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH 58
Query: 84 RNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
N+V + + + + ++ IV GG L L + + L + + + IA A++ L
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTV 200
H I+HRDLK +N+ LT IK+ D G+AR E+ +M + GT +M+PEL+S
Sbjct: 119 HEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN- 176
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260
K YN+K D ++ ++E+ K F Y + P ++ E
Sbjct: 177 -------KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPE 229
Query: 261 LSIILTSCWKEDPNARPNFTQIIQ 284
L ++ + + P RP+ I++
Sbjct: 230 LGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 72/266 (27%), Positives = 127/266 (47%), Gaps = 28/266 (10%)
Query: 46 KNQTVAIKIVHKGETPEE--IAK-------KESRFAR-EVAMLSRVQHRNLVKFIGACK- 94
+N T A + +G P+E +AK +++ +AR E+ L+ H +VK K
Sbjct: 77 RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136
Query: 95 EPVMVIVTELLSGGTLRKYL---LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 151
+ ++++ E SGG L K + L + V + F I A++ +HS ++HRDL
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLF-YQIVLALDEVHSRKMMHRDL 195
Query: 152 KPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKK 208
K N+ L IKL DFG +++ S + ++ ++ GT ++APEL+ E+K
Sbjct: 196 KSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW--------ERK 246
Query: 209 HYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSC 268
Y+ K D +S ++L+ELL PF+G S + + P V + +L
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPL 306
Query: 269 WKEDPNARPNFTQIIQM-LLNYLSAI 293
++P RP Q++ L Y++ +
Sbjct: 307 LSKNPALRPTTQQLLHTEFLKYVANL 332
|
Length = 478 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-18
Identities = 64/262 (24%), Positives = 117/262 (44%), Gaps = 24/262 (9%)
Query: 32 IGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G GA VY+G + VAIK++ + +P+ A KE E +++ V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKE--ILDEAYVMAGVGSPY 70
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
+ + +G C + +VT+L+ G L Y+ + R + + + + IA+ M L
Sbjct: 71 VCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TYRWMAPELYSTVTL 202
++HRDL N+L+ + +K+ DFGLAR + E G +WMA L
Sbjct: 130 LVHRDLAARNVLV-KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA--------L 180
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 261
+ + H+ D +S+ + +WEL+ P++G+ + P ++
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240
Query: 262 SIILTSCWKEDPNARPNFTQII 283
+I+ CW D RP F +++
Sbjct: 241 YMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-18
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + V++ K + + VA+K V + E + S RE+ +L ++H+N+V+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVR 63
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + +V E L+KY + +D + F + + + HSH ++
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSHNVL 121
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGE 206
HRDLKP+NLL+ ++ +KLADFGLAR + +AE T + P++ L
Sbjct: 122 HRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL---- 176
Query: 207 KKHYNHKVDSYSFAIVLWEL 226
Y+ +D +S + EL
Sbjct: 177 ---YSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 25/194 (12%)
Query: 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
T R L+N P L +GF+ +A ME L S +HRDL N+L+ E K +K
Sbjct: 222 ERTRRDTLINESP-ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG-KLVK 279
Query: 167 LADFGLAREESLTEMMTAETGTY---RWMAPE-----LYSTVTLRQGEKKHYNHKVDSYS 218
+ DFGLAR+ ++ T+ +WMAPE LY+T++ D +S
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS-------------DVWS 326
Query: 219 FAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNAR 276
F I+LWE+ P+ + + Y A + R + + +E+ I+ CW+E R
Sbjct: 327 FGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIR 386
Query: 277 PNFTQIIQMLLNYL 290
P+F+Q++ ++ + L
Sbjct: 387 PDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-18
Identities = 68/264 (25%), Positives = 126/264 (47%), Gaps = 20/264 (7%)
Query: 31 RIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG G ++VY + VA+K V E + A+++ +E+ +L ++ H N++K
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDC--VKEIDLLKQLNHPNVIK 66
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHG 145
++ + ++ + IV EL G L + + + R + + + + A+E +HS
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
++HRD+KP N+ +T +KL D GL R S T + GT +M+PE +
Sbjct: 127 VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE--------R 177
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEG--MSNLQAAYAAAFKNVRP-SAENVPEEL 261
+ YN K D +S +L+E+ + PF G M+ + P E+ E+L
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 262 SIILTSCWKEDPNARPNFTQIIQM 285
+++ C DP+ RP+ + Q+
Sbjct: 238 RELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-18
Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 47/269 (17%)
Query: 50 VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGG 108
VA+KI+ P+ + F +EV +LSR++ N+++ +G C E + ++TE + G
Sbjct: 49 VAVKILR----PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENG 104
Query: 109 TLRKYL--------------LNMRPRCLDVC---VAIGFALDIARAMECLHSHGIIHRDL 151
L ++L CL + AL IA M+ L S +HRDL
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 152 KPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGEKK 208
N L+ E+L TIK+ADFG++R + + RWMA E + G+
Sbjct: 165 ATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE-----CILMGK-- 216
Query: 209 HYNHKVDSYSFAIVLWELLH--NKLPFEGMSNLQAAYAAA--FKN-------VRPSAENV 257
+ D ++F + LWE+L + P+ +++ Q A F++ RP
Sbjct: 217 -FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPP--C 273
Query: 258 PEELSIILTSCWKEDPNARPNFTQIIQML 286
P+ L ++ CW D RP+F+ I L
Sbjct: 274 PQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 7e-18
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 52/228 (22%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE---IAKKESRFAREVAMLSRVQHRN 85
+IGEG + +VY+ + K + VA+K + + E +E I RE+ +L +++H N
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPIT-----AIREIKLLQKLRHPN 59
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYL-----------LNMRPRCLDVCVAI-GFALD 133
+V+ IVT G Y+ L P I +
Sbjct: 60 IVRLKE--------IVTSKGKGSI---YMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQ 108
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE------TG 187
+ ++ LHS+GI+HRD+K N+L+ D +KLADFGLAR T+ +A+ T
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLAR--PYTKRNSADYTNRVITL 165
Query: 188 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
YR PEL G + Y +VD +S +L EL K F+G
Sbjct: 166 WYR--PPELL------LGATR-YGPEVDMWSVGCILAELFLGKPIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 72/212 (33%), Positives = 106/212 (50%), Gaps = 28/212 (13%)
Query: 32 IGEGAHAKVYEGKYKNQTV--AIKIVHKGETPEEIAKKESR---FAREVAMLSRVQHRNL 86
IG+G+ KV K+K A+K++ K + I KK+ + A +L V+H L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQK----KAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 87 V----KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
V F A K + V + ++GG L +L R R A +A +IA A+ LH
Sbjct: 59 VGLHYSFQTADK---LYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLH 113
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVT 201
S II+RDLKPEN+LL + + L DFGL +E T+ GT ++APE+
Sbjct: 114 SLNIIYRDLKPENILL-DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV----- 167
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
LR K+ Y+ VD + VL+E+L+ PF
Sbjct: 168 LR---KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 7e-18
Identities = 69/208 (33%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNLV 87
IG+G+ KV K K A+K++ K + KKE A +L ++H LV
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI---LKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+ + + V + ++GG L +L R RC A +A ++A A+ LHS I
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLHSLNI 117
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQG 205
I+RDLKPEN+LL + L DFGL +E E T+ GT ++APE+ LR
Sbjct: 118 IYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPEV-----LR-- 169
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPF 233
K+ Y+ VD + VL+E+L+ PF
Sbjct: 170 -KEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 8e-18
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 57/285 (20%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G +V+ K + A+K++ K E + K R E +L+ + H L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR--NKVKRVLTEQEILATLDHPFLPTL 66
Query: 90 IGACKEPVMVI-VTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGII 147
+ + + V + GG L + LL +P +CL VA +A ++ A+E LH GI+
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFR-LLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLA----------------------REESLTEMMTAE 185
+RDLKPEN+LL E I L+DF L+ +E + E
Sbjct: 126 YRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 186 T--------GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237
GT ++APE+ S + VD ++ I+L+E+L+ PF+G S
Sbjct: 185 PSFRSNSFVGTEEYIAPEVIS--------GDGHGSAVDWWTLGILLYEMLYGTTPFKG-S 235
Query: 238 NLQAAYAAAFKNVR------PSAENVPEELSIILTSCWKEDPNAR 276
N F N+ P + V ++ +DP+ R
Sbjct: 236 NRD----ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 8e-18
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 44/282 (15%)
Query: 32 IGEGAHAKVY------EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEG KV EG + VA+K + IA +E+ +L + H N
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD----LKKEIEILRNLYHEN 67
Query: 86 LVKFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+VK+ G C E + ++ E L G+L++YL + + +++ + +A+ I + M+ L
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLG 126
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPELY 197
S +HRDL N+L+ E +K+ DFGL + +E T ++ + W APE
Sbjct: 127 SRQYVHRDLAARNVLV-ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF-WYAPECL 184
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELL----------HNKLPFEGMSNLQAAYAAAF 247
+ K Y D +SF + L+ELL L G ++ Q
Sbjct: 185 I-------QSKFYIAS-DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236
Query: 248 KNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ + P N PEE+ ++ CW+ P+ R F +I+
Sbjct: 237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 70/216 (32%), Positives = 97/216 (44%), Gaps = 34/216 (15%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G G +V + K KN+T A+K V K E ++ E +L H +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET--GQQEHIFSEKEILEECNHPFIVKL 58
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR--------AMEC 140
K+ + ++ E GG L L R R L F AR A E
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTIL---RDRGL-------FDEYTARFYIACVVLAFEY 108
Query: 141 LHSHGIIHRDLKPENLLLTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
LH+ GII+RDLKPENLLL D +KL DFG A++ + GT ++APE+
Sbjct: 109 LHNRGIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEII-- 164
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
K Y+ VD +S I+L+ELL + PF
Sbjct: 165 ------LNKGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 16/211 (7%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+ + K + VA+K + + ET +E S RE+++L + H N+V+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDE--GVPSTAIREISLLKELNHPNIVR 62
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ E + +V E L L+KY+ + LD + + + + + HSH ++
Sbjct: 63 LLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGE 206
HRDLKP+NLL+ + +KLADFGLAR + T E T + APE + L
Sbjct: 122 HRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE----ILLGS-- 174
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237
+ Y+ VD +S + E+++ + F G S
Sbjct: 175 -RQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 63/279 (22%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79
++ L +G G V++G + + +IKI +T ++ + +++ ML+
Sbjct: 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62
Query: 80 --RVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ H +V+ +G C + +VT+L G+L ++ R LD + + + IA+
Sbjct: 63 MGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKG 121
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA-------REESLTEMMTAETGTYR 190
M L H ++HR+L N+LL D +++ADFG+A ++ +E T +
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSI-VQIADFGVADLLYPDDKKYFYSEHKTP----IK 176
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKN 249
WMA E ++ + Y H+ D +S+ + +WE++ + P+ GM +
Sbjct: 177 WMALE---SILFGR-----YTHQSDVWSYGVTVWEMMSYGAEPYAGM------RPHEVPD 222
Query: 250 VRPSAENVPE------ELSIILTSCWKEDPNARPNFTQI 282
+ E + + ++ +++ CW D N RP F ++
Sbjct: 223 LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 70/275 (25%), Positives = 130/275 (47%), Gaps = 35/275 (12%)
Query: 32 IGEGAHAKVYEGKYKNQT---VAIK--IVHKGETPEEIAKKESRFAREVAMLS----RVQ 82
+G GA VY+ + KN +A+K VH ++ +++ V+ ++ +++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALD 133
H N+V++ E + IV +L+ G L ++ +++ R ++ V + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL- 126
Query: 134 IARAMECLHSHG-IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM 192
LH I+HRDL P N++L ED K + + DFGLA+++ +T+ GT +
Sbjct: 127 -----RYLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252
PE+ + E Y K D ++F +L+++ + PF + L A P
Sbjct: 181 CPEIV------KNEP--YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232
Query: 253 SAENV-PEELSIILTSCWKEDPNARPNFTQIIQML 286
E + E+++ ++TSC D ARP+ Q+ M+
Sbjct: 233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
++G+G + +V+ K K+ + VA+K + K + + E +L+ + LVK
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKK-SLLFK-LNEVRHVLTERDILTTTKSEWLVK 65
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ A ++ + + E + GG R L N+ L A + ++ A++ LH G I
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYI 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
HRDLKPEN L+ IKL DFGL++ + + G+ +MAPE+ +G+
Sbjct: 124 HRDLKPENFLIDAS-GHIKLTDFGLSKG--IVTYANSVVGSPDYMAPEVL------RGKG 174
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA--FKNV--RPSAENVPEELSI 263
Y+ VD +S +L+E L PF G S + +K RP ++ LS
Sbjct: 175 --YDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSD 231
Query: 264 ----ILTSCWKEDPNARPNFTQIIQM 285
++T + + I
Sbjct: 232 EAWDLITKLINDPSRRFGSLEDIKNH 257
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 69/264 (26%), Positives = 124/264 (46%), Gaps = 20/264 (7%)
Query: 31 RIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG G ++VY VA+K V + + AK + +E+ +L ++ H N++K
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNHPNVIK 66
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHG 145
+ + ++ + IV EL G L + + + + R + + + + A+E +HS
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
++HRD+KP N+ +T +KL D GL R S T + GT +M+PE +
Sbjct: 127 VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE--------R 177
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEG-MSNLQAAYAAAFKNVRP--SAENVPEEL 261
+ YN K D +S +L+E+ + PF G NL + + P +++ EEL
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 262 SIILTSCWKEDPNARPNFTQIIQM 285
++ C DP RP+ T + +
Sbjct: 238 RQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIK-IVHKGETP--EEIAKKESRFAREVAMLSRVQHRN 85
+IGEG++ V++ + + Q VAIK V + P ++IA RE+ ML +++H N
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA------LREIRMLKQLKHPN 61
Query: 86 LVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV I + + +V E L + L PR + + +A+ H H
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM-APELYSTVTLR 203
IHRD+KPEN+L+T+ IKL DFG AR + + RW APEL T
Sbjct: 120 NCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT-- 176
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 243
Y VD ++ V ELL + + G S++ Y
Sbjct: 177 -----QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-17
Identities = 64/256 (25%), Positives = 124/256 (48%), Gaps = 21/256 (8%)
Query: 40 VYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMV 99
VY+ + K VAIK++ E+ + E RE ++ ++ + +V+ IG C+ ++
Sbjct: 15 VYKMRKKQIDVAIKVLKNEN--EKSVRDE--MMREAEIMHQLDNPYIVRMIGVCEAEALM 70
Query: 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159
+V E+ SGG L K+L + + V + ++ M+ L +HRDL N+LL
Sbjct: 71 LVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV 129
Query: 160 EDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 215
+ K++DFGL++ ++S + +A +W APE + R+ ++ + D
Sbjct: 130 -NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE---CINFRK-----FSSRSD 180
Query: 216 SYSFAIVLWELL-HNKLPFEGMSNLQA-AYAAAFKNVRPSAENVPEELSIILTSCWKEDP 273
+S+ I +WE + + P++ M + ++ K + AE P E+ ++ CW
Sbjct: 181 VWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAE-CPPEMYALMKDCWIYKW 239
Query: 274 NARPNFTQIIQMLLNY 289
RPNF ++ + + Y
Sbjct: 240 EDRPNFAKVEERMRTY 255
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 60/217 (27%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVH---KGETPEEIAKKESRFAREVAMLSRVQHRN 85
++GEG +A VY+G+ + + VA+K +H + TP S RE++++ ++H N
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP-------STAIREISLMKELKHEN 59
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYL-LNMRPRCLDVCVAIGFALDIARAMECLHS 143
+V+ E +++V E + L+KY+ + LD F + + + H
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPE-LYSTVT 201
+ ++HRDLKP+NLL+ + +KLADFGLAR + + E T + AP+ L + T
Sbjct: 119 NRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 238
Y+ +D +S ++ E++ + F G +N
Sbjct: 178 --------YSTSIDIWSVGCIMAEMITGRPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-17
Identities = 77/265 (29%), Positives = 128/265 (48%), Gaps = 28/265 (10%)
Query: 32 IGEGAHAKVYEGKYKNQTV--AIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+GA KVY+ + K V A K++ ++ EE+ + E+ +L+ H N+VK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDT-KSEEELED----YMVEIDILASCDHPNIVKL 67
Query: 90 IGACK-EPVMVIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHS 143
+ A E + I+ E +GG + +L + P+ VC A+ LH
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCK------QTLEALNYLHE 121
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTL 202
+ IIHRDLK N+L T D IKLADFG++ + + T + + GT WMAPE+ V
Sbjct: 122 NKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV---VMC 177
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE--- 259
+ + Y++K D +S I L E+ + P ++ ++ A K+ P+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTLAQPSRWSS 236
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQ 284
E L C +++ +AR TQ++Q
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 66/208 (31%), Positives = 108/208 (51%), Gaps = 16/208 (7%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK- 88
+G+G+ KV+ + K NQ AIK + K + + + + V L+ +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHL 61
Query: 89 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + + V E L+GG L ++ + D+ A +A +I ++ LHS GI++
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEK 207
RDLK +N+LL D IK+ADFG+ +E L + T GT ++APE+ G+K
Sbjct: 120 RDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL------LGQK 172
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEG 235
YN VD +SF ++L+E+L + PF G
Sbjct: 173 --YNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-17
Identities = 54/154 (35%), Positives = 81/154 (52%), Gaps = 27/154 (17%)
Query: 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157
+ +V E + GG L N+ +D+ + FA + A+E LH++GI+HRDLKP+NLL
Sbjct: 76 LCMVMEYVEGGDCATLLKNIGALPVDM-ARMYFA-ETVLALEYLHNYGIVHRDLKPDNLL 133
Query: 158 LTEDLKTIKLADFGLAR---------------EESLTEMMTAET-GTYRWMAPELYSTVT 201
+T + IKL DFGL++ E+ E + + GT ++APE V
Sbjct: 134 ITS-MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE----VI 188
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
LRQG Y VD ++ I+L+E L +PF G
Sbjct: 189 LRQG----YGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-17
Identities = 75/245 (30%), Positives = 118/245 (48%), Gaps = 27/245 (11%)
Query: 32 IGEGAHAKVYEGK-YKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRN 85
IGEGA+ KV++ + KN + VA+K V + +T EE + REVA+L ++ H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLST--IREVAVLRHLETFEHPN 65
Query: 86 LVKFIGAC------KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
+V+ C +E + +V E + L YL + + + R ++
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
LHSH ++HRDLKP+N+L+T IKLADFGLAR S +T+ T + APE+
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV--- 180
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 258
L Q Y VD +S + E+ K F G S++ + P E+ P
Sbjct: 181 --LLQSS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWP 234
Query: 259 EELSI 263
++++
Sbjct: 235 RDVAL 239
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-17
Identities = 66/257 (25%), Positives = 128/257 (49%), Gaps = 19/257 (7%)
Query: 32 IGEGA--HAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG+ A + + +Q A+K + ++ + ++SR +E +L++++H N+V F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV--EDSR--KEAVLLAKMKHPNIVAF 63
Query: 90 IGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + + + IV E GG L + + R + + + + + ++ +H ++H
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGE 206
RD+K +N+ LT++ K +KL DFG AR + + A T GT ++ PE++ E
Sbjct: 124 RDIKSKNIFLTQNGK-VKLGDFGSARLLT-SPGAYACTYVGTPYYVPPEIW--------E 173
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 266
YN+K D +S +L+EL K PF+ S + +P + EL ++
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIK 233
Query: 267 SCWKEDPNARPNFTQII 283
+K +P +RP+ T I+
Sbjct: 234 QMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-17
Identities = 76/286 (26%), Positives = 130/286 (45%), Gaps = 43/286 (15%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNL 86
+IGEG+ V K+ + VA+K + ++ K++ R EV ++ QH N+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKM-------DLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 87 VKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLH 142
V+ + + +V E L GG L + + R + VC+A+ +A+ LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAV------LKALSVLH 133
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYSTVT 201
+ G+IHRD+K +++LLT D + +KL+DFG A+ + GT WMAPEL S +
Sbjct: 134 AQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLH------NKLPFEGMSNLQAAYAAAFKNVRPSAE 255
Y +VD +S I++ E++ N+ P + M ++ KN
Sbjct: 193 --------YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKN----LH 240
Query: 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 301
V L L DP R ++++ +L+ PP ++P
Sbjct: 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-17
Identities = 69/271 (25%), Positives = 115/271 (42%), Gaps = 17/271 (6%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IG G KV G+ ++V K ++ F +EV + H N+++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 92 ACKEPV-MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGII 147
C E + ++V E G L+ YL + R + V A ++A + LH I
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI 122
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTY--RWMAPELYSTVTLRQ 204
H DL N LT DL ++K+ D+GLA E+ + +T + RW+APEL
Sbjct: 123 HSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL 181
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQA-AYAAAFKNVRPSAENVPEELS 262
K K + +S + +WEL P+ +S+ Q ++++ + + S
Sbjct: 182 LPKDQ-TKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240
Query: 263 I----ILTSCWKEDPNARPNFTQIIQMLLNY 289
++ CW DP RP + + LL Y
Sbjct: 241 DRWYEVMQFCWL-DPETRPTAEE-VHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 62/285 (21%), Positives = 118/285 (41%), Gaps = 59/285 (20%)
Query: 32 IGEGAHAKVYEGKYKNQT------------VAIKIVHKGETPEEIAKKESRFAREVAMLS 79
+G+G +Y+G + Q+ V +K++ F +++S
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL------AFFETASLMS 56
Query: 80 RVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI----A 135
++ H++LVK G C ++V E + G L +L + V++ + LD+ A
Sbjct: 57 QLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLA 111
Query: 136 RAMECLHSHGIIHRDLKPENLLLT-EDLKT-----IKLADFGLAREESLTEMMTAETGTY 189
A+ L ++H ++ +N+L+ L IKL+D G+ +T +
Sbjct: 112 SALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--------ITVLSREE 163
Query: 190 R-----WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAY 243
R W+APE + + D +SF L E+ N + P +S+ +
Sbjct: 164 RVERIPWIAPECI------RNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER 217
Query: 244 AAAFKNVRPSAENVPE--ELSIILTSCWKEDPNARPNFTQIIQML 286
++ P +P+ EL+ ++ CW DP RP+F I++ L
Sbjct: 218 FYQDQHRLP----MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 42/137 (30%), Positives = 79/137 (57%), Gaps = 9/137 (6%)
Query: 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157
+ +V L++GG L+ ++ N+ R L++ I ++ I + LHS I++RD+KPEN+L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 158 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 217
L +D +L+D GLA E + +T GT +MAPE+ +++ Y++ VD +
Sbjct: 128 L-DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--------KEEPYSYPVDWF 178
Query: 218 SFAIVLWELLHNKLPFE 234
+ ++E++ + PF+
Sbjct: 179 AMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 25/244 (10%)
Query: 29 GPRIGEGAHAKV---YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
G +G+GA +V Y+ + A ++ E+PE +K+ S E+ +L +QH
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE-TSKEVSALECEIQLLKNLQHER 65
Query: 86 LVKFIGACK---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+V++ G + E + I E + GG+++ L L V + I M LH
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH 123
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYS 198
S+ I+HRD+K N +L + +KL DFG ++ M + + TGT WM+PE+ S
Sbjct: 124 SNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258
GE Y K D +S + E+L K P+ + A + A +P+ +P
Sbjct: 183 ------GEG--YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTNPQLP 231
Query: 259 EELS 262
+S
Sbjct: 232 SHIS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 74/255 (29%), Positives = 119/255 (46%), Gaps = 35/255 (13%)
Query: 23 PKHLFVGPRIGEGAHAKVYEGKYKNQT---VAIKIVHKGETPEEIAKKESRFAREVAMLS 79
P + +G +G+GA +VY Y T +A+K V E +K+ + E+ +L
Sbjct: 1 PTNWRLGKLLGQGAFGRVYLC-YDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLK 59
Query: 80 RVQHRNLVKFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+ H +V++ G ++P + I E + GG+++ L + L V + I
Sbjct: 60 NLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILE 117
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-----ESLTEMMTAETGTYRW 191
+ LHS+ I+HRD+K N +L + + +KL DFG ++ S T M + TGT W
Sbjct: 118 GVSYLHSNMIVHRDIKGAN-ILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGTPYW 175
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP---FEGMSNLQAAYAAAFK 248
M+PE+ S GE Y K D +S + E+L K P FE M AA FK
Sbjct: 176 MSPEVIS------GEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFK 220
Query: 249 -NVRPSAENVPEELS 262
+P+ +P +S
Sbjct: 221 IATQPTNPVLPPHVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 68/246 (27%), Positives = 110/246 (44%), Gaps = 33/246 (13%)
Query: 48 QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI--GACKEPVMVIVTELL 105
VAIK++ + + PEE + +RF RE A+ +R+ H N+V + G ++ V E +
Sbjct: 4 HEVAIKLL-RTDAPEE-EHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL--TEDLK 163
G TLR+ L L L + A+ C H+ GI+HRDLKP+N+++ T
Sbjct: 62 PGRTLREVLAADGA--LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 164 TIKLADFGLAR-----EESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNHKVD 215
K+ DFG+ ++ +T T GT + APE LR GE D
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-----QLR-GEPV--TPNSD 171
Query: 216 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE-----ELSIILTSCWK 270
Y++ ++ E L + +G S + Y + + P ++P L +L
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAEILY----QQLSPVDVSLPPWIAGHPLGQVLRKALN 227
Query: 271 EDPNAR 276
+DP R
Sbjct: 228 KDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 52/171 (30%), Positives = 87/171 (50%), Gaps = 10/171 (5%)
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
K E+ E +L +V R +V A + + + +V L++GG L+ ++ NM D
Sbjct: 42 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE 101
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184
A+ +A +I +E LH I++RDLKPEN+LL +D I+++D GLA E E +
Sbjct: 102 ERAVFYAAEITCGLEDLHRERIVYRDLKPENILL-DDYGHIRISDLGLAVEIPEGETIRG 160
Query: 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
GT +MAPE+ + + Y D + +++E++ K PF
Sbjct: 161 RVGTVGYMAPEVV--------KNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 3e-16
Identities = 61/214 (28%), Positives = 110/214 (51%), Gaps = 20/214 (9%)
Query: 31 RIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
++GEG++A VY+G + Q VA+K++ +T E + RE ++L ++H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISM-KTEEGVPFTA---IREASLLKGLKHANIVL 67
Query: 89 F--IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
I KE + + + + L +Y++ P L F + R + +H I
Sbjct: 68 LHDIIHTKETLTFVFEYMHT--DLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQG 205
+HRDLKP+NLL++ L +KLADFGLAR +S+ ++ ++E T + P++ T
Sbjct: 125 LHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT---- 179
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
Y+ +D + + E+L + F G+S++
Sbjct: 180 ---DYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 62/245 (25%), Positives = 105/245 (42%), Gaps = 44/245 (17%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFA------ 72
I +++ G +GEG + KV + + VAIK V E ++ K
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65
Query: 73 ---REVAMLSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDV---C 125
RE+ +++ ++H N++ + + + +V ++++ L+K +++ + R + C
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKK-VVDRKIRLTESQVKC 123
Query: 126 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----------- 174
+ L I + LH +HRDL P N+ + K+ADFGLAR
Sbjct: 124 IL----LQILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTL 178
Query: 175 ----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 230
E MT++ T + APEL L EK Y+ VD +S + ELL K
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPEL-----LMGAEK--YHFAVDMWSVGCIFAELLTGK 231
Query: 231 LPFEG 235
F G
Sbjct: 232 PLFPG 236
|
Length = 335 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 5e-16
Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRNL 86
IG GA+ VY+ + + VA+K V + +T E+ + REVA+L R++ H N+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLST--VREVALLKRLEAFDHPNI 64
Query: 87 VKFIGAC------KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
V+ + C +E + +V E + LR YL + P L R ++
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
LH++ I+HRDLKPEN+L+T +KLADFGLAR S +T T + APE+
Sbjct: 124 LHANCIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS 182
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237
T Y VD +S + E+ K F G S
Sbjct: 183 T--------YATPVDMWSVGCIFAEMFRRKPLFCGNS 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 24/267 (8%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRVQHRNLVK-- 88
I E +Y+G + N+ V I+ K + K E+ L R+ N++K
Sbjct: 28 IKENDQNSIYKGIFNNKEVIIRTFKK---FHKGHKVLIDITENEIKNLRRIDSNNILKIY 84
Query: 89 --FIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SH 144
I + P + ++ E + G LR+ L + + L + A+D + + L+
Sbjct: 85 GFIIDIVDDLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYT 142
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
+++L + L+TE+ K K+ GL + S Y + ++ + +
Sbjct: 143 NKPYKNLTSVSFLVTENYKL-KIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIF--- 196
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAENVPEELS 262
Y K D YS +VLWE+ K+PFE ++ + Y + P E+
Sbjct: 197 ---SEYTIKDDIYSLGVVLWEIFTGKIPFENLT-TKEIYDLIINKNNSLKLPLDCPLEIK 252
Query: 263 IILTSCWKEDPNARPNFTQIIQMLLNY 289
I+ +C D RPN +I+ L Y
Sbjct: 253 CIVEACTSHDSIKRPNIKEILYNLSLY 279
|
Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 7e-16
Identities = 67/292 (22%), Positives = 111/292 (38%), Gaps = 53/292 (18%)
Query: 31 RIGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLV 87
IG GA +V+ K Q A+K++ K + I + + R E +L+ +V
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM---IKRNQIAHVRAERDILADADSPWIV 64
Query: 88 KFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
K + + E + +V E + GG L L+ A + ++ A++ +H G
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGF 122
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLA-------------REESLTEMMTAET------- 186
IHRD+KP+N+L+ D IKLADFGL +
Sbjct: 123 IHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 187 ----------GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 236
GT ++APE V Y + D +S ++L+E+L+ PF
Sbjct: 182 QRRVRANSTVGTPDYIAPE----VLRGTP----YGLECDWWSLGVILYEMLYGFPPFYS- 232
Query: 237 SNLQAAYA--AAFKN--VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
LQ Y +K P V E ++ + + +F +I
Sbjct: 233 DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKS 284
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 22/174 (12%)
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
I ++ +A+ ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 182 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 239
Query: 188 TYR----WMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA 241
R WMAPE ++ V Y + D +SF ++LWE+ P+ G+ +
Sbjct: 240 DARLPLKWMAPETIFDRV---------YTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDE 289
Query: 242 AYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
+ K +R PE +L CW +P+ RP F+++++ L N L A
Sbjct: 290 EFCRRLKEGTRMRAPDYTTPEMYQTML-DCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 9e-16
Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 25/170 (14%)
Query: 74 EVAMLSRVQHRNLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNM--------RPRCLDV 124
E +L++V R +V A + + +V +++GG LR ++ N+ PR
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPR---- 98
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT- 183
A + I +E LH II+RDLKPEN+LL D ++++D GLA E + T
Sbjct: 99 --ACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTK 155
Query: 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
GT +MAPEL QGE+ Y+ VD ++ + L+E++ + PF
Sbjct: 156 GYAGTPGFMAPELL------QGEE--YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 74/229 (32%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 28 VGPR------IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79
VGPR IGEGA+ V +K VAIK + P E R RE+ +L
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS----PFEHQTFCQRTLREIKILR 58
Query: 80 RVQHRNLVKFIGACKEPV------MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
R +H N++ + + P + IV EL+ + L+ + D F
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYK--LIKTQHLSNDHIQY--FLYQ 114
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAR----EESLTEMMTAETG 187
I R ++ +HS ++HRDLKP NLLL DL K+ DFGLAR E T +T
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDL---KICDFGLARIADPEHDHTGFLTEYVA 171
Query: 188 TYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
T RW APE+ K Y +D +S +L E+L N+ F G
Sbjct: 172 T-RWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 28/269 (10%)
Query: 32 IGEGAHAKVYE--GKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G + KVY+ K A+KI+ +E + E + + H N+VKF
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNVVKF 84
Query: 90 IGA------CKEPVMVIVTELLSGGT---LRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
G + +V EL +GG+ L K LL R LD + ++
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQH 143
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-MTAETGTYRWMAPELYST 199
LH++ IIHRD+K N+LLT + +KL DFG++ + + T + GT WMAPE+
Sbjct: 144 LHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV--- 199
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259
+ Q Y+ + D +S I EL P M ++ + +N P+ + PE
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP-RNPPPTLLH-PE 257
Query: 260 ----ELSIILTSCWKEDPNARPNFTQIIQ 284
+ ++ C +D ARP+ T +++
Sbjct: 258 KWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 68/224 (30%), Positives = 100/224 (44%), Gaps = 24/224 (10%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+D K++ + P IG GA+ V K N+ VAIK + AK R RE+ +L
Sbjct: 3 VDTKYVPIKP-IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAK---RTLREIKLL 58
Query: 79 SRVQHRNLVKFIGACKEPVM------VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+ H N++ P IV EL+ L + + + + D C F
Sbjct: 59 RHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQY--FLY 115
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRW 191
+ R ++ +HS ++HRDLKP NLLL + +K+ DFGLAR S + MT T +
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSEKGDFMTEYVVTRWY 174
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
APEL + Y +D +S + ELL K F G
Sbjct: 175 RAPELLLNCS-------EYTTAIDVWSVGCIFAELLGRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 32 IGEGAHAKVYE-----GKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+G+G + KV++ G + A+K++ K K + E +L V+H +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN-QKDTAHTKAERNILEAVKHPFI 62
Query: 87 VKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
V I A + + ++ E LSGG L +L R A + +I+ A+E LH G
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 203
II+RDLKPEN+LL +KL DFGL + ES+ E T GT +MAPE+ R
Sbjct: 121 IIYRDLKPENILLDAQ-GHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILM----R 174
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
G + VD +S +++++L PF
Sbjct: 175 SG----HGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 69/209 (33%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 32 IGEGAHAKVYEGKYKNQTV--AIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV-- 87
IG+G+ KV ++K + A+K++ K ++ +K R V +L V+H LV
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGL 61
Query: 88 --KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
F A K + V + ++GG L +L R RC A +A +IA A+ LHS
Sbjct: 62 HFSFQTADK---LYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLN 116
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQ 204
I++RDLKPEN+LL + I L DFGL +E T+ GT ++APE+
Sbjct: 117 IVYRDLKPENILL-DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL------- 168
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
K+ Y+ VD + VL+E+L+ PF
Sbjct: 169 -HKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 70/223 (31%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
RIGEG + VY + + VA+K V + I RE+ +L ++H N+V+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS---LREITLLLNLRHPNIVE 70
Query: 89 FIGACKEPVMVIVTELLSG---------GTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
KE V+V + L L L NM P L + R ++
Sbjct: 71 L----KE---VVVGKHLDSIFLVMEYCEQDLASLLDNM-PTPFSESQVKCLMLQLLRGLQ 122
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYS 198
LH + IIHRDLK NLLLT D +K+ADFGLAR + MT + T + APEL
Sbjct: 123 YLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 241
T Y +D ++ +L ELL +K G S ++
Sbjct: 182 GCT-------TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 35/228 (15%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIK------IVHKGETPEEIAKKESRFAREVAMLSR 80
+G GA+ KV+ G + A+K IV K +T E +R R+V L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH-----TRTERQV--LEA 60
Query: 81 VQHRN-LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNM-RPRCLDVCVAIGFALDIARA 137
V+ LV A + + + ++ + ++GG L +L +V V I +I A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA---EIVLA 117
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPE 195
++ LH GII+RD+K EN+LL + + L DFGL++E E A + GT +MAPE
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQA 241
+ +R G H + VD +S ++ +ELL PF +G N Q+
Sbjct: 177 V-----IRGGSGGH-DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVA 76
W + ++ + P +G GA+ +V + VAIK K P + A R RE+
Sbjct: 11 WEVPDRYQNLSP-VGSGAYGQVCSAFDTKTGRKVAIK---KLSRPFQSAIHAKRTYRELR 66
Query: 77 MLSRVQHRNLVKFIGACKEPV-------MVIVTELLSGGTLRKYLLNMRPRCLD---VCV 126
+L + H N++ + + +VT L+ G L ++ + L +
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNI---VKCQKLSDDHIQF 122
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET 186
+ I R ++ +HS GIIHRDLKP N+ + ED + +K+ DFGLAR + MT
Sbjct: 123 LV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLAR--HTDDEMTGYV 176
Query: 187 GTYRW-MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
T RW APE + L HYN VD +S ++ ELL K F G
Sbjct: 177 AT-RWYRAPE----IML---NWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 131 ALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM--TAETG 187
A+ I +A+E LHS +IHRD+KP N+L+ + + +KL DFG++ L + + T + G
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-VKLCDFGISGY--LVDSVAKTIDAG 165
Query: 188 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 247
+MAPE + + +K Y+ K D +S I + EL + P++
Sbjct: 166 CKPYMAPERINP----ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221
Query: 248 KNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285
+ P AE E + C K++ RPN+ +++Q
Sbjct: 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 72/254 (28%), Positives = 120/254 (47%), Gaps = 33/254 (12%)
Query: 23 PKHLFVGPRIGEGAHAKVYEGKYKNQT---VAIKIVHKGETPEEIAKKESRFAREVAMLS 79
P + +G +G GA +VY Y T +A+K V +E +K+ + E+ +L
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLC-YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLK 59
Query: 80 RVQHRNLVKFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
++H +V++ G ++P + I E + GG+++ L L V + I +
Sbjct: 60 NLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQ 117
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM----MTAETGTYRWM 192
+ LHS+ I+HRD+K N +L + +KL DFG ++ M + + TGT WM
Sbjct: 118 GVSYLHSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP---FEGMSNLQAAYAAAFK- 248
+PE+ S GE Y K D +S A + E+L K P +E M AA FK
Sbjct: 177 SPEVIS------GEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKI 221
Query: 249 NVRPSAENVPEELS 262
+P+ +P+ +S
Sbjct: 222 ATQPTKPMLPDGVS 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 77/288 (26%), Positives = 134/288 (46%), Gaps = 47/288 (16%)
Query: 31 RIGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNL 86
+IGEG+ V K+ + VA+K++ ++ K++ R EV ++ QH+N+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMM-------DLRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 87 VKFIGA--CKEPVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECL 141
V+ + E + V++ E L GG L + R + VC ++ +A+ L
Sbjct: 81 VEMYKSYLVGEELWVLM-EFLQGGALTDIVSQTRLNEEQIATVCESV------LQALCYL 133
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTV 200
HS G+IHRD+K +++LLT D + +KL+DFG + S + GT WMAPE+ S
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS-- 190
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR----PSAEN 256
+ Y +VD +S I++ E++ + P+ S +Q A K +R P +N
Sbjct: 191 ------RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRLRDSPPPKLKN 239
Query: 257 ---VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 301
+ L L +P R +++ +L PE ++P
Sbjct: 240 AHKISPVLRDFLERMLTREPQERATAQELLDH--PFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 67/237 (28%), Positives = 114/237 (48%), Gaps = 20/237 (8%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+P+H + + R+G G + VY+ + + + A+KI+ K E ++ S +E+ M+
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDF----SLIQQEIFMV 60
Query: 79 SRVQHRNLVKFIGA--CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+H N+V + G+ +E + I E GG+L+ P L + +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLW-ICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQ 117
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPE 195
+ LHS G +HRD+K N+LLT D +KLADFG+A + + T + GT WMAPE
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252
+ + V G YN D ++ I EL + P + ++A + + N +P
Sbjct: 177 V-AAVEKNGG----YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 70/232 (30%), Positives = 103/232 (44%), Gaps = 53/232 (22%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA----REVAMLSRVQHR 84
RI EG + VY + K + VA+K + ++ K++ F RE+ +L ++QH
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKL-------KMEKEKEGFPITSLREINILLKLQHP 64
Query: 85 NLVKFIGACKEPVM-------VIVTELLSGGTLRKYLLNMRPR-------CLDVCVAIGF 130
N+V KE V+ +V E + L+ + M+ CL
Sbjct: 65 NIVTV----KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCL-------- 111
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT- 188
L + + LH + I+HRDLK NLLL +K+ DFGLARE S + T T
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLKPYTQLVVTL 170
Query: 189 -YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
YR APEL G K+ Y+ +D +S + ELL K F G S +
Sbjct: 171 WYR--APELL------LGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 57/271 (21%)
Query: 50 VAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELL 105
VA+K++ E A K +R F +E+ ++SR++ N+++ + C +P+ +I TE +
Sbjct: 49 VAVKML------REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMI-TEYM 101
Query: 106 SGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 156
G L ++L P + I A IA M+ L S +HRDL N
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161
Query: 157 LLTEDLKTIKLADFGLAREESLTEMMTAETGTY-----------RWMAPELYSTVTLRQG 205
L+ ++ TIK+ADFG++R +G Y RWM+ E ++ L +
Sbjct: 162 LVGKNY-TIKIADFGMSR--------NLYSGDYYRIQGRAVLPIRWMSWE---SILLGK- 208
Query: 206 EKKHYNHKVDSYSFAIVLWELLH--NKLPFEGMSNLQAAYAAA--FKNVR-----PSAEN 256
+ D ++F + LWE+L + P+ +S+ Q F++ P
Sbjct: 209 ----FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPAL 264
Query: 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLL 287
P+ L ++ SCW+ + RP+F +I LL
Sbjct: 265 CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-15
Identities = 59/261 (22%), Positives = 115/261 (44%), Gaps = 36/261 (13%)
Query: 50 VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGG 108
VA+K++ + + F +E+ ++SR+++ N+++ +G C + + ++TE + G
Sbjct: 47 VAVKMLR----ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG 102
Query: 109 TLRKYLLNMRPR----------CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 158
L ++L + + + A+ IA M+ L S +HRDL N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 159 TEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNHKVD 215
TIK+ADFG++R + + RWMA + ++ L + + D
Sbjct: 163 GNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA---WESILLGK-----FTTASD 213
Query: 216 SYSFAIVLWEL--LHNKLPFEGMSNLQAA------YAAAFKNVRPSAENV-PEELSIILT 266
++F + LWE+ L + P+ +S+ Q + + + S + P + ++
Sbjct: 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMM 273
Query: 267 SCWKEDPNARPNFTQIIQMLL 287
CW D RP F +I L
Sbjct: 274 RCWSRDIKDRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 74/270 (27%), Positives = 123/270 (45%), Gaps = 30/270 (11%)
Query: 32 IGEGAHAKVYE--GKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G + KV++ K A+KI+ +E + E + ++ H N+VKF
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKF 80
Query: 90 IGAC-KEPV-----MVIVTELLSGGT---LRKYLLNMRPRCLDVCVAIGFALDIA-RAME 139
G K+ V + +V EL +GG+ L K L R + +A + L A ++
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA--YILHEALMGLQ 138
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-MTAETGTYRWMAPELYS 198
LH + IHRD+K N+LLT + +KL DFG++ + + T + GT WMAPE+
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV-- 195
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258
+ Q Y+ + D +S I EL P + ++A + +N P+ P
Sbjct: 196 -IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP-RNPPPTLHQ-P 252
Query: 259 E----ELSIILTSCWKEDPNARPNFTQIIQ 284
E E + + C +D RP + ++Q
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 68/216 (31%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 32 IGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA V Q VAIK K P + R RE+ ++ V H+N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR------AMEC--- 140
+ T S + L M ++C I LD R M C
Sbjct: 81 LNV--------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIK 132
Query: 141 -LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
LHS GIIHRDLKP N+++ D T+K+ DFGLAR + MMT T + APE
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE---- 187
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
V L G Y VD +S ++ E++ + F G
Sbjct: 188 VILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 68/216 (31%), Positives = 99/216 (45%), Gaps = 33/216 (15%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G GA+ V K + VAIK + + E AK R RE+ +L +QH N++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAK---RAYRELTLLKHMQHENVIGL 79
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD----------IARAME 139
+ + T +SG + + L M D+ +G L + ++
Sbjct: 80 LD--------VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
+HS GIIHRDLKP NL + ED + +K+ DFGLAR MT T + APE
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR--HADAEMTGYVVTRWYRAPE---- 184
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
V L HYN VD +S ++ E+L K F+G
Sbjct: 185 VILNW---MHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-15
Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 10/171 (5%)
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
K ES E +L +V + +V A + + + +V +++GG L+ ++ NM +
Sbjct: 42 KGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE 101
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184
A+ +A +I +E LH ++RDLKPEN+LL +D I+++D GLA + E +
Sbjct: 102 ERALFYAAEILCGLEDLHRENTVYRDLKPENILL-DDYGHIRISDLGLAVKIPEGESIRG 160
Query: 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
GT +MAPE+ + + Y D + +++E++ + PF G
Sbjct: 161 RVGTVGYMAPEVLNN--------QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 6e-15
Identities = 87/318 (27%), Positives = 135/318 (42%), Gaps = 61/318 (19%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML---SRVQHRNL 86
+G+G KV K + A+KI+ K E I K+ EVA SRV
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKD-----EVAHTVTESRVLQNTR 53
Query: 87 VKFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
F+ A K + V E +GG L +L R R A + +I A+E L
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYL 111
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYST 199
HS +++RD+K ENL+L +D IK+ DFGL + E +++ T +T GT ++APE+
Sbjct: 112 HSRDVVYRDIKLENLMLDKD-GHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVL-- 167
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259
E Y VD + +V++E++ +LPF + + + +R PE
Sbjct: 168 ------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 221
Query: 260 ELSIILTSCWKEDPNAR----PNFTQIIQMLLNYLSAIAPPEPMIPHRIFNS-------E 308
S +L K+DP R P+ + + HR F S +
Sbjct: 222 AKS-LLAGLLKKDPKQRLGGGPSDAKEVME----------------HRFFLSINWQDVVQ 264
Query: 309 NTILPPESPGTSSLMTVR 326
+LPP P +S + R
Sbjct: 265 KKLLPPFKPQVTSEVDTR 282
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 7e-15
Identities = 46/113 (40%), Positives = 58/113 (51%), Gaps = 20/113 (17%)
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR------EESLTEMMTAETGTY 189
+A++ +HS +IHRDLKP N+LL D +KLADFGLAR E ++T T
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVAT- 175
Query: 190 RWM-APE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
RW APE L ST Y VD +S +L E+L K F G S L
Sbjct: 176 RWYRAPEILLGST---------RYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-15
Identities = 74/286 (25%), Positives = 130/286 (45%), Gaps = 43/286 (15%)
Query: 31 RIGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNL 86
+IGEG+ V K+ + VA+K + ++ K++ R EV ++ H N+
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM-------DLRKQQRRELLFNEVVIMRDYHHENV 81
Query: 87 VKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLH 142
V + + +V E L GG L + + R + VC L + RA+ LH
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVC------LSVLRALSYLH 135
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYSTVT 201
+ G+IHRD+K +++LLT D + IKL+DFG A+ + GT WMAPE+ S +
Sbjct: 136 NQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP 194
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLH------NKLPFEGMSNLQAAYAAAFKNVRPSAE 255
Y +VD +S I++ E++ N+ P + M ++ K+ +
Sbjct: 195 --------YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSS 246
Query: 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 301
+ L ++L +P+ R +++Q +L PP ++P
Sbjct: 247 VLRGFLDLMLV----REPSQRATAQELLQH--PFLKLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 9e-15
Identities = 59/184 (32%), Positives = 95/184 (51%), Gaps = 21/184 (11%)
Query: 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157
+ V E L+GG L + + + R D+ A +A +I ++ LHS GII+RDLK +N++
Sbjct: 71 LFFVMEFLNGGDL-MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM 128
Query: 158 LTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 216
L D IK+ADFG+ +E + + GT ++APE+ QG K Y VD
Sbjct: 129 LDRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL------QGLK--YTFSVDW 179
Query: 217 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP----EELSIILTSCWKED 272
+SF ++L+E+L + PF G + F+++R + P +E IL ++ D
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDE-----LFESIRVDTPHYPRWITKESKDILEKLFERD 234
Query: 273 PNAR 276
P R
Sbjct: 235 PTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 9e-15
Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 19/221 (8%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IG G KV + T ++V K +K+++ F ++ +QH N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 92 ACKEPV-MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIH 148
C E + ++V E G L+ YL + R + + A +IA + +H H +H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLH 122
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQG 205
DL N LT DL T+K+ D+G+ + + E RW+APEL V G
Sbjct: 123 SDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL---VGEFHG 178
Query: 206 -----EKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQ 240
E+ + + ++ + LWEL N P+ +S+ +
Sbjct: 179 GLITAEQTKPS---NVWALGVTLWELFENAAQPYSHLSDRE 216
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 9e-15
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +G G+ +V K+K + AIK + K E + K+ A+E ++L + H
Sbjct: 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK--MKQVQHVAQEKSILMELSHPF 79
Query: 86 LVKFI-GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V + E + + E + GG L +L DV A + ++ A E LHS
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV--AKFYHAELVLAFEYLHSK 137
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
II+RDLKPENLLL +K+ DFG A++ + + GT ++APE+
Sbjct: 138 DIIYRDLKPENLLLDNK-GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVI------- 187
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
+ K + VD ++ ++L+E + PF
Sbjct: 188 -QSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 9e-15
Identities = 88/328 (26%), Positives = 134/328 (40%), Gaps = 59/328 (17%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML---SRVQHRNL 86
+G+G KV + K + A+KI+ K E I K+ EVA SRV
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKK----EVIIAKD-----EVAHTLTESRVLQNTR 53
Query: 87 VKFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
F+ A K + V E +GG L +L R R A + +I A+ L
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALGYL 111
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTAETGTYRWMAPELYSTV 200
HS +++RDLK ENL+L +D IK+ DFGL +E S M GT ++APE+
Sbjct: 112 HSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--- 167
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 259
E Y VD + +V++E++ +LPF + + + +R P +
Sbjct: 168 -----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSP 220
Query: 260 ELSIILTSCWKEDPNAR--------------PNFTQIIQMLLNYLSAIAPP-EPMIPH-- 302
E +L K+DP R F I + + PP +P +
Sbjct: 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV-VQKKLEPPFKPQVTSET 279
Query: 303 --RIFNSENT-----ILPPESPGTSSLM 323
R F+ E T I PP+ + L+
Sbjct: 280 DTRYFDEEFTAQSITITPPDRYDSLGLL 307
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-15
Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 32/281 (11%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+ + L +G G V + K+ +A K+VH G + RE+ ++
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS----SVRKQILRELQIM 57
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ +V F GA E + + E + G+L + P +++ I A+ +
Sbjct: 58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKI--AVAVVEG 115
Query: 138 MECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+ L++ H I+HRD+KP N+L+ IKL DFG++ E + + GT +M+PE
Sbjct: 116 LTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVS-GELINSIADTFVGTSTYMSPER 173
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF---EGMSNLQAAYAAAFKNV--- 250
QG K Y K D +S I + EL K PF + Q +
Sbjct: 174 I------QGGK--YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225
Query: 251 ------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285
R + + PE+L + +C +DP RP Q+ M
Sbjct: 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 9e-15
Identities = 76/278 (27%), Positives = 121/278 (43%), Gaps = 31/278 (11%)
Query: 32 IGEGAHAKVYEGK----YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
IG G KV G+ Y V +K + + +E + +F E +QH NL+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE----QMKFLEEAQPYRSLQHSNLL 58
Query: 88 KFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCL---DVCVAIGFALDIARAMECLHS 143
+ +G C E ++V E G L+ YL + R L D A +IA + LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTV 200
+ IH DL N LLT DL T+K+ D+GL+ + + + RW+APEL V
Sbjct: 119 NNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 201 ---TLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQA-AYAAAFKNVRPSAE 255
L + K N +S + +WEL P+ +S+ Q Y + ++
Sbjct: 178 HGNLLVVDQTKESN----VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233
Query: 256 NVPEELSI----ILTSCWKEDPNARPNFTQIIQMLLNY 289
+ LS ++ CW + P RP+ + + +LL+Y
Sbjct: 234 RLKLPLSDRWYEVMQFCWLQ-PEQRPSAEE-VHLLLSY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G+ KV K K + A+K++ K +K R V +L V+H LV
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + + V + ++GG L +L R R A +A +IA A+ LHS I++
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
RDLKPEN+LL + + L DFGL +E + ++ T GT ++APE+ K
Sbjct: 120 RDLKPENILL-DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI--------RK 170
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPF 233
+ Y++ VD + VL+E+L+ PF
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 77/260 (29%), Positives = 130/260 (50%), Gaps = 28/260 (10%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKE-SRFAREVAMLSRVQHRN 85
+G GA+ KV+ G + A+K++ K ++ E +R R+V R Q
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPF 66
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV A + + + ++ + ++GG L +L + R R + V I ++ +I A+E LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFKEQEVQI-YSGEIVLALEHLHKL 124
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPELYSTVTL 202
GII+RD+K EN+LL + + L DFGL++E E E + GT +MAP++ +
Sbjct: 125 GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI-----V 178
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQAAYAAAFKNVRPSAENVPEE 260
R G+ H + VD +S ++++ELL PF +G N QA + + + S P+E
Sbjct: 179 RGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKSEPPYPQE 234
Query: 261 LSI----ILTSCWKEDPNAR 276
+S I+ +DP R
Sbjct: 235 MSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
K ES E +L +V R +V A + + + +V L++GG L+ ++ +M +
Sbjct: 42 KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE 101
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184
A+ +A +I +E LH I++RDLKPEN+LL +D I+++D GLA + +
Sbjct: 102 GRAVFYAAEICCGLEDLHQERIVYRDLKPENILL-DDHGHIRISDLGLAVHVPEGQTIKG 160
Query: 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA 244
GT +MAPE+ + + Y D ++ +L+E++ + PF+ Q
Sbjct: 161 RVGTVGYMAPEVV--------KNERYTFSPDWWALGCLLYEMIAGQSPFQ-----QRKKK 207
Query: 245 AAFKNVRPSAENVPEELSIILTSCWK--------EDPNAR 276
+ V + V EE S + + +DP R
Sbjct: 208 IKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPE----EIAKKESRFAREVAMLSRVQHRN 85
+G G KV +YK + AIK + KG+ E E R E A + +H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIF-ETA--NSERHPF 63
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV + V V E +GG L ++++ A+ +A + ++ LH +
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDL---MMHIHTDVFSEPRAVFYAACVVLGLQYLHEN 120
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLR 203
I++RDLK +NLLL + +K+ADFGL +E T+ GT ++APE+ +
Sbjct: 121 KIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT----- 174
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+ Y VD + ++++E+L + PF G
Sbjct: 175 ---ETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 70/266 (26%), Positives = 123/266 (46%), Gaps = 29/266 (10%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
RIG G + VY+ + N + AIK++ K E E+ A + +E+ M+ +H N+V
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVI-KLEPGEDFAVVQ----QEIIMMKDCKHSNIVA 70
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ G+ + + I E GG+L+ P L + + + + LHS G +
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGE 206
HRD+K N+LLT++ +KLADFG++ + + T + GT WMAPE+ +
Sbjct: 129 HRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV-----ER 182
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--------AENVP 258
K YN D ++ I EL + P + ++A + N +P + +
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242
Query: 259 EELSIILTSCWKEDPNARPNFTQIIQ 284
+ + LT ++P RP +++Q
Sbjct: 243 HFVKMALT----KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 78/311 (25%), Positives = 134/311 (43%), Gaps = 42/311 (13%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ KV + K + A+K++ K ++ + + + + L+R H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ P + V E ++GG L ++ + R D A +A +I A+ LH GII+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEK 207
RDLK +N+LL + KLADFG+ +E T+ GT ++APE+ ++
Sbjct: 120 RDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL--------QE 170
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 267
Y VD ++ ++L+E+L PFE N + A + + ++ IL +
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLSQDAVDILKA 229
Query: 268 CWKEDPNAR---------------PNFTQIIQMLLNYLSAIAPP-EPMIPHR-------- 303
++P R P F ++ LN I PP P I R
Sbjct: 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNR-RQIEPPFRPRIKSREDVSNFDP 288
Query: 304 IFNSENTILPP 314
F E+ +L P
Sbjct: 289 DFIKEDPVLTP 299
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 50/169 (29%), Positives = 86/169 (50%), Gaps = 10/169 (5%)
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
K E+ E +L +V R +V A + + + +V +++GG L+ ++ NM D
Sbjct: 42 KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDE 101
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184
AI +A ++ +E L I++RDLKPEN+LL +D I+++D GLA + E +
Sbjct: 102 QRAIFYAAELCCGLEDLQRERIVYRDLKPENILL-DDRGHIRISDLGLAVQIPEGETVRG 160
Query: 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
GT +MAPE+ EK Y D + +++E++ + PF
Sbjct: 161 RVGTVGYMAPEVI------NNEK--YTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 61/195 (31%), Positives = 86/195 (44%), Gaps = 27/195 (13%)
Query: 55 VHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYL 114
V K P + R RE+ +L V H+N++ + + T S +
Sbjct: 51 VKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN--------VFTPQKSLEEFQDVY 102
Query: 115 LNMRPRCLDVCVAIGFALDIAR------AMEC----LHSHGIIHRDLKPENLLLTEDLKT 164
L M ++C I LD R M C LHS GIIHRDLKP N+++ D T
Sbjct: 103 LVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-T 161
Query: 165 IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224
+K+ DFGLAR MMT T + APE V L G Y VD +S ++
Sbjct: 162 LKILDFGLARTACTNFMMTPYVVTRYYRAPE----VILGMG----YKENVDIWSVGCIMG 213
Query: 225 ELLHNKLPFEGMSNL 239
EL+ + F+G ++
Sbjct: 214 ELVKGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 22/216 (10%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA--REVAMLSRVQHRNL 86
++GEG++A VY+GK K + VA+K++ E ++ + F RE ++L ++H N+
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQE------EEGTPFTAIREASLLKGLKHANI 65
Query: 87 VKF--IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
V I KE + ++ + + L +Y+ + P L F + R + +H
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHT--DLCQYM-DKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
I+HRDLKP+NLL++ D +KLADFGLAR +S+ + W P V L
Sbjct: 123 YILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP---PDVLLGS 178
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
E Y+ +D + + E++ F GM ++Q
Sbjct: 179 TE---YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 69/217 (31%), Positives = 98/217 (45%), Gaps = 34/217 (15%)
Query: 32 IGEGAHAKV---YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG GA V Y+ ++ VAIK K P + R RE+ ++ V H+N++
Sbjct: 25 IGSGAQGIVCAAYDAVL-DRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 89 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR------AMEC-- 140
+ + T S + L M ++C I LD R M C
Sbjct: 81 LLN--------VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 141 --LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
LHS GIIHRDLKP N+++ D T+K+ DFGLAR + MMT T + APE
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE--- 188
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
V L G Y VD +S ++ E++ +K+ F G
Sbjct: 189 -VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 32/216 (14%)
Query: 32 IGEGAHAKV---YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G GA+ V Y+ + + Q VA+K K P + R RE+ +L ++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLR-QKVAVK---KLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 89 FIGACKEPVMV-------IVTELLSGGTLRKYLLNMRPRCLDVC-VAIGFAL-DIARAME 139
+ + +VT L+ LN +C + + F + + R ++
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGAD------LNNIVKCQKLSDEHVQFLIYQLLRGLK 132
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
+HS GIIHRDLKP N+ + ED + +++ DFGLAR+ + MT T + APE+
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQAD--DEMTGYVATRWYRAPEIMLN 189
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
HYN VD +S ++ ELL K F G
Sbjct: 190 WM-------HYNQTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 71/267 (26%), Positives = 119/267 (44%), Gaps = 33/267 (12%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
RIG GA VY+ ++ + A+K+++ G + + ++ RE+ +L V H N+VK
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIY-GNHEDTVRRQ---ICREIEILRDVNHPNVVK 136
Query: 89 FIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
C + + ++ E + GG+L + DV A I + LH
Sbjct: 137 ----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV------ARQILSGIAYLHR 186
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM---TAETGTYRWMAPELYSTV 200
I+HRD+KP NLL+ K +K+ADFG++R L + M + GT +M+PE +T
Sbjct: 187 RHIVHRDIKPSNLLI-NSAKNVKIADFGVSR--ILAQTMDPCNSSVGTIAYMSPERINT- 242
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE-GMSNLQAAYAAAFKNVRPSAE--NV 257
L G Y D +S + + E + PF G A+ A +P
Sbjct: 243 DLNHGAYDGYAG--DIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300
Query: 258 PEELSIILTSCWKEDPNARPNFTQIIQ 284
E ++ C + +P R + Q++Q
Sbjct: 301 SREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 66/216 (30%), Positives = 93/216 (43%), Gaps = 32/216 (14%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA V + VAIK K P + R RE+ ++ V H+N++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR------AMEC--- 140
+ + T S + + M ++C I LD R M C
Sbjct: 89 LN--------VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 141 -LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
LHS GIIHRDLKP N+++ D T+K+ DFGLAR + MMT T + APE
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE---- 195
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
V L G Y VD +S ++ E++ + F G
Sbjct: 196 VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 31/296 (10%)
Query: 32 IGEG--AHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G G +V K A+K++ K + + S F E +LS + +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQ--ETVSFFEEERDILSISNSPWIPQL 66
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
A ++ + +V E GG L LLN D +A + ++ A+ +H G +H
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH 125
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE--TGTYRWMAPELYSTVTLRQGE 206
RD+KPEN+L+ + IKLADFG A + +M+ ++ GT ++APE+ + T+
Sbjct: 126 RDIKPENVLI-DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT--TMNGDG 182
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 266
K Y + D +S ++ +E+++ + PF + A + N+ N L
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFH-----EGTSAKTYNNIM----NFQRFLK---- 229
Query: 267 SCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIF-----NSENTILPPESP 317
+ EDP +F +IQ LL E + H F N+ LPP P
Sbjct: 230 --FPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 64/234 (27%), Positives = 98/234 (41%), Gaps = 27/234 (11%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNLV 87
I +GA VY K + AIK++ K + IAK + A M+ + + +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM---IAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 88 K-FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
K + + + +V E L+GG + + L A + ++ +E LH GI
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
IHRD+KPENLL+ + +KL DFGL+R GT ++APE
Sbjct: 119 IHRDIKPENLLIDQT-GHLKLTDFGLSR---NGLENKKFVGTPDYLAPETI--------L 166
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260
+ D +S V++E L PF + A F N+ N PEE
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRRINWPEE 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 69/271 (25%), Positives = 124/271 (45%), Gaps = 30/271 (11%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVH-KGETPEEIAKKESRFAREVAML------SRVQ 82
+G GA V K + A+K+V +G + + +R EV L S V+
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADK----NRAQAEVCCLLNCDFFSIVK 95
Query: 83 -HRNLVKFIGACKEPV--MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARA 137
H + K E V + +V + + G LR+ + + R A + + A
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAP 194
+ +HS +IHRD+K N+LL + +KL DFG ++ + T ++ GT ++AP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254
E++ +K Y+ K D +S ++L+ELL K PF+G + + + P
Sbjct: 215 EIW--------RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266
Query: 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 285
++ E+ I+T+ DP RP+ ++++ M
Sbjct: 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 68/240 (28%), Positives = 120/240 (50%), Gaps = 24/240 (10%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
IG GA +V ++K + A+K++ K E I + +S F E +++ +V+
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM---IKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV--AIGFALDIARAMECLHSHG 145
A + + + +V E + GG L + N DV A + ++ A++ +HS G
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 203
+IHRD+KP+N+LL + +KLADFG + T M+ +T GT +++PE+ +
Sbjct: 163 LIHRDVKPDNMLL-DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS---- 217
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 263
QG +Y + D +S + L+E+L PF S L Y+ + ++ N PE++ I
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKIMDH--KNSLNFPEDVEI 274
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ KV E K ++ AIK++ K ++ + + + L+ +H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + V E ++GG L + R R D + +A ++ A+ LH HG+I+
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEK 207
RDLK +N+LL + KLADFG+ +E L + T GT ++APE+ ++
Sbjct: 120 RDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL--------QE 170
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFE 234
Y VD ++ ++++E++ + PFE
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIK-IVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV- 87
IG GA+ V + VAIK I H + P +AK R RE+ +L +H N++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT-LAK---RTLRELKILRHFKHDNIIA 68
Query: 88 -KFIGACKEPVM--VIVTELLSGGTLRKYLLNMRPRCLD-VCVAIGFALDIARAMECLHS 143
+ I V V L L + + +P + + F + R ++ +HS
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY---FLYQLLRGLKYIHS 125
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-----ESLTEMMTAETGTYRWM-APELY 197
+IHRDLKP NLL+ ED +++ DFG+AR MT T RW APEL
Sbjct: 126 ANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RWYRAPELL 183
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
++ Y +D +S + E+L + F G
Sbjct: 184 LSL-------PEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 22/157 (14%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-----REVAMLSRVQH 83
++GEG++A VY+G+ K Q VA+K EI + A RE ++L ++H
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALK---------EIRLEHEEGAPFTAIREASLLKDLKH 62
Query: 84 RNLVKF--IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
N+V I K+ + +V E L L++Y+ + L + F + R +
Sbjct: 63 ANIVTLHDIIHTKK-TLTLVFEYLDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYC 119
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178
H ++HRDLKP+NLL++E +KLADFGLAR +S+
Sbjct: 120 HQRRVLHRDLKPQNLLISE-RGELKLADFGLARAKSV 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 40/112 (35%), Positives = 67/112 (59%), Gaps = 12/112 (10%)
Query: 126 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE 185
A+ +A +IA + LHS GII+RDLK +N++L + IK+ADFG+ + E++ T
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCK-ENIFGGKTTR 159
Query: 186 T--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
T GT ++APE+ + + Y VD ++F ++L+E+L + PF+G
Sbjct: 160 TFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 71/237 (29%), Positives = 112/237 (47%), Gaps = 39/237 (16%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G +VY+ + K + A+K++ K +EI K +EVA + RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK----KEIVAK-----KEVA--HTIGERNILVR 49
Query: 90 IGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+ P +V +VT+ +SGG L +L + A + ++
Sbjct: 50 TLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVL 107
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAP 194
A+E LH + I++RDLKPEN+LL I L DFGL++ LT+ T T GT ++AP
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKAN-LTDNKTTNTFCGTTEYLAP 165
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251
E V L ++K Y VD +S ++++E+ PF Q AF VR
Sbjct: 166 E----VLL---DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR 215
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
IG GA +V ++K Q A+K++ K E I + +S F E +++ +V+
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM---IKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCV--AIGFALDIARAMECLHSHG 145
A ++ + +V E + GG L + N D+ A + ++ A++ +HS G
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG 162
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 203
IHRD+KP+N+LL + +KLADFG + M+ +T GT +++PE V
Sbjct: 163 FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE----VLKS 217
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
QG +Y + D +S + L+E+L PF
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 65/269 (24%), Positives = 112/269 (41%), Gaps = 28/269 (10%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVK 88
IG GA V + +K +A+K + K++ R ++ ++ R +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRS----TVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 89 FIGAC-KEPVMVIVTEL--LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL-HSH 144
F GA +E I EL +S KY+ + + + A+ +A+ L
Sbjct: 68 FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 145 GIIHRDLKPENLLLTEDLK-TIKLADFGLA--REESLTEMMTAETGTYRWMAPELYSTVT 201
IIHRD+KP N+LL D IKL DFG++ +S+ + T + G +MAPE
Sbjct: 128 KIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSA 183
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-----QAAYAAAFKNVRPSAEN 256
R G Y+ + D +S I L+E+ K P+ +++ Q
Sbjct: 184 -RDG----YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238
Query: 257 VPEELSIILTSCWKEDPNARPNFTQIIQM 285
+ C +D + RP + ++++
Sbjct: 239 FSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 71/252 (28%), Positives = 120/252 (47%), Gaps = 24/252 (9%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKE-SRFAREVAMLSRVQHRNL-- 86
+G+G KV K + A+KI+ K IAK E + E +L +H L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVI---IAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+K+ K+ + V E ++GG L +L R R + +I A++ LHS I
Sbjct: 60 LKYSFQTKDR-LCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQ 204
++RDLK ENL+L +D IK+ DFGL + E +T+ T +T GT ++APE+
Sbjct: 117 VYRDLKLENLMLDKD-GHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVL------- 167
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264
E Y VD + +V++E++ +LPF + + ++++ + + +
Sbjct: 168 -EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK-FPRTLSADAKSL 225
Query: 265 LTSCWKEDPNAR 276
L+ +DPN R
Sbjct: 226 LSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 70/276 (25%), Positives = 121/276 (43%), Gaps = 42/276 (15%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESR-----FAREVAMLSRVQHRNL 86
+G+G K+++G + ++ HK E ++ K R F +M+S++ H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGEL-HKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL 61
Query: 87 VKFIGAC---KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
V G C E +MV E + G+L YL +++ + A +A A+ L
Sbjct: 62 VLNYGVCVCGDESIMV--QEYVKFGSLDTYL-KKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 144 HGIIHRDLKPENLLLT--EDLKT-----IKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
G+ H ++ +N+LL ED KT IKL+D G++ E++ W+ PE
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---PWVPPEC 175
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG----MSNLQAAYAAAFKNVRP 252
++ + D +SF LWE+ F G +S L + F R
Sbjct: 176 IE-------NPQNLSLAADKWSFGTTLWEI------FSGGDKPLSALDSQKKLQFYEDRH 222
Query: 253 SAENVPE--ELSIILTSCWKEDPNARPNFTQIIQML 286
P+ EL+ ++ C +P+ RP+F II+ L
Sbjct: 223 QLP-APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 27/230 (11%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
W + ++ + P +G GA+ V + +T V K P + R RE+ +L
Sbjct: 13 WEVPERYQNLSP-VGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 79 SRVQHRNLVKFIGACKEPV-------MVIVTELLSGGTLRKYLLNMRPRCLDVCV-AIGF 130
++H N++ + + +VT L+ LN +C + + F
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD------LNNIVKCQKLTDDHVQF 124
Query: 131 AL-DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
+ I R ++ +HS IIHRDLKP NL + ED + +K+ DFGLAR + MT T
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTD--DEMTGYVATR 181
Query: 190 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
+ APE+ HYN VD +S ++ ELL + F G ++
Sbjct: 182 WYRAPEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEGA+ V + ++K + VAIK E EE+ KE+ RE+ ML ++ N+V+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEV--KETTL-RELKMLRTLKQENIVEL 65
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
A + + +V E + L LL P + + + +A+ H + I+H
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 208
RD+KPENLL++ + +KL DFG AR +L+E A Y +A Y + L G
Sbjct: 124 RDIKPENLLISHN-DVLKLCDFGFAR--NLSEGSNANYTEY--VATRWYRSPELLLGAP- 177
Query: 209 HYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
Y VD +S +L EL + F G S +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 22/221 (9%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKE-SRFAREVAMLSRVQHRN 85
+G GA+ KV+ G + A+K++ K ++ E +R R V R Q
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-QSPF 66
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV A + E + ++ + +SGG + +L R + V ++ +I A+E LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRF-YSGEIILALEHLHKL 124
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPELYSTVTL 202
GI++RD+K EN+LL + + L DFGL++E E + GT +MAPE+
Sbjct: 125 GIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII----- 178
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQA 241
+G+ H VD +S I+++ELL PF EG N Q+
Sbjct: 179 -RGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 36/218 (16%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIV---HKGETPEEIAKKESRFAREVAMLSRVQHRN 85
++GEG +A VY+G+ K + VA+K + H+ P REV++L ++H N
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAP-------CTAIREVSLLKDLKHAN 65
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYL------LNMRPRCLDVCVAIGFALDIARAM 138
+V E + +V E L L++YL +NM L F + R +
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKL-------FLFQLLRGL 117
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELY 197
H ++HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T + P++
Sbjct: 118 NYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
T Y+ ++D + + +E+ + F G
Sbjct: 177 LGST-------DYSTQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIV---HKGETPEEIAKKESRFAREVAMLSRVQHRN 85
++GEG +A V++G+ K VA+K + H+ P REV++L ++H N
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP-------CTAIREVSLLKNLKHAN 64
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V E + +V E L L++YL N V I F + R + H
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHKR 122
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLR 203
I+HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T + P++ T
Sbjct: 123 KILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST-- 179
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
Y+ +D + +L+E+ + F G
Sbjct: 180 -----EYSTPIDMWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 51/146 (34%), Positives = 82/146 (56%), Gaps = 8/146 (5%)
Query: 32 IGEGAHAKVYEGKYKNQT--VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
I GA KVY G+ KN + A+K+V K + + + + R+ LS+ +V
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF--IVHL 69
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + V +V E L GG + K LL++ D +A+ + ++A A++ LH HGIIH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDV-KSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIH 127
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAR 174
RDLKP+N+L++ + IKL DFGL++
Sbjct: 128 RDLKPDNMLISNE-GHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 7e-13
Identities = 66/256 (25%), Positives = 109/256 (42%), Gaps = 32/256 (12%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIK------IVHKGETPEEIAKKESRFAREVAMLSRVQH 83
IG+G+ KV + + ++ + A+K IV + E +A E +L++V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA--------ERTVLAQVNC 52
Query: 84 RNLV--KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+V KF E + +V ++GG L +L R D+ A + ++ A+E L
Sbjct: 53 PFIVPLKFSFQSPEK-LYLVLAFINGGELFHHL--QREGRFDLSRARFYTAELLCALENL 109
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTV 200
H +I+RDLKPEN+LL + I L DFGL + + GT ++APEL
Sbjct: 110 HKFNVIYRDLKPENILL-DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260
Y VD ++ ++L+E+L PF N+ Y + + +
Sbjct: 169 G--------YTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEPLRFPDGFDRD 219
Query: 261 LSIILTSCWKEDPNAR 276
+L DP R
Sbjct: 220 AKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 40/224 (17%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKG-----------ETPEEIAKKESRFAREVAML 78
IG G++AKV + K + A+K++ K +T + + + S V +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 79 SRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
S Q E + V E +SGG L ++ R R L A ++ +I+ A+
Sbjct: 63 SCFQ-----------TESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLAL 109
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
LH GII+RDLK +N+LL + IKL D+G+ + E + T T GT ++APE+
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEI 167
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE--GMSN 238
LR GE Y VD ++ ++++E++ + PF+ GMS+
Sbjct: 168 -----LR-GED--YGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 40/110 (36%), Positives = 65/110 (59%), Gaps = 10/110 (9%)
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE- 185
A+ +A +IA + LHS GII+RDLK +N++L + IK+ADFG+ +E + T
Sbjct: 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTF 161
Query: 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
GT ++APE+ + + Y VD ++F ++L+E+L + PFEG
Sbjct: 162 CGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 52/196 (26%), Positives = 81/196 (41%), Gaps = 25/196 (12%)
Query: 35 GAHAKVYEGKYKNQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92
G+ +V+ Q V +KI KG T E +L V H ++++
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQKGTT-----------LIEAMLLQNVNHPSVIRMKDT 125
Query: 93 -CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 151
+ +V S L YL R R L + A+ I + LH+ IIHRD+
Sbjct: 126 LVSGAITCMVLPHYSS-DLYTYL-TKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDV 183
Query: 152 KPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 211
K EN+ + D+ + + D G A+ + GT APE+ + + YN
Sbjct: 184 KTENIFI-NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLA--------RDKYN 234
Query: 212 HKVDSYSFAIVLWELL 227
K D +S IVL+E+L
Sbjct: 235 SKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 70/265 (26%), Positives = 122/265 (46%), Gaps = 26/265 (9%)
Query: 31 RIGEGAHAKVY-----EGKYKNQTVAIKIVHKGE-TPEEIAKKESRFAREVAMLSRVQHR 84
R+G+G+ VY + + + +K + GE P E + +E +LS++ H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHP 62
Query: 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECL 141
+VKF + E I+TE G L L ++ + L + + + + +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTV 200
H I+HRDLK +N+ L +L +K+ DFG++R ++ T TGT +M+PE
Sbjct: 123 HQRRILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK-- 178
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AENVPE 259
QG Y+ K D +S +L+E+ FEG N + + PS E
Sbjct: 179 --HQG----YDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPSLPETYSR 231
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQ 284
+L+ I+ S +DP+ RP+ +I++
Sbjct: 232 QLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 58/214 (27%), Positives = 111/214 (51%), Gaps = 28/214 (13%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ KV E K ++ AIKI+ K ++ + + + V L+ +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRV--LALQDKPPFLTQ 65
Query: 90 IGACKEPV--MVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHS 143
+ +C + V + V E ++GG L ++ + P+ A+ +A +I+ + LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQ------AVFYAAEISVGLFFLHR 119
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVT 201
GII+RDLK +N++L + IK+ADFG+ + E + + +T T GT ++APE+ +
Sbjct: 120 RGIIYRDLKLDNVMLDSE-GHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEIIAY-- 175
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+ Y VD +++ ++L+E+L + PF+G
Sbjct: 176 ------QPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
IG GA +V K + A+K++ K E I + +S F E +++ +V+
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM---IKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCV--AIGFALDIARAMECLHSHG 145
A ++ + +V E + GG L + N DV A + ++ A++ +HS G
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG 162
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 203
IHRD+KP+N+LL + +KLADFG + + M+ +T GT +++PE+ +
Sbjct: 163 FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS---- 217
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
QG +Y + D +S + L+E+L PF
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 87/321 (27%), Positives = 140/321 (43%), Gaps = 54/321 (16%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIV---HKGETPEEIAKKESRFAREVAMLSRVQHRN 85
++GEG +A V++G+ K VA+K + H+ P REV++L ++H N
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP-------CTAIREVSLLKDLKHAN 65
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG-------FALDIARA 137
+V + + +V E L L++Y+ D C I F I R
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYM--------DDCGNIMSMHNVKIFLYQILRG 116
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPEL 196
+ H ++HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T + P+
Sbjct: 117 LAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD- 174
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSAE 255
V L E Y+ ++D + + +E+ + F G S ++ F+ + P+ E
Sbjct: 175 ---VLLGSSE---YSTQIDMWGVGCIFFEMASGRPLFPG-STVEDELHLIFRLLGTPTEE 227
Query: 256 NVP-----EELSIILTSCWKEDP--NARPNF-TQIIQMLLNYL----SAIAPPEPMIPHR 303
P +E +K P N P T+ I++L +L E + H
Sbjct: 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287
Query: 304 IFNSENTILP--PESPGTSSL 322
F S T + PES SL
Sbjct: 288 YFRSLGTRIHSLPESISIFSL 308
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 32 IGEGAHAKVYEGKYKNQT---VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G+ +V YKN+ VAIK K + ++ K+ E +L+ + H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ--KQVDHVFSERKILNYINHPFCVN 95
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
G+ K E + +V E + GG +L R + V +A I E L S I+
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGE 206
+RDLKPENLLL +D IK+ DFG A+ + + T GT ++APE + L G
Sbjct: 154 YRDLKPENLLLDKD-GFIKMTDFGFAK---VVDTRTYTLCGTPEYIAPE----ILLNVGH 205
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPF 233
K D ++ I ++E+L PF
Sbjct: 206 GK----AADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 67/284 (23%), Positives = 118/284 (41%), Gaps = 58/284 (20%)
Query: 32 IGEGAHAKVYEGKYKNQT--------------VAIKIVHKGETPEEIAKKESRFAREVAM 77
+G G ++Y G + V +K++ +A F +M
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLA-----FFETASM 57
Query: 78 LSRVQHRNLVKFIGACKEPVM-VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF--ALDI 134
+ +V H+++V G C V ++V E + G L L M + + F A +
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD---LFMHRKSDVLTTPWKFKVAKQL 114
Query: 135 ARAMECLHSHGIIHRDLKPENLLL------TEDLKTIKLADFG-----LAREESLTEMMT 183
A A+ L ++H ++ +N+LL E IKL+D G L+R+E + +
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI-- 172
Query: 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEG--MSNLQ 240
W+APE + K+ + D +SF LWE+ +N ++P + ++ +
Sbjct: 173 ------PWIAPECVE-------DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE 219
Query: 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
Y V PS + EL+ ++T C DPN RP F I++
Sbjct: 220 RFYEGQCMLVTPSCK----ELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 7e-12
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKG--ETPEEIAKKESRFAREVAMLSRVQHRNLV 87
IG G++AKV + K +Q A+K+V K E+I ++ E + + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQT----EKHVFEQASSNPFL 58
Query: 88 KFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
+ +C + +V E ++GG L ++ R R L A +A +I A+ LH G
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 203
II+RDLK +N+LL D IKL D+G+ + E L T T GT ++APE+
Sbjct: 117 IIYRDLKLDNVLLDAD-GHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEIL------ 168
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234
+GE+ Y VD ++ ++++E++ + PF+
Sbjct: 169 RGEE--YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 62/244 (25%), Positives = 96/244 (39%), Gaps = 73/244 (29%)
Query: 32 IGEGAHAKVYEGKYKNQTV----AIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNL 86
IG G + +VY+ K KN AIK K + +E S+ A RE+A+L ++H N+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIK---KFKGDKEQYTGISQSACREIALLRELKHENV 64
Query: 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCL---------DVCVAIGF-----AL 132
V L + L + + D+ I F +
Sbjct: 65 VS---------------------LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRV 103
Query: 133 DIARAM------------ECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAR--E 175
I +M LHS+ ++HRDLKP N+L+ + +K+ D GLAR
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
Query: 176 ESLTEMMTAE----TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKL 231
L + + T YR APEL +HY +D ++ + ELL +
Sbjct: 164 APLKPLADLDPVVVTIWYR--APELLLGA-------RHYTKAIDIWAIGCIFAELLTLEP 214
Query: 232 PFEG 235
F+G
Sbjct: 215 IFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENL 156
+ V E +GG L +L R R A + +I A++ LHS +++RDLK ENL
Sbjct: 70 LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 127
Query: 157 LLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKV 214
+L +D IK+ DFGL + E + + T +T GT ++APE+ E Y V
Sbjct: 128 MLDKD-GHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVL--------EDNDYGRAV 177
Query: 215 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 274
D + +V++E++ +LPF + + + +R PE S +L+ K+DP
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKS-LLSGLLKKDPK 236
Query: 275 AR 276
R
Sbjct: 237 QR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 71/260 (27%), Positives = 125/260 (48%), Gaps = 30/260 (11%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKG--ETPEEIAKKESRFAREVAMLSRVQHRNLV 87
IG G++AKV + K + A+K+V K E+I ++ E + + + +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQT----EKHVFEQASNHPFL 58
Query: 88 KFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
+ +C E + V E ++GG L ++ R R L A ++ +I+ A+ LH G
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQ 204
II+RDLK +N+LL + IKL D+G+ +E T+ GT ++APE+ +
Sbjct: 117 IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL------R 169
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFE--GMSNL--QAAYAAAFKNVRPSAENVPEE 260
GE Y VD ++ ++++E++ + PF+ G S+ Q F+ + +P
Sbjct: 170 GED--YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 227
Query: 261 LSI----ILTSCWKEDPNAR 276
LS+ +L S +DP R
Sbjct: 228 LSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 52/197 (26%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFA----REVAMLSRVQHR 84
+IG+G +V++ ++K Q VA+K V +KE F RE+ +L ++H
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMEN------EKEG-FPITALREIKILQLLKHE 71
Query: 85 NLVKFIGACKEPVMVIVTELLSGGTLRK--YLLNMRPRCLDVC----------VAIGFAL 132
N+V I C+ T+ + YL+ + C + F L
Sbjct: 72 NVVNLIEICR-------TKATPYNRYKGSFYLV------FEFCEHDLAGLLSNKNVKFTL 118
Query: 133 -DIARAMECL-------HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---- 180
+I + M+ L H + I+HRD+K N+L+T+D +KLADFGLAR SL++
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKP 177
Query: 181 -MMTAETGTYRWMAPEL 196
T T + PEL
Sbjct: 178 NRYTNRVVTLWYRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 36/289 (12%)
Query: 13 LKLDA-KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES 69
L +D K+ D L IG G +VY+ ++K +A+K + + EE K
Sbjct: 3 LTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE--NKRI 60
Query: 70 RFAREVAMLSRVQHRNLVKFIGAC-----KEPVMVIVTELLSG--GTLRKYLLNMRPRCL 122
+V + S + +I C + + I EL+S L K + P +
Sbjct: 61 LMDLDVVLKS-----HDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDI 115
Query: 123 --DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
+ VAI AL + HG+IHRD+KP N+LL + +KL DFG++ L +
Sbjct: 116 LGKMTVAIVKALHYLK-----EKHGVIHRDVKPSNILL-DASGNVKLCDFGISGR--LVD 167
Query: 181 MM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM-S 237
T G +MAPE Y+ + D +S I L EL + P++ +
Sbjct: 168 SKAKTRSAGCAAYMAPERIDP----PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223
Query: 238 NLQAAYAAAFKN--VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ + P E + + C +D RP + +++Q
Sbjct: 224 EFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 45/227 (19%)
Query: 32 IGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNL 86
+G+GA+ V + +TVAIK + + + +AK R RE+ +L + H+N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAK---RALRELKLLRHFRGHKNI 64
Query: 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAI------------GFALDI 134
M IV G + L D+ I F I
Sbjct: 65 TCLYD------MDIVFP----GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTY 189
++ +HS ++HRDLKP NLL+ D + +K+ DFGLAR MT T
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSENPGENAGFMTEYVAT- 172
Query: 190 RWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
RW APE+ + + Y +D +S +L ELL K F+G
Sbjct: 173 RWYRAPEIMLSF-------QSYTKAIDVWSVGCILAELLGRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKG-ETPEEIAKKESRFAREVAMLSRVQ-HRNL 86
+IGEG ++V + + + + AIK + K ++ E++ RE+ L R+ H N+
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-----LREIQALRRLSPHPNI 60
Query: 87 VKFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
++ I + + +V EL+ L + + R R L + + ++++ +H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM-APELYSTVTL 202
+GI HRD+KPEN+L+ +D +KLADFG R T T RW APE L
Sbjct: 119 NGIFHRDIKPENILIKDD--ILKLADFGSCRGIYSKPPYTEYIST-RWYRAPE----CLL 171
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELL 227
G +Y K+D ++ V +E+L
Sbjct: 172 TDG---YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G GA+ V + VAIK +++ E AK R RE+ +L ++H N++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMKHENVIGL 79
Query: 90 IGACKEPVMV-------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECL 141
+ + + +V + GT L+ D I F + + + ++ +
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSED---RIQFLVYQMLKGLKYI 134
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 201
H+ GIIHRDLKP NL + ED + +K+ DFGLAR+ MT T + APE V
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQTD--SEMTGYVVTRWYRAPE----VI 187
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
L HY VD +S ++ E+L K F+G +L
Sbjct: 188 LNW---MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 40/192 (20%)
Query: 73 REVAMLSRVQHRNLVKFIGA-----------CKEPVMV----IVTELLSGGTLRKYLLNM 117
RE+ ++ R+ H N+VK + IV E + L +L
Sbjct: 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLAN-VLEQ 108
Query: 118 RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLAR-- 174
P L A F + R ++ +HS ++HRDLKP N+ + TEDL +K+ DFGLAR
Sbjct: 109 GP--LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLARIV 165
Query: 175 ------EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 228
+ L+E + T YR +P L + +Y +D ++ + E+L
Sbjct: 166 DPHYSHKGYLSEGLV--TKWYR--SPRLLLSPN-------NYTKAIDMWAAGCIFAEMLT 214
Query: 229 NKLPFEGMSNLQ 240
K F G L+
Sbjct: 215 GKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 2e-10
Identities = 43/152 (28%), Positives = 64/152 (42%), Gaps = 22/152 (14%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKI-VHKGETPEEIAKK--ESRFAREVAMLSRVQHRNLVK 88
I GA A++Y G + IK + K E+ ++ R RE ++SR + V
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVN 62
Query: 89 FIGACKEPVMV------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
V IV E + G L+ + + L++ IG + + LH
Sbjct: 63 ----VPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRL--VGK----LH 112
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
S GIIH DL N++L+ I L DFGLA
Sbjct: 113 SAGIIHGDLTTSNMILSGG--KIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 34/214 (15%)
Query: 35 GAHAKVY----EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90
G+ +V+ G + + V +K V G+TP RE+ +L + HR ++ I
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG----------REIDILKTISHRAIINLI 152
Query: 91 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRD 150
A + V + L Y+ P L+ + I L A+ LH GIIHRD
Sbjct: 153 HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRL--LEALAYLHGRGIIHRD 210
Query: 151 LKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM------APELYSTVTLRQ 204
+K EN+ L E + L DFG A + + Y W +PEL +
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACK---LDAHPDTPQCYGWSGTLETNSPELLALDP--- 263
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 238
Y K D +S +VL+E+ + G
Sbjct: 264 -----YCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292
|
Length = 392 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-10
Identities = 37/156 (23%), Positives = 59/156 (37%), Gaps = 17/156 (10%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKI-VHKGETPEEIAKK--ESRFAREVAMLSRVQHRNLVK 88
I +GA A +Y + +K + K E+ +K R RE +L++ V
Sbjct: 4 IKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVP 62
Query: 89 --FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+ +IV E + G L+ L D+ +G + + LH GI
Sbjct: 63 VPIVYDVDPDNGLIVMEYIEGELLKDAL---EEARPDLLREVG--RLVGK----LHKAGI 113
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM 182
+H DL N++L+ I DFGL E
Sbjct: 114 VHGDLTTSNIILSGG--RIYFIDFGLGEFSDEVEDK 147
|
Length = 204 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 68/305 (22%), Positives = 127/305 (41%), Gaps = 59/305 (19%)
Query: 31 RIGEGAHAKVYEGKYKNQTVAI---KIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
+IG G +V+ K+K I ++G E +S+ EV ++ ++H+N+V
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE----KSQLVIEVNVMRELKHKNIV 75
Query: 88 KFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAI--GFALDIARAMECLH 142
++I + I+ E G L + + +C + I +DI R + LH
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNI----QKCYKMFGKIEEHAIVDITRQL--LH 129
Query: 143 S-------------HGIIHRDLKPENLLLTEDLKTI----------------KLADFGLA 173
+ ++HRDLKP+N+ L+ ++ I K+ DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
+ + M + GT + +PEL E K Y+ K D ++ +++EL K PF
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLH------ETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 234 EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQII--QMLLNYLS 291
+N + + + +EL+I++ + RP+ Q + Q++ N
Sbjct: 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN--- 300
Query: 292 AIAPP 296
+ PP
Sbjct: 301 -VGPP 304
|
Length = 1021 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 64/284 (22%), Positives = 96/284 (33%), Gaps = 76/284 (26%)
Query: 130 FALDIAR--------AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL--------- 172
F D+AR A+E +H G IHRD+KP+N+L+ D IKL DFGL
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156
Query: 173 ---------AREESL-----------TEMMTAE---------------TGTYRWMAPELY 197
R++S+ + E GT ++APE
Sbjct: 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE-- 214
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA----AFKNVRPS 253
V LR G Y D +S ++L+E+L + PF + + ++
Sbjct: 215 --VLLRTG----YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQ 268
Query: 254 AENVPEELSIILTSCWKEDPNARPN---------FTQIIQMLLNYLSAIAPPEPMIPHRI 304
A+ E +IL C + N F + I AP P I H
Sbjct: 269 AKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPT 328
Query: 305 FNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCF 348
S + PE + D P + + F+ F
Sbjct: 329 DTSNFDPVDPEKLRSDDSGESSPDRNVKPNN--RKRTEHAFYEF 370
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 35/106 (33%), Positives = 60/106 (56%), Gaps = 9/106 (8%)
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
+A +I +E +H+ +++RDLKP N+LL E ++++D GLA + S + A GT+
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 190 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+MAPE+ L++G Y+ D +S +L++LL PF
Sbjct: 160 GYMAPEV-----LQKGVA--YDSSADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 43/165 (26%), Positives = 66/165 (40%), Gaps = 21/165 (12%)
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 203
H I+HRD+KP N+L+ IKL DFG++ + + M + GT +M+PE
Sbjct: 119 HKIMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------ 170
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 263
QG HY + D +S + L E+ + P A F E
Sbjct: 171 QGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMF-----GRPVSEGEAKE 221
Query: 264 ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 308
P++ I LL+Y+ + P P +P F+ E
Sbjct: 222 SHRPVSGHPPDSPRPMA--IFELLDYI--VNEPPPKLPSGAFSDE 262
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 65/269 (24%), Positives = 118/269 (43%), Gaps = 32/269 (11%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA---REVAMLSRVQHRNL 86
+G+G + VY+ ++ T+A+K + + ES+F E+ +L + +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDILHKAVSPYI 61
Query: 87 VKFIGA-CKEPVMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECL-HS 143
V F GA E + + E + G+L K Y + + V + + ++ L
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLA--REESLTEMMTAETGTYRWMAPELYSTVT 201
H IIHRD+KP N+L+ + +KL DFG++ SL + G +MAPE +
Sbjct: 122 HNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAK---TNIGCQSYMAPERIKSGG 177
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQAAYAAAFKNVRPSAENVPE 259
Q Y + D +S + + E+ + P+ E +N+ A +A P+ +P
Sbjct: 178 PNQ--NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT---LPS 232
Query: 260 ELSI----ILTSCWKEDPNARPNFTQIIQ 284
S + C + PN RP + Q+++
Sbjct: 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRVQHRNLVK 88
IG GA +V K KN + A+KI++K E + + E+ F E +L ++ +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEM---LKRAETACFREERDVLVNGDNQWITT 65
Query: 89 FIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A ++ + +V + GG L L R L +A + ++ A++ +H +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQLHYV 124
Query: 148 HRDLKPENLLLTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 205
HRD+KP+N+L+ + I+LADFG L E T + GT +++PE+ + +
Sbjct: 125 HRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM---ED 180
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237
K Y + D +S + ++E+L+ + PF S
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRVQHRNLVK 88
IG GA +V K KN Q A+KI++K E + + E+ F E +L R +
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEM---LKRAETACFREERDVLVNGDRRWITN 65
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + E + +V + GG L L R L +A + ++ A++ +H G +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQLGYV 124
Query: 148 HRDLKPENLLLTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 205
HRD+KP+N+LL ++ I+LADFG L T GT +++PE+ + +
Sbjct: 125 HRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM---ED 180
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPF 233
K Y + D +S + ++E+L+ + PF
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA +V K K+ + A+KI++K E + R R V + Q + +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHR 149
E + +V + GG L L R L +A + ++ A+ +H +HR
Sbjct: 69 -AFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQLHYVHR 126
Query: 150 DLKPENLLLTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
D+KP+N+LL + I+LADFG L + T + GT +++PE+ + G+
Sbjct: 127 DIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK- 184
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPF 233
Y + D +S + ++E+L+ + PF
Sbjct: 185 --YGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 50/242 (20%)
Query: 28 VGPRIGEGAHAKVYEGKY-KNQT-VAIK--IVHKGETPEEIAKKESRFAREVAMLSRVQH 83
+ ++GEG +VY+ + K VA+K ++H + I RE+ +L +++H
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA-----LREIKILKKLKH 66
Query: 84 RNLVKFI---------GACKEPVMVIVTEL----LSGGTLRKYLLNMRPRC-LDVCVAIG 129
N+V I K + +VT LSG LL P L
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG------LLE-NPSVKLTESQIKC 119
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETG 187
+ L + + LH + I+HRD+K N+L+ ++ +K+ADFGLAR + G
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILI-DNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 188 T---Y------RWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237
Y RW PEL GE++ Y VD + V E+ + +G S
Sbjct: 179 GTRKYTNLVVTRWYRPPELLL------GERR-YTTAVDIWGIGCVFAEMFTRRPILQGKS 231
Query: 238 NL 239
++
Sbjct: 232 DI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 8e-09
Identities = 40/154 (25%), Positives = 62/154 (40%), Gaps = 29/154 (18%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKI-VHKGETPEEIAKK--ESRFAREVAMLSRVQHRNLVK 88
I +GA A +Y G + IK V K E+ ++ R E +LSR + V
Sbjct: 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVN 60
Query: 89 FIGACKEPV--------MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
PV IV E + G L+ + ++ IG + +
Sbjct: 61 ------TPVVYDVDPDNKTIVMEYIEGKPLKDV---IEEGNDELLREIGRL--VGK---- 105
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
LH GI+H DL N+++ +D + L DFGL +
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD--KLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 8e-09
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 11/94 (11%)
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
LH H IIH D+K EN+L I L D+GL + GT + +PE
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY---DGTLDYFSPE----- 176
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234
+ + +Y+ D ++ ++ +ELL K PF+
Sbjct: 177 ---KIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 35/104 (33%), Positives = 60/104 (57%), Gaps = 9/104 (8%)
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
+A +I +E +H+ +++RDLKP N+LL E ++++D GLA + S + A GT+
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 190 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
+MAPE+ L++G Y+ D +S +L++LL PF
Sbjct: 160 GYMAPEV-----LQKGTA--YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 32 IGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G G VY+ + + +A+K++ T E + + E+ +L + ++ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE----LQKQIMSELEILYKCDSPYIIGF 64
Query: 90 IGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
GA E + I TE + GG+L Y R + V A+ + + + L S I+H
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILH 118
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 208
RD+KP N+L+ +KL DFG++ + + + GT +MAPE S GE+
Sbjct: 119 RDVKPSNMLVNTR-GQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERIS------GEQ- 169
Query: 209 HYNHKVDSYSFAIVLWELLHNKLPF 233
Y D +S I EL + P+
Sbjct: 170 -YGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
++ + RA+ +HS I HRDLKP+NLL+ + T+KL DFG A+ + + +
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 190 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
+ APEL T +Y +D +S ++ E++ F G S++
Sbjct: 235 FYRAPELMLGAT-------NYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 37/116 (31%), Positives = 55/116 (47%), Gaps = 23/116 (19%)
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT- 188
F + RA++ +H+ + HRDLKP+N+L D K +K+ DFGLAR + +T T
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLAR------VAFNDTPTA 160
Query: 189 --------YRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
RW APEL + + Y +D +S + E+L K F G
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFSK------YTPAIDIWSIGCIFAEVLTGKPLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 62/248 (25%), Positives = 106/248 (42%), Gaps = 35/248 (14%)
Query: 73 REVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
RE+ +L +V F GA + + I E + GG+L + L + ++ + A
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA 111
Query: 132 LDIARAMECL-HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
+ R + L H I+HRD+KP N+L+ IKL DFG++ + + M + GT
Sbjct: 112 --VLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRS 167
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQAAYAAAFK 248
+M+PE + + HY+ + D +S + L EL + P L+A + +
Sbjct: 168 YMSPE--------RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG---R 216
Query: 249 NVRPSAENVPEELSIILTSCWKEDPNARP--------NFTQIIQMLLNYLSAIAPPEPMI 300
V E P +S + P RP I LL+Y+ + P P +
Sbjct: 217 PVVDGEEGEPHSISP------RPRPPGRPVSGHGMDSRPAMAIFELLDYI--VNEPPPKL 268
Query: 301 PHRIFNSE 308
P+ +F +
Sbjct: 269 PNGVFTPD 276
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 40/232 (17%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G +VY ++ VA+K + + + + KK RF RE + + + H +V
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK--RFLREAKIAADLIHPGIVPV 67
Query: 90 IGACKEPVMVIVT-ELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDI----ARAME 139
C + V T + G TL+ L ++ + L ++G L I +E
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 140 CLHSHGIIHRDLKPENLLL---------------TEDLKTIKLADFGLAREESLTEMMTA 184
+HS G++HRDLKP+N+LL + L+ L D + MT
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 185 E---TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
GT +MAPE L + D Y+ ++L+++L P+
Sbjct: 188 PGKIVGTPDYMAPE-----RLLGVPA---SESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 43/212 (20%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
I G Y+GK + + +EI S + E+A + ++QH N+VK IG
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVV-------KEINDVNSIPSSEIADMGKLQHPNIVKLIG 750
Query: 92 ACK-EPVMVIVTELLSGGTLRKYLLNM---RPRCLDVCVAIGFALDIARAMECLHSH--- 144
C+ E ++ E + G L + L N+ R R +AIG IA+A+ LH
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRR----KIAIG----IAKALRFLHCRCSP 802
Query: 145 GIIHRDLKPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYR---WMAPELYSTV 200
++ +L PE +++ +D ++L SL ++ +T + ++APE
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLRL---------SLPGLLCTDTKCFISSAYVAPETR--- 850
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 232
E K K D Y F ++L ELL K P
Sbjct: 851 -----ETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 46/190 (24%), Positives = 77/190 (40%), Gaps = 41/190 (21%)
Query: 8 YLADELKLDAKWLIDPKHLFVGPR---IGEGAHAKVYEGKYKNQTVAIKI-VHKGETPEE 63
+ DE+ + W+ + + IG+GA A + +G+Y + IK V KG E
Sbjct: 316 FRTDEV--EVTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPE 373
Query: 64 IAKKESRFAREVAMLSRVQHRNLVKFIGACKE-----PV--------MVIVTELLSGGTL 110
+ ++ L + R + + + PV IV E + GG
Sbjct: 374 LDER----------LRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYI-GGKD 422
Query: 111 RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170
K +L P ++ +G +A+ LH GI+H DL N ++ +D + L DF
Sbjct: 423 LKDVLEGNP---ELVRKVG--EIVAK----LHKAGIVHGDLTTSNFIVRDD--RLYLIDF 471
Query: 171 GLAREESLTE 180
GL + L E
Sbjct: 472 GLGKYSDLIE 481
|
Length = 535 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 58/244 (23%), Positives = 100/244 (40%), Gaps = 55/244 (22%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA +V + K A+K + K E E+ R R++ L+ + +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI--LAEADNPWVVKL 66
Query: 90 IGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ ++ + ++ E L GG + L M+ + + A++ +H G IH
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLL--MKKDTFTEEETRFYIAETILAIDSIHKLGYIH 124
Query: 149 RDLKPENLLLTEDLKTIKLADFGL------AREESLTEMMT------------------- 183
RD+KP+NLLL IKL+DFGL + +++
Sbjct: 125 RDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 184 -AET-------------GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 229
AET GT ++APE++ + YN + D +S ++++E+L
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFL--------QTGYNKECDWWSLGVIMYEMLVG 235
Query: 230 KLPF 233
PF
Sbjct: 236 YPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 52/241 (21%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA +V + K A+KI+ K + E+ R R++ L +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI--LVEADSLWVVKM 66
Query: 90 IGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ ++ + + ++ E L GG + L M+ L + + A++ +H G IH
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124
Query: 149 RDLKPENLLLTEDLKTIKLADFGLA-------REE----------------SLTEMMTAE 185
RD+KP+NLLL + +KL+DFGL R E ++ AE
Sbjct: 125 RDIKPDNLLL-DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 186 T-------------GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 232
T GT ++APE++ ++ G YN D +S ++++E+L P
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIGYPP 235
Query: 233 F 233
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 68/284 (23%), Positives = 110/284 (38%), Gaps = 78/284 (27%)
Query: 98 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 155
+ V + + GG + L+ M P L A + ++ A+E +H G IHRD+KP+N
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMEVFPEVL----ARFYIAELTLAIESVHKMGFIHRDIKPDN 131
Query: 156 LLLTEDLKTIKLADFGLA------------------REESLT---------------EMM 182
+L+ D IKL DFGL R++S+ +
Sbjct: 132 ILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLK 190
Query: 183 TAE---------------TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 227
T E GT ++APE V LR+G Y D +S ++L+E+L
Sbjct: 191 TLEQRATKQHQRCLAHSLVGTPNYIAPE----VLLRKG----YTQLCDWWSVGVILFEML 242
Query: 228 HNKLPF----EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWK----------EDP 273
+ PF + L+ ++ P + PE + +I C +D
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302
Query: 274 NARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESP 317
A P F++ + + + AP P I H + S + ESP
Sbjct: 303 KAHPFFSE-VDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESP 345
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 7e-07
Identities = 55/232 (23%), Positives = 95/232 (40%), Gaps = 37/232 (15%)
Query: 71 FAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG 129
F +++S+V H +L G C + ++V E + G L L + R + V I
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR-VPVAWKIT 121
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTE------DLKTIKLADFG-----LAREESL 178
A +A A+ L ++H ++ +N+LL IKL+D G L+REE +
Sbjct: 122 VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERV 181
Query: 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 238
+ W+APE + D +SF L E+ F+G
Sbjct: 182 ERI--------PWIAPECVPGGN-------SLSTAADKWSFGTTLLEIC-----FDGEVP 221
Query: 239 LQAAYAAAFKNVRPSAENVPE----ELSIILTSCWKEDPNARPNFTQIIQML 286
L+ + + +PE EL+ +++ C +P RP+F I++ L
Sbjct: 222 LKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 71/287 (24%), Positives = 118/287 (41%), Gaps = 38/287 (13%)
Query: 39 KVYEGKYKNQTVAIKIVHKGETPEEIAKK----------ESRFAREVAMLSRVQHRNLVK 88
K+ E N V K+ HK + +A+K ++ RE+ +L +V
Sbjct: 9 KISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 67
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--PRCL--DVCVAIGFALDIARAMECLHS 143
F GA + + I E + GG+L + L P + V +A+ L R
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-----EK 122
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 203
H I+HRD+KP N+L+ IKL DFG++ + + M + GT +M+PE
Sbjct: 123 HKIMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------ 174
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPF--EGMSNLQAAYAAAFKNVRPSAENVPEEL 261
QG HY+ + D +S + L E+ + P L+ + + P+
Sbjct: 175 QG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG-DPAESETSPRP 231
Query: 262 SIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 308
P++RP I LL+Y+ + P P +P +F +E
Sbjct: 232 RPPGRPLSSYGPDSRPPMA--IFELLDYI--VNEPPPKLPSGVFGAE 274
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 52/241 (21%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA +V + K A+KI+ K + E+ R R++ L +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI--LVEADGAWVVKM 66
Query: 90 IGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ ++ + ++ E L GG + L M+ L + + A++ +H G IH
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124
Query: 149 RDLKPENLLLTEDLKTIKLADFGLA-------REE----------------SLTEMMTAE 185
RD+KP+NLLL + +KL+DFGL R E ++ AE
Sbjct: 125 RDIKPDNLLL-DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 186 T-------------GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 232
T GT ++APE++ ++ G YN D +S ++++E+L P
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIGYPP 235
Query: 233 F 233
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 18/40 (45%), Positives = 28/40 (70%)
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
I A++ LHS GI+HRD+KP+N++ +E + K+ D G A
Sbjct: 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 53/223 (23%), Positives = 86/223 (38%), Gaps = 63/223 (28%)
Query: 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157
+ V + + GG + L+ M D+ A + ++ A+E +H G IHRD+KP+N+L
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDL--ARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133
Query: 158 LTEDLKTIKLADFGLA------------------REESLTEMMTAE-------------- 185
+ D IKL DFGL R++S+
Sbjct: 134 IDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 186 ----------------TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 229
GT ++APE V LR G Y D +S ++L+E+L
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPE----VLLRTG----YTQLCDWWSVGVILYEMLVG 244
Query: 230 KLPFEGMSNLQAAYAA----AFKNVRPSAENVPEELSIILTSC 268
+ PF + L+ ++ P A+ PE +I+ C
Sbjct: 245 QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC 287
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 21/152 (13%)
Query: 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159
+++ ++ G+ L P + + R + LH +G IHR++K ++L++
Sbjct: 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135
Query: 160 ED-LKTIKLADFGLAREESLT----------EMMTAETGTYRWMAPELYSTVTLRQGEKK 208
D L ++ GL+ SL + T W++PEL LRQ +
Sbjct: 136 GDGLVSLS----GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL-----LRQ-DLY 185
Query: 209 HYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
YN K D YS I EL ++PF+ M Q
Sbjct: 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 19/82 (23%)
Query: 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR--------AMECLHSHGIIHRDL 151
++ E L GG L L+ F+ D+ R A+E +H G IHRD+
Sbjct: 78 LIMEFLPGGDLMTMLIKYDT----------FSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 152 KPENLLLTEDLKTIKLADFGLA 173
KP+N+L+ IKL+DFGL+
Sbjct: 128 KPDNILIDRG-GHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 40/225 (17%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IGEG + +VY+ + K + VA+K V E RE+ +L ++ HRN+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA---IREIKILRQLNHRNIVN- 70
Query: 90 IGACKEPVMVIVTELLSGGTLRK-----YLL--NMRPRCLDVCVA--IGFALD-IARAME 139
+ IVT+ +K YL+ M + + + + F+ D I M+
Sbjct: 71 -------LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 140 CL-------HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYR 190
L H +HRD+K N+LL + IKLADFGLAR + T + T
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ-IKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+ PEL GE++ Y +D +S +L EL K F+
Sbjct: 183 YRPPELL------LGEER-YGPAIDVWSCGCILGELFTKKPIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 23/51 (45%), Positives = 31/51 (60%), Gaps = 1/51 (1%)
Query: 123 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
D+ V G + + LH GI+HRD+KPENLL+T D +K+ DFG A
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 2e-05
Identities = 39/166 (23%), Positives = 62/166 (37%), Gaps = 38/166 (22%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHK-GETPEEIAKK---------------ESR 70
+G +IG G + VY + VA+K H+ G T K+ SR
Sbjct: 19 LGNQIGVGKESDVYLALDPDGNPVALKF-HRLGRTSFRKVKRKRDYLGDRKHASWLYLSR 77
Query: 71 FA--REVAMLSRVQHRNLVKFIGACKEPV----MVIVTELLSGGTLRKYLLNMRPRCLDV 124
A +E A L + +P+ +V E + G L + + P
Sbjct: 78 LAAQKEFAALKALYEEG-----FPVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPE---- 128
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170
+I + + HGIIH DL N+L+ +D K I + D+
Sbjct: 129 ----EVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK-IYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 53/230 (23%), Positives = 94/230 (40%), Gaps = 40/230 (17%)
Query: 27 FVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKE-------SRFAREVAMLS 79
+ G ++G G + VY+ K K+ G+ +E A K+ RE+A+L
Sbjct: 4 YEGCKVGRGTYGHVYKAKRKD----------GKDEKEYALKQIEGTGISMSACREIALLR 53
Query: 80 RVQHRNLVK----FIGACKEPVMVIVTELLSG-----GTLRKYLLNMRPRCLDVCVAIGF 130
++H N++ F+ V ++ R N +P L +
Sbjct: 54 ELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLAR--EESLTEMMTAE 185
I + LH++ ++HRDLKP N+L+ + +K+AD G AR L + +
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 186 --TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
T+ + APEL +HY +D ++ + ELL ++ F
Sbjct: 174 PVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 41/148 (27%), Positives = 65/148 (43%), Gaps = 21/148 (14%)
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYL---LNMRPRCLDVCVAIGFALDIARAMECLH 142
L K+I E + +V + GG L ++ LN+ C+ +A ++ A++ LH
Sbjct: 50 LHKYI--VSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR-----WAAEMVVALDALH 102
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 202
GI+ RDL P N+LL +D I+L F E + + E + APE+
Sbjct: 103 REGIVCRDLNPNNILL-DDRGHIQLTYFSRWSE--VEDSCDGEAVENMYCAPEV------ 153
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELLHNK 230
G D +S +L+ELL K
Sbjct: 154 --GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 33/151 (21%), Positives = 57/151 (37%), Gaps = 25/151 (16%)
Query: 31 RIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL---- 86
+ G +VY K++ +KI E K + REVA+L + + L
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVLKINPSRE-------KGADREREVAILQLLARKGLPVPK 57
Query: 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-- 144
V G + ++ E + G TL + + A +A + LH
Sbjct: 58 VLASGE-SDGWSYLLMEWIEGETLDEVSEEEKED---------IAEQLAELLAKLHQLPL 107
Query: 145 -GIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
+ H DL P N+L+ + K + + D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDG-KILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 39/116 (33%), Positives = 54/116 (46%), Gaps = 16/116 (13%)
Query: 115 LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFG- 171
L R R L + A + A++ +H GIIHRD+K EN+L+ ED I L DFG
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGA 306
Query: 172 --LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 225
AR T GT APE+ + G+ Y VD +S +V++E
Sbjct: 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLA------GDP--YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 40 VYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK----FIGAC 93
V+ K+K N VA+K ++ +E +E+ ++QH N++ FI
Sbjct: 16 VHLAKHKPTNTLVAVKKINLDSCSKE---DLKLLQQEIITSRQLQHPNILPYVTSFIVDS 72
Query: 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLK 152
+ + +V+ L++ G+ L P L +AI F L D+ A++ +HS G IHR +K
Sbjct: 73 E---LYVVSPLMAYGSCEDLLKTHFPEGLPE-LAIAFILKDVLNALDYIHSKGFIHRSVK 128
Query: 153 PENLLLTEDLKTIKLADFGLA--------REESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
++LL+ D K + L+ + R+ + + + W++PE+ L+Q
Sbjct: 129 ASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV-----LQQ 182
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 236
+ YN K D YS I EL + +PF+ M
Sbjct: 183 -NLQGYNEKSDIYSVGITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 52/230 (22%), Positives = 93/230 (40%), Gaps = 40/230 (17%)
Query: 27 FVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKE-------SRFAREVAMLS 79
+ G ++G G + VY+ K K+ G+ + A K+ RE+A+L
Sbjct: 4 YEGCKVGRGTYGHVYKAKRKD----------GKDDRDYALKQIEGTGISMSACREIALLR 53
Query: 80 RVQHRNLVK----FIGACKEPVMVIVTELLSG-----GTLRKYLLNMRPRCLDVCVAIGF 130
++H N++ F+ V ++ R N +P L +
Sbjct: 54 ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLAR--EESLTEMMTAE 185
I + LH++ ++HRDLKP N+L+ + +K+AD G AR L + +
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 186 --TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
T+ + APEL +HY +D ++ + ELL ++ F
Sbjct: 174 PVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 14/119 (11%)
Query: 120 RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA--REES 177
R + +C + + RA++ LH + IIHRD+K EN+ + + L DFG A +
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPVDI 235
Query: 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL--HNKLPFE 234
GT APEL + + Y VD +S IVL+E+ H+ L FE
Sbjct: 236 NANKYYGWAGTIATNAPELLA--------RDPYGPAVDIWSAGIVLFEMATCHDSL-FE 285
|
Length = 391 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 16/112 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYE----GKYKN---QTVAIKIVHKGETPEEIAKKESR 70
KW L +G +G GA KV + G K+ +TVA+K++ +G T E
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE----YKA 56
Query: 71 FAREVAMLSRV-QHRNLVKFIGACKE---PVMVIVTELLSGGTLRKYLLNMR 118
E+ +L + H N+V +GAC + P+MVIV E G L YL + R
Sbjct: 57 LMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 1e-04
Identities = 37/155 (23%), Positives = 56/155 (36%), Gaps = 25/155 (16%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVA--------ML 78
VG IG G A VY + + VA+KI ++ +K R L
Sbjct: 1 VGGPIGTGKEADVYLALDGDGEPVAVKI-YRTGRTSFKKRKRYRTGDYRFGRKKSNWRYL 59
Query: 79 SRV----QHRNLVKFIGA---CKEPVM----VIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
SR+ + RNL + A +P+ V+V E + G + L D
Sbjct: 60 SRLWAEKEFRNLKRLYEAGVPVPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLED---P 116
Query: 128 IGFALDIARAMECL-HSHGIIHRDLKPENLLLTED 161
I M L G++H DL N+L+ +
Sbjct: 117 EELYDQILELMRKLYREAGLVHGDLSEYNILVDDG 151
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 35/112 (31%), Positives = 51/112 (45%), Gaps = 16/112 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGK-------YKNQTVAIKIVHKGETPEEIAKKESR 70
KW L +G +G GA +V E +TVA+K++ +G T E
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE----HRA 56
Query: 71 FAREVAMLSRV-QHRNLVKFIGACKE---PVMVIVTELLSGGTLRKYLLNMR 118
E+ +L + H N+V +GAC + P+MVIV E G L YL + R
Sbjct: 57 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSNYLRSKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 7/113 (6%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGK----YKNQTVAIKIVHKGETPEEIAKK 67
+L D++W L +G +G GA KV EG ++Q V +K+ K P + +
Sbjct: 25 QLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPV-MKVAVKMLKPTARSSE 83
Query: 68 ESRFAREVAMLSRV-QHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR 118
+ E+ +++ + H N+V +GAC K + I+TE G L YL R
Sbjct: 84 KQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNR 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 37/117 (31%), Positives = 52/117 (44%), Gaps = 15/117 (12%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYE----GKYKNQ---TVAIKIVHKGETPEEI 64
+L D KW L G +G GA KV E G +K+ TVA+K++ P
Sbjct: 23 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKML----KPSAH 78
Query: 65 AKKESRFAREVAMLSRV-QHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMR 118
+ E+ +LS + H N+V +GAC P +VI TE G L +L R
Sbjct: 79 LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVI-TEYCCYGDLLNFLRRKR 134
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 33/150 (22%), Positives = 50/150 (33%), Gaps = 24/150 (16%)
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
HR K N+LLT D L G + + Y +MAPE+ +
Sbjct: 34 HRQAKSGNILLTWDGL---LKLDGSV---AFKTPEQSRPDPY-FMAPEVIQGQS------ 80
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 267
Y K D YS I L+E L +LP+ L A + P +
Sbjct: 81 --YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN---GMPADDPRD------R 129
Query: 268 CWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297
E +A +F +++ + L
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRREAA 159
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 352 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.57 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.31 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.28 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.23 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.11 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.09 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.07 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.84 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.75 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.73 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.57 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.53 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.49 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.42 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.42 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.33 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.31 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.31 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.29 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.17 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.05 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.01 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.98 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.89 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.86 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.77 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.73 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.67 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.59 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.49 | |
| PLN02236 | 344 | choline kinase | 97.46 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.31 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.29 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.23 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.21 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.19 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.04 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.42 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.36 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.34 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.28 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.11 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.07 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.04 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.97 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.74 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.72 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.38 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.31 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-55 Score=381.90 Aligned_cols=259 Identities=27% Similarity=0.359 Sum_probs=217.9
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHH--HHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI--AKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 96 (352)
..+.|.+.+.||+|+||.|-+|..+ |+.||||++......... ........+|+++|++|+|||||++++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3567888999999999999999874 999999999875443321 11233467999999999999999999999865
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCCcc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAR 174 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~a~ 174 (352)
..|+||||++||+|.+++-.++. +.+..-..++.||+.|+.|||++||+||||||+|||++.+ .-.+||+|||+|+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 67999999999999999987665 7888888999999999999999999999999999999765 2469999999999
Q ss_pred ccccccccccCCCcccccccccccccccccccccC-CCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cc
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKH-YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF----KN 249 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~-~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----~~ 249 (352)
.......+.+.+||+.|.|||++.. .+.. +..+.|+|||||++|-+++|.+||.+......+...+. ..
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~------kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLAS------KGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred ccccceehhhhcCCccccChhheec------CCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 9888888999999999999999976 2333 33489999999999999999999987554442333333 23
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
..+.+..++++..++|.+||..||++|||++++++|.|-
T Consensus 402 ~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 402 GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 345577899999999999999999999999999999553
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-54 Score=371.18 Aligned_cols=253 Identities=30% Similarity=0.419 Sum_probs=221.6
Q ss_pred eecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 96 (352)
.+.+++|++.++||+|+||+||.++. +++.||+|++++....+. +......+|..+|.+++||.||+++..|+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~--~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK--KEVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh--hhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 67789999999999999999999976 589999999988665443 4466788999999999999999999999865
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc-
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE- 175 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~- 175 (352)
.+|+|+||+.||.|.-++++.+. +++..+..++.+|+.||.|||++||+||||||+|||++.+ |+++|+|||+++.
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKED 175 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhc
Confidence 79999999999999999987554 9999999999999999999999999999999999999999 8999999999985
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
........+.+||+.|||||++.. ..|+.++|.||||+++|+|++|.+||.+.+.......+........+.
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~--------~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~ 247 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLG--------KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG 247 (357)
T ss_pred ccCCCccccccCCccccChHHHhc--------CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc
Confidence 334455667899999999999975 689999999999999999999999999976655555555544455566
Q ss_pred CCcHHHHHHHHHhhccCCCCCC----CHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARP----NFTQIIQM 285 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rp----s~~~i~~~ 285 (352)
.++.+.+++++.+|+.||++|. ++.+|.+|
T Consensus 248 ~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 248 YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 6999999999999999999995 67777776
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-54 Score=370.13 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=216.3
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-C
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 96 (352)
-+...+.+.+..||+|..|+||+++++ ++.+|+|++...... ....++.+|+++++.++||+||.+++.|.. +
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~----~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP----ALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH----HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 345568888999999999999999986 899999999554443 345568999999999999999999999874 4
Q ss_pred -ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
...++||||+||||++++...+. ++|..+..|+.++++||.|||+ ++|+||||||+||||+.. |.|||+|||.+.
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS~ 227 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVSG 227 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEeccccccH
Confidence 39999999999999999987644 9999999999999999999995 999999999999999998 899999999998
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcc
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM-----SNLQAAYAAAFKN 249 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~-----~~~~~~~~~~~~~ 249 (352)
..... ...+.+||..|||||.+.+ ..|+.++||||||++++|+.+|+.||... ...+....+....
T Consensus 228 ~lvnS-~a~tfvGT~~YMsPERi~g--------~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 228 ILVNS-IANTFVGTSAYMSPERISG--------ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP 298 (364)
T ss_pred Hhhhh-hcccccccccccChhhhcC--------CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence 75544 5678899999999999865 78999999999999999999999999874 2233334444444
Q ss_pred CCCCCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 250 VRPSAEN-VPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 250 ~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.+..+.. +|++++.|+..||++||.+||++.++++|.
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 4444665 999999999999999999999999999994
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=388.21 Aligned_cols=252 Identities=29% Similarity=0.460 Sum_probs=220.8
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 99 (352)
..+|..++.||+|||+.||++++ +|+.||+|++.+..... .....++.+|+++++.|+|||||+++++|++. +.|
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k--~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK--PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC--cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 47899999999999999999988 59999999997744332 24456789999999999999999999999975 799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+|.|+|..++|..++++++. ++|.+++.++.||+.||.|||+++|+|||||..|+|++++ -+|||+|||+|......
T Consensus 95 ivLELC~~~sL~el~Krrk~--ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKP--LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYD 171 (592)
T ss_pred EEEEecCCccHHHHHHhcCC--CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc-CcEEecccceeeeecCc
Confidence 99999999999999996554 9999999999999999999999999999999999999998 58999999999876543
Q ss_pred -cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCc
Q 018656 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 180 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (352)
+...+.+||+.|.|||++.. ...+..+||||+||+||.||.|++||+..+-. ..+..+....-..|..++
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k--------~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-ety~~Ik~~~Y~~P~~ls 242 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNK--------SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-ETYNKIKLNEYSMPSHLS 242 (592)
T ss_pred ccccceecCCCcccChhHhcc--------CCCCCchhhhhhhhHHHhhhhCCCCcccchHH-HHHHHHHhcCcccccccC
Confidence 66778899999999999964 66788999999999999999999999985444 444444444445566999
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
.+.++||..+|+.||.+|||+++++.| .++
T Consensus 243 ~~A~dLI~~lL~~~P~~Rpsl~~vL~h--~Ff 272 (592)
T KOG0575|consen 243 AEAKDLIRKLLRPNPSERPSLDEVLDH--PFF 272 (592)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcC--Hhh
Confidence 999999999999999999999999999 555
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-52 Score=373.54 Aligned_cols=275 Identities=43% Similarity=0.749 Sum_probs=240.3
Q ss_pred cccccceecCCceeeeccccCCCceEEEEEEECCce-EEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
.....|.|+.....+.+.||+|+||+||+|.+.|+. ||+|++......... ...|.+|+.++++++|||||+++++
T Consensus 31 ~~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 31 DELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred ccccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 344679999999999999999999999999999988 999999876544432 6679999999999999999999999
Q ss_pred eecC--ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCCCeEEeCCCCceEEec
Q 018656 93 CKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG-IIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 93 ~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~-ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
+.++ .+.+||||+++|+|.+++.......++...++.|+.||++|+.|||+++ ||||||||+|||++.+...+||+|
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence 9876 4999999999999999998744455999999999999999999999999 999999999999999833999999
Q ss_pred CCCccccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 170 FGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 170 fg~a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
||+++..... .......||..|||||++.+. ...|+.++||||+|+++|||+||+.||.+....+........
T Consensus 188 FGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~------~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~ 261 (362)
T KOG0192|consen 188 FGLSREKVISKTSMTSVAGTYRWMAPEVLRGE------KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG 261 (362)
T ss_pred CccceeeccccccccCCCCCccccChhhhcCC------CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 9999865544 344457899999999999641 367999999999999999999999999999887777777666
Q ss_pred cCCCC-CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 249 NVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 249 ~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
..+|. +..+++.+..++.+||..||.+||++.+++..|..+........
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~ 311 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAG 311 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence 66666 55699999999999999999999999999999998877655433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=359.08 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=218.0
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee-ee-cC-c
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA-CK-EP-V 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~-~~-~~-~ 97 (352)
..+|++.++||.|+||+||++.. +|..+|.|.++...... +..+....|+.+|++|+|||||+++++ +. +. .
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~---k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDA---KARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccH---HHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 45699999999999999999987 59999999998665544 456678899999999999999999984 44 33 4
Q ss_pred eEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CccCCCCCCCeEEeCCCCceEEecCC
Q 018656 98 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHS--HG--IIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~--~~--ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
++||||+|.+|+|.+.|+.. +.+.+++..+|.++.|++.||..+|+ .. |+||||||+||+++.+ |.|||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-Cceeeccch
Confidence 89999999999999999754 34579999999999999999999999 44 9999999999999998 899999999
Q ss_pred Ccccccccc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 018656 172 LAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 172 ~a~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
+++..+... ...+.+|||.||+||.+.. ..|+.+||||||||++|||+.-+.||.+.+-.+...++.....
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~--------~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHE--------SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhc--------CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 999755543 4456799999999999865 7899999999999999999999999999877777777777777
Q ss_pred CCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 251 RPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 251 ~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.|.+ ..+|.++..+|..|+..||+.||+...++..+
T Consensus 246 ~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 246 PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 7777 78999999999999999999999865555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=361.97 Aligned_cols=251 Identities=29% Similarity=0.455 Sum_probs=216.4
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
..+|.+.+.||.|+||+||+|+++ +..||||.+....-.. +....+..|+.+|+.++|||||++++++.. +.+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~---k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK---KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH---HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 457888899999999999999885 8999999998765322 334558899999999999999999999984 5899
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC-C----CceEEecCCCcc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-L----KTIKLADFGLAR 174 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~-~----~~vkl~Dfg~a~ 174 (352)
+|||||+||+|.+|+.+++. +++..++.++.||+.||++||+++||||||||+|||++.. . ..+||+|||+|+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999998765 9999999999999999999999999999999999999764 1 358999999999
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--CC
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RP 252 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~ 252 (352)
.........+.+|++.|||||++.. ..|+.|+|+||+|+++|++++|+.||...+..+.......... ..
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~--------~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~ 235 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMS--------QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV 235 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHh--------ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc
Confidence 9888888889999999999999864 7899999999999999999999999998777665554333222 22
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.+..++..+.+++...|+.+|.+|.+..+...+.
T Consensus 236 ~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 236 LPAELSNPLRELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred hhhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence 3455677788999999999999999988887763
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=370.73 Aligned_cols=269 Identities=32% Similarity=0.603 Sum_probs=238.9
Q ss_pred ccccccc-cccceecCCceeeeccccCCCceEEEEEEECCc-eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018656 9 LADELKL-DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ-TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86 (352)
Q Consensus 9 ~~~~~~~-~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 86 (352)
.++.... .+.|.|+++.+++++.||+|-||+|+.|.++|. .||+|.+....... ..|.+|+++|++|+|+||
T Consensus 190 ~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~------~~f~~Ea~iMk~L~H~~l 263 (468)
T KOG0197|consen 190 KPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP------EAFLREAQIMKKLRHEKL 263 (468)
T ss_pred CCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh------hHHHHHHHHHHhCcccCe
Confidence 4455455 778999999999999999999999999999976 99999998764433 247899999999999999
Q ss_pred eeeeeeeecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCce
Q 018656 87 VKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (352)
Q Consensus 87 v~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~v 165 (352)
|+++++|..+ -++|||||++.|+|.+|++...+..+...+.+.++.|||+|++||+++++|||||.++||||+++ ..+
T Consensus 264 V~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~v 342 (468)
T KOG0197|consen 264 VKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVV 342 (468)
T ss_pred EEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceE
Confidence 9999999865 59999999999999999998666679999999999999999999999999999999999999999 799
Q ss_pred EEecCCCccccccccccccC--CCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 018656 166 KLADFGLAREESLTEMMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 242 (352)
Q Consensus 166 kl~Dfg~a~~~~~~~~~~~~--~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 242 (352)
||+|||+|+....+...... .-..-|.|||++.. ..++.+|||||+|++|+||+| |+.||.+.++.+..
T Consensus 343 KIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~--------~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~ 414 (468)
T KOG0197|consen 343 KISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY--------GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL 414 (468)
T ss_pred EEcccccccccCCCceeecCCCCCCceecCHHHHhh--------CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH
Confidence 99999999954443332222 23568999999965 779999999999999999998 99999999999999
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 243 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.........|.|..+|+++.+++..||..+|++|||++.+...++++...
T Consensus 415 ~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 415 ELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 99998999999999999999999999999999999999999988877653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=366.59 Aligned_cols=253 Identities=28% Similarity=0.404 Sum_probs=218.5
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeecC
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP 96 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~ 96 (352)
...+.+|.+++.||.|+|++|++|+++ ++.||||++.+.....+ +....+.+|-.+|.+| .||.|++|+..|++.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike--~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE--KKVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh--cccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 556889999999999999999999874 89999999977544332 3345577899999999 899999999999965
Q ss_pred -ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
.+|+|+||+++|+|.++|.+.+. |++...+.++.||+.||+|||++|||||||||+|||++.+ ++++|+|||.|..
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~ 223 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKI 223 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeecccccc
Confidence 79999999999999999998765 9999999999999999999999999999999999999999 7999999999974
Q ss_pred ccccc------------c--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 018656 176 ESLTE------------M--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 241 (352)
Q Consensus 176 ~~~~~------------~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 241 (352)
..... . ..+++||..|.+||++.. ...++.+|||+|||++|+|+.|.+||.+.+...
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--------~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl- 294 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--------SPAGPSSDLWALGCILYQMLAGQPPFRAANEYL- 294 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcC--------CCCCcccchHHHHHHHHHHhcCCCCCccccHHH-
Confidence 32211 1 145789999999999965 677899999999999999999999999966544
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 242 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..+.+....-..++++|+...+||+++|..||.+|+|..+|.+|.
T Consensus 295 iFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 295 IFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 444444445566778999999999999999999999999999984
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=346.37 Aligned_cols=249 Identities=28% Similarity=0.397 Sum_probs=212.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
+.|....++|+|+||+||+|+++ |+.||||.+......... ..-..||+++|++|.|||+|.++++|.. ..+++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~V---kKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVV---KKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHH---HHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 35778889999999999999874 999999999876654433 3347799999999999999999999984 58999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc-cc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LT 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~~ 179 (352)
|+|||+. ++.+.+.... ..++...+..++.|++.|+.|||+++++||||||+||||+.+ |.+||+|||+|+... ++
T Consensus 79 VFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 79 VFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPG 155 (396)
T ss_pred Eeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCc
Confidence 9999976 4444455543 349999999999999999999999999999999999999998 899999999999765 66
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--------
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-------- 251 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------- 251 (352)
...+.++.|..|+|||.+.+ ...|++..||||+||++.||++|.+-|.+.++.++.+.+......
T Consensus 156 d~YTDYVATRWYRaPELLvG-------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVG-------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred chhhhhhhhhhccChhhhcc-------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 67777889999999999976 468999999999999999999999999999999888876654321
Q ss_pred ------------CC----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 ------------PS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 ------------~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
|. .+.++.-+.++++.||..||.+|++-++++.|
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11 12455678899999999999999999999886
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-51 Score=360.26 Aligned_cols=252 Identities=28% Similarity=0.399 Sum_probs=221.7
Q ss_pred ecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeecC-
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP- 96 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~- 96 (352)
+.-++|.+++.||.|+||.||+|.. +|+.||||.++...-.-. +-.=.||++.|++|+ ||||+++.+++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e----e~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE----ECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH----HHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3457899999999999999999987 489999999877543321 112358999999998 99999999998654
Q ss_pred -ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
.+|+||||| ..+|+++++.+ .+.|++..+..|+.||++||+|+|.+|+.|||+||+|||++.. ..+||+|||+|+.
T Consensus 83 ~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLARe 159 (538)
T KOG0661|consen 83 RILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLARE 159 (538)
T ss_pred ceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEecccccccc
Confidence 799999999 55999999987 6779999999999999999999999999999999999999965 5899999999999
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC-
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA- 254 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~- 254 (352)
.......+.++.|..|+|||++.. ...|+.+.|+||+||+++|+.+-++-|.|.++.++.++++.....|..
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLr-------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~ 232 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLR-------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD 232 (538)
T ss_pred cccCCCcchhhhcccccchHHhhh-------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence 888888889999999999999875 478999999999999999999999999999999999988876655542
Q ss_pred ----------------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 255 ----------------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 255 ----------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+..+.+..++|.+||..||.+|||+.+++++.
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 23568899999999999999999999999983
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=331.52 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=223.3
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
.+|...++||+|.||+||+|+++ |+.||||.+......+.. .....||++.|+.++|+||+.++++|. .+.+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi---~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI---NRTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc---cHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 47888999999999999999985 999999999887655432 234789999999999999999999997 458999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
|+||+ ..+|...|+.. ...++...+..++.++++||+|||++.|+||||||+|+||+++ |.+||+|||+|+......
T Consensus 79 VfEfm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 79 VFEFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccCCCC
Confidence 99999 46999999874 3459999999999999999999999999999999999999999 899999999999765443
Q ss_pred -ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC----
Q 018656 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---- 255 (352)
Q Consensus 181 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 255 (352)
.....+.|..|+|||.+.+ ...|+...|+||.||++.||+.|.+-|.|.++.++...+......|.+.
T Consensus 156 ~~~~~~V~TRWYRAPELLfG-------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFG-------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred cccccceeeeeccChHHhcc-------chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence 3334478999999999987 4789999999999999999999999999999988888777766655432
Q ss_pred -----------------------CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 018656 256 -----------------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 298 (352)
Q Consensus 256 -----------------------~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~ 298 (352)
..+.+..+++..||..||.+|+++.|++++ .++...+.+.+
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~ 292 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTP 292 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCC
Confidence 234678899999999999999999999999 77777555543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=359.39 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=218.3
Q ss_pred eecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeec-
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE- 95 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~- 95 (352)
.....+|.+++.||+|+||+|+.|.+ +|+.||+|++...............+.+|+.+++++. ||||+++++++..
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 34567999999999999999999987 4899999977664222111123445779999999998 9999999999974
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..+++||||+.||+|.+++.+.+. +.+..+..++.|+++|++|||++||+||||||+|||++.+.+++||+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 479999999999999999998443 999999999999999999999999999999999999998756999999999997
Q ss_pred c-ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 176 E-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 176 ~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
. .......+.+|++.|+|||++.+ ....-+.++||||+|++||.|++|..||...+. ......+.......+
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~------~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-~~l~~ki~~~~~~~p 243 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSG------KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-PNLYRKIRKGEFKIP 243 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCC------CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-HHHHHHHhcCCccCC
Confidence 7 56677788899999999999976 111345899999999999999999999998444 344444555555666
Q ss_pred CCC-cHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 255 ENV-PEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 255 ~~~-~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
..+ ++++..++.+||..||.+|+++.+++++-|
T Consensus 244 ~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 244 SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 777 999999999999999999999999997744
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=351.98 Aligned_cols=253 Identities=27% Similarity=0.456 Sum_probs=212.5
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee--cC-c
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--EP-V 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~-~ 97 (352)
..+|..++.||+|+||.||++.+. |+..|||.+....... .+.+.+|+.+|++++|||||++++... +. .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-----SESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-----HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 677999999999999999999885 7999999987763322 445889999999999999999999743 33 6
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
++++|||+++|+|.+++.+.+. .+++..++.+..|+++||+|||++|++||||||+|||++...+.+||+|||++....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999999998876 599999999999999999999999999999999999999932799999999988654
Q ss_pred c----ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcc-CC
Q 018656 178 L----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM-SNLQAAYAAAFKN-VR 251 (352)
Q Consensus 178 ~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~-~~~~~~~~~~~~~-~~ 251 (352)
. ........||+.|||||++.. +.....++|||||||++.||+||..||... ........+.... .+
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~-------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P 242 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRN-------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP 242 (313)
T ss_pred cccccccccccccCCccccCchhhcC-------CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC
Confidence 2 223445789999999999853 123336999999999999999999999873 3333344444333 34
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
..+..+|++.++|+.+|+..||.+|||+.++++|.+.
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 5577899999999999999999999999999999544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=364.46 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=222.7
Q ss_pred CceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 100 (352)
.-|++++.||.|+.|.|-.|++ +|+.+|||++.+..... ......+.+|+.+|+.+.||||+++++++..+ .+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s--~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS--SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc--cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 4589999999999999999987 59999999998762211 12334588999999999999999999999854 8999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
|.||++||.|++++-+.++ +++.++..++.||+.|+.|||..+|+||||||+|+|++.. +++||+|||+|.....+.
T Consensus 90 vlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc-cCEeeeccceeecccCCc
Confidence 9999999999999988766 9999999999999999999999999999999999999998 569999999999888888
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
...+.+|.++|+|||++.+. ...+.++||||.|+|||.||+|++||++. +...+......+....+..+|++
T Consensus 167 lLeTSCGSPHYA~PEIV~G~-------pYdG~~sDVWSCGVILfALLtG~LPFdDd-Nir~LLlKV~~G~f~MPs~Is~e 238 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGR-------PYDGRPSDVWSCGVILFALLTGKLPFDDD-NIRVLLLKVQRGVFEMPSNISSE 238 (786)
T ss_pred cccccCCCcccCCchhhcCC-------CCCCCccccchhHHHHHHHHhCCCCCCCc-cHHHHHHHHHcCcccCCCcCCHH
Confidence 89999999999999999873 45567999999999999999999999974 44555555666666778999999
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.++||++||..||.+|.|+++|++|.+
T Consensus 239 aQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 239 AQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHHHHHHhccCccccccHHHHhhCch
Confidence 999999999999999999999999954
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=352.78 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=217.3
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---Cc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~ 97 (352)
-..|..++.||+|.||.||+|++. |+.||+|.++.....+.. .....|||.+|++|+||||+++.+...+ +.
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~---~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF---PITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc---hHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 456888999999999999999984 899999999887644432 2347799999999999999999998764 47
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+|+|+|||+. +|.-++.... -.|++.++.-++.||+.||+|||.+||+|||||.+||||+++ |.+||+|||+|+.+.
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-GVLKIADFGLARFYT 269 (560)
T ss_pred EEEEEecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC-CCEEeccccceeecc
Confidence 9999999965 9999887643 349999999999999999999999999999999999999999 899999999999543
Q ss_pred c--ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC-
Q 018656 178 L--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA- 254 (352)
Q Consensus 178 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~- 254 (352)
. ....+..+.|..|+|||.+.+ ...|+.+.|+||.||||.||+.|++.|++.+..++...+......|..
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG-------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLG-------ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred CCCCcccccceEEeeccChHHhcC-------CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 3 334677789999999999988 468999999999999999999999999999988888777665444331
Q ss_pred ---------------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 255 ---------------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 255 ---------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
..+++...+|+..+|..||.+|.|+.+++.. .++
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s--eyF 403 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS--EYF 403 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC--ccc
Confidence 2356778899999999999999999999987 555
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=342.35 Aligned_cols=263 Identities=26% Similarity=0.450 Sum_probs=225.2
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
-..+..|.++.+.|.+...||.|..++||+|+. +++.||||++..+..... .+.+.+|+..++.++||||++++
T Consensus 15 ~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~----ld~l~kE~~~msl~~HPNIv~~~ 90 (516)
T KOG0582|consen 15 SSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND----LDALRKEVQTMSLIDHPNIVTYH 90 (516)
T ss_pred ccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh----HHHHHHHHHHhhhcCCCCcceEE
Confidence 345567999999999999999999999999987 489999999988766543 45688999999999999999999
Q ss_pred eeee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 91 GACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 91 ~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
..|. +..+|+||.||.+||+.+.+....+..++|..+..|++++++||.|||++|.||||||+.||||+.+ |.|+|+|
T Consensus 91 ~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLad 169 (516)
T KOG0582|consen 91 CSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLAD 169 (516)
T ss_pred EEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEcC
Confidence 9987 6689999999999999999998877789999999999999999999999999999999999999999 8999999
Q ss_pred CCCccc-cccc---cc-cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 018656 170 FGLARE-ESLT---EM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA 244 (352)
Q Consensus 170 fg~a~~-~~~~---~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 244 (352)
||.+.. ...+ .. ....+||++|||||++.. ....|+.|+||||+|++..||.+|+.||....+...+..
T Consensus 170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q------~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~ 243 (516)
T KOG0582|consen 170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ------QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL 243 (516)
T ss_pred ceeeeeecccCceeeEeeccccCcccccChHHhhh------cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence 998652 1111 11 156689999999999643 346789999999999999999999999999887766655
Q ss_pred HHhccCC-CC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 245 AAFKNVR-PS--------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 245 ~~~~~~~-~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
....... +. ...++.+++.++..||..||.+|||+.+++++.
T Consensus 244 tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 244 TLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred HhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 5444332 11 234677899999999999999999999999974
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=327.92 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=214.8
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 100 (352)
++|.+.+.||.|+||+|.+++.+ |..||+|++.+...-. .++.+...+|..+|+.+.||.++++++.+.+. .+|+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk--lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK--LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH--HHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 45888999999999999999875 8999999997754322 35667788999999999999999999998865 7999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||.+||.|..++++.+. +++..++.++.|++.||+|||+++|++|||||+|||++++ |.+||+|||+|+.....
T Consensus 122 vmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC-CcEEEEeccceEEecCc-
Confidence 9999999999999998665 9999999999999999999999999999999999999999 89999999999875433
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
.-+.+||+.|+|||++.. ..++.++|.||||+++|||+.|.+||.+.+. ...+..+.......|..++++
T Consensus 198 -T~TlCGTPeYLAPEii~s--------k~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v~fP~~fs~~ 267 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQS--------KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKVKFPSYFSSD 267 (355)
T ss_pred -EEEecCCccccChHHhhc--------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcccCCcccCHH
Confidence 456789999999999965 7889999999999999999999999998766 445555555566677889999
Q ss_pred HHHHHHHhhccCCCCC-----CCHHHHHHH
Q 018656 261 LSIILTSCWKEDPNAR-----PNFTQIIQM 285 (352)
Q Consensus 261 l~~li~~~l~~~p~~R-----ps~~~i~~~ 285 (352)
+++|+..+|+.|-.+| ....+|..|
T Consensus 268 ~kdLl~~LL~vD~t~R~gnlknG~~dIk~H 297 (355)
T KOG0616|consen 268 AKDLLKKLLQVDLTKRFGNLKNGVEDIKNH 297 (355)
T ss_pred HHHHHHHHHhhhhHhhhcCcCCCccccccC
Confidence 9999999999999999 234555555
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=346.68 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=214.5
Q ss_pred ecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-c
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 97 (352)
+.-++|.++..||+|+||.||+|+. +|+.+|+|++++..... ......+..|-.+|...++|.||+++..|++. +
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~--~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK--KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh--hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 4567899999999999999999975 59999999998765433 24456788899999999999999999999975 8
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+||||||++||++-.+|.+.+. +++..+..++.+++.|++.||+.|+|||||||+|+||+.. |++||+|||++....
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLD 292 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CCEeeccccccchhh
Confidence 9999999999999999987655 9999999999999999999999999999999999999999 899999999984110
Q ss_pred c----------------------cc-c-------------------------cccCCCcccccccccccccccccccccC
Q 018656 178 L----------------------TE-M-------------------------MTAETGTYRWMAPELYSTVTLRQGEKKH 209 (352)
Q Consensus 178 ~----------------------~~-~-------------------------~~~~~g~~~y~aPE~~~~~~~~~~~~~~ 209 (352)
. .. . .-+.+|||.|+|||++.+ ..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--------kg 364 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--------KG 364 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--------CC
Confidence 0 00 0 013469999999999976 66
Q ss_pred CCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh---ccCCCCCCCCcHHHHHHHHHhhccCCCCCC---CHHHHH
Q 018656 210 YNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF---KNVRPSAENVPEELSIILTSCWKEDPNARP---NFTQII 283 (352)
Q Consensus 210 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~i~ 283 (352)
|+..+|+||||||+||||.|.+||.+.+......++.. ....|....++++..+||.+||. ||.+|. +++||.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999999999999999999999887666555433 33456667888999999999999 999996 588888
Q ss_pred HHH
Q 018656 284 QML 286 (352)
Q Consensus 284 ~~l 286 (352)
+|.
T Consensus 444 ~HP 446 (550)
T KOG0605|consen 444 KHP 446 (550)
T ss_pred cCC
Confidence 873
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=352.15 Aligned_cols=247 Identities=32% Similarity=0.476 Sum_probs=217.9
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|.+.+.||+|+||+||+|+.+ .+.||||.+.+....+ +....+.+|+++++.++||||+.++++|+. ..+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~---k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE---KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch---HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 57899999999999999999876 6899999998876655 345568899999999999999999999985 58999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
|.||+.| +|..++...+. ++|+.+..++.|++.||.|||+++|+|||+||+|||+..+ +.+|++|||+|+......
T Consensus 79 Vte~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNT 154 (808)
T ss_pred Eehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCc
Confidence 9999966 99999987655 9999999999999999999999999999999999999998 899999999999765544
Q ss_pred -ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 181 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
......||+.|||||.+.+ ..|+..+|+|||||++||++.|++||...+- ....+.+.......+...+.
T Consensus 155 ~vltsikGtPlYmAPElv~e--------~pyd~~sDlWslGcilYE~~~G~PPF~a~si-~~Lv~~I~~d~v~~p~~~S~ 225 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEE--------QPYDHTSDLWSLGCILYELYVGQPPFYARSI-TQLVKSILKDPVKPPSTASS 225 (808)
T ss_pred eeeeeccCcccccCHHHHcC--------CCccchhhHHHHHHHHHHHhcCCCCchHHHH-HHHHHHHhcCCCCCcccccH
Confidence 4456679999999999854 8899999999999999999999999987443 44555566666666779999
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
++..|+..+|.+||.+|.+..+++.|.
T Consensus 226 ~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 226 SFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred HHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 999999999999999999999999984
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=347.39 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=228.0
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc-eE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV-MV 99 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~-~~ 99 (352)
++|..++.+|+|+||.++..+++ +..||+|.+......+... ....+|+.+++++.|||||.+.+.|.+ +. ++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r---~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER---RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh---HHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 57899999999999999998876 6789999998877665433 357899999999999999999999874 45 89
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
|+|+||+||+|.+.|.+.++..+++..++.|+.|++.|+.|||++.|+|||||++|||++.+ +.|+|+|||+|+.....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-CceeecchhhhhhcCCc
Confidence 99999999999999998887789999999999999999999999999999999999999999 78899999999987666
Q ss_pred c-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCc
Q 018656 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 180 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (352)
. ...+.+||+.|++||++.+ ..|+.++|||||||++|||++-+++|.+.+......++......|.+..++
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d--------~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys 231 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSD--------IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYS 231 (426)
T ss_pred hhhhheecCCCcccCHHHhCC--------CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCcccc
Confidence 5 6778899999999999965 779999999999999999999999999987777777777777889999999
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.+++.+|..||..+|..||++.+++.+.
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 9999999999999999999999999973
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=354.11 Aligned_cols=247 Identities=29% Similarity=0.475 Sum_probs=217.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
...|.....||+|+.|.||.|+.. ++.||||.+....... .+.+.+|+.+|+.++|+|||++++.|- ++.+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 567888899999999999999874 7889999998765533 345889999999999999999999875 56799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||++||+|.+.+.... ++|.++..|++++++||+|||.+||+|||||.+|||++.+ |.+||+|||++......
T Consensus 347 VVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeeccccc
Confidence 9999999999999997654 9999999999999999999999999999999999999999 78999999999865554
Q ss_pred c-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC--CCCC
Q 018656 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SAEN 256 (352)
Q Consensus 180 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 256 (352)
. .-.+.+||+.|||||+... ..|+++.||||||++++||+.|++||-..+.....+.+....... .++.
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtr--------k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTR--------KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEK 494 (550)
T ss_pred cCccccccCCCCccchhhhhh--------cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccc
Confidence 4 4466789999999999854 889999999999999999999999998877777666665554433 3678
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+++.+++|+.+||+.|+.+|+++.++++|.
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 999999999999999999999999999993
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=328.01 Aligned_cols=261 Identities=28% Similarity=0.338 Sum_probs=221.5
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---Cc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~ 97 (352)
-+.|+..+.|++|+||.||+|+++ ++.||+|.++.....+...- ...|||.+|.+++|||||.+-++... +.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI---tsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI---TSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc---hhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 467889999999999999999995 89999999988654433222 25699999999999999999998753 36
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+|+|||||+. +|..++.+.+ ..|...++.-++.|+++||+|||.+.|+||||||+|+|++.. |.+|++|||+|+.++
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYG 228 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhc
Confidence 9999999965 9999999876 459999999999999999999999999999999999999998 899999999999765
Q ss_pred cc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC--
Q 018656 178 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-- 254 (352)
Q Consensus 178 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 254 (352)
.. ...+..+.|..|+|||.+.+ ...|+.+.|+||+|||+.||+++++-|.|.+..++...+......|..
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG-------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLG-------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcC-------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 54 34566688999999999987 468999999999999999999999999999988888777665444331
Q ss_pred -----------------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 018656 255 -----------------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 298 (352)
Q Consensus 255 -----------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~ 298 (352)
..+++.-.++++.+|..||.+|.|+.+.++| .|+...+.+.+
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~ 372 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPID 372 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCC
Confidence 0144667889999999999999999999999 77777555443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=347.66 Aligned_cols=261 Identities=31% Similarity=0.566 Sum_probs=212.1
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l 89 (352)
+|.|..++|++.+.||+|+||.||+|.+. ++.||+|++....... ....+.+|+.+++.+ +||||+++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~~h~niv~~ 76 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS----EHKALMSELKILIHIGNHLNVVNL 76 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH----HHHHHHHHHHHHHHhccCcceeeE
Confidence 58999999999999999999999999752 4679999987543322 234588999999999 89999999
Q ss_pred eeeeec--CceEEEEEcCCCCCHHHHHHhcC-------------------------------------------------
Q 018656 90 IGACKE--PVMVIVTELLSGGTLRKYLLNMR------------------------------------------------- 118 (352)
Q Consensus 90 ~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~------------------------------------------------- 118 (352)
++++.. ..++++|||+++|+|.+++....
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (338)
T cd05102 77 LGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS 156 (338)
T ss_pred EeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence 998764 36899999999999999997532
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc---cccc
Q 018656 119 -----------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTA 184 (352)
Q Consensus 119 -----------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~ 184 (352)
...+++..+..++.|+++||+|||++||+||||||+||+++.+ +.++|+|||+++...... ....
T Consensus 157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccC
Confidence 1247788899999999999999999999999999999999988 799999999987532211 1122
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc-cCCCCCCCCcHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK-NVRPSAENVPEELS 262 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 262 (352)
..++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+............. .....+..+++++.
T Consensus 236 ~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 307 (338)
T cd05102 236 ARLPLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIY 307 (338)
T ss_pred CCCCccccCcHHhhc--------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 345678999998854 567899999999999999997 99999875543333332222 22333567889999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 263 IILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 263 ~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
+++.+||+.||.+|||+.++++.|+..+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=342.65 Aligned_cols=261 Identities=28% Similarity=0.386 Sum_probs=212.1
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHH---------HHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE---------IAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
--.+|++++.||+|.||.|-+|++. ++.||||++.+...... .....++..+||.+|++|.|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3568999999999999999999985 89999999976432111 111235788999999999999999999
Q ss_pred eeeecC---ceEEEEEcCCCCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceE
Q 018656 91 GACKEP---VMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (352)
Q Consensus 91 ~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~-~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vk 166 (352)
++..++ .+|||+|||..|.+...= ..+. +++.+++.++++++.||+|||.+||+||||||+|+||+++ |.||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-g~VK 250 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-GTVK 250 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC-CcEE
Confidence 999764 799999999888765422 2223 8999999999999999999999999999999999999999 8999
Q ss_pred EecCCCcccc------ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH
Q 018656 167 LADFGLAREE------SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240 (352)
Q Consensus 167 l~Dfg~a~~~------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 240 (352)
|+|||.+... .........+||+.|+|||...+.. .....+.+.||||||++||.|+.|+.||-+.....
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~----~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN----SFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC----CccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 9999998744 2233344568999999999886521 13445678999999999999999999999866555
Q ss_pred HHHHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 241 AAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 241 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
...++..... .|..+.+.+.++++|.+||.+||++|.++.+|..|.|-..
T Consensus 327 l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 327 LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 5555444332 3445568899999999999999999999999999977443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=335.86 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=220.4
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
..+|.+.+.||+|.||.|-+|++ .|+.||||.+++....+. ...-++.+|++++..|+||||+.++++|+. +.+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde--qDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE--QDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH--HHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 46899999999999999999987 399999999988766554 445678899999999999999999999985 4799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||..+|.|++|+..++. +++.+++.+++||.+|+.|||.++++|||||.+|||++++ +++||+|||++..+...
T Consensus 130 ivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-NNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-CCeeeeccchhhhhccc
Confidence 99999999999999998766 9999999999999999999999999999999999999999 89999999999998888
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
....+++|++-|.+||+..+- ..-++..|-||||++||.|+.|.+||++.+......++...... .+.-|.
T Consensus 207 kfLqTFCGSPLYASPEIvNG~-------PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr--EP~~PS 277 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGT-------PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR--EPETPS 277 (668)
T ss_pred cHHHHhcCCcccCCccccCCC-------CCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc--CCCCCc
Confidence 899999999999999999762 34467899999999999999999999997665444443332222 234567
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+..-+|++||..||++|.|+.+|..|-|
T Consensus 278 dA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 278 DASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred hHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 7889999999999999999999999976
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=329.64 Aligned_cols=256 Identities=26% Similarity=0.360 Sum_probs=222.6
Q ss_pred ceecCCceeeeccccCCCceEEEEEEECC--ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-c
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-E 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~ 95 (352)
-.+..+++++.+.||+|.-|+||+++.+| ..+|+|++.+..... .+...+.+.|.++|+.++||.++.|+..++ +
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~--rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS--RKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh--hhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 55677889999999999999999999874 799999998755433 356677888999999999999999999998 5
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
...+++||||+||+|..+.+++..+.+++..++.++.+++-||+|||.+|||.|||||+||||.++ |++.|+||.++..
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLSLR 228 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeecccccc
Confidence 589999999999999999999999999999999999999999999999999999999999999999 8999999999731
Q ss_pred cc----------------------------------c-c----------------------cccccCCCccccccccccc
Q 018656 176 ES----------------------------------L-T----------------------EMMTAETGTYRWMAPELYS 198 (352)
Q Consensus 176 ~~----------------------------------~-~----------------------~~~~~~~g~~~y~aPE~~~ 198 (352)
.. . . ....+.+||..|.|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 10 0 0 0112456999999999997
Q ss_pred ccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCC
Q 018656 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARP 277 (352)
Q Consensus 199 ~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp 277 (352)
+ ..-+.++|+|+||+++|||+.|..||.|.++.+....+..... .|....++..+++||+++|.+||.+|.
T Consensus 309 G--------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 309 G--------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred c--------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 6 5668899999999999999999999999988887777766554 344557889999999999999999999
Q ss_pred C----HHHHHHH
Q 018656 278 N----FTQIIQM 285 (352)
Q Consensus 278 s----~~~i~~~ 285 (352)
. +.+|.+|
T Consensus 381 g~~rGA~eIK~H 392 (459)
T KOG0610|consen 381 GSKRGAAEIKRH 392 (459)
T ss_pred ccccchHHhhcC
Confidence 8 8899888
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=344.62 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=201.9
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLS 106 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~ 106 (352)
+.||+|+||.||+|.++ |+.||+|++....... .....++.+|+.++++++||||+++++++.. +..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA--KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 36999999999999874 8899999987532211 1234567789999999999999999999874 57999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc-cccccccC
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTAE 185 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~~~~~~~~ 185 (352)
+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++... ........
T Consensus 79 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 79 GGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccce
Confidence 999999998654 38999999999999999999999999999999999999988 799999999987532 22233445
Q ss_pred CCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHH
Q 018656 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 265 (352)
Q Consensus 186 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 265 (352)
.|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..... ..........+..++.++.++|
T Consensus 156 ~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~li 226 (323)
T cd05571 156 CGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILMEEIRFPRTLSPEAKSLL 226 (323)
T ss_pred ecCccccChhhhcC--------CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-HHHHcCCCCCCCCCCHHHHHHH
Confidence 79999999999854 56789999999999999999999999875544333 3333333445678899999999
Q ss_pred HHhhccCCCCCC-----CHHHHHHHH
Q 018656 266 TSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 266 ~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
.+||..||.+|| ++.++++|-
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~ll~h~ 252 (323)
T cd05571 227 AGLLKKDPKQRLGGGPEDAKEIMEHR 252 (323)
T ss_pred HHHccCCHHHcCCCCCCCHHHHHcCC
Confidence 999999999999 899999883
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=348.65 Aligned_cols=266 Identities=33% Similarity=0.648 Sum_probs=228.1
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
+..|.|..+.+.++..||+|+||+||+|+|.| .||||++........ ..+.|++|+.++++-+|.||+-+.|++..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~---qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPE---QLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHH---HHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 37899999999999999999999999999987 489999998877664 45669999999999999999999999998
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+.+.||.-+|+|.+|+.++.....+ |.....+.|+.|+++|+.|||.++|||||||..|||+.++ +.|||+|||++..
T Consensus 460 p~~AIiTqwCeGsSLY~hlHv~etk-fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatv 537 (678)
T KOG0193|consen 460 PPLAIITQWCEGSSLYTHLHVQETK-FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATV 537 (678)
T ss_pred CceeeeehhccCchhhhhccchhhh-hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceee
Confidence 8789999999999999999876544 9999999999999999999999999999999999999998 8999999999874
Q ss_pred ccc---ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 018656 176 ESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 176 ~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
... ........|...|||||++.- .....|++.+||||+|+++|||++|.+||......+..+........+
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRm-----qd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRM-----QDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP 612 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhh-----cccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc
Confidence 332 223344568899999999863 235789999999999999999999999999544444444443333333
Q ss_pred C----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 253 S----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 253 ~----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
. ..+++.++++|+..||..++++||.+.+|+..|+..+..
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 2 467889999999999999999999999999988887764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=332.41 Aligned_cols=266 Identities=22% Similarity=0.315 Sum_probs=221.0
Q ss_pred cccccccceecCCceeee--ccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeee
Q 018656 12 ELKLDAKWLIDPKHLFVG--PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89 (352)
Q Consensus 12 ~~~~~~~~~i~~~~y~~~--~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l 89 (352)
..+..+.+.|+++++... ..||+|++|.||+|.++|+.||||++....... ......+.+|+.++++++||||+++
T Consensus 6 ~~~~~~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 6 RSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH--KVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred hhhcCcceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccccc--HHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 455667788888888888 889999999999999999999999987653322 1234568899999999999999999
Q ss_pred eeeeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCC
Q 018656 90 IGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK 163 (352)
Q Consensus 90 ~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~ 163 (352)
++++.+ ...++||||+++|+|.+++.+.. .+++...+.++.|++.||.|||+ .+++||||||+||+++++ +
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~ 160 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-Y 160 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-C
Confidence 998765 36899999999999999998754 48899999999999999999998 499999999999999998 7
Q ss_pred ceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 018656 164 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 243 (352)
Q Consensus 164 ~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 243 (352)
.+||+|||++...... .....++..|+|||++.+ ....++.++||||||+++|+|++|+.||.+.+..+...
T Consensus 161 ~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~ 232 (283)
T PHA02988 161 KLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLND------IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD 232 (283)
T ss_pred cEEEcccchHhhhccc--cccccCcccccCHHHhhh------ccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999999998754322 123468899999999853 12568899999999999999999999999876555444
Q ss_pred HHHhccCC-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 244 AAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 244 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
........ +.+..++.++.+++.+||+.||.+|||+.++++.|..+.
T Consensus 233 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 43333333 334478999999999999999999999999999987764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=333.89 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=206.7
Q ss_pred ceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
.|++.+.||+|+||.||+|.+ +|+.||+|++........ .....+.+|+.++++++|+||+++++++.+ +..++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh--hhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 378889999999999999987 489999999865432221 223457789999999999999999998874 579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
|||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++++ +.++|+|||++........
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGET 157 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCCe
Confidence 999999999998876554568999999999999999999999999999999999999987 7999999999876544333
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHhccCCCCCCCCc
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA---AYAAAFKNVRPSAENVP 258 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 258 (352)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... ............+..++
T Consensus 158 ~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 229 (285)
T cd05631 158 VRGRVGTVGYMAPEVINN--------EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFS 229 (285)
T ss_pred ecCCCCCCCccCHhhhcC--------CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCC
Confidence 445678999999999854 5678899999999999999999999987554221 12222222334456789
Q ss_pred HHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPN-----FTQIIQML 286 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps-----~~~i~~~l 286 (352)
.++.+++++||+.||.+||+ ++++++|.
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 99999999999999999997 89999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=329.51 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=216.0
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---C--
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---P-- 96 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~-- 96 (352)
-+|.-.+++|+|+||+||.|... ++.||||.+-....- -.+|+++|+.+.|||||++..+|.. .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---------KNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---------CcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 35777899999999999999764 789999988665432 2379999999999999999988752 2
Q ss_pred -ceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 97 -VMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
++.+||||++. +|.++++.. .+..++...+.-+..||++||+|||+.||+||||||+|+|+|.+.|.+||+|||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 56799999964 999999842 23348888999999999999999999999999999999999999899999999999
Q ss_pred cccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 018656 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253 (352)
Q Consensus 174 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (352)
+....+....+...+..|+|||.+.+ ...|+.+.||||.||++.||+.|++-|.|.+..+++..+......|.
T Consensus 174 K~L~~~epniSYicSRyYRaPELifg-------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFG-------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcC-------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 98888888888899999999999987 46899999999999999999999999999888877776665544433
Q ss_pred ----------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 018656 254 ----------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 296 (352)
Q Consensus 254 ----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~ 296 (352)
....+++..+|+.++|+.+|.+|.++.+++.| .++..+..+
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h--~fFdelr~~ 315 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH--PFFDELRDP 315 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc--hhhHHhhCc
Confidence 13467899999999999999999999999998 555444333
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=342.68 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=208.3
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
.-.+|.+.+.||+|+||.||+|+++ |+.||+|++....... ......+.+|+.++++++||||+++++++.+ +..
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK--MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 3478999999999999999999885 7899999987532111 1334568899999999999999999999874 579
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||++|++|.+++.+... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceEcCC
Confidence 999999999999999987543 8999999999999999999999999999999999999988 7999999999875432
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCc
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (352)
. .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....... ......+.+..++
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-i~~~~~~~p~~~~ 239 (329)
T PTZ00263 171 R--TFTLCGTPEYLAPEVIQS--------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK-ILAGRLKFPNWFD 239 (329)
T ss_pred C--cceecCChhhcCHHHHcC--------CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH-HhcCCcCCCCCCC
Confidence 2 223578999999999854 5578899999999999999999999987665443333 3333344456688
Q ss_pred HHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPN-----FTQIIQML 286 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps-----~~~i~~~l 286 (352)
..+.++|.+||+.||.+||+ +.++++|.
T Consensus 240 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 99999999999999999986 79998884
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=349.95 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=217.1
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE- 95 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~- 95 (352)
.+.-+++.++++||+|+||+|+++..+ ++.+|||++++...-.. ......+.|.+++... +||.+++++.+|+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~--d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR--DEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc--ccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 466789999999999999999999875 78999999988755432 3455677888888777 59999999999985
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
.++|+||||+.||++..++. ...+++..+..++..++.||.|||++|||+||||.+|||+|.+ |.+||+|||+++.
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe 517 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKE 517 (694)
T ss_pred CeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEecccccccc
Confidence 58999999999999544333 2349999999999999999999999999999999999999999 8999999999996
Q ss_pred cc-cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 176 ES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 176 ~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
.- .+..+.+.+||+.|+|||++.+ ..|+.+.|.||||++||+||.|+.||.+.+ ++.....+.......|
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e--------~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-Eee~FdsI~~d~~~yP 588 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTE--------QSYTRAVDWWGLGVLLYEMLVGESPFPGDD-EEEVFDSIVNDEVRYP 588 (694)
T ss_pred cCCCCCccccccCChhhcChhhhcc--------CcccchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcCCCCCC
Confidence 44 5667788999999999999965 889999999999999999999999999954 4566666677777788
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 285 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps-----~~~i~~~ 285 (352)
..+|.+..++++++|..||++|.. +++|..|
T Consensus 589 ~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 589 RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 899999999999999999999975 4666665
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=325.61 Aligned_cols=261 Identities=29% Similarity=0.364 Sum_probs=217.9
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--- 95 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--- 95 (352)
..+.+|...+.||.|+||.|+.|.++ |+.||||.+....... -...+..||+++++.++|+||+.+.+++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~---~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ---IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch---HHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 34556666899999999999999885 8999999987433322 234568899999999999999999999753
Q ss_pred ---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 96 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
...|+|+|++ +.+|.+.++..+. +++..+..++.||+.||.|+|+.+|+||||||.|++++.+ ..+|++|||+
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFGL 171 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFGL 171 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEeccccc
Confidence 2589999999 7799999987554 9999999999999999999999999999999999999998 8999999999
Q ss_pred cccccc---ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 173 AREESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 173 a~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
|+.... ....+..+.|..|.|||++.. ...|+.+.||||+||++.||++|++-|.|.+...+...+....
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~-------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLN-------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhc-------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 997653 455577789999999999865 4789999999999999999999999999977665554443333
Q ss_pred CCCC------------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 250 VRPS------------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 250 ~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
..|. .++.++...+++.+||..||.+|+|++++++| .++.....+.
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h--PYl~~~hdp~ 320 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH--PYLAPYHDPE 320 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC--hhhhhhcCCc
Confidence 3222 24567889999999999999999999999999 6666655544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=335.61 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=207.2
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||+||+|.++ |+.||+|++....... ......+.+|+.++++++||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR--LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh--hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 47899999999999999999985 8999999986532211 1334568899999999999999999998874 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+++++|.+++.+... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhccCC-
Confidence 9999999999999987544 8999999999999999999999999999999999999987 79999999998754322
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....... ........+..++..
T Consensus 155 -~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~ 224 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQS--------KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK-ILAGKLEFPRHLDLY 224 (291)
T ss_pred -cccccCChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhCCcCCCccCCHH
Confidence 223468999999998854 5578899999999999999999999988665443333 333334445677899
Q ss_pred HHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPN-----FTQIIQMLL 287 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps-----~~~i~~~l~ 287 (352)
+.++|++||+.||.+||+ ++++++|.|
T Consensus 225 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 225 AKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred HHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 999999999999999995 999998843
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=344.35 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=202.9
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
..|.+++.||+|+||+||+|++. ++.||||++....... ......+.+|+.++++++||||+++++++.+ ..+++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 78 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN--RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence 36889999999999999999884 7899999987543222 1334568899999999999999999999875 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
||||++|++|.+++.+... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCccccccc
Confidence 9999999999999987543 8999999999999999999999999999999999999987 79999999987532100
Q ss_pred -----------------------------------------------cccccCCCcccccccccccccccccccccCCCc
Q 018656 180 -----------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 212 (352)
Q Consensus 180 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~ 212 (352)
.......||+.|+|||++.+ ..++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~ 227 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--------KGYTQ 227 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--------CCCCC
Confidence 00123469999999999854 56788
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---cCCCCCCCCcHHHHHHHHHhh--ccCCCCCCCHHHHHHHH
Q 018656 213 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRPSAENVPEELSIILTSCW--KEDPNARPNFTQIIQML 286 (352)
Q Consensus 213 ~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l--~~~p~~Rps~~~i~~~l 286 (352)
++|||||||++|+|++|..||...+........... ...+....+++++.++|.+|+ ..+|..||++.+++.|.
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 999999999999999999999887655444443321 122334468999999999955 55666699999999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=317.30 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=217.6
Q ss_pred cCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~ 98 (352)
..+.|.+.+.||+|.|++|+++.+ +|+.+|+|++....... ...+.+.+|+++-+.|+||||+++.+.+. ++..
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~---~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc---ccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 356788999999999999999876 59999999886644333 23456889999999999999999999886 5689
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCCcccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREE 176 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~a~~~ 176 (352)
|+|+|++.|++|..-|-++. .+++..+..++.||+++|.|+|.+||+|||+||+|+++-+. +..+||+|||+|...
T Consensus 86 ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999999998887653 38999999999999999999999999999999999999432 347999999999987
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc---CCCC
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPS 253 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~ 253 (352)
..+......+||++|+|||++. +..|+..+|||+-|+++|-|+.|.+||.+.+.......+.... ..|.
T Consensus 164 ~~g~~~~G~~GtP~fmaPEvvr--------kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 164 NDGEAWHGFAGTPGYLSPEVLK--------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE 235 (355)
T ss_pred CCccccccccCCCcccCHHHhh--------cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc
Confidence 7666677789999999999985 4789999999999999999999999999976665555554433 3456
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
++.++++.++++++||..||.+|.|+.+.++|.|
T Consensus 236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 236 WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred cCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 8899999999999999999999999999999865
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=308.98 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=222.2
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 98 (352)
..+++.+++.||+|-||.||.|+.+ +--||+|++.+.... ......++.+|+++...|+||||++++++|.+. ..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~--~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL--KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH--HhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 3457899999999999999999875 678999999775532 234567789999999999999999999999865 89
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
|+++||..+|+|+..+.......+++...+.++.|++.||.|+|..+|+||||||+|+|++.. +.+|++|||-+....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC-
Confidence 999999999999999997666679999999999999999999999999999999999999998 899999999987654
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCc
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (352)
...-.+.+||..|.+||+..+ ...+...|+|++|++.||++.|.+||...+ ....++.+.......+..++
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~--------~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~~p~~is 246 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEG--------RGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLKFPSTIS 246 (281)
T ss_pred CCCceeeecccccCCHhhcCC--------CCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccccCCcccC
Confidence 344467789999999999854 778899999999999999999999999877 45555555555555668999
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
.+..++|.+||..+|.+|.+..++++|.|-
T Consensus 247 ~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 247 GGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred hhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 999999999999999999999999999653
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=353.60 Aligned_cols=263 Identities=23% Similarity=0.366 Sum_probs=218.7
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGA 92 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~ 92 (352)
.....|...++++.++|.+|||+.||+|.+. |..||+|.+... +. .....+.+|+.+|+.|. |+|||.+++.
T Consensus 29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de----~~L~~v~~EI~~MK~L~gh~nIV~yids 103 (738)
T KOG1989|consen 29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DE----EALNAVKREIDIMKLLSGHKNIVSYIDS 103 (738)
T ss_pred ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CH----HHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence 3557889999999999999999999999985 489999998776 32 33455889999999995 9999999994
Q ss_pred e-e----cC---ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeCCC
Q 018656 93 C-K----EP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDL 162 (352)
Q Consensus 93 ~-~----~~---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~~~ 162 (352)
. . .+ ..+|+||||.||+|-+++.++....|++.++++|+.|+++|+++||... |||||||-+||||+.+
T Consensus 104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~- 182 (738)
T KOG1989|consen 104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD- 182 (738)
T ss_pred ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-
Confidence 2 1 11 4789999999999999999887667999999999999999999999998 9999999999999999
Q ss_pred CceEEecCCCcccccccccc----------ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCC
Q 018656 163 KTIKLADFGLAREESLTEMM----------TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 232 (352)
Q Consensus 163 ~~vkl~Dfg~a~~~~~~~~~----------~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (352)
|.+||||||.+......... -...-|+.|+|||++.-++ +...++|+|||+|||+||-|+....|
T Consensus 183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys-----g~pI~eKsDIWALGclLYkLCy~t~P 257 (738)
T KOG1989|consen 183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS-----GLPIGEKSDIWALGCLLYKLCYFTTP 257 (738)
T ss_pred CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc-----CCCCcchhHHHHHHHHHHHHHHhCCC
Confidence 89999999998743222110 1224689999999987643 57889999999999999999999999
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 233 FEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
|+..... .........|..+.++..|.+||+.||+.||.+||++-+++..+..+...
T Consensus 258 Fe~sg~l---aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 258 FEESGKL---AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred cCcCcce---eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 9874221 11222334566679999999999999999999999999999998766543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=339.41 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=214.9
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 98 (352)
....|+..+.||+|+||.||+|.+. ++.||+|++......+. +..+++|+.++..++++||.++++.+..+ .+
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de----Iediqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE----IEDIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchh----hHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 3567788899999999999999884 89999999987665443 44588999999999999999999998754 79
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
+++||||.||++.+.+..... +.+..+.-++.+++.||.|||.++.+|||||++||++..+ |.+||+|||.+.....
T Consensus 87 wiiMey~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHHHHhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeeec
Confidence 999999999999999976432 5888899999999999999999999999999999999999 8999999999875444
Q ss_pred cc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 018656 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257 (352)
Q Consensus 179 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (352)
.. ...+.+||+.|||||++.+ ..|+.++||||||++.+||++|.+||....+......+.....+.....+
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~--------~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~ 235 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQ--------SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDF 235 (467)
T ss_pred hhhccccccccccccchhhhcc--------ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccccc
Confidence 33 2367899999999999964 68999999999999999999999999988775544444444444445688
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
++.+++|+..||.+||+.||++.++++|
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 9999999999999999999999999987
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=321.49 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=216.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC-eeeeeeeeec-C--
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACKE-P-- 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~~-~-- 96 (352)
...|...++||+|+||+||+|+.+ |+.||+|+++.....+.. -....+|+.+++.|+|+| |+++++++.. .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~---P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGV---PSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCC---CchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 456788889999999999999874 899999999887554321 223679999999999999 9999999863 3
Q ss_pred ----ceEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 97 ----VMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 97 ----~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
.+++|+||+ ..+|.+++..... ..++...+..++.||+.||+|||+++|+||||||+||+|+++ |.+||+||
T Consensus 87 ~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~-G~lKlaDF 164 (323)
T KOG0594|consen 87 RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS-GVLKLADF 164 (323)
T ss_pred cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC-CcEeeecc
Confidence 688999999 5699999998764 358889999999999999999999999999999999999997 89999999
Q ss_pred CCccccc-cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 171 GLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 171 g~a~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
|+|+... +.......++|..|+|||++.+ ...|+...||||+||+++||++++.-|.+.+..++...+....
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlG-------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLG-------STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcC-------CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 9999655 3444667789999999999987 3468999999999999999999999999999888877776665
Q ss_pred CCCCCC-----------------------------CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 250 VRPSAE-----------------------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 250 ~~~~~~-----------------------------~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
..|... ....+..+++.+||+.+|.+|.|+..+++| .++...
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h--~yf~~~ 308 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH--PYFSEL 308 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC--hhhccc
Confidence 554321 122468889999999999999999999998 444443
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=334.72 Aligned_cols=242 Identities=28% Similarity=0.368 Sum_probs=194.7
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHH-HHhcCCCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||+||+|.++ |+.||+|++....... ......+.+|.. +++.++||||+++++.+.+ ...++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK--KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 36999999999999984 8999999986532211 112233445544 5688999999999998874 5799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc-ccccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 184 (352)
++++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.... .......
T Consensus 79 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 79 NGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCcccc
Confidence 9999999997654 38999999999999999999999999999999999999988 799999999987432 2222334
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.... ........+..++.++.++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~l 226 (323)
T cd05575 156 FCGTPEYLAPEVLRK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN-ILNKPLRLKPNISVSARHL 226 (323)
T ss_pred ccCChhhcChhhhcC--------CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCHHHHHH
Confidence 568999999999854 5678899999999999999999999988655443333 3333334456789999999
Q ss_pred HHHhhccCCCCCCCH----HHHHHH
Q 018656 265 LTSCWKEDPNARPNF----TQIIQM 285 (352)
Q Consensus 265 i~~~l~~~p~~Rps~----~~i~~~ 285 (352)
|.+||+.||.+||++ .+++++
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 227 LEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 999999999999987 466665
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=341.69 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=207.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|.+.+.||+|+||+||+|++. |+.||||++....... ......+.+|+++++.++||||+++++++.+ +..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK--RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh--ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 47999999999999999999986 8999999987532211 1234568889999999999999999999875 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+++++|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+|||++.+ +.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEeecCCCCccCcccC
Confidence 999999999999998763 49999999999999999999999999999999999999988 799999999987543322
Q ss_pred ------------------------------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCC
Q 018656 181 ------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 230 (352)
Q Consensus 181 ------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~ 230 (352)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--------TPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--------CCCCCceeeEecchhhhhhccCC
Confidence 2234568999999999865 57889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHh---ccCCCCCCCCcHHHHHHHHHhhccCCCCCCC-HHHHHHHH
Q 018656 231 LPFEGMSNLQAAYAAAF---KNVRPSAENVPEELSIILTSCWKEDPNARPN-FTQIIQML 286 (352)
Q Consensus 231 ~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~i~~~l 286 (352)
.||.+............ ....+....+++++.++|.+||. ||.+||+ +.+++++.
T Consensus 228 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 99988765444333332 12233344579999999999997 9999999 99999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=333.73 Aligned_cols=243 Identities=26% Similarity=0.367 Sum_probs=201.2
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLS 106 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~ 106 (352)
+.||+|+||.||++++. |+.||+|++....... ......+.+|+++++.++||||+++++++.. +..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA--KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 36899999999999874 8899999987543211 1234567889999999999999999998874 57999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc-cccccccC
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTAE 185 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~~~~~~~~ 185 (352)
+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.... ........
T Consensus 79 ~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 79 GGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCCCcccccccc
Confidence 999999987654 38999999999999999999999999999999999999988 799999999987532 22223345
Q ss_pred CCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHH
Q 018656 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 265 (352)
Q Consensus 186 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 265 (352)
.|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..... ..........+..++.++.++|
T Consensus 156 ~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~li 226 (328)
T cd05593 156 CGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILMEDIKFPRTLSADAKSLL 226 (328)
T ss_pred cCCcCccChhhhcC--------CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-HHhccCCccCCCCCCHHHHHHH
Confidence 79999999999854 56788999999999999999999999876544332 2333333445678899999999
Q ss_pred HHhhccCCCCCC-----CHHHHHHHH
Q 018656 266 TSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 266 ~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
++||..||.+|| ++.++++|.
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 227 SGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred HHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 999999999997 899999884
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=333.32 Aligned_cols=243 Identities=26% Similarity=0.369 Sum_probs=200.6
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLS 106 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~ 106 (352)
+.||+|+||.||++++. |+.||+|++....... ......+.+|+++++.++||||+++++++.. +..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 36999999999999874 8899999987532211 1234457789999999999999999998874 57999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-ccccccC
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAE 185 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 185 (352)
+++|.+++.... .+++..++.++.||+.||+|||++|++||||||+|||++++ +.++|+|||++..... .......
T Consensus 79 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 79 GGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCccccc
Confidence 999999987654 38999999999999999999999999999999999999988 7999999999875322 2223345
Q ss_pred CCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHH
Q 018656 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 265 (352)
Q Consensus 186 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 265 (352)
.|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+........ .......+..+++++.++|
T Consensus 156 ~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~li 226 (323)
T cd05595 156 CGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-LMEEIRFPRTLSPEAKSLL 226 (323)
T ss_pred cCCcCcCCcccccC--------CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCHHHHHHH
Confidence 68999999999854 56788999999999999999999999876554333332 2233344567899999999
Q ss_pred HHhhccCCCCCC-----CHHHHHHHH
Q 018656 266 TSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 266 ~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
.+||..||.+|| ++.++++|.
T Consensus 227 ~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 227 AGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 999999999998 899999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.50 Aligned_cols=244 Identities=27% Similarity=0.381 Sum_probs=200.6
Q ss_pred ccccCCCceEEEEEEE-----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEE
Q 018656 30 PRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTE 103 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e 103 (352)
+.||+|+||.||++++ .++.||+|++........ ......+.+|+.+++.++||||+++++++.. +..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN-QKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhh-hhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 5799999999999975 378899999875322111 1233457789999999999999999999874 57999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-cccc
Q 018656 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMM 182 (352)
Q Consensus 104 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~~~~ 182 (352)
|+++++|.+++.+... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcc
Confidence 9999999999976543 8889999999999999999999999999999999999988 7999999999874322 2223
Q ss_pred ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHH
Q 018656 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 262 (352)
Q Consensus 183 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 262 (352)
....|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+........ .......+..+++++.
T Consensus 158 ~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 228 (323)
T cd05584 158 HTFCGTIEYMAPEILMR--------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI-LKGKLNLPPYLTPEAR 228 (323)
T ss_pred cccCCCccccChhhccC--------CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCHHHH
Confidence 34568999999999854 45678999999999999999999999886654433333 3333445677899999
Q ss_pred HHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 263 IILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 263 ~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
++|.+||+.||.+|| ++.+++++.
T Consensus 229 ~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 229 DLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred HHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 999999999999999 899999874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=321.55 Aligned_cols=257 Identities=29% Similarity=0.524 Sum_probs=215.2
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCc
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 97 (352)
|.+..++|++.+.||+|+||.||+|.+. ...||+|++...... ...+.+|++++++++||||+++++.+.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~------~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~ 74 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP 74 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC------HHHHHHHHHHHHhCCCCCcceEEEEECCCC
Confidence 7889999999999999999999999875 457999998753332 235788999999999999999999888778
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++||||+++++|.+++.+.....+++..++.++.|++.||+|||+++++|+||||+||+++++ +.++|+|||.+....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~ 153 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIE 153 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeecc
Confidence 8999999999999999987554558999999999999999999999999999999999999988 789999999987543
Q ss_pred cccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 178 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 178 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
.... .....++..|+|||.... ..++.++||||||+++|+|++ |..||.+................+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 225 (262)
T ss_pred ccccccccCCcccceecCHhHhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCc
Confidence 2221 112345678999998743 567889999999999999999 88999876655444433333334445
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
..++..+.+++.+||+.||.+||++.++++.|+.++
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 678999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=342.03 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=202.9
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||.||+|++. |+.||+|++....... ......+.+|++++++++||||+++++.+.+ +.+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM--RNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 47999999999999999999875 7899999986432111 1234567899999999999999999999874 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
||||+++++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||++......
T Consensus 79 v~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCccccccc
Confidence 999999999999998754 38999999999999999999999999999999999999988 79999999997421100
Q ss_pred -------------------------------------------cccccCCCcccccccccccccccccccccCCCcccch
Q 018656 180 -------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 216 (352)
Q Consensus 180 -------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 216 (352)
.......||+.|+|||++.+ ..++.++||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di 227 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--------TGYTQLCDW 227 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--------CCCCcceee
Confidence 00113468999999999854 567889999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCC---CHHHHHHHHH
Q 018656 217 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARP---NFTQIIQMLL 287 (352)
Q Consensus 217 wslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~i~~~l~ 287 (352)
|||||++|+|++|+.||.+.............. ..+....++.++.++|.+|+ .+|.+|+ ++.++++|.+
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 999999999999999998876554433332211 12334468899999999977 5999999 8999999843
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=332.35 Aligned_cols=248 Identities=27% Similarity=0.393 Sum_probs=206.4
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||.||+|++. |+.||+|++....... ......+.+|+.+++.++||||+++++++.+ +..++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK--LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 47999999999999999999984 7899999987532211 1334568889999999999999999999875 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||++|++|.+++.+... +++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCccccc--
Confidence 9999999999999976543 8999999999999999999999999999999999999988 7999999999875433
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc---CCCCC---
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSA--- 254 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~--- 254 (352)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+......... ..+..
T Consensus 154 ~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 225 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRG--------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP 225 (333)
T ss_pred ccCCcccCccccChhHhcC--------CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCcc
Confidence 2345578999999999854 567899999999999999999999998866544333322211 11221
Q ss_pred -CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 255 -ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 255 -~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..++.++.++|.+||..+|.+||++.+++++.
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 25689999999999999999999999999984
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=333.61 Aligned_cols=246 Identities=23% Similarity=0.364 Sum_probs=199.9
Q ss_pred eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHH---HhcCCCCCeeeeeeeeec-CceE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM---LSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
|++.+.||+|+||.||+|.+. |+.||||++....... ......+.+|+++ ++.++||||+++++++.. +..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA--RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 678899999999999999874 7899999987532111 1223446666555 466789999999999875 4799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc-c
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-L 178 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~ 178 (352)
+||||++|++|..++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++.... .
T Consensus 79 lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CcEEeCcccCCccCCCC
Confidence 99999999999988864 249999999999999999999999999999999999999998 799999999987432 2
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCc
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (352)
........|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+......... ......+..++
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~-~~~~~~p~~~~ 225 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTE--------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV-NDEVRYPRFLS 225 (324)
T ss_pred CCcccccccCccccCHhHhcC--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCCCCCC
Confidence 222345578999999998854 567889999999999999999999998866554433332 33334556789
Q ss_pred HHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
.++.++|.+||+.||.+|| ++.+++++.
T Consensus 226 ~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 226 REAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 9999999999999999999 688888873
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=332.74 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=222.8
Q ss_pred ceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv 101 (352)
=|.+.+.||+|-|.+|-+|++ +|+.||||++.+..... .....+.+|+++|+.++|||||+++++.... .+|+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~---~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT---LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch---hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 477888999999999999987 69999999998866544 2345688999999999999999999998744 79999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
+|.-++|+|++||.++.. .+.+..+.+++.||+.|+.|||+..+|||||||+|+.+-+..|-|||.|||++....++..
T Consensus 96 LELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 999999999999998765 4999999999999999999999999999999999999987779999999999999999998
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHH
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 261 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (352)
..+.+|...|.|||++.+ .....++.||||||++||.|++|++||+..+..+.+..+.... -..+..++.++
T Consensus 175 L~TsCGSLAYSAPEILLG-------DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-YtvPshvS~eC 246 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLG-------DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-YTVPSHVSKEC 246 (864)
T ss_pred hhcccchhhccCchhhhc-------CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-ccCchhhhHHH
Confidence 999999999999999987 2445679999999999999999999999887776666555433 34467899999
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 262 SIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 262 ~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+++|..||..||.+|.+.++|..+.|
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhcccc
Confidence 99999999999999999999999843
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=334.72 Aligned_cols=251 Identities=26% Similarity=0.326 Sum_probs=202.6
Q ss_pred ceeeeccccCCCceEEEEEEE-----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-Cc
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PV 97 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~ 97 (352)
+|++.+.||+|+||+||++++ +|+.||+|++....... .......+.+|+++++.+ +||||+++++++.. +.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ-KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 588999999999999999876 47899999986532211 122345677899999999 59999999998874 57
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+++||||+++++|.+++.+... +++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-CCEEEeeCcCCcccc
Confidence 8999999999999999976543 8999999999999999999999999999999999999988 799999999987532
Q ss_pred cc--cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccCCC
Q 018656 178 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRP 252 (352)
Q Consensus 178 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~ 252 (352)
.. .......||..|+|||++.+ ...++.++|||||||++|+|++|..||..... .............+
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRG-------KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP 229 (332)
T ss_pred ccCCCccccccCCccccCHHHhcC-------CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 22 12234578999999999854 23467899999999999999999999965322 22222223333344
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
.+..++..+.+++.+||+.||.+|| +++++++|.
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 230 FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 5667899999999999999999999 788999884
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=327.39 Aligned_cols=249 Identities=29% Similarity=0.407 Sum_probs=200.0
Q ss_pred CceeeeccccCCCceEEEEEEEC---CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC---CCCCeeeeeeeee---
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACK--- 94 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~--- 94 (352)
++|++.+.||+|+||+||+|++. |+.||+|++......... ...+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc---hHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 47999999999999999999873 678999998764433221 12344566665554 7999999999874
Q ss_pred ---cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 95 ---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 95 ---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
...+++||||++ ++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.+ +.++|+|||
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg 155 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFG 155 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC-CCEEEcccc
Confidence 236899999995 699999987655568999999999999999999999999999999999999988 799999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
++.............|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~ 227 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 227 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhC--------CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 9976544444445578999999998854 56788999999999999999999999987665544333221111
Q ss_pred CC--------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 PS--------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 ~~--------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+. ...++..+.+++.+||+.||++|||+.++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 10 13467888999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=337.54 Aligned_cols=258 Identities=24% Similarity=0.323 Sum_probs=214.0
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEEC---CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeee
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l 89 (352)
.....++.+..++|.+.+.||+|+||.||+|.++ +..||+|++....... ......+.+|+.+++.++||||+++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~Iv~~ 96 (340)
T PTZ00426 19 KEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK--QKQVDHVFSERKILNYINHPFCVNL 96 (340)
T ss_pred cccccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhCCCCCCcce
Confidence 3445567888899999999999999999999864 3579999886432211 1234568899999999999999999
Q ss_pred eeeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 90 IGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 90 ~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
++++.+ +..++||||+++++|.+++.+... +++..+..++.|++.||.|||++|++||||||+|||++.+ +.++|+
T Consensus 97 ~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~ 173 (340)
T PTZ00426 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMT 173 (340)
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEe
Confidence 999875 478999999999999999987543 8999999999999999999999999999999999999988 799999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.... ......
T Consensus 174 DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~i~~ 242 (340)
T PTZ00426 174 DFGFAKVVDTR--TYTLCGTPEYIAPEILLN--------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-YQKILE 242 (340)
T ss_pred cCCCCeecCCC--cceecCChhhcCHHHHhC--------CCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-HHHHhc
Confidence 99998754322 234578999999999854 5578899999999999999999999988655433 333333
Q ss_pred cCCCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 249 NVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
.....+..+++.+.++|++||+.||.+|+ +++++++|.
T Consensus 243 ~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 243 GIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 33445667899999999999999999995 899999983
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=337.44 Aligned_cols=266 Identities=32% Similarity=0.539 Sum_probs=215.6
Q ss_pred ccccccccceecCCceeeeccccCCCceEEEEEEE-------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-C
Q 018656 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (352)
Q Consensus 11 ~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (352)
..+.....|.+..++|++++.||+|+||.||+|.+ ++..||+|++...... .....+.+|+++++.+ +
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~Ei~il~~l~~ 97 (375)
T cd05104 22 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL----TEREALMSELKVLSYLGN 97 (375)
T ss_pred CCCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc----HHHHHHHHHHHHHHHhcC
Confidence 34777788999999999999999999999999964 2568999998754332 2234688999999999 8
Q ss_pred CCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC------------------------------------------
Q 018656 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP------------------------------------------ 119 (352)
Q Consensus 83 hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------------ 119 (352)
||||+++++++.+ +..++||||+++|+|.+++.....
T Consensus 98 HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 177 (375)
T cd05104 98 HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSY 177 (375)
T ss_pred CcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccc
Confidence 9999999999874 478999999999999999975321
Q ss_pred -------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 120 -------------------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 120 -------------------------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
..+++..++.++.|++.||+|||++|++||||||+|||++.+ +.++|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~ 256 (375)
T cd05104 178 VVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKIC 256 (375)
T ss_pred ccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEe
Confidence 147888999999999999999999999999999999999987 789999
Q ss_pred cCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 018656 169 DFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYA 244 (352)
Q Consensus 169 Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~ 244 (352)
|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........
T Consensus 257 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~ 328 (375)
T cd05104 257 DFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328 (375)
T ss_pred cCccceeccCcccccccCCCCCCcceeChhHhcC--------CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH
Confidence 9999875432211 112234567999998854 567899999999999999997 8999987654444444
Q ss_pred HHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 245 AAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 245 ~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
...... ...+...+.++.+++.+||+.||.+||++.++++.|+..
T Consensus 329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 333332 233456789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=321.20 Aligned_cols=255 Identities=26% Similarity=0.477 Sum_probs=211.5
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
|+..+|++.+.||+|+||.||+|.++ +..||+|.+....... ....+.+|+..+++++||||+++++++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK----QRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH----HHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 67889999999999999999999753 5689999987654322 23458899999999999999999999874
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++++|||.+.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~ 155 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQ 155 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCcccc
Confidence 58999999999999999998643 348999999999999999999999999999999999999988 799999999876
Q ss_pred cccccccc--ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCC
Q 018656 175 EESLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 175 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
........ ....++..|+|||.+.+ ..++.++|||||||++|++++ |..||..................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 227 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQY--------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL 227 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhh--------CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC
Confidence 53222211 12235678999998754 567889999999999999775 99999887665544444444444
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
+.+..+|..+.+++.+||+.+|.+||++.++++.|...
T Consensus 228 ~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 56778999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=320.21 Aligned_cols=255 Identities=31% Similarity=0.530 Sum_probs=214.5
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-C
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 96 (352)
|.|+.++|++.+.||+|+||.||+|.+. ++.||+|.+..... ....+.+|+.++++++|+||+++++.+.+ .
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM------SVQAFLEEANLMKTLQHDKLVRLYAVVTKEE 74 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch------hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 8899999999999999999999999875 67899998764322 13458899999999999999999998764 4
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..+++|||+++++|.+++.......+++..++.++.|++.||+|||+++++|+||||+||+++.+ +.++|+|||++...
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~ 153 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVI 153 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceec
Confidence 78999999999999999987655568999999999999999999999999999999999999988 79999999999754
Q ss_pred ccccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCC
Q 018656 177 SLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 253 (352)
Q Consensus 177 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (352)
..... .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+................+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR 225 (261)
T ss_pred CCCceeccCCCccceecCCHHHhcc--------CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 33221 122345678999998754 557889999999999999998 9999988666555444444444455
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
...++.++.+++.+||..+|++||+++++.+.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 66789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=337.74 Aligned_cols=271 Identities=30% Similarity=0.531 Sum_probs=218.8
Q ss_pred ccccccccccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHh
Q 018656 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79 (352)
Q Consensus 7 ~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~ 79 (352)
|.-...+.....|.+..++|++.+.||+|+||.||+|.+. +..||+|++....... ....+.+|+++++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~il~ 96 (374)
T cd05106 21 FIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD----EREALMSELKILS 96 (374)
T ss_pred eeCCccccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH----HHHHHHHHHHHHH
Confidence 4445557778889999999999999999999999998863 2579999997654332 2345889999999
Q ss_pred cC-CCCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcC---------------------------------------
Q 018656 80 RV-QHRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMR--------------------------------------- 118 (352)
Q Consensus 80 ~l-~hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------------------------------- 118 (352)
.+ +|+||+++++++.+ +..++||||+++|+|.+++....
T Consensus 97 ~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (374)
T cd05106 97 HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQ 176 (374)
T ss_pred hhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccc
Confidence 99 89999999999874 47899999999999999986432
Q ss_pred -----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 119 -----------------------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 119 -----------------------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
...+++..+++++.|++.||+|||++|++||||||+|||++++ +.++|+|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~D 255 (374)
T cd05106 177 GSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICD 255 (374)
T ss_pred ccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEee
Confidence 1247888899999999999999999999999999999999987 7999999
Q ss_pred CCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 018656 170 FGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAA 245 (352)
Q Consensus 170 fg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 245 (352)
||++........ .....++..|+|||++.. ..++.++||||||+++|+|++ |..||............
T Consensus 256 fGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~ 327 (374)
T cd05106 256 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327 (374)
T ss_pred ceeeeeccCCcceeeccCCCCccceeCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH
Confidence 999875332211 112235568999998854 568899999999999999997 99999876544433333
Q ss_pred HhccC-CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 246 AFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 246 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
..... ...+..+|.++.+++.+||+.||.+|||+.++++.|.+.+
T Consensus 328 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 328 VKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 33322 2334567899999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=319.40 Aligned_cols=256 Identities=30% Similarity=0.535 Sum_probs=215.2
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCc
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 97 (352)
|.+..++|++.+.||+|+||.||+|.+. +..+|+|.+....... ..+.+|+.++++++|+|++++++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~------~~~~~E~~~l~~l~~~~i~~~~~~~~~~~ 74 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP------ESFLEEAQIMKKLRHDKLVQLYAVVSEEP 74 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH------HHHHHHHHHHHhcCCCceEEEEeEECCCC
Confidence 7888999999999999999999999875 6789999987644322 24789999999999999999999988778
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.+++|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++++ +.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeecc
Confidence 8999999999999999987555568999999999999999999999999999999999999988 799999999987543
Q ss_pred cccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 178 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 178 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
.... .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..............+.+
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP 225 (260)
T ss_pred CcccccccCCCCCccccChHHHhc--------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 2221 112235568999998743 567889999999999999999 89999886665544444433344556
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
...+..+.+++.+||..+|.+|||++++.+.|+++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 77899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=333.09 Aligned_cols=253 Identities=30% Similarity=0.446 Sum_probs=221.9
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeecC-c
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-V 97 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~-~ 97 (352)
....|.+++.||+|.||+||++..+ |+.+|+|++.+...... .....+.+|+++|+++. ||||+.+.++++.. .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~--~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK--EDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc--ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 4668999999999999999999884 89999999987655332 13456889999999998 99999999999855 7
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC---CCceEEecCCCcc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---LKTIKLADFGLAR 174 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~---~~~vkl~Dfg~a~ 174 (352)
.++|||+|.||.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+... .+.++++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999999876 39999999999999999999999999999999999999544 2479999999999
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc---CC
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VR 251 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~---~~ 251 (352)
...........+||+.|+|||++.. ..|+...||||+|+++|.|++|..||.+.+.......+.... ..
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~--------~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~ 259 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGG--------RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS 259 (382)
T ss_pred EccCCceEeeecCCccccCchhhcC--------CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC
Confidence 8777667788899999999999854 678999999999999999999999999988666665555543 34
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+.++.++....++|+.||..||..|+|+.++++|.|
T Consensus 260 ~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 260 EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 557889999999999999999999999999999844
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=335.12 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=201.3
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 100 (352)
++|++.+.||+|+||+||+|.++ ++.||+|++....... ......+.+|+.++++++||||+++++.+.+. .+++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE--KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH--hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 47899999999999999999874 7899999986532211 23345688899999999999999999998854 7899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||++|++|.+++.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCcccccccc
Confidence 999999999999998754 39999999999999999999999999999999999999988 799999999986432110
Q ss_pred ------------------------------------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHH
Q 018656 181 ------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224 (352)
Q Consensus 181 ------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 224 (352)
......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--------TGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--------CCCCCchhhhhhHHHHH
Confidence 0123479999999999854 56788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhc--cCCCCCCCHHHHHHHH
Q 018656 225 ELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWK--EDPNARPNFTQIIQML 286 (352)
Q Consensus 225 ~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~--~~p~~Rps~~~i~~~l 286 (352)
+|++|..||.+.+............ ..|....+++++.++|.+++. .++..||+++++++|.
T Consensus 228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp 294 (363)
T cd05628 228 EMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNP 294 (363)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCC
Confidence 9999999998866554444333211 122234578999999998765 2333568999999983
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=331.24 Aligned_cols=242 Identities=28% Similarity=0.380 Sum_probs=194.0
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHH-HHhcCCCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||.||+|++. |+.||+|++....... ......+.+|.. +++.++||||+++++.+.+ +..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK--KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH--hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 36999999999999984 7899999986532211 122334555554 6788999999999998874 4799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc-cccccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~-~~~~~~~~ 184 (352)
+|++|..++.+.. .+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++... ........
T Consensus 79 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 79 NGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCcccc
Confidence 9999999887643 48999999999999999999999999999999999999988 79999999998753 22223344
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.... ...........+...+.++.++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~l 226 (321)
T cd05603 156 FCGTPEYLAPEVLRK--------EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YDNILHKPLQLPGGKTVAACDL 226 (321)
T ss_pred ccCCcccCCHHHhcC--------CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-HHHHhcCCCCCCCCCCHHHHHH
Confidence 578999999999854 5678899999999999999999999988654433 3333333444566788999999
Q ss_pred HHHhhccCCCCCCCHH----HHHHH
Q 018656 265 LTSCWKEDPNARPNFT----QIIQM 285 (352)
Q Consensus 265 i~~~l~~~p~~Rps~~----~i~~~ 285 (352)
+.+||+.||.+||+.. +++++
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 227 LVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred HHHHccCCHhhcCCCCCCHHHHhCC
Confidence 9999999999998754 55554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=337.56 Aligned_cols=262 Identities=23% Similarity=0.324 Sum_probs=212.1
Q ss_pred ccccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
....+.+..++|++.+.||+|+||.||+|++. ++.||+|++....... ......+.+|+.+++.++||||++++++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~il~~~~h~~iv~~~~~ 111 (370)
T cd05596 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK--RSDSAFFWEERDIMAHANSEWIVQLHYA 111 (370)
T ss_pred hhccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 33456778899999999999999999999885 7899999986422111 1223457789999999999999999998
Q ss_pred eec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 93 CKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 93 ~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
+.+ ...++||||++|++|.+++.+. .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG 187 (370)
T cd05596 112 FQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFG 187 (370)
T ss_pred EecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEecc
Confidence 875 4799999999999999998753 38899999999999999999999999999999999999988 799999999
Q ss_pred Ccccccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 172 LAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 172 ~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
++....... ......|++.|+|||++.+. .....++.++|||||||++|+|++|..||.+.+............
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 263 (370)
T cd05596 188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK 263 (370)
T ss_pred ceeeccCCCcccCCCCCCCcCeECHHHhccC----CCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence 987543322 12345799999999998541 122457889999999999999999999999866544433333221
Q ss_pred ---CCCCCCCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 018656 250 ---VRPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 286 (352)
Q Consensus 250 ---~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~i~~~l 286 (352)
..+....++.++.++|.+||+.+|.+ |+++.++++|.
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 264 NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 12333468999999999999999987 99999999984
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=331.61 Aligned_cols=238 Identities=28% Similarity=0.374 Sum_probs=191.2
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHH-HHHhcCCCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV-AMLSRVQHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||+||+|++. ++.||+|++........ .....+.+|. .+++.++||||+++++++.+ +..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK--KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh--hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 36999999999999885 67899999875322111 1222344444 45688899999999999874 5799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc-ccccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 184 (352)
++++|.+++.+... +++..+..++.||++||.|||++||+||||||+|||++.+ +.++|+|||++.... .......
T Consensus 79 ~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 79 NGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCccc
Confidence 99999999986443 8899999999999999999999999999999999999988 799999999987432 2223344
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+........ ..........++..+.++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~l 226 (325)
T cd05602 156 FCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI-LNKPLQLKPNITNSARHL 226 (325)
T ss_pred ccCCccccCHHHHcC--------CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH-HhCCcCCCCCCCHHHHHH
Confidence 579999999998854 56788999999999999999999999876654433333 333334456789999999
Q ss_pred HHHhhccCCCCCCCHHH
Q 018656 265 LTSCWKEDPNARPNFTQ 281 (352)
Q Consensus 265 i~~~l~~~p~~Rps~~~ 281 (352)
|.+||+.||.+||++.+
T Consensus 227 i~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 227 LEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHcccCHHHCCCCCC
Confidence 99999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=331.18 Aligned_cols=242 Identities=29% Similarity=0.406 Sum_probs=194.7
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhc-CCCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR-VQHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||+||+|.+. ++.||+|++........ .....+..|..++.. .+||||+++++++.. +..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED--DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh--hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 36999999999999875 78899999875322111 222334556666654 489999999999874 5799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-cccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~~~~~~ 184 (352)
+|++|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++..... ......
T Consensus 79 ~gg~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 79 NGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCcccc
Confidence 99999999976543 8999999999999999999999999999999999999988 7999999999875322 223344
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...... .........+..++.++.++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~l 226 (316)
T cd05592 156 FCGTPDYIAPEILKG--------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD-SILNDRPHFPRWISKEAKDC 226 (316)
T ss_pred ccCCccccCHHHHcC--------CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCHHHHHH
Confidence 578999999999854 567889999999999999999999998866543333 33333344466789999999
Q ss_pred HHHhhccCCCCCCCHH-HHHHH
Q 018656 265 LTSCWKEDPNARPNFT-QIIQM 285 (352)
Q Consensus 265 i~~~l~~~p~~Rps~~-~i~~~ 285 (352)
+.+||..||.+||++. +++++
T Consensus 227 l~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 227 LSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred HHHHccCCHHHcCCChHHHHcC
Confidence 9999999999999875 66665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=318.89 Aligned_cols=255 Identities=30% Similarity=0.534 Sum_probs=215.5
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCc
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 97 (352)
|.|..++|++.++||+|+||.||+|.+. ++.||+|.+...... ...+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS------PEAFLAEANLMKQLQHPRLVRLYAVVTQEP 74 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc------HHHHHHHHHHHHhcCCcCeeeEEEEEccCC
Confidence 7888999999999999999999999874 789999998754432 235788999999999999999999988778
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.+++|||+.+++|.+++.......+++..++.++.|++.||+|||+.|++|+||||+||+++++ +.++|+|||++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecC
Confidence 9999999999999999977655568999999999999999999999999999999999999988 799999999987543
Q ss_pred cccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 178 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 178 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
.... .....++..|+|||++.. ..++.++||||||+++|++++ |+.||.+.+..............+.+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP 225 (260)
T ss_pred CCCcccccCCcccccccCHHHhcc--------CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCC
Confidence 2211 122345678999998854 557889999999999999998 99999876654444443333344556
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
...+.++.+++.+||..+|++||+++++++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 7788999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=337.27 Aligned_cols=249 Identities=23% Similarity=0.334 Sum_probs=203.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 100 (352)
++|++.+.||+|+||+||+|++. |+.||||++....... ......+.+|+.+++.++||||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 47899999999999999999984 8899999987532211 13345678899999999999999999998754 7999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||++|++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++.......
T Consensus 79 v~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceeccccc
Confidence 999999999999998654 39999999999999999999999999999999999999988 799999999986422110
Q ss_pred ---------------------------------------ccccCCCcccccccccccccccccccccCCCcccchhhHHH
Q 018656 181 ---------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAI 221 (352)
Q Consensus 181 ---------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~ 221 (352)
......||+.|+|||++.. ..++.++|||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~ 227 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--------TGYNKECDWWSLGV 227 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--------CCCCCeeeeecchh
Confidence 0012358999999998854 56789999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCCC---HHHHHHHH
Q 018656 222 VLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQML 286 (352)
Q Consensus 222 il~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~i~~~l 286 (352)
++|+|++|..||.+.+............ ..+....+++++.++|.+||. +|.+|++ +.++++|.
T Consensus 228 il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9999999999998876554433332211 122334578999999999997 9999997 99999984
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=331.94 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=198.7
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||+||+|++. ++.||+|++....... ......+.+|..+++.+ +||||+++++++.. +.+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ--DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 36999999999999885 7899999987532211 12344567888888877 79999999999874 4799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-cccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~~~~~~ 184 (352)
+|++|.+++.+... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++..... ......
T Consensus 79 ~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 79 NGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCcccc
Confidence 99999999876543 9999999999999999999999999999999999999998 7999999999864222 222234
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...... .........+..++.++.++
T Consensus 156 ~~g~~~y~aPE~~~~--------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~l 226 (318)
T cd05570 156 FCGTPDYIAPEILSY--------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ-SILEDEVRYPRWLSKEAKSI 226 (318)
T ss_pred eecCccccCHHHhcC--------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH-HHHcCCCCCCCcCCHHHHHH
Confidence 468999999999854 567889999999999999999999998766543333 23333334456789999999
Q ss_pred HHHhhccCCCCCCCH-----HHHHHH
Q 018656 265 LTSCWKEDPNARPNF-----TQIIQM 285 (352)
Q Consensus 265 i~~~l~~~p~~Rps~-----~~i~~~ 285 (352)
|++||..||.+||++ .+++++
T Consensus 227 i~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 227 LKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 999999999999999 999887
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=334.32 Aligned_cols=268 Identities=31% Similarity=0.572 Sum_probs=228.6
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC---C---ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
+.|.+..++..+.++||+|+||.||+|+.+ + ..||+|........ ....+..+.+|.++++.++|||||+++
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~--~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL--TKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc--cHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 459999999999999999999999999864 2 23899988752211 124566799999999999999999999
Q ss_pred eeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 91 GACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 91 ~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
|+... .-+++|||+|+||+|.+|+++.+. .++..+...++.+.+.||+|||+++++||||-.+|+|++.+ +.+||+|
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISD 305 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISD 305 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCc
Confidence 99875 468999999999999999998765 59999999999999999999999999999999999999997 6789999
Q ss_pred CCCccccccccccc-cCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 018656 170 FGLAREESLTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 170 fg~a~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 247 (352)
||+++......... ...-...|+|||.+.. ..++.++||||+|+++||+++ |..||.+....+....+..
T Consensus 306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~~--------~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLNT--------GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred cccccCCcceeeccccccCcceecChhhhcc--------CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 99998754333322 2346789999999865 689999999999999999998 8889999988877777744
Q ss_pred -ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 018656 248 -KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 296 (352)
Q Consensus 248 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~ 296 (352)
....+.+...|.++..++.+|+..+|+.||++.++.+.+........++
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 4455667788999999999999999999999999999998887765543
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=332.05 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=199.1
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||.||+|++. |+.||+|++....... ......+..|.++++.+ +||||+++++++.+ +.+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ--DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh--hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 36999999999999885 6899999987532211 12334566788888766 89999999999875 4799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-cccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~~~~~~ 184 (352)
++++|..++.+... +++..+..++.|++.||.|||++||+||||||+||+++.+ +.++|+|||++..... ......
T Consensus 79 ~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 79 NGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeecccceecccCCccccc
Confidence 99999999976543 8999999999999999999999999999999999999988 7999999999875322 222334
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+........ .......+..++.++.++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i-~~~~~~~p~~~~~~~~~l 226 (321)
T cd05591 156 FCGTPDYIAPEILQE--------LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI-LHDDVLYPVWLSKEAVSI 226 (321)
T ss_pred cccCccccCHHHHcC--------CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCHHHHHH
Confidence 568999999998854 56788999999999999999999999986654443333 333334456689999999
Q ss_pred HHHhhccCCCCCC-------CHHHHHHHH
Q 018656 265 LTSCWKEDPNARP-------NFTQIIQML 286 (352)
Q Consensus 265 i~~~l~~~p~~Rp-------s~~~i~~~l 286 (352)
+..||+.||.+|| ++.+++++.
T Consensus 227 l~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 227 LKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred HHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 9999999999999 889998884
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=328.28 Aligned_cols=240 Identities=25% Similarity=0.367 Sum_probs=198.7
Q ss_pred ccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCCC
Q 018656 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGG 108 (352)
Q Consensus 32 lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 108 (352)
||+|+||.||+|.+. ++.||+|++....... ......+.+|+.++++++||||+++++++.+ +..++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS--RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 799999999999885 7889999986432111 1234567889999999999999999998874 5799999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-ccccccCCC
Q 018656 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETG 187 (352)
Q Consensus 109 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~g 187 (352)
+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+ +.++|+|||++..... ........|
T Consensus 79 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 79 ELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCccccccC
Confidence 9999998654 38999999999999999999999999999999999999988 7999999999875322 222334578
Q ss_pred cccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHH
Q 018656 188 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 267 (352)
Q Consensus 188 ~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 267 (352)
++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.... ...........+..+++++.++|.+
T Consensus 156 t~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~ 226 (312)
T cd05585 156 TPEYLAPELLLG--------HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRKILQEPLRFPDGFDRDAKDLLIG 226 (312)
T ss_pred CcccCCHHHHcC--------CCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-HHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 999999999854 5678899999999999999999999987654433 3333334444567889999999999
Q ss_pred hhccCCCCCCC---HHHHHHH
Q 018656 268 CWKEDPNARPN---FTQIIQM 285 (352)
Q Consensus 268 ~l~~~p~~Rps---~~~i~~~ 285 (352)
||..||.+||+ +.++++|
T Consensus 227 ~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 227 LLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HcCCCHHHcCCCCCHHHHHcC
Confidence 99999999974 6777777
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=318.15 Aligned_cols=256 Identities=29% Similarity=0.558 Sum_probs=213.5
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-c
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-E 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~ 95 (352)
|.++...|.+.+.||+|+||.||+|.+. ++.+|+|++..... ....+.+|++++++++||||+++++++. +
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch------HHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 7888999999999999999999999874 78999999864322 1235788999999999999999999986 4
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+..+++|||+++++|.+++.......+++..++.++.|+++||+|||++|++||||||+||+++++ +.++|+|||++..
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~ 153 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRL 153 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCccccc
Confidence 578999999999999999987655568999999999999999999999999999999999999988 7999999999876
Q ss_pred cccccccc--cCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 018656 176 ESLTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 176 ~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
........ ...++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.................
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME 225 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence 44332211 1224568999998754 567889999999999999998 999998866544433333333344
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
.+..+|.++.+++.+||..||++||++.++++.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 5677899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.48 Aligned_cols=241 Identities=29% Similarity=0.429 Sum_probs=198.4
Q ss_pred ccccCCCceEEEEEEE-----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEE
Q 018656 30 PRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTE 103 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e 103 (352)
+.||+|+||.||++++ .|+.||+|++...... .....++.+|++++++++||||+++++++.+ +..++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 5699999999999875 3789999998753221 1223457789999999999999999999874 57999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-ccc
Q 018656 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMM 182 (352)
Q Consensus 104 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~-~~~ 182 (352)
|+++++|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++...... ...
T Consensus 79 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 79 FLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCce
Confidence 999999999997654 38999999999999999999999999999999999999988 79999999998754333 223
Q ss_pred ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHH
Q 018656 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 262 (352)
Q Consensus 183 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 262 (352)
....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+........ .......+..++.++.
T Consensus 156 ~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i-~~~~~~~p~~~~~~~~ 226 (318)
T cd05582 156 YSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI-LKAKLGMPQFLSPEAQ 226 (318)
T ss_pred ecccCChhhcCHHHHcC--------CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCHHHH
Confidence 34578999999998854 55688999999999999999999999886654443333 2333344567899999
Q ss_pred HHHHHhhccCCCCCCC-----HHHHHHH
Q 018656 263 IILTSCWKEDPNARPN-----FTQIIQM 285 (352)
Q Consensus 263 ~li~~~l~~~p~~Rps-----~~~i~~~ 285 (352)
++|++||+.||.+||+ +.+++++
T Consensus 227 ~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 227 SLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred HHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 9999999999999999 5556665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=335.97 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=201.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 100 (352)
++|++.+.||+|+||+||++.+. |+.||||++...... .......+.+|++++++++||||+++++++.++ ..|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF--KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 47899999999999999999874 889999998653211 123345688999999999999999999998854 7999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||++|++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeeccccccccccc
Confidence 999999999999997654 38999999999999999999999999999999999999988 799999999985321100
Q ss_pred ------------------------------------------------ccccCCCcccccccccccccccccccccCCCc
Q 018656 181 ------------------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 212 (352)
Q Consensus 181 ------------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~ 212 (352)
......||+.|+|||++.+ ..++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ 227 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--------QGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--------CCCCC
Confidence 0012468999999999854 56789
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---cCCCCCCCCcHHHHHHHHHhhccCCCCC---CCHHHHHHHH
Q 018656 213 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRPSAENVPEELSIILTSCWKEDPNAR---PNFTQIIQML 286 (352)
Q Consensus 213 ~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~i~~~l 286 (352)
++|||||||++|+|++|..||.+.+........... ...+....++.++.++|.+||. +|.+| +++.++++|.
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 999999999999999999999886654443333221 1123334688999999999998 66665 6999999984
Q ss_pred H
Q 018656 287 L 287 (352)
Q Consensus 287 ~ 287 (352)
+
T Consensus 307 ~ 307 (377)
T cd05629 307 F 307 (377)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.42 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=202.9
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|.+.+.||+|+||+||+|++. ++.||+|++...... .......+.+|+.++++++||||+++++.+.+ ..+++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL--LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh--hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence 36889999999999999999884 789999998653221 12345568899999999999999999999875 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCccccccc
Confidence 999999999999997654 38999999999999999999999999999999999999988 79999999997421100
Q ss_pred -----------------------------------------------cccccCCCcccccccccccccccccccccCCCc
Q 018656 180 -----------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 212 (352)
Q Consensus 180 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~ 212 (352)
.......||+.|+|||++.+ ..++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~ 227 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--------TGYTQ 227 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--------CCCCC
Confidence 00112468999999999854 56788
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---cCCCCCCCCcHHHHHHHHHhhccCCCCCCC---HHHHHHHH
Q 018656 213 KVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NVRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQML 286 (352)
Q Consensus 213 ~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~i~~~l 286 (352)
++|||||||++|+|++|+.||.+.+........... ...|....++++..++|.+|+ .+|.+|++ +.++++|.
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 306 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHP 306 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCC
Confidence 999999999999999999999987665544443321 122334578999999999987 49999987 99998873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=304.20 Aligned_cols=264 Identities=21% Similarity=0.324 Sum_probs=215.3
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
...-.|+.++|++.+.||.|||+.||.++. +++.||+|.+..... +.+...++|++..++++||||++++++.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~-----~~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ-----EDIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch-----HHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 556779999999999999999999999875 589999999887663 3345688999999999999999999875
Q ss_pred e----c--CceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeCCCC
Q 018656 94 K----E--PVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLK 163 (352)
Q Consensus 94 ~----~--~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~~~~ 163 (352)
. + ...|++++|+..|+|.+.+.... +..+++.+++.|+.++++||++||+.. ++||||||+||+++++ +
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~ 166 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-G 166 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-C
Confidence 2 1 25899999999999999998653 446999999999999999999999999 9999999999999997 7
Q ss_pred ceEEecCCCccccccccc----------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCC
Q 018656 164 TIKLADFGLAREESLTEM----------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233 (352)
Q Consensus 164 ~vkl~Dfg~a~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 233 (352)
.++|+|||.+........ ......|..|+|||.+.. ..+...+.+.|||||||++|.|+.|..||
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v-----k~~~ti~ertDIWSLGCtLYa~mf~~sPf 241 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV-----KSHCTITERTDIWSLGCTLYAMMFGESPF 241 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheec-----ccCcccccccchhhhhHHHHHHHHcCCcc
Confidence 999999999875332211 123457999999999864 23567899999999999999999999999
Q ss_pred CCCChHHHHH--H-HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 234 EGMSNLQAAY--A-AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 234 ~~~~~~~~~~--~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
+-........ . .......|....+|+.+.++|+.||+.||.+||++.+++.++.+.+
T Consensus 242 e~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 242 ERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 6422211110 1 1111223555669999999999999999999999999999987653
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=329.89 Aligned_cols=247 Identities=25% Similarity=0.348 Sum_probs=201.5
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCC-Ceeeeeeeeec-CceEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR-NLVKFIGACKE-PVMVI 100 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~l~~~~~~-~~~~l 100 (352)
+|++.+.||+|+||.||+|.+. ++.||+|++....... ......+..|..++..+.|+ +|+++++++.+ +.+++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ--DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 5889999999999999999885 6789999987532211 12334577889999999765 57888888764 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc-cc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LT 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~~ 179 (352)
||||++|++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.++|+|||++.... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecCCCC
Confidence 9999999999999976543 8999999999999999999999999999999999999988 799999999986422 22
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....... ........+..++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~ 226 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS-IMEHNVSYPKSLSK 226 (324)
T ss_pred CceeeecCCccccChhhhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCH
Confidence 22344578999999999854 5678899999999999999999999988665443333 33333445667899
Q ss_pred HHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNF-----TQIIQM 285 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~-----~~i~~~ 285 (352)
++.+++.+||..||.+|++. .++++|
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 227 EAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999999999976 677776
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=324.47 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=201.4
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
.-++|++.+.||.|+||+||+|.+. ++.||+|++....... ....+.+|++++++++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKNLKHANIVTLHDIIHTERCL 78 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC----cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 3467999999999999999999874 7899999987543221 12346789999999999999999999874 478
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 79 ~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSV 155 (288)
T ss_pred EEEEeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeeccC
Confidence 999999965 9999987644 347899999999999999999999999999999999999988 7999999999875332
Q ss_pred c-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC------
Q 018656 179 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------ 251 (352)
Q Consensus 179 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~------ 251 (352)
. .......+++.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+...........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVLLG-------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred CCccccCceecccccChHHhcC-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 2 22234568999999998753 245788999999999999999999999886654433322111100
Q ss_pred --------------C---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 --------------P---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 --------------~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+ ....++.++.++|.+||+.||.+|||++++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 013467889999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=334.45 Aligned_cols=268 Identities=29% Similarity=0.531 Sum_probs=217.6
Q ss_pred ccccccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-
Q 018656 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ- 82 (352)
Q Consensus 11 ~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 82 (352)
..+..++.|.+++++|++++.||+|+||.||+|.+. +..||||++...... ...+.+.+|+++++++.
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~Ei~~l~~l~~ 99 (400)
T cd05105 24 MQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS----SEKQALMSELKIMTHLGP 99 (400)
T ss_pred ccCCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCC
Confidence 346778899999999999999999999999999863 246999998764432 22356889999999996
Q ss_pred CCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcC-------------------------------------------
Q 018656 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMR------------------------------------------- 118 (352)
Q Consensus 83 hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------------------------------------------- 118 (352)
||||+++++++.+ +..++||||+++|+|.+++.+..
T Consensus 100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (400)
T cd05105 100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMD 179 (400)
T ss_pred CCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccc
Confidence 9999999999875 57999999999999999986532
Q ss_pred ---------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 018656 119 ---------------------------------------------------PRCLDVCVAIGFALDIARAMECLHSHGII 147 (352)
Q Consensus 119 ---------------------------------------------------~~~~~~~~~~~i~~qi~~~L~~lH~~~iv 147 (352)
...+++..++.++.|+++||+|||+++++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 259 (400)
T cd05105 180 MKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV 259 (400)
T ss_pred cccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 12478888999999999999999999999
Q ss_pred cCCCCCCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHH
Q 018656 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224 (352)
Q Consensus 148 H~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 224 (352)
||||||+|||++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|
T Consensus 260 H~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ 330 (400)
T cd05105 260 HRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--------NLYTTLSDVWSYGILLW 330 (400)
T ss_pred CCCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC--------CCCCchhhHHHHHHHHH
Confidence 99999999999988 789999999987532221 1122346778999998854 55788999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 225 ELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 225 ~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
+|++ |..||................ ..+.+..++.++.+++.+||+.||++||++.++.+.|...++
T Consensus 331 ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 331 EIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 9997 999998754433333333322 234456789999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=340.71 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=202.0
Q ss_pred cCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec----
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---- 95 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---- 95 (352)
..++|++++.||+|+||+||+|.+ +++.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---------YKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 456899999999999999999987 478999998854321 23479999999999999999887532
Q ss_pred -----CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 96 -----PVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 96 -----~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
..+++||||+++ +|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 146799999964 788777532 234599999999999999999999999999999999999998764579999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
|||+++............|++.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+..+........
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLG-------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999986544444445678999999998754 245788999999999999999999999887655444333221
Q ss_pred cCCC----------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 249 NVRP----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 249 ~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
...+ .+...|.++.+||.+||+.||.+|||+.++++|. |+..+
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp--~f~~~ 357 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP--FFDDL 357 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh--hHHhh
Confidence 1110 1234678999999999999999999999999994 44443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=330.05 Aligned_cols=242 Identities=26% Similarity=0.397 Sum_probs=195.4
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||.||+|+++ |+.||+|++....... .........|..++..+ +||||+++++++.+ +..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI--DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 46999999999999885 7899999987532111 11233456677777654 89999999999874 5799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-cccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~~~~~~ 184 (352)
++++|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++..... ......
T Consensus 79 ~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 79 NGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCceec
Confidence 99999999976543 8999999999999999999999999999999999999988 7999999999874221 222344
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.... ...........+..++.++.++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l 226 (316)
T cd05620 156 FCGTPDYIAPEILQG--------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-FESIRVDTPHYPRWITKESKDI 226 (316)
T ss_pred cCCCcCccCHHHHcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCCCCCCHHHHHH
Confidence 578999999999854 5678899999999999999999999987655433 3333333334455688999999
Q ss_pred HHHhhccCCCCCCCH-HHHHHH
Q 018656 265 LTSCWKEDPNARPNF-TQIIQM 285 (352)
Q Consensus 265 i~~~l~~~p~~Rps~-~~i~~~ 285 (352)
|.+||..||.+||++ +++++|
T Consensus 227 i~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 227 LEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred HHHHccCCHHHcCCChHHHHcC
Confidence 999999999999998 467766
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=316.13 Aligned_cols=252 Identities=30% Similarity=0.560 Sum_probs=211.9
Q ss_pred ceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee--cC
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--EP 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~ 96 (352)
|.++..+|++.+.||+|+||.||++...|..+++|....... ...+.+|+.++++++|+|++++++++. +.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch-------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence 888999999999999999999999999999999999865332 235788999999999999999998753 34
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..++++||+++++|.+++.+.....+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++...
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~ 152 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA 152 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceec
Confidence 68999999999999999987665568999999999999999999999999999999999999988 79999999998753
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
.... ....++..|+|||++.. ..++.++|||||||++|+|++ |+.||....................+.
T Consensus 153 ~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd05082 153 SSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 222 (256)
T ss_pred cccC--CCCccceeecCHHHHcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 3221 23345678999998754 567889999999999999997 999998765544433333333334456
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
.+|..+.+++.+||..+|.+|||+.++++.|..
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=330.21 Aligned_cols=244 Identities=25% Similarity=0.393 Sum_probs=199.1
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||.||+|.+. ++.||+|++....... ......+.+|..+++.+ +||||+++++++.+ ..+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND--DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 36899999999999884 7899999997643222 12345577899999888 79999999999874 5789999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc-cccccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~-~~~~~~~~ 184 (352)
+|++|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++... ........
T Consensus 79 ~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 79 SGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccccCCCcccc
Confidence 9999999987654 39999999999999999999999999999999999999988 79999999998742 22223344
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhccCCCCCCC
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--------NLQAAYAAAFKNVRPSAEN 256 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~ 256 (352)
..|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.... ................+..
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 227 (329)
T cd05588 156 FCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS 227 (329)
T ss_pred ccCCccccCHHHHcC--------CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCC
Confidence 578999999999854 567889999999999999999999996321 1122333333444445677
Q ss_pred CcHHHHHHHHHhhccCCCCCCC------HHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPN------FTQIIQML 286 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps------~~~i~~~l 286 (352)
++.++.++|++||+.||.+|++ +.++++|.
T Consensus 228 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05588 228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP 263 (329)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCC
Confidence 8999999999999999999987 78888873
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=325.83 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=201.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|.+.+.||+|+||.||+|+++ |+.||+|++....... ....+.+|+.+++.++||||+++++++.+ ...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG----TPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc----cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 578999999999999999999984 8899999987543322 12246789999999999999999999874 4789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL- 178 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~- 178 (352)
+||||+. ++|.+++.++. ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKSVP 156 (303)
T ss_pred EEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceeccCC
Confidence 9999995 68888887643 348999999999999999999999999999999999999987 7999999999874322
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-cCCC-----
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-NVRP----- 252 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~----- 252 (352)
........+++.|+|||++.+ ...++.++|||||||++|+|++|..||.+............. ...+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLG-------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred CccCCCCcccCCCCChHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhc
Confidence 222234568999999998753 245788999999999999999999999876543332221110 0000
Q ss_pred -----------------C---------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 253 -----------------S---------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 253 -----------------~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
. ...++.++.+++.+||+.||.+|||+.++++| .++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h--~~f~~~ 294 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH--EYFSDL 294 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC--cccccC
Confidence 0 01245678999999999999999999999998 445443
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=315.56 Aligned_cols=255 Identities=30% Similarity=0.528 Sum_probs=212.7
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCc
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 97 (352)
|.+...+|.+...||+|++|.||+|.+. +..+|+|.+...... ...+.+|++++++++|||++++++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM------PEAFLQEAQIMKKLRHDKLVPLYAVVSEEP 74 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 7788889999999999999999999886 457999987654321 235788999999999999999999988778
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++++ +.++|+|||++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEcc
Confidence 8999999999999999987655568999999999999999999999999999999999999988 799999999987543
Q ss_pred cccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 178 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 178 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
.... .....++..|+|||...+ ..++.++|+||||+++|+|++ |..||.+................+.+
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCP 225 (260)
T ss_pred CCcccccCCCccchhhCCHHHhcc--------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 2221 112345678999998743 567889999999999999999 99999886655444443333334446
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
...+..+.+++.+||..||.+||+++++++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 6789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=330.68 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=199.9
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec------C
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------P 96 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------~ 96 (352)
+|++.+.||+|+||.||+|.++ |+.||||++....... ....++.+|+++++.++||||+++++++.. .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc---hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 5899999999999999999874 7999999986432211 223457899999999999999999998742 2
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..++||||+ +++|.+++..... +++..+..++.|+++||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 78 ~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~ 153 (338)
T cd07859 78 DIYVVFELM-ESDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVA 153 (338)
T ss_pred eEEEEEecC-CCCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCcccccc
Confidence 479999999 5699999876543 8999999999999999999999999999999999999988 79999999998753
Q ss_pred cccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----
Q 018656 177 SLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF----- 247 (352)
Q Consensus 177 ~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~----- 247 (352)
.... ......|++.|+|||++.+ ....++.++|||||||++|+|++|+.||.+.+..........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 227 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGS------FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhc------cccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 2211 1234578999999998743 124678899999999999999999999987554322111000
Q ss_pred --------------------ccCCC-----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 248 --------------------KNVRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 248 --------------------~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
....+ ....+++++.+++.+||..||.+||++++++++ .|+..
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h--p~f~~ 295 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD--PYFKG 295 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC--chhhh
Confidence 00001 123567889999999999999999999999998 44443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=328.52 Aligned_cols=261 Identities=30% Similarity=0.561 Sum_probs=211.6
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l 89 (352)
+|.+.+++|++.+.||+|+||.||+|.+. ++.||+|++...... .....+.+|+.+++++ +|+||+++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA----SEYKALMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH----HHHHHHHHHHHHHHhhccCcchhhe
Confidence 59999999999999999999999999643 468999998754332 2234577899999999 89999999
Q ss_pred eeeeec--CceEEEEEcCCCCCHHHHHHhcCC------------------------------------------------
Q 018656 90 IGACKE--PVMVIVTELLSGGTLRKYLLNMRP------------------------------------------------ 119 (352)
Q Consensus 90 ~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------------------ 119 (352)
++++.. ..++++|||+++++|.+++.....
T Consensus 77 ~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (337)
T cd05054 77 LGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV 156 (337)
T ss_pred eeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhc
Confidence 998763 478999999999999999865321
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc---ccccC
Q 018656 120 -----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAE 185 (352)
Q Consensus 120 -----------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~ 185 (352)
..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++....... .....
T Consensus 157 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred ccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCC
Confidence 257899999999999999999999999999999999999987 789999999987532211 11233
Q ss_pred CCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHH
Q 018656 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSI 263 (352)
Q Consensus 186 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 263 (352)
.++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+......... ....+...+.++.+
T Consensus 236 ~~~~~y~aPE~~~~--------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 236 RLPLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYS 307 (337)
T ss_pred CCCccccCcHHhcC--------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHH
Confidence 45678999998854 568899999999999999997 999998754433333322222 22334567899999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 264 ILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 264 li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
++.+||+.+|.+||++.+++++|...++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=332.54 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=209.2
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
....+..++|++.+.||+|+||.||++++. ++.+|+|++....... ......+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 446677889999999999999999999985 7899999986422111 122345778999999999999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ ...++||||++|++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a 189 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTC 189 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccc
Confidence 5 4799999999999999999754 38999999999999999999999999999999999999988 79999999998
Q ss_pred cccccccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-
Q 018656 174 REESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV- 250 (352)
Q Consensus 174 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~- 250 (352)
........ .....||+.|+|||++... .....++.++|||||||++|+|++|..||.+.+.............
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS 265 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhcc----CCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Confidence 76432221 2345799999999998541 1123478899999999999999999999988765544444333221
Q ss_pred --CCCCCCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 018656 251 --RPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 286 (352)
Q Consensus 251 --~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~i~~~l 286 (352)
.+....++..+.+++..||..++.+ |+++.++++|.
T Consensus 266 ~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 266 LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 2233467899999999999855543 89999999984
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=325.90 Aligned_cols=251 Identities=22% Similarity=0.366 Sum_probs=205.4
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~ 97 (352)
+..++|++.+.||+|+||.||++++. |..+|+|++...... ....++.+|++++++++||||+++++++. ++.
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH----HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 45688999999999999999999985 788999998764332 23456889999999999999999999986 457
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.++||||+++++|.+++..... +++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.++|+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 154 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 154 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCcccccc
Confidence 9999999999999999987543 89999999999999999999986 69999999999999988 79999999998754
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH----------
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA---------- 246 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~---------- 246 (352)
.. .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.............
T Consensus 155 ~~-~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (331)
T cd06649 155 ID-SMANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGE 225 (331)
T ss_pred cc-cccccCCCCcCcCCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCC
Confidence 32 22344578999999999854 567889999999999999999999997644322111100
Q ss_pred -----------------------------------hccCCCC--CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 247 -----------------------------------FKNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 247 -----------------------------------~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.....+. ...++.++.+||.+||+.||++|||+.++++|.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000111 2247889999999999999999999999999954
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=314.55 Aligned_cols=255 Identities=31% Similarity=0.552 Sum_probs=212.4
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cC
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EP 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~ 96 (352)
|.++.++|++.+.||+|++|.||+|.+. ++.||+|.+...... ...+.+|+.++++++||||+++++++. .+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD------PKDFLAEAQIMKKLRHPKLIQLYAVCTLEE 74 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc------HHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence 7788999999999999999999999875 678999998754322 234778999999999999999999887 45
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..+++|||+++++|.+++.......+++..+..++.|++.||.+||++|++|+||||+||+++.+ +.++|+|||++...
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~ 153 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVI 153 (261)
T ss_pred CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-CCEEECCcceEEEc
Confidence 78999999999999999987654568999999999999999999999999999999999999988 78999999998764
Q ss_pred ccccccc--cCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCC
Q 018656 177 SLTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 253 (352)
Q Consensus 177 ~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (352)
....... ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+................+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALY--------NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC 225 (261)
T ss_pred cCCcccccCCCcCceeccCcccccc--------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 4221111 1122457999998754 567889999999999999999 9999988665544444433333445
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
+..++..+.+++.+||+.+|.+||++.++++.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 66789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=321.03 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=205.8
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|++.+.||+|+||+||++.+. ++.||+|++........ .....+.+|+.++++++||||+++++.+.. ...++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhh--hhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 4788999999999999999874 88999999865432211 223457789999999999999999999874 579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
|||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++++ +.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGET 157 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCCc
Confidence 999999999999876554569999999999999999999999999999999999999988 7999999999876543333
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH---HHHhccCCCCCCCCc
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY---AAAFKNVRPSAENVP 258 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~ 258 (352)
.....|+..|+|||++.+ ..++.++||||+|+++|+|++|..||.+........ ..........+..++
T Consensus 158 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKN--------ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS 229 (285)
T ss_pred cccccCCCCccCcHHhcC--------CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccC
Confidence 344578999999999854 567889999999999999999999998755432221 112222223355689
Q ss_pred HHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARP-----NFTQIIQM 285 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rp-----s~~~i~~~ 285 (352)
..+.+++.+||..||.+|| ++++++++
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999999999999 88899887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=329.24 Aligned_cols=243 Identities=27% Similarity=0.371 Sum_probs=200.2
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLS 106 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~ 106 (352)
+.||+|+||.||++.+. |+.||+|++....... ......+.+|+++++.++||||+++++++.. +..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA--KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 36999999999999874 8899999987532211 1234457789999999999999999998874 57999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecCCCccccc-ccccccc
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 184 (352)
+++|.+++.... .+++..++.++.||+.||+|||+ +||+||||||+|||++.+ +.+||+|||++.... .......
T Consensus 79 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 79 GGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCccccc
Confidence 999999987654 38999999999999999999997 799999999999999988 799999999987432 2223334
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..... ..........+..+++++.++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-~~i~~~~~~~p~~~~~~~~~l 226 (325)
T cd05594 156 FCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-ELILMEEIRFPRTLSPEAKSL 226 (325)
T ss_pred ccCCcccCCHHHHcc--------CCCCCccccccccceeeeeccCCCCCCCCCHHHHH-HHHhcCCCCCCCCCCHHHHHH
Confidence 579999999999854 56788999999999999999999999876554333 333333334466789999999
Q ss_pred HHHhhccCCCCCC-----CHHHHHHHH
Q 018656 265 LTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 265 i~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
|.+||+.||.+|+ ++.++++|.
T Consensus 227 i~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 227 LSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred HHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 9999999999996 899999884
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=331.08 Aligned_cols=267 Identities=23% Similarity=0.337 Sum_probs=212.6
Q ss_pred ccccccccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 018656 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88 (352)
Q Consensus 11 ~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 88 (352)
+++..-..+.+..++|++.+.||+|+||.||+|+++ ++.+|+|++....... ......+.+|+.+++.++||||++
T Consensus 30 ~~~~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~e~~i~~~~~hp~iv~ 107 (371)
T cd05622 30 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQ 107 (371)
T ss_pred hHhhHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCCe
Confidence 344445557778899999999999999999999885 7899999986432111 122345778999999999999999
Q ss_pred eeeeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 89 FIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 89 l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
+++++.+ ...++||||++|++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL 183 (371)
T cd05622 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKL 183 (371)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEE
Confidence 9999875 4799999999999999998753 38999999999999999999999999999999999999988 79999
Q ss_pred ecCCCcccccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 018656 168 ADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 245 (352)
Q Consensus 168 ~Dfg~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 245 (352)
+|||++....... ......||+.|+|||++... .....++.++|||||||++|+|++|..||.+.+........
T Consensus 184 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 259 (371)
T cd05622 184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259 (371)
T ss_pred EeCCceeEcCcCCcccccCcccCccccCHHHHhcc----CCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999987543222 12345799999999998541 11234788999999999999999999999986654443333
Q ss_pred Hhcc---CCCCCCCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHHH
Q 018656 246 AFKN---VRPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQMLL 287 (352)
Q Consensus 246 ~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~i~~~l~ 287 (352)
.... ..+....++.++.++|..||..++.+ |+++.++++|.+
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 260 MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 3221 22344578999999999999844433 789999999853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=341.71 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=212.4
Q ss_pred cCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC---
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--- 96 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 96 (352)
..++|++.+.||+|+||+||+|++ +|+.||||++....... ....++.+|+.++..++|+||+++++.+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE---ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH---HHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 457999999999999999999987 48999999987654433 2344678999999999999999998776421
Q ss_pred ------ceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 97 ------VMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 97 ------~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
.+++||||+++|+|.+++..+. ...+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vkL~ 185 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLG 185 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEEEE
Confidence 3689999999999999997542 2458999999999999999999999999999999999999988 799999
Q ss_pred cCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 018656 169 DFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 245 (352)
Q Consensus 169 Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 245 (352)
|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+........
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR--------KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99998753321 22334579999999999854 56889999999999999999999999987665555555
Q ss_pred HhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 246 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
......+.+..+++++.+++.+||..||.+||++.+++++.
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 258 LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 44455566778999999999999999999999999999873
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=323.09 Aligned_cols=248 Identities=26% Similarity=0.324 Sum_probs=199.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
++|++.+.||+|+||+||+|+++ ++.||+|++....... .....+.+|+.+++.++||||+++++++. ++..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE---EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc---cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 36999999999999999999985 7889999987653322 22345778999999999999999999987 457999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||++++.|..+.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 78 VFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCcccccccc
Confidence 99999887666554432 348999999999999999999999999999999999999988 799999999987643221
Q ss_pred --ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--------
Q 018656 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-------- 250 (352)
Q Consensus 181 --~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-------- 250 (352)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLG--------APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred cccccccccccccCCcHHHcC--------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 2234468999999998854 4578899999999999999999999988665443322111000
Q ss_pred ------------CCC-----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 ------------RPS-----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 ------------~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+. ...++.++.++|.+||+.||.+|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 12367889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=327.46 Aligned_cols=242 Identities=26% Similarity=0.378 Sum_probs=198.0
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||+||+|.++ ++.||+|++....... ......+..|..+++.+ +||||+++++++.+ +.+++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ--DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh--ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 36999999999999885 7899999986532111 12234566788888766 79999999999875 4799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc-ccccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 184 (352)
++++|.+++.+... +++..++.++.|++.||+|||++|++||||||+|||++.+ +.++|+|||++.... .......
T Consensus 79 ~~g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 79 NGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcccc
Confidence 99999999986543 8999999999999999999999999999999999999988 799999999987532 2223344
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..... ..........+..++.++.++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~l 226 (320)
T cd05590 156 FCGTPDYIAPEILQE--------MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF-EAILNDEVVYPTWLSQDAVDI 226 (320)
T ss_pred cccCccccCHHHHcC--------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-HHHhcCCCCCCCCCCHHHHHH
Confidence 578999999998854 56788999999999999999999999886654433 333333344456789999999
Q ss_pred HHHhhccCCCCCCCH------HHHHHH
Q 018656 265 LTSCWKEDPNARPNF------TQIIQM 285 (352)
Q Consensus 265 i~~~l~~~p~~Rps~------~~i~~~ 285 (352)
+++||+.||.+||++ +++++|
T Consensus 227 i~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 227 LKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 999999999999998 777776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=329.18 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=207.9
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|.+.+.||+|+||+||+++++ |+.||+|++....... ......+.+|+.+++.++||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA--QETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 47899999999999999999884 8899999987543211 2334568889999999999999999998875 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+++++|.+++.+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+ +.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANK 156 (330)
T ss_pred EECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECCCCC
Confidence 999999999999998753 249999999999999999999999999999999999999988 799999999987543322
Q ss_pred --ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc---CCCCCC
Q 018656 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAE 255 (352)
Q Consensus 181 --~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~ 255 (352)
......|++.|+|||++...... ....++.++|||||||++|+|++|..||...+............ ..+...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGD--GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP 234 (330)
T ss_pred ceeeecccCCccccCHHHhcccccc--ccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCC
Confidence 12334689999999998642211 13567889999999999999999999998766544433332221 123344
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.++.++.+++..||. +|.+||++.++++|.
T Consensus 235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 235 KVSSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 688999999999998 999999999999884
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=327.14 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=201.5
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-CceEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~l 100 (352)
+|.+.+.||+|+||.||+|.+. ++.||+|++....... ......+..|..++..+ .|++|+++++++.+ +.+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ--DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 4788999999999999999885 6799999987543211 12233466677777777 58999999998874 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-c
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-T 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~ 179 (352)
||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++..... .
T Consensus 79 v~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-CcEEEccCCCceecCCCC
Confidence 9999999999999976543 8999999999999999999999999999999999999998 7999999999875322 2
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+......... ......+..++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~ 226 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-EHNVAYPKSMSK 226 (323)
T ss_pred CccccCCCChhhcCHHHhcC--------CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCCCcCCH
Confidence 22344578999999999854 567899999999999999999999998866544433333 333344567899
Q ss_pred HHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNF-----TQIIQM 285 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~-----~~i~~~ 285 (352)
++.+++.+||+.||.+|++. .+++++
T Consensus 227 ~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 227 EAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 99999999999999999984 677665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=326.91 Aligned_cols=242 Identities=28% Similarity=0.355 Sum_probs=194.1
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHH-HHhcCCCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||+||+|.+. |+.+|+|++........ .....+.+|.. +++.++||||+++++.+.. +..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR--KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh--hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 36999999999999884 88999999865322111 22234455554 5678999999999998874 5899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc-ccccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 184 (352)
++++|..++.+.. .+++..++.++.||+.||+|||++|++||||||+|||++.+ +.++|+|||++.... .......
T Consensus 79 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 79 NGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCccc
Confidence 9999999987654 38999999999999999999999999999999999999988 799999999987432 2223344
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+........ ...........+..+.++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 226 (325)
T cd05604 156 FCGTPEYLAPEVIRK--------QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI-LHKPLVLRPGASLTAWSI 226 (325)
T ss_pred ccCChhhCCHHHHcC--------CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH-HcCCccCCCCCCHHHHHH
Confidence 578999999999854 56788999999999999999999999886654433333 233333455788999999
Q ss_pred HHHhhccCCCCCCCHH----HHHHH
Q 018656 265 LTSCWKEDPNARPNFT----QIIQM 285 (352)
Q Consensus 265 i~~~l~~~p~~Rps~~----~i~~~ 285 (352)
+++||..||.+||++. +++++
T Consensus 227 l~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 227 LEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred HHHHhccCHHhcCCCCCCHHHHhcC
Confidence 9999999999999875 56555
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=318.86 Aligned_cols=254 Identities=32% Similarity=0.588 Sum_probs=210.7
Q ss_pred cCCceeeeccccCCCceEEEEEEECC-------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
+-++|++.+.||+|+||.||+|.+.+ ..|++|.+...... .....+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 78 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP----KVQQEFRQEAELMSDLQHPNIVCLLGVCT 78 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH----HHHHHHHHHHHHHHhcCCcccceEEEEEc
Confidence 44678999999999999999998742 56999998754432 23456889999999999999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~ 159 (352)
+ ...+++|||+++++|.+++..... ..+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 4 478999999999999999976422 3478899999999999999999999999999999999999
Q ss_pred CCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 018656 160 EDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEG 235 (352)
Q Consensus 160 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~ 235 (352)
++ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 159 ~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 159 EG-LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--------GKFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred CC-CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc--------CcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 88 789999999987532221 2233456788999998754 567889999999999999998 9999988
Q ss_pred CChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 236 MSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
....+...........+.+..+|.++.+++.+||+.||.+||++.+++++|..
T Consensus 230 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 230 FSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 77655544444444445567899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=314.07 Aligned_cols=251 Identities=33% Similarity=0.620 Sum_probs=212.1
Q ss_pred ceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCce
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVM 98 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 98 (352)
|++.-++|++.+.||+|+||.||++...++.+|+|.+..... ...+.+|+.++++++||||+++++++..+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~-------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT-------AQAFLEETAVMTKLHHKNLVRLLGVILHNGL 73 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch-------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCCc
Confidence 788889999999999999999999998999999999865322 2357889999999999999999999887788
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
+++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGSM 152 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CcEEECCCccceeccc
Confidence 999999999999999987655568999999999999999999999999999999999999988 7999999999875322
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENV 257 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (352)
. ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.......................+
T Consensus 153 ~--~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (254)
T cd05083 153 G--VDNSKLPVKWTAPEALKH--------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGC 222 (254)
T ss_pred c--CCCCCCCceecCHHHhcc--------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcC
Confidence 2 122344678999998754 567889999999999999997 99999886654443333333223335678
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
|..+.+++.+||+.+|.+||+++++++.+.
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=311.85 Aligned_cols=253 Identities=32% Similarity=0.605 Sum_probs=213.5
Q ss_pred ceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCc
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPV 97 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~ 97 (352)
|.++.++|++.+.||.|+||.||+|...|+.||+|.+..... ...++.+|+.+++.++|+||+++++++. +..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP 74 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence 678889999999999999999999999999999999875432 2456889999999999999999999987 557
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||.+....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~ 153 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEAS 153 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEcccccccccc
Confidence 9999999999999999987665569999999999999999999999999999999999999988 789999999987653
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCC
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAEN 256 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 256 (352)
... .....+..|+|||.+.. ..++.++|+||||+++|++++ |..||....................+..
T Consensus 154 ~~~--~~~~~~~~~~ape~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05039 154 QGQ--DSGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEG 223 (256)
T ss_pred ccc--ccCCCcccccCchhhcC--------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccC
Confidence 222 12345678999998754 557789999999999999997 9999987655443333332222333567
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
+|+.+.+++.+||..+|.+||++.++++.|..
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 88999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=313.18 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=210.1
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
+++|.+++.||+|++|.||.|.+ +++.+|+|.+...............+.+|++++++++||||+++++++.+ ...+
T Consensus 1 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 1 PTNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CCcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 36799999999999999999986 48999999987655443333445678899999999999999999999874 4899
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+++||+++++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++++ +.++|+|||++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence 99999999999999987544 8999999999999999999999999999999999999987 79999999998753322
Q ss_pred ccc----ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-CCCCC
Q 018656 180 EMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-VRPSA 254 (352)
Q Consensus 180 ~~~----~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 254 (352)
... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+............ ....+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred ccccccccCCCcCccccCcceecc--------CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCC
Confidence 111 23457889999999864 457889999999999999999999998765544443333322 22345
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..++..+.++|.+||..+|.+|||+.+++++.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 67899999999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=312.40 Aligned_cols=255 Identities=29% Similarity=0.536 Sum_probs=211.6
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
|++++|.+.+.||+|+||+||+|.+. ...||+|++...... .....+.+|+.++++++||||+++++.+.+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD----KQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh----HHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 46788999999999999999999874 347999998765432 234458889999999999999999998864
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+..+++|||+++++|.+++..... .+++..++.++.|++.||+|||++|++|+||||+||+++++ +.++|+|||++.
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~ 154 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSR 154 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhh
Confidence 578999999999999999977543 48999999999999999999999999999999999999988 789999999988
Q ss_pred ccccc-c--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 018656 175 EESLT-E--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 175 ~~~~~-~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
..... . ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 226 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR 226 (266)
T ss_pred cccccccceeccCCCCCccccChhhhcc--------CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC
Confidence 65311 1 1112234678999998754 567889999999999999997 9999987665554444443334
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
.+.+..++..+.+++.+||+.+|.+||++.+++++|..+
T Consensus 227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 455678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=321.85 Aligned_cols=258 Identities=23% Similarity=0.486 Sum_probs=211.6
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--Cc----eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
+...+|++.+.||+|+||.||+|.+. |+ .||+|++...... ....++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP----KANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 55678999999999999999999863 33 4899998653332 23446889999999999999999999998
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
....++++||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++.
T Consensus 80 ~~~~~~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~ 157 (316)
T cd05108 80 TSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAK 157 (316)
T ss_pred CCCceeeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEccccccc
Confidence 8888999999999999999987543 48899999999999999999999999999999999999988 789999999998
Q ss_pred ccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 018656 175 EESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 175 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
....... .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+....+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~ 229 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 229 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhcc--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCC
Confidence 5433221 112234678999998854 567889999999999999997 9999988665443333333334
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.+.+..++.++.+++.+||..||.+||++.+++..+......
T Consensus 230 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 230 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 455667889999999999999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=339.47 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=208.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC---CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCce
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVM 98 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~ 98 (352)
...|.+.+.||+|+||.||+|.+. ++.||+|.+..... .....+.+|+.+++.++||||+++++++. ++..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-----~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-----RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-----HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 345999999999999999999763 57788887644321 22345778999999999999999999987 4589
Q ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 99 VIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
++||||++|++|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~ 219 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC-CcEEEEeCcCceec
Confidence 9999999999999988653 23358999999999999999999999999999999999999988 79999999999754
Q ss_pred cccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 018656 177 SLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253 (352)
Q Consensus 177 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (352)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..............+.
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 291 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWER--------KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291 (478)
T ss_pred CCccccccccccCCCccccCHhHhCC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 3221 2334569999999998854 5688999999999999999999999988766555555554555556
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+..++.++.++|.+||..||.+||++.+++.+
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 67889999999999999999999999999865
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.30 Aligned_cols=256 Identities=29% Similarity=0.553 Sum_probs=209.6
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
|.+..++|++.+.||+|+||.||+|.+. +..||+|++...... .....+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~e~~~l~~l~~~~iv~~~~ 76 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM----RERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 7889999999999999999999999764 357999987643322 22345889999999999999999999
Q ss_pred eeec-CceEEEEEcCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC
Q 018656 92 ACKE-PVMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 162 (352)
Q Consensus 92 ~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~ 162 (352)
++.+ ...++||||+++++|.+++.+... ..++...++.++.|+++||+|||+.|++|+||||+||+++++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~- 155 (277)
T cd05062 77 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED- 155 (277)
T ss_pred EEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-
Confidence 9874 478999999999999999976432 235778899999999999999999999999999999999988
Q ss_pred CceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCCh
Q 018656 163 KTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 238 (352)
Q Consensus 163 ~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~ 238 (352)
+.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+...
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc--------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 7999999999874322211 112345778999998854 567889999999999999998 7899988666
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 239 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.............+.+..++..+.+++.+||+.||.+|||+.++++.++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 228 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 5444444444444556778999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=317.25 Aligned_cols=264 Identities=33% Similarity=0.587 Sum_probs=216.5
Q ss_pred cccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCC
Q 018656 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRN 85 (352)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~ 85 (352)
.++..|.++.++|++.+.||+|+||.||++.+. ...+|+|.+...... .....+.+|+.+++++ +|+|
T Consensus 2 ~~~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~ 77 (293)
T cd05053 2 PLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE----KDLSDLVSEMEMMKMIGKHKN 77 (293)
T ss_pred CCCcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH----HHHHHHHHHHHHHHhhcCCCC
Confidence 357889999999999999999999999999864 257999998764332 2234588999999999 8999
Q ss_pred eeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 018656 86 LVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRD 150 (352)
Q Consensus 86 iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~D 150 (352)
|+++++++.. +..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||++|++|||
T Consensus 78 i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~d 157 (293)
T cd05053 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD 157 (293)
T ss_pred eeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 9999999874 47999999999999999997532 24589999999999999999999999999999
Q ss_pred CCCCCeEEeCCCCceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHH
Q 018656 151 LKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 227 (352)
Q Consensus 151 ikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll 227 (352)
|||+||+++.+ +.++|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|+|+
T Consensus 158 lkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~ 228 (293)
T cd05053 158 LAARNVLVTED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLLWEIF 228 (293)
T ss_pred cceeeEEEcCC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc--------CCcCcccceeehhhHHHHHh
Confidence 99999999988 7999999999875433211 112234578999998744 56788999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 228 H-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 228 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
+ |..||.+....+.............+..++..+.+++.+||..||.+|||+.++++.|.+.+
T Consensus 229 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 229 TLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 7 99999886654444333333333445678899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=310.82 Aligned_cols=255 Identities=31% Similarity=0.528 Sum_probs=213.9
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCc
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 97 (352)
|.+..++|++.+.||+|+||.||++.+. +..+++|.+..... ....+.+|++++++++|+||+++++.+.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------SVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 74 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh------HHHHHHHHHHHHHhcCCCCcceEEEEEcCCC
Confidence 8899999999999999999999999874 67799998764321 2346888999999999999999999988888
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.+++|||+++++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~ 153 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIE 153 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeecc
Confidence 9999999999999999987655568889999999999999999999999999999999999988 799999999987543
Q ss_pred cccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 178 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 178 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
.... .....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+.+..............+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 225 (260)
T ss_pred CCCcccccCCcccccccCHhHhcc--------CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCc
Confidence 2211 112235677999998854 557889999999999999998 99999886655444444333344456
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
...+.++.+++.+||..+|.+||++.++.+.|.+
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 6788999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.62 Aligned_cols=268 Identities=32% Similarity=0.575 Sum_probs=217.4
Q ss_pred cccccccceecCCceeeeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-
Q 018656 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV- 81 (352)
Q Consensus 12 ~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 81 (352)
++...+.|.+..++|.+++.||+|+||.||++.+. +..+|+|.+....... ....+.+|+.+++.+
T Consensus 6 ~~~~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~e~~~l~~l~ 81 (307)
T cd05098 6 ELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK----DLSDLISEMEMMKMIG 81 (307)
T ss_pred cCCCCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH----HHHHHHHHHHHHHHhc
Confidence 34557789999999999999999999999999763 2469999987643322 234578899999999
Q ss_pred CCCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 018656 82 QHRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGI 146 (352)
Q Consensus 82 ~hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~i 146 (352)
+||||+++++++.+ +..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|+
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi 161 (307)
T cd05098 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC 161 (307)
T ss_pred CCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 79999999999874 578999999999999999986532 247889999999999999999999999
Q ss_pred ccCCCCCCCeEEeCCCCceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHH
Q 018656 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVL 223 (352)
Q Consensus 147 vH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 223 (352)
+||||||+||+++.+ +.++|+|||++........ .....++..|+|||++.+ ..++.++|+||||+++
T Consensus 162 ~H~dlkp~Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l 232 (307)
T cd05098 162 IHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLL 232 (307)
T ss_pred ccccccHHheEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhcc--------CCCCcHHHHHHHHHHH
Confidence 999999999999988 7999999999875432211 111234568999998854 5678899999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 224 WELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 224 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
|+|++ |..||.+....+.............+..++.++.+++.+||..+|.+||++.++++.|..++..
T Consensus 233 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 233 WEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 99998 8899987554333333333333344667889999999999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=310.92 Aligned_cols=245 Identities=25% Similarity=0.493 Sum_probs=203.0
Q ss_pred cccCCCceEEEEEEE----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCceEEEEEcCC
Q 018656 31 RIGEGAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLS 106 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~lv~e~~~ 106 (352)
.||+|+||.||+|.+ ++..+|+|++....... .....+.+|+.+++.++||||+++++++.+...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP---ALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH---HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCC
Confidence 589999999999965 36889999987554322 23456889999999999999999999988778899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc----c
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM----M 182 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~----~ 182 (352)
+++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++........ .
T Consensus 79 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeec
Confidence 999999997644 38999999999999999999999999999999999999988 7899999999875432221 1
Q ss_pred ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHH
Q 018656 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 261 (352)
Q Consensus 183 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (352)
....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+................+.+..+++++
T Consensus 156 ~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 227 (257)
T cd05116 156 THGKWPVKWYAPECMNY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEM 227 (257)
T ss_pred CCCCCCccccCHhHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 12234578999998743 557789999999999999997 999998766554444444333345567799999
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 262 SIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 262 ~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
.++|.+||+.||.+||++.+|...|.++
T Consensus 228 ~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 228 YDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=329.56 Aligned_cols=246 Identities=27% Similarity=0.315 Sum_probs=208.2
Q ss_pred ceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC------CCCeeeeeeeee-c
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ------HRNLVKFIGACK-E 95 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~l~~~~~-~ 95 (352)
+|.+.+.||+|+||.|.+|.+ +++.||||+++.... ...+...|+.+|..|+ --|+|+++++|. .
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR------FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH------HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 889999999999999999988 489999999987553 3334567888888886 358999999987 5
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC-CCceEEecCCCcc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAR 174 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~-~~~vkl~Dfg~a~ 174 (352)
++++||+|.+ +.+|+++++.+....++...++.++.||+.||..||+.||||+||||+|||+.+. ...|||+|||.+.
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 6899999999 6799999999998899999999999999999999999999999999999999543 4589999999998
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
....... +.+.+..|+|||++.+ ..|+.+.||||||||++||++|.+-|.|.+..++...+......|..
T Consensus 340 ~~~q~vy--tYiQSRfYRAPEVILG--------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 340 FESQRVY--TYIQSRFYRAPEVILG--------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred ccCCcce--eeeeccccccchhhcc--------CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 7544332 6788999999999987 67899999999999999999999999998887776655544332220
Q ss_pred --------------------------------------------------C------------CCcHHHHHHHHHhhccC
Q 018656 255 --------------------------------------------------E------------NVPEELSIILTSCWKED 272 (352)
Q Consensus 255 --------------------------------------------------~------------~~~~~l~~li~~~l~~~ 272 (352)
+ .-...+.+||++||..|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 0 01144789999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 018656 273 PNARPNFTQIIQMLL 287 (352)
Q Consensus 273 p~~Rps~~~i~~~l~ 287 (352)
|.+|+|..++++|.+
T Consensus 490 P~~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 490 PAERITPAQALNHPF 504 (586)
T ss_pred chhcCCHHHHhcCcc
Confidence 999999999999954
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=310.76 Aligned_cols=255 Identities=31% Similarity=0.548 Sum_probs=214.9
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-C
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 96 (352)
|.++.++|++.+.||+|+||.||+|.+. +..+|||.+...... ...+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS------PEAFLQEAQIMKKLRHDKLVQLYAVCSEEE 74 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC------HHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence 7889999999999999999999999875 578999998754332 2347889999999999999999999875 5
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..+++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++++ +.++|+|||++...
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~ 153 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLI 153 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceec
Confidence 89999999999999999987665568999999999999999999999999999999999999998 89999999998754
Q ss_pred ccccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCC
Q 018656 177 SLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPS 253 (352)
Q Consensus 177 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (352)
..... .....++..|+|||.+.+ ..++.++|+||||+++|++++ |+.||.+................+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANY--------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR 225 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 32211 112234568999998754 567889999999999999998 9999988766555544444444455
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
+...|.++.+++.+||..+|.+||+++++.+.++.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 66789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.08 Aligned_cols=254 Identities=28% Similarity=0.491 Sum_probs=202.1
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC------------------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK------------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ 82 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 82 (352)
+...+|++.+.||+|+||.||+|.+. +..||+|++...... .....+.+|++++++++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~ 77 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK----NARNDFLKEVKILSRLK 77 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH----HHHHHHHHHHHHHhhcC
Confidence 34678999999999999999999752 346999998765432 23456889999999999
Q ss_pred CCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 018656 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP-----------------RCLDVCVAIGFALDIARAMECLHSH 144 (352)
Q Consensus 83 hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-----------------~~~~~~~~~~i~~qi~~~L~~lH~~ 144 (352)
||||+++++++.+ +..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+.
T Consensus 78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 9999999999874 578999999999999999865421 2367788999999999999999999
Q ss_pred CCccCCCCCCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHH
Q 018656 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAI 221 (352)
Q Consensus 145 ~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~ 221 (352)
|++||||||+||+++.+ +.+||+|||++....... ......++..|+|||++.. ..++.++||||||+
T Consensus 158 ~ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~ 228 (304)
T cd05096 158 NFVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--------GKFTTASDVWAFGV 228 (304)
T ss_pred CccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--------CCCCchhhhHHHHH
Confidence 99999999999999988 799999999987533221 1223345788999998754 56788999999999
Q ss_pred HHHHHHh--CCCCCCCCChHHHHHHHHhc-------cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 222 VLWELLH--NKLPFEGMSNLQAAYAAAFK-------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 222 il~~ll~--g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
++|+|++ +..||...+........... .....+..+|..+.+++.+||+.||.+|||+.++.+.|.
T Consensus 229 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 9999986 66788775544332221110 111224568899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=309.93 Aligned_cols=250 Identities=28% Similarity=0.549 Sum_probs=206.4
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
++++.|++.+.||+|+||.||++.++ +..+|+|.+...... ...+.+|++++++++||||+++++++.+ ...
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc------HHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 46778999999999999999999886 568999987644322 2347889999999999999999999874 478
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
+++|||+++++|.+++..... .+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCC
Confidence 999999999999999976433 48999999999999999999999999999999999999987 7899999999875432
Q ss_pred cccc--ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 179 TEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 179 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
.... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||...+..+.............+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 224 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNF--------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224 (256)
T ss_pred CceeccCCCCCchhhCChhhccc--------CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence 2211 12234568999998854 457889999999999999999 999998876655544444433344456
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..+..+.+++.+||+.+|.+||++.++++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 6788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=329.59 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=196.3
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~ 97 (352)
+...+|.+.+.||+|+||.||+|.+. ++.||+|.... ..+.+|++++++++||||+++++++. ...
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 44578999999999999999999984 88999997432 23678999999999999999999987 457
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++++|++ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++....
T Consensus 158 ~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 158 TCLILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPV 233 (391)
T ss_pred eEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-CCEEEEeCCcccccc
Confidence 89999999 568999887654 38999999999999999999999999999999999999988 799999999986432
Q ss_pred c--ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH-------HHHHHHH--
Q 018656 178 L--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-------QAAYAAA-- 246 (352)
Q Consensus 178 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-------~~~~~~~-- 246 (352)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .......
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLAR--------DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred cccccccccccCccCCCChhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 2 122234579999999999854 56789999999999999999999876432210 0000000
Q ss_pred -----------------------hc--cCCCC-------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 247 -----------------------FK--NVRPS-------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 247 -----------------------~~--~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
.. ...+. ...++.++.++|.+||+.||.+|||+.+++++ .|+...
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h--p~f~~~ 382 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF--AAFQDI 382 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC--hhhccC
Confidence 00 00000 11356789999999999999999999999998 455543
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=314.17 Aligned_cols=256 Identities=30% Similarity=0.535 Sum_probs=211.3
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
|.++.++|++.+.||+|+||.||+|.++ +..||+|.+....... ....+.+|+.+++.++||||+++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR----ERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH----HHHHHHHHHHHHHhCCCCceeEEEE
Confidence 7889999999999999999999999874 2679999986543322 2345788999999999999999999
Q ss_pred eeec-CceEEEEEcCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC
Q 018656 92 ACKE-PVMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 162 (352)
Q Consensus 92 ~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~ 162 (352)
++.. ...++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++|+||||+||+++.+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~- 155 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED- 155 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-
Confidence 9874 479999999999999999975432 236888999999999999999999999999999999999998
Q ss_pred CceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCCh
Q 018656 163 KTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 238 (352)
Q Consensus 163 ~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~ 238 (352)
+.++|+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|++++ |..||.+.+.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc--------CCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 799999999987533222 1223346788999998753 557889999999999999998 9999987665
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 239 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.............+.+..++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 228 EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 5544444433344456678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.72 Aligned_cols=250 Identities=26% Similarity=0.337 Sum_probs=200.0
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC--
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-- 96 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-- 96 (352)
...++|++.+.||+|+||.||++.+. |+.||+|++....... ....++.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ---THAKRAYRELVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch---hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence 34578999999999999999999874 8899999987543322 2234577899999999999999999987532
Q ss_pred -----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 97 -----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 97 -----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++|+|||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg 168 (359)
T cd07876 95 LEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFG 168 (359)
T ss_pred ccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCC
Confidence 47999999965 67776643 28899999999999999999999999999999999999988 799999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV- 250 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~- 250 (352)
++.............|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.............
T Consensus 169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 240 (359)
T cd07876 169 LARTACTNFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240 (359)
T ss_pred CccccccCccCCCCcccCCCCCchhccC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9976444444445678999999999854 5678899999999999999999999987654332211111000
Q ss_pred -------------------CC---------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 251 -------------------RP---------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 251 -------------------~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+ .....++++.++|.+||..||.+|||+.++++|.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00 01124578999999999999999999999999844
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=310.77 Aligned_cols=250 Identities=29% Similarity=0.539 Sum_probs=206.7
Q ss_pred ecCCceeeeccccCCCceEEEEEEECC-ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
|++++|++.+.||+|+||+||.|.+.+ ..+|+|.+...... ...+.+|+.++++++||||+++++++.+ ...
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 467889999999999999999998864 46999988654332 2347899999999999999999999874 468
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
+++|||+.+++|.+++..... .+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||.+.....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecCC
Confidence 999999999999999976543 48999999999999999999999999999999999999988 7999999999874332
Q ss_pred cccc--ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 179 TEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 179 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
.... ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||..................+.+.
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLY--------SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH 224 (256)
T ss_pred CceeecCCCccChhhCCHHHHhc--------CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCC
Confidence 2211 12235678999998854 457889999999999999998 999998766554444444443444456
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..+..+.+++.+||..||.+||++.++++.+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 6789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=319.32 Aligned_cols=267 Identities=32% Similarity=0.568 Sum_probs=216.8
Q ss_pred ccccceecCCceeeeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCC
Q 018656 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHR 84 (352)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 84 (352)
.+.+|.+...+|++++.||+|+||.||+|++. +..||+|++...... .....+.+|+++++++ +||
T Consensus 3 ~~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~~h~ 78 (334)
T cd05100 3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD----KDLSDLVSEMEMMKMIGKHK 78 (334)
T ss_pred CCcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH----HHHHHHHHHHHHHHhhcCCC
Confidence 45789999999999999999999999999752 236899987753322 2345688999999999 899
Q ss_pred Ceeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 018656 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHR 149 (352)
Q Consensus 85 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~ 149 (352)
||+++++++.+ +..++++||+++++|.+++.+.. ...++...++.++.|++.||.|||++|++||
T Consensus 79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~ 158 (334)
T cd05100 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHR 158 (334)
T ss_pred CeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 99999999874 47899999999999999997643 1247788899999999999999999999999
Q ss_pred CCCCCCeEEeCCCCceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHH
Q 018656 150 DLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226 (352)
Q Consensus 150 Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~l 226 (352)
||||+||+++.+ +.++|+|||+++....... .....++..|+|||++.. ..++.++||||||+++|+|
T Consensus 159 dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 229 (334)
T cd05100 159 DLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLLWEI 229 (334)
T ss_pred ccccceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhcc--------CCcCchhhhHHHHHHHHHH
Confidence 999999999988 7999999999875432211 112234567999998854 5678899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 227 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 227 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
++ |..||.+.+..............+.+..++.++.+++.+||..+|.+||++.++++.|........
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 230 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 98 889998866544444333333344566788999999999999999999999999999988875433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=347.39 Aligned_cols=262 Identities=22% Similarity=0.385 Sum_probs=212.5
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--- 95 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--- 95 (352)
....+|.+.+.||+|+||+||+|.+. ++.+|+|++....... .....+.+|+.++++|+||||+++++++.+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e---~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE---REKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH---HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34468999999999999999999985 7889999987654333 234568899999999999999999998753
Q ss_pred CceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CCccCCCCCCCeEEeCC-----
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSH-------GIIHRDLKPENLLLTED----- 161 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-------~ivH~Dikp~Nili~~~----- 161 (352)
..+|+||||+++++|.++|.... ...+++..++.|+.||+.||.|||+. +|+||||||+||||+.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 36899999999999999997632 23599999999999999999999995 49999999999999642
Q ss_pred -----------CCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCC
Q 018656 162 -----------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 230 (352)
Q Consensus 162 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~ 230 (352)
.+.+||+|||++.............||+.|+|||++.+ ....++.++|||||||++|+|++|.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g------e~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH------ETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc------cCCCCCchhHHHHHHHHHHHHHHCC
Confidence 13489999999986544444455679999999998854 2245788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 231 LPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
.||........................+.++.+||..||..+|.+||++.+++.+ .++...
T Consensus 241 ~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h--~~ik~i 301 (1021)
T PTZ00266 241 TPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY--QIIKNV 301 (1021)
T ss_pred CCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc--HHHhhc
Confidence 9998766655554444433333345678999999999999999999999999987 444433
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=325.98 Aligned_cols=243 Identities=26% Similarity=0.370 Sum_probs=194.1
Q ss_pred ccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC---CCCCeeeeeeeeec-CceEEEEEcC
Q 018656 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 32 lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
||+|+||+||+|+++ |+.||+|++....... .........|..++..+ +||||+++++++.+ ...++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA--KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh--hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 799999999999885 8999999986432211 12233445566666655 69999999999875 4799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-cccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~~~~~~ 184 (352)
++++|.+++.+.. .+++..++.++.||++||+|||++||+||||||+|||++.+ +.++|+|||++..... ......
T Consensus 79 ~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 79 SGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCccC
Confidence 9999999987644 38999999999999999999999999999999999999988 7999999999875322 223345
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..||..|+|||++.+ ...++.++|||||||++|+|++|..||.+.+...................++.++.++
T Consensus 156 ~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 228 (330)
T cd05586 156 FCGTTEYLAPEVLLD-------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQF 228 (330)
T ss_pred ccCCccccCHHHHcC-------CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 579999999998853 2347889999999999999999999998865544333333333333334688999999
Q ss_pred HHHhhccCCCCCC----CHHHHHHHH
Q 018656 265 LTSCWKEDPNARP----NFTQIIQML 286 (352)
Q Consensus 265 i~~~l~~~p~~Rp----s~~~i~~~l 286 (352)
+++||..||.+|| ++.++++|.
T Consensus 229 i~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 229 VKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred HHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 9999999999998 688888874
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=302.57 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=219.2
Q ss_pred CceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCC---hHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeecC-
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGET---PEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP- 96 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~- 96 (352)
..|.-.+.||.|..++|-++.+ +|..+|+|++..... .++.......-.+|+.+|+++ .||+|+.+.++++.+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4566678899999999998865 488889998865432 222334445567899999999 799999999999865
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.+++|+|.|+.|.|.||+...-. +++....+|+.|+++|++|||.++|+||||||+|||++++ -+++|+|||++...
T Consensus 97 F~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn-~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN-MNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc-cceEEeccceeecc
Confidence 68999999999999999987554 9999999999999999999999999999999999999998 58999999999998
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh---ccCCCC
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF---KNVRPS 253 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~~ 253 (352)
..+......+||++|+|||.+.... ..+...|+...|+||+|+++|.|+.|.+||.......-...+.. ....|.
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m--~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSM--YENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeec--ccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 8888888899999999999886632 23457789999999999999999999999987554433333333 344577
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+.+++++.+++|.+||+.||.+|.|+++++.|.+
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 8899999999999999999999999999999954
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.33 Aligned_cols=256 Identities=32% Similarity=0.577 Sum_probs=213.2
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-C
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 96 (352)
|.....+|++.+.||.|+||.||+|.+. ++.+++|++..... .....+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-----LKQQDFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-----hhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 3445567999999999999999999886 68899999875433 123357889999999999999999999874 4
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..+++|||+++++|.+++.+.....+++..++.++.|++.||.|||++|++|+||+|+||+++++ +.++|+|||.+...
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~ 154 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLI 154 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhc
Confidence 78999999999999999987665668999999999999999999999999999999999999998 79999999998754
Q ss_pred cccc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 177 SLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 177 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
.... ......++..|+|||.+.. ..++.++||||||+++|+|++ |+.||..................+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 226 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASH--------GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP 226 (261)
T ss_pred CCccccccCCCCceEecCHHHHcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCC
Confidence 3221 1123345678999998743 567889999999999999998 89999886655444444444344556
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
..+++++.+++.+||+.||.+|||+.++++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 7889999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=313.62 Aligned_cols=258 Identities=29% Similarity=0.525 Sum_probs=212.5
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
|.+.+|.+.+.||+|+||.||++.+. +..+|+|.+..... .....+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-----NARKDFHREAELLTNLQHEHIVKFYGVC 76 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 56789999999999999999999752 35688998765332 2344688999999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRP-----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~ 161 (352)
.. +..+++|||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 77 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 74 579999999999999999975431 248999999999999999999999999999999999999988
Q ss_pred CCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCC
Q 018656 162 LKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMS 237 (352)
Q Consensus 162 ~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~ 237 (352)
+.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||....
T Consensus 157 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 157 -LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred -CcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 799999999987542221 1122345778999998854 567889999999999999998 999998766
Q ss_pred hHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 238 NLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
..............+.+..++.++.+++.+||+.||.+|||+.++.+.|.++...
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 228 NNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 5554444444444445567889999999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=316.78 Aligned_cols=267 Identities=31% Similarity=0.579 Sum_probs=216.8
Q ss_pred cccccceecCCceeeeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CC
Q 018656 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QH 83 (352)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 83 (352)
..+..|.+...+|.+++.||+|+||.||++.+. +..+|+|++...... .....+.+|+++++++ +|
T Consensus 2 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~~h 77 (314)
T cd05099 2 PLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD----KDLADLISEMELMKLIGKH 77 (314)
T ss_pred CCcccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh----HHHHHHHHHHHHHHhccCC
Confidence 457789999999999999999999999999752 346999998754432 2244578899999999 69
Q ss_pred CCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 018656 84 RNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIH 148 (352)
Q Consensus 84 p~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH 148 (352)
|||+++++++.+ +..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|
T Consensus 78 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H 157 (314)
T cd05099 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIH 157 (314)
T ss_pred CCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 999999999874 478999999999999999976431 34888999999999999999999999999
Q ss_pred CCCCCCCeEEeCCCCceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHH
Q 018656 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 225 (352)
Q Consensus 149 ~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ 225 (352)
|||||+||+++.+ +.++|+|||+++....... .....++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 158 ~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~e 228 (314)
T cd05099 158 RDLAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGILMWE 228 (314)
T ss_pred ccccceeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHcc--------CCcCccchhhHHHHHHHH
Confidence 9999999999988 7999999999975432111 112234467999998754 567889999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 226 LLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 226 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
|++ |..||.+..................+..++.++.+++.+||..||.+||++.++++.+.......
T Consensus 229 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 229 IFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 998 89999876654433333333233445678899999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=312.18 Aligned_cols=257 Identities=23% Similarity=0.440 Sum_probs=207.3
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--Cc----eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
+..++|++.+.||+|+||+||+|.+. |+ .+++|.+...... .....+..|+..+++++||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR----QTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch----HHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 45568899999999999999999873 44 4777776543221 22345778888999999999999999988
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+...++++||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++++ +.+||+|||+++
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~ 157 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVAD 157 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccce
Confidence 778899999999999999997643 348999999999999999999999999999999999999988 799999999987
Q ss_pred cccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 018656 175 EESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 175 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
...... ......++..|+|||.+.+ ..++.++||||||+++|++++ |..||.+...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 229 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILF--------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER 229 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhcc--------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc
Confidence 532221 1223346778999998854 567899999999999999998 9999987654433222222233
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
.+.+..++.++..++.+||..||.+|||+.++++.+....+
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 34456678899999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=312.94 Aligned_cols=254 Identities=29% Similarity=0.545 Sum_probs=208.7
Q ss_pred CCceeeeccccCCCceEEEEEEE------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
-..|++.+.||+|+||+||+|.+ .+..+++|.+...... .....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP----QQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH----HHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 46788999999999999999975 2578999998754432 223468899999999999999999999874
Q ss_pred CceEEEEEcCCCCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMR---------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~ 160 (352)
...+++|||+++++|.+++.... ...+++..++.++.|++.||+|||++|++|+||||+||++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 47899999999999999986432 124788899999999999999999999999999999999998
Q ss_pred CCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 018656 161 DLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM 236 (352)
Q Consensus 161 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~ 236 (352)
+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.
T Consensus 160 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 160 Q-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred C-CcEEeccccccccccCCcceecccCCCccceecChHHhcc--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 8 789999999987532221 1233345678999998854 557889999999999999998 99999876
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 237 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
...............+.+..++..+.+++.+||+.||.+||++.++++++..|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 231 SNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 65444444444444556778899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=329.13 Aligned_cols=251 Identities=31% Similarity=0.603 Sum_probs=218.1
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
++-|.|.=+.+.-.+-||+|+-|.||+|+..++.||||.++.- -..+|+-|++|+||||+.+.++|..
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el------------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL------------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh------------hhhhHHHHHhccCcceeeEeeeecC
Confidence 4458888888888888999999999999999999999987531 2247889999999999999999974
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
++++||||||..|.|...++.... +.......|..+|+.|+.|||.+.|||||||.-||||+-+ ..|||+|||.++
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGTSK 260 (904)
T ss_pred CceeEEeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccchH
Confidence 689999999999999999987544 9999999999999999999999999999999999999988 699999999998
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-CCCC
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-VRPS 253 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~ 253 (352)
........-++.||..|||||++.. ...+++.||||+|++|||||||..||...+.....+...... ..|.
T Consensus 261 e~~~~STkMSFaGTVaWMAPEvIrn--------ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv 332 (904)
T KOG4721|consen 261 ELSDKSTKMSFAGTVAWMAPEVIRN--------EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV 332 (904)
T ss_pred hhhhhhhhhhhhhhHhhhCHHHhhc--------CCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC
Confidence 7655555567899999999999965 778999999999999999999999998765443333332222 3467
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
+..+|+.++-|+++||+-.|..||++.+++.|+.-+
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 889999999999999999999999999999998644
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.56 Aligned_cols=249 Identities=26% Similarity=0.325 Sum_probs=201.2
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--- 95 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--- 95 (352)
...++|++.+.||+|+||.||+|.+. ++.||||++....... .....+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc---hhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence 34678999999999999999999884 7899999987643322 223457789999999999999999998742
Q ss_pred ----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 96 ----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 96 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
...++||||++ ++|.+++.. .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.++|+|||
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG 171 (364)
T cd07875 98 LEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFG 171 (364)
T ss_pred ccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCC
Confidence 24799999995 578887753 28889999999999999999999999999999999999988 799999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
++.............++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..............
T Consensus 172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 172 LARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred CccccCCCCcccCCcccCCcCCHHHHhC--------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9986554444455678999999999854 56788999999999999999999999886654433222211110
Q ss_pred --------------------CC---------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 252 --------------------PS---------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 252 --------------------~~---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+. ....+.++.++|.+||+.||.+|||+.++++|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00 111346789999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=322.17 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=202.4
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||+||++++. ++.||+|++....... ......+.+|+.+++.++|+||+++++++.+ +..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK--RAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 47899999999999999999875 7899999986422111 1234557889999999999999999999874 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||++|++|.+++.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecCCCC
Confidence 999999999999997643 348999999999999999999999999999999999999988 799999999986543322
Q ss_pred c--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc----CCCCC
Q 018656 181 M--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN----VRPSA 254 (352)
Q Consensus 181 ~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~----~~~~~ 254 (352)
. .....|++.|+|||++.... .....++.++|||||||++|+|++|+.||.+.+..+......... ..+..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 233 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233 (331)
T ss_pred CccccceeccccccCHHHHhhcc---ccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCcc
Confidence 2 12246899999999985311 012456789999999999999999999998866544433332211 12223
Q ss_pred CCCcHHHHHHHHHhhccCCC--CCCCHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPN--ARPNFTQIIQML 286 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~--~Rps~~~i~~~l 286 (352)
..++.++.++|++||..++. .|+++.++++|.
T Consensus 234 ~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 45899999999998865444 378999999994
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=309.56 Aligned_cols=258 Identities=30% Similarity=0.545 Sum_probs=214.2
Q ss_pred eecCCceeeeccccCCCceEEEEEEECC-----ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
.+...+|.+.+.||+|+||.||+|.+.+ ..++||........ .....+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP----SVREKFLQEAYIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH----HHHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence 4677889999999999999999998642 36899988665432 23446889999999999999999999998
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+...++||||+++++|.+++.+... .+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~ 155 (270)
T cd05056 78 ENPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSR 155 (270)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceee
Confidence 8888999999999999999976443 48999999999999999999999999999999999999987 799999999987
Q ss_pred cccccccc--ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCC
Q 018656 175 EESLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 175 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
........ ....++..|+|||.+.. ..++.++||||||+++|++++ |..||.+................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL 227 (270)
T ss_pred ecccccceecCCCCccccccChhhhcc--------CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC
Confidence 54332211 12234568999998753 557889999999999999986 99999887765555444444444
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
+.+..+|..+.+++.+|+..+|.+|||+.++++.|.+...
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 5567889999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=316.38 Aligned_cols=248 Identities=29% Similarity=0.376 Sum_probs=197.1
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC---CCCCeeeeeeeeec----
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE---- 95 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~---- 95 (352)
+|++.+.||+|+||+||+|+++ |+.||+|.+......... ...+.+|+.+++++ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL---PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC---chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 5889999999999999999884 789999998754322211 11244566666554 79999999998753
Q ss_pred --CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 96 --~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
...+++|||++ ++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++++ +.++|+|||++
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~ 155 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLA 155 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCcc
Confidence 24799999996 489999887655569999999999999999999999999999999999999988 79999999998
Q ss_pred cccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--
Q 018656 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-- 251 (352)
Q Consensus 174 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-- 251 (352)
.............++..|+|||++.+ ..++.++|||||||++|+|++|..||.+................
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227 (288)
T ss_pred ccccCcccCCCccccccccCchHhhC--------CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC
Confidence 76544433345578999999998854 56788999999999999999999999876554433322211000
Q ss_pred ------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 ------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.....++..+.++|.+||+.||.+|||+.+++.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0013567889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=318.68 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=203.0
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
-++|.+.+.||+|+||.||+|++. ++.||+|++........ ...+.+|+.++++++||||+++++++. ++..+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 467999999999999999999874 78899999875433221 224678999999999999999999987 45799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||+++ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSVP 157 (309)
T ss_pred EEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecCCC
Confidence 99999965 8998887643 348899999999999999999999999999999999999988 79999999998753322
Q ss_pred -cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-------
Q 018656 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------- 251 (352)
Q Consensus 180 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~------- 251 (352)
.......++..|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.+..+...........
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLG-------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred ccccccccccccccCCHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 22233467899999998754 245788999999999999999999999876544332222111000
Q ss_pred -------------C---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 252 -------------P---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 252 -------------~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
+ ....++.++.++|.+||..||.+|||+.+++++ .|+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h--~~~~~~ 292 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH--AYFRSL 292 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC--hhhhhc
Confidence 0 113578899999999999999999999999998 444443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=314.70 Aligned_cols=243 Identities=26% Similarity=0.375 Sum_probs=194.4
Q ss_pred ccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCCC
Q 018656 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGG 108 (352)
Q Consensus 32 lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 108 (352)
||+|+||.||++.+. |+.||+|++........ .....+..|++++++++||||+++++++.. ...++||||++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~--~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK--SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc--hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 799999999999874 89999999864322111 122345679999999999999999999874 4789999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCCCc
Q 018656 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188 (352)
Q Consensus 109 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~ 188 (352)
+|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++.............|+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCCC
Confidence 99999876665568999999999999999999999999999999999999988 78999999998765443333445789
Q ss_pred ccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHh-ccCCCCCCCCcHHHHHH
Q 018656 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA---AYAAAF-KNVRPSAENVPEELSII 264 (352)
Q Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~l~~l 264 (352)
..|+|||++.+ ..++.++|||||||++|+|++|..||........ ...... .........++.++.++
T Consensus 158 ~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (277)
T cd05607 158 NGYMAPEILKE--------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDI 229 (277)
T ss_pred CCccCHHHHcc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHH
Confidence 99999999854 4588999999999999999999999976433211 111111 11122234689999999
Q ss_pred HHHhhccCCCCCCCHHHHHHH
Q 018656 265 LTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 265 i~~~l~~~p~~Rps~~~i~~~ 285 (352)
+.+||+.||.+||++.++++.
T Consensus 230 i~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 230 CRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHhccCHhhCCCCccchhh
Confidence 999999999999999655543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=311.17 Aligned_cols=258 Identities=24% Similarity=0.491 Sum_probs=210.8
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--Cc----eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
++...+|++.+.||+|+||+||+|.+. |+ .||+|++...... .....+.+|+.+++.++||||+++++++
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP----KANKEILDEAYVMAGVGSPYVCRLLGIC 78 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH----HHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 456788999999999999999999863 44 4899998754432 2244588899999999999999999999
Q ss_pred ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 94 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
.....++++||+++|+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++++ +.++|+|||++
T Consensus 79 ~~~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~~kL~dfG~~ 156 (279)
T cd05109 79 LTSTVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NHVKITDFGLA 156 (279)
T ss_pred cCCCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCCCce
Confidence 8888899999999999999997643 348999999999999999999999999999999999999887 78999999998
Q ss_pred cccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc
Q 018656 174 REESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 174 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 249 (352)
+....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 228 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILH--------RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence 75432221 112234678999998754 567889999999999999998 999998765544333333333
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
..+.+..++.++.+++.+||..||.+||++.++++.+.....
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 445566789999999999999999999999999988766543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=319.63 Aligned_cols=243 Identities=26% Similarity=0.397 Sum_probs=198.6
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||.||+|.+. ++.||+|++....... ......+.+|+.++.++ +||||+++++++.+ +.+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD--DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 36999999999999874 7899999997643222 13345678899998888 69999999999874 5789999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc-ccccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 184 (352)
+|++|.+++.... .+++..++.++.||+.||+|||++|++||||||+|||++.+ +.++|+|||++.... .......
T Consensus 79 ~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 79 NGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCceec
Confidence 9999999987654 39999999999999999999999999999999999999988 799999999987422 2223344
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhccCCCCCCCCc
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS------NLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~ 258 (352)
..|++.|+|||++.+ ..++.++||||||+++|+|++|..||.... ................+..++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 227 (327)
T cd05617 156 FCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLS 227 (327)
T ss_pred ccCCcccCCHHHHCC--------CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCC
Confidence 579999999999854 567889999999999999999999996422 223333344444445567789
Q ss_pred HHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPN------FTQIIQM 285 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps------~~~i~~~ 285 (352)
..+.+++.+||..||.+|++ +.++++|
T Consensus 228 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 99999999999999999997 4688777
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=323.23 Aligned_cols=243 Identities=25% Similarity=0.402 Sum_probs=196.6
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||.||+|++. ++.||+|++........ .....+.+|+.++.++ +||||+++++++.. +..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD--EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch--hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 36999999999999885 78999999876432221 2334577888888776 89999999999874 5799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc-ccccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~-~~~~~~~ 184 (352)
++++|..++.... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.... .......
T Consensus 79 ~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 79 NGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCcccc
Confidence 9999999887654 39999999999999999999999999999999999999988 799999999987432 2222344
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhccCCCCCCC
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--------NLQAAYAAAFKNVRPSAEN 256 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~ 256 (352)
..|+..|+|||++.+ ..++.++|||||||++|+|++|..||.... ................+..
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 227 (329)
T cd05618 156 FCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 227 (329)
T ss_pred ccCCccccCHHHHcC--------CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCC
Confidence 578999999999854 567889999999999999999999995311 1122233333334445677
Q ss_pred CcHHHHHHHHHhhccCCCCCCC------HHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPN------FTQIIQM 285 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps------~~~i~~~ 285 (352)
++..+.++|.+||+.||.+||+ +.++++|
T Consensus 228 ~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 228 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 8999999999999999999998 5788877
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=313.47 Aligned_cols=260 Identities=30% Similarity=0.482 Sum_probs=208.4
Q ss_pred CceeeeccccCCCceEEEEEEEC--Cc--eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-Cc
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PV 97 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~ 97 (352)
++|++.+.||+|+||.||+|.++ +. .+++|.+...... .....+.+|+.+++++ +||||+++++++.+ +.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE----NDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH----HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 57899999999999999999874 33 4688877643322 2234588899999999 79999999999874 47
Q ss_pred eEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC
Q 018656 98 MVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~ 163 (352)
.++++||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~ 156 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-L 156 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-C
Confidence 8999999999999999976431 248889999999999999999999999999999999999987 7
Q ss_pred ceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 018656 164 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 242 (352)
Q Consensus 164 ~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 242 (352)
.++|+|||++..............+..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~ 228 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY--------SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 899999999864322211112233567999998754 567889999999999999997 99999886655444
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 018656 243 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 296 (352)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~ 296 (352)
.........+.+..++.++.+++.+||..+|.+||+++++++.|..+.......
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 229 EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 433333333445678999999999999999999999999999998888765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=307.93 Aligned_cols=250 Identities=32% Similarity=0.601 Sum_probs=205.4
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
|+..+|++.+.||+|+||.||++.+. +..+|+|++...... ...+.+|++++++++||||+++++++.+ +..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred CChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 45678999999999999999999886 568999998654322 2247789999999999999999998864 478
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||+++++|.+++..+.. .+++..++.++.|++.||+|||++|++||||||+||+++++ +.++|+|||+++....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLD 152 (256)
T ss_pred EEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceeccc
Confidence 999999999999999986543 48999999999999999999999999999999999999988 7999999999875432
Q ss_pred ccccc--cCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 179 TEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 179 ~~~~~--~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
..... ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+...........+.+.
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDY--------SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPK 224 (256)
T ss_pred ccccccCCCCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 21111 1123457999998854 567889999999999999998 899998766554444443333344566
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.+|.++.+++.+||..+|.+|||+.++++.+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 7899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=311.60 Aligned_cols=259 Identities=28% Similarity=0.547 Sum_probs=209.6
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
|.++.++|++.+.||+|+||.||+|.++ +..||+|.+....... ....+.+|+.++++++||||+++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR----ERIEFLNEASVMKGFTCHHVVRLLG 76 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH----HHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 8899999999999999999999998653 3479999876543322 2335778999999999999999999
Q ss_pred eeec-CceEEEEEcCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC
Q 018656 92 ACKE-PVMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 162 (352)
Q Consensus 92 ~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~ 162 (352)
++.+ ...+++|||+++++|.+++.+... ...+...++.++.|++.||.|||++|++||||||+||+++++
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~- 155 (288)
T cd05061 77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD- 155 (288)
T ss_pred EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-
Confidence 8874 478999999999999999976432 224667888999999999999999999999999999999987
Q ss_pred CceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCCh
Q 018656 163 KTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 238 (352)
Q Consensus 163 ~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~ 238 (352)
+.++|+|||+++....... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+...
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhcc--------CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 7999999999874322211 112245678999998754 567889999999999999998 7899987665
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 239 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
.+...........+.+..+++.+.+++.+||+.||.+|||+.++++.+...+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 228 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 5444333333334445677899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=320.10 Aligned_cols=254 Identities=22% Similarity=0.370 Sum_probs=204.6
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
+..++|++.+.||+|+||.||++.+. ++.+|+|++...... .....+.+|+++++.++||||+++++++.+ +.
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH----HHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence 45689999999999999999999985 788999988765332 234468899999999999999999999874 58
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.++||||+++++|.+++.+... +++..+..++.|++.||.|||+. +++|+||||+|||++.+ +.++|+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~ 154 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-CCEEEeeCCcchhh
Confidence 9999999999999999987543 89999999999999999999985 79999999999999987 78999999998753
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH-----------
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA----------- 245 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~----------- 245 (352)
.. .......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||............
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (333)
T cd06650 155 ID-SMANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225 (333)
T ss_pred hh-hccccCCCCccccCHHHhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence 22 22234568999999999854 55788999999999999999999999764432211100
Q ss_pred --------------------------------HhccCCCC--CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 246 --------------------------------AFKNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 246 --------------------------------~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
......+. ...++.++.+++.+||+.||.+|||+.+++.+ .+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h--~~~~ 303 (333)
T cd06650 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH--AFIK 303 (333)
T ss_pred ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC--HHHh
Confidence 00001111 12367889999999999999999999999998 4444
Q ss_pred c
Q 018656 292 A 292 (352)
Q Consensus 292 ~ 292 (352)
.
T Consensus 304 ~ 304 (333)
T cd06650 304 R 304 (333)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.83 Aligned_cols=256 Identities=25% Similarity=0.319 Sum_probs=203.9
Q ss_pred cccccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
+..+......++|++.+.||+|+||.||+|.+. ++.||+|++....... ....++.+|+.+++.++||||+++++
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~ 83 (355)
T cd07874 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIISLLN 83 (355)
T ss_pred ccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh---HHHHHHHHHHHHHHHhCCCchhceee
Confidence 334444455689999999999999999999874 8899999987654332 22345778999999999999999999
Q ss_pred eeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCc
Q 018656 92 ACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (352)
Q Consensus 92 ~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~ 164 (352)
++.. ...+++|||+++ +|.+++.. .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~ 157 (355)
T cd07874 84 VFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CT 157 (355)
T ss_pred eeeccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CC
Confidence 8753 247999999965 77777753 28899999999999999999999999999999999999988 79
Q ss_pred eEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 018656 165 IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA 244 (352)
Q Consensus 165 vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 244 (352)
+||+|||+++............|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......
T Consensus 158 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (355)
T cd07874 158 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229 (355)
T ss_pred EEEeeCcccccCCCccccCCccccCCccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999986544444455678999999999854 5678899999999999999999999987654333221
Q ss_pred HHhccCC-----------------------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHH
Q 018656 245 AAFKNVR-----------------------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQII 283 (352)
Q Consensus 245 ~~~~~~~-----------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~ 283 (352)
....... ......+.++.++|.+||..||.+|||+.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell 309 (355)
T cd07874 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309 (355)
T ss_pred HHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence 1110000 00122456789999999999999999999999
Q ss_pred HHH
Q 018656 284 QML 286 (352)
Q Consensus 284 ~~l 286 (352)
+|.
T Consensus 310 ~hp 312 (355)
T cd07874 310 QHP 312 (355)
T ss_pred cCc
Confidence 983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=314.74 Aligned_cols=265 Identities=31% Similarity=0.568 Sum_probs=215.2
Q ss_pred ccccceecCCceeeeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCC
Q 018656 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHR 84 (352)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 84 (352)
....|.+...+|.+++.||+|+||.||+|++. +..+|+|+....... .....+.+|+.+++.+ +||
T Consensus 6 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~~E~~~l~~l~~h~ 81 (304)
T cd05101 6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE----KDLSDLVSEMEMMKMIGKHK 81 (304)
T ss_pred cCCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch----HHHHHHHHHHHHHHhhccCC
Confidence 34569999999999999999999999999742 346999988654322 2345688999999999 899
Q ss_pred Ceeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 018656 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 149 (352)
Q Consensus 85 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~ 149 (352)
||+++++++.. ...+++|||+++++|.+++.+... ..++...++.++.|++.||.|||++|++||
T Consensus 82 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred CchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 99999999874 578999999999999999986432 247888899999999999999999999999
Q ss_pred CCCCCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHH
Q 018656 150 DLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226 (352)
Q Consensus 150 Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~l 226 (352)
||||+||+++.+ +.++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|
T Consensus 162 dlkp~Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el 232 (304)
T cd05101 162 DLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEI 232 (304)
T ss_pred ccccceEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhcc--------CCCCchhhHHHHHHHHHHH
Confidence 999999999987 799999999987543221 1122345678999998854 5578899999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 227 LH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 227 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
++ |..||.+.+................+..++.++.+++.+||..+|.+||++.++++.|..++.-
T Consensus 233 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 233 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 98 8889987655444333333333344567889999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=313.24 Aligned_cols=256 Identities=28% Similarity=0.491 Sum_probs=210.5
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
|+-.+|++.+.||+|+||.||+|.+. ++.||+|++...... .....+.+|+.+++.++||||+++++++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 77 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG----PLREEFKHEAMMRSRLQHPNIVCLLGVV 77 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH----HHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 44567889999999999999999863 467999998754432 2345688899999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEE
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 158 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili 158 (352)
.+ ...++++||+.+++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 74 47899999999999999986321 1247888999999999999999999999999999999999
Q ss_pred eCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCC
Q 018656 159 TEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFE 234 (352)
Q Consensus 159 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~ 234 (352)
+++ +.+||+|||+++...... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.
T Consensus 158 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 158 FDK-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--------GKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred cCC-CceEecccccccccccchheeeccCccCCccccCHHHHhc--------CCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 987 789999999987533222 1223346789999998754 557889999999999999998 889998
Q ss_pred CCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 235 GMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
+....+...........+.+..++..+.+++.+||+.+|.+||++++++..|+.|
T Consensus 229 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 229 GYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred CCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 8766555555555555566778999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=319.61 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=199.1
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeec-CceEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~l 100 (352)
+|.+.+.||+|+||+||+|+++ |+.||+|++....... ......+..|..+++.+. |++|+++++++.+ +.+++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ--DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 3678899999999999999885 7899999987532111 122345677888888885 5777888888874 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
||||++|++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++......
T Consensus 79 v~Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeccccccccCCCC
Confidence 9999999999999976543 9999999999999999999999999999999999999988 79999999998753222
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+........... ......+..++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-~~~~~~p~~~~~ 226 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM-EHNVSYPKSLSK 226 (323)
T ss_pred ccccCccCCccccCHHHHcC--------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCCccCCH
Confidence 22334568999999998854 567889999999999999999999998866544333333 333344567899
Q ss_pred HHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNF-----TQIIQM 285 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~-----~~i~~~ 285 (352)
++.+++.+||+.+|.+|++. .++++|
T Consensus 227 ~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 227 EAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 99999999999999999974 566665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=312.13 Aligned_cols=254 Identities=31% Similarity=0.556 Sum_probs=210.1
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
+...+|.+.+.||+|+||.||+|.+. ++.||+|++...... .....+.+|++++++++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 77 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN----DARKDFEREAELLTNFQHENIVKFYGVC 77 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH----HHHHHHHHHHHHHHhcCCCCchheeeEE
Confidence 34567899999999999999999763 468999998765442 2345688999999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRP------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~ 160 (352)
.. ...+++|||+++++|.+++...+. ..+++..+..++.|++.||.+||++|++||||||+||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 74 579999999999999999976532 34788999999999999999999999999999999999998
Q ss_pred CCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 018656 161 DLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM 236 (352)
Q Consensus 161 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~ 236 (352)
+ +.++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.
T Consensus 158 ~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 158 D-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred C-CeEEECCcccceecccCcceecCCCCcccceecChhhhcc--------CCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 8 899999999987432211 1123345788999998854 568889999999999999998 99999876
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 237 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
...............+.+..++..+.+++.+||+.||.+||++.++++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 229 SNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 665554444444444456678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=306.39 Aligned_cols=245 Identities=24% Similarity=0.520 Sum_probs=202.1
Q ss_pred cccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCceEEEEEcCC
Q 018656 31 RIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLS 106 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~lv~e~~~ 106 (352)
.||+|+||.||+|.+. +..||+|++...... .....+.+|+.++++++||||+++++++..+..++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~----~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK----SVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh----HHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCC
Confidence 3899999999999763 456999998765332 23456889999999999999999999998888999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc----c
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM----M 182 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~----~ 182 (352)
+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++........ .
T Consensus 78 ~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 78 GGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCccccccCCccceecc
Confidence 999999997543 348999999999999999999999999999999999999988 7999999999874332211 1
Q ss_pred ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHH
Q 018656 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 261 (352)
Q Consensus 183 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (352)
....++..|+|||.+.. ..++.++||||||+++|++++ |..||..................+.+..+++++
T Consensus 156 ~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (257)
T cd05115 156 SAGKWPLKWYAPECINF--------RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEM 227 (257)
T ss_pred CCCCCCcccCCHHHHcc--------CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 11223578999998753 557889999999999999996 999998876655544444444445567789999
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 262 SIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 262 ~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
.+++.+||..+|++||++.++.+.|..+
T Consensus 228 ~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 228 YALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=319.17 Aligned_cols=242 Identities=29% Similarity=0.405 Sum_probs=194.8
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhc-CCCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR-VQHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||+||+|+++ ++.||||++....... .........|..+++. ++||||+++++++.+ +.+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 36999999999999985 6889999987532111 1122345567777765 499999999999874 4789999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-cccccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~~~~~~ 184 (352)
+|++|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++..... ......
T Consensus 79 ~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 79 NGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCceee
Confidence 99999999986443 8999999999999999999999999999999999999988 7999999999874322 222334
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
..|+..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+......... ......+..++.++.++
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~l 226 (316)
T cd05619 156 FCGTPDYIAPEILLG--------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR-MDNPCYPRWLTREAKDI 226 (316)
T ss_pred ecCCccccCHHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCCccCCHHHHHH
Confidence 568999999999854 567889999999999999999999998866544333332 22233455688999999
Q ss_pred HHHhhccCCCCCCCHH-HHHHH
Q 018656 265 LTSCWKEDPNARPNFT-QIIQM 285 (352)
Q Consensus 265 i~~~l~~~p~~Rps~~-~i~~~ 285 (352)
+.+||..||.+||++. +++++
T Consensus 227 i~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 227 LVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred HHHHhccCHhhcCCChHHHHcC
Confidence 9999999999999996 77665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=305.45 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=208.4
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|.+.+.||+|++|.||+|.+. |+.|++|.+....... .....+.+|++++++++||||+++++.+.+ +..++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR---REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH---HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 4788899999999999999874 7899999986543322 234568899999999999999999999874 579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~- 180 (352)
|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-CCEEEcccccceeccCccc
Confidence 999999999999987655569999999999999999999999999999999999999988 799999999987543322
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
......++..|+|||++.+ ..++.++|+||||+++++|++|+.||...+..............+....++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd08529 157 FANTIVGTPYYLSPELCED--------KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQ 228 (256)
T ss_pred hhhccccCccccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHH
Confidence 2233467889999998854 55788999999999999999999999876654444443333344445578899
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHhhC
Confidence 9999999999999999999999886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.71 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=201.5
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||+||++.++ ++.||+|++....... ......+.+|+.++..++||+|+++++.+.+ ..+++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE--KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 36889999999999999999874 7899999987432111 2334568889999999999999999999875 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||++|++|.+++.+... +++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCccccccc
Confidence 9999999999999986543 8999999999999999999999999999999999999988 899999999986321110
Q ss_pred ------------------------------------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHH
Q 018656 181 ------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224 (352)
Q Consensus 181 ------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 224 (352)
......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~~~~~DiwSlGvily 227 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--------TGYNKLCDWWSLGVIMY 227 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--------CCCCCcceeccccceee
Confidence 0113468999999999854 56788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCC---CHHHHHHHH
Q 018656 225 ELLHNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARP---NFTQIIQML 286 (352)
Q Consensus 225 ~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~i~~~l 286 (352)
+|++|..||.+.+............ ..+....++.++.++|.+|+. ||.+|+ ++.++++|.
T Consensus 228 el~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 228 EMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP 294 (360)
T ss_pred ecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence 9999999998866654443333211 122233578999999999875 999998 478888883
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=323.31 Aligned_cols=267 Identities=29% Similarity=0.544 Sum_probs=217.1
Q ss_pred ccccccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-
Q 018656 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ- 82 (352)
Q Consensus 11 ~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 82 (352)
..+..+..|.+..++|.+++.||+|+||.||+|.+. ++.||+|++....... ....+.+|++++.++.
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~----~~~~~~~E~~~l~~l~~ 99 (401)
T cd05107 24 MQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS----EKQALMSELKIMSHLGP 99 (401)
T ss_pred CCCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh----HHHHHHHHHHHHHhcCC
Confidence 346677789999999999999999999999999864 3579999997643322 2345889999999997
Q ss_pred CCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC------------------------------------------
Q 018656 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP------------------------------------------ 119 (352)
Q Consensus 83 hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------------ 119 (352)
||||+++++++.. +..++||||+++|+|.+++.+...
T Consensus 100 H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (401)
T cd05107 100 HLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYM 179 (401)
T ss_pred CCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccc
Confidence 9999999999874 578999999999999999975321
Q ss_pred ------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 018656 120 ------------------------------------------------------RCLDVCVAIGFALDIARAMECLHSHG 145 (352)
Q Consensus 120 ------------------------------------------------------~~~~~~~~~~i~~qi~~~L~~lH~~~ 145 (352)
..+++..++.++.|++.||+|||+.+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ 259 (401)
T cd05107 180 DMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN 259 (401)
T ss_pred ccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 13677788999999999999999999
Q ss_pred CccCCCCCCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHH
Q 018656 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 222 (352)
Q Consensus 146 ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 222 (352)
++||||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++||||||++
T Consensus 260 ivHrdlkp~NiLl~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGvi 330 (401)
T cd05107 260 CVHRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--------NLYTTLSDVWSFGIL 330 (401)
T ss_pred cCcccCCcceEEEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--------CCCCcHhHHHHHHHH
Confidence 9999999999999987 799999999987532211 1122346788999998854 557889999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 223 LWELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 223 l~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
+|+|++ |..||................ ..+.+..++.++.+++.+||..+|.+||++.++++.|+..+
T Consensus 331 l~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 331 LWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 999998 899998755544433333332 23345678899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=337.44 Aligned_cols=265 Identities=31% Similarity=0.547 Sum_probs=230.9
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 88 (352)
...-.|.+.+..+.+.||+|+||+||+|+-. ...||||.++..... .....|+||+.++..++|||||+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~----~~~~dF~REaeLla~l~H~nIVr 553 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN----QARQDFRREAELLAELQHPNIVR 553 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH----HHHHHHHHHHHHHHhccCCCeEE
Confidence 3346788999999999999999999999763 356999999876553 24557999999999999999999
Q ss_pred eeeeeecC-ceEEEEEcCCCCCHHHHHHhcCCC--------C----CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q 018656 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPR--------C----LDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 155 (352)
Q Consensus 89 l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~--------~----~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~N 155 (352)
++|+|.++ -+++|+||+..|+|.+|+..+.+. . ++..+.+.|+.||+.|++||-++.+|||||-.+|
T Consensus 554 LlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRN 633 (774)
T KOG1026|consen 554 LLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRN 633 (774)
T ss_pred EEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhh
Confidence 99999855 689999999999999999877532 2 8889999999999999999999999999999999
Q ss_pred eEEeCCCCceEEecCCCcccccccccc---ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCC
Q 018656 156 LLLTEDLKTIKLADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKL 231 (352)
Q Consensus 156 ili~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 231 (352)
+||+++ -.|||+|||+++..=..+.. ....-..+|||||.+.. +.++.+|||||+|++|||+++ |..
T Consensus 634 CLVge~-l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--------~kFTteSDVWs~GVvLWEIFsyG~Q 704 (774)
T KOG1026|consen 634 CLVGEN-LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--------GKFTTESDVWSFGVVLWEIFSYGKQ 704 (774)
T ss_pred ceeccc-eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--------CcccchhhhhhhhhhhhhhhccccC
Confidence 999998 69999999999853222111 12235689999999865 789999999999999999997 999
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 232 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
||.+.++.+....+......+.+.++|.++..++..||+.+|.+||++.+|-..|..+....
T Consensus 705 Py~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 705 PYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred cccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 99999999998888888888999999999999999999999999999999999998887653
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=306.59 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=208.8
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|++.+.||.|+||.||++.+. ++.+|+|.+...... .....+.+|+.++++++||||+++++.+.+ +.++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch----HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 5889999999999999999874 789999998654332 223457789999999999999999999874 589999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~- 180 (352)
|||+++++|.+++.......+++..++.++.|++.||.+||++|++|+||||+||+++++ +.++|+|||.+.......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeeccccc
Confidence 999999999999976555568999999999999999999999999999999999999987 799999999987543322
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
......++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+..............+.+..++..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (255)
T cd08219 156 YACTYVGTPYYVPPEIWEN--------MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYE 227 (255)
T ss_pred ccccccCCccccCHHHHcc--------CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHH
Confidence 2234568899999998754 45788999999999999999999999886655554444444455556778999
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+.+++.+||+.||.+||++.+++..
T Consensus 228 ~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 228 LRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHhCCcccCCCHHHHhhc
Confidence 9999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=312.59 Aligned_cols=243 Identities=24% Similarity=0.362 Sum_probs=195.8
Q ss_pred ccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCCC
Q 018656 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGG 108 (352)
Q Consensus 32 lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 108 (352)
||+|+||+||++.+. |+.||+|++....... ......+..|+++++.++||||+++.+++.. ...++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh--hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 799999999999874 8899999986543221 1223457789999999999999999998874 4789999999999
Q ss_pred CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-cccccC
Q 018656 109 TLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAE 185 (352)
Q Consensus 109 sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~-~~~~~~ 185 (352)
+|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++...... ......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCccceecCCCCcccccc
Confidence 999887542 22358999999999999999999999999999999999999987 78999999998753322 222345
Q ss_pred CCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHhccCCCCCCCCcHHHH
Q 018656 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA---AYAAAFKNVRPSAENVPEELS 262 (352)
Q Consensus 186 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~ 262 (352)
.|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||........ ............+..++.++.
T Consensus 158 ~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (280)
T cd05608 158 AGTPGFMAPELLQG--------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASK 229 (280)
T ss_pred CCCcCccCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHH
Confidence 78999999999854 5678899999999999999999999986543211 111122222333567899999
Q ss_pred HHHHHhhccCCCCCC-----CHHHHHHH
Q 018656 263 IILTSCWKEDPNARP-----NFTQIIQM 285 (352)
Q Consensus 263 ~li~~~l~~~p~~Rp-----s~~~i~~~ 285 (352)
+++.+||+.||.+|| +++++++|
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 999999999999999 77888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=320.48 Aligned_cols=262 Identities=29% Similarity=0.556 Sum_probs=209.8
Q ss_pred cceecCCceeeeccccCCCceEEEEEEE-------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l 89 (352)
+|.+..++|++++.||+|+||+||+|.+ .++.||||++....... ....+.+|+.++.++ +||||+++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~~h~niv~~ 76 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----EHRALMSELKILIHIGHHLNVVNL 76 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH----HHHHHHHHHHHHHhccCCccHhhh
Confidence 5999999999999999999999999974 26789999987544322 234588899999999 68999999
Q ss_pred eeeeec--CceEEEEEcCCCCCHHHHHHhcCC------------------------------------------------
Q 018656 90 IGACKE--PVMVIVTELLSGGTLRKYLLNMRP------------------------------------------------ 119 (352)
Q Consensus 90 ~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------------------ 119 (352)
++++.. ...+++|||+++++|.+++.....
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (343)
T cd05103 77 LGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK 156 (343)
T ss_pred cceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence 998753 468999999999999999875321
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc-
Q 018656 120 -----------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM- 181 (352)
Q Consensus 120 -----------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~- 181 (352)
..+++..+..++.|+++||+|||++|++||||||+||+++.+ +.++|+|||++........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcch
Confidence 236788889999999999999999999999999999999987 7999999999875322111
Q ss_pred --cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc-cCCCCCCCC
Q 018656 182 --MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK-NVRPSAENV 257 (352)
Q Consensus 182 --~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 257 (352)
.....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||............... ...+.+...
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 307 (343)
T ss_pred hhcCCCCCCcceECcHHhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCC
Confidence 112235678999998754 567889999999999999996 99999775433332222222 222334557
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 258 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
++++.+++.+||+.||.+||++.+++++|...+++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 88999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=313.54 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=204.7
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
.|+..+.||+|+||.||++.+. ++.||+|.+........ .....+.+|+.++++++|++|+++++.+.+ +..++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch--HHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 3677889999999999999885 78999998865432221 223456789999999999999999998864 578999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
|||++|++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCcc
Confidence 999999999999976655569999999999999999999999999999999999999988 7899999999875443333
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHhccCCCCCCCCc
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ---AAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 258 (352)
.....|+..|+|||++.+ ..++.++||||+|+++|+|++|+.||....... .............+..++
T Consensus 158 ~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFS 229 (285)
T ss_pred ccCCCCCccccChHHHcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCC
Confidence 344578999999999854 567889999999999999999999998754321 111111111222345788
Q ss_pred HHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPN-----FTQIIQMLL 287 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps-----~~~i~~~l~ 287 (352)
+++.+++.+||+.||.+||| +.++++|.+
T Consensus 230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 230 PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred HHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 99999999999999999999 899999843
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=310.71 Aligned_cols=247 Identities=35% Similarity=0.632 Sum_probs=201.9
Q ss_pred eeeccccCCCceEEEEEEEC------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 27 FVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 27 ~~~~~lG~G~~g~Vy~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
.+.+.||.|.||.||+|.+. +..|+||++....... ....+.+|++.+++++||||+++++++. .+..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE----EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH----HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccc----cceeeeeccccccccccccccccccccccccccc
Confidence 46788999999999999887 6789999996544332 2456889999999999999999999998 45699
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL- 178 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~- 178 (352)
+|+||+++++|.+++.......+++..++.|+.|++.||.|||+++++|+||+++||+++.+ +.+||+|||++.....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence 99999999999999998745569999999999999999999999999999999999999998 7999999999876521
Q ss_pred --ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 179 --TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 179 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
............|+|||.+.. ..++.++||||||+++||+++ |+.||......+...........+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKD--------GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPD 228 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHH--------SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBT
T ss_pred ccccccccccccccccccccccc--------ccccccccccccccccccccccccccccccccccccccccccccceecc
Confidence 122233457789999999855 457999999999999999999 789998887666555554444555677
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.++..+.+++.+||..||.+||++.++++.|
T Consensus 229 ~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 8999999999999999999999999999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=314.21 Aligned_cols=260 Identities=28% Similarity=0.486 Sum_probs=205.7
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--Cc--eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE- 95 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~- 95 (352)
.-.+|++.+.||+|+||.||+|.+. +. .+++|.+...... .....+.+|+.++.++ +||||+++++++.+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH----HHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 3457899999999999999999874 44 3566665533221 2344678899999999 89999999999874
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~ 161 (352)
+..+++|||+++++|.+++.+... ..+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 579999999999999999975431 247899999999999999999999999999999999999988
Q ss_pred CCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHH
Q 018656 162 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQ 240 (352)
Q Consensus 162 ~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~ 240 (352)
+.++|+|||++.............++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 161 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 231 (303)
T cd05088 161 -YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231 (303)
T ss_pred -CcEEeCccccCcccchhhhcccCCCcccccCHHHHhc--------cCCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence 7999999999864322211122234668999998744 457889999999999999998 999998765544
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
.............+..++.++.+++.+||+.+|.+||++.+++..+...+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 232 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 333222222233455688999999999999999999999999999987766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=304.01 Aligned_cols=244 Identities=33% Similarity=0.581 Sum_probs=199.0
Q ss_pred ccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCC
Q 018656 30 PRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLS 106 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~ 106 (352)
+.||+|+||.||+|.+ +++.+|+|.+...... .....+.+|++++++++||||+++++++.. ...++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP----DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 3699999999999987 4889999987654332 234568899999999999999999999874 47899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccccc---c
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM---T 183 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~---~ 183 (352)
+++|.+++.+.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++......... .
T Consensus 77 ~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 77 GGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCcccccccccccCC
Confidence 999999997643 248999999999999999999999999999999999999988 78999999998753322111 1
Q ss_pred cCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHH
Q 018656 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 262 (352)
Q Consensus 184 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 262 (352)
....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||..................+.+..++..+.
T Consensus 155 ~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (252)
T cd05084 155 MKQIPVKWTAPEALNY--------GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVY 226 (252)
T ss_pred CCCCceeecCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHH
Confidence 1123457999998754 557889999999999999997 9999987665544443333334455667899999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 263 IILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 263 ~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+++.+||..+|.+|||+.++++.|.
T Consensus 227 ~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 227 RLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHh
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=323.33 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=201.4
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
.....++|.+++.||+|+||.||+|.+. |+.||||++...... .....+.+|+++++.++|+||+++++++.+
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED----TVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH----HHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 3344567889999999999999999885 899999998654332 234568899999999999999999999874
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+.+++||||+++++|.+.. ..++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 145 ~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~ 217 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRI 217 (353)
T ss_pred CeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccccccee
Confidence 5789999999999986532 26778888999999999999999999999999999999988 7999999999875
Q ss_pred cccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHhccCC
Q 018656 176 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA---AYAAAFKNVR 251 (352)
Q Consensus 176 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~---~~~~~~~~~~ 251 (352)
.... .......|+..|+|||++.... ..+...+.++|||||||++|+|++|+.||........ ..........
T Consensus 218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 294 (353)
T PLN00034 218 LAQTMDPCNSSVGTIAYMSPERINTDL---NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP 294 (353)
T ss_pred cccccccccccccCccccCcccccccc---ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC
Confidence 4322 2223457899999999874310 0123345689999999999999999999974332211 1112222233
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..+..++.++.++|.+||..||.+||++.++++|.
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 34567899999999999999999999999999983
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.13 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=211.7
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 101 (352)
+|++.+.||+|++|.||++.+. ++.+|+|.+....... .....+.+|++++++++||||+++++.+. ++..++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK---DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc---HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 5889999999999999999874 7899999987654332 23456889999999999999999999876 4579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
|||+++++|.+++.......+++..++.++.|++.+|+|||++|++|+||+|+||+++++.+.++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999999998765556899999999999999999999999999999999999987656789999999886544433
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHH
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 261 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 261 (352)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+..............+.+..++.++
T Consensus 158 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (256)
T cd08220 158 AYTVVGTPCYISPELCEG--------KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDL 229 (256)
T ss_pred ccccccCCcccCchhccC--------CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHH
Confidence 344568899999998854 457889999999999999999999998866555444444444455566789999
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHH
Q 018656 262 SIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 262 ~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+++.+||..+|.+|||+.+++++
T Consensus 230 ~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 230 RQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHccCChhhCCCHHHHhhC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=304.04 Aligned_cols=250 Identities=27% Similarity=0.413 Sum_probs=210.7
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|++.+.||.|+||.||.+++. ++.+++|.+....... ....++.+|++++++++|+||+++++++.+ +..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch---hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 6899999999999999988774 7899999986554332 223457899999999999999999999874 478999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~- 180 (352)
|||+++++|.+++.+.....+++..+..++.|++.+|.|||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence 999999999999987644568999999999999999999999999999999999999988 789999999987543322
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..................+....++.+
T Consensus 157 ~~~~~~~~~~y~ape~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG--------VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSE 228 (256)
T ss_pred cccccCCCccccCHhhcCC--------CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHH
Confidence 2334568999999998754 45678899999999999999999999886665555555544455556778999
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+.+++.+||..+|.+||++.++++++
T Consensus 229 ~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 229 LISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHHHHHcccCcccCCCHHHHhhCc
Confidence 99999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=329.24 Aligned_cols=244 Identities=25% Similarity=0.472 Sum_probs=207.6
Q ss_pred cccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCC
Q 018656 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSG 107 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~ 107 (352)
+||+|.||+||.|++. ..++|||-+...... ..+-+..|+++.++|+|.|||+++|.+.+ +.+-|.||.++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-----~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-----EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-----hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 6899999999999985 567899987655443 34558899999999999999999999874 578899999999
Q ss_pred CCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc-ccccccccc
Q 018656 108 GTLRKYLLNMRPRCL--DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTA 184 (352)
Q Consensus 108 ~sL~~~l~~~~~~~~--~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~-~~~~~~~~~ 184 (352)
|||.++++...+ ++ .+..+-.+..||++||.|||++.|||||||-+|+||+-..|.+||+|||-++. .+.+....+
T Consensus 657 GSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 999999987653 25 88889999999999999999999999999999999988879999999999875 445566678
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHH-HhccCCCCCCCCcHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA-AYAA-AFKNVRPSAENVPEELS 262 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~l~ 262 (352)
+.||..|||||++.. ....|++++|||||||++.||.||++||......+. ..+. ..+.-+|.+..++.+.+
T Consensus 736 FTGTLQYMAPEvIDq------G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak 809 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQ------GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAK 809 (1226)
T ss_pred cccchhhhChHhhcc------CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHH
Confidence 899999999999965 236789999999999999999999999976444333 3333 23344566889999999
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHH
Q 018656 263 IILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 263 ~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+||.+|+.++|..||++.+++...
T Consensus 810 ~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 810 NFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred HHHHHHcCCCcccCccHHHhccCc
Confidence 999999999999999999999863
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=311.49 Aligned_cols=264 Identities=31% Similarity=0.549 Sum_probs=214.8
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCC
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHR 84 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 84 (352)
+..+.+|.+...+|.+.+.||+|+||.||++.+. +..+|+|++...... .....+.+|+++++++ +||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~~h~ 99 (302)
T cd05055 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS----SEREALMSELKIMSHLGNHE 99 (302)
T ss_pred ccccccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh----HHHHHHHHHHHHHHhccCCC
Confidence 4555679999999999999999999999999752 457999988754432 2234688999999999 799
Q ss_pred Ceeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC
Q 018656 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (352)
Q Consensus 85 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~ 163 (352)
||+++++.+.. +..+++|||+++++|.+++.......+++..++.++.|++.||+|||+++++|+||||+||+++.+ +
T Consensus 100 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~ 178 (302)
T cd05055 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-K 178 (302)
T ss_pred CcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-C
Confidence 99999999874 579999999999999999976554458999999999999999999999999999999999999887 7
Q ss_pred ceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChH
Q 018656 164 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 239 (352)
Q Consensus 164 ~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 239 (352)
.++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+....
T Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~ 250 (302)
T cd05055 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250 (302)
T ss_pred eEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc--------CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence 89999999987543221 1122345678999998754 557889999999999999998 99999876544
Q ss_pred HHHHHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 240 QAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 240 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
........... ...+...+.++.+++.+||..+|.+||++.++++.+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 251 SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 33333332222 233456789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=317.93 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=202.8
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||+||++.++ ++.+|+|++....... ......+.+|+.++..++|++|+++++++.+ ..+++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK--RAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHH--hhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 47899999999999999999885 6889999986422111 1223457789999999999999999999875 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+++|+|.+++.+... .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++|+|||++.......
T Consensus 79 v~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecccCC
Confidence 9999999999999986432 48999999999999999999999999999999999999987 799999999986532221
Q ss_pred --ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC----CCCC
Q 018656 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV----RPSA 254 (352)
Q Consensus 181 --~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~ 254 (352)
......||+.|+|||++.... .....++.++|||||||++|+|++|+.||.+.+............. ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAME---DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233 (332)
T ss_pred cceecccccCccccCHHHHhccc---cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcc
Confidence 122346899999999885321 0124578899999999999999999999988765554444433221 1223
Q ss_pred CCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 286 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~--Rps~~~i~~~l 286 (352)
..++.++.+++++||..++.+ |+++.++++|.
T Consensus 234 ~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~ 267 (332)
T cd05623 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP 267 (332)
T ss_pred ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence 467999999999999665544 68999999983
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=309.46 Aligned_cols=254 Identities=29% Similarity=0.544 Sum_probs=206.0
Q ss_pred ceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cC
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EP 96 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~ 96 (352)
+|++.+.||+|+||.||+|.+. ...+++|.+....... ....+.+|+.+++.++||||+++++.+. ++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS----ELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH----HHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4788999999999999999874 2568999887654432 2356889999999999999999999987 45
Q ss_pred ceEEEEEcCCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 018656 97 VMVIVTELLSGGTLRKYLLNMR----------------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 154 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~ 154 (352)
..++++||+.+++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 7899999999999999987532 124788999999999999999999999999999999
Q ss_pred CeEEeCCCCceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CC
Q 018656 155 NLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NK 230 (352)
Q Consensus 155 Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~ 230 (352)
||+++++ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |.
T Consensus 157 nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l~el~t~g~ 227 (290)
T cd05045 157 NVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--------HIYTTQSDVWSFGVLLWEIVTLGG 227 (290)
T ss_pred eEEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHcc--------CCcchHhHHHHHHHHHHHHHhcCC
Confidence 9999987 7999999999875322211 122245678999998744 557889999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 231 LPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
.||.+................+.+..++.++.+++.+||+.+|.+||++.++++.|++.+.
T Consensus 228 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 228 NPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 9998766544333333223334466788999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=303.76 Aligned_cols=245 Identities=29% Similarity=0.521 Sum_probs=203.2
Q ss_pred ccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCceEEEEEc
Q 018656 30 PRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTEL 104 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~lv~e~ 104 (352)
+.||+|+||.||+|.+. +..+|+|.+...... .....+.+|+++++++.||||+++++++.....+++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEe
Confidence 46999999999999763 267999998765443 234568899999999999999999999887789999999
Q ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccccc-c
Q 018656 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-T 183 (352)
Q Consensus 105 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~-~ 183 (352)
+++++|.+++.+.. .+++..++.++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++......... .
T Consensus 77 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceeecCCcccc
Confidence 99999999998765 48999999999999999999999999999999999999988 79999999998754322211 1
Q ss_pred ---cCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 184 ---AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 184 ---~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
...++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+..+...........+.+..++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQ 225 (257)
T ss_pred cccCccccccccCHHHhcC--------CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCH
Confidence 1123467999998754 557889999999999999997 9999987666544444433334455677899
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
.+.+++.+||..+|.+||++.++++.|.+.
T Consensus 226 ~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 226 EIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=309.59 Aligned_cols=257 Identities=28% Similarity=0.516 Sum_probs=209.8
Q ss_pred cCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
...+|.+.+.||+|+||.||++.+. +..+++|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-----AARKDFQREAELLTNLQHEHIVKFYGVCG 77 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-----HHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence 4567889999999999999999753 34588888754332 22345889999999999999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~ 159 (352)
. ...++||||+++++|.+++..+.. ..+++..++.++.||+.||+|||++|++||||||+||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 4 478999999999999999976432 2478999999999999999999999999999999999999
Q ss_pred CCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 018656 160 EDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEG 235 (352)
Q Consensus 160 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~ 235 (352)
.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||..
T Consensus 158 ~~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 158 AN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred cC-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 88 799999999987533221 1223456788999998754 567889999999999999998 9999987
Q ss_pred CChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 236 MSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
..................+..+|..+.+++.+||+.||.+||++.++++.+.+....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 229 LSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 665544443333333344566789999999999999999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=306.41 Aligned_cols=252 Identities=28% Similarity=0.510 Sum_probs=202.2
Q ss_pred eeeeccccCCCceEEEEEEEC--Cc--eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec------
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------ 95 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 95 (352)
+.+++.||+|+||.||+|.+. ++ .+|+|.+....... .....+.+|+++++.++||||+++++.+..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR---SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 356788999999999999875 32 68999887653322 234568889999999999999999987632
Q ss_pred -CceEEEEEcCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
...+++|||+++++|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.+ +.++|+||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Df 156 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADF 156 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCC
Confidence 2468999999999999988532 12348999999999999999999999999999999999999987 78999999
Q ss_pred CCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 018656 171 GLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 171 g~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 246 (352)
|++........ .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+...........
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 228 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD--------RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccC--------CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99875433221 122245678999998754 567889999999999999999 899998766554433333
Q ss_pred hccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 247 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
.....+.+..++..+.++|.+||+.||.+|||+.++++.|...
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 3333345667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=305.98 Aligned_cols=255 Identities=29% Similarity=0.527 Sum_probs=208.8
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK- 94 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~- 94 (352)
|+..+|++.+.||+|+||.||+|.+. +..+|+|.+...... .....+.+|+.++++++||||+++++++.
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE----KQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 46778999999999999999999873 237999998654432 22446889999999999999999999986
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
++..+++|||+++++|.+++.... ..+++..++.++.|++.||.+||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~ 154 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSR 154 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCccc
Confidence 457899999999999999998654 348999999999999999999999999999999999999988 799999999987
Q ss_pred ccccccc--c--ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc
Q 018656 175 EESLTEM--M--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 175 ~~~~~~~--~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 249 (352)
....... . ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||......+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~ 226 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhcc--------CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC
Confidence 5433211 1 11223568999998854 567889999999999999886 999998766554444433333
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
..+....+|..+.+++.+||+.+|.+||++.++++.|...
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 4455667899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=303.68 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=206.9
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee--cCceEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--EPVMVI 100 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~~~l 100 (352)
.|++.+.||.|++|.||++.+. ++.+|+|.+....... .....+.+|++++++++|+|++++++.+. +..+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR---RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH---HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 4889999999999999999874 7889999986543322 23445788999999999999999998875 335899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
+|||+++++|.+++.......+++.+++.++.|++.||++||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQC 156 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEecccC
Confidence 9999999999999987555568999999999999999999999999999999999999988 79999999998754322
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
.......+++.|+|||++.+ ..++.++|+||||+++++|++|+.||...+..............+.+..+++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSN--------KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSP 228 (257)
T ss_pred CccccccCCcCccChhHhcC--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCH
Confidence 22234468899999998854 5677899999999999999999999987665444443333333344567889
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+.+++.+||+.||.+||++.+++++
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcC
Confidence 99999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=305.43 Aligned_cols=252 Identities=31% Similarity=0.538 Sum_probs=205.0
Q ss_pred eeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC----
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 96 (352)
|++++.||+|+||.||+|.+. +..||+|.+....... .....+.+|+..++.++||||+++++++...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY---SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH---HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 568899999999999999863 3679999987644332 2344688999999999999999999986432
Q ss_pred ---ceEEEEEcCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 97 ---VMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 97 ---~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
..++++||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++++ +.++|+|
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~d 156 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVAD 156 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECC
Confidence 3699999999999999985532 2358999999999999999999999999999999999999988 7999999
Q ss_pred CCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 018656 170 FGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAA 245 (352)
Q Consensus 170 fg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 245 (352)
||+++....... .....++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+.....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL 228 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhccc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999875332211 112234678999998743 567889999999999999999 99999886665544444
Q ss_pred HhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 246 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
........+..++.++.+++.+||+.||.+||++.++++.|.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 44444455678899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.67 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=204.1
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 101 (352)
.|+..+.||+|+||+||+|.+. ++.+|+|++....... ......+.+|++++++++|+||+.+.+.+. ++..+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK--RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh--hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 3677889999999999999884 7899999986543221 122345678999999999999999998876 4578999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
|||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++++ +.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGES 157 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecCCCCc
Confidence 999999999999876555569999999999999999999999999999999999999988 7899999999875433333
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH---HhccCCCCCCCCc
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA---AFKNVRPSAENVP 258 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~ 258 (352)
.....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.......... ...........++
T Consensus 158 ~~~~~g~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNN--------QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFS 229 (285)
T ss_pred ccCCCCCcCccChHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCC
Confidence 344578999999999854 56788999999999999999999999876543322221 1111223345688
Q ss_pred HHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPN-----FTQIIQM 285 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps-----~~~i~~~ 285 (352)
.++.+++..||+.||.+||+ +++++.+
T Consensus 230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 99999999999999999999 7788887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=323.09 Aligned_cols=249 Identities=28% Similarity=0.367 Sum_probs=199.7
Q ss_pred ceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC------
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP------ 96 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------ 96 (352)
+|++++.||+|+||+||++.+ +|+.||||.+....... ....++.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL---VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch---HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 467889999999999999987 48999999986543222 2234678999999999999999999998643
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..++|+||+. ++|.+++.... .+++..++.++.|++.||.|||++|++||||||+|||++.+ +.++|+|||++...
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~ 153 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVE 153 (372)
T ss_pred eEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeec
Confidence 5899999995 68888886543 49999999999999999999999999999999999999988 79999999998754
Q ss_pred ccc--cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-----
Q 018656 177 SLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN----- 249 (352)
Q Consensus 177 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~----- 249 (352)
... .......++..|+|||.+.+ ...++.++|||||||++|+|++|+.||.+.+............
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcC-------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 322 22233467899999998854 2346889999999999999999999998866544332221100
Q ss_pred ------------------CC--------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 250 ------------------VR--------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 250 ------------------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.. ......++++.++|.+||+.||.+|||+.+++++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 00 112345788999999999999999999999999843
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=305.38 Aligned_cols=250 Identities=28% Similarity=0.484 Sum_probs=205.9
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHH----HHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE----IAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
+|.++..||+|++|.||+|.+. ++.+|+|.+........ .......+.+|+.++++++||||+++++++.+ ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788889999999999999874 78999998876543221 12334568899999999999999999999874 57
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++++||+++++|.+++..... +++..+..++.|++.||+|||++|++||||+|+||+++++ +.++|+|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCcccc
Confidence 8999999999999999987543 8999999999999999999999999999999999999988 789999999987543
Q ss_pred ccc-------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 018656 178 LTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 178 ~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 229 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQ--------TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS 229 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhcc--------CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC
Confidence 211 1112357889999998754 4567899999999999999999999987665444443333333
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...+..++..+.++|++||+.||.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 34456789999999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=319.88 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=200.2
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.|.+ +++|++.+.||+|+||+||+|.+. ++.||||++....... .....+.+|++++++++||||+++++++..
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07878 10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL---IHARRTYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh---HHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence 3433 678999999999999999999874 7899999987543221 223457789999999999999999988742
Q ss_pred -------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 96 -------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 96 -------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
...+++++++ +++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++++ +.+||+
T Consensus 86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~ 160 (343)
T cd07878 86 ATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRIL 160 (343)
T ss_pred cccccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEc
Confidence 2478999998 78999887642 39999999999999999999999999999999999999988 799999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
|||++...... .....|+..|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+........
T Consensus 161 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 231 (343)
T cd07878 161 DFGLARQADDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV 231 (343)
T ss_pred CCccceecCCC--cCCccccccccCchHhcC-------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 99998764322 234578999999998754 245788999999999999999999999875543332222111
Q ss_pred cCC---------------------C---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 249 NVR---------------------P---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 249 ~~~---------------------~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
... + .....++.+.++|.+||..||.+|||+.++++|.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000 0 0123566789999999999999999999999983
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=306.23 Aligned_cols=258 Identities=25% Similarity=0.484 Sum_probs=210.8
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
+++++|++.+.||+|+||.||+|.+. +..|++|.+...... .....+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE----IQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 67889999999999999999999874 478999987643322 23456889999999999999999999875
Q ss_pred c--CceEEEEEcCCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceE
Q 018656 95 E--PVMVIVTELLSGGTLRKYLLNMRP------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (352)
Q Consensus 95 ~--~~~~lv~e~~~~~sL~~~l~~~~~------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vk 166 (352)
. ...+++++|+++++|.+++..... ..+++..++.++.|++.||+|||+++++|+||||+||+++.+ +.++
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~k 157 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQVK 157 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcEE
Confidence 4 478999999999999999976432 358999999999999999999999999999999999999988 7999
Q ss_pred EecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 018656 167 LADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 242 (352)
Q Consensus 167 l~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 242 (352)
|+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++|++++ |+.||.........
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 229 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN--------KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc--------CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 99999987532221 1122345778999998854 557889999999999999998 99999876554433
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 243 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
.........+....+|+++.+++.+||..||++|||+.++++.|....+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 230 AYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 3222222233455678999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=337.79 Aligned_cols=261 Identities=31% Similarity=0.571 Sum_probs=224.5
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC---Cc----eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK---NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
+.+++.++...||+|.||.||.|... |. .||||.+....... ....|.+|..+|+.++||||++++|++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~----~~~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ----EVSDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH----HHHHHHHHHHHHhcCCCcceeeEEEee
Confidence 55899999999999999999999764 33 48888887765543 355699999999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
-+ ...+|++|||+||+|..||++.. ...++..+.+.++.|+++|..||+++++|||||..+|+|++.. ..|||
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKI 843 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKI 843 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEE
Confidence 75 46899999999999999998762 3458999999999999999999999999999999999999998 89999
Q ss_pred ecCCCccccccccc-ccc--CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 018656 168 ADFGLAREESLTEM-MTA--ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAY 243 (352)
Q Consensus 168 ~Dfg~a~~~~~~~~-~~~--~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~ 243 (352)
+|||+|+..-.... ... ..-...|||||.+.. +.++.++||||||+++||+++ |..||.+.++.+...
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--------~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~ 915 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--------GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL 915 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhh--------cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH
Confidence 99999994222221 111 133578999999964 789999999999999999998 999999999988888
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 244 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
........+.+..+|..+.+++.+||+.+|++||++..|++.+........
T Consensus 916 ~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 916 DVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 777777788899999999999999999999999999999998777665543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=307.07 Aligned_cols=253 Identities=28% Similarity=0.515 Sum_probs=206.7
Q ss_pred ecCCceeeeccccCCCceEEEEEEE-------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
|+.++|.+.+.||+|+||.||++.. .+..+++|.+..... .....+.+|++++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-----SARQDFQREAELLTVLQHQHIVRFYGVC 76 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH-----HHHHHHHHHHHHHhcCCCCCCceEEEEE
Confidence 4667899999999999999999864 245788888764322 2344688999999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRP-------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~ 159 (352)
.+ ...+++|||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 77 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 75 468999999999999999986542 2488999999999999999999999999999999999999
Q ss_pred CCCCceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 018656 160 EDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEG 235 (352)
Q Consensus 160 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~ 235 (352)
++ +.++|+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||..
T Consensus 157 ~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 157 QG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred CC-CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc--------CCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 87 7999999999864322211 122235678999998754 557889999999999999998 9999987
Q ss_pred CChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 236 MSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
..................+..+|+.+.+++.+||+.||.+||++.++++.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 228 LSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 6655544444433334445678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=301.40 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=214.1
Q ss_pred Cceeee-ccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec----
Q 018656 24 KHLFVG-PRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE---- 95 (352)
Q Consensus 24 ~~y~~~-~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~---- 95 (352)
++|++- ++||-|-.|.|..+.+ +|+++|+|++... .+..+|+++.-.. .|||||.++++|..
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 445554 7899999999999876 4999999998642 2356888877666 69999999999863
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCC
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGL 172 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~ 172 (352)
.++.+|||.++||.|.+.+..++...++|.++..|+.||+.|+.|||+.+|.||||||+|+|.+.. ...+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 378999999999999999999988889999999999999999999999999999999999999643 24799999999
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH---HH----HHH
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ---AA----YAA 245 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~---~~----~~~ 245 (352)
|+.........+.+-|+.|.|||++.. ..|+...|+||||+++|-|++|.+||....... .. ...
T Consensus 211 AK~t~~~~~L~TPc~TPyYvaPevlg~--------eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 211 AKETQEPGDLMTPCFTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred ccccCCCccccCCcccccccCHHHhCc--------hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 998776667778889999999999854 669999999999999999999999997654321 11 111
Q ss_pred HhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 018656 246 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300 (352)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~~~ 300 (352)
......+.++.+|++.+++|+.+|..+|++|.|+.+++++.|-......+..+..
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~ 337 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS 337 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence 2233456678899999999999999999999999999999665544444444433
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=318.12 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=206.1
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeee-
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC- 93 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~- 93 (352)
.+..|..+.|++.+.||+||.+.||++... .+.||+|.+....... ...+-+.+|++.|.+| .|.+||+++++-
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~---qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN---QTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH---HHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 456788999999999999999999999875 4566666655433322 3355689999999999 599999999995
Q ss_pred ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 94 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
.++.+|+||||- ..+|..++++.... ++.-.+..++.||+.++.++|+.||||.||||+|+|+-. |.+||+|||+|
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G~LKLIDFGIA 506 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--GRLKLIDFGIA 506 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--eeEEeeeechh
Confidence 478999999997 56999999886543 444588899999999999999999999999999999987 58999999999
Q ss_pred ccccccc---ccccCCCccccccccccccccccc---ccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 018656 174 REESLTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 174 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~---~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 247 (352)
....... ...+.+||+.|||||.+...+... +.....+.++|||||||+||+|+.|+.||....+.......+.
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 8544332 345678999999999998755432 1234578899999999999999999999987554333333333
Q ss_pred ccCC--CCCCCCc-HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 248 KNVR--PSAENVP-EELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 248 ~~~~--~~~~~~~-~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.... +.+..-+ .++.++++.||+.||.+||++.++++|
T Consensus 587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2211 1122111 339999999999999999999999998
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=306.03 Aligned_cols=254 Identities=30% Similarity=0.535 Sum_probs=204.6
Q ss_pred cCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
..++|.+.+.||+|++|.||+|.+. +..|++|......... ....+.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ----DESDFLMEALIMSKFNHQNIVRLIGVSF 79 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 4578999999999999999999874 3678889876543322 2345788999999999999999999876
Q ss_pred -cCceEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC--CceE
Q 018656 95 -EPVMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIK 166 (352)
Q Consensus 95 -~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~--~~vk 166 (352)
....+++|||++|++|.+++..... ..+++..++.++.|++.||+|||+++++|+||||+||+++.++ ..++
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 4478999999999999999976542 2489999999999999999999999999999999999998652 3689
Q ss_pred EecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 018656 167 LADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 242 (352)
Q Consensus 167 l~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 242 (352)
|+|||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~ 231 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD--------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhc--------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999875422111 112233568999999854 568899999999999999996 99999886655444
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 243 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
...........+..+|..+.+++.+||+.+|.+||++.++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 333333333445678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=304.37 Aligned_cols=254 Identities=29% Similarity=0.505 Sum_probs=207.0
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--C---ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
+...|++.+.||+|+||.||+|.++ + ..||||++...... .....+..|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE----KQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH----HHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 4567899999999999999999874 3 35999998764332 234568899999999999999999999874
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~~ 155 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRF 155 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCccccc
Confidence 47899999999999999997643 348999999999999999999999999999999999999887 7999999999864
Q ss_pred ccccccc----ccCC--CcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 018656 176 ESLTEMM----TAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 176 ~~~~~~~----~~~~--g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 248 (352)
....... .... .+..|+|||.+.. ..++.++||||||+++|++++ |..||...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~ 227 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD 227 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhcc--------CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 3222111 1111 2457999998854 567889999999999999886 99999886655444444333
Q ss_pred cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 249 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
...+.+..+|..+.+++.+||+.+|.+||++.+++..|..+
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 34455678899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=316.07 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=202.5
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||+||+++++ ++.||+|++....... ......+.+|..+++.++|++|+++++++.+ +..++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK--RAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHh--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 47999999999999999999885 7889999986532111 1234457789999999999999999999874 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||++|++|.+++.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++.......
T Consensus 79 v~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-CCEEEEeccceeeccCCC
Confidence 999999999999998643 248999999999999999999999999999999999999988 799999999987543322
Q ss_pred c--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC----CCCC
Q 018656 181 M--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV----RPSA 254 (352)
Q Consensus 181 ~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~~ 254 (352)
. .....|++.|+|||++.+... ....++.++||||||+++|+|++|+.||.+.+............. ....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 233 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMED---GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233 (331)
T ss_pred ceeeccccCCcccCCHHHHhcccc---CCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence 1 123468999999998854210 113567899999999999999999999988665444433332221 1123
Q ss_pred CCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 286 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~--Rps~~~i~~~l 286 (352)
..++.++.+++.+||..++.+ |++++++++|.
T Consensus 234 ~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 234 TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 457899999999999876554 56899998884
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=307.57 Aligned_cols=259 Identities=28% Similarity=0.412 Sum_probs=209.2
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
.+|+...+.|++.+.||+|+||.||+|++. ++.+++|++..... .....+.+|+.+++.++||||+++++.+.
T Consensus 5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (292)
T cd06644 5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-----EELEDYMVEIEILATCNHPYIVKLLGAFY 79 (292)
T ss_pred hcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCcEeeeEEEEE
Confidence 457777889999999999999999999884 78999999865432 23455788999999999999999999876
Q ss_pred -cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 -EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
++..++||||+++++|..++.+.. ..+++..++.++.|++.+|.|||++|++||||+|+||+++.+ +.++|+|||++
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~ 157 (292)
T cd06644 80 WDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVS 157 (292)
T ss_pred eCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccc
Confidence 558999999999999999876543 348999999999999999999999999999999999999887 79999999988
Q ss_pred cccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--
Q 018656 174 REESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-- 250 (352)
Q Consensus 174 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-- 250 (352)
...... .......++..|+|||.+.+... ....++.++|+||||+++|+|++|..||...+.............
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETM---KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234 (292)
T ss_pred eeccccccccceecCCccccCceeeccccc---cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc
Confidence 643222 12234467889999998753110 124567899999999999999999999987654433333222211
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...+..++.++.+++.+||..||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 12245678899999999999999999999999987
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=322.25 Aligned_cols=250 Identities=28% Similarity=0.392 Sum_probs=218.3
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
+.|.-.+.||.|+||.||-|++. .+.||||.+........ ...+.+..|+++|++++|||+|.+-+||- +.+.|+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~--EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccH--HHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 34566788999999999999984 78999999987665443 66788999999999999999999999987 568999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||| -||-.|.+.-++ +++-+.++..|+.+.+.||+|||+.+.||||||..|||+++. |.|||+|||.|....+
T Consensus 104 VMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 104 VMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-GLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-CeeeeccccchhhcCc--
Confidence 99999 568888887654 459999999999999999999999999999999999999998 8999999999876443
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC-CCCCcH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AENVPE 259 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 259 (352)
..+++|||.|||||++..+. .+.|+.++||||||++-.+|...++|+-.++....++-+.....+.. ...++.
T Consensus 179 -AnsFvGTPywMAPEVILAMD-----EGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~ 252 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMD-----EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD 252 (948)
T ss_pred -hhcccCCccccchhHheecc-----ccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHH
Confidence 35679999999999987643 57899999999999999999999999998888888887776655444 457899
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.+..|+..||++-|.+|||.++++.|.
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 999999999999999999999998873
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=301.65 Aligned_cols=244 Identities=34% Similarity=0.646 Sum_probs=206.0
Q ss_pred ccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEE
Q 018656 30 PRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTE 103 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e 103 (352)
+.||+|+||.||+|.+. +..+++|++....... ....+.+|++.++.++|+||+++++++.. ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 46999999999999885 7789999987655433 34568899999999999999999999875 57999999
Q ss_pred cCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 104 LLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 104 ~~~~~sL~~~l~~~~-------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
|+++++|.+++.... ...+++..++.++.|++.||++||++|++|+||+|+||+++++ +.++|+|||.+...
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~ 155 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDV 155 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEccccccccc
Confidence 999999999998752 2459999999999999999999999999999999999999998 79999999999864
Q ss_pred ccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 018656 177 SLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 177 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
... .......++..|+|||.+.. ..++.++||||||+++|+|++ |..||......+...........+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKD--------GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP 227 (262)
T ss_pred ccccccccccCCCcCccccCHHHhcc--------CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 432 12233457889999998754 467889999999999999999 699998876655444444444445
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.+..+|.++.+++.+||..+|.+|||+.+++++|
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 5678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=329.83 Aligned_cols=260 Identities=29% Similarity=0.522 Sum_probs=231.6
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
-.||.....+.++||.|.||+|++|+.+ ...||||.++..... +.+..|..|..+|-+++||||++|.++.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte----kqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE----KQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH----HHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 5688899999999999999999999885 357999999887663 4566799999999999999999999998
Q ss_pred ecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 94 ~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
... -..||.|||++|+|+.|++++.++ |+..++..+++.|+.|+.||-++|+|||||...||||+.+ -.+|++|||+
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGL 777 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGL 777 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccc
Confidence 755 578999999999999999998765 9999999999999999999999999999999999999998 7999999999
Q ss_pred cccccccc--ccccC--CCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 018656 173 AREESLTE--MMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 173 a~~~~~~~--~~~~~--~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 247 (352)
++....+. ..++. ....+|.|||.+.. ..++.+|||||+|++|||.+. |..||..+++.+....+..
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~--------RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~ 849 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ 849 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhh--------cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence 98543322 11222 23579999999865 789999999999999999775 9999999999999999999
Q ss_pred ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 248 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
....|.+.++|..|.+|+..||++|..+||.+.+|+..|.+.+++
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 999999999999999999999999999999999999999998865
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=303.63 Aligned_cols=257 Identities=26% Similarity=0.519 Sum_probs=212.5
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--Cc----eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
+...+|++.+.||+|+||+||+|.+. |+ .+|+|+....... .....+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP----KANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 55678999999999999999999863 33 5899987765442 33456889999999999999999999998
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
....++++||+++++|.+++.+... .+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||+++
T Consensus 80 ~~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~~ 157 (279)
T cd05057 80 SSQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAK 157 (279)
T ss_pred cCceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCcccc
Confidence 8889999999999999999987543 38999999999999999999999999999999999999887 789999999987
Q ss_pred cccccccc---ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 018656 175 EESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 175 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
........ ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+....+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 229 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILH--------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER 229 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhc--------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Confidence 54322211 11223568999998743 567889999999999999998 9999988765554444443334
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
.+.+...+..+.+++.+||..||.+||++.++++.+....+
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 45566788999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=303.70 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=203.8
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---Cc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~ 97 (352)
+.+|++++.||+|+||.||.+.+. |+.||||++...............+.+|+.+++++.||||+++++++.+ ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 468999999999999999999874 7899999886543322222345578899999999999999999998764 35
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
++++|||+++++|.+++.+... +++..++.++.|++.||++||+++++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCccccccc
Confidence 8899999999999999986543 8899999999999999999999999999999999999988 799999999987533
Q ss_pred cc----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-C
Q 018656 178 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-P 252 (352)
Q Consensus 178 ~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~ 252 (352)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.................. .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPV 229 (265)
T ss_pred cccccccccccCCCCccccChhhhcC--------CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCC
Confidence 21 11233458889999998854 45688999999999999999999999876544433333222222 2
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.+..++..+.+++++|+. +|.+||++++++++.
T Consensus 230 ~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 230 LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 345677889999999995 999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=310.26 Aligned_cols=247 Identities=34% Similarity=0.552 Sum_probs=202.1
Q ss_pred eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVT 102 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv~ 102 (352)
|++++.||+|+||+||++.+. ++.+|+|++......... .....+|+.++++++||||+++++++. +...+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE---REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH---HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc---cchhhhhhhccccccccccccccccccccccccccc
Confidence 789999999999999999996 568999999886544432 223456999999999999999999987 55789999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc-cccccc
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEM 181 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~-~~~~~~ 181 (352)
|++++++|.+++.+... +++..++.++.|+++||++||++|++|+||||+||+++++ +.++|+|||.+.. ......
T Consensus 78 ~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKP--LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEETTEBHHHHHHHHSS--BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccc
Confidence 99999999999985444 8999999999999999999999999999999999999977 8999999999875 233344
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc------CCCCCC
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN------VRPSAE 255 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~------~~~~~~ 255 (352)
.....++..|+|||++.. ...++.++|+||||+++|+|++|..||................ ......
T Consensus 155 ~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQ-------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR 227 (260)
T ss_dssp BSSSSSSGGGSCHHHHTT-------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT
T ss_pred cccccccccccccccccc-------cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccc
Confidence 456678999999999751 3678899999999999999999999999863222222111111 111122
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+.++.+++.+||+.||.+||++.+++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 335899999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=306.38 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=202.1
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~ 98 (352)
..++|++.+.||+|+||.||+|.+. ++.||+|++...... ....+.+|+.++++++||||+++++.+. +...
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-----DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-----hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 4568999999999999999999874 789999998754322 1234778999999999999999999986 4578
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-GDVKLADFGVAAKITA 158 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEECcCccceeecc
Confidence 99999999999999987654 38999999999999999999999999999999999999887 7899999999875432
Q ss_pred cc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-C---C
Q 018656 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-P---S 253 (352)
Q Consensus 179 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~---~ 253 (352)
.. ......++..|+|||.+... ....++.++|+||+|+++|+|++|+.||.................. + .
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVE-----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKD 233 (267)
T ss_pred cccccCccccCccccCHhHcccc-----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcc
Confidence 21 12334688899999987431 1244678999999999999999999999754433222211111111 1 1
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
...++..+.+++++||..+|.+||+++++++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 235788999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=337.59 Aligned_cols=258 Identities=23% Similarity=0.347 Sum_probs=205.6
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||.||+|.+. |+.||+|++....... .....++.+|++++++++||||+++++++.+ +..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~--e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN--PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC--HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 57999999999999999999885 8899999987543322 2334578899999999999999999999874 47899
Q ss_pred EEEcCCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 101 VTELLSGGTLRKYLLNMR---------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
+|||++|++|.+++.... ...++...++.++.|+++||+|||++||+||||||+||+++.+ +.++|+|||
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d-g~vKLiDFG 158 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-GEVVILDWG 158 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-CCEEEEecC
Confidence 999999999999987531 1235667788999999999999999999999999999999988 799999999
Q ss_pred Cccccccc-------------------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCC
Q 018656 172 LAREESLT-------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 232 (352)
Q Consensus 172 ~a~~~~~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (352)
++...... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..|
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--------~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--------VPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--------CCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 98754110 01112468999999998854 5678899999999999999999999
Q ss_pred CCCCChHHHHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhhc
Q 018656 233 FEGMSNLQAAYAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSA 292 (352)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~i~~~l~~~~~~ 292 (352)
|.................. .....+|+.+.+++.+||..||.+|| +++++++.+..+++.
T Consensus 231 F~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 231 YRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 9875543332222111111 11346889999999999999999996 567777778777664
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=307.60 Aligned_cols=247 Identities=27% Similarity=0.372 Sum_probs=206.9
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||.||++.+. ++.+|+|++....... .+....+.+|++++++++||||+++++++.+ +..++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK--LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 47999999999999999999884 7999999986533211 2345668899999999999999999999875 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC-
Confidence 999999999999998764 38999999999999999999999999999999999999988 79999999998765433
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
.....+++.|+|||.+.+ ...+.++|+||||+++|+|++|..||....... ..........+.+..++..
T Consensus 155 -~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 224 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILS--------KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-IYEKILEGKVRFPSFFSPD 224 (290)
T ss_pred -CCCCCCCccccChhhhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCCccCCccCCHH
Confidence 234468899999998754 456789999999999999999999998766433 2333333344556678999
Q ss_pred HHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
+.++|.+||..||.+|+ ++++++++.
T Consensus 225 l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 225 AKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred HHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 99999999999999999 888888873
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=301.60 Aligned_cols=250 Identities=28% Similarity=0.488 Sum_probs=205.7
Q ss_pred ceeeeccccCCCceEEEEEEE-CCceEEEEEcccCCCh-HHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY-KNQTVAIKIVHKGETP-EEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~-~~~~vaiK~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|++++.||+|+||.||+|.+ +|+.+|+|.+...... .........+.+|+.++++++|+||+++++++.+ ...+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478899999999999999987 5889999988754322 2222345668899999999999999999999874 478999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc---
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL--- 178 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~--- 178 (352)
+||+++++|.+++.+... +++..+..++.|++.||+|||+.|++|+||+|+||+++++ +.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhhhccc
Confidence 999999999999976543 8999999999999999999999999999999999999987 7999999999864321
Q ss_pred ----ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--cCCC
Q 018656 179 ----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK--NVRP 252 (352)
Q Consensus 179 ----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~ 252 (352)
........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+........... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINE--------SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229 (265)
T ss_pred cccccccccccCCCccccChhhhcC--------CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence 112234468899999998854 55788999999999999999999999876554433332222 2233
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+..++.++.++|++||..+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 456789999999999999999999999999886
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=307.69 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=211.2
Q ss_pred ccccccccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 018656 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88 (352)
Q Consensus 11 ~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 88 (352)
++++.....--...+|++.+.||+|+||.||+|.+. ++.+++|.+....... ...+.+|+.+++.++||||++
T Consensus 7 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~e~~~l~~~~h~~v~~ 81 (296)
T cd06654 7 EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVN 81 (296)
T ss_pred HHHHhccccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-----HHHHHHHHHHHHhCCCCCEee
Confidence 445444445555789999999999999999999874 7899999987654332 245788999999999999999
Q ss_pred eeeeee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 89 l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
+++.+. ....++||||+++++|.+++.+. .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl 157 (296)
T cd06654 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKL 157 (296)
T ss_pred EEEEEEeCCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEE
Confidence 999886 45899999999999999998653 38899999999999999999999999999999999999988 79999
Q ss_pred ecCCCcccccccc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 018656 168 ADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 168 ~Dfg~a~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 246 (352)
+|||++....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.............
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~ 229 (296)
T cd06654 158 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229 (296)
T ss_pred CccccchhccccccccCcccCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh
Confidence 9999987533222 1233468899999998754 556789999999999999999999998766544333332
Q ss_pred hccC--CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 247 FKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 247 ~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.... .+.+..++..+.+++.+||..+|.+||++.+++++.
T Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 2221 123456889999999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=326.30 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=189.7
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC------CCCCeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV------QHRNLVKFIGA 92 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~l~~~ 92 (352)
+...+|++.+.||+|+||+||+|.+. ++.||||++...... ......|+++++.+ .|+++++++++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY------TRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh------HHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 34578999999999999999999874 789999998643211 12234455555544 45668899988
Q ss_pred eec--CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCC------
Q 018656 93 CKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK------ 163 (352)
Q Consensus 93 ~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~------ 163 (352)
+.. ...++|||++ |++|.+++.+... +++..+..|+.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHGP--FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 864 3689999998 7899999987543 9999999999999999999998 59999999999999986521
Q ss_pred ---------ceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCC
Q 018656 164 ---------TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234 (352)
Q Consensus 164 ---------~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 234 (352)
.+||+|||.+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~--------~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG--------LGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc--------CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 499999998764322 2345679999999999865 568899999999999999999999998
Q ss_pred CCChHHHHHHHHhccCC-------------------------CC----------------CCCCcHHHHHHHHHhhccCC
Q 018656 235 GMSNLQAAYAAAFKNVR-------------------------PS----------------AENVPEELSIILTSCWKEDP 273 (352)
Q Consensus 235 ~~~~~~~~~~~~~~~~~-------------------------~~----------------~~~~~~~l~~li~~~l~~~p 273 (352)
+.+..+........... +. .....+.+.+||.+||..||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 86654332221111000 00 00013457799999999999
Q ss_pred CCCCCHHHHHHHH
Q 018656 274 NARPNFTQIIQML 286 (352)
Q Consensus 274 ~~Rps~~~i~~~l 286 (352)
.+|||++++++|.
T Consensus 427 ~~R~ta~e~L~Hp 439 (467)
T PTZ00284 427 QKRLNARQMTTHP 439 (467)
T ss_pred hhCCCHHHHhcCc
Confidence 9999999999983
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=301.74 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=204.7
Q ss_pred CceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
++|++.+.||+|+||.||+|++ +++.||||.+....... ......+.+|+.++++++||||+++++++. .+..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD--AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC--HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 5799999999999999999987 48999999876533222 133456888999999999999999999886 457899
Q ss_pred EEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 101 VTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||+++++|.+++.... ...+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC-CCEEECccccceeccc
Confidence 999999999999886432 2348999999999999999999999999999999999999988 7899999999875432
Q ss_pred cc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHhc-cCCCC-C
Q 018656 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ-AAYAAAFK-NVRPS-A 254 (352)
Q Consensus 179 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~~~~~~~-~~~~~-~ 254 (352)
.. ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||....... ........ ...+. .
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT 230 (267)
T ss_pred hhHHHhcCCCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCCh
Confidence 22 1223468889999998854 456789999999999999999999996543221 22222222 22222 3
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
..++..+.+++.+||..+|.+||++.++++.+...
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 46788999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=309.63 Aligned_cols=251 Identities=28% Similarity=0.417 Sum_probs=206.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|++|+||+|.+. ++.+|+|.+....... ......+.+|+++++.++||||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK--RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch--HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 47899999999999999999884 7999999987654332 1344568899999999999999999999874 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
+|||+.|++|.+++.+.....+++..++.++.|+++||+|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhcccccc
Confidence 9999999999999987655569999999999999999999999999999999999999988 799999999976432211
Q ss_pred ------------------------------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCC
Q 018656 181 ------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 230 (352)
Q Consensus 181 ------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~ 230 (352)
......|+..|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--------DGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--------CCCCchHHHHHHHHHHHHHhhCC
Confidence 0112357889999999854 45788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCCC----HHHHHHH
Q 018656 231 LPFEGMSNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPN----FTQIIQM 285 (352)
Q Consensus 231 ~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~i~~~ 285 (352)
.||.+.+............. .+....++..+.+++.+||..||.+||+ +++++.+
T Consensus 230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 230 TPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 99987665544443332222 2223347899999999999999999999 8888887
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.85 Aligned_cols=255 Identities=29% Similarity=0.524 Sum_probs=208.8
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--C---ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
|...+|+..+.||+|+||.||+|.+. + ..+++|.+...... .....+.+|++++++++||||+++.+++.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE----KQRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH----HHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 45678899999999999999999874 3 36999988654332 224468899999999999999999999874
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
...+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++++ +.++|+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~ 155 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSR 155 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccce
Confidence 47899999999999999997643 348999999999999999999999999999999999999987 789999999987
Q ss_pred ccccccc--c--ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc
Q 018656 175 EESLTEM--M--TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 175 ~~~~~~~--~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 249 (352)
....... . .....+..|+|||.+.. ..++.++||||||+++|+|++ |..||...+............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~ 227 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhc--------CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC
Confidence 5432211 1 11123457999998754 567889999999999999997 999998766655544444444
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
..+....++.++.+++.+||+.+|.+||++.++++.|.+.
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 4555667899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=301.32 Aligned_cols=251 Identities=27% Similarity=0.482 Sum_probs=208.3
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|+..+.||+|++|+||+|.+. ++.|++|.+...............+.+|+.+++.++|+||+++++++.+ ...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999874 8999999987654333223445678899999999999999999998874 578999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
+||+++++|.+++.+... +++..++.++.|++.||++||+.|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccceecccccc
Confidence 999999999999987543 8899999999999999999999999999999999999988 7999999999876544433
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh-ccCCCCCCCCcHH
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF-KNVRPSAENVPEE 260 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 260 (352)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|+.||.............. ......+..++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~-------~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQ-------QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDE 230 (258)
T ss_pred ccccCCCcceeCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHH
Confidence 445568899999998754 12378899999999999999999999987664444444333 2222335678899
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+.+++.+||+.+|.+||++.+++.+
T Consensus 231 ~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 231 AKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhcC
Confidence 9999999999999999999999876
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=302.32 Aligned_cols=251 Identities=27% Similarity=0.458 Sum_probs=203.8
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---Cc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~ 97 (352)
+.+|++.+.||+|+||.||+|.+ ++..|++|++..........+....+.+|+.++++++||||+++++++.+ ..
T Consensus 1 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 1 PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 35789999999999999999987 47899999987654333223445668899999999999999999998763 46
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+++++||+++++|.+++.+... +++..++.++.|++.||+|||+++++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~ 157 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCCCccccc
Confidence 8899999999999999986543 8999999999999999999999999999999999999987 789999999987432
Q ss_pred cc----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 018656 178 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253 (352)
Q Consensus 178 ~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (352)
.. .......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||..................+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISG--------EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ 229 (266)
T ss_pred cccccCCccccCCccccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCC
Confidence 21 11223457889999998854 5578899999999999999999999987655444443333222222
Q ss_pred -CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 -AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 -~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+..+++.+..++ .||..+|.+||+++++++|
T Consensus 230 ~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 230 LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 445778899998 5777899999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=303.83 Aligned_cols=248 Identities=29% Similarity=0.475 Sum_probs=197.6
Q ss_pred eeeeccccCCCceEEEEEEE------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---C
Q 018656 26 LFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---P 96 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~ 96 (352)
|++.+.||+|+||+||++.. .++.||+|++...... .....+.+|+++++.++||||+++++++.. .
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ----QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh----HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 48899999999999988642 3678999998765332 223457889999999999999999998753 3
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..+++|||+++++|.+++... .+++..++.++.|++.||.|||++|++||||||+||+++++ +.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~ 157 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAV 157 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeeccccccc
Confidence 589999999999999999763 39999999999999999999999999999999999999988 79999999998754
Q ss_pred ccccc----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH-----------
Q 018656 177 SLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA----------- 241 (352)
Q Consensus 177 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~----------- 241 (352)
..... .....++..|+|||.+.. ..++.++||||||+++|+|++|..||........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--------NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--------cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence 33211 122245677999998753 5678899999999999999999999865322100
Q ss_pred ---HHH-HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 242 ---AYA-AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 242 ---~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
... .......+.+..++.++.+++.+||+.+|++|||++++++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 000 001112233567889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=305.71 Aligned_cols=254 Identities=28% Similarity=0.538 Sum_probs=207.8
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
++..+|++...||+|+||.||+|.+. +..+|+|++...... .....+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~ei~~l~~l~h~~iv~~~~~~ 77 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA----DMQADFQREAALMAEFDHPNIVKLLGVC 77 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH----HHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence 46678999999999999999999863 578999998755432 2234588899999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRP--------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dik 152 (352)
.+ ...++++||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 74 478999999999999999975321 247888999999999999999999999999999
Q ss_pred CCCeEEeCCCCceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-
Q 018656 153 PENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 228 (352)
Q Consensus 153 p~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~- 228 (352)
|+||+++.+ +.++|+|||++........ ......+..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 158 p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~~ 228 (288)
T cd05050 158 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIFSY 228 (288)
T ss_pred HhheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc--------CCCCchhHHHHHHHHHHHHHhC
Confidence 999999988 7999999999874322211 122234667999998754 567889999999999999997
Q ss_pred CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 229 NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
|..||.+....+...........+.+..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 229 GMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 88899876665544444444444456678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=311.64 Aligned_cols=250 Identities=18% Similarity=0.334 Sum_probs=196.4
Q ss_pred eeccccCC--CceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEEE
Q 018656 28 VGPRIGEG--AHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVT 102 (352)
Q Consensus 28 ~~~~lG~G--~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv~ 102 (352)
++.+||+| +|++||++.++ |+.||+|.+........ ....+.+|+.+++.++||||+++++++. ++..++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE---MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH---HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 56789999 78999999874 89999999876544332 2345778999999999999999999987 45799999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc---
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT--- 179 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~--- 179 (352)
||+++++|.+++..+....+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++++||+.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-CcEEEcccchhhcccccccc
Confidence 99999999999987655568999999999999999999999999999999999999988 78999999865422110
Q ss_pred -----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC----
Q 018656 180 -----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV---- 250 (352)
Q Consensus 180 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~---- 250 (352)
.......++..|+|||++.+ ....++.++|||||||++|+|++|..||.................
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 231 (327)
T ss_pred ccccccccccccceecccChHHhhc------ccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccc
Confidence 01122356778999999854 124578899999999999999999999986544332222111100
Q ss_pred -----------------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 251 -----------------------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 251 -----------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+....+++.+.+++.+||+.||.+|||+++++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0011235678999999999999999999999999843
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=300.90 Aligned_cols=248 Identities=30% Similarity=0.517 Sum_probs=197.5
Q ss_pred ccccCCCceEEEEEEEC--Cc--eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-CceEEEEE
Q 018656 30 PRIGEGAHAKVYEGKYK--NQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVMVIVTE 103 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e 103 (352)
+.||+|+||.||+|.+. +. .+++|.+...... .....+.+|+++++++ +||||+++++++.. +..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH----HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 36899999999999875 33 4688887643322 2234578899999999 89999999999874 57899999
Q ss_pred cCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 104 LLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 104 ~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
|+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~d 155 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIAD 155 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECC
Confidence 9999999999976431 247899999999999999999999999999999999999988 7999999
Q ss_pred CCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 018656 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 170 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 248 (352)
||++..............+..|+|||++.. ..++.++||||||+++|+|++ |..||.+.+...........
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 227 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHcc--------CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC
Confidence 999864322211112234567999998744 567889999999999999996 99999876554433333222
Q ss_pred cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 249 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
...+.+..++.++.+++.+||..||.+|||+.+++..|...+
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 233345567899999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=298.12 Aligned_cols=245 Identities=28% Similarity=0.526 Sum_probs=202.7
Q ss_pred ccccCCCceEEEEEEEC---C--ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCceEEEEEc
Q 018656 30 PRIGEGAHAKVYEGKYK---N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTEL 104 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~---~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~lv~e~ 104 (352)
+.||+|++|+||+|.+. + ..+|+|++...... .....+.+|+.++++++||||+++++.+.+...++++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEe
Confidence 46899999999999873 2 36899998775543 345568899999999999999999999877889999999
Q ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc----
Q 018656 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---- 180 (352)
Q Consensus 105 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---- 180 (352)
+++++|.+++.+.....+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEecccccccccccccccee
Confidence 999999999987653458999999999999999999999999999999999999998 799999999987543311
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh-ccCCCCCCCCc
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF-KNVRPSAENVP 258 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 258 (352)
......++..|+|||.+.. ..++.++||||||+++|+|++ |..||......+....... ....+.+..+|
T Consensus 156 ~~~~~~~~~~y~~pE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRT--------RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACP 227 (257)
T ss_pred cccCCCCCceecCHHHhcc--------cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCC
Confidence 1122356788999998754 567889999999999999998 9999987666554333332 22223355688
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
..+.+++.+||+.+|.+||++.++++.|.
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 99999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=305.05 Aligned_cols=249 Identities=30% Similarity=0.415 Sum_probs=199.5
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 101 (352)
+|++.+.||+|++|.||+|.+. |+.||+|++....... .....+.+|+.++++++||||+++++++. ++..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE---GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC---CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 4888999999999999999874 8899999987543322 12234778999999999999999999987 4589999
Q ss_pred EEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 102 TELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
|||++ ++|.+++..... ..+++..++.++.|+++||+|||++|++|+||+|+||+++++ +.++|+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeecCCCc
Confidence 99996 589998876432 458999999999999999999999999999999999999988 79999999998753322
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC---------
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--------- 250 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--------- 250 (352)
.......+++.|+|||++.+ ...++.++|+||||+++|+|++|+.||.+...............
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLG-------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred ccccCCcccccccChHHhcC-------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 12233467889999998753 23467899999999999999999999987654433322111000
Q ss_pred -------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 -------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
......+++++.++|++||..||.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 01123578999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=324.13 Aligned_cols=263 Identities=27% Similarity=0.441 Sum_probs=219.1
Q ss_pred cccccccccccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC
Q 018656 8 YLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85 (352)
Q Consensus 8 ~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 85 (352)
|+-..+..++-|.|-++ ||.|+||.||+|.++ +-..|-|++..... .....+.-||.+|..+.||+
T Consensus 23 hv~rdlnP~d~WeIiGE-------LGDGAFGKVyKA~nket~~lAAaKvIetkse-----EELEDylVEIeILa~CdHP~ 90 (1187)
T KOG0579|consen 23 HVYRDLNPRDHWEIIGE-------LGDGAFGKVYKAVNKETKLLAAAKVIETKSE-----EELEDYLVEIEILAECDHPV 90 (1187)
T ss_pred HHhccCCHHHHHHHHhh-------hcCccchhhhhhhcccchhhhhhhhhcccch-----hHHhhhhhhhhhhhcCCChH
Confidence 55556666666666555 999999999999876 44567777765432 23445788999999999999
Q ss_pred eeeeeeee-ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCc
Q 018656 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (352)
Q Consensus 86 iv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~ 164 (352)
|+++++.| .++.++++.|||.||-.+..+-.-+ +.+.+.++..+++|++.||.|||+++|||||||..|||++.+ |.
T Consensus 91 ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-Gd 168 (1187)
T KOG0579|consen 91 IVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-GD 168 (1187)
T ss_pred HHHHHHHHhccCceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-Cc
Confidence 99999875 5889999999999999998876643 459999999999999999999999999999999999999999 89
Q ss_pred eEEecCCCccccc-cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 018656 165 IKLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 243 (352)
Q Consensus 165 vkl~Dfg~a~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 243 (352)
++|+|||.+.... .-....+++||++|||||+.....+ +...|+.++||||||++|.+|..+.+|-...+......
T Consensus 169 irLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~---KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll 245 (1187)
T KOG0579|consen 169 IRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETF---KDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 245 (1187)
T ss_pred EeeecccccccchhHHhhhccccCCcccccchheeeccc---cCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH
Confidence 9999999876432 2233467799999999999876433 45789999999999999999999999999888887777
Q ss_pred HHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 244 AAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 244 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
++.....+. .++.++..+.+|+.+||..||..||++.++++|.+
T Consensus 246 KiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 246 KIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred HHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 766654433 37889999999999999999999999999999843
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=304.43 Aligned_cols=254 Identities=28% Similarity=0.514 Sum_probs=205.1
Q ss_pred ecCCceeeeccccCCCceEEEEEEECC------------------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYKN------------------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ 82 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~------------------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 82 (352)
+..++|++.+.||+|+||.||+|.+.+ ..||+|.+...... .....+.+|++++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~e~~~l~~l~ 77 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD----NAREDFLKEVKILSRLS 77 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH----HHHHHHHHHHHHHHhcC
Confidence 346789999999999999999987642 45899998765443 23456889999999999
Q ss_pred CCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 018656 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (352)
Q Consensus 83 hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dik 152 (352)
||||+++++++.. +..+++||++++++|.+++.+... ..+++..++.++.|++.||+|||++|++|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 9999999999874 589999999999999999976541 248999999999999999999999999999999
Q ss_pred CCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-
Q 018656 153 PENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 228 (352)
Q Consensus 153 p~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~- 228 (352)
|+||+++++ +.++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++
T Consensus 158 p~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 158 TRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--------GKFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred hhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--------CCCCccchhhhhHHHHHHHHhc
Confidence 999999998 799999999987532221 1223346778999998754 467899999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHhc-------cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 229 -NKLPFEGMSNLQAAYAAAFK-------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 229 -g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
|..||............... ...+.+..+|.++.+++.+||+.||.+|||+.++++.|.
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 229 CREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 77888775544433322211 112234567899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=307.83 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=200.5
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
-++|++.+.||.|+||.||+|.+. ++.||+|.+....... ....+.+|+.++++++||||+++++++.. ...+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 467999999999999999999874 7899999986543222 12246789999999999999999999874 5789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||++ ++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++++ +.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIP 157 (301)
T ss_pred EEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccCCC
Confidence 9999996 59999887643 348999999999999999999999999999999999999988 79999999998753322
Q ss_pred c-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--------
Q 018656 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-------- 250 (352)
Q Consensus 180 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-------- 250 (352)
. ......+++.|+|||++.+ ...++.++||||||+++|+|++|+.||.+.+.............
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred CCcccccceeecccCcHHHhC-------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence 1 2233457899999998753 24567899999999999999999999987665433222111100
Q ss_pred ------------CC---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 251 ------------RP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 251 ------------~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.+ ....+++.+.++|.+||..||.+|||+.+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00 0135788999999999999999999999999983
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=310.45 Aligned_cols=252 Identities=34% Similarity=0.526 Sum_probs=199.4
Q ss_pred CceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC--ceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--VMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~l 100 (352)
++|.-.+.||+|+||.||+|... |+.||||.+....... ..+|.+|+.++.+++|||+|+++|+|.+. ...+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-----EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-----hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 45666688999999999999886 5899999877655431 22399999999999999999999999855 3899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
|+||+++|+|.+++.......++|..+.+|+.++++||+|||... |+||||||+|||+|++ ...||+|||+|+...
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCC
Confidence 999999999999998754326999999999999999999999965 9999999999999988 699999999997654
Q ss_pred c-ccccccC-CCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcc
Q 018656 178 L-TEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS------NLQAAYAAAFKN 249 (352)
Q Consensus 178 ~-~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~------~~~~~~~~~~~~ 249 (352)
. ....... .||.+|+|||.+.. +..+.++||||+|+++.|+++|+.+.+... ..+.........
T Consensus 229 ~~~~~~~~~~~gt~gY~~PEy~~~--------g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 229 EGDTSVSTTVMGTFGYLAPEYAST--------GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccccceeeecCCCCccCChhhhcc--------CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 4 3333333 89999999999854 678999999999999999999998876432 111111111111
Q ss_pred -----CCCC-C-CCCc--HH---HHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 250 -----VRPS-A-ENVP--EE---LSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 250 -----~~~~-~-~~~~--~~---l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
..+. . ...+ .+ +..+..+|++.+|..||++.++++.|...
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 1111 1 2333 23 55678899999999999999998888443
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=302.66 Aligned_cols=246 Identities=27% Similarity=0.446 Sum_probs=204.5
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||.|++|.||+|.+. ++.+|+|++....... ....+.+|+++++.++|+||+++.+.+.+ ...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED----EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch----HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 47889999999999999999874 7899999987654322 23457889999999999999999998764 57899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
|+||+++++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||+++++ +.++|+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeecccc
Confidence 99999999999999764 48999999999999999999999999999999999999998 79999999998765433
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC-Cc
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN-VP 258 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 258 (352)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+................... ++
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~--------~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQ--------SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFS 224 (274)
T ss_pred cccccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccC
Confidence 22234567889999999854 4488999999999999999999999987654433333222222222333 88
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.++.+++.+||..+|.+||++++++++
T Consensus 225 ~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 225 KPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=297.20 Aligned_cols=250 Identities=30% Similarity=0.563 Sum_probs=204.2
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
+++..|++.+.||+|+||.||++.+. ++.+|+|.+....... ..+.+|++++++++||||+++++++.. ...
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE------EDFIEEAQVMMKLSHPKLVQLYGVCTERSPI 74 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH------HHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence 46778999999999999999999875 7889999887543322 247789999999999999999999864 578
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++++||+++++|.+++..... .+++..++.++.|++.+|++||+.+++|+||||+||+++.+ +.++|+|||.+.....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeeccc
Confidence 999999999999999976433 48899999999999999999999999999999999999987 7999999999875432
Q ss_pred ccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 179 TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 179 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||....................+.
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSF--------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPR 224 (256)
T ss_pred CcccccCCCccchhhcCHhHhcc--------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCC
Confidence 211 112234578999998754 557889999999999999998 999998765544333333222223345
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..+..+.+++.+||+.+|.+||++.++++.+
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 5789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=299.09 Aligned_cols=249 Identities=28% Similarity=0.426 Sum_probs=209.3
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|++.+.||+|+||.||++.+. |+.||+|.+....... .....+.+|+.++++++||||+++++++.+ +..++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP---KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh---HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 5889999999999999999874 7899999986543322 223467899999999999999999999874 478999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~- 180 (352)
+||+.+++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEEeeccceeecCcchh
Confidence 999999999999987554458999999999999999999999999999999999999987 789999999987543322
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
......++..|+|||++.+ ...+.++|+||||+++++|++|..||..................+.+..++.+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd08218 157 LARTCIGTPYYLSPEICEN--------RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYD 228 (256)
T ss_pred hhhhccCCccccCHHHhCC--------CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHH
Confidence 1223467889999998754 45778999999999999999999999876665555555444444556778999
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+.++|.+||+.+|.+||++.+++++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 229 LRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhhC
Confidence 9999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.90 Aligned_cols=254 Identities=25% Similarity=0.456 Sum_probs=202.0
Q ss_pred cCCceeeeccccCCCceEEEEEEE------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
+.+.|++.+.||+|+||.||+|.. .+..||+|.+...... .....+.+|++++++++||||+++.+++.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG----NHIADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH----HHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 456789999999999999999874 3788999998654332 224468899999999999999999998864
Q ss_pred ---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 96 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
...+++|||++|++|.+++.+.. ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~ 155 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGL 155 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCcc
Confidence 36899999999999999997643 248999999999999999999999999999999999999988 7899999999
Q ss_pred cccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh----------
Q 018656 173 AREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---------- 238 (352)
Q Consensus 173 a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~---------- 238 (352)
+....... ......++..|+|||.+.+ ..++.++||||||+++|+|+++..|+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQ--------SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTH 227 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhcc--------CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccc
Confidence 87543321 1123456778999998754 5578899999999999999998765432110
Q ss_pred ----HHHHHH-HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 239 ----LQAAYA-AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 239 ----~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
...... .......+.+..++..+.+++.+||+.||.+||++.++++.++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 228 GQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 011111 111222344567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=302.50 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=202.9
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~ 98 (352)
..++|.+.+.||+|+||.||+|.+. ++.||+|++...... ....+.+|+.+++.++||||+++++.+. ++..
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-----DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-----HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 4568999999999999999999874 789999998754322 2234778999999999999999999886 4589
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
+++|||+++++|.+++...+. +++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITA 158 (267)
T ss_pred EEEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECcceeeeEccC
Confidence 999999999999999976543 8999999999999999999999999999999999999987 7899999999864322
Q ss_pred c-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC----
Q 018656 179 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---- 253 (352)
Q Consensus 179 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---- 253 (352)
. .......|+..|+|||++... ....++.++|+|||||++|+|++|..||..................+.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVE-----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred cccccccccCcccccChhhhccc-----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence 2 122344689999999987421 124578899999999999999999999976554333332222222211
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...++..+.+++.+||+.+|.+||++++++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 22577899999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=316.35 Aligned_cols=261 Identities=30% Similarity=0.568 Sum_probs=230.9
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC----Cc--eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK----NQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~----~~--~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
..|.+.++...+.++||.|-||.||+|..+ |+ .||||+.+.....+. .+.|..|.-+++.++||||++++
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~----tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD----TEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh----HHHHHHHHHHHHhCCCcchhhee
Confidence 378999999999999999999999999764 43 588999888776654 45699999999999999999999
Q ss_pred eeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 91 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 91 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
|+|.+.-.|+|||.++-|.|..|++.++. .++......++.||+.||+|||+..+|||||...|||+.+. .-|||+||
T Consensus 458 Gv~~e~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDF 535 (974)
T KOG4257|consen 458 GVCVEQPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADF 535 (974)
T ss_pred eeeeccceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeeccc
Confidence 99999999999999999999999998654 49999999999999999999999999999999999999987 68999999
Q ss_pred CCccccccccccccCC--CcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 018656 171 GLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 171 g~a~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 247 (352)
|+++............ -..-|||||.+.. ..++.++|||.||+.+||++. |.-||.+..+.+.......
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINf--------RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn 607 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINF--------RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN 607 (974)
T ss_pred chhhhccccchhhccccccceeecCccccch--------hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC
Confidence 9999765554443333 3567999998754 678999999999999999875 9999999998888777777
Q ss_pred ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 248 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
....|.++++|+.|..++.+||+.+|.+||.+.++...|.+.++
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 88889999999999999999999999999999999998877665
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=302.94 Aligned_cols=247 Identities=28% Similarity=0.471 Sum_probs=205.7
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|++.+.||.|++|.||+|.+ .|+.|++|.+...... ....+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-----KKELIINEILVMKELKNPNIVNFLDSFLVGDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-----hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence 46799999999999999999987 4899999988654332 23457889999999999999999999874 5799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+|+||+++++|.+++... .+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 93 VVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhcccc
Confidence 999999999999998753 38999999999999999999999999999999999999987 79999999998753332
Q ss_pred cc-cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc--CCCCCCC
Q 018656 180 EM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAEN 256 (352)
Q Consensus 180 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 256 (352)
.. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+............ ....+..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (296)
T ss_pred cccCCCcCCCccccCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCccc
Confidence 21 233468889999998754 557889999999999999999999998876654443332222 1223557
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+++.+.++|++||..||.+||++.+++.+-
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 889999999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=302.65 Aligned_cols=253 Identities=26% Similarity=0.430 Sum_probs=204.8
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE---- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~---- 95 (352)
...|.+.+.||+|+||.||+|.+. ++.+|+|++...... ...+.+|+.+++++ +||||+++++.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 456888999999999999999874 789999998654322 23477899999998 79999999998753
Q ss_pred ---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 96 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
...+++|||+++++|.+++.......+++..+..++.|++.||+|||+++++|+||+|+||+++++ +.++|+|||+
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~ 157 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGV 157 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-CCEEEccCCC
Confidence 358999999999999999987655568999999999999999999999999999999999999988 7899999999
Q ss_pred ccccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-C
Q 018656 173 AREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-V 250 (352)
Q Consensus 173 a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~ 250 (352)
+...... .......|+..|+|||++...+ .....++.++|+||+||++|+|++|..||................ .
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234 (272)
T ss_pred ceecccccccCCcccccccccCHhHhcccc---CcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCC
Confidence 8754322 2223456889999999885421 113467889999999999999999999997655444333322222 1
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
......++.++.+++.+||..||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 22245678999999999999999999999999887
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=318.17 Aligned_cols=252 Identities=30% Similarity=0.419 Sum_probs=219.3
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
-..|.+...||+|.|++|.+|++ ++..||||++.+..-.. ...+.+.+|+++++.|+|||||+++.+.. ...+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~---~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP---SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh---HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 45788999999999999999987 59999999998765544 33445889999999999999999999988 66899
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||+.+|.+++|+.+++. +.+..+..++.|+.+|++|||+++|+|||||++|||++.+ -++||+|||++......
T Consensus 132 lV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN-MNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc-cceeeeccccceeeccc
Confidence 99999999999999998876 7779999999999999999999999999999999999998 47999999999988888
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
....+.+|++.|+|||++.+ ....++..|+||||+++|.|+.|.+||++.+..... ..........+..++.
T Consensus 209 ~~lqt~cgsppyAaPEl~~g-------~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-~rvl~gk~rIp~~ms~ 280 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNG-------KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-PRVLRGKYRIPFYMSC 280 (596)
T ss_pred ccccccCCCCCccChHhhcC-------cccCCcceehhhhhhhheeeeecccccCCccccccc-chheeeeecccceeec
Confidence 88899999999999999977 246788999999999999999999999985543322 2222233344556789
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
++.++|+++|.++|.+|++.+++.++-|.
T Consensus 281 dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 281 DCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred hhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 99999999999999999999999998663
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=296.36 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=214.7
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-c
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-E 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~ 95 (352)
--+.-+++...++||+|.||.|-+++.+ |+.||||++++.-.... .....-..|-++|+..+||.+..+...|+ .
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak--dEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK--DEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh--HHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 3445567888999999999999999875 89999999987654332 33445667889999999999999988887 5
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..+++||||.+||.|.-++.+. +.+++...+.+...|+.||.|||+++||.||||.+|+|++.+ |++||+|||+++.
T Consensus 241 drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD-GHIKitDFGLCKE 317 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD-GHIKITDFGLCKE 317 (516)
T ss_pred ceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC-CceEeeecccchh
Confidence 5899999999999999988764 349999999999999999999999999999999999999999 8999999999985
Q ss_pred -cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 176 -ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 176 -~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
...+...++.+||+.|+|||++.. ..|+.+.|.|.+|+++|||++|++||...+. ..+...+.......+
T Consensus 318 ~I~~g~t~kTFCGTPEYLAPEVleD--------nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 318 EIKYGDTTKTFCGTPEYLAPEVLED--------NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFELILMEDLKFP 388 (516)
T ss_pred cccccceeccccCChhhcCchhhcc--------ccccceeehhhhhHHHHHHHhccCcccccch-hHHHHHHHhhhccCC
Confidence 445566788999999999999954 7899999999999999999999999987554 344445555555667
Q ss_pred CCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 285 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rp-----s~~~i~~~ 285 (352)
..++++.+.++..+|.+||.+|. ++.+|.++
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 88999999999999999999995 35566555
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=294.94 Aligned_cols=244 Identities=30% Similarity=0.568 Sum_probs=198.8
Q ss_pred ccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCC
Q 018656 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSG 107 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~ 107 (352)
++||+|+||.||+|... +..+|+|++....... ....+.+|+++++.++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE----LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHH----HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 36999999999999864 7889999987654322 23458899999999999999999999874 478999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccccc--ccC
Q 018656 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM--TAE 185 (352)
Q Consensus 108 ~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~--~~~ 185 (352)
++|.+++.... ..+++..++.++.|++.+|.|+|++|++|+||+|+||+++.+ +.++|+|||++......... ...
T Consensus 77 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 77 GDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceeccccccccCCCC
Confidence 99999987643 348899999999999999999999999999999999999988 78999999998653322111 122
Q ss_pred CCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 186 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
.++..|+|||++.. ..++.++||||||+++|++++ |..||.+..................+..++..+.++
T Consensus 155 ~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (250)
T cd05085 155 QIPIKWTAPEALNY--------GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKV 226 (250)
T ss_pred CCcccccCHHHhcc--------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 34567999998854 557889999999999999998 999998766554433333332333456788999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHH
Q 018656 265 LTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 265 i~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+.+||..+|.+||++.++++.+.
T Consensus 227 i~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 227 MQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHcccCcccCCCHHHHHHHhc
Confidence 99999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.51 Aligned_cols=255 Identities=26% Similarity=0.443 Sum_probs=205.0
Q ss_pred CceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
.+|++.+.||+|+||.||++.+ +|+.++||.+....... ......+.+|+++++.++||||+++++++. ++..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh--HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 4688899999999999999986 48899999876543322 233456889999999999999999999886 457999
Q ss_pred EEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 101 VTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
+|||+++++|.+++... ....+++..++.++.|+++||.|||++|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhcccc
Confidence 99999999999998742 22358999999999999999999999999999999999999987 7999999999875433
Q ss_pred cc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHhc-cCCC-CC
Q 018656 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA-YAAAFK-NVRP-SA 254 (352)
Q Consensus 179 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~~~~-~~~~-~~ 254 (352)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....... ...... ...+ ..
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS 230 (267)
T ss_pred CCcccccccCCcCccCHHHhcC--------CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCc
Confidence 22 2233468899999998854 45788999999999999999999999764432211 111111 1122 23
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
..++.++.+++.+||..||.+|||+.++++.+...
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 46889999999999999999999999999887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=299.11 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=207.2
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee---cCceE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK---EPVMV 99 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~---~~~~~ 99 (352)
+|++.+.||.|+||.||++.+. |+.+|+|++....... ....++.+|++++++++||||+++++.+. +...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE---KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH---HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 5888999999999999999874 7899999987654332 23456888999999999999999999774 23689
Q ss_pred EEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 100 IVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLH-----SHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH-----~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
++|||+++++|.+++.... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++++ +.++|+|||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~ 156 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGL 156 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEecccc
Confidence 9999999999999997642 345899999999999999999999 8999999999999999988 8999999999
Q ss_pred ccccccccc-cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 173 AREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 173 a~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
+........ .....++..|+|||.+.. ..++.++|+||||+++++|++|..||...+..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNH--------MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR 228 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcC--------CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC
Confidence 886544332 334568999999998854 45788999999999999999999999886644433333333334
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+..++..+.+++.+||+.+|.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 4566788999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=295.89 Aligned_cols=248 Identities=29% Similarity=0.514 Sum_probs=196.4
Q ss_pred ccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee--cCceEEEE
Q 018656 30 PRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--EPVMVIVT 102 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~~~lv~ 102 (352)
+.||+|+||.||+|.+. +..+|+|.+...... .....+.+|+.+++.++||||+++++++. ++..+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL----EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH----HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 36899999999999863 357999987543322 22446788999999999999999999764 44689999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc--
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~-- 180 (352)
||+.+++|.+++.+... ..++..+..++.|+++||.|||+.+++||||||+||+++++ +.++|+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 77 PYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred ecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCccccccccCCcce
Confidence 99999999999976433 36778888999999999999999999999999999999988 789999999987432211
Q ss_pred ---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCC
Q 018656 181 ---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAEN 256 (352)
Q Consensus 181 ---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 256 (352)
......++..|+|||.+.. ..++.++||||||+++|+|++ |.+||...+..............+.+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY 226 (262)
T ss_pred eecccccCcCCccccChhHhcc--------CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCc
Confidence 1122345678999998754 567889999999999999999 5667776554443333332223344566
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
+|..+.+++.+||..+|.+||++.++++.+...+.
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 78999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=301.83 Aligned_cols=248 Identities=27% Similarity=0.368 Sum_probs=206.9
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|++.+.||+|+||.||+|.++ ++.||+|++....... ......+.+|++++++++||||+++++.+.+ ...++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE--KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc--hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 5899999999999999999885 8999999987543222 1234568899999999999999999998875 479999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
+||++|++|.+++.... .+++..+..++.|+++||.|||++|++|+||+|+||+++++ +.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccCCCcc
Confidence 99999999999998753 48999999999999999999999999999999999999988 7999999999886544433
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhccCCCCCCCCcH
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN--LQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 259 (352)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||..... ...............+..++.
T Consensus 156 ~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCR--------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWST 227 (258)
T ss_pred ccccCCChhhcCHHHHcc--------cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcH
Confidence 445568899999998854 4478899999999999999999999987654 222222222234445667889
Q ss_pred HHHHHHHHhhccCCCCCCCH--HHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNF--TQIIQM 285 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~--~~i~~~ 285 (352)
.+.++|.+||..||.+||+. .+++++
T Consensus 228 ~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 228 EAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred HHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 99999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=296.45 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=205.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
.+|++.+.||+|+||.||+|.+. |+.||+|.+........ .....+.+|++++++++|+||+++++.+.+ +..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA--KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccch--hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 57999999999999999999885 89999998875333221 234568899999999999999999999874 57899
Q ss_pred EEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 101 VTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
+|||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC-CcEEEeccceeeeccC
Confidence 999999999999987532 2348999999999999999999999999999999999999988 7899999999875432
Q ss_pred cc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH-HHHH-HHHhccCCCCCC
Q 018656 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-QAAY-AAAFKNVRPSAE 255 (352)
Q Consensus 179 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~~-~~~~~~~~~~~~ 255 (352)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... .... ........+.+.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPA 230 (267)
T ss_pred CCcccceecCCccccCHHHhcc--------CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCCh
Confidence 21 2233468889999998754 55788999999999999999999999654321 1111 111222223333
Q ss_pred -CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 256 -NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 256 -~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
.++..+.++|.+||..+|.+||++.++++.+...
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 6888999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.64 Aligned_cols=259 Identities=25% Similarity=0.525 Sum_probs=208.9
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--Cc----eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
++..++|+..+.||+|+||.||+|.+. |+ .+|+|.+...... .....+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~h~niv~~~~~~ 78 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP----KANVEFMDEALIMASMDHPHLVRLLGVC 78 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 345678889999999999999999873 44 5788887654332 2233578899999999999999999998
Q ss_pred ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 94 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
..+..++++||+++|+|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++++ +.+||+|||++
T Consensus 79 ~~~~~~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~ 156 (303)
T cd05110 79 LSPTIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLA 156 (303)
T ss_pred cCCCceeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEcccccc
Confidence 87778899999999999999976532 48999999999999999999999999999999999999887 78999999999
Q ss_pred cccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc
Q 018656 174 REESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 174 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 249 (352)
........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+..............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 228 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHY--------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE 228 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhcc--------CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence 75432221 122335678999998754 567889999999999999997 999998765443333333333
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
..+.+..++..+.+++..||..+|.+||++.++++.+......
T Consensus 229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 3444566889999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.32 Aligned_cols=249 Identities=28% Similarity=0.377 Sum_probs=200.8
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++...||+|++|.||+|.+. |+.||+|++........ ....+.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV---IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc---ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 47999999999999999999885 78999998865432221 12347789999999999999999999875 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+++++|..++.... .+++..++.++.|++.||+|||++|++|+||||+||+++++ +.++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 78 VFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPG 154 (286)
T ss_pred EEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecCCCc
Confidence 999999988888776533 38999999999999999999999999999999999999988 799999999987543332
Q ss_pred -ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc----------
Q 018656 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---------- 249 (352)
Q Consensus 181 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~---------- 249 (352)
......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+....+.........
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVG-------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred ccccCcccccccCCHHHHhC-------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 2233457889999998743 2456789999999999999999999998866544433221100
Q ss_pred ----------CCCC----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 250 ----------VRPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 250 ----------~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+. ...++..+.+++.+||..+|.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0010 13567889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=304.61 Aligned_cols=258 Identities=29% Similarity=0.379 Sum_probs=205.5
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|.+.+.||+|++|.||+|.+. |+.||+|.+...............+..|++++++++|+||+++++++.+ ...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 5888999999999999999874 7899999997765442222334457789999999999999999999875 579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-c
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~-~ 180 (352)
|||+ +++|.+++.... ..+++..++.++.|+++||.|||++|++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCCCc
Confidence 9999 889999997654 349999999999999999999999999999999999999988 79999999998754332 2
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC--------
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-------- 252 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------- 252 (352)
......++..|+|||.+.+ ...++.++|+|||||++|+|++|.+||.+................+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFG-------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred cccccccceeeeCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 2233456788999998743 2456889999999999999999988887765543322221111000
Q ss_pred -------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 253 -------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 253 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
.....+..+.++|.+||+.||.+|||+.+++++ .|+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~--~~~~~~~ 289 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH--PYFSNDP 289 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC--ccccCCC
Confidence 013457889999999999999999999999997 5555433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=304.81 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=200.1
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
.+|++.+.||+|+||.||++.+. |..+|+|.+...... ....++.+|++++++++||||+++++++. ++..++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP----AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 36899999999999999999874 788999988754332 23445888999999999999999999987 458999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+|||+++++|.+++.+.. .+++..+..++.|+++||.|||+ .+++|+||||+||+++++ +.++|+|||++......
T Consensus 77 v~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS 153 (308)
T ss_pred EeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCccccccc
Confidence 999999999999998754 38999999999999999999997 599999999999999988 78999999998653222
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh------------
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF------------ 247 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~------------ 247 (352)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQG--------THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred -ccccCCCCcCccChhHhcC--------CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 2234578899999998754 4578899999999999999999999975442221111100
Q ss_pred -----------------------ccCCCC--CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 248 -----------------------KNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 248 -----------------------~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
....+. ...++.++.+++.+||..||++||++.+++++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 000011 1236788999999999999999999999999944
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=297.15 Aligned_cols=251 Identities=29% Similarity=0.438 Sum_probs=205.5
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
.++|.+.+.||.|+||.||+|.+. ++.+++|++...... ....+.+|+.++++++||||+++++.+. ...++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-----DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-----hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 468999999999999999999874 788999998764332 2456889999999999999999999876 45799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
++|||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-CCEEECccccchhhhhh
Confidence 9999999999999987652 248999999999999999999999999999999999999988 78999999998754332
Q ss_pred c-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC----CC
Q 018656 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----SA 254 (352)
Q Consensus 180 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----~~ 254 (352)
. ......++..|+|||.+... ....++.++|+||||+++|+|++|..||..................+ ..
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~-----~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVE-----RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDK 229 (262)
T ss_pred hhccccccCCccccCchhhccc-----ccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccch
Confidence 2 22344678899999987541 01367889999999999999999999998766554444333321111 13
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..++.++.+++.+||..+|.+|||+.+++.+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 3567889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=301.07 Aligned_cols=244 Identities=24% Similarity=0.430 Sum_probs=197.6
Q ss_pred CceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
++|++.+.||+|+||.||+|.+ +++.||+|++...... .....+.+|++++++++||||+++++.+. ++..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV----ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh----HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence 4678899999999999999987 4789999998754332 22345889999999999999999999887 457899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+++++|..+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-
Confidence 99999999997652 27888999999999999999999999999999999999998 79999999998754322
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH------HHHHHHhccCCC--
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ------AAYAAAFKNVRP-- 252 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~------~~~~~~~~~~~~-- 252 (352)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ...........+
T Consensus 149 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (279)
T cd06619 149 IAKTYVGTNAYMAPERISG--------EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220 (279)
T ss_pred cccCCCCChhhcCceeecC--------CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC
Confidence 2234578999999998854 557889999999999999999999996532211 111111111111
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.....++++.+++.+||..||.+||++++++++.+
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 23457889999999999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=301.40 Aligned_cols=254 Identities=29% Similarity=0.410 Sum_probs=206.7
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|++.+.||.|+||.||++.+. ++.+|+|++..... .....+.+|++++++++||||+++++.+.. ...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-----EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-----HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 357999999999999999999874 78999999865432 233458889999999999999999999874 5789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||+++++|.+++.+.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKST 156 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhccc
Confidence 9999999999999987643 349999999999999999999999999999999999999988 79999999987653322
Q ss_pred c-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--CCCCCC
Q 018656 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSAEN 256 (352)
Q Consensus 180 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 256 (352)
. ......++..|+|||.+.... .....++.++|+||||+++|+|++|..||................. ...+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACET---FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSK 233 (280)
T ss_pred ccccceeecchhhcCHHHHhhcc---cCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCccc
Confidence 1 223346889999999875311 1124567899999999999999999999988665444333332221 122456
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
++.++.+++.+||..+|.+||++.+++++.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 234 WSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 889999999999999999999999999983
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=301.85 Aligned_cols=249 Identities=28% Similarity=0.388 Sum_probs=202.6
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|++.+.||+|++|.||+|.+. |+.||+|++....... .....+.+|+.++++++||||+++++++.+ ...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG---GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc---hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 5889999999999999999874 7899999987655333 223458899999999999999999999874 578999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~- 180 (352)
+||+ +++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 78 MEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEP 154 (286)
T ss_pred eccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCC
Confidence 9999 999999987644 459999999999999999999999999999999999999987 799999999987543332
Q ss_pred -ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-------
Q 018656 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP------- 252 (352)
Q Consensus 181 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------- 252 (352)
......++..|+|||.+.+ ...++.++||||||+++|+|++|.+||.+................+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYG-------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred CccccccCcccccCceeeec-------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 2334568899999998753 2456889999999999999999988887765433322221111100
Q ss_pred ----------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 253 ----------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 253 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.....+.++.++|.+||..||.+||+++++++|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0135678899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=296.45 Aligned_cols=251 Identities=25% Similarity=0.431 Sum_probs=205.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---Cc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~ 97 (352)
+.+|++.+.||+|+||.||+|.+. ++.+|+|.+...............+.+|++++++++||||+++++++.+ ..
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 468999999999999999999874 8899999886543222223445678899999999999999999998764 35
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+++++||+++++|.+++..... +++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECccccccccc
Confidence 8899999999999999986543 8899999999999999999999999999999999999987 789999999987543
Q ss_pred cc----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-C
Q 018656 178 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-P 252 (352)
Q Consensus 178 ~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~ 252 (352)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.................. .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISG--------EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM 229 (264)
T ss_pred cccccCccccccCCcccccCHhhhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCC
Confidence 21 11223468899999998854 45678999999999999999999999876554444433322222 2
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+..+++.+.+++.+||. +|..||++.+++.|
T Consensus 230 ~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 230 LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 366788999999999999 67999999998876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=295.57 Aligned_cols=246 Identities=36% Similarity=0.685 Sum_probs=204.9
Q ss_pred eeeccccCCCceEEEEEEECC------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 27 FVGPRIGEGAHAKVYEGKYKN------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 27 ~~~~~lG~G~~g~Vy~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
++.+.||.|+||.||++.+.+ ..+|+|++....... ....+.+|+.+++.++|+||+++++++.+ +..+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ----QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH----HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 567889999999999998863 789999997654432 34568899999999999999999999875 5799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
++|||+++++|.+++.......+++..++.++.|++.||++||+.|++|+||+|+||+++++ +.++|+|||++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-CeEEEcccCCceecccc
Confidence 99999999999999987554448999999999999999999999999999999999999998 79999999998754433
Q ss_pred cccc--cCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCC
Q 018656 180 EMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAEN 256 (352)
Q Consensus 180 ~~~~--~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 256 (352)
.... ...++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+..............+.+..
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 228 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKD--------GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPEN 228 (258)
T ss_pred cccccccCCCcccccChHHhcc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCc
Confidence 2211 1236789999998743 567889999999999999998 8899987665554444444444455667
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
++.++.+++.+||..||.+|||+.++++.
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 229 CPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred CCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 89999999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=301.54 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=203.7
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee-
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK- 94 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~- 94 (352)
+....++|++.+.||+|+||+||++.+. ++.+|+|+....... ...+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI------DEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch------HHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4445788999999999999999999884 789999987643221 23467899999999 7999999999863
Q ss_pred -----cCceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 95 -----EPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 95 -----~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
++..++||||++|++|.+++... ....+++..++.++.|++.||.|||+++++||||||+||+++.+ +.++|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~kl 165 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKL 165 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC-CCEEE
Confidence 23689999999999999988643 22358999999999999999999999999999999999999988 78999
Q ss_pred ecCCCcccccccc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 018656 168 ADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 168 ~Dfg~a~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 246 (352)
+|||++....... ......|+..|+|||++.... .....++.++|||||||++|+|++|+.||.............
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhh---hccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 9999987543222 223446899999999875311 012457889999999999999999999998765443332221
Q ss_pred hcc--CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 247 FKN--VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 247 ~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
... ....+..++.++.+++.+||+.||.+||++.++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 111 1112345678999999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=307.87 Aligned_cols=242 Identities=23% Similarity=0.307 Sum_probs=185.3
Q ss_pred eccccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---CceEEE
Q 018656 29 GPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVMVIV 101 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~~lv 101 (352)
+.+||+|+||+||+|++. ++.||+|.+....... .+.+|++++++++||||+++++++.. ...+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISM-------SACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcH-------HHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 467999999999999863 5789999986543322 36689999999999999999998753 368999
Q ss_pred EEcCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC---CCCceEEecCC
Q 018656 102 TELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFG 171 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~-------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~---~~~~vkl~Dfg 171 (352)
|||+ +++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||++. ..+.+||+|||
T Consensus 79 ~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred Eecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 9999 458988876432 224899999999999999999999999999999999999942 23689999999
Q ss_pred Cccccccc----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH--------
Q 018656 172 LAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-------- 239 (352)
Q Consensus 172 ~a~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-------- 239 (352)
++...... .......+|+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 230 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 230 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcC-------CCCcCchhhHHHHHHHHHHHHhCCCCccCCccccccccccc
Confidence 99754322 12234578999999998854 245788999999999999999999999753321
Q ss_pred -HHHHHHHhccCCC-------------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHH
Q 018656 240 -QAAYAAAFKNVRP-------------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQ 281 (352)
Q Consensus 240 -~~~~~~~~~~~~~-------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 281 (352)
............+ .....+.++.++|.+||+.||.+|||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e 310 (317)
T cd07868 231 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 310 (317)
T ss_pred HHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHH
Confidence 0000000000000 00123456889999999999999999999
Q ss_pred HHHH
Q 018656 282 IIQM 285 (352)
Q Consensus 282 i~~~ 285 (352)
+++|
T Consensus 311 ~l~h 314 (317)
T cd07868 311 AMQD 314 (317)
T ss_pred HhcC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=299.89 Aligned_cols=252 Identities=28% Similarity=0.489 Sum_probs=198.9
Q ss_pred cCCceeeeccccCCCceEEEEEEE------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK- 94 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~- 94 (352)
+.++|++.+.||+|+||.||++.. .++.||+|.+..... .....+.+|++++++++||||+++++++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-----EHLRDFEREIEILKSLQHDNIVKYKGVCYS 76 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCCeeEEEEEEcc
Confidence 457899999999999999999874 378899999865432 23456889999999999999999999764
Q ss_pred --cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 95 --EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 95 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
....++|+||+++++|.+++.+... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~ 154 (284)
T cd05081 77 AGRRNLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGL 154 (284)
T ss_pred CCCCceEEEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCcc
Confidence 2368999999999999999976432 48999999999999999999999999999999999999988 7899999999
Q ss_pred ccccccccc----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH--------
Q 018656 173 AREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ-------- 240 (352)
Q Consensus 173 a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-------- 240 (352)
+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK 226 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhcc--------CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccc
Confidence 875432211 111223456999998754 557889999999999999999877654322110
Q ss_pred -------HHHH-HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 241 -------AAYA-AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 241 -------~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
.... .......+....++.++.+++.+||..+|.+|||+.++++.|+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 227 QGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred ccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 0001 11112234456788999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=299.71 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=204.8
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
..|+..+.||+|+||.||+|.+. ++.||+|++...... .....+.+|++++++++||||+++++++.+ ...++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 45788899999999999999874 789999998754332 234568899999999999999999999874 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||++|++|.+++... .+++..+..++.|++.||++||+++++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-CCEEEcccccceeccCCc
Confidence 99999999999998753 38899999999999999999999999999999999999988 799999999987543322
Q ss_pred c-cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 181 M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 181 ~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......................++.
T Consensus 156 ~~~~~~~~~~~y~apE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQ--------SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSK 227 (277)
T ss_pred cccccccCcccccCHhHhcc--------CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhH
Confidence 1 223457889999998754 4578899999999999999999999987665444333322222333456788
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+.+++.+||..+|.+||++.+++.+.+
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 228 PFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 9999999999999999999999999844
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=300.98 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=204.4
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
+.|++.+.||+|+||.||++.+. +..+++|.+..... .....+.+|+++++.++||||+++++.+. ++..++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-----HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 34678899999999999999885 67889998854332 23445788999999999999999999886 457899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
|+||+++++|..++.+.. ..+++..+..++.|+++||.|||+.|++||||||+||+++.+ +.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 80 LIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-CCEEEccccccccccccc
Confidence 999999999999886532 348999999999999999999999999999999999999988 79999999998753222
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc--CCCCCCCC
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENV 257 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 257 (352)
.......++..|+|||++.... .....++.++|+||+||++|+|++|..||...+............ ..+.+..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 234 (282)
T ss_pred cccccccccccccCHhhccccC---CCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCcccc
Confidence 2223456889999999874311 123557789999999999999999999998766544444333222 12235568
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+.++.++|.+||+.||.+||++.+++++.
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 89999999999999999999999999884
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=304.55 Aligned_cols=246 Identities=28% Similarity=0.467 Sum_probs=203.2
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|++.+.||+|+||.||++.+ .|+.||+|.+....... ...+.+|+.+++.++||||+++++.+.. +..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 47899999999999999999987 48999999987544322 2457889999999999999999999874 5799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||+++++|.+++.+. .+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 168 (297)
T ss_pred EeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEccCC
Confidence 999999999999998653 38899999999999999999999999999999999999988 79999999998754322
Q ss_pred c-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--CCCCC
Q 018656 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAEN 256 (352)
Q Consensus 180 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 256 (352)
. ......+++.|+|||.+.+ ..++.++|+||||+++|++++|..||.+.+.............. ..+..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240 (297)
T ss_pred ccCcCcccCCccccCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence 2 1223468889999998754 55788999999999999999999999875543332222211111 12456
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
++..+.+++.+||..+|.+||++.+++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 78899999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=298.09 Aligned_cols=251 Identities=23% Similarity=0.423 Sum_probs=203.0
Q ss_pred ceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChH-HHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPE-EIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
+|+.++.||+|++|.||++.+ +++.+|+|++....... ........+.+|++++++++|+||+++++++.+ +..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 578889999999999999987 48999999987544322 222345678999999999999999999999875 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
|+||+++++|.+++.+.. .+++..++.++.|++.||.|||++|++|+||+|+||+++.++..++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 999999999999998654 389999999999999999999999999999999999998764579999999987543221
Q ss_pred -----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH---HHHh-ccCC
Q 018656 181 -----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY---AAAF-KNVR 251 (352)
Q Consensus 181 -----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~---~~~~-~~~~ 251 (352)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... .... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRG--------EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230 (268)
T ss_pred ccCCccccccccccceeCHhHhcc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC
Confidence 1123457889999998754 556889999999999999999999997544322111 1111 1122
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+..++.++.+++.+||..+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 3345688999999999999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=301.23 Aligned_cols=253 Identities=25% Similarity=0.472 Sum_probs=200.9
Q ss_pred cCCceeeeccccCCCceEEEEEEECC----------------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYKN----------------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 85 (352)
...+|++.+.||+|+||.||++.+.+ ..||+|.+...... .....+.+|++++++++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~ei~~l~~l~h~~ 78 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK----TARNDFLKEIKIMSRLKNPN 78 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhCCCCC
Confidence 45689999999999999999987632 24899998765432 23446889999999999999
Q ss_pred eeeeeeeee-cCceEEEEEcCCCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 018656 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRP----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 154 (352)
Q Consensus 86 iv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~----------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~ 154 (352)
|+++++++. ++..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred cCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 999999986 4578999999999999999965421 13688899999999999999999999999999999
Q ss_pred CeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh--C
Q 018656 155 NLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH--N 229 (352)
Q Consensus 155 Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~--g 229 (352)
||+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++|+||||+++|+|++ |
T Consensus 159 Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~~l~el~~~~~ 229 (295)
T cd05097 159 NCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTLWEMFTLCK 229 (295)
T ss_pred hEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhcc--------CCcCchhhHHHHHHHHHHHHHcCC
Confidence 9999987 789999999987532221 1122345678999998754 567899999999999999988 6
Q ss_pred CCCCCCCChHHHHHHHHh------c-cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 230 KLPFEGMSNLQAAYAAAF------K-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~------~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
..||...+.......... . .....+..+|..+.+++.+||+.||.+||+++++++.|.
T Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 230 EQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 778877554433222111 0 112234567899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.75 Aligned_cols=244 Identities=34% Similarity=0.608 Sum_probs=200.3
Q ss_pred ccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCC
Q 018656 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSG 107 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~ 107 (352)
+.||+|+||.||++.+. ++.|++|++...... .....+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 36999999999999876 899999998765543 234468899999999999999999999874 478999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccccc---cc
Q 018656 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM---TA 184 (352)
Q Consensus 108 ~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~---~~ 184 (352)
++|.+++.+... .+++..++.++.+++.+|+|||+++++||||+|+||+++.+ +.++|+|||++......... ..
T Consensus 77 ~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 77 GSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-CcEEEeeccccccccCCcceecccc
Confidence 999999976433 48899999999999999999999999999999999999988 79999999998754321111 11
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 263 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 263 (352)
...+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||..................+.+..++.++.+
T Consensus 155 ~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (251)
T cd05041 155 KQIPIKWTAPEALNY--------GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYR 226 (251)
T ss_pred CcceeccCChHhhcc--------CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 233567999998754 557889999999999999998 88999876654444433333333446678899999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHH
Q 018656 264 ILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 264 li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
++.+||..+|.+||++.++++.|.
T Consensus 227 li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 227 LMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=299.52 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=198.8
Q ss_pred ccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCCC
Q 018656 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGG 108 (352)
Q Consensus 32 lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 108 (352)
||+|+||+||+|.+. |+.+|+|++....... ......+.+|++++++++||||+++++.+.. +..++||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK--RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh--hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 699999999999874 8899999986543211 1234456789999999999999999998874 5799999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCCCc
Q 018656 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188 (352)
Q Consensus 109 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~ 188 (352)
+|.+++.+.....+++..++.++.|++.||.|||++|++|+||+|+||+++++ +.++|+|||.+.............++
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccccCC
Confidence 99999987665569999999999999999999999999999999999999988 79999999998754433333445678
Q ss_pred ccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHhccCCCCCCCCcHHHHHHH
Q 018656 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAYAAAFKNVRPSAENVPEELSIIL 265 (352)
Q Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li 265 (352)
..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ..............+..+++.+.++|
T Consensus 158 ~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 229 (277)
T cd05577 158 PGYMAPEVLQG--------EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLC 229 (277)
T ss_pred CCcCCHHHhcC--------CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHH
Confidence 89999998754 44788999999999999999999999775432 11222222223334567899999999
Q ss_pred HHhhccCCCCCC-----CHHHHHHHH
Q 018656 266 TSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 266 ~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
.+||+.||.+|| ++.+++++.
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~ll~h~ 255 (277)
T cd05577 230 EALLQKDPEKRLGCRGGSADEVREHP 255 (277)
T ss_pred HHHccCChhHccCCCcccHHHHHhCh
Confidence 999999999999 777788873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=300.06 Aligned_cols=253 Identities=26% Similarity=0.500 Sum_probs=201.2
Q ss_pred cCCceeeeccccCCCceEEEEEEEC------------------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK------------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH 83 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~------------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 83 (352)
..++|++.+.||+|+||.||++++. +..+|+|++...... .....+.+|+++++.++|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK----NARNDFLKEIKIMSRLKD 78 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH----HHHHHHHHHHHHHHhCCC
Confidence 4568999999999999999998643 236899998754322 234568899999999999
Q ss_pred CCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 018656 84 RNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 153 (352)
Q Consensus 84 p~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp 153 (352)
+||+++++++.. +..+++|||+++++|.+++.+... ..+++..++.++.|++.||+|||+.|++|+||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 79 PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred CCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 999999999874 578999999999999999976432 2367788999999999999999999999999999
Q ss_pred CCeEEeCCCCceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh--
Q 018656 154 ENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-- 228 (352)
Q Consensus 154 ~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-- 228 (352)
+||+++.+ +.++|+|||++........ .....++..|+|||.... ..++.++|+|||||++|+|++
T Consensus 159 ~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 159 RNCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--------GKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred heEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--------CCccchhhhhHHHHHHHHHHHhC
Confidence 99999987 7999999999875422211 112234678999997643 567889999999999999998
Q ss_pred CCCCCCCCChHHHHHHHH-------hccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 229 NKLPFEGMSNLQAAYAAA-------FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 229 g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
|..||...+..+...... .....+.+..++..+.+++.+||+.||.+||++.++.+.|.
T Consensus 230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 230 KEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 778997655433322111 11123445678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=297.70 Aligned_cols=245 Identities=32% Similarity=0.616 Sum_probs=198.2
Q ss_pred ccccCCCceEEEEEEECC--------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 30 PRIGEGAHAKVYEGKYKN--------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~~--------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
+.||+|+||.||+|.+.. +.+++|.+...... .....+.+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD----QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch----hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 359999999999998642 57999988654322 223458889999999999999999998864 57999
Q ss_pred EEEcCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC-----ceEEecC
Q 018656 101 VTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-----TIKLADF 170 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~-----~vkl~Df 170 (352)
+|||+++++|.+++.+.. ...+++..++.++.|++.||.|||+++++|+||+|+||+++.+ + .++|+||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~~~~~~l~df 155 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEK-GYDADRVVKIGDF 155 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecC-CCCCCcceEECCc
Confidence 999999999999997542 2347889999999999999999999999999999999999886 4 7999999
Q ss_pred CCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 018656 171 GLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 171 g~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 246 (352)
|++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.............
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 227 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLD--------GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHcc--------CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh
Confidence 99875432211 122345678999998854 567889999999999999998 999998766554444333
Q ss_pred hccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 247 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.......+..+|..+.+++.+||..+|.+||++.++++.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 33333446678999999999999999999999999998874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=300.50 Aligned_cols=254 Identities=25% Similarity=0.416 Sum_probs=203.9
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee----
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK---- 94 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~---- 94 (352)
..+.|++.+.||+|+||.||+|.+. ++.+|+|++..... ....+..|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED------EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH------HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 3568899999999999999999884 78999999765321 223577899999988 7999999999874
Q ss_pred ---cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 95 ---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 95 ---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
....+++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+++++ +.++|+|||
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~-~~~~l~dfg 166 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFG 166 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCc
Confidence 2368999999999999999987665568999999999999999999999999999999999999988 789999999
Q ss_pred Cccccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-
Q 018656 172 LAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN- 249 (352)
Q Consensus 172 ~a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~- 249 (352)
++...... .......|+..|+|||.+.... .....++.++|+||||+++|+|++|..||................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~---~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 243 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCccc---CcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC
Confidence 98754321 2223456889999999875311 113567789999999999999999999997655433333222221
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.......++.++.++|++||..||.+||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 112234688999999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=296.57 Aligned_cols=250 Identities=29% Similarity=0.477 Sum_probs=207.4
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|.+.+.||+|+||.||++.++ |..+|+|.+....... .....+.+|+.+++.++|+||+++++.+.+ ...+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV---KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc---hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 5889999999999999999885 7899999986542211 223457789999999999999999998874 478999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~- 180 (352)
+||+++++|.+++.......+++..++.++.|+++||.|||+.+++|+||+|+||+++++...++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999999876555589999999999999999999999999999999999998874467999999987543322
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
......|+..|+|||.+.. ..++.++|+||||+++++|++|..||...+..............+....++.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN--------RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRD 229 (257)
T ss_pred cccccCCCccccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHH
Confidence 2223468899999998754 45788999999999999999999999876655544444444444455678899
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+.+++.+||..+|++|||+.+++.+
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 230 LRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHHhccChhhCcCHHHHhhC
Confidence 9999999999999999999999887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=303.93 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=195.4
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|.+.+.||+|+||.||+|.+. |+.+|+|.+....... .....+.+|++++++++||||+++++++.+ ...+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc---cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 5888999999999999999984 8899999987543222 122346789999999999999999999874 479999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-c
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~-~ 180 (352)
+||++ ++|.+++.... ..+++..++.++.|+++||.|||++|++||||||+||+++.+ +.++|+|||++...... .
T Consensus 78 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 78 FEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVR 154 (284)
T ss_pred EecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccCCCCC
Confidence 99996 58888887543 348999999999999999999999999999999999999988 79999999998754322 2
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-c----------
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-N---------- 249 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~---------- 249 (352)
......++..|+|||.+.+ ...++.++||||||+++|+|++|..|+............... .
T Consensus 155 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred CcCCCccccCCcChHHHhC-------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH
Confidence 2233467889999998754 234678999999999999999998886443332222111110 0
Q ss_pred ------C------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 250 ------V------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 250 ------~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
. ......++.++.++|.+||+.||.+|||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 01123577899999999999999999999999887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=294.94 Aligned_cols=246 Identities=28% Similarity=0.437 Sum_probs=204.1
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|.+.+.||+|+||.||+|.+. ++.+++|.+..... ...+.+|++++++++||||+++++.+.+ ...+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence 467999999999999999999885 68999999864321 4568899999999999999999999874 5899
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+++||+++++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++++ +.++|+|||++......
T Consensus 75 l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-CcEEEcccccchhcccC
Confidence 9999999999999997643 348999999999999999999999999999999999999988 78999999998764433
Q ss_pred c-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--CCCCCC
Q 018656 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSAEN 256 (352)
Q Consensus 180 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 256 (352)
. ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||................. ...+..
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQE--------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEK 224 (256)
T ss_pred ccccccccCCccccCHHHHhc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhh
Confidence 2 2233457889999998854 4678899999999999999999999987655443333222111 112345
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
++.++.+++.+||+.||.+|||+.+++++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 77899999999999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=299.51 Aligned_cols=248 Identities=26% Similarity=0.433 Sum_probs=203.0
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
+.|+..+.||+|+||.||+|.+. ++.||+|++...... .....+.+|++++++++||||+++++.+.. ...++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch----HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 35777889999999999999874 789999998654332 223568899999999999999999998874 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
|+||+++++|.+++... .+++..++.++.|++.||.|||++|++|+||+|+||+++++ +.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEccccccccccCcc
Confidence 99999999999998642 38999999999999999999999999999999999999988 799999999987543322
Q ss_pred -ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 181 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......................++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQ--------SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSK 227 (277)
T ss_pred hhhhcccCcccccCHHHhCc--------CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCH
Confidence 1223457889999998854 4578899999999999999999999976554433333222222223456788
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
++.+++.+||..+|.+||++.+++.+.+
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 228 PFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 9999999999999999999999999843
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=311.25 Aligned_cols=243 Identities=24% Similarity=0.355 Sum_probs=190.8
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
+...+|.+.+.||+|+||.||+|.+. ++.||+|+..... ...|+.++++++||||+++++++.+ ..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----------~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----------TLIEAMLLQNVNHPSVIRMKDTLVSGAI 131 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----------cHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence 44567999999999999999999985 6789999854322 3468899999999999999999874 47
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++|||++ .++|.+++.... ..+++..++.|+.|++.||.|||++||+||||||+|||++.+ +.++|+|||++....
T Consensus 132 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 132 TCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAAQFPV 208 (357)
T ss_pred eEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEecCccccccc
Confidence 89999999 468999887643 358999999999999999999999999999999999999988 789999999987543
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCC-CCCCChH---------HHHHHHHh
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNL---------QAAYAAAF 247 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~---------~~~~~~~~ 247 (352)
.........||..|+|||++.+ ..++.++|||||||++|+|+++..| |...... ........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~ 280 (357)
T PHA03209 209 VAPAFLGLAGTVETNAPEVLAR--------DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280 (357)
T ss_pred cCcccccccccccccCCeecCC--------CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence 3333345578999999999854 5678899999999999999985444 3332111 00011000
Q ss_pred c-cCC----C----------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 248 K-NVR----P----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 248 ~-~~~----~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
. ... + ....++.++.++|.+||+.||.+|||+.++++|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 000 0 012456677889999999999999999999998
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=295.06 Aligned_cols=250 Identities=28% Similarity=0.445 Sum_probs=204.6
Q ss_pred CceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
++|++++.||.|+||+||+|.+ ++..+++|++....... ....+.+|+++++.++|+||+++++.+. +...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 4789999999999999999987 47899999986544332 3456889999999999999999999876 457999
Q ss_pred EEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
++|++++++|.+++..... ..+++..++.++.|++.||++||++|++|+||+|+||+++++ +.++|+|||++......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADG 155 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccC
Confidence 9999999999999986533 458999999999999999999999999999999999999988 78999999998643322
Q ss_pred c-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC-
Q 018656 180 E-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 253 (352)
Q Consensus 180 ~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~- 253 (352)
. ......++..|+|||.+.. ...++.++|+||||+++|+|++|+.||...+................
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQ-------VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLE 228 (267)
T ss_pred ccccccccccccCChhhcChHHHcc-------ccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcC
Confidence 2 1133468899999998754 13578899999999999999999999987655443333322221111
Q ss_pred ----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 ----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...+++.+.+++.+||..||.+||++.++++|
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 13678999999999999999999999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=298.11 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=203.8
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeecC---
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP--- 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~--- 96 (352)
..+|++.+.||+|++|.||+|.++ ++.+++|++..... ....+.+|+.+++++ +|+||+++++++.+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch------hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 478999999999999999999984 68899999865432 224588999999999 799999999998643
Q ss_pred ----ceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 97 ----VMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 97 ----~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~ 157 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDF 157 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCC
Confidence 3799999999999999987643 3458999999999999999999999999999999999999988 79999999
Q ss_pred CCccccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 171 GLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 171 g~a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
|++...... .......++..|+|||.+.... .....++.++||||||+++|+|++|..||................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 234 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDE---QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccc---cccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC
Confidence 998653322 2223456889999999875421 113456789999999999999999999998655443333332221
Q ss_pred CC--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 250 VR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 250 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.. .....++.++.+++.+||..||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 1123477899999999999999999999999886
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=345.04 Aligned_cols=252 Identities=28% Similarity=0.400 Sum_probs=212.6
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
.-+|+-+..||.|.||.||.|.+ +|+..|+|-+...... .+....+.+|++++..++|||+|+++++-. ....+
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34788899999999999999976 5899999988765443 344556889999999999999999999964 45789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
|.||||.||+|.+.+.-.. ..++.....+..|++.|++|||+.|||||||||+||+++.+ |.+|++|||.|......
T Consensus 1311 IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-CcEEeecccceeEecCc
Confidence 9999999999999887533 37788888899999999999999999999999999999998 79999999999865443
Q ss_pred c-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccCCCC
Q 018656 180 E-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFKNVRPS 253 (352)
Q Consensus 180 ~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~ 253 (352)
. ......||+.|||||++.+. +...-..++||||||||+.||+||+.||...++ ....+.......++.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t-----~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGT-----KGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhccc-----ccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC
Confidence 2 23456899999999999873 234556799999999999999999999977554 344555555556667
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
|..++++-++||.+||+.||++|.++.|++++
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 88899999999999999999999999999998
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=314.43 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=195.0
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK- 94 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~- 94 (352)
.+...+|.+.+.||+|+||.||+|... +..|++|.+.... ...+|++++++++||||+++++++.
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----------~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----------TPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----------cHHHHHHHHHhcCCCCccceeeeEee
Confidence 344567999999999999999999763 4679999876432 2457999999999999999999887
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+...+++||++. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.++|+|||++.
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~~~~l~DfG~a~ 233 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-ENAVLGDFGAAC 233 (392)
T ss_pred CCEEEEEehhcC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEccCcccc
Confidence 457899999994 68999985433 49999999999999999999999999999999999999988 799999999987
Q ss_pred cccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHh-
Q 018656 175 EESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAYAAAF- 247 (352)
Q Consensus 175 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~~~~~~- 247 (352)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... ........
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~ 305 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLAL--------DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence 543221 1224568999999999854 56788999999999999999999999764321 11111000
Q ss_pred ------------------------ccCCCC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 248 ------------------------KNVRPS--------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 248 ------------------------~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
....+. ...++.++.++|.+||..||.+||++.+++.+.
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000000 124567889999999999999999999999993
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=296.32 Aligned_cols=254 Identities=26% Similarity=0.524 Sum_probs=205.7
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
+..++|++...||.|+||.||+|+.+ .+.+++|.+...... .....+.+|++++++++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE----NLQSEFRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch----HHHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 45688999999999999999999863 357999987654332 2344688999999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCce
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRPR-------CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~v 165 (352)
.+ ...++||||+++++|.+++...... .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~ 156 (275)
T cd05046 78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-REV 156 (275)
T ss_pred CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-CcE
Confidence 75 5789999999999999999865521 48999999999999999999999999999999999999988 799
Q ss_pred EEecCCCccccccc--cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 018656 166 KLADFGLAREESLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 242 (352)
Q Consensus 166 kl~Dfg~a~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 242 (352)
+++|||++...... .......++..|+|||.+.+ ...+.++||||||+++|+|++ |..||.........
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~ 228 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE--------DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHH
Confidence 99999998643221 11223356778999998754 456789999999999999998 88899765554433
Q ss_pred HHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 243 YAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 243 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
........ .+....+|..+.+++.+||+.+|.+||++.+++..+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 229 NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 33332221 2335678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=315.50 Aligned_cols=261 Identities=28% Similarity=0.506 Sum_probs=230.0
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEEC---C--ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCee
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 87 (352)
-..+.+-+|..+.+.+++.||+|+||+|++|.|+ | -.||||+++...... ....|.+|+.+|.+|+|||++
T Consensus 99 p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~----~mddflrEas~M~~L~H~hli 174 (1039)
T KOG0199|consen 99 PSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA----IMDDFLREASHMLKLQHPHLI 174 (1039)
T ss_pred cCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch----hHHHHHHHHHHHHhccCccee
Confidence 4556678899999999999999999999999996 3 369999998765543 345699999999999999999
Q ss_pred eeeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 88 KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 88 ~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
+|+++..+.-..+|+|.+++|||.+.+.+.....|.......++.||+.|+.||.++++|||||-..|+++-.. ..|||
T Consensus 175 RLyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI 253 (1039)
T KOG0199|consen 175 RLYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKI 253 (1039)
T ss_pred EEeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeee
Confidence 99999998889999999999999999998656678899999999999999999999999999999999999776 78999
Q ss_pred ecCCCccccccccccc----cCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 018656 168 ADFGLAREESLTEMMT----AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 242 (352)
Q Consensus 168 ~Dfg~a~~~~~~~~~~----~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 242 (352)
+|||+.+....+...- .......|+|||.+.. ..++.++|+|++|+++|||++ |..||.+....+.+
T Consensus 254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh--------~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL 325 (1039)
T KOG0199|consen 254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH--------RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL 325 (1039)
T ss_pred ecccceeccCCCCcceEecCCCcCcccccCHhHhcc--------ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH
Confidence 9999998654443222 2234678999999965 789999999999999999998 89999999998888
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 243 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..+......+.+..+|+++.+++..||+.+|.+||++..|.+.+
T Consensus 326 ~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 326 KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 88887778888999999999999999999999999999998653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=333.38 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=216.0
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 96 (352)
.-+.+++|.+.++||+|+||.|..++.+ ++.||+|++.+-.... ......|..|-.+|..-+.+-|+.++-.|++.
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK--r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK--RAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh--chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 4567889999999999999999999885 7899999987622111 12234588889999999999999999999865
Q ss_pred -ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
++|+||||++||+|-.++.+.. .+++..++.++..|+.||..||+.|+|||||||+|||++.. |++||+|||.+-.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFGsClk 224 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFGSCLK 224 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccchhHHh
Confidence 8999999999999999999877 49999999999999999999999999999999999999999 8999999999876
Q ss_pred cccccc--cccCCCcccccccccccccccccccc-cCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---c
Q 018656 176 ESLTEM--MTAETGTYRWMAPELYSTVTLRQGEK-KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---N 249 (352)
Q Consensus 176 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~ 249 (352)
...+.. ....+|||.|.|||++.... .+ +.|++.+|.||||+++|||+.|..||...+.....-++... .
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~----~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQG----DGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL 300 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhc----CCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc
Confidence 543332 34458999999999997632 33 78999999999999999999999999987666555555443 2
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCC---HHHHHHHH
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQML 286 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~i~~~l 286 (352)
..|....+|.+.++||+..+. +|+.|.. ++++..|.
T Consensus 301 ~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 301 SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 234445699999999999987 7778877 99999984
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=307.36 Aligned_cols=249 Identities=26% Similarity=0.330 Sum_probs=199.2
Q ss_pred ecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--- 95 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--- 95 (352)
...++|++.+.||+|+||.||+|.+ +|+.||+|++....... ....++.+|+.++++++||||+++++++..
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV---THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS 89 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh---hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence 3457899999999999999999987 48999999986543222 223456789999999999999999998752
Q ss_pred ----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 96 ----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 96 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
...++||||+. ++|.+++... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||
T Consensus 90 ~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg 163 (353)
T cd07850 90 LEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFG 163 (353)
T ss_pred ccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCc
Confidence 24799999995 5888887642 8899999999999999999999999999999999999998 799999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
++.............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 235 (353)
T cd07850 164 LARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235 (353)
T ss_pred cceeCCCCCCCCCCcccccccCHHHHhC--------CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9986544433344568899999998854 56788999999999999999999999876543322211110000
Q ss_pred C-------------------------------------C-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 252 P-------------------------------------S-----AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 252 ~-------------------------------------~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+ . ....+..+.++|.+||+.||.+|||+.+++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0 0 113466789999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=293.74 Aligned_cols=242 Identities=28% Similarity=0.389 Sum_probs=199.8
Q ss_pred ccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCCC
Q 018656 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGG 108 (352)
Q Consensus 32 lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 108 (352)
||.|++|.||+|.+. ++.+|+|++........ .....+.+|++++++++||||+++++.+.+ ...++++||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET--GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh--hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 799999999999986 89999999876543221 234568899999999999999999999874 4799999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCCCc
Q 018656 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188 (352)
Q Consensus 109 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~ 188 (352)
+|.+++.+... +++..+..++.|++.||+|||++|++|+||+|+||+++++ +.++|+|||++.............++
T Consensus 79 ~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 79 ELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred cHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccCC
Confidence 99999987543 8999999999999999999999999999999999999988 79999999998865443323344688
Q ss_pred ccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHh-ccCCCCCCCCcHHHHHHH
Q 018656 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NLQAAYAAAF-KNVRPSAENVPEELSIIL 265 (352)
Q Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~l~~li 265 (352)
..|+|||.+.. ..++.++|+||||+++|+|++|..||.... .......... ......+...+.++.++|
T Consensus 156 ~~~~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 227 (262)
T cd05572 156 PEYVAPEIILN--------KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLI 227 (262)
T ss_pred cCccChhHhcC--------CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence 99999998753 457889999999999999999999998765 2222222221 223334556689999999
Q ss_pred HHhhccCCCCCCC-----HHHHHHHH
Q 018656 266 TSCWKEDPNARPN-----FTQIIQML 286 (352)
Q Consensus 266 ~~~l~~~p~~Rps-----~~~i~~~l 286 (352)
.+||..||.+||+ +.+++++.
T Consensus 228 ~~~l~~~p~~R~~~~~~~~~~l~~~~ 253 (262)
T cd05572 228 KQLLRRNPEERLGNLKGGIKDIKKHK 253 (262)
T ss_pred HHHccCChhhCcCCcccCHHHHhcCh
Confidence 9999999999999 89999873
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=298.98 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=205.0
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
++|++.+.||+|+||.||++.+. |+.||+|.+...... .....+.+|+.++++++||||+++++.+. ++..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE----SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH----HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 46889999999999999999985 899999988654322 22356889999999999999999999876 558999
Q ss_pred EEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 101 VTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccC
Confidence 999999999999987632 2258999999999999999999997 599999999999999987 7999999999875422
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHH---HHhccCCCCCC
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA---AAFKNVRPSAE 255 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~~~~ 255 (352)
. ......++..|+|||.+.+.... ....++.++|+|||||++|+|++|..||........... .........+.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPN--QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS 232 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCC--ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc
Confidence 2 22344678899999987542110 224568899999999999999999999976443222211 12222233456
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.++.++.++|.+||..+|.+||++.+++++.|
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 68999999999999999999999999999843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=301.23 Aligned_cols=255 Identities=28% Similarity=0.348 Sum_probs=202.5
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---C
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---P 96 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~ 96 (352)
.-++|++.+.||+|+||.||+|.+. |+.||+|++........ ....+.+|+.++++++|+||+++++++.+ +
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG---IPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC---CcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 4578999999999999999999884 89999999875433221 11235679999999999999999999864 3
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..++||||+. ++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++++ +.++|+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~ 158 (309)
T cd07845 82 SIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTY 158 (309)
T ss_pred eEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeec
Confidence 5899999995 58999887643 348999999999999999999999999999999999999988 79999999998754
Q ss_pred ccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--
Q 018656 177 SLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 253 (352)
Q Consensus 177 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 253 (352)
... .......++..|+|||.+.+ ...++.++||||||+++|+|++|..||.+.+..............+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLG-------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES 231 (309)
T ss_pred CCccCCCCcccccccccChhhhcC-------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 332 12223345788999998753 24568899999999999999999999988766544333322111000
Q ss_pred ---------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 254 ---------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 254 ---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
....++++.++|.+||..||++|||+.+++.| .|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h--~~f~ 294 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES--SYFK 294 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC--hhhc
Confidence 12257889999999999999999999999998 4444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=298.64 Aligned_cols=249 Identities=27% Similarity=0.381 Sum_probs=199.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
.+|++.+.||+|+||.||++.+. ++.|++|.+....... ......+.+|+++++.++||||+++++.+.. +..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL--RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh--HHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 36889999999999999999885 6899999886543211 2334568899999999999999999998874 46899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 79 VMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccCcCc
Confidence 999999999999997654 38999999999999999999999999999999999999987 799999999876311100
Q ss_pred ----------------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 018656 181 ----------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA 244 (352)
Q Consensus 181 ----------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 244 (352)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~ 227 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0112356788999998754 5678899999999999999999999987665544433
Q ss_pred HHhccC-CC-CCCCCcHHHHHHHHHhhccCCCCCCCH---HHHHHH
Q 018656 245 AAFKNV-RP-SAENVPEELSIILTSCWKEDPNARPNF---TQIIQM 285 (352)
Q Consensus 245 ~~~~~~-~~-~~~~~~~~l~~li~~~l~~~p~~Rps~---~~i~~~ 285 (352)
...... .+ ....++.++.++|.+||+.||.+||+. .+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 332221 12 223688999999999999999999984 555555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=298.92 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=200.6
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|++.+.||.|++|.||+|.+. |+.||||.+....... .....+.+|++++++++||||+++++++.+ +..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc---ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 5888999999999999999884 8899999886543322 123457889999999999999999999874 579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~- 180 (352)
|||+. ++|.+++.......+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR 155 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEeeccchhhcccCcc
Confidence 99995 689999877655568999999999999999999999999999999999999988 799999999987543221
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC--------
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-------- 252 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------- 252 (352)
......++..|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.+..............+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred ccccccccccccCCeEEec-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 2233356889999998754 2345788999999999999999999998766544333322111110
Q ss_pred --------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 --------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
....++.++.++|.+||+.||.+||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 023467889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=298.32 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=202.9
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
+...+|++.+.||+|+||+||++.+. |+.||+|++...... .....+.+|+++++.++||||+++++.+.. +.
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS----SVRKQILRELQIMHECRSPYIVSFYGAFLNENN 77 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc----hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence 34578999999999999999999885 889999988764432 224468899999999999999999999874 57
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.++||||+++++|.+++.+.+ .+++..+..++.+++.+|.|||+ .+++|+||+|+||+++++ +.++|+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~ 154 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGEL 154 (284)
T ss_pred EEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccch
Confidence 999999999999999987754 38999999999999999999997 589999999999999988 79999999997643
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH----------HHHHHHH
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL----------QAAYAAA 246 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~----------~~~~~~~ 246 (352)
... ......|+..|+|||++.+ ..++.++|+|||||++|++++|..||...... .......
T Consensus 155 ~~~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 155 INS-IADTFVGTSTYMSPERIQG--------GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred hhh-ccCccccCcccCCHHHHcc--------CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 221 1233468999999998754 46788999999999999999999999864432 0111111
Q ss_pred hcc-CCCC-CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 247 FKN-VRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 247 ~~~-~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
... .... ...++.++.+++.+||..||.+||++.+++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111 1111 224788999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=292.81 Aligned_cols=252 Identities=27% Similarity=0.505 Sum_probs=200.5
Q ss_pred eeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC----
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 96 (352)
|.+.+.||+|+||.||+|.++ ++.+|||++....... ....++.+|++++++++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS---SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 567889999999999999753 5789999987654333 2244578899999999999999999987421
Q ss_pred ---ceEEEEEcCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 97 ---VMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 97 ---~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
..+++++|+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||+++++ +.++|+|
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~d 156 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVAD 156 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECc
Confidence 2478999999999999875322 1247889999999999999999999999999999999999887 7899999
Q ss_pred CCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 018656 170 FGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAA 245 (352)
Q Consensus 170 fg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 245 (352)
||+++...... ......++..|++||.+.. ..++.++||||||+++|+|++ |..||.+..........
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLAD--------NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhc--------CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 99987543221 1122345678999998743 557889999999999999998 89999876554433333
Q ss_pred HhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 246 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
............+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 229 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 33333334456889999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=296.40 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=201.1
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||.|++|+||+|.++ |+.||+|.+....... .....+.+|++++++++||||+++++++.+ ...++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE---GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc---cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 47899999999999999999875 7899999986543322 223457789999999999999999999874 58999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
||||++ ++|.+++.......+++..++.++.||+.||+|||++|++|+||+|+||+++.+.+.+||+|||++......
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 999995 589888876655557889999999999999999999999999999999999865468999999998754322
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-------
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP------- 252 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------- 252 (352)
.......++..|+|||.+.+ ...++.++||||||+++|+|++|..||..................+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLG-------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cccccCceeecccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 12233467889999998743 2456789999999999999999999998765544333322111000
Q ss_pred ---------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 ---------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
....++.++.+++.+||+.+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 023567889999999999999999999999997
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=293.30 Aligned_cols=252 Identities=25% Similarity=0.440 Sum_probs=201.9
Q ss_pred ceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCCh-----HHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-C
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETP-----EEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 96 (352)
+|.+.+.||+|+||.||+|.+ +|+.+|+|.+...... .........+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588899999999999999976 4889999987643221 1122334568889999999999999999999874 4
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..++||||+++++|.+++.+.. .+++..+..++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeeccccccc
Confidence 7899999999999999998764 48999999999999999999999999999999999999987 79999999998754
Q ss_pred cccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-
Q 018656 177 SLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP- 252 (352)
Q Consensus 177 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~- 252 (352)
.... ......++..|+|||.+.. ....++.++|+||||+++|++++|..||..................+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP 232 (272)
T ss_pred cccccccccccccCCccccCHHHhcc------ccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCc
Confidence 3221 1223457889999998754 11347889999999999999999999997655443333222221111
Q ss_pred ----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 ----SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
....++.++.+++.+||..+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 123568999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=289.72 Aligned_cols=249 Identities=31% Similarity=0.485 Sum_probs=210.6
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|.+.+.||.|+||.||++.+. ++.+++|++....... .....+.+|+++++.++|||++++.+.+.+ ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE---KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh---HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 5889999999999999999986 8999999987654432 234457899999999999999999998864 578999
Q ss_pred EEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 102 TELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||+++++|.+++.+.. ...+++..++.++.+++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence 99999999999998753 3559999999999999999999999999999999999999987 79999999998754433
Q ss_pred c-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCc
Q 018656 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 180 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (352)
. ......+++.|+|||.+.. ..++.++|+||+|+++++|++|..||..................+.+..++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQN--------KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYS 228 (258)
T ss_pred cceecceeeeecccChhHhcc--------CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCC
Confidence 2 2233468889999998754 557889999999999999999999998766554444444444555566889
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+.+++.+||..+|.+||++.+++++
T Consensus 229 ~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 229 SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=294.92 Aligned_cols=247 Identities=24% Similarity=0.406 Sum_probs=202.2
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
++|.+.+.||.|++|.||++.++ ++.+++|.+...... .....+.+|++++++++||||+++++.+. +...++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE----AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh----HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 35788899999999999999986 889999998765443 23456889999999999999999999886 457999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
++||+++++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++++ +.++|+|||.+......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhhHHH
Confidence 999999999999998753 348999999999999999999999 999999999999999997 79999999998754322
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhccCCCC-C
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS----NLQAAYAAAFKNVRPS-A 254 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~----~~~~~~~~~~~~~~~~-~ 254 (352)
.. ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.... ..............+. +
T Consensus 155 ~~-~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06605 155 LA-KTFVGTSSYMAPERIQG--------NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP 225 (265)
T ss_pred Hh-hcccCChhccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC
Confidence 22 22678899999998854 467889999999999999999999997642 1111222222222222 2
Q ss_pred CC-CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 255 EN-VPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 255 ~~-~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.. ++.++.++|.+||..||.+|||+.+++.+
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 22 78999999999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=299.95 Aligned_cols=254 Identities=27% Similarity=0.406 Sum_probs=203.3
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
.+.|.....||+|+||.||++.+. ++.||||.+..... .....+.+|+.+++.++||||+++++.+. .+..+
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-----HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 345555678999999999999874 78999998754322 23445889999999999999999999876 45789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||+++++|.+++... .+++..++.++.|++.||+|||++|++||||||+||+++++ +.++|+|||++......
T Consensus 96 lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 96 VVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKE 171 (292)
T ss_pred EEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhcccc
Confidence 999999999999988542 38999999999999999999999999999999999999988 79999999998643222
Q ss_pred c-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--cCCCCCCC
Q 018656 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK--NVRPSAEN 256 (352)
Q Consensus 180 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~ 256 (352)
. ......++..|+|||.+.. ..++.++|+||||+++|+|++|..||............... ...+....
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHK 243 (292)
T ss_pred cccCceeecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccc
Confidence 1 1233468899999998754 45788999999999999999999999876654433322221 11222346
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
++..+.+++.+||..||.+|||+++++++ .++....+
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~--~~~~~~~~ 280 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH--PFLKLAGP 280 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC--hhhhccCC
Confidence 78899999999999999999999999997 44444333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.31 Aligned_cols=252 Identities=26% Similarity=0.409 Sum_probs=197.0
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHH-HhcCCCCCeeeeeeeee-cCceE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM-LSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
.+|++.+.||+|+||.||++.+. |+.||+|++........ ..++..|+.. ++.++||||+++++++. ++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE----QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH----HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 36889999999999999999885 89999999876543222 2234455554 66779999999999986 45799
Q ss_pred EEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 100 IVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
++|||++ ++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||++...
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeeccccccc
Confidence 9999995 6898888653 224589999999999999999999998 99999999999999988 79999999998764
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccCCC-CC
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFKNVRP-SA 254 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~-~~ 254 (352)
..........++..|+|||.+.+.. ....++.++|+||||+++|+|++|+.||..... .............. ..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPEL----NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA 230 (283)
T ss_pred ccccccccccCCccccChhhcCCcc----cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc
Confidence 3333223356888999999875411 124567899999999999999999999975332 22222222211111 13
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+|.++.++|.+||..+|.+||++.+++++
T Consensus 231 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 4588999999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=291.41 Aligned_cols=239 Identities=23% Similarity=0.415 Sum_probs=187.8
Q ss_pred ccccCCCceEEEEEEEC--------------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 30 PRIGEGAHAKVYEGKYK--------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
+.||+|+||.||+|... ...+++|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-----DISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 36899999999999742 23588888754321 233457889999999999999999999874
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC------ceEEe
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK------TIKLA 168 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~------~vkl~ 168 (352)
...+++|||+++++|..++.+.. ..+++..++.++.|+++||+|||++|++||||||+|||++.++. .++++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 47899999999999999987643 34899999999999999999999999999999999999976521 38999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHh
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~ 247 (352)
|||++...... ....++..|+|||.+.. ...++.++||||||+++|+|+ .|..||.......... ..
T Consensus 155 d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~--~~ 222 (262)
T cd05077 155 DPGIPITVLSR---QECVERIPWIAPECVED-------SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER--FY 222 (262)
T ss_pred CCCCCccccCc---ccccccccccChhhhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH--HH
Confidence 99998653221 23467889999998742 255788999999999999998 5888887654332211 11
Q ss_pred ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 248 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..........+.++.+++.+||+.||.+||++.+|++++
T Consensus 223 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 122223334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=298.02 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=206.1
Q ss_pred ceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 101 (352)
-|.+..+||+|+||.||+|.+ .|+.+|||.+....+ .+.+..|+.+++++..|+||++++.+- ...+++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-------HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 355678899999999999976 499999999876544 345788999999999999999999765 5689999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-c
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~-~ 180 (352)
||||..|+..+.++.+ .+++++.++..++...++||+|||...-+|||||..|||++.+ |..||+|||.|-..... .
T Consensus 107 MEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-chhhhhhccccchhhhhHH
Confidence 9999999999988764 3569999999999999999999999999999999999999998 89999999998754322 2
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--CCCCCCc
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAENVP 258 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 258 (352)
...+..||+.|||||++.. -.|+.++||||||++..||..|++||....+......+-.+..+ ..++.++
T Consensus 185 KRNTVIGTPFWMAPEVI~E--------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEE--------IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWS 256 (502)
T ss_pred hhCccccCcccccHHHHHH--------hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhh
Confidence 2356689999999999854 56888999999999999999999999887665443333222111 1256788
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.++.+|++.||.++|++|-|+.++++|.
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 9999999999999999999999999983
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=290.47 Aligned_cols=250 Identities=30% Similarity=0.452 Sum_probs=203.1
Q ss_pred ceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 101 (352)
+|++.+.||+|+||.||++.+ .++.|++|++...... ......+.+|+.++++++|+||+++++.+. .+..++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 588999999999999999987 4789999998765543 234567899999999999999999999876 4579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
+||+++++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++++ +.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 78 MEYCSGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EecCCCCcHHHHHhhcCC--CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCC
Confidence 999999999999986433 8899999999999999999999999999999999999997 7999999999875433222
Q ss_pred -----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHhccC--CCC
Q 018656 182 -----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY-AAAFKNV--RPS 253 (352)
Q Consensus 182 -----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~--~~~ 253 (352)
.....++..|+|||.+.... ....+.++||||+|+++|++++|+.||.......... ....... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGK-----GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD 229 (264)
T ss_pred cccccccCCcCCcCccChhhccCCC-----CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCc
Confidence 11345788999999986411 1347889999999999999999999997654332222 2222111 122
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...++..+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 33458999999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=295.27 Aligned_cols=254 Identities=28% Similarity=0.516 Sum_probs=204.4
Q ss_pred cCCceeeeccccCCCceEEEEEEEC------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
..++|++.+.||+|+||.||+|.+. ++.+|+|++...... .....+.+|+++++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~ 77 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEK 77 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence 4567888999999999999999853 678999998765543 234568899999999999999999998764
Q ss_pred ---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 96 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
...+++|||+++++|.+++..... .+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||.
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~ 155 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGL 155 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEccccc
Confidence 368999999999999999987543 48999999999999999999999999999999999999988 7999999999
Q ss_pred ccccccccc----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH--------
Q 018656 173 AREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ-------- 240 (352)
Q Consensus 173 a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-------- 240 (352)
+........ .....++..|+|||.+.. ..++.++||||||+++|+|++|..|+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 227 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRT--------SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ 227 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHcc--------CCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc
Confidence 876442211 112244567999998754 467889999999999999999999986532211
Q ss_pred ------HHHHHHh-ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 241 ------AAYAAAF-KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 241 ------~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
....... ....+.+..++.++.+++.+||..+|.+||++.++++.+.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 228 GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111 122334567789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=292.42 Aligned_cols=254 Identities=25% Similarity=0.435 Sum_probs=204.5
Q ss_pred ceeeeccccCCCceEEEEEEEC---CceEEEEEcccCCChH-----HHHHHHHHHHHHHHHHhc-CCCCCeeeeeeeee-
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPE-----EIAKKESRFAREVAMLSR-VQHRNLVKFIGACK- 94 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~---~~~vaiK~~~~~~~~~-----~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~- 94 (352)
+|++.+.||+|+||.||++.+. ++.+|+|.+....... .......++.+|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788899999999999999885 5789999876532211 112334557788888765 79999999999887
Q ss_pred cCceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
++..+++|||+++++|.+++... ....+++..++.++.|++.+|.+||+ .|++|+||+|+||+++++ +.++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~-~~~~l~dfg 159 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITDFG 159 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC-CcEEEeccc
Confidence 45899999999999999988542 23458999999999999999999996 789999999999999988 799999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVKN--------EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred ceeecccccccccccCcccCcChhhhcC--------CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 9886544433445578899999998854 55788999999999999999999999876554444333333333
Q ss_pred CCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 252 PSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 252 ~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+.. ..++.++.+++.+||+.||.+||++.++..++.
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 333 367899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=290.14 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=205.8
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
.+|++.+.||+|++|.||+|.+. |+.|++|++...... .....+.+|+..+++++|+||+++++.+.. ...++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 36888999999999999999885 899999998775542 234568899999999999999999999874 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
++||+++++|.+++.... .+++..++.++.|+++||+|||+ +|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 77 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 77 VLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENT 153 (264)
T ss_pred EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceecccC
Confidence 999999999999998753 48999999999999999999999 999999999999999988 79999999998754333
Q ss_pred ccc-ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhc-cCCCCCC
Q 018656 180 EMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NLQAAYAAAFK-NVRPSAE 255 (352)
Q Consensus 180 ~~~-~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--~~~~~~~~~~~-~~~~~~~ 255 (352)
... ....++..|+|||.+.. ..++.++|+||||+++|+|++|..||.... ........... .......
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQG--------ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPA 225 (264)
T ss_pred CCcccceeecccccCHhhhCC--------CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCc
Confidence 222 24467889999998754 567889999999999999999999998764 22222222222 2233344
Q ss_pred C-CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 256 N-VPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 256 ~-~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
. ++..+.++|.+||..+|.+||++.+++++
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 5 88999999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=291.77 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=199.4
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
+..+......||+|+||.||+|.+. +..|++|.+...... ....+.+|+.++++++|+||+++++++.. +..
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-----YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-----HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 3444445567999999999999874 678999987654432 23468899999999999999999999874 578
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCL--DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~--~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
++++||+++++|.+++..... .+ ++..+..++.|++.||+|||++|++||||||+||+++.+.+.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999999986432 24 888899999999999999999999999999999999875478999999998754
Q ss_pred ccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHH-hccCCCC
Q 018656 177 SLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA-AYAAA-FKNVRPS 253 (352)
Q Consensus 177 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~~~~~-~~~~~~~ 253 (352)
... .......++..|+|||.+.. ....++.++|+||+|+++|+|++|..||........ ..... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDK------GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233 (268)
T ss_pred ccCCCccccCCCCccccChhhhcc------ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC
Confidence 322 22233457899999998744 123467899999999999999999999976433222 11111 1222233
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+..+++++.+++.+||..+|.+|||+.+++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 56788999999999999999999999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=292.63 Aligned_cols=246 Identities=27% Similarity=0.437 Sum_probs=202.1
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
-|++.+.||.|+||.||+|.+. ++.+|+|+....... .....+.+|+.++++++||||+++++.+.+ ...++|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 3667888999999999999874 789999987654332 234568899999999999999999999875 479999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~- 180 (352)
|||+++++|.+++.+. .+++..+..++.|++.++.+||+.|++|+||+|+||+++++ +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecccchh
Confidence 9999999999998753 38999999999999999999999999999999999999988 789999999986543322
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
......++..|+|||.+.+ ...+.++|+||||+++|+|++|..||.......................++.+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP 228 (277)
T ss_pred hhccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHH
Confidence 1223467889999998754 45678899999999999999999999875544333333222233335568899
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+.+++.+||..+|.+||++.+++++.
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 229 LKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCH
Confidence 99999999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.79 Aligned_cols=241 Identities=22% Similarity=0.294 Sum_probs=190.1
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
...|.+...||+|+||.||+|.+. ++.||||.... ..+.+|++++++++|+||+++++++. ++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 557999999999999999999985 78899996322 12568999999999999999999876 55789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
++||++ .++|.+++.... ..+++..++.|+.|++.||.|||++||+||||||+|||++.+ +.++|+|||+++.....
T Consensus 237 lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-CCEEEcccCCceecccc
Confidence 999999 469999887643 349999999999999999999999999999999999999988 78999999998753222
Q ss_pred c---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhc-
Q 018656 180 E---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-------LQAAYAAAFK- 248 (352)
Q Consensus 180 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-------~~~~~~~~~~- 248 (352)
. ......||..|+|||++.+ ..++.++|||||||++|+|++|..|+-.... ..........
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~ 385 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAG--------DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA 385 (461)
T ss_pred cccccccccCCCcCCcCHHHHcC--------CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence 1 1223468999999999854 5678899999999999999998765432111 1111111110
Q ss_pred cC-------------------------CCC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 249 NV-------------------------RPS--------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 249 ~~-------------------------~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.. .+. ...++.++.+||.+||+.||.+|||+.++++|
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000 01345689999999999999999999999998
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=293.51 Aligned_cols=246 Identities=27% Similarity=0.442 Sum_probs=199.3
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC---CCCeeeeeeeeec-Cce
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRNLVKFIGACKE-PVM 98 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~-~~~ 98 (352)
.|++.+.||+|+||.||+|.+. ++.+|+|++....... ....+.+|+++++++. |||++++++++.+ ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD----DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch----hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 5788899999999999999974 8899999987543322 2335778899988886 9999999998864 578
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
+++|||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecCC
Confidence 9999999999999998653 48999999999999999999999999999999999999987 8999999999875433
Q ss_pred cc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC-CCC
Q 018656 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-AEN 256 (352)
Q Consensus 179 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 256 (352)
.. ......|+..|+|||.+.. +..++.++|+||||+++|+|++|..||.+.................. ...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITE-------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNG 226 (277)
T ss_pred CccccccccCCcceeCHHHhcc-------CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCccc
Confidence 22 2233468889999998743 24567899999999999999999999987654333222111111111 223
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
++.++.+++.+||..||.+||++.+++.+
T Consensus 227 ~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 227 YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 78899999999999999999999999997
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=294.22 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=202.3
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec---
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE--- 95 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~--- 95 (352)
...+|.+.+.||+|+||.||++.+. ++.+|+|++...... ...+.+|+.+++++ +|||++++++++..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV------DEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH------HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 3578999999999999999999884 789999998654321 23466888999988 89999999998753
Q ss_pred ---CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 96 ---PVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 96 ---~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
...++|+||+++++|.+++... ....+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.++|+||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~-~~~kl~df 172 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDF 172 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEeec
Confidence 2589999999999999998642 23458999999999999999999999999999999999999988 78999999
Q ss_pred CCcccccccc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 171 GLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 171 g~a~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
|++....... ......++..|+|||.+.... .....++.++||||||+++|+|++|+.||................
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCC---CcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 9987543222 123346889999999874311 012346889999999999999999999998765544443332221
Q ss_pred CC--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 250 VR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 250 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.. ..+..++.++.++|.+||+.+|.+||++.+++++
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 1244577889999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=290.06 Aligned_cols=238 Identities=23% Similarity=0.420 Sum_probs=189.5
Q ss_pred ccccCCCceEEEEEEECCc------------eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCc
Q 018656 30 PRIGEGAHAKVYEGKYKNQ------------TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~~~------------~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 97 (352)
+.||+|+||.||+|.+.+. .+++|+....... ...+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD------SLAFFETASLMSQLSHKHLVKLYGVCVRDE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh------HHHHHHHHHHHHcCCCcchhheeeEEecCC
Confidence 4699999999999988532 3777876543321 346889999999999999999999887677
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC-------ceEEecC
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-------TIKLADF 170 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~-------~vkl~Df 170 (352)
.++||||+++++|.+++..... .+++..+..++.|++.||+|||++|++||||||+||+++.+ + .++|+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~-~~~~~~~~~~kl~Df 152 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY-GLNEGYVPFIKLSDP 152 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecC-ccccCCceeEEeCCC
Confidence 8999999999999999987543 48999999999999999999999999999999999999877 4 6999999
Q ss_pred CCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc
Q 018656 171 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 171 g~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 249 (352)
|++..... .....++..|+|||++.. ....++.++||||||+++|+|++ |..||............. .
T Consensus 153 g~a~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~--~ 221 (259)
T cd05037 153 GIPITVLS---REERVERIPWIAPECIRN------GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ--D 221 (259)
T ss_pred Cccccccc---ccccccCCCccChhhhcC------CCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh--c
Confidence 99875433 223456788999999854 11367889999999999999999 688887654322222111 1
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
....+......+.+++.+||..+|.+||++.++++.|
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1112222347899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=302.09 Aligned_cols=242 Identities=22% Similarity=0.319 Sum_probs=184.2
Q ss_pred eccccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee---cCceEEE
Q 018656 29 GPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK---EPVMVIV 101 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~---~~~~~lv 101 (352)
+.+||+|+||+||+|.+. +..||+|.+...... ..+.+|++++++++||||+++++++. +...+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 467999999999999864 478999988654322 23678999999999999999999874 3468999
Q ss_pred EEcCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC---CCCceEEecCC
Q 018656 102 TELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFG 171 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~-------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~---~~~~vkl~Dfg 171 (352)
+||+. ++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||++.. ..+.++|+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 99995 58888875321 224889999999999999999999999999999999999942 23689999999
Q ss_pred Ccccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH--------
Q 018656 172 LAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-------- 239 (352)
Q Consensus 172 ~a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-------- 239 (352)
+++...... ......++..|+|||++.+ ...++.++|||||||++|+|++|..||......
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~ 230 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFH 230 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcC-------CCccCcHHHHHhHHHHHHHHHhCCCCccccccccccccccc
Confidence 997543221 1234468899999998854 245788999999999999999999999753321
Q ss_pred -HHHHHHHhccC-------------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHH
Q 018656 240 -QAAYAAAFKNV-------------------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQ 281 (352)
Q Consensus 240 -~~~~~~~~~~~-------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 281 (352)
........... .......+..+.+++.+||+.||.+|||+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e 310 (317)
T cd07867 231 HDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ 310 (317)
T ss_pred HHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHH
Confidence 00000000000 0001123456888999999999999999999
Q ss_pred HHHH
Q 018656 282 IIQM 285 (352)
Q Consensus 282 i~~~ 285 (352)
+++|
T Consensus 311 ~l~h 314 (317)
T cd07867 311 ALQD 314 (317)
T ss_pred HhcC
Confidence 9987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=289.45 Aligned_cols=248 Identities=27% Similarity=0.425 Sum_probs=208.0
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|++.+.||.|+||.||++.+. ++.+++|.+....... .....+.+|+++++.++|+||+++.+++.+ ...++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ---KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH---HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 5888999999999999999874 7899999987644332 234457789999999999999999988764 579999
Q ss_pred EEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 102 TELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||+++++|.+++.+.. ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence 99999999999987632 2458999999999999999999999999999999999999987 78999999998765433
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..............+....++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG--------RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQ 227 (256)
T ss_pred -CcccccCCccccCHHHHCC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCH
Confidence 3334568899999998754 5577899999999999999999999988766544444444444445567889
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
++.+++.+||..+|.+||++.+++++
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 228 DLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 99999999999999999999999886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=286.37 Aligned_cols=247 Identities=29% Similarity=0.501 Sum_probs=209.0
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|.+.+.||+|++|.||++.+. ++.|++|.+....... .....+.+|++++++++|||++++++++.+ ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE---EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH---HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 5888999999999999999874 7899999997765432 334568899999999999999999998764 578999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
|||+++++|.+++.... .+++..++.++.|++.+|.+||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 78 LEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCcc
Confidence 99999999999998763 48999999999999999999999999999999999999987 7999999999886443322
Q ss_pred -cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 182 -MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 182 -~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
.....++..|+|||...+ ..++.++|+||||+++|+|++|..||..................+.+..++..
T Consensus 155 ~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEM--------SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPE 226 (254)
T ss_pred cccccccchhhcCHhhhcC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHH
Confidence 233467889999998754 34778999999999999999999999876655555554444444556788999
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+.+++.+||..+|++||++.+++.+
T Consensus 227 ~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 227 LKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHHHHHHHHhCChhhCcCHHHHhcC
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=286.80 Aligned_cols=246 Identities=32% Similarity=0.539 Sum_probs=205.1
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
.|.+.+.||+|++|.||++.+. ++.+++|++..... .....+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4778899999999999999985 88999999876543 234568899999999999999999999874 578999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
+||+++++|.+++.... ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeecccccccccccc
Confidence 99999999999998753 348999999999999999999999999999999999999987 7999999999876544332
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--CCCCcH
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--AENVPE 259 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 259 (352)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+................ ...++.
T Consensus 154 ~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (253)
T cd05122 154 RNTMVGTPYWMAPEVING--------KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSD 225 (253)
T ss_pred ccceecCCcccCHHHHcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCH
Confidence 345568899999998854 4478899999999999999999999987654444333333222222 233489
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+.++|.+||+.||.+|||+.+++++
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999999886
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=289.77 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=191.9
Q ss_pred cccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcC
Q 018656 31 RIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
.||+|+||+||+|... ...+++|.+...... .....+.+|+..++.++||||+++++.+.+ ...++||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP----DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh----HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence 5999999999999653 356888877644332 223457889999999999999999998874 4799999999
Q ss_pred CCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc--
Q 018656 106 SGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (352)
Q Consensus 106 ~~~sL~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~-- 180 (352)
++++|.+++..... ...++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEeccccccccccchhe
Confidence 99999999977542 234677888999999999999999999999999999999998 799999999986432211
Q ss_pred -ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCC-----CC
Q 018656 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR-----PS 253 (352)
Q Consensus 181 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~-----~~ 253 (352)
......++..|+|||++...... .....++.++|||||||++|+|++ |..||......+........... ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQD-LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235 (269)
T ss_pred eccCCCCCcccccCHHHHhhcccc-ccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence 11223456789999987531100 012456889999999999999998 78899876655544433332221 12
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
...++..+..++..|+ .||.+||+++++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 3467888999999999 5999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=287.79 Aligned_cols=247 Identities=30% Similarity=0.473 Sum_probs=207.4
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---CceE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVMV 99 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~~ 99 (352)
+|++.+.||+|++|.||+|.+. ++.+++|++...... ......+.+|+.++++++||||+++++.+.+ ...+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 4788899999999999999986 889999998765543 2335568899999999999999999999874 4789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+++||+++++|.+++.+.. .+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEecccc
Confidence 9999999999999998765 49999999999999999999999999999999999999997 79999999998865444
Q ss_pred cc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh--ccCCCCC
Q 018656 180 EM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF--KNVRPSA 254 (352)
Q Consensus 180 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~ 254 (352)
.. .....++..|+|||.+.. ...+.++|+||||+++|+|++|..||.............. ......+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRG--------EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIP 226 (260)
T ss_pred cccccccCCCCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCC
Confidence 32 344568899999998754 4478899999999999999999999987652222222211 2233446
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..++..+.+++.+||+.||.+||++.+++.+
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 6778999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.56 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=191.0
Q ss_pred ccccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEc
Q 018656 30 PRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTEL 104 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~ 104 (352)
+.||+|+||.||+|.+. +..+|+|.+....... ....+.+|+.++++++||||+++++.+.+ ...++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ----EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChH----HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 35899999999999764 3579999887654322 22358889999999999999999999875 468999999
Q ss_pred CCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 105 LSGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 105 ~~~~sL~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
+++++|.+++..... ...++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCcce
Confidence 999999999975432 245677888899999999999999999999999999999987 7999999999864322211
Q ss_pred ---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCC----CC
Q 018656 182 ---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR----PS 253 (352)
Q Consensus 182 ---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~----~~ 253 (352)
.....++..|+|||++..... ......++.++|+||||+++|+|++ |..||......+........... +.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHG-NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eecCCCcCCcccccCHhHhccccc-cccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 122356788999998853110 0001246789999999999999996 99999876654433322221111 11
Q ss_pred -CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 254 -AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 254 -~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
....+..+.+++..|+ .+|.+|||+++++..|
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 2246788999999999 6899999999999775
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.43 Aligned_cols=239 Identities=23% Similarity=0.443 Sum_probs=189.3
Q ss_pred ccccCCCceEEEEEEEC--C-------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 30 PRIGEGAHAKVYEGKYK--N-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~-------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
+.||+|+||.||+|.+. + ..+++|.+.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 36999999999999774 2 247777764322 2334567889999999999999999999874 5789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC-------ceEEecCCC
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-------TIKLADFGL 172 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~-------~vkl~Dfg~ 172 (352)
+||||+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+.. .++++|||+
T Consensus 76 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999999999986543 4899999999999999999999999999999999999987632 279999998
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccCC
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
+...... ....++..|+|||++.+ ...++.++||||||+++|+|++| ..||.......... ......
T Consensus 155 ~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~--~~~~~~ 222 (258)
T cd05078 155 SITVLPK---EILLERIPWVPPECIEN-------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ--FYEDRH 222 (258)
T ss_pred ccccCCc---hhccccCCccCchhccC-------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH--HHHccc
Confidence 8654322 23467889999998853 24468899999999999999998 46666544432222 112223
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..+...+.++.+++.+||+.||.+|||++++++.|
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 223 QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 34455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=296.20 Aligned_cols=249 Identities=29% Similarity=0.411 Sum_probs=199.8
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||.||+|.+. ++.||+|++....... .....+.+|+++++.++||||+++++++.+ +..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK---MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc---hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 47899999999999999999984 7899999986544332 123457789999999999999999999874 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
|+||+++++|.++..... .+++..++.++.|++.||+|||+.|++|+||+|+||+++++ +.++|+|||++......
T Consensus 78 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCc
Confidence 999999999988776533 38999999999999999999999999999999999999988 79999999998753322
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-----------
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK----------- 248 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~----------- 248 (352)
.......++..|+|||.+.+ ...++.++||||||+++|+|++|..||...............
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVG-------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred cccCcccceeeccCcHHhcc-------ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 22233467889999998753 234678899999999999999999999765543322221110
Q ss_pred ---------cCCC----------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 249 ---------NVRP----------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 249 ---------~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...+ ....++..+.+++.+||..+|.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000 123578899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=293.70 Aligned_cols=255 Identities=18% Similarity=0.243 Sum_probs=190.4
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHH------HHHHHHHHHHHHhcCCCCCeee
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAK------KESRFAREVAMLSRVQHRNLVK 88 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~ 88 (352)
.+..++|++.+.||+|+||+||+|.+. +..+|+|+............ .......+...++.+.|+++++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 356789999999999999999999875 34677776544332211110 0112234445667789999999
Q ss_pred eeeeeecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC
Q 018656 89 FIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (352)
Q Consensus 89 l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~ 163 (352)
+++++... ..+++++++ ..++.+.+..... .++..++.++.|++.||+|||+++++||||||+|||++.+ +
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKC--KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-N 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhcc--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-C
Confidence 99876532 357888888 4578777765432 6788899999999999999999999999999999999887 7
Q ss_pred ceEEecCCCccccccc--------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCC
Q 018656 164 TIKLADFGLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235 (352)
Q Consensus 164 ~vkl~Dfg~a~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 235 (352)
.++|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--------~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--------ACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 8999999998753211 11123469999999998854 6689999999999999999999999987
Q ss_pred CChHHHHHH-------HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 236 MSNLQAAYA-------AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 236 ~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
......... .............+..+.+++..|++.+|.+||++.++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 236 FGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 633221111 111111223456789999999999999999999999998864
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=292.19 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=211.1
Q ss_pred ccccccccccccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 018656 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84 (352)
Q Consensus 7 ~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 84 (352)
|.+.+.+..++ ....|.+...||+|++|.||++.+. ++.+++|++..... ....+.+|+..+++++|+
T Consensus 6 ~~~~~~~~~~~----~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~ 75 (286)
T cd06614 6 AALKDIVSEGD----PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHP 75 (286)
T ss_pred hhHhhhcCCCC----ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCC
Confidence 34444444432 3566889999999999999999886 88999999876443 234578899999999999
Q ss_pred Ceeeeeeeee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC
Q 018656 85 NLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (352)
Q Consensus 85 ~iv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~ 163 (352)
||+++++.+. +...++++||+++++|.+++.... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.+ +
T Consensus 76 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~ 153 (286)
T cd06614 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-G 153 (286)
T ss_pred CeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-C
Confidence 9999999886 458999999999999999998765 349999999999999999999999999999999999999987 7
Q ss_pred ceEEecCCCcccccccc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 018656 164 TIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 242 (352)
Q Consensus 164 ~vkl~Dfg~a~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 242 (352)
.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.........
T Consensus 154 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 154 SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR--------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred CEEECccchhhhhccchhhhccccCCcccCCHhHhcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999876433221 2233457889999998754 45788999999999999999999999876655444
Q ss_pred HHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 243 YAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 243 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.........+ ....++.++.++|.+||+.+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 4333322222 233488999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=291.66 Aligned_cols=238 Identities=22% Similarity=0.404 Sum_probs=186.9
Q ss_pred cccCCCceEEEEEEEC--------------------------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 018656 31 RIGEGAHAKVYEGKYK--------------------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~~--------------------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 84 (352)
.||+|+||.||+|... ...|++|++..... .....+.+|+.+++.++||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-----DIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-----HHHHHHHHHHHHHhcCCCC
Confidence 6999999999998641 13488888754321 2334578899999999999
Q ss_pred Ceeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC-
Q 018656 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 162 (352)
Q Consensus 85 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~- 162 (352)
||+++++++.+ ...++||||+++++|..++.+.. ..+++..+..++.|+++||+|||++|++||||||+||+++..+
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 99999999874 57899999999999999987643 3489999999999999999999999999999999999997541
Q ss_pred -----CceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHH-hCCCCCCCC
Q 018656 163 -----KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGM 236 (352)
Q Consensus 163 -----~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll-~g~~p~~~~ 236 (352)
..++++|||++...... ....++..|+|||.+.. ...++.++||||||+++|+++ +|..||...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG-------GNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred ccCccceeeecCCccccccccc---cccccCCcccCchhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 24899999987543211 22357788999998743 245788999999999999985 699999876
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 237 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.......... .....+...+..+.++|.+||+.+|.+||++.++++.|
T Consensus 226 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 226 TPSEKERFYE--KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ChHHHHHHHH--hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 5433222111 12223344567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=292.88 Aligned_cols=245 Identities=26% Similarity=0.341 Sum_probs=194.4
Q ss_pred eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeec---CceE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE---PVMV 99 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~---~~~~ 99 (352)
|++.+.||+|+||.||+|.+. ++.||+|++........ .....+|+.+++++. |+||+++++++.+ +..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 678899999999999999874 78999999876433221 112347888888885 9999999998863 5789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.|++||||+|+||+++. +.++|+|||++......
T Consensus 77 lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 77 LVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence 9999996 58888887643 34899999999999999999999999999999999999998 68999999999765444
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--------
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-------- 251 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-------- 251 (352)
.......++..|+|||.+.. ...++.++|||||||++|+|++|..||.+.+..+...........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLT-------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred CCcCCCCCCcccCChhHhhc-------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 33344567899999997643 245678999999999999999999999876543322211110000
Q ss_pred --------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 --------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.....++.++.++|.+||..+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0023568999999999999999999999999987
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=295.82 Aligned_cols=251 Identities=26% Similarity=0.355 Sum_probs=197.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeecC-c--
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-V-- 97 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~-~-- 97 (352)
++|++.+.||+|+||.||+|.+. |+.||+|++....... .....+.+|+.+++.+. ||||+++++++... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE---GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc---CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 46899999999999999999874 7899999886643322 12234778999999995 69999999987632 2
Q ss_pred ---eEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 98 ---MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 98 ---~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
.+++|||+++ +|.+++.... ...+++..++.++.|++.||.|||++|++||||+|+||+++.+.+.++|+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 8999886543 23589999999999999999999999999999999999999844899999999
Q ss_pred Cccccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 018656 172 LAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 172 ~a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
++...... .......+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.+.............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLG-------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhC-------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 98753222 11223356888999998743 24568899999999999999999999987665443332221100
Q ss_pred CC---------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 RP---------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 ~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+ ....++.++.++|.+||..||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 013578899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=296.37 Aligned_cols=253 Identities=25% Similarity=0.390 Sum_probs=197.5
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeee-cCce
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACK-EPVM 98 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~-~~~~ 98 (352)
.++|.....||+|+||+||++.+. |+.+|+|.+...... .....+.+|+.++.++. ||||+++++++. ++..
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE----KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh----HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 456777889999999999999884 789999998764433 23446788999999995 999999999876 4578
Q ss_pred EEEEEcCCCCCHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 99 VIVTELLSGGTLRKYL---LNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l---~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+++|||+. ++|.++. .......+++..+..++.|++.||+|||+. +++||||||+||+++.+ +.++|+|||++.
T Consensus 79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~ 156 (288)
T cd06616 79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISG 156 (288)
T ss_pred EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhH
Confidence 99999985 4665543 222334599999999999999999999975 99999999999999987 789999999987
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC--
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-- 252 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 252 (352)
............++..|+|||.+.... ...++.++||||||+++|+|++|+.||..................+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd06616 157 QLVDSIAKTRDAGCRPYMAPERIDPSA-----RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL 231 (288)
T ss_pred HhccCCccccccCccCccCHHHhcccc-----ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcC
Confidence 543333333446889999999985410 1367889999999999999999999997654322222221111111
Q ss_pred ---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 253 ---SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 253 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
....++.++.+++.+||+.||.+|||+++++++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1235789999999999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=295.58 Aligned_cols=248 Identities=24% Similarity=0.395 Sum_probs=195.0
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|++|+||+|.++ ++.||+|.+....... ....+.+|++++++++||||+++++++.+ ...++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 67999999999999999999874 7899999987543221 11235689999999999999999999874 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+.+ +|.+++..... .+++..++.++.|+++||.|||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 81 v~e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-GELKLADFGLARAKSVPS 157 (291)
T ss_pred EEecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-CCEEECccccccccCCCC
Confidence 9999975 99999876543 58999999999999999999999999999999999999988 799999999987533221
Q ss_pred -ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-cCC-------
Q 018656 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-NVR------- 251 (352)
Q Consensus 181 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~------- 251 (352)
......++..|+|||.+.+ ...++.++||||+|+++|+|++|..||.+............. ...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLG-------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred ccccccccccccCCcHHhhc-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 1122346889999998753 234678999999999999999999999765522211111100 000
Q ss_pred ----------------------CCCCCCc--HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 ----------------------PSAENVP--EELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 ----------------------~~~~~~~--~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.....++ .++.+++.+||+.+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0011233 788999999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=294.55 Aligned_cols=252 Identities=29% Similarity=0.412 Sum_probs=203.5
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.+.|.+.+.||+|+||+||+|.+. |+.||+|++........ .....+.+|+.+++.++||||+++.+++.+ ...+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 467999999999999999999874 89999999865432221 234568899999999999999999999874 5789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+|+||+. ++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 92 lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 92 LVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSPA 168 (307)
T ss_pred EEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecCCC
Confidence 9999996 58888776533 348999999999999999999999999999999999999988 79999999998654322
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-CCCCCCc
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 258 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 258 (352)
....++..|+|||++... ....++.++||||||+++|+|++|..||.+.+.............. .....++
T Consensus 169 ---~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWS 240 (307)
T ss_pred ---CCccCCccccCceeeecc-----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhC
Confidence 234678899999987431 1245788999999999999999999999876654443333322111 1234578
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
..+.++|.+||..||.+||++.+++.+.+
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 89999999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=301.30 Aligned_cols=247 Identities=28% Similarity=0.367 Sum_probs=195.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 96 (352)
.++|++.+.||+|+||.||+|.+. |+.||+|++...... ....++.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ----TFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc----hhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 468999999999999999999874 889999998643222 2234577899999999999999999886532
Q ss_pred --ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 97 --VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 97 --~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
..++++||+. ++|.+++... .+++..++.++.|++.||++||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECccccee
Confidence 4799999995 5888887542 38999999999999999999999999999999999999988 799999999987
Q ss_pred cccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-
Q 018656 175 EESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN- 249 (352)
Q Consensus 175 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~- 249 (352)
...... ......|+..|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.+............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~ 227 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 533221 1123467899999998643 2457889999999999999999999997754322111110000
Q ss_pred -----------------------CCC------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 250 -----------------------VRP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 250 -----------------------~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+ ....++.++.+++.+||+.+|.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 013457889999999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=294.73 Aligned_cols=247 Identities=29% Similarity=0.467 Sum_probs=201.9
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
..+|.+.+.||+|+||.||++.+ +++.|++|.+...... ....+.+|+.+++.++||||+++++.+.. ...+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-----KKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-----HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 47899999999999999999986 4788999998643322 23457889999999999999999999874 5799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+|+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceeccccc
Confidence 999999999999999753 37899999999999999999999999999999999999988 79999999987643322
Q ss_pred c-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc--CCCCCCC
Q 018656 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAEN 256 (352)
Q Consensus 180 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 256 (352)
. ......+++.|+|||.+.. ..++.++|+||||+++|++++|+.||...+............ ..+.+..
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240 (293)
T ss_pred ccccccccCChhhcCchhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccc
Confidence 2 2233468889999998754 457889999999999999999999998755433322221111 1122445
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
++..+.+++++||..+|.+||++.+++.+-
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 778999999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=291.74 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=189.5
Q ss_pred cccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHH---HHhcCCCCCeeeeeeeee-cCceEEEEEc
Q 018656 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA---MLSRVQHRNLVKFIGACK-EPVMVIVTEL 104 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~hp~iv~l~~~~~-~~~~~lv~e~ 104 (352)
.||+|+||.||++.+. |+.+|+|++......... ....+.+|.. ++...+||||+.+++.+. ++..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch--HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999999999874 789999998764332211 1112333433 344457999999999886 4578999999
Q ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccccccc
Q 018656 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184 (352)
Q Consensus 105 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~ 184 (352)
+++++|.+++..+.. +++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++....... ...
T Consensus 79 ~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~-~~~ 154 (279)
T cd05633 79 MNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHA 154 (279)
T ss_pred CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceeccccC-ccC
Confidence 999999999986543 9999999999999999999999999999999999999988 799999999986543222 223
Q ss_pred CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHhccCCCCCCCCcHHHH
Q 018656 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ--AAYAAAFKNVRPSAENVPEELS 262 (352)
Q Consensus 185 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~ 262 (352)
..|+..|+|||.+.. +..++.++|+||+||++|+|++|..||....... .............+..++.++.
T Consensus 155 ~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (279)
T cd05633 155 SVGTHGYMAPEVLQK-------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELK 227 (279)
T ss_pred cCCCcCccCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHH
Confidence 468999999998742 2457889999999999999999999997543221 1111221222233567889999
Q ss_pred HHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 263 IILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 263 ~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
++|.+||..||.+|| ++.++++|.
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 228 SLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 999999999999999 699999983
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=294.73 Aligned_cols=249 Identities=28% Similarity=0.383 Sum_probs=199.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|++|.||+|.+. ++.|++|++....... .....+.+|++++++++|+||+++++++.+ +..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE---DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc---cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 47999999999999999999885 7899999887543322 223568899999999999999999999874 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
+|||++++.|..+..+. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 78 VFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARP 154 (288)
T ss_pred EEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCc
Confidence 99999886666655543 338999999999999999999999999999999999999987 799999999987544332
Q ss_pred --ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--------
Q 018656 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-------- 250 (352)
Q Consensus 181 --~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-------- 250 (352)
......++..|+|||++.. ...++.++|+||||+++|+|++|+.||.+....+..........
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVG-------DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred cccccCcccccCCcCCchhcC-------CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 2334567889999999854 12678899999999999999999999987655433322211000
Q ss_pred -------------C----------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 -------------R----------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 -------------~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
. ..+..++.++.++|++||..+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 0122348889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=291.40 Aligned_cols=244 Identities=27% Similarity=0.402 Sum_probs=198.5
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 101 (352)
.|.-.+.||+|++|.||++.+. ++.+++|++..... .....+.+|+.+++.++||||+++++++. .+..+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-----hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 4555678999999999999874 78899998754322 22345789999999999999999999876 4579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~- 180 (352)
+||++|++|.+++.. . .+++..+..++.|++.||++||++|++||||+|+||+++.+ +.++|+|||.+.......
T Consensus 95 ~e~~~~~~L~~~~~~-~--~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-T--RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-C--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhccCCc
Confidence 999999999999876 2 38999999999999999999999999999999999999988 799999999876432221
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--CCCCCCc
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAENVP 258 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 258 (352)
......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.............. .....++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVS 242 (285)
T ss_pred ccccccCCccccCHHHhcC--------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCC
Confidence 1233468899999998754 45788999999999999999999999876554433333222111 1133478
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+.+++.+||..+|.+||++.+++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=290.61 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=199.2
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---Cce
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVM 98 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~ 98 (352)
++|...+.||.|++|.||++.+. ++.+|+|.+...... ....++.+|++++++++||||+++++++.+ +.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP----DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch----HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 36888999999999999999984 789999998764432 234568899999999999999999998753 368
Q ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 99 VIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
++||||+++++|.+++... ....+++..+..++.|++.||+|||+.|++|+||+|+||+++++ +.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~ 155 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGEL 155 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeeccccccc
Confidence 9999999999999987642 23458999999999999999999999999999999999999988 78999999998654
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccCCC
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN----LQAAYAAAFKNVRP 252 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~ 252 (352)
.... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .............+
T Consensus 156 ~~~~-~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd06621 156 VNSL-AGTFTGTSFYMAPERIQG--------KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP 226 (287)
T ss_pred cccc-cccccCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch
Confidence 3222 123457889999998754 5678899999999999999999999986521 11111211111111
Q ss_pred C-------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 253 S-------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 253 ~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
. ...+++.+.+++.+||..+|.+|||+.+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 1 124568899999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=301.09 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=198.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
..+|.+.+.||.|+||+||+|.++ |+.||+|.+..... .....+.+|+++++.++||||+++++.+..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 578999999999999999999884 78999999866543 223457789999999999999999887643
Q ss_pred ----------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCce
Q 018656 96 ----------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (352)
Q Consensus 96 ----------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~v 165 (352)
...+++|||++ ++|.+++... .+++..++.++.|+++||.|||+.|++||||||+||+++.+.+.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 24789999996 5899888642 389999999999999999999999999999999999998664689
Q ss_pred EEecCCCcccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 018656 166 KLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 241 (352)
Q Consensus 166 kl~Dfg~a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 241 (352)
+|+|||++....... ......++..|+|||.+.. ...++.++|||||||++|+|++|+.||.+.+....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 227 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhC-------ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999986432211 1122357889999997643 24577899999999999999999999987654333
Q ss_pred HHHHHhcc-----------------------CCC------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 242 AYAAAFKN-----------------------VRP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 242 ~~~~~~~~-----------------------~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
........ ..+ ....++.++.+++.+||+.||.+|||+.+++.+ .|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h--~~~~~ 305 (342)
T cd07854 228 MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH--PYMSC 305 (342)
T ss_pred HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC--Ccccc
Confidence 22211110 000 023577889999999999999999999999998 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=293.53 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=199.1
Q ss_pred eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVT 102 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 102 (352)
|++.+.||.|++|.||+|.++ |+.||+|++....... .....+.+|+.+++.++|||++++++++.+ +..++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE---GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc---cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 567889999999999999874 8999999987653322 122347789999999999999999999874 5799999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-c
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-M 181 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~-~ 181 (352)
||++ ++|.+++.......+++..++.++.|+++||+|||+++++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT 155 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccc
Confidence 9994 699999987664459999999999999999999999999999999999999987 799999999987543221 2
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-----------
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV----------- 250 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----------- 250 (352)
.....++..|+|||++.+ ...++.++|+||||+++|+|++|..||...+.............
T Consensus 156 ~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 156 YTHEVVTLWYRAPEILLG-------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred cCccccccCCCCCceeec-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence 223356889999998743 23467889999999999999999999987655433322211100
Q ss_pred -----------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 -----------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
......++..+.++|.+||+.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01134677899999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=299.80 Aligned_cols=248 Identities=27% Similarity=0.338 Sum_probs=197.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-----
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP----- 96 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 96 (352)
.+|.+.+.||+|+||+||+|.+. |+.||||.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR---IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc---chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 36999999999999999999874 8999999987543222 1233567899999999999999999987532
Q ss_pred -ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..++++||+. ++|.+++.... .+++..++.++.|++.||.|||+++++|+||||+||+++.+ +.++|+|||++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCccccc
Confidence 4799999994 69999987654 49999999999999999999999999999999999999988 7999999999875
Q ss_pred cccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------
Q 018656 176 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK------ 248 (352)
Q Consensus 176 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~------ 248 (352)
.... .......++..|+|||.+.. ...++.++||||||+++|+|++|+.||.+.+...........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLN-------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred cCCCcccccccccccCccChHHHhc-------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 4332 22334467889999998753 134788999999999999999999999775432211111000
Q ss_pred ------------------cC------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 249 ------------------NV------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 249 ------------------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.. ......++.++.++|++||+.+|.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00 00124678899999999999999999999999999
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=278.17 Aligned_cols=258 Identities=22% Similarity=0.414 Sum_probs=214.5
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA 92 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~ 92 (352)
..++..|.+..+....||+|+-|.|++++.. |...|||.+......++ ..++...+.++... +.|+||+.+++
T Consensus 84 g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee----~kRILmDldvv~~s~dcpyIV~c~Gy 159 (391)
T KOG0983|consen 84 GQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE----NKRILMDLDVVLKSHDCPYIVQCFGY 159 (391)
T ss_pred CcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH----HHHHHHhhhHHhhccCCCeeeeeeeE
Confidence 4557777788888999999999999999875 79999999987665443 34677777776655 58999999999
Q ss_pred ee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEEecC
Q 018656 93 CK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 93 ~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
|- +...++.||.+ +..++.++.+.+ ++++|..+-.+...+++||.||.++ ||+|||+||+|||++.. |++||+||
T Consensus 160 Fi~n~dV~IcMelM-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-GniKlCDF 236 (391)
T KOG0983|consen 160 FITNTDVFICMELM-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GNIKLCDF 236 (391)
T ss_pred EeeCchHHHHHHHH-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-CCEEeecc
Confidence 97 55789999999 557777776543 4599999999999999999999876 89999999999999998 89999999
Q ss_pred CCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 018656 171 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 171 g~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
|++-........+...|.+.|||||.+... ....|+.++||||||++++||.||+.||.+.+..-..........
T Consensus 237 GIsGrlvdSkAhtrsAGC~~YMaPERidp~-----~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e 311 (391)
T KOG0983|consen 237 GISGRLVDSKAHTRSAGCAAYMAPERIDPP-----DKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE 311 (391)
T ss_pred cccceeecccccccccCCccccCccccCCC-----CCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC
Confidence 999876666666777899999999998652 357899999999999999999999999998655444444444444
Q ss_pred CCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 RPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 ~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.|. ...+++.+.+|+..||++|+.+||.+.++++|
T Consensus 312 PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 312 PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 343 34589999999999999999999999999998
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=301.00 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=201.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----C
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-----P 96 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~ 96 (352)
.+|.+.+.||+|++|.||+|.+. |+.||+|++....... .....+.+|+.++++++||||+++++++.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP---TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc---cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 68999999999999999999874 8999999987643322 223457789999999999999999988742 3
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..++||||+. ++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceee
Confidence 6899999995 699999876443 8999999999999999999999999999999999999988 79999999998753
Q ss_pred cccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---
Q 018656 177 SLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK--- 248 (352)
Q Consensus 177 ~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--- 248 (352)
.... ......++..|+|||.+.. ...++.++||||||+++|+|++|+.||.+.+...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~ 230 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLS-------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcC-------CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence 3221 1123468889999998743 234788999999999999999999999876543221111110
Q ss_pred --------------------cC--CCC-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 249 --------------------NV--RPS-----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 249 --------------------~~--~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
.. .+. ...++.++.++|.+||+.+|.+||++.+++.+ .|+.....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~--~~~~~~~~ 302 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH--PFLAQYHD 302 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC--hhhhhccC
Confidence 00 000 13468899999999999999999999999998 44444333
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=297.75 Aligned_cols=248 Identities=21% Similarity=0.359 Sum_probs=194.9
Q ss_pred ccccCC--CceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEc
Q 018656 30 PRIGEG--AHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTEL 104 (352)
Q Consensus 30 ~~lG~G--~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~ 104 (352)
..||+| +||+||+|.+ .|+.||+|++....... .....+.+|+.+++.++||||+++++++.. +..++|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE---EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 457777 9999999988 48999999987654433 234568899999999999999999999974 478999999
Q ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc---
Q 018656 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM--- 181 (352)
Q Consensus 105 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~--- 181 (352)
+.+++|.+++.+.....+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++++||+.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCcccc
Confidence 999999999987655569999999999999999999999999999999999999988 7999999986532111100
Q ss_pred -----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC------
Q 018656 182 -----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------ 250 (352)
Q Consensus 182 -----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~------ 250 (352)
.....++..|+|||++.+ ....++.++|||||||++|+|++|..||.+...............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQ------DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccccCccCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence 011234567999999854 124578899999999999999999999987654333222211100
Q ss_pred ----------------------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 251 ----------------------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 251 ----------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+....++..+.+++++||+.||.+|||+.+++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0112235678999999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=302.56 Aligned_cols=259 Identities=31% Similarity=0.570 Sum_probs=223.6
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
++|.+++.++.+-++||-|-||.||.|.|+ .-.||||.++.... ....|..|.++|+.+.|||+|+++++|.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM------eveEFLkEAAvMKeikHpNLVqLLGVCT 333 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCT 333 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch------hHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence 689999999999999999999999999997 56799998865432 2346999999999999999999999997
Q ss_pred -cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 -EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+.-+|||.|||..|+|.+|+++.....++....+.++-||.+|++||..+++|||||...|.|+.++ ..||++|||++
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-hiVKvADFGLs 412 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HIVKVADFGLS 412 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-ceEEeeccchh
Confidence 6689999999999999999998776678888999999999999999999999999999999999998 79999999999
Q ss_pred cccccccccccCCC---cccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc
Q 018656 174 REESLTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 174 ~~~~~~~~~~~~~g---~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 249 (352)
+....+.. ....| ..-|.|||-+.. ..++.++|||+||++|||+.| |..||.+.+..+...-.....
T Consensus 413 RlMtgDTY-TAHAGAKFPIKWTAPEsLAy--------NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy 483 (1157)
T KOG4278|consen 413 RLMTGDTY-TAHAGAKFPIKWTAPESLAY--------NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY 483 (1157)
T ss_pred hhhcCCce-ecccCccCcccccCcccccc--------cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc
Confidence 86433322 22222 467999998855 568899999999999999998 999999977665554444445
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
....+..+|+.+..|++.||+.+|.+||++.++-+.++..+.
T Consensus 484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 556688999999999999999999999999999998876654
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=295.27 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=200.1
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
..|.....||+|+||.||+|.+. ++.||+|++...... ....+.+|+.+++.++||||+++++.+. ++..++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-----RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-----hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 44555668999999999999874 899999998654321 2345788999999999999999999876 458999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
++||+++++|.+++... .+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 96 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 96 LMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-CcEEEeechhHhhccccc
Confidence 99999999999987652 38999999999999999999999999999999999999988 799999999986433221
Q ss_pred -ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc--CCCCCCCC
Q 018656 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENV 257 (352)
Q Consensus 181 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 257 (352)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||................ .......+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISR--------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243 (297)
T ss_pred ccccceecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCC
Confidence 1233568899999998854 457889999999999999999999998765544333322211 11223467
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+..+.++|.+||+.+|.+||++.+++++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 88999999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=291.26 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=194.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
..+|++.+.||+|+||.||+|.+. |+.||+|++....... ....+.+|+.+++.++|+||+++.+++.+ ...+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 368999999999999999999874 8899999986543221 12246689999999999999999999875 4789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-GELKLADFGLARAKSIP 156 (291)
T ss_pred EEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-CcEEEeccccccccCCC
Confidence 9999995 68888776543 347888899999999999999999999999999999999988 79999999998753222
Q ss_pred -cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-cCC------
Q 018656 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-NVR------ 251 (352)
Q Consensus 180 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~------ 251 (352)
.......++..|+|||.+.+ ...++.++||||||+++|+|++|..||.+............. ...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLG-------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred CCCCCCccccccccCCceeec-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence 12233457899999998753 234677899999999999999999999875542221111100 000
Q ss_pred ------------------CC-------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 ------------------PS-------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 ------------------~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+. .-..+.++.+++.+||..||.+|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 01235788999999999999999999999876
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=294.04 Aligned_cols=250 Identities=26% Similarity=0.296 Sum_probs=199.7
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-c--Cc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-E--PV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~--~~ 97 (352)
.++|++.+.||+|+||.||+|.+. ++.+++|.+....... .....+.+|+.++++++||||+++++++. . ..
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE---GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc---cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 357899999999999999999985 7889999987554322 12234678999999999999999999875 3 57
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++|+||++ ++|.+++..... .+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~ 157 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYG 157 (293)
T ss_pred EEEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeecc
Confidence 999999996 599999876443 58999999999999999999999999999999999999988 799999999987544
Q ss_pred cc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-----
Q 018656 178 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR----- 251 (352)
Q Consensus 178 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~----- 251 (352)
.. .......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||..................
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLG-------AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230 (293)
T ss_pred CCccccccccccccccCchhhcC-------CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence 33 22233457889999998754 234678999999999999999999999876654333222111000
Q ss_pred ------------------------C-CCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 ------------------------P-SAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 ------------------------~-~~~~-~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
. .+.. ++..+.++|++||+.||++|||+.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0111 57889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=298.03 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=218.7
Q ss_pred ceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
+-+....++..++||+||||.||-++. +|+.||+|.+.+..... ..-+....+|-.+|.+++.+.||.+--.|+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk--r~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK--RKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH--hhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 566778888999999999999998764 69999999887654322 2334557789999999999999999888874
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+.+++|+..|+||+|.=+|.+.+...+++..++.++.+|+.||++||+.+||.||+||+|||+|+. |+++|+|.|+|..
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~-GhvRISDLGLAve 336 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH-GHVRISDLGLAVE 336 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC-CCeEeeccceEEe
Confidence 589999999999999999999887789999999999999999999999999999999999999998 8999999999998
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHhccCCC
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ---AAYAAAFKNVRP 252 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~ 252 (352)
..........+||.+|||||++.+ +.|+...|.|||||++|+|+.|+.||....... ............
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~n--------e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e 408 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQN--------EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE 408 (591)
T ss_pred cCCCCccccccCcccccCHHHHcC--------CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh
Confidence 888888888899999999999965 569999999999999999999999997644322 223333334444
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 285 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~i~~~ 285 (352)
.++.+|++.+.+.+.+|+.||.+|.. ++++.+|
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 56889999999999999999999964 5677776
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=307.14 Aligned_cols=249 Identities=25% Similarity=0.469 Sum_probs=210.3
Q ss_pred CCce-eeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---C
Q 018656 23 PKHL-FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---P 96 (352)
Q Consensus 23 ~~~y-~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~ 96 (352)
..+| ++..+||+|+|-+||+|.|. |-.||--.++...... .....++|..|+.+|+.|+||||+++++.+.+ .
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q-~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQ-SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhc-ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 3444 45688999999999999885 6666644433322111 12345689999999999999999999999864 3
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
++.+|.|.+..|+|..|+++++. .+...+..|++||++||.|||++. |+|||||-+||||+...|.|||+|.|+|.
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHH
Confidence 68999999999999999998876 899999999999999999999997 99999999999999988999999999998
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC-
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 253 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~- 253 (352)
....... .+.+|||.|||||++ ...|++..||||||+.+.||+|+..||..-.+..+.++....+..|.
T Consensus 195 l~r~s~a-ksvIGTPEFMAPEmY---------EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 195 LLRKSHA-KSVIGTPEFMAPEMY---------EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred Hhhcccc-ceeccCccccChHHH---------hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 7544433 457999999999998 37899999999999999999999999998888888888877776665
Q ss_pred -CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 -AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 -~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..--.+++++||.+||.. ...|||+.+++.+
T Consensus 265 l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 265 LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 223358899999999998 9999999999998
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=288.78 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=190.6
Q ss_pred cccCCCceEEEEEEEC--CceEEEEEcccCCChHHHH-HHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCC
Q 018656 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIA-KKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLS 106 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~ 106 (352)
.||+|+||.||+|.+. ++.||+|++.......... .........++.++...||+|+++.+.+.+ +..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 7899999987643321111 111111223445566789999999999874 57899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCC
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET 186 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 186 (352)
|++|.+++.+.. .+++..++.++.|++.||+|||+++++||||||+||+++.+ +.++|+|||++....... .....
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~~-~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASV 156 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccCccC-CcCcC
Confidence 999999987644 49999999999999999999999999999999999999988 789999999987543222 23446
Q ss_pred CcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHhccCCCCCCCCcHHHHHH
Q 018656 187 GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--QAAYAAAFKNVRPSAENVPEELSII 264 (352)
Q Consensus 187 g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l 264 (352)
|+..|+|||.+.. +..++.++||||+|+++|+|++|..||...... ..............+..++.++.++
T Consensus 157 ~~~~y~aPE~~~~-------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 229 (278)
T cd05606 157 GTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 229 (278)
T ss_pred CCcCCcCcHHhcC-------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHH
Confidence 8999999999753 235788999999999999999999999875321 1112222222333455678999999
Q ss_pred HHHhhccCCCCCC-----CHHHHHHH
Q 018656 265 LTSCWKEDPNARP-----NFTQIIQM 285 (352)
Q Consensus 265 i~~~l~~~p~~Rp-----s~~~i~~~ 285 (352)
+.+||..+|.+|| ++.+++++
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 230 LEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 9999999999999 99999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=291.86 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=205.2
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
+.|...+.||+|+||.||++.+. |+.+|+|++....... .+....+.+|++++++++|||++++++++.+ ...++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS--NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc--hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 44778899999999999999874 7899999987543322 1334568899999999999999999999874 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+.| +|.+.+.... ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 103 v~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 103 VMEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIASP-- 177 (317)
T ss_pred EEeCCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCccccCC--
Confidence 9999965 8888776543 348999999999999999999999999999999999999987 7999999998865332
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-CCCCCCcH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 259 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 259 (352)
.....++..|+|||.+... ....++.++|+||+|+++|+|++|..||.................. .....++.
T Consensus 178 -~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD 251 (317)
T ss_pred -cccccCCccccChhhhhcC-----CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccH
Confidence 2334688899999987431 1245788999999999999999999999876554444444333322 23456788
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
.+.+++.+||+.+|.+||++.+++++++...
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 9999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=290.53 Aligned_cols=248 Identities=24% Similarity=0.396 Sum_probs=198.5
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|++.+.||.|++|.||+|.+. |+.||||++....... ....+.+|+.++++++||||+++++.+.+ +..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG----TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc----chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 5889999999999999999984 8899999987654322 12346789999999999999999999874 578999
Q ss_pred EEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 102 TELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
|||+++ +|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++++ +.++|+|||++......
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPV 154 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCc
Confidence 999975 8999887654 2358999999999999999999999999999999999999988 79999999998743322
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-------
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP------- 252 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------- 252 (352)
.......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.+..+...........+
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLG-------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPG 227 (284)
T ss_pred cccccccccccccChHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHH
Confidence 11223457889999998754 2346789999999999999999999998766543322221110000
Q ss_pred ---------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 ---------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+.++..+.+++.+||+.||.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 012457889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=291.11 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=200.9
Q ss_pred ceeeeccccCCCceEEEEEEE-----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-Cc
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PV 97 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~ 97 (352)
+|++.+.||+|+||.||.+.+ +|+.||+|++....... ......++.+|+++++++ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh-cchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 588999999999999999986 47899999986532211 112345678899999999 69999999998874 47
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++|+||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceecc
Confidence 899999999999999998654 38899999999999999999999999999999999999988 799999999987543
Q ss_pred ccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccCCC
Q 018656 178 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRP 252 (352)
Q Consensus 178 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~ 252 (352)
... ......|+..|+|||.+.. ....++.++||||||+++|+|++|..||..... .............+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRG------GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230 (290)
T ss_pred cccccccccccCCcccCChhhccC------CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC
Confidence 322 1223468899999998754 123467889999999999999999999964322 12222223333445
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 285 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~i~~~ 285 (352)
.+..++..+.+++.+||+.||.+|| +..+++++
T Consensus 231 ~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 231 YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 5667889999999999999999997 77888776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=290.14 Aligned_cols=261 Identities=24% Similarity=0.419 Sum_probs=204.6
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA 92 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~ 92 (352)
+..|.++.++|.+.+.||+|++|+||+|.+. ++.||||.+........ ...+.+|+.++.+. .||||++++++
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE----NKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH----HHHHHHHHHHHHhccCCCchHhhhee
Confidence 4568889999999999999999999999986 89999999876443222 23455677666666 59999999999
Q ss_pred eec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 93 CKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 93 ~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
+.+ ...+++|||+ +++|.+++.... ..+++..+..++.|++.||+|||+ .|++||||+|+||+++++ +.++|+||
T Consensus 83 ~~~~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~df 159 (296)
T cd06618 83 FITDSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDF 159 (296)
T ss_pred eecCCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECcc
Confidence 874 4799999998 458888776643 358999999999999999999997 599999999999999987 79999999
Q ss_pred CCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 018656 171 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 171 g~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
|++.............++..|+|||.+.+.. ....++.++||||||+++|+|++|+.||.................
T Consensus 160 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 235 (296)
T cd06618 160 GISGRLVDSKAKTRSAGCAAYMAPERIDPPD----PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE 235 (296)
T ss_pred ccchhccCCCcccCCCCCccccCHhhcCCCC----CccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC
Confidence 9987543333333345788999999885411 124578899999999999999999999976433222222222222
Q ss_pred C---CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 251 R---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 251 ~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
. +....++.++.+++.+||..||.+||++.+++++.+
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 1 222357899999999999999999999999999844
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=292.60 Aligned_cols=254 Identities=23% Similarity=0.305 Sum_probs=196.6
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 96 (352)
+.-+-++|.+.+.||+|+||.||+|.+. ++.||||++........ ....+.+|++++++++||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC---chhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 4445678999999999999999999884 89999998865433221 122356899999999999999999987532
Q ss_pred ---------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 97 ---------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 97 ---------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
..++||||+. ++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl 160 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKL 160 (310)
T ss_pred cccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEE
Confidence 4699999995 58888887643 248999999999999999999999999999999999999988 79999
Q ss_pred ecCCCcccccccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 018656 168 ADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 242 (352)
Q Consensus 168 ~Dfg~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 242 (352)
+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|++|..||.+.+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~ 233 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL 233 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcC-------CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999987543221 1123457788999998754 234678999999999999999999999876543322
Q ss_pred HHHHhccC--C------------------CC-----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 243 YAAAFKNV--R------------------PS-----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 243 ~~~~~~~~--~------------------~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
........ . +. ....+..+.++|.+||..||.+|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 234 TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 21111000 0 00 01134667899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=295.28 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=196.7
Q ss_pred Cce-eeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHH---------HHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 24 KHL-FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAK---------KESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 24 ~~y-~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
++| .+.+.||+|+||+||+|.+. ++.||+|++........... ....+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 344 45678999999999999874 88999999865433221000 0124678999999999999999999
Q ss_pred eee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 92 ACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 92 ~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
++. +...+++|||+. ++|.+++..... +++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEECCc
Confidence 987 457899999996 599999876443 8999999999999999999999999999999999999988 79999999
Q ss_pred CCcccccc---------------ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCC
Q 018656 171 GLAREESL---------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235 (352)
Q Consensus 171 g~a~~~~~---------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 235 (352)
|++..... ........++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-------AEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhccc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99875431 111122346788999998754 23467899999999999999999999988
Q ss_pred CChHHHHHHHHhccCCC---------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 236 MSNLQAAYAAAFKNVRP---------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 236 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
................+ .....+.++.++|.+||..+|.+||++++++.+.
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 66544333222111100 0134578899999999999999999999999983
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.08 Aligned_cols=252 Identities=28% Similarity=0.363 Sum_probs=203.8
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC------
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP------ 96 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------ 96 (352)
+|++.+.||.|++|.||+|.+. |+.+|||++....... .....+.+|+.+++.++||||+++.+++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL---IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc---hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 5889999999999999999974 7999999987643211 2334588899999999999999999987643
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..+++|||++ ++|.+++.+.. .+++..++.++.|++.||++||++|++|+||||+||+++.+ +.++|+|||++...
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~ 153 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGV 153 (330)
T ss_pred ceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEee
Confidence 6899999996 58999987654 49999999999999999999999999999999999999998 89999999998864
Q ss_pred cccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 018656 177 SLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 177 ~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
.... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.+..............+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLS-------SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cccccccccccccccccCcCCceeeec-------ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 4332 2334567889999999865 1267889999999999999999999998766543322222211110
Q ss_pred ------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 253 ------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 253 ------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
....++.++.++|.+||+.+|.+||++.+++.+ .|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~--~~~~~ 294 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH--PYLAQ 294 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC--ccHHh
Confidence 123467889999999999999999999999998 34444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=296.87 Aligned_cols=256 Identities=26% Similarity=0.324 Sum_probs=200.3
Q ss_pred cCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec----
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---- 95 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---- 95 (352)
.+++|.+.+.||+|+||.||+|.+ +|+.||+|++....... .....+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI---IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh---HHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 347799999999999999999986 48899999987543222 223457789999999999999999998752
Q ss_pred ---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 96 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
...+++++++ +++|.+++... .+++..++.++.|++.||+|||++|++||||||+||+++++ +.++|+|||+
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~ 166 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGL 166 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC-CCEEEecccc
Confidence 2467888887 78999887643 38999999999999999999999999999999999999998 7999999999
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-- 250 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-- 250 (352)
+..... ......++..|+|||.+.+ ...++.++|||||||++|+|++|+.||.................
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 167 ARHTDD--EMTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred cccccc--cccccccCCCccCHHHHhC-------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 875432 2234467889999998743 24567899999999999999999999976554332221111000
Q ss_pred ----------------------CC------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 018656 251 ----------------------RP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 296 (352)
Q Consensus 251 ----------------------~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~ 296 (352)
.+ .....++++.++|.+||..||.+||++.+++++ .++.....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h--~~f~~~~~~ 309 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQYHDP 309 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC--hhhhhcCCC
Confidence 00 012357889999999999999999999999999 455544333
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.55 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=193.3
Q ss_pred ceeeeccccCCCceEEEEEEE----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---Cc
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~ 97 (352)
+|.+.+.||+|+||.||+|.+ .++.||+|++....... ......+.+|+.+++.++||||+++++++.+ ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY--TGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc--cCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 478899999999999999987 46899999987643111 1122346789999999999999999999874 46
Q ss_pred eEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC----CCCceEEecC
Q 018656 98 MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE----DLKTIKLADF 170 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~----~~~~vkl~Df 170 (352)
.++||||++ ++|.+++.... ...+++..++.++.|++.||.|||+++++||||||+||+++. + +.+||+||
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~-~~~kl~Df 156 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDL 156 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCcc-ceEEECCC
Confidence 899999996 47888775432 225899999999999999999999999999999999999988 6 78999999
Q ss_pred CCcccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH------
Q 018656 171 GLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ------ 240 (352)
Q Consensus 171 g~a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~------ 240 (352)
|++....... ......++..|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 229 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence 9987543221 1223457889999998753 2456889999999999999999999997654321
Q ss_pred ---HHHHHHh------------------------ccCCCCC------------CCCcHHHHHHHHHhhccCCCCCCCHHH
Q 018656 241 ---AAYAAAF------------------------KNVRPSA------------ENVPEELSIILTSCWKEDPNARPNFTQ 281 (352)
Q Consensus 241 ---~~~~~~~------------------------~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rps~~~ 281 (352)
....... ....... ...+.++.+++.+||+.||.+|||+.+
T Consensus 230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e 309 (316)
T cd07842 230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE 309 (316)
T ss_pred HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 0000000 0000011 156678999999999999999999999
Q ss_pred HHHH
Q 018656 282 IIQM 285 (352)
Q Consensus 282 i~~~ 285 (352)
++++
T Consensus 310 il~~ 313 (316)
T cd07842 310 ALEH 313 (316)
T ss_pred HhcC
Confidence 9887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=258.76 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=205.4
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 101 (352)
+|.-.++||+|.||+||+|++. ++.||+|.++.....+.... ...+|+-+++.+.|.|||+++++.+ ++.+.+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvps---salreicllkelkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcH---HHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence 4666788999999999999874 79999999988776654433 4789999999999999999999976 6689999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~- 180 (352)
+|||. -+|..|...-.+ .++.+.+.+++.|+++||.++|++++.|||+||+|.+|+.+ |.+||+|||+++......
T Consensus 80 fe~cd-qdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-gelkladfglarafgipvr 156 (292)
T KOG0662|consen 80 FEFCD-QDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHHhh-HHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-CcEEecccchhhhcCCceE
Confidence 99994 599999887544 39999999999999999999999999999999999999998 899999999998655443
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCC-----
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA----- 254 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~----- 254 (352)
-.+..+.|..|.+|.++.+ ..-|+...|+||.||++.|+.. |++-|.+.+-.++...+......|..
T Consensus 157 cysaevvtlwyrppdvlfg-------akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred eeeceeeeeeccCcceeee-------eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 3455678999999999987 3678899999999999999986 77778886665655555444333321
Q ss_pred -----------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 255 -----------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 255 -----------------------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+.++..-+++++.+|.-+|.+|.++++.+++
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1223446789999999999999999999887
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.44 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=198.5
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
+|.+.+.||+|+||.||++.+. +..+++|++...............+.+|+.+++.++||||+++++.+.+ ...+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999885 4556666655432211111223346678999999999999999998764 478999
Q ss_pred EEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-
Q 018656 102 TELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL- 178 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~- 178 (352)
+||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+||+++++ .++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~--~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC--CEeecccCceeecCCC
Confidence 9999999999998642 23458999999999999999999999999999999999999864 699999999875422
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCc
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (352)
........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||....................+..++
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKH--------QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYS 230 (260)
T ss_pred cccccCCCCCcCccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhc
Confidence 222334567889999998743 456778999999999999999999998755444333333333333356788
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.++.++|.+||..+|.+||++.+++++
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 231 RQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.11 Aligned_cols=252 Identities=21% Similarity=0.373 Sum_probs=198.2
Q ss_pred eeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEc
Q 018656 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTEL 104 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~ 104 (352)
+.+++.+|.|+++.|+++..+++.||+|++....... .....+.+|++++++++||||+++++++.+ ...+++|||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK---EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccch---hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 4566677777887778777789999999987653222 234568899999999999999999999874 578999999
Q ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-----
Q 018656 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT----- 179 (352)
Q Consensus 105 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~----- 179 (352)
+++++|.+++.+.....+++..+..++.|++.||+|||+++|+||||||+||+++.+ +.++|+|||.+......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeecccccccc
Confidence 999999999987655568999999999999999999999999999999999999987 79999999987633211
Q ss_pred ---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC------
Q 018656 180 ---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV------ 250 (352)
Q Consensus 180 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~------ 250 (352)
.......++..|+|||++.. ....++.++|+||+|+++|+|++|..||.................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQ------NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccccCHHHhcC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence 11223456788999998854 124578899999999999999999999987654433222211100
Q ss_pred ---------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 251 ---------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 251 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+....++.++.+++.+||..||.+|||+++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0001234567889999999999999999999999844
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=282.47 Aligned_cols=240 Identities=25% Similarity=0.339 Sum_probs=189.6
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHH-HHhcCCCCCeeeeeeeeec-CceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
+.||+|+||.||+|.+. |+.||+|++........ .....+..|.. .....+|+|++++++++.. ...++++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK--NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH--HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 56999999999999884 78999999865432111 11223344444 3455689999999999875 4799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccC
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE 185 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 185 (352)
++++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||+++++ +.++|+|||++..... ....
T Consensus 80 ~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 80 NGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceeccc---cccC
Confidence 99999999986543 8999999999999999999999999999999999999987 7999999999875332 2334
Q ss_pred CCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--C-CCCCCCcHHHH
Q 018656 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--R-PSAENVPEELS 262 (352)
Q Consensus 186 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~l~ 262 (352)
.++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+............. . .....++.++.
T Consensus 154 ~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05611 154 VGTPDYLAPETILG--------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAV 225 (260)
T ss_pred CCCcCccChhhhcC--------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHH
Confidence 68889999998754 3478899999999999999999999987665443333222211 1 12346789999
Q ss_pred HHHHHhhccCCCCCCCH---HHHHHH
Q 018656 263 IILTSCWKEDPNARPNF---TQIIQM 285 (352)
Q Consensus 263 ~li~~~l~~~p~~Rps~---~~i~~~ 285 (352)
+++.+||+.||.+||++ .+++.+
T Consensus 226 ~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 226 DLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHHccCCHHHccCCCcHHHHHcC
Confidence 99999999999999955 566666
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=288.80 Aligned_cols=248 Identities=29% Similarity=0.440 Sum_probs=204.5
Q ss_pred CceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeec-CceE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~ 99 (352)
++|.+.+.||+|+||.||++.+ +|+.+++|++....... ......+.+|.+++++++ ||||+++++++.+ ...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc--hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 4789999999999999999988 48999999987643222 123356788999999998 9999999998864 5799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
++||++++++|.+++.+.. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEecCCccccccCCc
Confidence 9999999999999998754 39999999999999999999999999999999999999988 79999999998743322
Q ss_pred c---------------------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh
Q 018656 180 E---------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 238 (352)
Q Consensus 180 ~---------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 238 (352)
. ......++..|+|||.+.. ..++.++|+||||++++++++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--------KPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--------CCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 1 1123357889999998754 4578899999999999999999999987654
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 018656 239 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF----TQIIQM 285 (352)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~~i~~~ 285 (352)
... ...........+..+++.+.+++.+||+.+|.+||++ .++++|
T Consensus 228 ~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YLT-FQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHH-HHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 332 2222233334556789999999999999999999999 888876
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=294.44 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=202.6
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.|.+ ..+|++.+.||+|+||.||+|.+. |+.||||++....... .....+.+|++++++++||||+++++++..
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE---LFAKRAYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence 3554 567999999999999999999874 8899999986543322 233457899999999999999999998863
Q ss_pred C-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 96 P-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 96 ~-------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
+ ..++||||+ +++|.+++... .+++..++.++.|++.||+|||+.|++||||||+||+++++ +.++|+
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~ 160 (343)
T cd07880 86 DLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKIL 160 (343)
T ss_pred CccccccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEe
Confidence 2 358999999 77999888642 38999999999999999999999999999999999999987 789999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
|||++...... .....++..|+|||.+.+ ...++.++|+||||+++|++++|..||.+.+...........
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~ 231 (343)
T cd07880 161 DFGLARQTDSE--MTGYVVTRWYRAPEVILN-------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV 231 (343)
T ss_pred ecccccccccC--ccccccCCcccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99998754322 233467889999998743 134678999999999999999999999876543332221111
Q ss_pred cCC------------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 249 NVR------------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 249 ~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
... .....++..+.++|.+||..||.+|||+.+++.+ .+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~--~~~~~~ 304 (343)
T cd07880 232 TGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH--PYFEEF 304 (343)
T ss_pred cCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC--ccHhhh
Confidence 000 0124577889999999999999999999999987 444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=296.80 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=202.6
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.|.+ .++|++...||+|++|.||+|++. ++.||+|++....... .....+.+|+.+++.++||||+++.+++..
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07851 10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA---IHAKRTYRELRLLKHMDHENVIGLLDVFTP 85 (343)
T ss_pred eecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh---hHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence 3444 557999999999999999999985 7899999886543222 223457789999999999999999887653
Q ss_pred C-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 96 P-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 96 ~-------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
. ..++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||++|++||||+|+||+++++ +.++|+
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~ 160 (343)
T cd07851 86 ASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKIL 160 (343)
T ss_pred cccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEc
Confidence 2 389999999 6799999875 238999999999999999999999999999999999999988 799999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
|||++...... .....++..|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.............
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~ 231 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL 231 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhC-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Confidence 99998764332 334567889999998743 235678999999999999999999999876554333222111
Q ss_pred cCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 249 NVRP------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 249 ~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
...+ ....++.++.++|.+||..||.+|||+.+++++ .|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h--~~~~~ 303 (343)
T cd07851 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH--PYLAE 303 (343)
T ss_pred cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC--CCccc
Confidence 1100 012458899999999999999999999999998 44443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=280.58 Aligned_cols=249 Identities=26% Similarity=0.410 Sum_probs=202.2
Q ss_pred eccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeecC-ceEEEEEc
Q 018656 29 GPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTEL 104 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~~lv~e~ 104 (352)
.+.||+|+|+.|--+.. +|..||||++.+... ..+.++.+|++++.++ .|+||++++++|+++ .+|+|||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-----HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-----HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc-----hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 47899999999998865 699999999987643 4467899999999999 599999999999865 79999999
Q ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCCcccccc----
Q 018656 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREESL---- 178 (352)
Q Consensus 105 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~a~~~~~---- 178 (352)
+.||+|...|.++.- |++.++.++..+|+.||.+||.+||.||||||+|||-..- ...|||+||.+......
T Consensus 158 m~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999999999987654 9999999999999999999999999999999999999543 34699999999763211
Q ss_pred ----ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH--------------
Q 018656 179 ----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ-------------- 240 (352)
Q Consensus 179 ----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-------------- 240 (352)
.....+.+|+..|||||+...+.. ....|+++.|.||||+++|-||.|.+||.+.-..+
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~---qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVD---QATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhcc---ccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 112345578999999998755321 23678999999999999999999999998744321
Q ss_pred HHHHHHhcc----CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 241 AAYAAAFKN----VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 241 ~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+...+... ....+..+|.+.+++++.+|..|+.+|.++.+++.+.|
T Consensus 313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 111222211 11225678999999999999999999999999999854
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=282.81 Aligned_cols=249 Identities=24% Similarity=0.411 Sum_probs=189.2
Q ss_pred cccCCCceEEEEEEEC-C---ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceEEEEEcC
Q 018656 31 RIGEGAHAKVYEGKYK-N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~~-~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~e~~ 105 (352)
.||+|+||.||++... + ..+++|.+...... .....+.+|+.+++.++||||+++++.+.+. ..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS----KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh----HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 5999999999999753 2 34667766543322 2245688999999999999999999998754 789999999
Q ss_pred CCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc---c
Q 018656 106 SGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---E 180 (352)
Q Consensus 106 ~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~---~ 180 (352)
++++|.+++.+... ...++..++.++.|++.||+|||+.+++||||||+|||++.+ +.++|+|||++...... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccccCcchhhh
Confidence 99999999976432 346777888999999999999999999999999999999988 78999999997532111 1
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC----CC-CC
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV----RP-SA 254 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~----~~-~~ 254 (352)
......++..|+|||++..... ......++.++||||||+++|+|++ |..||................. .+ ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHG-GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred cccCCcCcccccCchhcccccC-ccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 1223467889999998743110 0112346789999999999999997 5778877655443333222211 11 23
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..+++.+.+++..|+ .+|.+||+++++++.|
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 457889999999999 6899999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=290.51 Aligned_cols=251 Identities=25% Similarity=0.303 Sum_probs=198.1
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC---
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--- 96 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 96 (352)
.-++|++.+.||+|+||.||+|.++ |+.||+|++........ ....+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~---~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC---chHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3467899999999999999999984 78999999876433221 123467899999999999999999987532
Q ss_pred --------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 97 --------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 97 --------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
.+++++||+++ +|.+++.+.. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++++ +.++|+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~ 158 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLA 158 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeC
Confidence 58999999975 7888776542 348999999999999999999999999999999999999988 799999
Q ss_pred cCCCcccccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 018656 169 DFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 169 Dfg~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 246 (352)
|||++....... ......++..|+|||.+.+ ...++.++|||||||++++|++|+.||...+.........
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLG-------EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999987543322 1122346788999998743 2346789999999999999999999998755443332222
Q ss_pred hccCC-----------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 247 FKNVR-----------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 247 ~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..... .....+|..+.+++.+||..||.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 21100 0123468999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=286.73 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=201.2
Q ss_pred eeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVT 102 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv~ 102 (352)
|.....||+|+||.||++.+ +|+.+|||.+..... .....+.+|+.+++.++|+||+++++.+. ....+++|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-----hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 33446799999999999987 488999998754332 23445889999999999999999999987 45899999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-c
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-M 181 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~-~ 181 (352)
||+++++|.+++... .+++..++.++.|++.+|+|||++|++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 97 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEcccccceeccccccc
Confidence 999999999987543 38999999999999999999999999999999999999988 789999999876543221 2
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--cCCCCCCCCcH
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK--NVRPSAENVPE 259 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 259 (352)
.....++..|+|||.+.. ..++.++|+||+|+++|+|++|..||.+............. ........++.
T Consensus 173 ~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06657 173 RKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSP 244 (292)
T ss_pred ccccccCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCH
Confidence 233467899999998743 45678999999999999999999999875544332222211 11223456789
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
.+.+++.+||..||.+||++.+++++ .++....+
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~--~~~~~~~~ 278 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAGP 278 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC--hHHhccCC
Confidence 99999999999999999999999998 55554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=286.96 Aligned_cols=247 Identities=26% Similarity=0.351 Sum_probs=197.5
Q ss_pred eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---CceEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVMVI 100 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~~~l 100 (352)
|.+.+.||.|++|.||+|.+. |+.+|+|++....... .....+.+|+.++++++|||++++++++.+ +..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE---GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc---cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 678889999999999999885 6899999998764222 223457789999999999999999999874 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
|+||+++ +|.+++.... ..+++..++.++.|+++||++||++|++|+||+|+||+++++ +.++|+|||++.......
T Consensus 78 v~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 78 VFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRN 154 (287)
T ss_pred Eeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCC
Confidence 9999964 9999887653 359999999999999999999999999999999999999998 799999999987543332
Q ss_pred --ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC-----
Q 018656 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS----- 253 (352)
Q Consensus 181 --~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----- 253 (352)
......++..|+|||.+.+ ...++.++||||||+++|+|++|..||..................+.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLG-------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred cccccccccccccCCceeeEc-------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 1233456788999998753 23467899999999999999999999987664333222211110000
Q ss_pred ------------------------CCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 ------------------------AEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 ------------------------~~~-~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
... ++..+.+++++||..+|.+||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 011 37889999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=284.76 Aligned_cols=240 Identities=30% Similarity=0.416 Sum_probs=195.9
Q ss_pred ccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCCC
Q 018656 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGG 108 (352)
Q Consensus 32 lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 108 (352)
||.|+||.||++.+. |+.+++|++....... ......+.+|++++++++||||+++++.+.. ...++++||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR--KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh--hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999985 8999999986543322 2445678899999999999999999988874 4799999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc--------
Q 018656 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-------- 180 (352)
Q Consensus 109 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~-------- 180 (352)
+|.+++.+.. .+++..++.++.|++.||.|||++|++|+||+|+||+++++ +.++|+|||++.......
T Consensus 79 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 79 DLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-CCEEEEecccchhcccCccccccccc
Confidence 9999998755 48999999999999999999999999999999999999998 799999999987533221
Q ss_pred -ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC--CC
Q 018656 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE--NV 257 (352)
Q Consensus 181 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 257 (352)
......++..|+|||.... ...+.++|+||||+++|++++|..||.............. ...+.+. .+
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 226 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--------QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-GKIEWPEDVEV 226 (265)
T ss_pred ccccCcccCccccCHHHhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCcCCCccccC
Confidence 1223457889999998754 4478899999999999999999999987665444333322 2222222 34
Q ss_pred cHHHHHHHHHhhccCCCCCCCH---HHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPNF---TQIIQM 285 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps~---~~i~~~ 285 (352)
+..+.+++.+||+.+|.+|||+ .+++++
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 8999999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=284.37 Aligned_cols=247 Identities=30% Similarity=0.390 Sum_probs=196.3
Q ss_pred eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC---CCCCeeeeeeeeecC-c--
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKEP-V-- 97 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~~-~-- 97 (352)
|++.+.||+|+||.||+|.++ ++.||+|++........ ....+.+|+.+++++ +||||+++++++.+. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG---IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch---hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 678899999999999999985 79999999976544322 122355677666555 699999999998643 3
Q ss_pred ---eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 98 ---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 98 ---~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
.+++|||+++ +|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.
T Consensus 78 ~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~ 155 (287)
T cd07838 78 ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLAR 155 (287)
T ss_pred CceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcce
Confidence 8999999964 89999877555469999999999999999999999999999999999999998 899999999987
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC--
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-- 252 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 252 (352)
............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+...........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQ--------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSE 227 (287)
T ss_pred eccCCcccccccccccccChHHhcc--------CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCCh
Confidence 6544433344457889999998854 457889999999999999999999998766544333222111000
Q ss_pred ------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 ------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
....++..+.+++.+||+.||.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 012356778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=287.52 Aligned_cols=247 Identities=28% Similarity=0.429 Sum_probs=200.0
Q ss_pred eeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVT 102 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 102 (352)
|...+.||+|+||+||+|.+ +|+.|++|++........ .....+.+|+.+++.++|||++++++++.+ ...++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN--EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 56667899999999999987 488999999875433221 334567889999999999999999999875 4789999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccccc
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM 182 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~ 182 (352)
||+. ++|.+++.... ..+++..++.++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++..... .
T Consensus 101 e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~~---~ 174 (313)
T cd06633 101 EYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASKSSP---A 174 (313)
T ss_pred ecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-CCEEEeecCCCcccCC---C
Confidence 9995 58888876543 348999999999999999999999999999999999999988 7899999999864322 2
Q ss_pred ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-CCCCCcHHH
Q 018656 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-SAENVPEEL 261 (352)
Q Consensus 183 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 261 (352)
....++..|+|||.+... ....++.++||||||+++|+|++|..||...+............... ....++..+
T Consensus 175 ~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (313)
T cd06633 175 NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249 (313)
T ss_pred CCccccccccChhhcccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHH
Confidence 345688899999987431 12457789999999999999999999998766554444443332222 234577889
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHH
Q 018656 262 SIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 262 ~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+++.+||+.+|.+||++.+++.+
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=291.99 Aligned_cols=254 Identities=26% Similarity=0.360 Sum_probs=199.8
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec---C
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE---P 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~---~ 96 (352)
.++|.+.+.||+|+||.||+|.+. |+.+|+|++....... .....+.+|+.+++++ +||||+++++++.. .
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA---TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc---hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 467889999999999999999874 7899999886432221 1223467899999999 99999999998753 2
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..++||||++ ++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhcc
Confidence 5899999996 5999998764 48899999999999999999999999999999999999998 79999999998743
Q ss_pred cccc------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 018656 177 SLTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 177 ~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
.... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 230 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLG-------STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230 (337)
T ss_pred ccccccccCcchhcccccccccCceeeec-------cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 2221 2233468889999998743 24567899999999999999999999987554432221111100
Q ss_pred C------------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 251 R------------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 251 ~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
. .....++.++.++|.+||+.||.+|||+.+++++ .++...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~--~~~~~~ 301 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH--PYVAQF 301 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC--hhhhhh
Confidence 0 0123468899999999999999999999999998 444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=285.78 Aligned_cols=247 Identities=30% Similarity=0.418 Sum_probs=198.5
Q ss_pred eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeec-CceEEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~lv 101 (352)
|++.+.||+|++|+||+|.+. ++.|+||.+........ .....+|+..+++++ ||||+++++++.+ +..++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE----ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh----HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 678889999999999999984 78899999865433211 223457899999998 9999999998864 579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
|||+ +++|.+++.......+++..++.++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCC
Confidence 9999 7899999987654458999999999999999999999999999999999999987 7999999999876544434
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC---------
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--------- 252 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------- 252 (352)
.....++..|+|||++.. ...++.++|+||||+++++|++|+.||..................+
T Consensus 155 ~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07830 155 YTDYVSTRWYRAPEILLR-------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY 227 (283)
T ss_pred cCCCCCcccccCceeeec-------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence 445568889999998743 2446889999999999999999999997765443332222110000
Q ss_pred --------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 --------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.....+.++.++|++||+.||.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 228 KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 012336889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=294.15 Aligned_cols=256 Identities=27% Similarity=0.364 Sum_probs=200.7
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.|.+ ..+|.+...||+|+||.||+|.+. |+.||+|++......+ .....+.+|+++++.++||||+++++++..
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 85 (342)
T cd07879 10 VWEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE---IFAKRAYRELTLLKHMQHENVIGLLDVFTS 85 (342)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc---cchhHHHHHHHHHHhcCCCCccchhheecc
Confidence 4666 458999999999999999999874 8999999987543322 123357789999999999999999998753
Q ss_pred C-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 96 P-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 96 ~-------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
. ..++++||+. .+|.++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL~ 159 (342)
T cd07879 86 AVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKIL 159 (342)
T ss_pred cccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEe
Confidence 2 3689999995 47777653 238999999999999999999999999999999999999988 799999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
|||++..... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+.+...........
T Consensus 160 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~ 230 (342)
T cd07879 160 DFGLARHADA--EMTGYVVTRWYRAPEVILN-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230 (342)
T ss_pred eCCCCcCCCC--CCCCceeeecccChhhhcC-------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999875422 1233467889999998743 234788999999999999999999999876543332221111
Q ss_pred cC------------------------CC------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 249 NV------------------------RP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 249 ~~------------------------~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
.. .+ .....+..+.++|.+||+.||.+||++.+++.| .+++...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h--~~f~~~~ 304 (342)
T cd07879 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH--PYFDSFR 304 (342)
T ss_pred cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC--cchhhcc
Confidence 00 00 013467889999999999999999999999998 5555443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=278.88 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=212.8
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHh-cCCCCCeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLS-RVQHRNLVKFIGA 92 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~l~~~ 92 (352)
+..|.+...+.+-...||.|+||+|++..++ |+..|||.++..... +...++..|..... .-+.||||++++.
T Consensus 56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~----keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE----KEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch----HHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 3448999999999999999999999998875 899999999886652 33456777776554 4479999999997
Q ss_pred -eecCceEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEE
Q 018656 93 -CKEPVMVIVTELLSGGTLRKYLLN---MRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 93 -~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl 167 (352)
|.++..|+.||.+ ..||+.+... -+...++|..+-.|....+.||.||... .|+||||||+|||++.. |.+||
T Consensus 132 ~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKL 209 (361)
T KOG1006|consen 132 LFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKL 209 (361)
T ss_pred hhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEee
Confidence 5688999999999 5687776542 2345699999999999999999999865 89999999999999998 89999
Q ss_pred ecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 018656 168 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 247 (352)
+|||++-........+...|...|+|||.+.. ....|+.+||+||||++|||+.||..||.+-+..-.......
T Consensus 210 CDFGIcGqLv~SiAkT~daGCrpYmAPERi~p------~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv 283 (361)
T KOG1006|consen 210 CDFGICGQLVDSIAKTVDAGCRPYMAPERIDP------SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV 283 (361)
T ss_pred ecccchHhHHHHHHhhhccCCccccChhccCC------ccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH
Confidence 99999876655555566789999999999866 335689999999999999999999999988766544444444
Q ss_pred ccCCCC---C---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 248 KNVRPS---A---ENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 248 ~~~~~~---~---~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
....|. . -.++..+..+|..||.+|.+.||.+.++.++
T Consensus 284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 444333 1 2478999999999999999999999999987
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=290.36 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=195.1
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
.++|++.+.||+|+||.||+|.+. ++.+|+|++........ ....+.+|+++++.++||||+++++.+.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 478999999999999999999884 78999998865433221 11235689999999999999999987632
Q ss_pred ----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 96 ----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 96 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
..+++++||+. ++|.+.+.... ..+++..+..++.|+++||+|||++|++|+||||+||+++++ +.++|+|||
T Consensus 84 ~~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg 160 (311)
T cd07866 84 KRKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFG 160 (311)
T ss_pred cccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCc
Confidence 24799999995 47887776533 349999999999999999999999999999999999999998 799999999
Q ss_pred Cccccccccc------------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH
Q 018656 172 LAREESLTEM------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239 (352)
Q Consensus 172 ~a~~~~~~~~------------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 239 (352)
++........ .....+++.|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-------ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhC-------CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9874322111 122346788999998743 245788999999999999999999999876654
Q ss_pred HHHHHHHhccCCCC-----------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 240 QAAYAAAFKNVRPS-----------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 240 ~~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
............+. ...+++++.++|.+||+.||.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 43332221111000 12345778999999999999999999999886
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.26 Aligned_cols=257 Identities=26% Similarity=0.470 Sum_probs=215.7
Q ss_pred ceecCCceeeeccccCCCceEEEEEEECC-ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cC
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EP 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~ 96 (352)
-.+.++...+.++||+|-||+|.++...| ..||+|.++...... ....|.+|+++|.+|+||||++++++|. ++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~----~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN----ARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh----HHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 45778899999999999999999999876 999999998765533 3567999999999999999999999997 66
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
-+.+|+||+++|+|.+|+.++....+.-....+|+.||+.|++||.+.++|||||.+.|+|++.+ .++||+|||.++..
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIKIADFGMSRNL 687 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEEecCccccccc
Confidence 78999999999999999999865445566777899999999999999999999999999999998 79999999999842
Q ss_pred ccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHH--hCCCCCCCCChHHHHHHHHhccCC
Q 018656 177 SLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL--HNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 177 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll--~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
-.... ....+-..+|||+|.+.. ++++.++|+|++|+++||++ +...||...++++...........
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsill--------gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~ 759 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRD 759 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHh--------ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCC
Confidence 22211 122345789999998865 78999999999999999976 578999987776655544332222
Q ss_pred -------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 252 -------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 252 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
..+.-+|.++.+++.+||..+..+||+++++..+|..
T Consensus 760 ~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 760 QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 3366789999999999999999999999999888754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=304.18 Aligned_cols=254 Identities=31% Similarity=0.509 Sum_probs=199.1
Q ss_pred eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-------
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP------- 96 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------- 96 (352)
|...+.||+|+||.||+++++ |+.||||.++..... ...++..+|++++++|+|||||+++++-++.
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~----r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL----RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhccc----chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 344466999999999999974 999999999875532 2344578999999999999999999985432
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC---CCceEEecCCC
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---LKTIKLADFGL 172 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~---~~~vkl~Dfg~ 172 (352)
...++||||.||||...+++... ..+++.+++.++.++..||.|||++||+||||||.||++-.+ ....||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 36899999999999999987543 469999999999999999999999999999999999998433 23579999999
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhc
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN----LQAAYAAAFK 248 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~----~~~~~~~~~~ 248 (352)
|+..+.+....+.+||..|++||++-. ...|+...|.||+||++|+..||..||...-. ....+.....
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~-------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYER-------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhh-------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 999888888899999999999999842 37889999999999999999999999954322 2233333322
Q ss_pred cCC--------------------CCCCCCcHH----HHHHHHHhhccCCCCCC--CHHHHHHHHHHhh
Q 018656 249 NVR--------------------PSAENVPEE----LSIILTSCWKEDPNARP--NFTQIIQMLLNYL 290 (352)
Q Consensus 249 ~~~--------------------~~~~~~~~~----l~~li~~~l~~~p~~Rp--s~~~i~~~l~~~~ 290 (352)
... |.+..+++. +...+..+|..+|.+|- ...++...+..++
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 211 112223333 45677888999999998 5555555444333
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=285.71 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=199.1
Q ss_pred ceeeeccccCCCceEEEEEEE-----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-Cc
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PV 97 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~ 97 (352)
+|++.+.||+|++|.||++.+ +++.||||++...... .......++.+|+++++++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~-~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV-QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH-hhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 488899999999999999875 3678999998753221 1123345688999999999 69999999998874 47
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++||||+++++|.+++.... .+++..++.++.|++++|.|||+.|++|+||+|.||+++.+ +.++|+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 156 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECccccccc
Confidence 889999999999999987643 38999999999999999999999999999999999999988 789999999987533
Q ss_pred cccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccCCC
Q 018656 178 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRP 252 (352)
Q Consensus 178 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~ 252 (352)
.... .....++..|+|||.+.+ .....+.++|+||||+++|+|++|..||..... .............+
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRG------GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230 (288)
T ss_pred cccccccccccCCccccCHHHhcC------CCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC
Confidence 2221 123457899999998754 112367899999999999999999999964321 11222223333445
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.+..++.++.+++.+||+.||++|||+.++.+.+
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence 5667889999999999999999999977665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=287.36 Aligned_cols=252 Identities=27% Similarity=0.391 Sum_probs=201.5
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
...|...+.||+|+||.||+|+++ ++.+++|.+........ ....++.+|+++++.++|+|++++.+++.+ ...+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh--HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 455778889999999999999884 78899998865322221 234457789999999999999999998874 4789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||+. ++|.+++.... ..+++..++.++.|++.||.|||+++++||||+|+||+++.+ +.++|+|||++......
T Consensus 92 lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeecCc
Confidence 9999996 58888776543 348999999999999999999999999999999999999987 79999999998754322
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-CCCCCCc
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVP 258 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 258 (352)
....++..|+|||.+... ....++.++|||||||++|+|++|..||.................. .....++
T Consensus 169 ---~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240 (308)
T ss_pred ---ccccCCccccCHHHHhhc-----ccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCccccc
Confidence 234678899999987431 1245678999999999999999999999775544433333322222 2244688
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
..+.++|.+||..+|.+||++.+++++.+
T Consensus 241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 99999999999999999999999999844
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=281.68 Aligned_cols=238 Identities=22% Similarity=0.299 Sum_probs=188.1
Q ss_pred ceeeeccc--cCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee-cCce
Q 018656 25 HLFVGPRI--GEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK-EPVM 98 (352)
Q Consensus 25 ~y~~~~~l--G~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~-~~~~ 98 (352)
+|.+.+.+ |+|+||.||++.++ ++.+|+|++........ |+.....+ +||||+++++.+. ++..
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----------e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----------EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----------hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 45555555 99999999999874 78899999865432211 22222212 7999999999987 4579
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||+++++|.+++.+.. .+++..++.++.|+++||.|||+.|++||||+|+||+++.+++.++|+|||++.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 99999999999999998754 4999999999999999999999999999999999999998844899999999875432
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH---HHHHhccCCCCCC
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA---YAAAFKNVRPSAE 255 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~---~~~~~~~~~~~~~ 255 (352)
. ....++..|+|||++.+ ..++.++|+||+|+++|+|++|..||......... .........+...
T Consensus 163 ~---~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T PHA03390 163 P---SCYDGTLDYFSPEKIKG--------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK 231 (267)
T ss_pred C---ccCCCCCcccChhhhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccc
Confidence 2 23468899999999854 55788999999999999999999999864432211 1111122234455
Q ss_pred CCcHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPN-FTQIIQM 285 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps-~~~i~~~ 285 (352)
.+++.+.++|.+||+.+|.+||+ ++++++|
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 232 NVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 78999999999999999999995 6999987
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=297.38 Aligned_cols=263 Identities=24% Similarity=0.381 Sum_probs=218.8
Q ss_pred cccccccccccceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC
Q 018656 8 YLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85 (352)
Q Consensus 8 ~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 85 (352)
.+-+.++...-|.|..+ ++||+|-||+||-|.+ +|+.||||++.+...... .+..+.+|+++|+.+.||.
T Consensus 553 qiqe~vd~stvYQif~d-----evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k---qesqlR~EVaILq~l~HPG 624 (888)
T KOG4236|consen 553 QIQENVDISTVYQIFAD-----EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK---QESQLRNEVAILQNLHHPG 624 (888)
T ss_pred hhhhhhhHHHHHHhhhH-----hhccCCcceeeecceecccCceeeeeeeecccCCCc---hHHHHHHHHHHHHhcCCCC
Confidence 44444555544555444 6699999999998866 599999999988766553 3467999999999999999
Q ss_pred eeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--C
Q 018656 86 LVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--L 162 (352)
Q Consensus 86 iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~ 162 (352)
||.+..-|+. +..++|||.+.| +..+.|-......+++.....++.||+.||.|||.++|+|+||||+|||+.+. .
T Consensus 625 iV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~F 703 (888)
T KOG4236|consen 625 IVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPF 703 (888)
T ss_pred eeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCC
Confidence 9999988885 479999999955 66666655555669999999999999999999999999999999999999643 4
Q ss_pred CceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 018656 163 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 242 (352)
Q Consensus 163 ~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 242 (352)
..+||+|||+|+.........+.+||+.|+|||++.. +.|...-|+||.|+++|.-+.|..||....+....
T Consensus 704 PQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrn--------kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ 775 (888)
T KOG4236|consen 704 PQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRN--------KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ 775 (888)
T ss_pred CceeeccccceeecchhhhhhhhcCCccccCHHHHhh--------ccccccccceeeeEEEEEEecccccCCCccchhHH
Confidence 5899999999998888777888899999999999965 78899999999999999999999999876555444
Q ss_pred HHHHhccCC-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 243 YAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 243 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+......+ ..+..++.+..++|..+|+..-++|.+.++.+.|.|
T Consensus 776 IQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 776 IQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred hhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 443333333 346789999999999999999999999999998865
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=307.79 Aligned_cols=255 Identities=19% Similarity=0.235 Sum_probs=184.9
Q ss_pred CCceeeeccccCCCceEEEEEEEC---CceEEEEEcccCCC------------hHHHHHHHHHHHHHHHHHhcCCCCCee
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGET------------PEEIAKKESRFAREVAMLSRVQHRNLV 87 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~vaiK~~~~~~~------------~~~~~~~~~~~~~E~~~l~~l~hp~iv 87 (352)
.++|++++.||+|+||+||+|..+ ++..++|.+..... ..........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 368999999999999999998753 22233221110000 000012344678999999999999999
Q ss_pred eeeeeeec-CceEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC
Q 018656 88 KFIGACKE-PVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (352)
Q Consensus 88 ~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~ 163 (352)
++++++.+ +..|++++++ +++|.+++.... ........++.++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~-~ 304 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD-G 304 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-C
Confidence 99999874 4789999999 568888875432 1123456778899999999999999999999999999999988 7
Q ss_pred ceEEecCCCcccccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCC-CCCCC--h
Q 018656 164 TIKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMS--N 238 (352)
Q Consensus 164 ~vkl~Dfg~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~--~ 238 (352)
.+||+|||++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..+ |.... .
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--------DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 99999999997543322 2223579999999999854 5678899999999999999998754 43221 1
Q ss_pred HHHHHHHHhccC----------------------C--C-------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 239 LQAAYAAAFKNV----------------------R--P-------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 239 ~~~~~~~~~~~~----------------------~--~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
............ . + ....++.++.++|.+||+.||.+|||+.+++.+.+
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 111111111000 0 0 01235677888899999999999999999999843
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=278.99 Aligned_cols=240 Identities=33% Similarity=0.430 Sum_probs=199.2
Q ss_pred ccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCCC
Q 018656 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGG 108 (352)
Q Consensus 32 lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 108 (352)
||.|+||.||++.+. ++.+++|++........ .....+.+|+.++++++||||+++++.+.. ...+++|||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR--KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch--HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 699999999999885 79999999876543221 245568899999999999999999998874 5799999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-cccccCCC
Q 018656 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETG 187 (352)
Q Consensus 109 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~g 187 (352)
+|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++...... .......+
T Consensus 79 ~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 79 ELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcC
Confidence 9999998754 38999999999999999999999999999999999999988 79999999998764332 22344568
Q ss_pred cccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHH
Q 018656 188 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 267 (352)
Q Consensus 188 ~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 267 (352)
+..|+|||...+ ...+.++|+||||+++|++++|..||...+... ..........+.+..++..+.+++++
T Consensus 156 ~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~i~~ 226 (250)
T cd05123 156 TPEYLAPEVLLG--------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-IYEKILKDPLRFPEFLSPEARDLISG 226 (250)
T ss_pred CccccChHHhCC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 889999998754 446789999999999999999999998765432 23333334445566779999999999
Q ss_pred hhccCCCCCCCH---HHHHHH
Q 018656 268 CWKEDPNARPNF---TQIIQM 285 (352)
Q Consensus 268 ~l~~~p~~Rps~---~~i~~~ 285 (352)
||..||.+||++ ++++++
T Consensus 227 ~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 227 LLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred HhcCCHhhCCCcccHHHHHhC
Confidence 999999999999 676665
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=287.11 Aligned_cols=251 Identities=28% Similarity=0.387 Sum_probs=197.9
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec--Cce
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--PVM 98 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~ 98 (352)
..+|++.+.||.|+||.||+|.+. |+.||+|++....... .....+.+|+.+++.++||||+++.+++.. ...
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP---VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc---chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 456999999999999999999875 7899999876543222 123457789999999999999999998863 468
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++++||+ +++|.+++... .+++..+..++.|+++||.|||++|++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 86 ~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQDP 160 (328)
T ss_pred EEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccCC
Confidence 9999999 66899888642 38888899999999999999999999999999999999987 7999999999875322
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----------
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---------- 248 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---------- 248 (352)
......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+.............
T Consensus 161 --~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIMLT-------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred --CcCCCcccccccCceeeec-------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 2233467889999998643 245788999999999999999999999875542211110000
Q ss_pred ---------------cCCC-----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 249 ---------------NVRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 249 ---------------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
...+ ....++.++.++|.+||+.+|.+||++.+++.+ .++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~--~~~~~ 293 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH--PYLAP 293 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC--Ccccc
Confidence 0000 013567899999999999999999999999998 44443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=284.93 Aligned_cols=247 Identities=29% Similarity=0.398 Sum_probs=199.7
Q ss_pred eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVT 102 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 102 (352)
|.+.+.||+|++|.||+|.+. |+.+++|.+....... .....+.+|++++++++|+||+++++++.. ...++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE---GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc---hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 567788999999999999874 8899999987654432 223467789999999999999999998864 5789999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-c
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-M 181 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~-~ 181 (352)
||+++ +|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+....... .
T Consensus 78 e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 78 EFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred eccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCccc
Confidence 99965 8988887643 348999999999999999999999999999999999999987 789999999987554332 2
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC---------
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--------- 252 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------- 252 (352)
.....++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+.+..+...........+
T Consensus 155 ~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 155 YTHYVVTRWYRAPELLLG-------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred ccCccCcccccCcHHHhc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccch
Confidence 233467889999998754 2367889999999999999999999998866544433322211110
Q ss_pred --------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 --------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
....++.++.++|.+||+.||.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 112467889999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=295.57 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=219.5
Q ss_pred cCCceeeeccccCCCceEEEEEEECCce--EEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYKNQT--VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
.-+++..+..||-||||.|=++..+++. +|+|++++...-+. +....+..|-++|..+..|.||+++..|.+ .+.
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt--kQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT--KQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch--hHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 3456778889999999999998887655 89999987665443 556678899999999999999999999885 489
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
|++||-|-||.|...++.++. |++.....++..+++|++|||++|||.|||||+|.+++.+ |.+||.|||+|+....
T Consensus 496 YmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhcc
Confidence 999999999999999998765 9999999999999999999999999999999999999998 8999999999999888
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-cCCCCCCCC
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK-NVRPSAENV 257 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 257 (352)
+..+-+.+||+.|.|||++.+ ...+.++|.||||+++|||++|.+||.+.++......+... .....|..+
T Consensus 573 g~KTwTFcGTpEYVAPEIILn--------KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I 644 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILN--------KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRI 644 (732)
T ss_pred CCceeeecCCcccccchhhhc--------cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhccccc
Confidence 888889999999999999875 55678999999999999999999999998776544433322 223346788
Q ss_pred cHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPN-----FTQIIQMLL 287 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps-----~~~i~~~l~ 287 (352)
+....++|++++..+|.+|.. +.+|..|.|
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 999999999999999999975 788988854
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=275.63 Aligned_cols=258 Identities=23% Similarity=0.311 Sum_probs=206.8
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
+.++.+.|.-..+||+|.||+||+|+.+ |+.||+|++......+... ....+|+++|..|.|+|++.++++|..
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp---italreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc---HHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 6677888999999999999999999764 7889998876543322221 135689999999999999999998742
Q ss_pred --------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 96 --------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 96 --------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
..+|+||.+|+. +|...+.+... .++...+..++.+++.||.|+|++.|+|||+||+|+||+.+ +.++|
T Consensus 89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~v-r~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilkl 165 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKV-RFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKL 165 (376)
T ss_pred cCCcccccceeeeeHHHhhh-hHHHHhcCccc-cccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEe
Confidence 258999999955 99998887543 39999999999999999999999999999999999999998 89999
Q ss_pred ecCCCcccccccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 018656 168 ADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 242 (352)
Q Consensus 168 ~Dfg~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 242 (352)
+|||+++..+... ..+..+.|..|++||.+.+ ...|+++.|||+.||++.+|+++.+-+++.++.++.
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG-------~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql 238 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG-------DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL 238 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhc-------ccccCCcchhHhHHHHHHHHHccCccccCChHHHHH
Confidence 9999997543321 2234456999999999987 478999999999999999999999999987776665
Q ss_pred HHHHhccCCCC---C-------------------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 243 YAAAFKNVRPS---A-------------------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 243 ~~~~~~~~~~~---~-------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
..+........ + ..-.++..+++..+|..||.+|++++++++|.+-
T Consensus 239 ~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 239 HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 54433222110 0 0112467789999999999999999999999544
Q ss_pred h
Q 018656 289 Y 289 (352)
Q Consensus 289 ~ 289 (352)
+
T Consensus 319 ~ 319 (376)
T KOG0669|consen 319 W 319 (376)
T ss_pred h
Confidence 3
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=286.45 Aligned_cols=252 Identities=26% Similarity=0.335 Sum_probs=195.2
Q ss_pred ceeeeccccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee---c-
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK---E- 95 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~---~- 95 (352)
+|.+.+.||+|+||.||++.+. +..||+|++....... .....+.+|+.+++++ +||||+++++.+. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK---ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc---hhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 5888999999999999999885 5689999986533222 1234577899999999 5999999998643 1
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
...+++++++. ++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||++.+ +.++|+|||++.
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~ 153 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLAR 153 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCce
Confidence 25789999984 69999987544 38999999999999999999999999999999999999988 799999999987
Q ss_pred cccccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-
Q 018656 175 EESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK- 248 (352)
Q Consensus 175 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~- 248 (352)
...... ......|+..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLS-------FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence 533211 1223468899999998743 245788999999999999999999999875532221111100
Q ss_pred ------------------------cCC-----CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 249 ------------------------NVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 249 ------------------------~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
... .....++..+.+++.+||+.||.+|||+.+++.+ .|+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~--~~~~~ 297 (332)
T cd07857 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH--PYLAI 297 (332)
T ss_pred CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC--hhhhh
Confidence 000 0123457889999999999999999999999998 44443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=312.98 Aligned_cols=247 Identities=30% Similarity=0.446 Sum_probs=191.4
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee----------
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA---------- 92 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~---------- 92 (352)
++..++.||+||||.||+++++ |+.||||.+..... .....++.+|+.++.+|+|||||+++..
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s----~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKAS----DKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchH----HHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3556789999999999999996 99999999987652 2445679999999999999999999540
Q ss_pred ------------------------------------------------e-------------------------------
Q 018656 93 ------------------------------------------------C------------------------------- 93 (352)
Q Consensus 93 ------------------------------------------------~------------------------------- 93 (352)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred -----------------------ec--------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 018656 94 -----------------------KE--------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142 (352)
Q Consensus 94 -----------------------~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH 142 (352)
.+ -.+||-||||+...|.+++.++.... .....|+++++|++||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 00 13689999999888888887654311 47789999999999999999
Q ss_pred hCCCccCCCCCCCeEEeCCCCceEEecCCCcccc-------------------ccccccccCCCcccccccccccccccc
Q 018656 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-------------------SLTEMMTAETGTYRWMAPELYSTVTLR 203 (352)
Q Consensus 143 ~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~-------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~ 203 (352)
++|+|||||||.|||++++ +.|||+|||+|... ......+..+||.-|+|||++.+.+
T Consensus 715 ~~giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~-- 791 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS-- 791 (1351)
T ss_pred hCceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc--
Confidence 9999999999999999988 89999999999741 0111334568999999999997632
Q ss_pred cccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC----cHHHHHHHHHhhccCCCCCCCH
Q 018656 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV----PEELSIILTSCWKEDPNARPNF 279 (352)
Q Consensus 204 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~ 279 (352)
...|+.|.|+||||++++||+. ||...-.+............|.+..+ -+.=..+|++||+.||.+|||+
T Consensus 792 ---~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 792 ---SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred ---cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence 1479999999999999999984 57654433333333333333433221 2345679999999999999999
Q ss_pred HHHHHH
Q 018656 280 TQIIQM 285 (352)
Q Consensus 280 ~~i~~~ 285 (352)
.+++..
T Consensus 866 ~eLL~s 871 (1351)
T KOG1035|consen 866 TELLNS 871 (1351)
T ss_pred HHHhhc
Confidence 999875
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=280.03 Aligned_cols=247 Identities=28% Similarity=0.384 Sum_probs=197.7
Q ss_pred eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVT 102 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 102 (352)
|++.+.||+|++|.||+|.+. ++.+++|++....... .....+.+|+.++++++|+||+++++++.+ +..++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE---GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc---cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 567788999999999999885 7999999988754222 223456789999999999999999998874 5899999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-c
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-M 181 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~-~ 181 (352)
||++ ++|.+++.+.. ..+++..++.++.|++.||++||++|++||||+|+||+++++ +.++|+|||++....... .
T Consensus 78 e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 78 EYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred cCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCccc
Confidence 9996 59999998753 249999999999999999999999999999999999999997 799999999987543322 2
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-----------
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV----------- 250 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----------- 250 (352)
.....++..|+|||.+.. ...++.++|+||||+++|++++|..||.+...............
T Consensus 155 ~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 155 YTHEVVTLWYRAPEILLG-------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred cCccccCcCcCChHHhcC-------CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhc
Confidence 233456788999998754 23678899999999999999999999987654333222111000
Q ss_pred --------C---------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 --------R---------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 --------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
. .....++..+.++|++||..||.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 0012357889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=306.41 Aligned_cols=147 Identities=31% Similarity=0.503 Sum_probs=129.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
-++|++.+.||+|+||+||+|.+. ++.||||++....... ......+.+|+.+++.++||||+++++++. ....+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~--~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN--KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC--HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence 368999999999999999999986 8999999987543322 133456888999999999999999998887 45799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+||||+.|++|.+++..... +++..++.|+.||+.||+|||++||+||||||+|||++.+ +.++|+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~--l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 99999999999999976543 8999999999999999999999999999999999999988 799999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=271.07 Aligned_cols=257 Identities=23% Similarity=0.291 Sum_probs=199.8
Q ss_pred CceeeeccccCCCceEEEEEEEC------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee--c
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--E 95 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~ 95 (352)
..|.++..||+|.||.||+|..+ ...+|||.+....+... .....-||+.+++.++||||+.+..++- +
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG---iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG---ISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC---cCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 46788889999999999999543 23699999877644332 2223668999999999999999998874 5
Q ss_pred CceEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC---CCceEEec
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---LKTIKLAD 169 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~---~~~vkl~D 169 (352)
...++++||.+. +|.+.|.-+. .+.++...+.+|+.||+.|+.|||++=|+||||||+||||..+ .|.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 689999999965 8998886442 3469999999999999999999999999999999999999765 46899999
Q ss_pred CCCccccccc----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh-------
Q 018656 170 FGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN------- 238 (352)
Q Consensus 170 fg~a~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~------- 238 (352)
+|+++..... ......+.|..|+|||.+.+ ...|+++.||||+||++.||++-.+-|.+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG-------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~P 252 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG-------ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNP 252 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcc-------cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCC
Confidence 9999865432 12334467999999999987 47899999999999999999998887765321
Q ss_pred --HHHHHHHHhccCCCCCCC------------------------------------CcHHHHHHHHHhhccCCCCCCCHH
Q 018656 239 --LQAAYAAAFKNVRPSAEN------------------------------------VPEELSIILTSCWKEDPNARPNFT 280 (352)
Q Consensus 239 --~~~~~~~~~~~~~~~~~~------------------------------------~~~~l~~li~~~l~~~p~~Rps~~ 280 (352)
.++...+......|.... -++.-.+++.++|+.||.+|.|++
T Consensus 253 fq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~ 332 (438)
T KOG0666|consen 253 FQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAE 332 (438)
T ss_pred chHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHH
Confidence 123333333323322111 123366799999999999999999
Q ss_pred HHHHHHHHhhhcc
Q 018656 281 QIIQMLLNYLSAI 293 (352)
Q Consensus 281 ~i~~~l~~~~~~~ 293 (352)
+++++ .++...
T Consensus 333 qAleh--~yF~~d 343 (438)
T KOG0666|consen 333 QALEH--PYFTED 343 (438)
T ss_pred HHhcc--cccccC
Confidence 99998 455443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=279.36 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=206.2
Q ss_pred ceecCCceeeeccccCCCceEEEEEEECC--ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 95 (352)
-.|...++.+..+||+|+||.|.+|..+| +.||||++++.-.... ...+.-+.|-++|... +-|.+++++.+|+.
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd--DDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD--DDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec--CcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 46777889999999999999999998874 7899999887533221 1222344566777665 56788898888874
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+.+|+||||+.||+|--.|++-+. +.+..+..++.+|+-||-+||++||+.||||.+|||++.+ |++||+|||+++
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcK 498 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCK 498 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeeccccc
Confidence 589999999999999998987665 8899999999999999999999999999999999999999 899999999998
Q ss_pred cccc-ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 018656 175 EESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253 (352)
Q Consensus 175 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (352)
.... .....+.+||+.|+|||++.. ..|+.++|.||+|++||||+.|++||++.+.. ...+.+.......
T Consensus 499 Eni~~~~TTkTFCGTPdYiAPEIi~Y--------qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-elF~aI~ehnvsy 569 (683)
T KOG0696|consen 499 ENIFDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQAIMEHNVSY 569 (683)
T ss_pred ccccCCcceeeecCCCcccccceEEe--------cccccchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHccCcC
Confidence 5433 345677899999999999865 78999999999999999999999999996654 4555555555667
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCC
Q 018656 254 AENVPEELSIILTSCWKEDPNARPN 278 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps 278 (352)
+..+|.+..++....|.+.|.+|..
T Consensus 570 PKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 570 PKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cccccHHHHHHHHHHhhcCCccccC
Confidence 7889999999999999999999953
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=292.88 Aligned_cols=242 Identities=25% Similarity=0.347 Sum_probs=199.0
Q ss_pred cCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeecC-c
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~ 97 (352)
....|.+...+|.|+|++|-.+.+ +++..++|++...... ..+|+.++... +||||+++.+++.++ .
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~---------~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD---------NQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc---------cccccchhhhhcCCCcceeecceecCCce
Confidence 356788888899999999999877 4889999999776221 23566555555 799999999999865 8
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe-CCCCceEEecCCCcccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT-EDLKTIKLADFGLAREE 176 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~-~~~~~vkl~Dfg~a~~~ 176 (352)
.|+|||.+.|+-|.+.+..... +. .++..|+.+|+.|+.|||++|++||||||+|||++ +. +.++|+|||.++..
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~-g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSA-GHLRLTYFGFWSEL 466 (612)
T ss_pred eeeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCC-CcEEEEEechhhhC
Confidence 9999999999999988876443 33 77888999999999999999999999999999995 55 89999999999865
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 256 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 256 (352)
... ..+.+-|..|.|||++.. ..|++++|+||||++||+||+|+.||.............. ..+....
T Consensus 467 ~~~--~~tp~~t~~y~APEvl~~--------~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~--~~~~s~~ 534 (612)
T KOG0603|consen 467 ERS--CDTPALTLQYVAPEVLAI--------QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ--MPKFSEC 534 (612)
T ss_pred chh--hcccchhhcccChhhhcc--------CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc--CCccccc
Confidence 444 334467899999999853 7899999999999999999999999988665523332221 2222378
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
+|.+.++++++||+.||.+||+++++..|-|.
T Consensus 535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 535 VSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999999999544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=297.96 Aligned_cols=253 Identities=27% Similarity=0.417 Sum_probs=215.0
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK----- 94 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~----- 94 (352)
..-|.+++.||.|.+|.||+++. +|+.+|+|+.....+.+. .+..|.++++.+ .|||++.+++++.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de------EiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE------EIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH------HHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 34567888999999999999875 589999999988766554 355688888888 7999999999873
Q ss_pred -cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 -EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
++.+|+|||||.|||..|++++.....+.|..+..|+..++.||.+||++.++|||||-.|||++.+ +.|||+|||.+
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e-~~VKLvDFGvS 170 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN-AEVKLVDFGVS 170 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc-CcEEEeeeeee
Confidence 3479999999999999999998888889999999999999999999999999999999999999998 79999999998
Q ss_pred cccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 018656 174 REESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 174 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
.....+ ....+.+||+.|||||++.... .....|+..+|+||||++..||..|.+|+-++.+...+..+.....+.
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~e---~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACDE---SPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeeecccccccCcCCCcccccceeeeccc---CCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 754333 3345678999999999986632 334678889999999999999999999999888776666554433222
Q ss_pred C--CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 S--AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 ~--~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
. +..++.++.+||..||.+|..+||+..++++|
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1 56788999999999999999999999999886
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=259.58 Aligned_cols=245 Identities=22% Similarity=0.390 Sum_probs=205.5
Q ss_pred cCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeecC--
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-- 96 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~-- 96 (352)
..++|++.+++|+|.+++||.|.+ +++.++||++++ .....+.+|+++|..|. ||||++++++..++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 688999999999999999999985 589999999875 33456899999999996 99999999998764
Q ss_pred -ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
...+|+||+++.+...+... ++..++..++.++++||.|||++||.|||+||.|+||+.....++|+|+|+|..
T Consensus 108 ktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred cCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 67899999999888776643 888899999999999999999999999999999999998778899999999988
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHhccCC---
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF-EGMSNLQAAYAAAFKNVR--- 251 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~--- 251 (352)
..+..-....+.+..|--||.+... ..|+.+-|+|||||++..|++.+.|| .|.++.++..++......
T Consensus 183 YHp~~eYnVRVASRyfKGPELLVdy-------~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 183 YHPGKEYNVRVASRYFKGPELLVDY-------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred cCCCceeeeeeehhhcCCchheeec-------hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 7766666666778899999998763 57888999999999999999998887 455555554443322111
Q ss_pred ------------CC---------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 252 ------------PS---------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 252 ------------~~---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
|. ..-++++..+++..+|..|-.+|+|+.++..|.
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 00 122468899999999999999999999999883
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=278.35 Aligned_cols=259 Identities=23% Similarity=0.336 Sum_probs=209.8
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHH--HHHHHHHHHHHHHhcCCCCCeeeeeeeee--
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIA--KKESRFAREVAMLSRVQHRNLVKFIGACK-- 94 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-- 94 (352)
...++|.+.++||+|||+.||+|-+- ++.||+|+-.....+.+.. .+.....+|.++.+.|+||.||++++++.
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 34678999999999999999999873 7899999987766654422 33456778999999999999999999986
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeCC--CCceEEecC
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTED--LKTIKLADF 170 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~~--~~~vkl~Df 170 (352)
...++-|+|||+|.+|+=|++.+.- +++.+++.|+.||+.||.||.... |+|-||||.|||+-++ -|.+||+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 3478999999999999999987765 999999999999999999999885 9999999999999554 368999999
Q ss_pred CCccccccc--------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH
Q 018656 171 GLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 242 (352)
Q Consensus 171 g~a~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~ 242 (352)
|+++..... .......||..|++||.+.. .......+.+.||||+|+++|..+.|+-||......+..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvV----gkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVV----GKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeec----CCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 999853322 22345679999999998865 223467888999999999999999999999874433322
Q ss_pred HHHHh-----ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 243 YAAAF-----KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 243 ~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..... .-..|..+.++++..+||++||++.-++|.+..++..+
T Consensus 694 LqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 694 LQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred HhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 22111 11234556889999999999999999999988888665
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=281.55 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=202.7
Q ss_pred ecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-c
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 97 (352)
+|.+.|..++.||-|+||+|.+++. +...||+|.+++..... .......+.|-.+|...+.+-||+|+..|+++ .
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~--rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM--RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh--hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 5667888999999999999999864 57789999998755433 24456788899999999999999999999865 8
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+|+||+|++||++-.++-+.+- |+|..++.++.++..|+++.|..|+|||||||+|||||.+ |++||+|||++....
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFR 780 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cceeeeeccccccce
Confidence 9999999999999999987665 9999999999999999999999999999999999999999 899999999985211
Q ss_pred ccc-------------------------------------------ccccCCCcccccccccccccccccccccCCCccc
Q 018656 178 LTE-------------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKV 214 (352)
Q Consensus 178 ~~~-------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~ 214 (352)
... ..-..+||+.|+|||++.. ..++..+
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--------~g~~q~c 852 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--------TGYTQLC 852 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--------cCccccc
Confidence 100 0012469999999999854 7789999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCChHHHHHHHH---hccCCCCCCCCcHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 018656 215 DSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA---FKNVRPSAENVPEELSIILTSCWKEDPNARP---NFTQIIQM 285 (352)
Q Consensus 215 DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~i~~~ 285 (352)
|.||.|++||+|+.|+.||...+......+++ .....+.-.+++.++.++|.+++. +++.|. ..+++..|
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaH 928 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAH 928 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcC
Confidence 99999999999999999998766554433322 122334456889999999887654 566664 45667666
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=266.45 Aligned_cols=223 Identities=23% Similarity=0.255 Sum_probs=177.8
Q ss_pred CCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCCCCHH
Q 018656 35 GAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGGTLR 111 (352)
Q Consensus 35 G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~ 111 (352)
|.+|.||++.++ |+.||+|.+..... ..+|...+....||||+++++++.+ ...+++|||++|++|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 899999999984 88999999865421 2334455555679999999999875 4789999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCCCcccc
Q 018656 112 KYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191 (352)
Q Consensus 112 ~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y 191 (352)
+++.+... +++..+..++.|+++||+|||++|++||||||+||+++.+ +.++++|||.+...... .....++..|
T Consensus 74 ~~l~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~y 148 (237)
T cd05576 74 SHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENMY 148 (237)
T ss_pred HHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCccc
Confidence 99976543 8999999999999999999999999999999999999988 78999999987653322 2234567789
Q ss_pred cccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhcc
Q 018656 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKE 271 (352)
Q Consensus 192 ~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 271 (352)
+|||.... ..++.++|+||+|+++|+|++|..|+...... .........+..++..+.++|.+||+.
T Consensus 149 ~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~ 215 (237)
T cd05576 149 CAPEVGGI--------SEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQF 215 (237)
T ss_pred cCCcccCC--------CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccC
Confidence 99998743 55788999999999999999999887643211 000111123456889999999999999
Q ss_pred CCCCCCCH-----HHHHHH
Q 018656 272 DPNARPNF-----TQIIQM 285 (352)
Q Consensus 272 ~p~~Rps~-----~~i~~~ 285 (352)
||.+||++ +++++|
T Consensus 216 dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 216 NPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred CHHHhcCCCccchHHHHcC
Confidence 99999986 666554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=292.93 Aligned_cols=266 Identities=31% Similarity=0.585 Sum_probs=220.6
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-C
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (352)
+..+..|.+++++..+.+.||.|.||.|++|.-. ...||||.+...... .....+..|+++++.+ .
T Consensus 285 ~~~~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~----~~~~~~~~El~~m~~~g~ 360 (609)
T KOG0200|consen 285 LPEDPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS----SEKKDLMSELNVLKELGK 360 (609)
T ss_pred cCcCCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc----HHHHHHHHHHHHHHHhcC
Confidence 3455599999999999999999999999998643 346999998876654 2345689999999999 6
Q ss_pred CCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcC-------C-------CCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 018656 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMR-------P-------RCLDVCVAIGFALDIARAMECLHSHGII 147 (352)
Q Consensus 83 hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-------~-------~~~~~~~~~~i~~qi~~~L~~lH~~~iv 147 (352)
||||+.+++++.+ +.+++|+||+..|+|.+|++..+ . ..++..+.+.++.||+.|++||++..++
T Consensus 361 H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 361 HPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred CcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 9999999999875 68999999999999999998766 0 1388899999999999999999999999
Q ss_pred cCCCCCCCeEEeCCCCceEEecCCCcccccccccc--ccCCC--cccccccccccccccccccccCCCcccchhhHHHHH
Q 018656 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM--TAETG--TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVL 223 (352)
Q Consensus 148 H~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~g--~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 223 (352)
||||-.+|||++.+ ..+|++|||+++........ +...+ ...|||||.+.. ..|+.++||||+|+++
T Consensus 441 HRDLAaRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--------~~ft~kSDVWSfGI~L 511 (609)
T KOG0200|consen 441 HRDLAARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--------RVFTSKSDVWSFGILL 511 (609)
T ss_pred chhhhhhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--------CcccccchhhHHHHHH
Confidence 99999999999998 79999999999853332222 22232 456999999854 6789999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHh-ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 224 WELLH-NKLPFEGMSNLQAAYAAAF-KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 224 ~~ll~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
||+++ |..||.+............ ......+..++.++.++++.||..+|.+||++.++.+.+...+.
T Consensus 512 ~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 512 WEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 99998 8999998663333344333 33446678889999999999999999999999999999988554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.69 Aligned_cols=246 Identities=23% Similarity=0.285 Sum_probs=197.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC--C----Ceeeeeeeee
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--R----NLVKFIGACK 94 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p----~iv~l~~~~~ 94 (352)
..+|.+...+|+|.||.|..+-+. +..||||+++. ..++....+-|+++++++.+ | -++.+.++|+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN------VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 789999999999999999999774 78999999864 23445556679999999942 2 3567777787
Q ss_pred -cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC------------
Q 018656 95 -EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED------------ 161 (352)
Q Consensus 95 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~------------ 161 (352)
.+..++|+|.+ |-|+++++.++...+++...++.|+.||++++++||+++++|.||||+|||+.+.
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 67899999999 7799999999888889999999999999999999999999999999999998421
Q ss_pred -------CCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCC
Q 018656 162 -------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234 (352)
Q Consensus 162 -------~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 234 (352)
...|+++|||.|+..... ..+.+.|..|.|||++.+ -..+.++||||+||||+|+.+|..-|+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLg--------LGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILG--------LGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheec--------cCcCCccCceeeeeEEEEeeccceecc
Confidence 135899999999864333 256688999999999987 557889999999999999999999998
Q ss_pred CCChHHHHHHH-HhccCCCC-------------------C-------------------------CCCcHHHHHHHHHhh
Q 018656 235 GMSNLQAAYAA-AFKNVRPS-------------------A-------------------------ENVPEELSIILTSCW 269 (352)
Q Consensus 235 ~~~~~~~~~~~-~~~~~~~~-------------------~-------------------------~~~~~~l~~li~~~l 269 (352)
+.++.+.+.-. ...+..|. + +.-...|.+||++||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 87654432110 00111000 0 001144889999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 018656 270 KEDPNARPNFTQIIQM 285 (352)
Q Consensus 270 ~~~p~~Rps~~~i~~~ 285 (352)
..||.+|+|+.|++.|
T Consensus 391 ~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 391 EFDPARRITLREALSH 406 (415)
T ss_pred ccCccccccHHHHhcC
Confidence 9999999999999998
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=271.62 Aligned_cols=255 Identities=27% Similarity=0.503 Sum_probs=198.1
Q ss_pred CCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC--CCCCeeeeeeeeec--C--
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV--QHRNLVKFIGACKE--P-- 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~~~~~~--~-- 96 (352)
.++.++.+.||+|.||+||+|+|.|+.||||++.... +....+|.++.+.. +|+||+.+++.-.. +
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd--------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD--------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccc--------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 4578899999999999999999999999999997633 33477888887765 99999999987432 2
Q ss_pred -ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCCeEEeCCCCceEE
Q 018656 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--------~ivH~Dikp~Nili~~~~~~vkl 167 (352)
++++|.+|.+.|||+||+.++ .++....++++..++.||++||.. .|+|||||..||||.++ +.+.|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEE
Confidence 699999999999999999873 389999999999999999999964 49999999999999999 89999
Q ss_pred ecCCCccccccc-----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC----------CCC
Q 018656 168 ADFGLAREESLT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN----------KLP 232 (352)
Q Consensus 168 ~Dfg~a~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g----------~~p 232 (352)
+|+|+|...... ......+||.+|||||++...- +.+.-+--..+||||+|.++||++.. ++|
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdeti--n~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETI--NMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhc--ChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999754332 2345668999999999986511 11112223479999999999999853 578
Q ss_pred CCCCChHHHHHHHHh-----ccCCCCCC----CCc--HHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 233 FEGMSNLQAAYAAAF-----KNVRPSAE----NVP--EELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 233 ~~~~~~~~~~~~~~~-----~~~~~~~~----~~~--~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
|.+..+.+.....+. ...+|..+ ..+ ..+.++++.||..||..|.|+-.+.+.+.+..+
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 866544433333222 22333322 111 447789999999999999999999888776553
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=285.57 Aligned_cols=255 Identities=24% Similarity=0.486 Sum_probs=214.9
Q ss_pred CCceeeeccccCCCceEEEEEEEC------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 96 (352)
....+..++||+|+||+||+|.|- +-+||||++....... ....+.+|+-.|.+++|||++++++++..+
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~----~s~e~LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK----ASIELLDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch----hhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence 445566789999999999999872 4579999987654432 234588999999999999999999999988
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.+.||.+|+++|+|.+|++.++. .+-....+.|..||++|+.|||.+.++||||-.+||||..- +.+|+.|||+++..
T Consensus 771 ~~qlvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 771 TLQLVTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLL 848 (1177)
T ss_pred hHHHHHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhcc
Confidence 89999999999999999998654 48899999999999999999999999999999999999987 79999999999865
Q ss_pred ccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 018656 177 SLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 177 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
..... .....-.+-|+|-|.+.. ..++.++||||+|+++||++| |..||.+..-.+...........+
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~--------~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs 920 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRI--------RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS 920 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhc--------cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC
Confidence 44322 112223567888887743 789999999999999999998 999999987766655555555667
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
-++.++-++..++.+||..|+..||+++++...+....+
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 788999999999999999999999999999988776554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=265.44 Aligned_cols=258 Identities=30% Similarity=0.443 Sum_probs=198.0
Q ss_pred ceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC--CCCCeeeeeeeeecC
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV--QHRNLVKFIGACKEP 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~l~~~~~~~ 96 (352)
=+.+-...++.++||+|+||.||+|..+++.||||++.. ...+.+.+|-++.+.. +|+||+++++.-..+
T Consensus 205 pl~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~ 276 (534)
T KOG3653|consen 205 PLLELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRG 276 (534)
T ss_pred ccccCCchhhHHHhhcCccceeehhhccCceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence 455567788999999999999999999999999999865 3345677887776654 899999999885432
Q ss_pred -----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCCCeEEeCCC
Q 018656 97 -----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---------GIIHRDLKPENLLLTEDL 162 (352)
Q Consensus 97 -----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---------~ivH~Dikp~Nili~~~~ 162 (352)
.+++|++|.+.|+|.+|+..+- +++....+|+..+++||+|||+. .|+|||||..||||.+|
T Consensus 277 t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D- 352 (534)
T KOG3653|consen 277 TADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND- 352 (534)
T ss_pred CccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-
Confidence 6899999999999999998754 99999999999999999999974 59999999999999999
Q ss_pred CceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCC---------
Q 018656 163 KTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK--------- 230 (352)
Q Consensus 163 ~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~--------- 230 (352)
....|+|||+|.....+. ..-..+||.+|||||++-+.-.-+ ....-.+.||||+|.++|||++..
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~--d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp 430 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQ--DRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP 430 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccc--cHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence 799999999998654332 223468999999999997632111 123345799999999999999753
Q ss_pred ---CCCCC---CCh-HHHHHH-HHhccCCCCCC------CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 231 ---LPFEG---MSN-LQAAYA-AAFKNVRPSAE------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 231 ---~p~~~---~~~-~~~~~~-~~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
+||+. ..+ .+.... ...+..+|... .-..-+.+.+..||..|++.|.|+.=+-+.+.+..
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 34431 111 112221 22233333321 23356889999999999999999988877766554
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=255.18 Aligned_cols=235 Identities=35% Similarity=0.533 Sum_probs=195.8
Q ss_pred CceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCCCCHHH
Q 018656 36 AHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGGTLRK 112 (352)
Q Consensus 36 ~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~ 112 (352)
+||.||+|.+. |+.+++|++........ ...+.+|++.+++++|+||+++++.+.. ...++++|++++++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 68999999985 69999999877554332 4568899999999999999999998874 58999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCCCccccc
Q 018656 113 YLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM 192 (352)
Q Consensus 113 ~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~ 192 (352)
++..... ++...++.++.+++.++.+||+.+++|+||+|+||+++++ +.++|+|||.+.............++..|+
T Consensus 77 ~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 77 LLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCC
Confidence 9986544 8999999999999999999999999999999999999998 799999999998755544445567889999
Q ss_pred ccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC---CcHHHHHHHHHhh
Q 018656 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN---VPEELSIILTSCW 269 (352)
Q Consensus 193 aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l 269 (352)
|||.+.. ..++.++|+||||++++++++|..||....................... ++.++.+++.+||
T Consensus 154 ~pE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 225 (244)
T smart00220 154 APEVLLG--------KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLL 225 (244)
T ss_pred CHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHc
Confidence 9998753 5567899999999999999999999987444343333333332222222 8899999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 018656 270 KEDPNARPNFTQIIQM 285 (352)
Q Consensus 270 ~~~p~~Rps~~~i~~~ 285 (352)
..+|.+||++.+++++
T Consensus 226 ~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 226 VKDPEKRLTAEEALQH 241 (244)
T ss_pred cCCchhccCHHHHhhC
Confidence 9999999999999885
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=306.81 Aligned_cols=240 Identities=26% Similarity=0.374 Sum_probs=183.6
Q ss_pred ceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
.+...+.||+|+||+||+|.+ .|..||+|.+...... ..+|++.+++++||||+++++++.+ +..++|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 455677899999999999987 4889999988643321 1246888999999999999999974 478999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH---SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
|||+++++|.+++.. +++..+..++.|+++||+||| +.+++||||||+||+++.+ +..++. ||.......
T Consensus 762 ~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc
Confidence 999999999999963 889999999999999999999 6799999999999999887 455554 554432211
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcc-----
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL----QAAYAAAFKN----- 249 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~----- 249 (352)
.....++..|+|||++.+ ..++.++||||+||++|||++|+.||...... ..........
T Consensus 835 ---~~~~~~t~~y~aPE~~~~--------~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRET--------KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred ---CCCccccccccCcccccC--------CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh
Confidence 123367899999998754 56889999999999999999999998542211 1111100000
Q ss_pred -CCCC-------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 250 -VRPS-------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 250 -~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
..+. ......++.+++.+||+.||.+||++.++++.++...+
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 0011 11122457789999999999999999999999987654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=287.15 Aligned_cols=262 Identities=20% Similarity=0.243 Sum_probs=174.7
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
.+....++|.+.+.||+|+||.||+|.+. +..||+|.+......+. ...+ .++...+.++..+..
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-------~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-------WMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-------HHHH--HHHhhchhhHHHHHH
Confidence 45567789999999999999999999874 67899998754322111 1111 111122222222221
Q ss_pred e-------eecCceEEEEEcCCCCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 018656 92 A-------CKEPVMVIVTELLSGGTLRKYLLNMRPR------------------CLDVCVAIGFALDIARAMECLHSHGI 146 (352)
Q Consensus 92 ~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~------------------~~~~~~~~~i~~qi~~~L~~lH~~~i 146 (352)
. -.+...++|+||+++++|.+++...... ......+..++.|++.||+|||++||
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 1 1245789999999999999998754210 11234567899999999999999999
Q ss_pred ccCCCCCCCeEEeCCCCceEEecCCCcccccc--ccccccCCCccccccccccccccccccc--------------ccCC
Q 018656 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESL--TEMMTAETGTYRWMAPELYSTVTLRQGE--------------KKHY 210 (352)
Q Consensus 147 vH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~--------------~~~~ 210 (352)
+||||||+|||++.+.+.+||+|||++..... ........+++.|+|||.+......... ...+
T Consensus 277 iHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred EeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999999999987547899999999974322 2233456789999999976432110000 1134
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc----------CCCC-----------CCCCcHHHHHHHHHhh
Q 018656 211 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN----------VRPS-----------AENVPEELSIILTSCW 269 (352)
Q Consensus 211 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~----------~~~~-----------~~~~~~~l~~li~~~l 269 (352)
+.++|||||||++|+|+++..|+... ........... ..+. .........+||.+||
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 56779999999999999987665431 11111110000 0000 0112234558999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhc
Q 018656 270 KEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 270 ~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
+.||.+|||+.++++| .|+..
T Consensus 435 ~~dP~kR~ta~e~L~H--pff~~ 455 (566)
T PLN03225 435 RFKGRQRISAKAALAH--PYFDR 455 (566)
T ss_pred cCCcccCCCHHHHhCC--cCcCC
Confidence 9999999999999998 44443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=257.15 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=214.3
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA 92 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~ 92 (352)
..+|-+.-.+|.+..+||+|+|+.|..++.+ .+.||+|++++....+. +.++-.+.|-.+..+. +||.+|-+..+
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd--edidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD--EDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc--ccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 3568889999999999999999999999874 78899999987655443 2334455676666666 79999999999
Q ss_pred ee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 93 CK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 93 ~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
|+ +..+++|.||++||+|-=+++++.. ++++.++.+...|+.||.|||++||+.||||.+|+|++.. |++||+|+|
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghikltdyg 396 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYG 396 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-Cceeecccc
Confidence 98 5689999999999999877776544 9999999999999999999999999999999999999998 899999999
Q ss_pred Cccc-cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCC-------CChHHHHH
Q 018656 172 LARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG-------MSNLQAAY 243 (352)
Q Consensus 172 ~a~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~-------~~~~~~~~ 243 (352)
.++. .......++.+||+.|.|||++.+ ..|+...|.|+||++++||+.|+.||+- .+.++...
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrg--------eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf 468 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF 468 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcc--------cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH
Confidence 9985 455667788899999999999965 7899999999999999999999999953 22344455
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCC------CHHHHHHH
Q 018656 244 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARP------NFTQIIQM 285 (352)
Q Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~i~~~ 285 (352)
+.+.......+..++-....+++..|.+||.+|. .+.++..|
T Consensus 469 qvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h 516 (593)
T KOG0695|consen 469 QVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH 516 (593)
T ss_pred HHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc
Confidence 5555555556677777788899999999999984 35566555
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=233.66 Aligned_cols=218 Identities=25% Similarity=0.388 Sum_probs=176.9
Q ss_pred ceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeee-e
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC-K 94 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~-~ 94 (352)
..+.......+..||+|++|.|=+.++ +|+..|+|.+...-... ...++.+|+.+..+. ..|.+|.+++.+ .
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q----~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ----EQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH----HHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 556666667788999999999977766 59999999987765432 234577888887766 789999999975 4
Q ss_pred cCceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
++..++.||.+ ..||+.+.++- .+..++|..+-+|+..++.||.|||++ .++|||+||+||||+.+ |+||++|||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiCDFG 194 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKICDFG 194 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEcccc
Confidence 77899999999 66999887643 345699999999999999999999987 89999999999999999 899999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHH
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS-NLQAAYAAA 246 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~-~~~~~~~~~ 246 (352)
++-.....-..+-..|...|+|||.+.. ..+...|+.++||||||++++||.+++.||.... +.+++.+..
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~----e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINP----ELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCc----ccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 9876554444444678999999999865 3345689999999999999999999999997643 444444333
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=268.20 Aligned_cols=266 Identities=20% Similarity=0.210 Sum_probs=184.0
Q ss_pred ecCCceeeeccccCCCceEEEEEEE------------------CCceEEEEEcccCCChHHHH---------HHHHHHHH
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKY------------------KNQTVAIKIVHKGETPEEIA---------KKESRFAR 73 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~------------------~~~~vaiK~~~~~~~~~~~~---------~~~~~~~~ 73 (352)
+..++|.+.++||+|+||+||+|.+ .++.||||.+.......... ........
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3688999999999999999999864 24679999986543211100 01112334
Q ss_pred HHHHHhcCCCCCe-----eeeeeeee---------cCceEEEEEcCCCCCHHHHHHhcCC--------------------
Q 018656 74 EVAMLSRVQHRNL-----VKFIGACK---------EPVMVIVTELLSGGTLRKYLLNMRP-------------------- 119 (352)
Q Consensus 74 E~~~l~~l~hp~i-----v~l~~~~~---------~~~~~lv~e~~~~~sL~~~l~~~~~-------------------- 119 (352)
|+.++.+++|.++ +++++++. ++..++|+||+++++|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666777765544 56666553 3468999999999999999864211
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccc--cCCCcccccccc
Q 018656 120 --RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT--AETGTYRWMAPE 195 (352)
Q Consensus 120 --~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~g~~~y~aPE 195 (352)
..+++..++.++.|++.+|.|||+++|+||||||+||+++.+ +.++|+|||++.......... ...+++.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 124567788999999999999999999999999999999988 789999999986543322222 223578999999
Q ss_pred ccccccccccc--------------ccCCCcccchhhHHHHHHHHHhCCC-CCCCCChHHHHHH----------HHh--c
Q 018656 196 LYSTVTLRQGE--------------KKHYNHKVDSYSFAIVLWELLHNKL-PFEGMSNLQAAYA----------AAF--K 248 (352)
Q Consensus 196 ~~~~~~~~~~~--------------~~~~~~~~DiwslG~il~~ll~g~~-p~~~~~~~~~~~~----------~~~--~ 248 (352)
.+......... ......+.|+||+||++|+|++|.. ||........... ... .
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 87542110000 0111235799999999999999875 7654221111111 000 1
Q ss_pred cCCCCCCCCcHHHHHHHHHhhccCC---CCCCCHHHHHHHHH
Q 018656 249 NVRPSAENVPEELSIILTSCWKEDP---NARPNFTQIIQMLL 287 (352)
Q Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~~i~~~l~ 287 (352)
...+.....++...+++.+||..+| .+|+|+.++++|.|
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 1122345678999999999999866 68999999999843
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=279.87 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=186.0
Q ss_pred eccccCCCceEE-EEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-CceEEEEEcC
Q 018656 29 GPRIGEGAHAKV-YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVMVIVTELL 105 (352)
Q Consensus 29 ~~~lG~G~~g~V-y~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~lv~e~~ 105 (352)
.+++|.|+.|+| |+|...|+.||||.+... ......+|++.|+.- +|||||++++.-.+ ..+||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e--------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEE--------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhH--------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 466899999975 899999999999987643 234577999999988 69999999998765 4789999999
Q ss_pred CCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC---C-CCceEEecCCCccccccc
Q 018656 106 SGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---D-LKTIKLADFGLAREESLT 179 (352)
Q Consensus 106 ~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~---~-~~~vkl~Dfg~a~~~~~~ 179 (352)
. -+|.+++..... ........+.+..|+++||++||+.+||||||||+||||+. + ..+++|+|||+++....+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 5 599999987411 11111455778999999999999999999999999999975 2 247999999999864433
Q ss_pred c----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccCCCCC
Q 018656 180 E----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 180 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
. ......||.+|+|||++.. ...+.+.|||||||++|+.++| ..||......+..............
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~--------~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLRE--------DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLE 736 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhc--------cccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeec
Confidence 2 2345679999999999965 3345699999999999999885 8999875544433322222111111
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.....+..++|.+|+.++|..||++.+++.|.
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 12222889999999999999999999999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=248.84 Aligned_cols=250 Identities=27% Similarity=0.345 Sum_probs=208.0
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.-...+.+|.-...+|.|.- .|..|-+. +++||+|.+..+.... ....+..+|..++..++|+||++++.++.-
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~---~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQ---THAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccC---ccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 45667889999999999999 77777664 9999999987763332 224457799999999999999999999852
Q ss_pred C-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 96 P-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 96 ~-------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
. ..|+|||++ ..+|.+.+.. .++...+..|+.|++.|+.|||+.||+||||||+||++..+ ..+|+.
T Consensus 87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~ 160 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKIL 160 (369)
T ss_pred cccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeec
Confidence 2 579999999 5699998873 27888999999999999999999999999999999999998 899999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
|||+|+.....-..+..+.+..|.|||++.+ -.+.+.+||||+||++.||++|..-|.|.+..++..+....
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~--------~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~ 232 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ 232 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheec--------cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence 9999998777656677889999999999987 34889999999999999999999999987776665554443
Q ss_pred cCCCCC----------------------------------------C-CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 249 NVRPSA----------------------------------------E-NVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 249 ~~~~~~----------------------------------------~-~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...|.+ + .-+.-.++++.+||..||++|.+++++++|
T Consensus 233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 333221 0 112447789999999999999999999998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=250.88 Aligned_cols=247 Identities=28% Similarity=0.366 Sum_probs=199.2
Q ss_pred eeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC------c
Q 018656 26 LFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP------V 97 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~------~ 97 (352)
.+-.+.||.|+||+||...+ .|+.|++|.+..-.... ....++.+|++++..++|.||+..+++.+.. .
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L---~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNL---ASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHH---HHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 34456799999999999988 49999999876544333 2345688999999999999999999987644 3
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+|++.|.+ ..+|...|-..+ .++...+.-++.||++||.|||+.+|.||||||.|+|++++ ..+||+|||+++...
T Consensus 132 iYV~TELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccc
Confidence 68888988 568888776543 48888999999999999999999999999999999999998 899999999999654
Q ss_pred cc--cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--
Q 018656 178 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 253 (352)
Q Consensus 178 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 253 (352)
.. ..++..+.|..|.|||++.+ ...|+.+.||||.||++.|++..+.-|+..++.++..-+......|.
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMG-------aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMG-------ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhc-------chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence 43 23445578999999999987 46899999999999999999999999988877766655444433332
Q ss_pred -------------------CC------------CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 254 -------------------AE------------NVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 254 -------------------~~------------~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.+ .-..+-..++..+|..||+.|.+.++.+.++
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11 1123456778889999999999999888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=273.46 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=212.3
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
+.+|.+..++|+|+||.||+|+++ ++..|+|+++.....+ ..-+++|+-+++.++||||+.+++.+- ...++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-----~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-----FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-----ccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 578999999999999999999985 8999999998876543 334778999999999999999999886 56899
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
++||||.||+|++...-.+ .+++.++...++..++||+|||++|=+|||||-.||++++. |.+|++|||.+-.....
T Consensus 89 icMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQITAT 165 (829)
T ss_pred EEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhhhh
Confidence 9999999999999766544 49999999999999999999999999999999999999998 89999999998754433
Q ss_pred -cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC----C
Q 018656 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS----A 254 (352)
Q Consensus 180 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----~ 254 (352)
...+++.||+.|||||+..- +..+.|...+|||++|++..|+-.-++|.-.....+.+.-.......|. .
T Consensus 166 i~KrksfiGtpywmapEvaav-----erkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAV-----ERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK 240 (829)
T ss_pred hhhhhcccCCccccchhHHHH-----HhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC
Confidence 23356789999999998653 2457899999999999999999998888776666655555544444433 4
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...++.+.+|++.+|..+|++||+++.++.|
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 5678999999999999999999999998875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=258.38 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=201.1
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC------CCCeeeeeeee
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ------HRNLVKFIGAC 93 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~l~~~~ 93 (352)
.-.+|.+....|+|-||+|..|.+. |..||||+++.... ....-+.|+++|++|+ .-|+++++-.|
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~------M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV------MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH------HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 3467888889999999999999985 88999999986432 1223568999999994 35789998877
Q ss_pred e-cCceEEEEEcCCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 94 K-EPVMVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 94 ~-~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
. .+++++|+|.+ ..+|.+.+++.+.. .+....+..++.||+.||..|...||+|.||||+||||+++...+||||||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 5 56899999999 67999999987643 588889999999999999999999999999999999999987899999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
.|.....+.. +.+..+..|.|||++.+ ..|+...|+||.||+||||.||+.-|.|.++.+-+.-.+.....
T Consensus 583 SA~~~~enei-tPYLVSRFYRaPEIiLG--------~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 583 SASFASENEI-TPYLVSRFYRAPEIILG--------LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred cccccccccc-cHHHHHHhccCcceeec--------CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 9987554433 44556788999999987 66888999999999999999999999998775543322211110
Q ss_pred -CC----------------------------------------C-----------CCCc-------HHHHHHHHHhhccC
Q 018656 252 -PS----------------------------------------A-----------ENVP-------EELSIILTSCWKED 272 (352)
Q Consensus 252 -~~----------------------------------------~-----------~~~~-------~~l~~li~~~l~~~ 272 (352)
|. | ..+| ..+.+|+..||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 00 0 0111 44888999999999
Q ss_pred CCCCCCHHHHHHH
Q 018656 273 PNARPNFTQIIQM 285 (352)
Q Consensus 273 p~~Rps~~~i~~~ 285 (352)
|.+|.|..+++.|
T Consensus 734 P~KRit~nqAL~H 746 (752)
T KOG0670|consen 734 PEKRITVNQALKH 746 (752)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999999988
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=240.67 Aligned_cols=261 Identities=25% Similarity=0.447 Sum_probs=219.5
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
.-+.+.++++...+-+|.||+||.|.+. .+.|.+|.++....+- +...+..|--++..+.|||+..+.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~i----Qv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQI----QVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHH----HHHHHHHHHHHHhcCcCCCccceeE
Confidence 4466788999999999999999999653 3567788887665543 3456888988999999999999999
Q ss_pred eeec--CceEEEEEcCCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC
Q 018656 92 ACKE--PVMVIVTELLSGGTLRKYLLNM------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (352)
Q Consensus 92 ~~~~--~~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~ 163 (352)
++.+ ...++++.+..-|+|..|+..- ..+.++-.+...++.|++.|++|||+.|++|.||...|.+|++. -
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-L 433 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-L 433 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-e
Confidence 8764 3689999999999999999822 23467888899999999999999999999999999999999988 7
Q ss_pred ceEEecCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChH
Q 018656 164 TIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 239 (352)
Q Consensus 164 ~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 239 (352)
+|||+|-.+++..-+. ...........|||||.+.. ..|+.++|+||||+++|||++ |+.||...++.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n--------~~yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN--------SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhh--------hhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 9999999998843222 22333456778999999865 789999999999999999998 99999998888
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 240 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
+...-.........+.++|+++..++..||...|++||+++++..-|.++-..
T Consensus 506 Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 506 EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 77777777777777889999999999999999999999999999988776543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=241.56 Aligned_cols=132 Identities=27% Similarity=0.420 Sum_probs=114.4
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC--------CCCeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--------HRNLVKFI 90 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hp~iv~l~ 90 (352)
+...+|.+.++||.|-|++||+|.|+ .+.||+|+.+... .+.+....||++|++++ ..+||+|+
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq------hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ------HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh------HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 34579999999999999999999996 6899999986522 34445778999998873 35799999
Q ss_pred eeeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEe
Q 018656 91 GACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLT 159 (352)
Q Consensus 91 ~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~ 159 (352)
+.|.. .+.++|+|++ |.+|..+|.....+.++...+..|++|++.||.|||.. ||||.||||+|||+.
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 99862 2789999999 88999999988888899999999999999999999987 999999999999983
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-31 Score=225.14 Aligned_cols=209 Identities=35% Similarity=0.605 Sum_probs=180.0
Q ss_pred ccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEcCCCC
Q 018656 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGG 108 (352)
Q Consensus 32 lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~ 108 (352)
||+|++|.||++.+. |+.+++|++....... ....+.+|++.++.+.|++|+++++++.. ...++++|+++|+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 689999999999986 8999999988765432 23468899999999999999999999875 5789999999989
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC-CCCceEEecCCCcccccccc-ccccCC
Q 018656 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAREESLTE-MMTAET 186 (352)
Q Consensus 109 sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~-~~~~vkl~Dfg~a~~~~~~~-~~~~~~ 186 (352)
+|.+++.... ..++...++.++.+++++|.+||+.|++|+||+|.||+++. + +.++|+|||.+....... ......
T Consensus 77 ~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 77 SLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcchhhccc
Confidence 9999998753 24899999999999999999999999999999999999998 6 799999999987543332 123346
Q ss_pred CcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHH
Q 018656 187 GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 266 (352)
Q Consensus 187 g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 266 (352)
+...|++||.... ....+.+.|+|++|++++++ ..+.+++.
T Consensus 155 ~~~~~~~pe~~~~-------~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~ 195 (215)
T cd00180 155 GTPAYMAPEVLLG-------KGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIR 195 (215)
T ss_pred CCCCccChhHhcc-------cCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHH
Confidence 7889999998754 12677899999999999999 67999999
Q ss_pred HhhccCCCCCCCHHHHHHH
Q 018656 267 SCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 267 ~~l~~~p~~Rps~~~i~~~ 285 (352)
.|+..||.+||++.+++++
T Consensus 196 ~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 196 KMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHhhCCcccCcCHHHHhhC
Confidence 9999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=254.45 Aligned_cols=214 Identities=24% Similarity=0.340 Sum_probs=175.7
Q ss_pred ccccccccceecCCc---eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHH---HHHHHHHHHHHHHHhcCC
Q 018656 11 DELKLDAKWLIDPKH---LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI---AKKESRFAREVAMLSRVQ 82 (352)
Q Consensus 11 ~~~~~~~~~~i~~~~---y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~ 82 (352)
.+.+.+..|....++ |...+.+|.|+||.|+.|.++ ...|+||.+.+.+.-.+. ....-.+-.|+++|.+|+
T Consensus 545 ~e~e~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~ 624 (772)
T KOG1152|consen 545 VEPEGNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLN 624 (772)
T ss_pred cCccccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhh
Confidence 345555566666544 799999999999999999886 567999988775442210 011223446999999997
Q ss_pred ---CCCeeeeeeeeecC-ceEEEEEcC-CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeE
Q 018656 83 ---HRNLVKFIGACKEP-VMVIVTELL-SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157 (352)
Q Consensus 83 ---hp~iv~l~~~~~~~-~~~lv~e~~-~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nil 157 (352)
|+||++++++|+++ ++|++||-. +|-+|.++|..... ++|.++..|+.|++.|+++||++||+|||||-+|+.
T Consensus 625 ~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvi 702 (772)
T KOG1152|consen 625 KHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVI 702 (772)
T ss_pred hcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccCceecccccccEE
Confidence 99999999999865 788999876 34599999987655 999999999999999999999999999999999999
Q ss_pred EeCCCCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCC
Q 018656 158 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235 (352)
Q Consensus 158 i~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 235 (352)
++.+ |-+||+|||.+.... .......+||..|+|||++.+ ....++..|||+||+++|.++....||..
T Consensus 703 vd~~-g~~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g-------~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 703 VDSN-GFVKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGG-------EKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EecC-CeEEEeeccchhhhc-CCCcceeeeeccccchhhhCC-------CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9998 899999999987543 344577899999999999976 34567789999999999999999999853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=226.30 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=188.4
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeee-ee-cCc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA-CK-EPV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~-~~-~~~ 97 (352)
.+.|.+.+.||+|.||.+.+++++ ++.+++|.+..+... ...|.+|...--.| .|.||+.-+++ |+ .+.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt------~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT------QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh------HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 567888899999999999999986 688999998765543 33588888766666 58999988876 44 357
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEE-eCCCCceEEecCCCcccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLAREE 176 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili-~~~~~~vkl~Dfg~a~~~ 176 (352)
+++++||++.|+|.+-+... .+-|.....++.|+++|+.|+|++++||||||.+|||| +.|.-+|||+|||..+..
T Consensus 97 YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred EEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 88999999999999887653 38888899999999999999999999999999999999 455569999999998764
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHH---HHhcc---C
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA---AAFKN---V 250 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~---~~~~~---~ 250 (352)
+... ....-+..|.+||...... .......+.+|+|.||+++|.+++|..||+...-.+..+. .-... .
T Consensus 174 g~tV--~~~~~~~~y~~pe~~~~~~---ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 174 GTTV--KYLEYVNNYHAPELCDTVV---NEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA 248 (378)
T ss_pred Ccee--hhhhhhcccCCcHHHhhcc---ccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence 3322 2223456789999875532 1234567889999999999999999999986433222211 11111 1
Q ss_pred C-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018656 251 R-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284 (352)
Q Consensus 251 ~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~ 284 (352)
. .....+++.+..+.++-|..++++|--+.+..+
T Consensus 249 ~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 249 LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred CchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 1 124567888999999999999999944444433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=220.42 Aligned_cols=207 Identities=38% Similarity=0.571 Sum_probs=171.8
Q ss_pred eeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVT 102 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~ 102 (352)
|.+.+.||+|++|.||++.+. ++.+++|.+...... .....+.+|++.+++++|+|++++++.+.. ...++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 567888999999999999885 689999999875543 134568889999999999999999998874 5799999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc--
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~-- 180 (352)
|++++++|.+++...... +++..++.++.+++.+|.+||+.+++|+||+|.||+++.+ +.++|+|||.+.......
T Consensus 77 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred eccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccc
Confidence 999999999999865432 7899999999999999999999999999999999999988 799999999987654332
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCC-CChHHHHHHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG-MSNLQAAYAA 245 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~-~~~~~~~~~~ 245 (352)
......++..|++||.+. ....++.++|+|+||+++++|++|+.||.. ..........
T Consensus 155 ~~~~~~~~~~~~~pe~~~-------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~ 213 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLL-------GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDV 213 (225)
T ss_pred cccceeccCCcCCHhHhc-------CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHH
Confidence 334456788999999873 125567799999999999999999999977 4444343333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=234.43 Aligned_cols=244 Identities=26% Similarity=0.411 Sum_probs=193.4
Q ss_pred CCceeeeccccCCCceEEEEEEE-----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee-c
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK-E 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~-~ 95 (352)
...|...++||.|+|++||+|.+ +++.||+|.+....... ++.+|+++|..+ .+.||+++.+++. .
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~-------ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS-------RILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch-------HHHHHHHHHHHhccchhhhcchhhhccC
Confidence 56788999999999999999864 36789999987765544 488999999999 6999999999987 5
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+...+|+||++..+..++... ++..++..+++.++.||.++|.+|||||||||+|++.+...++-.|+|||+|..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 689999999999999998875 788999999999999999999999999999999999998888899999999851
Q ss_pred c-----------------cc----------------cc------------ccccCCCcccccccccccccccccccccCC
Q 018656 176 E-----------------SL----------------TE------------MMTAETGTYRWMAPELYSTVTLRQGEKKHY 210 (352)
Q Consensus 176 ~-----------------~~----------------~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~ 210 (352)
. .. .. ......||++|.|||++... ...
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-------~~Q 255 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-------PRQ 255 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-------cCc
Confidence 0 00 00 00123589999999998763 456
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCCCChHHHHH-------------HHHh------------------------------
Q 018656 211 NHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY-------------AAAF------------------------------ 247 (352)
Q Consensus 211 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-------------~~~~------------------------------ 247 (352)
+.+.||||.|+++..+++++.||-......... +...
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 889999999999999999999984422211000 0000
Q ss_pred --ccCC------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 248 --KNVR------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 248 --~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.... ...+..+..+.+++.+||+.||.+|.|++++++|
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0000 0012345678999999999999999999999998
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=215.46 Aligned_cols=269 Identities=22% Similarity=0.319 Sum_probs=217.5
Q ss_pred ceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 95 (352)
=.|.+-+|+++++||+|+||+++.|.+ ++++||||......... ++..|.+..+.| ..++|..++-+..+
T Consensus 23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP-------QLrdEYr~YKlL~g~~GIP~vYYFGqe 95 (449)
T KOG1165|consen 23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP-------QLRDEYRTYKLLGGTEGIPQVYYFGQE 95 (449)
T ss_pred ceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcc-------hHHHHHHHHHHHcCCCCCCceeeeccc
Confidence 457788999999999999999999987 69999999876654433 467788888888 57889888887776
Q ss_pred C-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC----CCCceEEecC
Q 018656 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE----DLKTIKLADF 170 (352)
Q Consensus 96 ~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~----~~~~vkl~Df 170 (352)
+ +-.+|+|.+ |.||.|+..--+. .|+...+..++.|++.-++|+|++++|.|||||+|+||.. +.+.+.++||
T Consensus 96 G~~NiLVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 96 GKYNILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred cchhhhhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 6 668999999 8899998876544 4999999999999999999999999999999999999943 3457999999
Q ss_pred CCccccccccc--------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC---hH
Q 018656 171 GLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS---NL 239 (352)
Q Consensus 171 g~a~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~---~~ 239 (352)
|+|+....... .++..||.+||+-..+.+ .+.+.+.|+-|||-+++++|.|.+||++.. +.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--------rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK 245 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK 245 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeecccc--------chhhhhhhHHHhhhhhhhhccCCCccccccCcchH
Confidence 99986554432 345579999999988866 778999999999999999999999998843 23
Q ss_pred HHHHHHHhccCCCC----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCCCccc
Q 018656 240 QAAYAAAFKNVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRI 304 (352)
Q Consensus 240 ~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~~~~~~~ 304 (352)
+...++..+..... -.++|.++...++..-..+-.+-|+++-+...+...+........-..+|.
T Consensus 246 ~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~ 314 (449)
T KOG1165|consen 246 EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWM 314 (449)
T ss_pred HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 33333333322221 357899999999999999999999999999999888887776665554443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=227.30 Aligned_cols=258 Identities=26% Similarity=0.349 Sum_probs=202.4
Q ss_pred ceeeeccccCCCceEEEEEEECC---ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC----CCCeeeeeeeee--c
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYKN---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ----HRNLVKFIGACK--E 95 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----hp~iv~l~~~~~--~ 95 (352)
+|.+.+.||+|+||.||.+.+.. +.+|+|+......... ..+..|..++..+. .+++..+++... +
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 89999999999999999999864 4799999876433221 13667888887776 368899998883 4
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC----CceEEecCC
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL----KTIKLADFG 171 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~----~~vkl~Dfg 171 (352)
...++||+.+ |.+|.++......+.++...+..|+.|++.+|++||+.|++||||||+|+++.... ..+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 4789999999 89999988776656799999999999999999999999999999999999997652 469999999
Q ss_pred Ccc--cccccc--------c-cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH
Q 018656 172 LAR--EESLTE--------M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240 (352)
Q Consensus 172 ~a~--~~~~~~--------~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 240 (352)
+++ ...... . .....||..|+++.++.+ ...+.+.|+|||++++.+++.|.+||.+.....
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--------~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~ 244 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--------IEQGRRDDLESLFYMLLELLKGSLPWEALEMTD 244 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--------CccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence 998 321111 1 123459999999998865 778999999999999999999999997765432
Q ss_pred HHH---HHHhccCCC-CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 018656 241 AAY---AAAFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 296 (352)
Q Consensus 241 ~~~---~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~ 296 (352)
... ......... .....+.++..+...+-..+...+|.+..+...+..........
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~ 304 (322)
T KOG1164|consen 245 LKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSK 304 (322)
T ss_pred hHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCC
Confidence 211 111122222 23456688899988888899999999999999988877665333
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=206.85 Aligned_cols=285 Identities=20% Similarity=0.258 Sum_probs=221.8
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC-CCeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGA 92 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~ 92 (352)
+...+|...+|++.++||+|+||.+|.|.. .|+.||||+........ ++..|.++.+.|++ ..|..+..+
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-------qL~yEskvY~iL~~g~GiP~i~~y 79 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-------QLLYESKVYRILQGGVGIPHIRHY 79 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-------chhHHHHHHHHhccCCCCchhhhh
Confidence 344577889999999999999999999976 49999999987654433 36778888888864 566666666
Q ss_pred eec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEec
Q 018656 93 CKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLAD 169 (352)
Q Consensus 93 ~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~D 169 (352)
..+ .+-.+||+.+ |.||.++..--. +.++...++-++-|++.-++|+|.++++||||||+|+|+.-+ -+.+.|+|
T Consensus 80 ~~e~~ynvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 80 GTEKDYNVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred ccccccceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEe
Confidence 654 4678999999 889999876433 348999999999999999999999999999999999999543 35799999
Q ss_pred CCCcccccccc--------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 018656 170 FGLAREESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 241 (352)
Q Consensus 170 fg~a~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 241 (352)
||+|+...... ......||.+|++-..+.+ ...+.+.|+-|+|.++.++..|.+||++......
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--------~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--------IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhh--------hhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 99998543321 1234469999999888765 5668899999999999999999999998654322
Q ss_pred ---HHHHHhccCCCC----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCCCcccccCCCCCCCC
Q 018656 242 ---AYAAAFKNVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPP 314 (352)
Q Consensus 242 ---~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (352)
...+........ =..+|.++.-.+..|-..--.+-|++.-+.+.+.-.+..+........+|..-..+.....
T Consensus 230 ~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q~~ 309 (341)
T KOG1163|consen 230 KQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQSG 309 (341)
T ss_pred HHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHhhccc
Confidence 222222222221 2578999999999999999999999999999998888888888887777765544443333
Q ss_pred CCC
Q 018656 315 ESP 317 (352)
Q Consensus 315 ~~~ 317 (352)
.++
T Consensus 310 ~~~ 312 (341)
T KOG1163|consen 310 RSR 312 (341)
T ss_pred CCC
Confidence 333
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=256.78 Aligned_cols=197 Identities=19% Similarity=0.252 Sum_probs=141.6
Q ss_pred hcCCC-CCeeeeeeeee--------cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 018656 79 SRVQH-RNLVKFIGACK--------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHR 149 (352)
Q Consensus 79 ~~l~h-p~iv~l~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~ 149 (352)
+.++| +||+++++.+. +..++.++|++ +++|.+++... ...+++..++.++.||++||+|||++||+||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 34455 57777777661 23577888888 66999999753 3459999999999999999999999999999
Q ss_pred CCCCCCeEEeCC------------------CCceEEecCCCccccccc-----------------cccccCCCccccccc
Q 018656 150 DLKPENLLLTED------------------LKTIKLADFGLAREESLT-----------------EMMTAETGTYRWMAP 194 (352)
Q Consensus 150 Dikp~Nili~~~------------------~~~vkl~Dfg~a~~~~~~-----------------~~~~~~~g~~~y~aP 194 (352)
||||+||||+.. .+.+|++|||+++..... .......||+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999542 245667777776532100 000113578899999
Q ss_pred ccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCC
Q 018656 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPN 274 (352)
Q Consensus 195 E~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 274 (352)
|++.+ ..++.++|||||||++|||++|..|+...... ..........+...........++.+||..+|.
T Consensus 185 E~~~~--------~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~ 254 (793)
T PLN00181 185 EEDNG--------SSSNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSLRHRVLPPQILLNWPKEASFCLWLLHPEPS 254 (793)
T ss_pred hhhcc--------CCCCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHHHHhhcChhhhhcCHHHHHHHHHhCCCChh
Confidence 99854 56789999999999999999998887642211 111111111121112245567889999999999
Q ss_pred CCCCHHHHHHHHH
Q 018656 275 ARPNFTQIIQMLL 287 (352)
Q Consensus 275 ~Rps~~~i~~~l~ 287 (352)
+||++.+++++.+
T Consensus 255 ~Rps~~eil~h~~ 267 (793)
T PLN00181 255 CRPSMSELLQSEF 267 (793)
T ss_pred hCcChHHHhhchh
Confidence 9999999998743
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=204.37 Aligned_cols=162 Identities=25% Similarity=0.314 Sum_probs=127.7
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCCC
Q 018656 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187 (352)
Q Consensus 108 ~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 187 (352)
|+|.+++..++ ..+++.+++.|+.|++.||.|||+++ ||+||+++.+ +.+++ ||++...... ...|
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeeccc----cCCC
Confidence 68999998643 34999999999999999999999998 9999999988 78888 9998754332 2268
Q ss_pred cccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-------CCCCCcH-
Q 018656 188 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-------SAENVPE- 259 (352)
Q Consensus 188 ~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~- 259 (352)
++.|+|||++.+ ..++.++|||||||++|+|++|+.||..................+ ....++.
T Consensus 67 ~~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 67 DPYFMAPEVIQG--------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred cccccChHHhcC--------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence 899999999854 567889999999999999999999997654433222222221111 1223334
Q ss_pred -HHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 260 -ELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 260 -~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
++.+++.+||..||.+||++.+++++++....
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 69999999999999999999999999876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=212.47 Aligned_cols=167 Identities=20% Similarity=0.152 Sum_probs=126.6
Q ss_pred ecCCceeeeccccCCCceEEEEEEE---CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKY---KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 97 (352)
....+|.+.+.||+|+||+||+|.+ .++.+|||++...............+.+|++++++++|+|++..+.. .+.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--~~~ 92 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--TGK 92 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--cCC
Confidence 4467799999999999999999987 36778999875332100011234568999999999999999853322 245
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCCeEEeCCCCceEEecCCCcccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL-KPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Di-kp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.++||||++|++|.. +. . .. ...++.|++++|.|||++||+|||| ||+|||++.+ +.++|+|||+++..
T Consensus 93 ~~LVmE~~~G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~~~ 162 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-AR--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLASVF 162 (365)
T ss_pred cEEEEEccCCCCHHH-hC--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccceec
Confidence 799999999999973 21 1 11 1467899999999999999999999 9999999877 78999999999843
Q ss_pred cccc---------ccccCCCcccccccccccc
Q 018656 177 SLTE---------MMTAETGTYRWMAPELYST 199 (352)
Q Consensus 177 ~~~~---------~~~~~~g~~~y~aPE~~~~ 199 (352)
.... ......+++.|.|||.+..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 3221 1134467888999999865
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=231.07 Aligned_cols=251 Identities=19% Similarity=0.222 Sum_probs=189.0
Q ss_pred ceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVTE 103 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv~e 103 (352)
++...+.||++.|-+|.+|++....|+||++.+..+........+++ .|++ ...+++||++++..+.. +...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 67888999999999999999976669999999888776666655555 3444 56679999999987754 557889999
Q ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc----ccc
Q 018656 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE----SLT 179 (352)
Q Consensus 104 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~----~~~ 179 (352)
|.. -+|+|.+..+.. +...+...|+.||+.||..+|..||+|||||.+||||++- +.+.|+||...+.. ++.
T Consensus 102 yvk-hnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHh-hhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccCCccCCCCCc
Confidence 994 599999987665 8888999999999999999999999999999999999997 89999999987631 111
Q ss_pred c----ccccCCCcccccccccccccc--cccc-cccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc-cC
Q 018656 180 E----MMTAETGTYRWMAPELYSTVT--LRQG-EKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK-NV 250 (352)
Q Consensus 180 ~----~~~~~~g~~~y~aPE~~~~~~--~~~~-~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~-~~ 250 (352)
. ...+...-.+|.|||.+...- .... .....++++||||+||+++||++ |++||.-. ++..-... ..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCcc
Confidence 1 123334557899999876511 1111 12237899999999999999988 78888531 11110000 00
Q ss_pred CCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 RPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 ~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+. ..--+..++++|..|++.||.+|.++++.++.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000 01112468999999999999999999999885
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-24 Score=194.74 Aligned_cols=252 Identities=31% Similarity=0.464 Sum_probs=200.1
Q ss_pred eeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCC-CeeeeeeeeecC-ceEEEEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR-NLVKFIGACKEP-VMVIVTE 103 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~l~~~~~~~-~~~lv~e 103 (352)
|.+...||.|+||.||++.+. ..+++|.+........ .....+.+|+..+..+.|+ +++++.+.+... ..+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999988 8889999877654432 2345688999999999988 799999998654 4799999
Q ss_pred cCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc--
Q 018656 104 LLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (352)
Q Consensus 104 ~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~-- 180 (352)
++.+++|.+++..... ..++......++.|++.++.++|+.+++|||+||+||+++.....++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999987776542 1489999999999999999999999999999999999999873379999999987433222
Q ss_pred -----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccCCC
Q 018656 181 -----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRP 252 (352)
Q Consensus 181 -----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~ 252 (352)
......|+..|+|||.+.+.. ...+....|+||+|++++++++|..||..... .............+
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~-----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLS-----LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccCCHHHhcCCC-----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 345668999999999885410 14678899999999999999999999887664 33333333333322
Q ss_pred -C----CCCC----cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 -S----AENV----PEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 -~----~~~~----~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
. .... ...+.+++..++..+|..|.+.......
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1 1111 2578999999999999999998887776
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=223.31 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=188.6
Q ss_pred eeeccccCCCceEEEEEEEC--CceEEEEEcccCC-ChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceEEEE
Q 018656 27 FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGE-TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (352)
Q Consensus 27 ~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~lv~ 102 (352)
....++|.|++|.|+.+... .+.++.|...... ..+........+..|+-+-..+.|||++..+..+.+. ..+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45677999999988877653 3444444333110 1122223333377888888999999998887766533 333449
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc---
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT--- 179 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~--- 179 (352)
|||++ +|..++..... +...++-.++.|++.||.|+|+.|+.|||+||+|++++.+ +.+|++|||.+.....+
T Consensus 401 E~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceeeccCcch
Confidence 99999 99999987533 8888899999999999999999999999999999999998 79999999998743222
Q ss_pred --cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcc-------
Q 018656 180 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY-AAAFKN------- 249 (352)
Q Consensus 180 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~------- 249 (352)
.......|+..|+|||++.+. .......||||.|++++.|.+|+.||......+... ......
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~-------~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGK-------EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG 549 (601)
T ss_pred hhhhhcCcccCCcCcCccccccc-------ccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC
Confidence 233456799999999999762 333457999999999999999999998766554432 111111
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.......+|...+.+|.+||+.||.+|.|+++|++. .|++.
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d--~W~~~ 590 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND--EWIRS 590 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC--hHhhh
Confidence 112245688999999999999999999999999997 44443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=187.83 Aligned_cols=174 Identities=14% Similarity=0.155 Sum_probs=134.8
Q ss_pred ecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHH------HHHHHHHHhcCCCCCeeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESR------FAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~------~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
+-..+|++.++||.|+||.||++.+++..+|||++........ ....+ +.+|++.+.++.||+|....+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~--~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTE--RFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchH--HHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4478999999999999999999877788999999987655443 22222 678999999999999999988754
Q ss_pred c---------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCce
Q 018656 95 E---------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (352)
Q Consensus 95 ~---------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~v 165 (352)
. +..+++|||++|.+|.++.. +++. ...+++.+|..+|+.|++|||++|+||+++.+ + +
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i 173 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-L 173 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-E
Confidence 2 24789999999999988732 3332 35699999999999999999999999999987 6 9
Q ss_pred EEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHH
Q 018656 166 KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 227 (352)
Q Consensus 166 kl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll 227 (352)
+|+|||............. ... ...+..++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~d~-----------~vl--------er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR-----------IDL--------ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHHH-----------HHH--------HhHhcccccccceeEeehHHH
Confidence 9999998765422211111 111 134556899999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=191.55 Aligned_cols=241 Identities=20% Similarity=0.298 Sum_probs=155.8
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC----------CCeeeeeee
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH----------RNLVKFIGA 92 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------p~iv~l~~~ 92 (352)
.+..+..||.|+++.||.+.+. |+.+|+|+........ ......+.+|.-....+.+ -.++--++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~--~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADAS--ANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTH--TTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccc--hHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 4567889999999999999995 7999999998776332 3445667777655544322 111111111
Q ss_pred ---------ee---cC------ceEEEEEcCCCCCHHHHHHh---cCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 018656 93 ---------CK---EP------VMVIVTELLSGGTLRKYLLN---MRPR--CLDVCVAIGFALDIARAMECLHSHGIIHR 149 (352)
Q Consensus 93 ---------~~---~~------~~~lv~e~~~~~sL~~~l~~---~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~ivH~ 149 (352)
+. +. ..+++|+-+ .++|.+++.. .... .+.......+..|+++.+++||..|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 11 11 347788888 5699888643 2221 13344455677899999999999999999
Q ss_pred CCCCCCeEEeCCCCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC
Q 018656 150 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 229 (352)
Q Consensus 150 Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g 229 (352)
||+|+|++++.+ |.+.|+||+........... ...+..|.+||..............++.+.|.|+||+++|.|++|
T Consensus 170 di~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQD-GGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TT-S-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCC-CCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999998 89999999987765443322 345578999997644210001335678899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCC
Q 018656 230 KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR 276 (352)
Q Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 276 (352)
..||........... ...... ++|+.++.+|..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999986543211111 233445 899999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=185.32 Aligned_cols=254 Identities=28% Similarity=0.506 Sum_probs=201.3
Q ss_pred ecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceE
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 99 (352)
|+-++..+.-+|...-.|+.|+|+|.|..++.|++....... .....|..|.-.|+-+.||||+.+++.|..+ .+.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~---risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTA---RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcch---hhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 344556677889999999999999999999999987655443 2334588899999999999999999999864 899
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeCCCCceEE--ecCCCccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKL--ADFGLARE 175 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~~~~~vkl--~Dfg~a~~ 175 (352)
++..|++.|||+..+........+..++.+++.++++|++|||+.. |.---|....++|+++ -..+| +|--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad~kfsfq 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMADTKFSFQ 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheecccceeeee
Confidence 9999999999999998876666788899999999999999999985 3344677889999887 34443 33222211
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-CC
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-SA 254 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 254 (352)
. ....-.+.|++||.+...+ ....-.++|+||+++++||+.|...||...++.+.-.++.....++ .+
T Consensus 343 e------~gr~y~pawmspealqrkp-----ed~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip 411 (448)
T KOG0195|consen 343 E------VGRAYSPAWMSPEALQRKP-----EDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP 411 (448)
T ss_pred c------cccccCcccCCHHHHhcCc-----hhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC
Confidence 1 1223468999999985421 1223457999999999999999999999988877766666655544 47
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
++++..+.+++.-|+..||.+||.++.++-.|+..
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 89999999999999999999999999988777653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=180.18 Aligned_cols=143 Identities=20% Similarity=0.177 Sum_probs=109.0
Q ss_pred eccccCCCceEEEEEEE-CCceEEEEEcccCCChHHHH---------------------HHHHHHHHHHHHHhcCCCCCe
Q 018656 29 GPRIGEGAHAKVYEGKY-KNQTVAIKIVHKGETPEEIA---------------------KKESRFAREVAMLSRVQHRNL 86 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~-~~~~vaiK~~~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l~hp~i 86 (352)
...||+|+||.||+|.+ +|+.||||+++......... .......+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999987 49999999997653211100 011233459999999987776
Q ss_pred eeeeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCCeEEeCCCCce
Q 018656 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPENLLLTEDLKTI 165 (352)
Q Consensus 87 v~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l-H~~~ivH~Dikp~Nili~~~~~~v 165 (352)
...... .....++||||++|++|....... ..+++..+..++.|++.+|.++ |+.||+||||||+||++++ +.+
T Consensus 82 ~~p~~~-~~~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~--~~v 156 (190)
T cd05147 82 PCPEPI-LLKSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD--GKL 156 (190)
T ss_pred CCCcEE-EecCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--CcE
Confidence 433322 222348999999988776654332 2489999999999999999999 7999999999999999984 579
Q ss_pred EEecCCCcccc
Q 018656 166 KLADFGLAREE 176 (352)
Q Consensus 166 kl~Dfg~a~~~ 176 (352)
+|+|||++...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=204.03 Aligned_cols=225 Identities=28% Similarity=0.408 Sum_probs=185.0
Q ss_pred cccCCCceEEEEEE-----ECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeee-cCceEEEEE
Q 018656 31 RIGEGAHAKVYEGK-----YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACK-EPVMVIVTE 103 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~-~~~~~lv~e 103 (352)
.+|+|+||.|++++ +.|..+|+|+..+...... .......|..++...+ ||.++++...++ +..++++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~---~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR---DRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccc---cccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 47999999999753 4578899998876543322 1124556778888886 999999999887 568999999
Q ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccc
Q 018656 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT 183 (352)
Q Consensus 104 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~ 183 (352)
+..|+.|...+.+... +.+.....+...++-+++++|+.+++|||+|++||+++.+ |++++.|||+++........
T Consensus 78 ~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred hcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-CccccCCchhhhHhHhhhhc-
Confidence 9999999998876554 7888888899999999999999999999999999999999 89999999998864433322
Q ss_pred cCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHH
Q 018656 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 263 (352)
Q Consensus 184 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 263 (352)
+||..|+|||++.+ ...++|.||+|+++++|++|..||.+ .....+.+...+.+..++...+.
T Consensus 154 --cgt~eymApEI~~g----------h~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~~p~~l~~~a~~ 216 (612)
T KOG0603|consen 154 --CGTYEYRAPEIING----------HLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELEMPRELSAEARS 216 (612)
T ss_pred --ccchhhhhhHhhhc----------cCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccCCchhhhHHHHH
Confidence 89999999999852 46789999999999999999999987 23334444455667788899999
Q ss_pred HHHHhhccCCCCCCCH
Q 018656 264 ILTSCWKEDPNARPNF 279 (352)
Q Consensus 264 li~~~l~~~p~~Rps~ 279 (352)
++.+++..+|..|...
T Consensus 217 ~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 217 LFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHhhCHHHHhcc
Confidence 9999999999999644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=185.61 Aligned_cols=199 Identities=23% Similarity=0.328 Sum_probs=147.2
Q ss_pred CCCCeeeeeeeee----------------------------cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHH
Q 018656 82 QHRNLVKFIGACK----------------------------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133 (352)
Q Consensus 82 ~hp~iv~l~~~~~----------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~q 133 (352)
.|||||+++..|. ..++|+||..++. +|.+|+..+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 5999999976541 1257999999955 9999997654 566667779999
Q ss_pred HHHHHHHHHhCCCccCCCCCCCeEEe--CC-CCceEEecCCCcccccc-------ccccccCCCcccccccccccccccc
Q 018656 134 IARAMECLHSHGIIHRDLKPENLLLT--ED-LKTIKLADFGLAREESL-------TEMMTAETGTYRWMAPELYSTVTLR 203 (352)
Q Consensus 134 i~~~L~~lH~~~ivH~Dikp~Nili~--~~-~~~vkl~Dfg~a~~~~~-------~~~~~~~~g~~~y~aPE~~~~~~~~ 203 (352)
+++|+.|||++||.|||+|.+|||+. +| -..++++|||++-.... ....-...|....||||+....+-.
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999999999999999999999993 22 34689999998753221 0111123467788999998764421
Q ss_pred cccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHH
Q 018656 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA-AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 282 (352)
Q Consensus 204 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 282 (352)
. ..-.-.++|.|+.|.+.||++....||.+.-.... ...-.....++.++.+|+.+++++...|+.||++|++..-.
T Consensus 430 ~--avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 430 N--AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred c--eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 1 12223589999999999999999999977322111 11122334566788999999999999999999999987766
Q ss_pred HHHH
Q 018656 283 IQML 286 (352)
Q Consensus 283 ~~~l 286 (352)
.+.+
T Consensus 508 ANvl 511 (598)
T KOG4158|consen 508 ANVL 511 (598)
T ss_pred HhHH
Confidence 5544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=171.95 Aligned_cols=188 Identities=13% Similarity=0.083 Sum_probs=138.7
Q ss_pred eeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeecCceEEEEEcCC
Q 018656 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEPVMVIVTELLS 106 (352)
Q Consensus 28 ~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~lv~e~~~ 106 (352)
+...|++|+||+||.+...+.+++.+.+......... -....+.+|++++++|. +++|++++++ ...+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~-~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRG-VAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhh-HHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeeec
Confidence 4567999999999988888889988877654332211 11235789999999995 5889999886 34699999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCCeEEeCCCCceEEecCCCcccccccccc---
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL-KPENLLLTEDLKTIKLADFGLAREESLTEMM--- 182 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Di-kp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~--- 182 (352)
|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+ +.++|+|||++.........
T Consensus 82 G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchHHHH
Confidence 9999764321 1 1357889999999999999999999 7999999987 78999999999743322210
Q ss_pred -c----------cCCCcccccccccccccccccccccCCC-cccchhhHHHHHHHHHhCCCCCCCC
Q 018656 183 -T----------AETGTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYSFAIVLWELLHNKLPFEGM 236 (352)
Q Consensus 183 -~----------~~~g~~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~~ll~g~~p~~~~ 236 (352)
. -...++.|++|+..... ...+ ...+.++.|+-+|.++|+..+..+.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l-------~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVL-------KRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhh-------ccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 01246667777643221 1122 4578889999999999999887653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=171.81 Aligned_cols=144 Identities=20% Similarity=0.151 Sum_probs=109.9
Q ss_pred eccccCCCceEEEEEEEC-CceEEEEEcccCCChH---------------------HHHHHHHHHHHHHHHHhcCCCCCe
Q 018656 29 GPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPE---------------------EIAKKESRFAREVAMLSRVQHRNL 86 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~hp~i 86 (352)
...||+|++|.||+|.+. |+.||||+++...... ........+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999875 9999999998753210 000112334678999999999887
Q ss_pred eeeeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCce
Q 018656 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTI 165 (352)
Q Consensus 87 v~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~v 165 (352)
.....+... ..++||||++|+++....... ..++...+..++.|++.+|.++|+ +||+||||||+||+++ + +.+
T Consensus 82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-~~~ 156 (190)
T cd05145 82 PVPEPILLK-KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-GKP 156 (190)
T ss_pred CCceEEEec-CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-CCE
Confidence 443333222 248999999887654432222 237888999999999999999999 9999999999999998 4 789
Q ss_pred EEecCCCccccc
Q 018656 166 KLADFGLAREES 177 (352)
Q Consensus 166 kl~Dfg~a~~~~ 177 (352)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=197.56 Aligned_cols=250 Identities=22% Similarity=0.313 Sum_probs=185.7
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEE-CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC---CCCeee
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRNLVK 88 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~ 88 (352)
+....-..+..+.|.|-+.||+|+||.||+|.. +|+.||+|+-+....++-+.. .+++.||+ -+.|+.
T Consensus 687 l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~--------~q~~~RLk~~~~~~~~~ 758 (974)
T KOG1166|consen 687 LNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC--------LQVMERLKPQMLPSIMH 758 (974)
T ss_pred cCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh--------HHHHHhhchhhhcchHH
Confidence 344444567788899999999999999999976 489999999999998885443 34555555 234444
Q ss_pred eeeeee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC------C
Q 018656 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE------D 161 (352)
Q Consensus 89 l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~------~ 161 (352)
+...+. .+..++|+||.+.|+|.+++... +.+++..+..+..|++..+++||..+|||+||||+|+||.. +
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence 444333 45679999999999999999844 44999999999999999999999999999999999999943 2
Q ss_pred CCceEEecCCCcccc---ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh
Q 018656 162 LKTIKLADFGLAREE---SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 238 (352)
Q Consensus 162 ~~~vkl~Dfg~a~~~---~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 238 (352)
..-++|+|||.+... ..+...+...+|..+-.+|+..+ ...+...|.|.|+.+++-||+|+.-
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g--------rpWtYq~DyfGlAa~~h~mLFG~y~------ 902 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG--------RPWTYQIDYFGLAATVHVMLFGKYM------ 902 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC--------CCCchhhhhHHHHHHHHHHHHHHHH------
Confidence 235999999998642 23334556678999999999865 7788899999999999999999521
Q ss_pred HHHHHHHHhccCCCCCCCCc-----HHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 239 LQAAYAAAFKNVRPSAENVP-----EELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
+ ......+.. ..+++ .-+.+|+..+|..|-..=|...+++..++.++.
T Consensus 903 -q---~~~g~~~~~-~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 903 -E---VKNGSSWMV-KTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred -H---hcCCcceec-cccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1 000000111 11122 235578888888555555888888888776654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=163.24 Aligned_cols=134 Identities=17% Similarity=0.259 Sum_probs=103.2
Q ss_pred eccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-----CCCCeeeeeeeeecC----ceE
Q 018656 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-----QHRNLVKFIGACKEP----VMV 99 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~l~~~~~~~----~~~ 99 (352)
...||+|+||.||.....+.. +||++...... ....+.+|+++++.+ .||||+++++++..+ ..+
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~-----~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG-----GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc-----hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 367999999999973333444 68988764322 234588999999999 579999999999754 333
Q ss_pred -EEEEc--CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCccCCCCCCCeEEeCC---CCceEEecCCC
Q 018656 100 -IVTEL--LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM-ECLHSHGIIHRDLKPENLLLTED---LKTIKLADFGL 172 (352)
Q Consensus 100 -lv~e~--~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L-~~lH~~~ivH~Dikp~Nili~~~---~~~vkl~Dfg~ 172 (352)
+|+|| +.+++|.+++.+. . +++. ..++.|++.++ +|||+++|+||||||+|||++.. ...++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~--~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-R--YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-c--ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5579999999753 2 6665 35678888887 99999999999999999999742 23799999554
Q ss_pred c
Q 018656 173 A 173 (352)
Q Consensus 173 a 173 (352)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=167.99 Aligned_cols=151 Identities=23% Similarity=0.217 Sum_probs=115.4
Q ss_pred ceecCCceeeeccccCCCceEEEEEE-E--CCceEEEEEcccCCChH-------------------HHHHHHHHHHHHHH
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGK-Y--KNQTVAIKIVHKGETPE-------------------EIAKKESRFAREVA 76 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~-~--~~~~vaiK~~~~~~~~~-------------------~~~~~~~~~~~E~~ 76 (352)
|.--+.-|.+.+.||+|++|.||+|. + +|+.||+|++....... ........+.+|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 44445578999999999999999998 3 58999999987643210 11112234678999
Q ss_pred HHhcCCCC--CeeeeeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCC
Q 018656 77 MLSRVQHR--NLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG-IIHRDLKP 153 (352)
Q Consensus 77 ~l~~l~hp--~iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~-ivH~Dikp 153 (352)
.++++.+. .+.++++. ...++||||++|.+|..+..... .+....+..++.|++.+|++||+.| ++||||||
T Consensus 103 ~L~~L~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp 177 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSE 177 (237)
T ss_pred HHHHHHhcCCCCCeeeEe---cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCCh
Confidence 99999753 23444432 34589999999988877653322 2666777899999999999999999 99999999
Q ss_pred CCeEEeCCCCceEEecCCCcccc
Q 018656 154 ENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 154 ~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
+||+++ + +.++|+|||.+...
T Consensus 178 ~NIli~-~-~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-D-GKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-C-CCEEEEEChhhhcc
Confidence 999999 4 68999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-20 Score=156.99 Aligned_cols=138 Identities=28% Similarity=0.381 Sum_probs=112.7
Q ss_pred ccccCCCceEEEEEEECCceEEEEEcccCCChH---HHHHHHHHHHHHHHHHhcCCCCCeeeeeeee-ecCceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPE---EIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~~~lv~e~~ 105 (352)
+.||+|++|.||+|.+.|..+++|+........ .......++.+|++++..+.|++|.....++ .....+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 569999999999999999999999866433221 1122245678899999999999887655554 355789999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.||+++ + +.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 9999999986532 2 7788999999999999999999999999999999 4 6899999998765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=154.67 Aligned_cols=134 Identities=25% Similarity=0.351 Sum_probs=106.5
Q ss_pred cccCCCceEEEEEEECCceEEEEEcccCCC---hHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee-eecCceEEEEEcCC
Q 018656 31 RIGEGAHAKVYEGKYKNQTVAIKIVHKGET---PEEIAKKESRFAREVAMLSRVQHRNLVKFIGA-CKEPVMVIVTELLS 106 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~-~~~~~~~lv~e~~~ 106 (352)
.||+|+||+||+|.+.|..+++|+...... .........++.+|+++++.+.|+++.....+ ..+...+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 489999999999999999999998654322 11222334678899999999988765433322 23456789999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ + +.++++|||++..
T Consensus 81 g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 999999876421 1 7899999999999999999999999999999 4 7899999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=182.07 Aligned_cols=203 Identities=31% Similarity=0.431 Sum_probs=150.7
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCceEE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVI 100 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~l 100 (352)
...+..++.|..|+||.||..+++ .+++|+|+-+. . .+.|- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~----------lilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N----------LILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-c----------hhhhc--cccccCCccee-------------
Confidence 567889999999999999999886 78899954221 1 01111 33333444444
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
|+-...++..+. ++.. ++.+++|||+-||+|||+||+|.+|+.- |++|++|||++......
T Consensus 136 -------gDc~tllk~~g~--lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGP--LPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -------chhhhhcccCCC--Ccch--------hhHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhhhc
Confidence 344444444333 4432 2789999999999999999999999987 89999999998631110
Q ss_pred ---------------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 018656 180 ---------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA 244 (352)
Q Consensus 180 ---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 244 (352)
-..+..+||+.|.|||++.. +.|++.+|+|++|+++|+++-|..||.+.+.++..-.
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--------qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~ 269 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 269 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhh--------hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh
Confidence 11233479999999999864 7799999999999999999999999999877654443
Q ss_pred HHh--ccCCCCCCCCcHHHHHHHHHhhccCCCCCC
Q 018656 245 AAF--KNVRPSAENVPEELSIILTSCWKEDPNARP 277 (352)
Q Consensus 245 ~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 277 (352)
... ..+......++++.+++|.++|..+|..|-
T Consensus 270 visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 270 VISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 332 234444667889999999999999999995
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=174.45 Aligned_cols=147 Identities=23% Similarity=0.335 Sum_probs=115.6
Q ss_pred ccceecCCc---eeeeccccCCCceEEEEEEECCceEEEEEcccCCCh-H--HHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 17 AKWLIDPKH---LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETP-E--EIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 17 ~~~~i~~~~---y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~-~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
..|..+... |...+.||+|+||+||++.+.+..+++|+....... . .......++.+|+++++.++|++++...
T Consensus 323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eeeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 447666554 345899999999999999998777777654332111 1 1112345688999999999999988766
Q ss_pred eeee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 91 GACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 91 ~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
.++. ....++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||+++ + +.++|+|
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liD 470 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLID 470 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEe
Confidence 5544 446789999999999999885 2456899999999999999999999999999994 3 6899999
Q ss_pred CCCccc
Q 018656 170 FGLARE 175 (352)
Q Consensus 170 fg~a~~ 175 (352)
||+++.
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=152.01 Aligned_cols=140 Identities=24% Similarity=0.244 Sum_probs=107.9
Q ss_pred ceeeeccccCCCceEEEEEEE-CCceEEEEEcccCCChHH-----------------HHHHHHHHHHHHHHHhcCCCCC-
Q 018656 25 HLFVGPRIGEGAHAKVYEGKY-KNQTVAIKIVHKGETPEE-----------------IAKKESRFAREVAMLSRVQHRN- 85 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~-~~~~vaiK~~~~~~~~~~-----------------~~~~~~~~~~E~~~l~~l~hp~- 85 (352)
.|.+.+.||+|+||.||++.+ +|+.+|||++........ .........+|..++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 478889999999999999988 589999998765431110 0011233667888888887764
Q ss_pred -eeeeeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCc
Q 018656 86 -LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (352)
Q Consensus 86 -iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~ 164 (352)
++..++ ....+++|||++|++|.+.... .....++.+++.++.++|+.|++|+||+|+||+++.+ +.
T Consensus 96 ~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~ 163 (198)
T cd05144 96 PVPKPID---WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EK 163 (198)
T ss_pred CCCceee---cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-Cc
Confidence 444443 3456899999999998765421 2345788999999999999999999999999999987 79
Q ss_pred eEEecCCCcccc
Q 018656 165 IKLADFGLAREE 176 (352)
Q Consensus 165 vkl~Dfg~a~~~ 176 (352)
++|+|||.+...
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-20 Score=168.68 Aligned_cols=242 Identities=25% Similarity=0.347 Sum_probs=158.8
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee--
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG-- 91 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~-- 91 (352)
.......+.+-+..+..+++.++...-. .+.++-+....... .......+++-.+....|.+..-+.+
T Consensus 239 ~~~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~-----~~~~~~~r~~~~l~~~~~~~~s~~~d~~ 313 (516)
T KOG1033|consen 239 RHEESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL-----CACKYTFRQLGVLVDSSHSNRSILEDLR 313 (516)
T ss_pred cccccccccccccccccccCCchhhhhcccchhhhhccchhhhccch-----hhhhhhhhhhhheeccccCCcccccCCC
Confidence 3334444555566666666666654321 22333333222221 11122445555555555444433333
Q ss_pred -----eee------cCceEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe
Q 018656 92 -----ACK------EPVMVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (352)
Q Consensus 92 -----~~~------~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~ 159 (352)
.+. ..++|+.|++|.-.+|.+|+..+. ....+......++.|++.|++| +|.+|+|+||.||+..
T Consensus 314 ~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~ 390 (516)
T KOG1033|consen 314 PSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS 390 (516)
T ss_pred CchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc
Confidence 111 125899999999999999997443 3346777888999999999999 9999999999999998
Q ss_pred CCCCceEEecCCCcccccccc-------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCC
Q 018656 160 EDLKTIKLADFGLAREESLTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKL 231 (352)
Q Consensus 160 ~~~~~vkl~Dfg~a~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 231 (352)
.+ ..++|.|||+........ ......||..||+||.+.+ ..|+.++||||||++++|++. -..
T Consensus 391 ~d-~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--------~~y~~kvdIyaLGlil~EL~~~f~T 461 (516)
T KOG1033|consen 391 DD-DQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--------QQYSEKVDIYALGLILAELLIQFST 461 (516)
T ss_pred cc-hhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--------hhhhhhcchhhHHHHHHHHHHHhcc
Confidence 88 689999999987544333 3456689999999999865 889999999999999999987 222
Q ss_pred CCCCCChHHHHHHHHhccCCC--CCCCCcHHHHHHHHHhhccCCCCCCCHHHH
Q 018656 232 PFEGMSNLQAAYAAAFKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQI 282 (352)
Q Consensus 232 p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~i 282 (352)
++. .............| ...++|. =..|+.++|.+.|.+||++.+.
T Consensus 462 ~~e----r~~t~~d~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 462 QFE----RIATLTDIRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHH----HHHhhhhhhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence 221 11122222222222 1233433 3579999999999999944433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6e-19 Score=162.87 Aligned_cols=212 Identities=33% Similarity=0.503 Sum_probs=160.3
Q ss_pred HhcCCCCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ccCCCCCCC
Q 018656 78 LSRVQHRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI-IHRDLKPEN 155 (352)
Q Consensus 78 l~~l~hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i-vH~Dikp~N 155 (352)
|+.+.|.|+.++++.+.+ +..++|.+||..|+|.+.+.... ..++......++++++.||+|+|.--| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 467899999999999864 58899999999999999998743 348999999999999999999999876 999999999
Q ss_pred eEEeCCCCceEEecCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCC
Q 018656 156 LLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 232 (352)
Q Consensus 156 ili~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (352)
.+++.. -.+||+|||+....... .......-..-|.|||.+....... .....+.+.|+||+|++++|+++.+.|
T Consensus 80 Clvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~-~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 80 CLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS-LESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc-ccccccccCCeehHHHHHHHHHhccCc
Confidence 999998 48999999997654211 1111122456799999987632111 113367889999999999999999999
Q ss_pred CCCCChH----HHHHHHHhccC---CCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 233 FEGMSNL----QAAYAAAFKNV---RPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 233 ~~~~~~~----~~~~~~~~~~~---~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
|...... +.......... +|. ....++++..++++||..+|..||+++++...+......
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9763321 12222111111 222 114566899999999999999999999999887665543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=150.80 Aligned_cols=162 Identities=20% Similarity=0.223 Sum_probs=120.6
Q ss_pred cccccccccccccceecCCceeee-cccc-CCCceEEEEEEECCceEEEEEcccCCChHHH--------HHHHHHHHHHH
Q 018656 6 RFYLADELKLDAKWLIDPKHLFVG-PRIG-EGAHAKVYEGKYKNQTVAIKIVHKGETPEEI--------AKKESRFAREV 75 (352)
Q Consensus 6 ~~~~~~~~~~~~~~~i~~~~y~~~-~~lG-~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~--------~~~~~~~~~E~ 75 (352)
.++-++.+.....+.+++..+... ..|| .||.|+||.+...+..++||.+......... .....++.+|+
T Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~ 91 (239)
T PRK01723 12 ILFDAERLRDPDPALFDPDFWQQQARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEF 91 (239)
T ss_pred EEEeccccCCCchhhcCHHHHhhcCceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHH
Confidence 345555566666666777665544 4577 9999999999888999999988643221110 12345688999
Q ss_pred HHHhcCCCCCe--eeeeeeeec--C---ceEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 018656 76 AMLSRVQHRNL--VKFIGACKE--P---VMVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147 (352)
Q Consensus 76 ~~l~~l~hp~i--v~l~~~~~~--~---~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~iv 147 (352)
+++.+|.|++| ++.++.... . ..++|||+++| .+|.+++... .+++.. +.+++.+|.+||++||+
T Consensus 92 ~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~ 164 (239)
T PRK01723 92 RLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVY 164 (239)
T ss_pred HHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCC
Confidence 99999988775 666665432 2 23599999997 6999988652 255543 57899999999999999
Q ss_pred cCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 148 HRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 148 H~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
|+||||+|||++.+ +.++|+|||.+..
T Consensus 165 HrDlkp~NILv~~~-~~v~LIDfg~~~~ 191 (239)
T PRK01723 165 HADLNAHNILLDPD-GKFWLIDFDRGEL 191 (239)
T ss_pred CCCCCchhEEEcCC-CCEEEEECCCccc
Confidence 99999999999987 6899999998865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=138.94 Aligned_cols=140 Identities=29% Similarity=0.322 Sum_probs=96.8
Q ss_pred eeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHH-------------------HHHHHHHHHHHhcCCCCC--
Q 018656 28 VGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKK-------------------ESRFAREVAMLSRVQHRN-- 85 (352)
Q Consensus 28 ~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~-------------------~~~~~~E~~~l~~l~hp~-- 85 (352)
+++.||+|+||+||+|.+. |+.||||++............ ......|...+.++.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 3567999999999999886 899999998764322111110 001134555555554332
Q ss_pred eeeeeeeeecCceEEEEEcCCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCC
Q 018656 86 LVKFIGACKEPVMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK 163 (352)
Q Consensus 86 iv~l~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~ 163 (352)
+.+.++. ...+++|||++|+.+.. .+.... .. ..+..++.+++.++.++|. .|++|+||||+||+++ + +
T Consensus 81 ~~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~ 151 (187)
T cd05119 81 VPKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-G 151 (187)
T ss_pred CCceEec---CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-C
Confidence 3344433 34689999999854321 111111 11 5677899999999999999 9999999999999999 5 7
Q ss_pred ceEEecCCCcccc
Q 018656 164 TIKLADFGLAREE 176 (352)
Q Consensus 164 ~vkl~Dfg~a~~~ 176 (352)
.++|+|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 8999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-19 Score=171.50 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=195.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC---CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeecC-c
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-V 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~-~ 97 (352)
...|.+.+.||+|+|+.|-.+... ...+|.|.+....... ....+...|..+-+.+. |+|++.+++...+. .
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~---~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSE---DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS 95 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCcc---chhhhcCccccccccccccccccccCCccCCCcc
Confidence 456778888999999999887663 4456666665543222 22234556888888886 99999999998755 6
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCCeEEeCCCC-ceEEecCCCccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLK-TIKLADFGLARE 175 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH-~~~ivH~Dikp~Nili~~~~~-~vkl~Dfg~a~~ 175 (352)
.+++.++..|+++.+.+........+......++.|+..++.|+| ..++.|+||||+|.+++.. + .++++|||+|..
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s-~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES-GSALKIADFGLATA 174 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-CCcccCCCchhhcc
Confidence 889999999999999884222224677778889999999999999 9999999999999999988 5 899999999986
Q ss_pred ccc----ccccccCCC-cccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-
Q 018656 176 ESL----TEMMTAETG-TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN- 249 (352)
Q Consensus 176 ~~~----~~~~~~~~g-~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~- 249 (352)
... ........| ++.|.|||...+ .....+..|+||.|+++..+++|..||.........+......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~-------~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~ 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSG-------KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccc-------hhhcCCCcccccccccccccccCCCCccccccccccceeecccc
Confidence 544 223344567 999999999865 2455778999999999999999999997755444332211111
Q ss_pred ---CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 250 ---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 250 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
....+..++....+++.+++..+|..|.+.+++...-
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~ 287 (601)
T KOG0590|consen 248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDN 287 (601)
T ss_pred cccccCccccCChhhhhcccccccCCchhccccccccccc
Confidence 2344677888999999999999999999999887763
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.6e-17 Score=128.67 Aligned_cols=131 Identities=23% Similarity=0.277 Sum_probs=108.9
Q ss_pred eeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC--CCeeeeeeeee-cCceEEEEEc
Q 018656 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACK-EPVMVIVTEL 104 (352)
Q Consensus 28 ~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~-~~~~~lv~e~ 104 (352)
+.+.||+|.++.||++...+..+++|+...... ...+.+|+..++.+.+ .++++++.... .+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 346799999999999999889999999866543 2347788898888866 58888888765 3578999999
Q ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---GIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 105 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
++|.++..+ +......++.+++++|+++|.. +++|+|++|+||++++. +.++++|||.+..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence 988877654 4456677899999999999995 69999999999999986 7899999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-15 Score=140.80 Aligned_cols=253 Identities=23% Similarity=0.241 Sum_probs=184.8
Q ss_pred ceecCCceeeeccccC--CCceEEEEEEE----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeee
Q 018656 19 WLIDPKHLFVGPRIGE--GAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIG 91 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~--G~~g~Vy~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~ 91 (352)
.......+.+.+.+|. |.+|.||.+.. .+..+|+|.-........ ...+=.+|....+.+ .|++.++...
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~---~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL---DSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc---ccccccchhhcccccCccccccccCc
Confidence 4445566777888999 99999998765 378889887443332111 111233566666666 5999999777
Q ss_pred eeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCccCCCCCCCeEEeCCCCceE
Q 018656 92 ACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR----AMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (352)
Q Consensus 92 ~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~----~L~~lH~~~ivH~Dikp~Nili~~~~~~vk 166 (352)
.+.+ +.+|+-.|.| +.+|.++..... ..++...++.++.+..+ ||.++|..+++|-|+||+||++..+....+
T Consensus 186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 186 AWEGSGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccccCCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceee
Confidence 7764 4678888888 689999987643 34889999999999999 999999999999999999999988866899
Q ss_pred EecCCCcccccccccccc------CCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH
Q 018656 167 LADFGLAREESLTEMMTA------ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240 (352)
Q Consensus 167 l~Dfg~a~~~~~~~~~~~------~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 240 (352)
++|||+............ ..|...|++||... ..++..+|+++||.++.+..++.-+........
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~---------~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN---------GLATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc---------cccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 999999887665543222 25778999999974 467889999999999999988765554432111
Q ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 241 AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+............-...+.++...+..|+..+|..|++.+.+..+
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 111100000111123455677779999999999999999888765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-14 Score=119.00 Aligned_cols=128 Identities=23% Similarity=0.243 Sum_probs=96.0
Q ss_pred eccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCee-eeeeeeecCceEEEEEcCCC
Q 018656 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV-KFIGACKEPVMVIVTELLSG 107 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~l~~~~~~~~~~lv~e~~~~ 107 (352)
.+.|+.|.++.||+++..++.+++|+........ ..+.+|..+++.+.+.+++ +++.. .....++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~------~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELL------INRENEAENSKLAAEAGIGPKLYYF-DPETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcccc------cCHHHHHHHHHHHHHhCCCCceEEE-eCCCCeEEEEecCC
Confidence 3568999999999999999999999976543211 1245788888887554443 45544 33346899999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI-----IHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 108 ~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i-----vH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
.++.+. . .. ...++.+++++|+.||+.++ +|+|++|.||+++ + +.++++|||.+..
T Consensus 76 ~~l~~~----~---~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE----D---FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc----c---cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEecccccC
Confidence 887653 0 11 12356799999999999985 9999999999999 4 5799999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-13 Score=120.80 Aligned_cols=258 Identities=17% Similarity=0.280 Sum_probs=176.2
Q ss_pred CCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeee--------e
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA--------C 93 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~--------~ 93 (352)
++-...+..||+|+-+-+|-.-.-+..|| |+.......... ..++.|... .||-+-.-+.+ -
T Consensus 10 ge~i~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~a--------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 10 GEPIPPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQA--------QKVAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred CcccCCCccccCCccceeeecchhhchhh-eeecCCCchHHH--------HHHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 44455678899999999996544444454 888776554431 112333333 56654331221 1
Q ss_pred ecCceEEEEEcCCCCC-HHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 94 KEPVMVIVTELLSGGT-LRKYLLN----MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 94 ~~~~~~lv~e~~~~~s-L~~~l~~----~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
.....-++|..++|.. ...+++- +......+...++.++.|+.+.+.||..|.+-+|++++|+|++++ +.|+|+
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LV 159 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLV 159 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEE
Confidence 2224788999998863 2232221 111247788999999999999999999999999999999999998 799999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC-CCCCCCCChH-------H
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNL-------Q 240 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~-------~ 240 (352)
|-.......++......+|...|.+||...--++ .+..-+..+|.|.||+++++++.| +.||.+.... +
T Consensus 160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf---~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSF---VGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred cccceeeccCCceEecccCccccCCHHHhccccc---cccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 9776665566666777889999999998653221 234567789999999999999886 9999874321 1
Q ss_pred HHH--------HHHhccCCCC-----CCCCcHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHHhhhcc
Q 018656 241 AAY--------AAAFKNVRPS-----AENVPEELSIILTSCWKE--DPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 241 ~~~--------~~~~~~~~~~-----~~~~~~~l~~li~~~l~~--~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
... ........|. ..-+++++..+..+|+.. ++.-|||++..+..|......+
T Consensus 237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 237 TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 000 0111111222 345789999999999964 3568999999888876655443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.2e-14 Score=131.86 Aligned_cols=143 Identities=23% Similarity=0.294 Sum_probs=97.0
Q ss_pred ccccCCCceEEEEEEE-CCceEEEEEcccCCChHHH-----------------------------HH------HHHHHHH
Q 018656 30 PRIGEGAHAKVYEGKY-KNQTVAIKIVHKGETPEEI-----------------------------AK------KESRFAR 73 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~-~~~~vaiK~~~~~~~~~~~-----------------------------~~------~~~~~~~ 73 (352)
+.||.|++|.||+|+. +|+.||||+.+......-. .. .+-.+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999987 4999999998664321100 00 0112444
Q ss_pred HHHHHhcC----CCCCeeeeeeeee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 018656 74 EVAMLSRV----QHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR-AMECLHSHGI 146 (352)
Q Consensus 74 E~~~l~~l----~hp~iv~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~-~L~~lH~~~i 146 (352)
|.+.+.++ ++.+-+.+-.++. ....++||||++|++|.++...... ..+ ...++.+++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 55555444 2322233323322 2346999999999999988754221 122 2345566665 4788999999
Q ss_pred ccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 147 IHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 147 vH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+|+|++|.||+++.+ +.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 999999999999887 799999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.3e-13 Score=109.82 Aligned_cols=149 Identities=23% Similarity=0.264 Sum_probs=113.6
Q ss_pred eeccccCCCceEEEEEEECCceEEEEEcccC---CChHHHHHHHHHHHHHHHHHhcCCCCCeeeee-eeeecCceEEEEE
Q 018656 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKG---ETPEEIAKKESRFAREVAMLSRVQHRNLVKFI-GACKEPVMVIVTE 103 (352)
Q Consensus 28 ~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~-~~~~~~~~~lv~e 103 (352)
....+-||+-+.|+++.+.|+.++||.-... .+..+..-...+..+|.+.+.++.--.|.--. -++....-.++||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 3466889999999999999999999865432 33344445567888999999888644443222 2223335689999
Q ss_pred cCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCce--EEecCCCcccc
Q 018656 104 LLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI--KLADFGLAREE 176 (352)
Q Consensus 104 ~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~v--kl~Dfg~a~~~ 176 (352)
|++| .++.+++................+..+-+.+.-||.++++|+||..+||++..+++.+ .++|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9977 4899999876654455555578899999999999999999999999999998775655 89999998653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.4e-13 Score=128.94 Aligned_cols=139 Identities=20% Similarity=0.259 Sum_probs=89.8
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCCh-----------------------------HHHHHHHHH------HH
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETP-----------------------------EEIAKKESR------FA 72 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~-----------------------------~~~~~~~~~------~~ 72 (352)
+.||+|++|.||+|+.+ |+.||||+.++.... +...+.... +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 68999999999999874 899999999865211 011111222 33
Q ss_pred HHHHHHhcC----CCCCeeeeeeeee--cCceEEEEEcCCCCCHHHHH--HhcCC--CCCCHHHHHHHHHHHHHHHHHHH
Q 018656 73 REVAMLSRV----QHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYL--LNMRP--RCLDVCVAIGFALDIARAMECLH 142 (352)
Q Consensus 73 ~E~~~l~~l----~hp~iv~l~~~~~--~~~~~lv~e~~~~~sL~~~l--~~~~~--~~~~~~~~~~i~~qi~~~L~~lH 142 (352)
+|...+.++ .+.+.+.+-.++. ....++||||+.|++|.++- ...+. ..+.+..+..++.| +.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HH
Confidence 444444444 2333333333332 23578999999999998753 22221 01333333334444 44
Q ss_pred hCCCccCCCCCCCeEEeCCCC----ceEEecCCCcccc
Q 018656 143 SHGIIHRDLKPENLLLTEDLK----TIKLADFGLAREE 176 (352)
Q Consensus 143 ~~~ivH~Dikp~Nili~~~~~----~vkl~Dfg~a~~~ 176 (352)
..|++|+|++|.||+++.+ + .++++|||++...
T Consensus 278 ~~GffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSL 314 (537)
T ss_pred hCCeeeCCCChHHeEEecC-CCCCCeEEEEecceEEEC
Confidence 6899999999999999887 5 8999999998654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.1e-13 Score=125.92 Aligned_cols=161 Identities=18% Similarity=0.247 Sum_probs=125.1
Q ss_pred CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCH
Q 018656 46 KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124 (352)
Q Consensus 46 ~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 124 (352)
.+.+|.|.+...... . ......+-++.++.++||||+++++.+. ++.+|+|+|-+ ..|..++.+ +..
T Consensus 36 ~~~~vsVF~~~~~~~-~----~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~ 103 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG-E----VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGK 103 (690)
T ss_pred cCCceEEEEEeCCCc-h----hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHH
Confidence 477888887766544 1 2234667889999999999999999987 56899999998 689999987 446
Q ss_pred HHHHHHHHHHHHHHHHHH-hCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc-cccCCCccccccccccccccc
Q 018656 125 CVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-MTAETGTYRWMAPELYSTVTL 202 (352)
Q Consensus 125 ~~~~~i~~qi~~~L~~lH-~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~ 202 (352)
..+...+.||+.||.+|| +.+++|++|..+.|+|+.. |.+||++|.++........ .........|..|+.+..
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~--- 179 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP--- 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc---
Confidence 777888999999999997 5689999999999999998 8999999998865433221 122233345667775422
Q ss_pred ccccccCCCcccchhhHHHHHHHHHhC
Q 018656 203 RQGEKKHYNHKVDSYSFAIVLWELLHN 229 (352)
Q Consensus 203 ~~~~~~~~~~~~DiwslG~il~~ll~g 229 (352)
-+...|.|.|||++++++.|
T Consensus 180 -------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 -------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -------cccchhhhhHHHHHHHHhCc
Confidence 12457999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.4e-13 Score=110.94 Aligned_cols=141 Identities=16% Similarity=0.150 Sum_probs=99.8
Q ss_pred eccccCCCceEEEEEEEC--------CceEEEEEcccCCCh---------------------HHHHHHHHHHHHHHHHHh
Q 018656 29 GPRIGEGAHAKVYEGKYK--------NQTVAIKIVHKGETP---------------------EEIAKKESRFAREVAMLS 79 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~--------~~~vaiK~~~~~~~~---------------------~~~~~~~~~~~~E~~~l~ 79 (352)
..+||.|--+.||.|... +..+|||+.+..... ........-..+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 356999999999999754 378999988652110 001111112237999998
Q ss_pred cCCC--CCeeeeeeeeecCceEEEEEcCCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCC
Q 018656 80 RVQH--RNLVKFIGACKEPVMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPEN 155 (352)
Q Consensus 80 ~l~h--p~iv~l~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~i~~qi~~~L~~l-H~~~ivH~Dikp~N 155 (352)
++.. -++.+.+++ ..-++||||+.+..+.. .+.. . .++......+..+++.+|..+ |+.|++|+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd-~--~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKD-A--KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhc-c--ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 8843 456666654 45689999997654422 1222 1 255566777889999999998 89999999999999
Q ss_pred eEEeCCCCceEEecCCCccccc
Q 018656 156 LLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 156 ili~~~~~~vkl~Dfg~a~~~~ 177 (352)
|++++ +.+.|+|||.+...+
T Consensus 156 IL~~~--~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD--GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC--CcEEEEECCCceeCC
Confidence 99985 479999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.4e-13 Score=107.28 Aligned_cols=135 Identities=23% Similarity=0.329 Sum_probs=102.8
Q ss_pred ccccCCCceEEEEEEECCceEEEEEcccCC---ChHHHHHHHHHHHHHHHHHhcCCCCCe--eeeeeeeecCceEEEEEc
Q 018656 30 PRIGEGAHAKVYEGKYKNQTVAIKIVHKGE---TPEEIAKKESRFAREVAMLSRVQHRNL--VKFIGACKEPVMVIVTEL 104 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~hp~i--v~l~~~~~~~~~~lv~e~ 104 (352)
..+++|+-+.+|.+.+.|..+++|.-.... +..+..-...+..+|.+++.++.--.| ..++++ ......|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-D~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-DPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-cCCCCEEEEEE
Confidence 358999999999998888888888654432 222333335667789999988854444 333333 34467899999
Q ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 105 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
++|..|.+++... ...++..+-.-+.-||..||+|+||.++||+++.+ .+.++|||++...
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCccccc
Confidence 9999999998764 13467777788899999999999999999999986 5999999998753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.8e-13 Score=116.71 Aligned_cols=196 Identities=21% Similarity=0.304 Sum_probs=134.0
Q ss_pred HHhcCCCCCeeeeeeeeec------CceEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--C
Q 018656 77 MLSRVQHRNLVKFIGACKE------PVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHG--I 146 (352)
Q Consensus 77 ~l~~l~hp~iv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--i 146 (352)
.+-++.|.|+++++.++.+ ....++.||+..|+|.+++++... ..+......+|+-||+.||.|||+-. +
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 3445679999999888753 257899999999999999987643 45888888999999999999999986 9
Q ss_pred ccCCCCCCCeEEeCCCCceEEecCCCcccc-----ccccccccCCCcccccccccccccccccccccCCCcccchhhHHH
Q 018656 147 IHRDLKPENLLLTEDLKTIKLADFGLAREE-----SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAI 221 (352)
Q Consensus 147 vH~Dikp~Nili~~~~~~vkl~Dfg~a~~~-----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~ 221 (352)
+|+++..+-|++..+ |-+|+.--.-.... ....-.....+.++|.|||.= .....+.++|||++|.
T Consensus 200 ihgnlTc~tifiq~n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg--------~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHN-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG--------TTTNTTGASDIYKFGM 270 (458)
T ss_pred ccCCcchhheeecCC-ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC--------cccccccchhhhhhhH
Confidence 999999999999976 56665432211100 001111223467899999953 2245677899999999
Q ss_pred HHHHHHhCCCCCC-CCChHHHHHHHHhccCCCCCCCCc-HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 222 VLWELLHNKLPFE-GMSNLQAAYAAAFKNVRPSAENVP-EELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 222 il~~ll~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
...+|..+..--. +.+.......+ ..-.. .+. .-=+.++..||+..|..||++.+++.|.
T Consensus 271 cAlemailEiq~tnseS~~~~ee~i-a~~i~----~len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 271 CALEMAILEIQSTNSESKVEVEENI-ANVII----GLENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHHHHHheeccCCCcceeehhhhh-hhhee----eccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 9999988765321 11111000000 00000 011 1123578899999999999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.9e-13 Score=124.10 Aligned_cols=247 Identities=19% Similarity=0.155 Sum_probs=174.7
Q ss_pred CCceeeeccccCCCceEEEEEEE---CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee-cCc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY---KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK-EPV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~-~~~ 97 (352)
..++.....||.|.|+.|+.... .+..|++|-+......... ...-..|+-+...+ .|.+++.+...+. ...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~---di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS---DIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh---hhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 45677889999999999998753 2678888877665443321 11233566665555 5888888766554 556
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.|+=-|||+++++...+.-... +.+...+++..|++.++.++|++.++|+|++|+||++.+++...++.|||......
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~--~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQM--LDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHh--cCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 7899999999988877643332 88889999999999999999999999999999999998865688999999886411
Q ss_pred cccccccCCCccccc-ccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC
Q 018656 178 LTEMMTAETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 256 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~-aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 256 (352)
-. ........++. ..|++. +...+..+.|++|||..+.+.+++..--.... .+........+....
T Consensus 419 ~~--~~~~~~~~r~~p~~~~~~-------e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~ 485 (524)
T KOG0601|consen 419 FS--SGVFHHIDRLYPIAEILL-------EDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPG 485 (524)
T ss_pred ee--cccccccccccccchhhc-------cccccccccccccccccccccccCcccCcccc----cceeeecccccCCCc
Confidence 11 11122333344 244442 24667889999999999999999854322111 112222233444555
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
....+..+.+.++.+++..||.+.++..+..
T Consensus 486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 486 LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 5688888999999999999999988876643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-12 Score=126.65 Aligned_cols=249 Identities=22% Similarity=0.274 Sum_probs=174.1
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-c
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-E 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~ 95 (352)
|-.....+.+.+-+-+|.++.++.+.-. |...++|+......... .......++-+++-.-.+|-+++..-.+- .
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~--~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT--NDYESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc--ccccccCCccCccccCCCCceecccCCCCCC
Confidence 5566777888889999999999987653 43344443322111000 00111223333333334566665544432 3
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
...+++++|..+++|...+.+.+ +.++.-....+..+..++++||...+.|+|++|.|+++..+ +..++.|||....
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLSK 953 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCccccccc
Confidence 46899999999999999988765 36666777788899999999999999999999999999988 7999999984321
Q ss_pred cc-------c------------------c-------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHH
Q 018656 176 ES-------L------------------T-------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVL 223 (352)
Q Consensus 176 ~~-------~------------------~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 223 (352)
.. . . .......+|+.|.+||...+ ......+|+|+.|+++
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--------~~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--------RRHGSAADWWSSGVCL 1025 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--------ccCCCcchhhhhhhhh
Confidence 00 0 0 00112358999999999876 4567789999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHhcc--CCCCCCCCcHHHHHHHHHhhccCCCCCCCHH
Q 018656 224 WELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVPEELSIILTSCWKEDPNARPNFT 280 (352)
Q Consensus 224 ~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 280 (352)
++.++|..||......+.-..+.... +...+...+.+.++++...|..+|.+|..+.
T Consensus 1026 ~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1026 FEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999999866654432222211 2222456788999999999999999997766
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.9e-10 Score=104.05 Aligned_cols=214 Identities=14% Similarity=0.182 Sum_probs=151.1
Q ss_pred CceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-----cCceEEEEEcCCCC
Q 018656 36 AHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-----EPVMVIVTELLSGG 108 (352)
Q Consensus 36 ~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~~~lv~e~~~~~ 108 (352)
--.+.|++.. +|..|++|.++....... . ....-++.++++.|+|||++.+++. +..+.+|++|.++.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--N---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--c---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 3456788865 489999999844322211 0 1234578899999999999988764 45789999999874
Q ss_pred -CHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 109 -TLRKYLLNMR-------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 109 -sL~~~l~~~~-------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+|.++.-... +...+|..+|.++.||..||.++|+.|+..+-|.|.+|+++.+ .+++|+.-|...
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~-~RIriS~C~i~D 441 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK-MRIRISGCGIMD 441 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc-ceEEEeccccee
Confidence 7887654332 1247889999999999999999999999999999999999987 488888777665
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
....+. .+| + .--.+.|.=.||.+++.|.+|..--...+....... ....
T Consensus 442 vl~~d~-----------~~~--l-----------e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~------~~I~ 491 (655)
T KOG3741|consen 442 VLQEDP-----------TEP--L-----------ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHL------TRIT 491 (655)
T ss_pred eecCCC-----------Ccc--h-----------hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHH------HHhh
Confidence 432222 011 1 112367999999999999999643111111111111 1112
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..++.++++++......++++ -++.+++.++
T Consensus 492 ~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 492 TTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 468899999999999999986 5677776653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.27 E-value=2e-10 Score=100.39 Aligned_cols=138 Identities=17% Similarity=0.129 Sum_probs=96.1
Q ss_pred ceEEEEEEECCceEEEEEcccCCChHHHHH------HHHHHHHHHHHHhcCCCCCe--eeeeeeee---c---CceEEEE
Q 018656 37 HAKVYEGKYKNQTVAIKIVHKGETPEEIAK------KESRFAREVAMLSRVQHRNL--VKFIGACK---E---PVMVIVT 102 (352)
Q Consensus 37 ~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~hp~i--v~l~~~~~---~---~~~~lv~ 102 (352)
...|++....|+.|.||............. -...+.+|...+.+|..-+| ++.+.+.. . ...++|+
T Consensus 35 ~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 35 GRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred CceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 334667777899999997643331110000 00136678888777743222 23333332 1 2478999
Q ss_pred EcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC------CCCceEEecCCCcc
Q 018656 103 ELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE------DLKTIKLADFGLAR 174 (352)
Q Consensus 103 e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~------~~~~vkl~Dfg~a~ 174 (352)
|++++. +|.+++........+......++.+++..+.-||+.||+|+|+++.|||++. +...+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999886 8999986533334667778889999999999999999999999999999975 23579999999875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.4e-11 Score=101.31 Aligned_cols=139 Identities=22% Similarity=0.311 Sum_probs=104.3
Q ss_pred ccccCCCceEEEEEEECC-ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC--CCeeeeeeeeec----CceEEEE
Q 018656 30 PRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACKE----PVMVIVT 102 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~----~~~~lv~ 102 (352)
+.||.|..+.||++...+ +.+++|+........ ....+.+|.++++.+.+ ..+.+++.+..+ +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~----~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP----SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCc----ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 568999999999998764 899999986543210 12247789999998865 345667776654 3568999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-------------------------------------- 144 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-------------------------------------- 144 (352)
||++|.+|.+.+.. ..+++.....++.+++++|..||+.
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99999888875532 2367777777888888888888742
Q ss_pred ------------------CCccCCCCCCCeEEeCC-CCceEEecCCCccc
Q 018656 145 ------------------GIIHRDLKPENLLLTED-LKTIKLADFGLARE 175 (352)
Q Consensus 145 ------------------~ivH~Dikp~Nili~~~-~~~vkl~Dfg~a~~ 175 (352)
.++|+|++|.||+++.+ .+.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 35899999999999883 25688999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.4e-11 Score=96.99 Aligned_cols=129 Identities=26% Similarity=0.275 Sum_probs=84.2
Q ss_pred EEEEEE-CCceEEEEEcccCCC---------------------hHHHHHHHHHHHHHHHHHhcCCCC--Ceeeeeeeeec
Q 018656 40 VYEGKY-KNQTVAIKIVHKGET---------------------PEEIAKKESRFAREVAMLSRVQHR--NLVKFIGACKE 95 (352)
Q Consensus 40 Vy~~~~-~~~~vaiK~~~~~~~---------------------~~~~~~~~~~~~~E~~~l~~l~hp--~iv~l~~~~~~ 95 (352)
||.|.. .|+.+|+|+.+.... ............+|.+.|.++..- ++.+.+++.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 899987 488999998765211 112223345677899999999765 456666552
Q ss_pred CceEEEEEcCC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 96 PVMVIVTELLS--GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC-LHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 96 ~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~-lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
.-.+||||++ |..+..+.... ++......++.+++..+.. +|..|++|+|+.+.||+++.+ .+.++|||.
T Consensus 80 -~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~q 152 (188)
T PF01163_consen 80 -RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFGQ 152 (188)
T ss_dssp -TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GTT
T ss_pred -CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecCc
Confidence 3479999998 66666544322 2233455677888885444 689999999999999999986 799999998
Q ss_pred ccccc
Q 018656 173 AREES 177 (352)
Q Consensus 173 a~~~~ 177 (352)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 87543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.4e-10 Score=93.29 Aligned_cols=129 Identities=25% Similarity=0.275 Sum_probs=89.3
Q ss_pred ECCceEEEEEcccCCChH--HHHHHHHHHHHHHHHHhcCCCCC--eeeeeeeeec-----CceEEEEEcCCCC-CHHHHH
Q 018656 45 YKNQTVAIKIVHKGETPE--EIAKKESRFAREVAMLSRVQHRN--LVKFIGACKE-----PVMVIVTELLSGG-TLRKYL 114 (352)
Q Consensus 45 ~~~~~vaiK~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~~~-----~~~~lv~e~~~~~-sL~~~l 114 (352)
..++.+.+|......... ...-...+..+|...+.+|..-+ +++.+.+... ...++|+|++++. +|.+++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence 346666666543221111 00012345677888777764322 2344444332 1468999999884 899999
Q ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC--CceEEecCCCccc
Q 018656 115 LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLARE 175 (352)
Q Consensus 115 ~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~--~~vkl~Dfg~a~~ 175 (352)
..... .+......++.+++..+.-||++||+|+|+++.|||++.+. ..+.++||+-+..
T Consensus 110 ~~~~~--~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 110 QQWEQ--LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred Hhhcc--cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 86443 66677788999999999999999999999999999998872 2799999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.8e-09 Score=88.59 Aligned_cols=143 Identities=14% Similarity=0.100 Sum_probs=102.7
Q ss_pred ccCCCceEEEEEEECCceEEEEEcccCCChHHH-HHHHHHHHHHHHHHhcCCCCC--eeeeeeee--ecC---ceEEEEE
Q 018656 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHRN--LVKFIGAC--KEP---VMVIVTE 103 (352)
Q Consensus 32 lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~--~~~---~~~lv~e 103 (352)
-|.||-|-|+.....|+.+-+|.-.......-. ..-+..|.+|+..+++|..-+ +.+..... ..+ ..+||+|
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 578999999998888888888865421110000 011335889999988884322 44444221 122 4789999
Q ss_pred cCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCc--eEEecCCCccc
Q 018656 104 LLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT--IKLADFGLARE 175 (352)
Q Consensus 104 ~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~--vkl~Dfg~a~~ 175 (352)
-++| .+|.+++.+..-...+......++.+++.++.-||+.|+.|+|+.+.||+++.+ +. +.++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 8854 499999876543346788888999999999999999999999999999999855 45 99999987653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-09 Score=93.21 Aligned_cols=140 Identities=27% Similarity=0.278 Sum_probs=100.7
Q ss_pred eeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChH-----------------HHHHHHHHHHHHHHHHhcCCCC--C
Q 018656 26 LFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPE-----------------EIAKKESRFAREVAMLSRVQHR--N 85 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~-----------------~~~~~~~~~~~E~~~l~~l~hp--~ 85 (352)
+.++..||-|--|.||.|.+. |.++|||.=+...+.- .....+....+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 457889999999999999985 9999999654432211 1112233456788999888543 4
Q ss_pred eeeeeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCce
Q 018656 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (352)
Q Consensus 86 iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~v 165 (352)
|.+-++ .+...+|||+++|..|...- ++....-.++..|++-+..+-..|++|+|+++-||+++++ |.+
T Consensus 173 VP~P~~---~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~~ 241 (304)
T COG0478 173 VPKPIA---WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GDI 241 (304)
T ss_pred CCCccc---cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CCE
Confidence 554444 34568999999997776532 1222334455666666666668999999999999999998 789
Q ss_pred EEecCCCcccc
Q 018656 166 KLADFGLAREE 176 (352)
Q Consensus 166 kl~Dfg~a~~~ 176 (352)
.++||-.+...
T Consensus 242 ~vIDwPQ~v~~ 252 (304)
T COG0478 242 VVIDWPQAVPI 252 (304)
T ss_pred EEEeCcccccC
Confidence 99999877654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.02 E-value=9e-09 Score=85.85 Aligned_cols=140 Identities=19% Similarity=0.224 Sum_probs=94.5
Q ss_pred ecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHH------HHHHHHHHhcCCC---CCeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESR------FAREVAMLSRVQH---RNLVKFIG 91 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~------~~~E~~~l~~l~h---p~iv~l~~ 91 (352)
+...+|.+.+++-......|.+-.-.|+.+++|..+......+ ..... ..+++..+.++.. -....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~e--r~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPE--RRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHH--HHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3456788888888888888888888899999999876543221 11111 1233333333322 22223222
Q ss_pred eee------cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCce
Q 018656 92 ACK------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (352)
Q Consensus 92 ~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~v 165 (352)
+.. ....+++|||++|..|.+... +++. +...+.+++.-+|+.|++|+|..|.|++++++ .+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i 173 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GI 173 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cE
Confidence 222 124568999999998877542 3332 44667788999999999999999999999975 59
Q ss_pred EEecCCCcc
Q 018656 166 KLADFGLAR 174 (352)
Q Consensus 166 kl~Dfg~a~ 174 (352)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.5e-10 Score=106.95 Aligned_cols=144 Identities=19% Similarity=0.316 Sum_probs=104.6
Q ss_pred HHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEEecCCCcccccc-cc---------ccccCCCcccccccccccccc
Q 018656 133 DIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TE---------MMTAETGTYRWMAPELYSTVT 201 (352)
Q Consensus 133 qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~~---------~~~~~~g~~~y~aPE~~~~~~ 201 (352)
+.+.|+.++|+. ++||++|.|++|.++.. +.+||+.|+++..... .+ ..........|.|||.+.+
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-- 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-- 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--
Confidence 444899999976 89999999999999998 8999999998764222 11 1112235678999999865
Q ss_pred cccccccCCCcccchhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcc---CCCCCCCCcHHHHHHHHHhhccCCCCCC
Q 018656 202 LRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKN---VRPSAENVPEELSIILTSCWKEDPNARP 277 (352)
Q Consensus 202 ~~~~~~~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp 277 (352)
...+.++|++|||+++|.+. .|+.-+.+.............. ..-....+|+++++=+.+++..++.-||
T Consensus 184 ------~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 184 ------TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred ------ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 56688999999999999998 4555554433222222211111 1223468999999999999999999999
Q ss_pred CHHHHHHH
Q 018656 278 NFTQIIQM 285 (352)
Q Consensus 278 s~~~i~~~ 285 (352)
++..+...
T Consensus 258 ~~~~l~~~ 265 (700)
T KOG2137|consen 258 TLDLLLSI 265 (700)
T ss_pred chhhhhcc
Confidence 87777554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.1e-08 Score=79.11 Aligned_cols=131 Identities=22% Similarity=0.317 Sum_probs=96.3
Q ss_pred ceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCee-eeeeeeecCceEEEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV-KFIGACKEPVMVIVTE 103 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~l~~~~~~~~~~lv~e 103 (352)
..+..+.||+|++|.||++.+.|..+|+|+-+.+.... .+..|.+++..++..++. +++.+..+ ++.||
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~-------~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me 92 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRR-------NLEKEAKILEILAGEGVTPEVYFYGED---FIRME 92 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCcchh-------hHHHHHHHHHHhhhcCCCceEEEechh---hhhhh
Confidence 34556889999999999999999999999987766544 377899999988877765 44444332 34499
Q ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC-CCCeEEeCCCCceEEecCCCccc
Q 018656 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK-PENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 104 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dik-p~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
|+.|.+|.+.-.. .+... +..+++.-.-|-..||-|+.|. |...++.++ +.+.|+||..|+.
T Consensus 93 ~i~G~~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIG-----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhc-----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 9999899886642 12222 3345555566778899999997 665556555 5899999999874
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-06 Score=81.77 Aligned_cols=142 Identities=22% Similarity=0.270 Sum_probs=89.7
Q ss_pred ccccCCCceEEEEEEEC-CceEEEEEcccCCChH-----------------------------HHHHHHHH------HHH
Q 018656 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPE-----------------------------EIAKKESR------FAR 73 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~-----------------------------~~~~~~~~------~~~ 73 (352)
..|+.++-|.||+|+.. |+.||||+.++.-... ...+.... +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56899999999999986 9999999987632111 11111122 222
Q ss_pred HHHHHhcC-----CCCCeeeeeeeee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 018656 74 EVAMLSRV-----QHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146 (352)
Q Consensus 74 E~~~l~~l-----~hp~iv~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 146 (352)
|.+.+.++ +.++| .+=.++- .+.-.++|||++|..+.+...... ..++...+.....++ -+..+=..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 33333333 12222 2222222 245689999999999999843222 225644433322222 1334445899
Q ss_pred ccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 147 IHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 147 vH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
+|.|.+|.||+++.+ |++.+.|||+....
T Consensus 287 fHaDpHpGNi~v~~~-g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSD-GRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecC-CcEEEEcCcceecC
Confidence 999999999999999 89999999997654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.7e-07 Score=80.31 Aligned_cols=135 Identities=15% Similarity=0.168 Sum_probs=79.5
Q ss_pred ccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC--eeeeeeeeec-CceEEEEEcCC
Q 018656 30 PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN--LVKFIGACKE-PVMVIVTELLS 106 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~~~-~~~~lv~e~~~ 106 (352)
..||+|..+.||+. .|..+++|......... ...+|.++++.+..-+ +.+.+++..+ +...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~~-------~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDKE-------TIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCCHH-------HHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999984 46678899986543222 2567888888875333 3566666553 45688999998
Q ss_pred CCC-HHHHHH--------------h----cC---CCCCCHHHHHH-HHHH----------HHHH-HHHHH----hCCCcc
Q 018656 107 GGT-LRKYLL--------------N----MR---PRCLDVCVAIG-FALD----------IARA-MECLH----SHGIIH 148 (352)
Q Consensus 107 ~~s-L~~~l~--------------~----~~---~~~~~~~~~~~-i~~q----------i~~~-L~~lH----~~~ivH 148 (352)
|.+ +...+. + -. ....+...... +..+ +... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 221111 0 00 00111111000 1000 0011 11111 124689
Q ss_pred CCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 149 RDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 149 ~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+|+.|.||+++++ + +.++||+.+..
T Consensus 158 gD~~~~Nii~~~~-~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGK-G-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCC-C-cEEEechhcCc
Confidence 9999999999987 5 89999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=1e-06 Score=75.72 Aligned_cols=77 Identities=16% Similarity=0.248 Sum_probs=54.5
Q ss_pred eccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCC--Ceeeeeeeee----cCceEEEE
Q 018656 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR--NLVKFIGACK----EPVMVIVT 102 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~l~~~~~----~~~~~lv~ 102 (352)
++.|+.|..+.||+....+..+++|..... .....+.+|..+++.+... .+.+++.... ....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP-------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH-------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC-------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 356899999999999998889999997553 1233466777777777422 3556665432 22579999
Q ss_pred EcCCCCCHHH
Q 018656 103 ELLSGGTLRK 112 (352)
Q Consensus 103 e~~~~~sL~~ 112 (352)
++++|.++..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999988887
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.1e-06 Score=74.31 Aligned_cols=141 Identities=22% Similarity=0.224 Sum_probs=89.4
Q ss_pred ccccCCCceEEEEEEE-CCceEEEEEcccCCChHHH-------------------HHHHHHHHHHHHHHhcCCCC--Cee
Q 018656 30 PRIGEGAHAKVYEGKY-KNQTVAIKIVHKGETPEEI-------------------AKKESRFAREVAMLSRVQHR--NLV 87 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~-~~~~vaiK~~~~~~~~~~~-------------------~~~~~~~~~E~~~l~~l~hp--~iv 87 (352)
-.|++|--+.||+|.. .+..+|+|+....-..... .....=...|...|+++.-- .+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3688899999999986 4899999998753221110 00001122356666665322 222
Q ss_pred eeeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceE
Q 018656 88 KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIK 166 (352)
Q Consensus 88 ~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vk 166 (352)
+-+.+ ..-.+||||+....+-. ..-..-.++..+...+..++++.+.-|-. .++||+||+.=|||+.. +.+.
T Consensus 134 ~Pi~~---~~nVLvMEfIg~~g~pA--P~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~--~~p~ 206 (268)
T COG1718 134 EPIAF---RNNVLVMEFIGDDGLPA--PRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD--GEPY 206 (268)
T ss_pred Cceee---cCCeEEEEeccCCCCCC--CCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC--CeEE
Confidence 22222 23479999995431000 00011123444677788889998888877 89999999999999994 5899
Q ss_pred EecCCCccccc
Q 018656 167 LADFGLAREES 177 (352)
Q Consensus 167 l~Dfg~a~~~~ 177 (352)
++|+|.|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.49 E-value=2e-06 Score=74.70 Aligned_cols=70 Identities=20% Similarity=0.199 Sum_probs=48.6
Q ss_pred CceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeec-CceEEEEEcCCCCCHHHH
Q 018656 36 AHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE-PVMVIVTELLSGGTLRKY 113 (352)
Q Consensus 36 ~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~ 113 (352)
.-..||+....+..+++|...... ...+.+|+++++.+. +--+.+++++... +..++|||+++|.+|.+.
T Consensus 11 ~~~~v~~~~~~~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 11 SGATVYRLDGKNPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CcCeEEEEcCCCCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 448899997777889999876542 112556777777663 3335566766653 467899999999887754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.1e-06 Score=79.42 Aligned_cols=142 Identities=20% Similarity=0.247 Sum_probs=88.8
Q ss_pred ccccCCCceEEEEEEEC-CceEEEEEcccCCChHH-------------------------H-HHH------HHHHHHHHH
Q 018656 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEE-------------------------I-AKK------ESRFAREVA 76 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~-------------------------~-~~~------~~~~~~E~~ 76 (352)
+.||.-+.|.||+|+.+ |+.||||+-++.-...- . .+. +-.|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56999999999999875 89999998766322110 0 000 111223333
Q ss_pred HH----hcCCCCC------eeeeeeeeecCceEEEEEcCCCCCHHHH--HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 018656 77 ML----SRVQHRN------LVKFIGACKEPVMVIVTELLSGGTLRKY--LLNMRPRCLDVCVAIGFALDIARAMECLHSH 144 (352)
Q Consensus 77 ~l----~~l~hp~------iv~l~~~~~~~~~~lv~e~~~~~sL~~~--l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~ 144 (352)
.. +.+.|-+ |.+++..+ .....++|||++|..+.+. +.++ .++...+..-+.+.. ++-+=..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHH--HHHHHhc
Confidence 22 2223444 33333332 2357999999999877765 3333 367665544333332 2334456
Q ss_pred CCccCCCCCCCeEEeC---CCCceEEecCCCccccc
Q 018656 145 GIIHRDLKPENLLLTE---DLKTIKLADFGLAREES 177 (352)
Q Consensus 145 ~ivH~Dikp~Nili~~---~~~~vkl~Dfg~a~~~~ 177 (352)
|++|+|=+|.||+++. ....+.+.|||+....+
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 8999999999999983 34689999999987543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.6e-06 Score=85.64 Aligned_cols=205 Identities=17% Similarity=0.148 Sum_probs=140.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 018656 66 KKESRFAREVAMLSRVQHRNLVKFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140 (352)
Q Consensus 66 ~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~ 140 (352)
+.++...-|+..+....|+|+..++.+..+. ...+..++|...++...+..-.. ++....+.+..++++||.|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHH
Confidence 3344555678888999999999999886432 35678899999999998876544 8888899999999999999
Q ss_pred HHhCCCccCCCCCC---CeEEeCCCCceEEe--cCCCccccccccccccCCCcccccccccccccccccccccCCCcccc
Q 018656 141 LHSHGIIHRDLKPE---NLLLTEDLKTIKLA--DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 215 (352)
Q Consensus 141 lH~~~ivH~Dikp~---Nili~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~D 215 (352)
+|+....|.-+..+ +-.++.. +.+..+ ||+.+.................+.++|.... +........|
T Consensus 302 ~h~~~l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~------~~~~~~r~~d 374 (1351)
T KOG1035|consen 302 LHSLSLEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE------NTAKKSRLTD 374 (1351)
T ss_pred HHHhccceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCcccccccccccc------ccchhhhhhH
Confidence 99996665555444 3333333 345555 8887776555554444555667777876643 2233344579
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 216 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 216 iwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
+|.+|.....+..|..+-.-... ... -........+.+....|+..++++|+++.+++.+....
T Consensus 375 L~~lgll~~~~~~~~~i~~~~~~----~~~------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 375 LWCLGLLLLQLSQGEDISEKSAV----PVS------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLR 438 (1351)
T ss_pred HHHHHHHHhhhhhcCcccccccc----hhh------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence 99999999999887543211000 000 00111222678889999999999999999999985443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.3e-08 Score=91.69 Aligned_cols=184 Identities=21% Similarity=0.184 Sum_probs=133.4
Q ss_pred eeeeccccCCCceEEEEEEECCc-eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC-eeeeeeeee-cCceEEEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYKNQ-TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACK-EPVMVIVT 102 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~~~-~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~-~~~~~lv~ 102 (352)
+...+-+++|+++.+++.+.+.+ ....+.+... . ...-++++|.+++||| .+..++-++ +...++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~---l-------~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT---L-------SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc---h-------hhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 45567789999999999988743 3334554332 1 1345788999999999 666666665 56899999
Q ss_pred EcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc
Q 018656 103 ELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (352)
Q Consensus 103 e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~ 181 (352)
+++.++ +-...... ....+.+.+...+.+.-+++++++|+..=+|+| ||+.++. ..+..||+..........
T Consensus 314 ~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~ 386 (829)
T KOG0576|consen 314 RICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMK 386 (829)
T ss_pred hhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCcccc
Confidence 999877 22221111 111245555666777788899999999778998 8888774 789999999876555545
Q ss_pred cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCC
Q 018656 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234 (352)
Q Consensus 182 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 234 (352)
.....+++.++|||+... ..+....|.|++|.-..++.-|.+|-.
T Consensus 387 ~~t~~~~~~~~~pev~~~--------~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQE--------NTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCCCCCCCCchhhcc--------cccccCCCccCCCcchhhcCCCCCCCC
Confidence 566789999999998754 567888999999987777777766643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.33 E-value=9.1e-06 Score=67.38 Aligned_cols=98 Identities=22% Similarity=0.272 Sum_probs=78.3
Q ss_pred HHHHHHHhcCCC-CCeeeeeeeeecCceEEEEEcCCCCCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---C
Q 018656 72 AREVAMLSRVQH-RNLVKFIGACKEPVMVIVTELLSGGTLRKY---LLNMRPRCLDVCVAIGFALDIARAMECLHS---H 144 (352)
Q Consensus 72 ~~E~~~l~~l~h-p~iv~l~~~~~~~~~~lv~e~~~~~sL~~~---l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~ 144 (352)
..|.-+++.+++ +++++++|.|.+ +++.||...+++... +... ...++..+.+|+.++++.+.+++. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~---~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR---FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC---EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888865 699999999865 779999976665421 1111 126899999999999999999998 3
Q ss_pred CCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 145 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 145 ~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
.+.-.|++|+|+-++++ +++|++|.+.+..
T Consensus 82 ~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDD-GRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCC-CcEEEEechhcch
Confidence 58889999999999988 7999999998754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.3e-06 Score=72.22 Aligned_cols=72 Identities=14% Similarity=0.218 Sum_probs=44.5
Q ss_pred ccccCCCce-EEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCC---Ceeeeeeeeec----CceEEE
Q 018656 30 PRIGEGAHA-KVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR---NLVKFIGACKE----PVMVIV 101 (352)
Q Consensus 30 ~~lG~G~~g-~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~l~~~~~~----~~~~lv 101 (352)
+.|+.||.. .||+. +..+++|+...... ...+.+|.++++.+... .+.++++.... +..+++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~~-------~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAGY-------AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccch-------HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457767776 48876 45678887554221 22477888888777421 33444444332 245889
Q ss_pred EEcCCCCCHH
Q 018656 102 TELLSGGTLR 111 (352)
Q Consensus 102 ~e~~~~~sL~ 111 (352)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.2e-05 Score=66.44 Aligned_cols=130 Identities=26% Similarity=0.368 Sum_probs=92.3
Q ss_pred CCceeeeccccCCCc-eEEEEEEECCceEEEEEccc---CCCh---H----------HHHHHHHHHHHHHHHHhcC---C
Q 018656 23 PKHLFVGPRIGEGAH-AKVYEGKYKNQTVAIKIVHK---GETP---E----------EIAKKESRFAREVAMLSRV---Q 82 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~-g~Vy~~~~~~~~vaiK~~~~---~~~~---~----------~~~~~~~~~~~E~~~l~~l---~ 82 (352)
..+++.++.||.|.- |.||+++-.|+.||+|+... .... + ....+..-|..|.+..-+| .
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 378999999999999 99999999999999999321 1110 0 0012334577788877666 4
Q ss_pred CCCe--eeeeeeee-c------------------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 018656 83 HRNL--VKFIGACK-E------------------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141 (352)
Q Consensus 83 hp~i--v~l~~~~~-~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l 141 (352)
+.++ ++.+++.. . ....||.||.+... .+... -+.+|++-+..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHHH
Confidence 5566 88888862 1 02467888876544 12322 256777788899
Q ss_pred HhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 142 H~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
|..||+-+|+++.|.. + -+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc---C---CEEEecccC
Confidence 9999999999999987 2 279999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-05 Score=82.12 Aligned_cols=78 Identities=17% Similarity=0.287 Sum_probs=55.3
Q ss_pred eccccCCCceEEEEEEECC----ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCe--eeeeeeeec----Cc
Q 018656 29 GPRIGEGAHAKVYEGKYKN----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNL--VKFIGACKE----PV 97 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i--v~l~~~~~~----~~ 97 (352)
...++.|.+..+|+....+ ..+++|+........ ....+.+|.++++.+. |++| .+++.++.+ +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~----~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ----SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc----cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 5668999999999987653 468888765432211 1224778999999885 6655 777877765 36
Q ss_pred eEEEEEcCCCCCH
Q 018656 98 MVIVTELLSGGTL 110 (352)
Q Consensus 98 ~~lv~e~~~~~sL 110 (352)
.|+||||++|..+
T Consensus 119 ~flVME~v~G~~~ 131 (822)
T PLN02876 119 AFYIMEYLEGRIF 131 (822)
T ss_pred ceEEEEecCCccc
Confidence 7999999988653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.9e-05 Score=68.63 Aligned_cols=78 Identities=18% Similarity=0.081 Sum_probs=55.9
Q ss_pred eeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC---CCeeeeeeeeec----Cce
Q 018656 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH---RNLVKFIGACKE----PVM 98 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---p~iv~l~~~~~~----~~~ 98 (352)
..-.+.||.|..+.||.....+..+++|..+..... ..+.+|...++.|.. -.+.++++++.. +..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~-------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGNPMPLMARSFSTP-------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCCEEEEEecccccc-------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 334567999999999999876667888885432121 136788888887742 357788877642 468
Q ss_pred EEEEEcCCCCCH
Q 018656 99 VIVTELLSGGTL 110 (352)
Q Consensus 99 ~lv~e~~~~~sL 110 (352)
++|||+++|.++
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.4e-05 Score=67.53 Aligned_cols=136 Identities=18% Similarity=0.173 Sum_probs=78.2
Q ss_pred cccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe-eeeeeeeecCceEEEEEcCCCCC
Q 018656 31 RIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL-VKFIGACKEPVMVIVTELLSGGT 109 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~lv~e~~~~~s 109 (352)
.+..|-...+|+....|+.+++|+......... ....+|.++++.+...++ .+++.... -++|+||++|..
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~-----~~r~~E~~~l~~l~~~g~~P~~i~~~~---~~~v~e~i~G~~ 74 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALG-----VDRQREYQILQALSALGLAPKPILVNE---HWLLVEWLEGEV 74 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCccccccc-----CcHHHHHHHHHHHHhcCCCCceEEEeC---CEEEEEeccCcc
Confidence 356788889999887788999998654322110 013567777777753333 34444332 368999999876
Q ss_pred HHHH--------------HHhcC-----CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCCccCCCC
Q 018656 110 LRKY--------------LLNMR-----PRCLDVC-VAIGFALDI---------ARAMECLHS--------HGIIHRDLK 152 (352)
Q Consensus 110 L~~~--------------l~~~~-----~~~~~~~-~~~~i~~qi---------~~~L~~lH~--------~~ivH~Dik 152 (352)
+... +.+-. ...++.. .+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 5421 11100 1111211 111221111 111222221 248999999
Q ss_pred CCCeEEeCCCCceEEecCCCcccc
Q 018656 153 PENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 153 p~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
|.||+++++ + +.|+||+.+...
T Consensus 155 ~~Nil~~~~-~-~~lIDwE~a~~g 176 (256)
T TIGR02721 155 AYNLVVTPQ-G-LKLIDWEYASDG 176 (256)
T ss_pred cCcEEEeCC-C-CEEEeccccCcC
Confidence 999999986 4 789999988653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00015 Score=60.51 Aligned_cols=132 Identities=20% Similarity=0.318 Sum_probs=86.2
Q ss_pred ccccCCCceEEEEEEECCceEEEEEcccCCChHHH-----------HHHHHHHHHHHHHHhcCC------CCCeeeeeee
Q 018656 30 PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI-----------AKKESRFAREVAMLSRVQ------HRNLVKFIGA 92 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~------hp~iv~l~~~ 92 (352)
..||+|+.-.||..-+ +...+||+.......... ........+|+.....+. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 5699999999996532 345678988776500000 011233455555555444 8889999999
Q ss_pred eecC-ceEEEEEcCC------CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC--C
Q 018656 93 CKEP-VMVIVTELLS------GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--K 163 (352)
Q Consensus 93 ~~~~-~~~lv~e~~~------~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~--~ 163 (352)
.+.+ -..+|+|.+. ..+|.+++.... +++ .. ...+-+-..+|-+.+|+.+|++|+||++.... .
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 8755 4677777653 247999985432 555 33 33444556788899999999999999995431 2
Q ss_pred -ceEEec
Q 018656 164 -TIKLAD 169 (352)
Q Consensus 164 -~vkl~D 169 (352)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 567777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.6e-05 Score=64.78 Aligned_cols=73 Identities=16% Similarity=0.204 Sum_probs=46.6
Q ss_pred eccccCCCceEEEEEEEC---CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC-eeeeeeeeecCceEEEEEc
Q 018656 29 GPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACKEPVMVIVTEL 104 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~~~~~~lv~e~ 104 (352)
.+.|..|-...+|+.... ++.|++|+........ ....+|..+++.+...+ .++++..... .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~------~d~~~E~~~~~~l~~~gl~P~v~~~~~~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI------IDRERELRIHKLLSKHGLAPKLYATFQN---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce------ecHHHHHHHHHHHHhCCCCCeEEEEeCC---cEEEEe
Confidence 356788888999998765 5789999875432111 01236777777774333 3444443332 479999
Q ss_pred CCCCCH
Q 018656 105 LSGGTL 110 (352)
Q Consensus 105 ~~~~sL 110 (352)
++|.++
T Consensus 74 i~G~~l 79 (235)
T cd05157 74 IPGRTL 79 (235)
T ss_pred eCCCcC
Confidence 998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.2e-05 Score=70.60 Aligned_cols=139 Identities=23% Similarity=0.277 Sum_probs=96.1
Q ss_pred ceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHH-----------------HHHHHHHHHHHHHhcCCC--C
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIA-----------------KKESRFAREVAMLSRVQH--R 84 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h--p 84 (352)
=+.+++.||-|--+-||.+-+. |++.++|.-+.....-... -.+-...+|.+.|+.|.- -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4567899999999999999886 9999999655433322111 111123357777777732 2
Q ss_pred CeeeeeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCc
Q 018656 85 NLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (352)
Q Consensus 85 ~iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~ 164 (352)
-|.+.+ .....++|||++.|..|.+.-.- .+. -.+...+..-+.-|-..|+||+|..--||+|+++ +.
T Consensus 173 pVPkpi---D~~RH~Vvmelv~g~Pl~~v~~v-----~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~ 240 (465)
T KOG2268|consen 173 PVPKPI---DHNRHCVVMELVDGYPLRQVRHV-----EDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD-DK 240 (465)
T ss_pred CCCCcc---cccceeeHHHhhcccceeeeeec-----CCh---HHHHHHHHHHHHHHHHcCceecccchheeEEecC-CC
Confidence 233333 33456899999999888764321 222 2345556666777889999999999999999987 78
Q ss_pred eEEecCCCccc
Q 018656 165 IKLADFGLARE 175 (352)
Q Consensus 165 vkl~Dfg~a~~ 175 (352)
++++||-....
T Consensus 241 i~vIDFPQmvS 251 (465)
T KOG2268|consen 241 IVVIDFPQMVS 251 (465)
T ss_pred EEEeechHhhc
Confidence 99999987654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.89 E-value=7.3e-05 Score=66.94 Aligned_cols=138 Identities=20% Similarity=0.212 Sum_probs=80.2
Q ss_pred eccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCC--Ceeeeeeee-------ecCceE
Q 018656 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR--NLVKFIGAC-------KEPVMV 99 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~l~~~~-------~~~~~~ 99 (352)
.+.|..|....+|+....+..+++|+... .... .+..|++++..+.+. .+.+.+... ..+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~-~~~~-------~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK-VSAE-------ELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC-CChH-------hccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56688888899999877777899998764 2211 244566666655322 234443321 134578
Q ss_pred EEEEcCCCCCHHH-----------HHHhc----CC--C------CCCHHHH----------HHHHHHHHHHHHHHHh---
Q 018656 100 IVTELLSGGTLRK-----------YLLNM----RP--R------CLDVCVA----------IGFALDIARAMECLHS--- 143 (352)
Q Consensus 100 lv~e~~~~~sL~~-----------~l~~~----~~--~------~~~~~~~----------~~i~~qi~~~L~~lH~--- 143 (352)
+|+++++|..+.. .+.+- .. . ...+... ......+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876432 01000 00 0 0000000 0011112233444443
Q ss_pred ----CCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 144 ----HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 144 ----~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
.+++|+|+.|.||+++++ +.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence 479999999999999986 5668999998653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00023 Score=64.44 Aligned_cols=31 Identities=35% Similarity=0.568 Sum_probs=26.0
Q ss_pred CCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 144 ~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
.+++|+|+.|.||+++.+ ...-++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGD-RLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence 389999999999999865 4457999998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00047 Score=62.09 Aligned_cols=143 Identities=21% Similarity=0.251 Sum_probs=81.1
Q ss_pred ceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCC--Ceeeeeeee-------ec
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR--NLVKFIGAC-------KE 95 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~l~~~~-------~~ 95 (352)
...-++.++.|....+|+....+..+++|+.......+. +..|.+++..|... .+.+.+... .+
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~~~-------i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVKAEE-------LPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCCCCHHH-------HHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 344567788888889999876666788998765332222 33455555555211 133443321 13
Q ss_pred CceEEEEEcCCCCCHH-----------HHHHhcC--CCCCC-------HHHHHH----------------HHHHHHHHHH
Q 018656 96 PVMVIVTELLSGGTLR-----------KYLLNMR--PRCLD-------VCVAIG----------------FALDIARAME 139 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~-----------~~l~~~~--~~~~~-------~~~~~~----------------i~~qi~~~L~ 139 (352)
+..+++++|++|.++. ..+.+.. ...++ ....+. ....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 4578999999885432 1111000 00000 000000 0111233455
Q ss_pred HHHh-------CCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 140 CLHS-------HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 140 ~lH~-------~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
++.. .+++|+|+.+.|++++.+ +.+.++||+.+..
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~ 217 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFACT 217 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECC-ceEEEeecccccC
Confidence 5532 589999999999999987 5668999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00095 Score=61.79 Aligned_cols=79 Identities=22% Similarity=0.124 Sum_probs=50.6
Q ss_pred eccccCCCceEEEEEEECC--ceEEEEEcccCCC--hHHHHHHHHHHHHHHHHHhcCC---CCCeeeeeeeeecCceEEE
Q 018656 29 GPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGET--PEEIAKKESRFAREVAMLSRVQ---HRNLVKFIGACKEPVMVIV 101 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~--~~vaiK~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~~~~~lv 101 (352)
.+.||.|.+..||++.+.+ +.++||....... .+.-.....+...|.+.|+.+. ..++++++.+ .+...++|
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-D~~~~~lV 109 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-DEELAVTV 109 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-CCCCCEEE
Confidence 3569999999999998864 4899998542211 0000011234566777777652 3456666666 33457899
Q ss_pred EEcCCCC
Q 018656 102 TELLSGG 108 (352)
Q Consensus 102 ~e~~~~~ 108 (352)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=5.5e-06 Score=85.45 Aligned_cols=155 Identities=12% Similarity=0.027 Sum_probs=112.6
Q ss_pred HHHHHHHHhcCCCCCeeeeeeeee---cCceEEEEEcCCCCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 018656 71 FAREVAMLSRVQHRNLVKFIGACK---EPVMVIVTELLSGGTLRKYLLNMRPR--CLDVCVAIGFALDIARAMECLHSHG 145 (352)
Q Consensus 71 ~~~E~~~l~~l~hp~iv~l~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~ 145 (352)
...|...++...|+++.....-.. ....+..++|+.+|.+.+.|.+.-.+ .+.+..+.....+.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555566678998887766543 23578999999999999998764322 2333333333334466667777652
Q ss_pred -----CccCCCCCCCeEEeCCCCceEEecCCCcc-ccccccccccCCCcccccccccccccccccccccCCCcccchhhH
Q 018656 146 -----IIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 219 (352)
Q Consensus 146 -----ivH~Dikp~Nili~~~~~~vkl~Dfg~a~-~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 219 (352)
.+|+++|+.|.+|..+ -+++++++|+.+ ............+++.|++|++... -.++.++|+|.+
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~--------ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE--------IKFTKRSDILRR 1426 (2724)
T ss_pred cCCccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH--------HhhhhHHHHHHH
Confidence 6899999999999887 589999999998 4333344456678889999998754 567778999999
Q ss_pred HHHHHHHHhCCCCCC
Q 018656 220 AIVLWELLHNKLPFE 234 (352)
Q Consensus 220 G~il~~ll~g~~p~~ 234 (352)
|+-+|....|..+|.
T Consensus 1427 s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHhcccHHHH
Confidence 999999998877764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00013 Score=68.03 Aligned_cols=152 Identities=16% Similarity=0.164 Sum_probs=93.1
Q ss_pred HHHHHHHHhcCCCCCeeeeeeeeecC--ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 018656 71 FAREVAMLSRVQHRNLVKFIGACKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148 (352)
Q Consensus 71 ~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH 148 (352)
+....++++.+.|+|...++++.... +..+|+|++ +.||++.+..+.-. .. ++. +|
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~---~~-------s~~-----------~~ 86 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLK---DE-------SLL-----------AH 86 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccc---hh-------hhc-----------cc
Confidence 55667889999999999999997643 688999999 78999988764311 10 111 22
Q ss_pred CCCCCCCeEEeCCCCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh
Q 018656 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 228 (352)
Q Consensus 149 ~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~ 228 (352)
+=+ +.| ....+| .++... |- ...+++||||+|.++.++.-
T Consensus 87 ~~~-~~~--------~~~~td-~~~t~~-----------------~~-------------~~~pKsdVwsl~~i~~el~L 126 (725)
T KOG1093|consen 87 GVL-HLN--------IIYITD-HFLTKY-----------------PS-------------PIGPKSDVWSLGFIILELYL 126 (725)
T ss_pred ccc-eeh--------hhhccc-cccccC-----------------CC-------------CCCcchhhhhHHHHHHHHHH
Confidence 211 112 223333 111000 11 11248999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhccCCCC-----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q 018656 229 NKLPFEGMSNLQAAYAAAFKNVRPS-----------AENVPEELSIILTSCWKEDPNARPNFTQIIQ 284 (352)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~ 284 (352)
|..-+......+...........+. .-.++..+.++...|+...|..||...++.+
T Consensus 127 ~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 127 GISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred hhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 8776665444444333333222221 1124455667888899999988886655543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00039 Score=62.41 Aligned_cols=74 Identities=20% Similarity=0.291 Sum_probs=45.4
Q ss_pred ccccCCCceEEEEEEEC--------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC-eeeeeeeeecCceEE
Q 018656 30 PRIGEGAHAKVYEGKYK--------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACKEPVMVI 100 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~~~~~~l 100 (352)
+.|..|-...+|+.... ++.+++|+........ ....+|.++++.+...+ ..+++..+.+ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~------~~r~~E~~~~~~l~~~g~~P~~~~~~~~---~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELL------IDRERELVVFARLSERNLGPKLYGIFPN---GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcce------echHHHHHHHHHHHhCCCCCceEEEeCC---Cc
Confidence 44667777789988754 4789999966532211 12456777777664322 3455555443 35
Q ss_pred EEEcCCCCCHHH
Q 018656 101 VTELLSGGTLRK 112 (352)
Q Consensus 101 v~e~~~~~sL~~ 112 (352)
|+||++|.++..
T Consensus 75 v~e~i~G~~l~~ 86 (302)
T cd05156 75 IEEFIPSRTLTT 86 (302)
T ss_pred hhheeCCCcCCH
Confidence 889988876643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0011 Score=58.64 Aligned_cols=32 Identities=31% Similarity=0.549 Sum_probs=25.6
Q ss_pred CCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 145 ~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.++|+|++|.||+++++....-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 37999999999999975233569999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0012 Score=60.30 Aligned_cols=149 Identities=21% Similarity=0.313 Sum_probs=84.4
Q ss_pred ccce--ecCCceeeeccccCCCceEEEEEEEC------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe-e
Q 018656 17 AKWL--IDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL-V 87 (352)
Q Consensus 17 ~~~~--i~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v 87 (352)
..|. .+.+...+. .|..|-.-.+|++... ++.|++|+...... . ..++ .+|..+++.+..-++ .
T Consensus 28 ~~w~~~~~~~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~----~idR-~~E~~~~~~l~~~gl~P 100 (344)
T PLN02236 28 SKWGDVVDDEALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-L----FFDR-DDEIRTFECMSRHGQGP 100 (344)
T ss_pred chhcCCCCcCcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-e----eech-HHHHHHHHHHHHcCCCC
Confidence 4474 245555555 4555888899998753 36899998765421 1 1122 467777777754333 3
Q ss_pred eeeeeeecCceEEEEEcCCCCCHHHH--------------HHhc---C-C--C-CCCHHHHHHHHHHH------------
Q 018656 88 KFIGACKEPVMVIVTELLSGGTLRKY--------------LLNM---R-P--R-CLDVCVAIGFALDI------------ 134 (352)
Q Consensus 88 ~l~~~~~~~~~~lv~e~~~~~sL~~~--------------l~~~---~-~--~-~~~~~~~~~i~~qi------------ 134 (352)
++++.+..+ .|.+|+++.+|... +.+- . . . ......+..+..++
T Consensus 101 ~~~~~~~~g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~ 177 (344)
T PLN02236 101 RLLGRFPNG---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEF 177 (344)
T ss_pred ceEEEECCc---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhc
Confidence 555655443 57889887666421 0000 0 0 0 11112222222111
Q ss_pred --------HHHHHH-HH----hCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 135 --------ARAMEC-LH----SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 135 --------~~~L~~-lH----~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+..|.. +. ...++|+|+++.||+++++.+.+.++||..+..
T Consensus 178 ~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 178 RLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 111111 11 225899999999999987546799999998764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0031 Score=56.42 Aligned_cols=139 Identities=20% Similarity=0.265 Sum_probs=84.5
Q ss_pred eeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC--CCeeeeeeeeec---CceEEEE
Q 018656 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACKE---PVMVIVT 102 (352)
Q Consensus 28 ~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~---~~~~lv~ 102 (352)
+.+.+..|..-.+|....++++++++ ....... ........+|..+++.+.- --+...++.|.+ +..|.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~---~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDP---VESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe-cCCcccc---chhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 33445555555667777778999999 3221111 1223346678888877743 223444566653 3579999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHH-HHHHHHHHHHHh--------------------------------------
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFA-LDIARAMECLHS-------------------------------------- 143 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~-~qi~~~L~~lH~-------------------------------------- 143 (352)
+|++|..+.+...... .. .+.+ ..+++.|+.||+
T Consensus 105 ~~veGe~~~~~~~~~~---~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 105 EWVEGEVVWSALPPES---LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEecceeccCcCCccc---ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 9998853333221100 11 1112 355555666663
Q ss_pred --------------------CCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 144 --------------------HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 144 --------------------~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
..++|+|+.+.|++++++ +.+=++||+.+...++
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lGDP 231 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATLGDP 231 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEeccccccCCc
Confidence 137999999999999998 4588999999876443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0027 Score=57.20 Aligned_cols=142 Identities=23% Similarity=0.274 Sum_probs=89.5
Q ss_pred eccccCCCceEEEEEEEC-CceEEEEEcccC-----------------------CChHHHHHHHHHHHHHHHHHhcCCCC
Q 018656 29 GPRIGEGAHAKVYEGKYK-NQTVAIKIVHKG-----------------------ETPEEIAKKESRFAREVAMLSRVQHR 84 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~-----------------------~~~~~~~~~~~~~~~E~~~l~~l~hp 84 (352)
--+|..|--+.||-|... |..+|||+++.. ..+....+. =...|++-|++|+..
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~--WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKT--WAEKEMRNLKRLNNA 226 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHH--HHHHHHHHHHHHHhc
Confidence 356889999999999775 888999987541 111111111 123577778888655
Q ss_pred CeeeeeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCCeEEeCCCC
Q 018656 85 NLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPENLLLTEDLK 163 (352)
Q Consensus 85 ~iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l-H~~~ivH~Dikp~Nili~~~~~ 163 (352)
.|. .-....-....|||+++....--.-.- ....++...+..+-.|++.-+.-| |..++||.||.--|+|+.. |
T Consensus 227 GIP-~PePIlLk~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd--G 301 (520)
T KOG2270|consen 227 GIP-CPEPILLKNHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD--G 301 (520)
T ss_pred CCC-CCCceeeecceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC--C
Confidence 532 222222224589999994322111010 112366666666666666666555 4558999999999999987 5
Q ss_pred ceEEecCCCccccc
Q 018656 164 TIKLADFGLAREES 177 (352)
Q Consensus 164 ~vkl~Dfg~a~~~~ 177 (352)
.+.++|.+.+....
T Consensus 302 ~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEEccccccCC
Confidence 89999999876543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0072 Score=55.93 Aligned_cols=86 Identities=19% Similarity=0.054 Sum_probs=53.9
Q ss_pred eeccccCCCceEEEEEEECCceEEEEEcccCCC--hHHHHHHHHHHHHHHHHHhcCC---CCCeeeeeeeeecCceEEEE
Q 018656 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET--PEEIAKKESRFAREVAMLSRVQ---HRNLVKFIGACKEPVMVIVT 102 (352)
Q Consensus 28 ~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~~~~~lv~ 102 (352)
-.+.||.|....||+..+.+..++||.-..... .+.-.....+-..|...|+.+. ...+.+++.++.+. .+++|
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~-~vlvM 114 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM-ALIGM 114 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC-CEEEE
Confidence 356789999999999988777899997662211 0000001223344566665553 35778888887744 57789
Q ss_pred EcCCC--CCHHHHH
Q 018656 103 ELLSG--GTLRKYL 114 (352)
Q Consensus 103 e~~~~--~sL~~~l 114 (352)
|++++ ..+.+.+
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99976 2444444
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0034 Score=57.12 Aligned_cols=144 Identities=17% Similarity=0.184 Sum_probs=79.4
Q ss_pred cCCceeeeccccCCCceEEEEEEECC-----ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe-eeeeeeeec
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL-VKFIGACKE 95 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~ 95 (352)
+.+...+... ..|-...+|+....+ ..|++|+........ .+ -.+|..+++.+..-++ .++++++..
T Consensus 13 ~~~~i~i~~l-~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-----Id-R~~E~~il~~l~~~gl~P~~l~~~~~ 85 (330)
T PLN02421 13 DDSDFSVERI-SGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-----ID-RERELQAIKYLSAAGFGAKLLGVFGN 85 (330)
T ss_pred CcCceEEEEe-CCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-----ec-hHHHHHHHHHHHhcCCCCceeEEeCC
Confidence 3445555554 448888899886543 379999876532211 11 2467777777754444 355555533
Q ss_pred CceEEEEEcCCCCCHHH--------------HHHhcCCCC------C-CHHHHHHHHHHH--------------------
Q 018656 96 PVMVIVTELLSGGTLRK--------------YLLNMRPRC------L-DVCVAIGFALDI-------------------- 134 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~--------------~l~~~~~~~------~-~~~~~~~i~~qi-------------------- 134 (352)
+ +|.+|++|..|.. .+.+-.... . ....+..+..++
T Consensus 86 G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~ 162 (330)
T PLN02421 86 G---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFE 162 (330)
T ss_pred c---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHH
Confidence 3 4888887765532 111100000 1 112222222211
Q ss_pred -----HHHHHHHH-hCC----CccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 135 -----ARAMECLH-SHG----IIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 135 -----~~~L~~lH-~~~----ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+..+..+. ..+ ++|+|+.+.||+++++.+.++++||..|-.
T Consensus 163 ~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 163 ELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11122222 112 699999999999986546899999998754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0022 Score=58.29 Aligned_cols=77 Identities=22% Similarity=0.125 Sum_probs=45.6
Q ss_pred cccCCCceEEEEEEECC--ceEEEEEcccCCC--hHHHHHHHHHHHHHHHHHhcCC--CCCeeeeeeeeecCceEEEEEc
Q 018656 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGET--PEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGACKEPVMVIVTEL 104 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~~~--~~vaiK~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~lv~e~ 104 (352)
.||.|....||++.+.+ +.++||.-..... .+.-.....+..-|...|+... -|..++-+-.+......++||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 47999999999998764 5899996532110 0000011223445666666653 3444443444455567799999
Q ss_pred CCC
Q 018656 105 LSG 107 (352)
Q Consensus 105 ~~~ 107 (352)
++.
T Consensus 82 L~~ 84 (370)
T TIGR01767 82 LSH 84 (370)
T ss_pred Ccc
Confidence 954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0018 Score=59.50 Aligned_cols=79 Identities=22% Similarity=0.178 Sum_probs=48.1
Q ss_pred eccccCCCceEEEEEEEC--CceEEEEEcccCCC-hHHHHHHHHHHHHHHHHHhcCC--CCCeeeeeeeeecCceEEEEE
Q 018656 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGET-PEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGACKEPVMVIVTE 103 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~lv~e 103 (352)
.+.||-|.-..||++.+. ++.++||.-...-. .+.-.-...|..-|.+.|+.+. -|..++-+-.+......+|||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vME 113 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVME 113 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHH
Confidence 566899999999999985 67899986432111 0000111234455667776652 354444444445556788999
Q ss_pred cCCC
Q 018656 104 LLSG 107 (352)
Q Consensus 104 ~~~~ 107 (352)
+++.
T Consensus 114 dL~~ 117 (409)
T PRK12396 114 DLSD 117 (409)
T ss_pred hCcc
Confidence 9854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.013 Score=49.27 Aligned_cols=84 Identities=14% Similarity=0.174 Sum_probs=56.7
Q ss_pred HHHHHHHHhcCCCCCeeeeeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcc
Q 018656 71 FAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--GIIH 148 (352)
Q Consensus 71 ~~~E~~~l~~l~hp~iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--~ivH 148 (352)
+.++.+++.++ -.|+++..- ..-...++.|+|-.... ..- .++.-=+.+|.-.|+. +.+|
T Consensus 105 y~nky~v~Arm--hGilrL~ND-n~~~yGvIlE~Cy~~~i-----------~~~----N~i~agi~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 105 YFNKYRVFARM--HGILRLKND-NNYKYGVILERCYKIKI-----------NFS----NFITAGIKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhhHHHHh--hheeEeecC-CCceeEEEEeeccCccc-----------chh----HHHHHhHHHHHHhhccCCCeec
Confidence 56777887766 357777632 11246789999833110 111 1122225678888954 6999
Q ss_pred CCCCCCCeEEeCCCCceEEecCCCc
Q 018656 149 RDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 149 ~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+|..|+|||-+.. |.+||.|-+..
T Consensus 167 GD~np~NiM~D~~-G~lKlVDP~~L 190 (308)
T PF07387_consen 167 GDCNPDNIMCDKF-GYLKLVDPVCL 190 (308)
T ss_pred CCCChhheeecCC-CCEEecChhhh
Confidence 9999999999998 89999998854
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.04 Score=49.88 Aligned_cols=136 Identities=23% Similarity=0.300 Sum_probs=77.5
Q ss_pred ccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC---CC---eeeeeeee---ecC--ceEE
Q 018656 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH---RN---LVKFIGAC---KEP--VMVI 100 (352)
Q Consensus 32 lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---p~---iv~l~~~~---~~~--~~~l 100 (352)
|.+ .-..+|+....+..+++|+........ .+..|++.+..|.- += +..+-|-. ..+ ..+-
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~~~~~-------~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPGWTRA-------EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCCCCHH-------HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 444 556688888876667999988763322 24556666666621 11 22222211 123 7789
Q ss_pred EEEcCCCCCHHH------------HHH-------hcC---CC---CCCHH----H---------HHHHHHHHHHHHHHHH
Q 018656 101 VTELLSGGTLRK------------YLL-------NMR---PR---CLDVC----V---------AIGFALDIARAMECLH 142 (352)
Q Consensus 101 v~e~~~~~sL~~------------~l~-------~~~---~~---~~~~~----~---------~~~i~~qi~~~L~~lH 142 (352)
+++|++|..+.. ++- ... +. ...+. . -.....++...++.+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999987772 110 000 00 01111 0 0002223444444444
Q ss_pred hC--------C--CccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 143 SH--------G--IIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 143 ~~--------~--ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+. + +||+|+.|.||+++.+...+-++||+.+..
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 32 3 999999999999998722488999998754
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.037 Score=46.85 Aligned_cols=75 Identities=17% Similarity=0.195 Sum_probs=52.6
Q ss_pred eccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC---CCCeeeeeeeee-cCceEEEEEc
Q 018656 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRNLVKFIGACK-EPVMVIVTEL 104 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~-~~~~~lv~e~ 104 (352)
.+.+.-|..-..|...+...++.+|+-.. ...+.|..|+.-|+.|. .-.|.+++.+.. ..+.|+|+||
T Consensus 21 r~~v~gG~inea~~v~dg~~~~FvK~n~~--------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~ 92 (286)
T COG3001 21 REEVSGGDINEAWRLRDGTDPFFVKCNQR--------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY 92 (286)
T ss_pred ccccCCccccceeEeecCCcceEEEecch--------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence 34566677777787777788999998432 33445777777666663 445677777754 4589999999
Q ss_pred CCCCCHH
Q 018656 105 LSGGTLR 111 (352)
Q Consensus 105 ~~~~sL~ 111 (352)
++-+.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9876665
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.025 Score=50.26 Aligned_cols=75 Identities=15% Similarity=0.159 Sum_probs=44.8
Q ss_pred eeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC---CCCCeeeeeeeee-cCceEEE
Q 018656 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACK-EPVMVIV 101 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~-~~~~~lv 101 (352)
.+-.+.++.|....+|+....++.+.+|+-..... ..+..|.+-|+.| ..-.+++++.+.. ++..++|
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~--------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR--------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC--------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhhH--------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 44557789999999999987889999998763221 1356677666666 3445667777765 3456999
Q ss_pred EEcCCCC
Q 018656 102 TELLSGG 108 (352)
Q Consensus 102 ~e~~~~~ 108 (352)
+||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.041 Score=49.08 Aligned_cols=74 Identities=20% Similarity=0.253 Sum_probs=44.5
Q ss_pred cCCCceEEEEEEEC----------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-------------CCCeeee
Q 018656 33 GEGAHAKVYEGKYK----------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-------------HRNLVKF 89 (352)
Q Consensus 33 G~G~~g~Vy~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------------hp~iv~l 89 (352)
|.|-.|.+|++..+ ...++||.................+.+|+.+.+.+- ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 67888889876542 235888987633333333344566778887766551 1234555
Q ss_pred eeeeecC-ceEEEEEcCC
Q 018656 90 IGACKEP-VMVIVTELLS 106 (352)
Q Consensus 90 ~~~~~~~-~~~lv~e~~~ 106 (352)
+....++ ...||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 5554443 4788888773
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.053 Score=50.27 Aligned_cols=80 Identities=18% Similarity=0.304 Sum_probs=46.2
Q ss_pred cCCceeeeccccCCCceEEEEEEECC---ce-----EEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe-eeeeee
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYKN---QT-----VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL-VKFIGA 92 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~-----vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~ 92 (352)
+.+...+ +.|..|-...+|++...+ .. |.+++... ..... .+ -.+|+++++.+...++ .++++.
T Consensus 49 ~~~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~----Id-R~~E~~i~~~Ls~~glgP~l~~~ 121 (383)
T PTZ00384 49 NPEFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLV----ID-NDLQYNIAKLLGDNNFGPKIIGR 121 (383)
T ss_pred CcccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceE----ec-cHHHHHHHHHHHhCCCCCeEEEe
Confidence 3344444 456569999999987542 22 44444221 11111 11 2468888888865555 455555
Q ss_pred eecCceEEEEEcCCCCCHH
Q 018656 93 CKEPVMVIVTELLSGGTLR 111 (352)
Q Consensus 93 ~~~~~~~lv~e~~~~~sL~ 111 (352)
+.. ++|.||++|.+|.
T Consensus 122 f~~---g~l~efIeGr~l~ 137 (383)
T PTZ00384 122 FGD---FTIQEWVEGNTMG 137 (383)
T ss_pred cCC---EEEEEEeccccCC
Confidence 543 6899999887664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.12 Score=54.33 Aligned_cols=32 Identities=38% Similarity=0.511 Sum_probs=26.0
Q ss_pred CCCccCCCCCCCeEEeCCC-CceE-EecCCCccc
Q 018656 144 HGIIHRDLKPENLLLTEDL-KTIK-LADFGLARE 175 (352)
Q Consensus 144 ~~ivH~Dikp~Nili~~~~-~~vk-l~Dfg~a~~ 175 (352)
.++||+|+.+.||+++.+. +.+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998762 1455 999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.12 Score=46.47 Aligned_cols=30 Identities=20% Similarity=0.243 Sum_probs=26.7
Q ss_pred CCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 145 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 145 ~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+++|+|+.++|++++.+ +.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 79999999999999887 6789999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.077 Score=50.17 Aligned_cols=83 Identities=16% Similarity=0.227 Sum_probs=49.6
Q ss_pred cce-ecCCceeeeccccCCCceEEEEEEEC----------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018656 18 KWL-IDPKHLFVGPRIGEGAHAKVYEGKYK----------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86 (352)
Q Consensus 18 ~~~-i~~~~y~~~~~lG~G~~g~Vy~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 86 (352)
.|. +..+.. -++.|..|-.-.+|++... ++.|++++........ . .-.+|..+++.+..-+|
T Consensus 99 ~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-----I-dR~~E~~v~~~ls~~gi 171 (442)
T PTZ00296 99 EWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-----Y-NPISEFEVYKTMSKYRI 171 (442)
T ss_pred ccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-----e-CHHHHHHHHHHHHHCCC
Confidence 365 334555 6677778888889988753 4679999875532211 1 12346666666644344
Q ss_pred e-eeeeeeecCceEEEEEcCCCCCH
Q 018656 87 V-KFIGACKEPVMVIVTELLSGGTL 110 (352)
Q Consensus 87 v-~l~~~~~~~~~~lv~e~~~~~sL 110 (352)
- ++++.+.. +.|.+|++|.+|
T Consensus 172 ~P~l~~~f~g---g~I~efi~g~~l 193 (442)
T PTZ00296 172 APQLLNTFSG---GRIEEWLYGDPL 193 (442)
T ss_pred CCceEEEeCC---CEEEEeeCCccC
Confidence 2 45555443 457888887644
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.031 Score=50.55 Aligned_cols=70 Identities=19% Similarity=0.285 Sum_probs=55.1
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+.|++|++. |++|.- +. .....++..++.+.+..++-+..+ ..-|||+.-.||+|+ . |+|.|+||-+++.
T Consensus 300 y~yl~~kdh-gt~is~-ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISI-IK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-GNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeee-ee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c-CceEEEEeeeeec
Confidence 678888887 666543 22 145677888888888887777766 588999999999999 4 7999999999984
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.06 Score=49.47 Aligned_cols=61 Identities=20% Similarity=0.217 Sum_probs=43.3
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCccCCCCCCCeEEeCC
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC-LHSHGIIHRDLKPENLLLTED 161 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~-lH~~~ivH~Dikp~Nili~~~ 161 (352)
..++-+|..|-++..++.-.. .++.....++.-...||-. +--.+++|.|+.|.||++.-.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 467778888999999987533 4555555555555555443 334579999999999999543
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.79 Score=41.59 Aligned_cols=29 Identities=31% Similarity=0.358 Sum_probs=23.9
Q ss_pred CCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 144 ~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
.+++|+|+.+.||+++ + .+.++||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D--GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C--CcEEEeCCCCCC
Confidence 3689999999999995 3 367999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 352 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-36 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-35 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-34 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-34 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-34 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-34 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-34 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-34 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-34 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-34 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-33 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-33 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-33 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-33 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-33 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-33 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-32 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-31 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-31 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-30 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-30 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-30 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-30 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-30 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-30 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-30 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-30 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-30 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-30 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-30 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-30 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-30 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-30 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-30 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-30 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-29 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-29 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-29 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-29 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-29 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-29 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-29 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-29 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-29 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-29 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-29 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-29 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-29 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-29 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-29 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-29 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-29 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-28 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-28 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-28 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-28 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-28 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-28 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-28 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-28 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-28 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-28 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-28 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-28 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-28 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-28 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-28 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-28 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-28 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-28 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-28 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-28 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-28 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-27 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-27 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-27 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-27 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-27 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-27 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-27 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-27 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-27 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-27 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-27 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-27 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-27 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-27 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-27 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-27 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-27 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-27 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-27 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-27 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-27 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-27 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-27 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-27 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-27 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-27 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-27 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-27 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-27 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-26 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-26 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-26 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-26 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-26 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-26 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-26 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-26 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-26 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-26 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-26 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-26 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-26 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-26 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-26 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-26 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-26 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-26 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-26 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-26 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-26 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-26 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-26 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-26 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-26 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-26 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-26 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-26 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-26 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-25 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-25 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-25 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-25 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-25 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-25 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-25 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-25 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-25 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-25 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-25 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-25 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-25 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-25 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-25 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-25 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-25 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-25 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-25 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-25 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-25 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-25 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-24 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-24 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-24 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-24 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-24 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-24 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-24 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-24 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-24 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-24 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-24 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-24 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-24 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-24 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-24 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-24 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-24 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-24 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-24 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-24 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-24 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-24 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-24 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-24 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-24 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-24 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-24 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-24 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-24 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-24 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-24 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-24 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-24 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-24 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-24 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-24 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-24 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-24 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-24 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-24 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-24 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-24 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-24 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-23 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-23 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-23 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-23 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-23 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-23 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-23 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-22 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-22 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-22 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-22 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-22 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-22 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-22 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-22 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-22 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-22 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-22 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-22 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-22 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-22 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-22 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-22 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-22 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-21 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-21 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-21 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-21 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-21 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-20 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-20 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-20 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-20 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-19 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-19 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-19 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-19 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-19 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-16 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-16 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-16 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-15 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-15 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-15 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-15 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-15 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-14 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-12 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-09 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-09 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 6e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-09 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 6e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-123
Identities = 95/291 (32%), Positives = 149/291 (51%), Gaps = 22/291 (7%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
I L + +IG G+ V+ ++ VA+KI+ + + E F REVA++
Sbjct: 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVN---EFLREVAIM 88
Query: 79 SRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIAR 136
R++H N+V F+GA + P + IVTE LS G+L + L R LD + A D+A+
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 137 AMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMA 193
M LH+ I+HR+LK NLL+ + T+K+ DFGL+R ++ T + GT WMA
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253
PE+ + N K D YSF ++LWEL + P+ ++ Q A FK R
Sbjct: 208 PEVL--------RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259
Query: 254 A-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 303
N+ +++ I+ CW +P RP+F I+ +L + + PP P+R
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP----PNR 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 350 bits (899), Expect = e-121
Identities = 93/317 (29%), Positives = 150/317 (47%), Gaps = 28/317 (8%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+ID K + V +G GA V + K++ + VAIK + + F E+ L
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKA-------FIVELRQL 55
Query: 79 SRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARA 137
SRV H N+VK GAC PV +V E GG+L L P A+ + L ++
Sbjct: 56 SRVNHPNIVKLYGACLNPVC-LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 138 MECLHSH---GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAP 194
+ LHS +IHRDLKP NLLL +K+ DFG A + + MT G+ WMAP
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAP 172
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-QAAYAAAFKNVRPS 253
E++ E +Y+ K D +S+ I+LWE++ + PF+ + A RP
Sbjct: 173 EVF--------EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224
Query: 254 -AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTIL 312
+N+P+ + ++T CW +DP+ RP+ +I++++ + + + + + +S L
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS----L 280
Query: 313 PPESPGTSSLMTVRDDI 329
PP G +
Sbjct: 281 PPGEDGRVEPYVDFAEF 297
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 346 bits (890), Expect = e-120
Identities = 66/278 (23%), Positives = 127/278 (45%), Gaps = 19/278 (6%)
Query: 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFARE 74
++ ID K L ++ E ++++G+++ + +K++ + ++ F E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSR---DFNEE 57
Query: 75 VAMLSRVQHRNLVKFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
L H N++ +GAC+ P ++T + G+L L +D A+ FA
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 132 LDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
LD+AR M LH+ I L ++++ ED+ T +++ +
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVKFSFQ----SPGRMYAP 172
Query: 190 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249
W+APE L++ + D +SFA++LWEL+ ++PF +SN++ A +
Sbjct: 173 AWVAPEA-----LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG 227
Query: 250 VRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+RP+ + +S ++ C EDP RP F I+ +L
Sbjct: 228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-119
Identities = 89/280 (31%), Positives = 137/280 (48%), Gaps = 25/280 (8%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
ID L + IG G KVY + VA+K + E+I++ +E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARH-DPDEDISQTIENVRQEAKLF 60
Query: 79 SRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ ++H N++ G C KEP + +V E GG L + L + + + + +A+ IAR
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARG 117
Query: 138 MECLHSHG---IIHRDLKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETG 187
M LH IIHRDLK N+L+ + + K +K+ DFGLARE T M+A G
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AG 176
Query: 188 TYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 247
Y WMAPE+ ++ D +S+ ++LWELL ++PF G+ L AY A
Sbjct: 177 AYAWMAPEVI--------RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 248 KNVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+ PE + ++ CW DP++RP+FT I+ L
Sbjct: 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 346 bits (889), Expect = e-119
Identities = 82/288 (28%), Positives = 138/288 (47%), Gaps = 23/288 (7%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES 69
E + + +IG+G V++G+ VAIK + G++ E E
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 70 R--FAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
F REV ++S + H N+VK G P +V E + G L LL+ + + V
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRLLD-KAHPIKWSVK 124
Query: 128 IGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLK----TIKLADFGLAREESLTEM 181
+ LDIA +E + + I+HRDL+ N+ L + K+ADFGL+++
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHS 182
Query: 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 241
++ G ++WMAPE E++ Y K D+YSFA++L+ +L + PF+ S +
Sbjct: 183 VSGLLGNFQWMAPETIG------AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 242 AYAAA--FKNVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+ + +RP+ E+ P L ++ CW DP RP+F+ I++ L
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 341 bits (876), Expect = e-117
Identities = 77/279 (27%), Positives = 134/279 (48%), Gaps = 18/279 (6%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAM 77
+W I + L +G IG+G +VY G++ VAI+++ E+ K F REV
Sbjct: 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLK---AFKREVMA 82
Query: 78 LSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+ +H N+V F+GAC P + I+T L G TL + + + LDV A +I +
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVK 141
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT------EMMTAETGTYR 190
M LH+ GI+H+DLK +N+ D + + DFGL + + + + G
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 191 WMAPELYSTVTL-RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249
+APE+ ++ + +K ++ D ++ + +EL + PF+ +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-TG 258
Query: 250 VRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
++P S + +E+S IL CW + RP FT+++ ML
Sbjct: 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-114
Identities = 86/294 (29%), Positives = 143/294 (48%), Gaps = 19/294 (6%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M+ + W I + VG RIG G+ VY+GK+ VA+K+++
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP 59
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
+ + F EV +L + +H N++ F+G P + IVT+ G +L +L +
Sbjct: 60 TPQQLQ---AFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETK 116
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
++ I A AR M+ LH+ IIHRDLK N+ L ED T+K+ DFGLA E+S
Sbjct: 117 -FEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWS 174
Query: 181 ---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237
+G+ WMAPE+ +R + Y+ + D Y+F IVL+EL+ +LP+ ++
Sbjct: 175 GSHQFEQLSGSILWMAPEV-----IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229
Query: 238 NLQAAYAA-AFKNVRPSA----ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
N ++ P N P+ + ++ C K+ + RP+F +I+ +
Sbjct: 230 NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 4e-98
Identities = 79/304 (25%), Positives = 124/304 (40%), Gaps = 31/304 (10%)
Query: 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVA 76
+ P L G +G+G + + ++ + + EE + F +EV
Sbjct: 3 PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT---FLKEVK 59
Query: 77 MLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
++ ++H N++KFIG K+ + +TE + GGTLR + +M + + FA DIA
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIA 118
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-------------- 181
M LHS IIHRDL N L+ E+ + +ADFGLAR +
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 182 -MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
G WMAPE+ + + Y+ KVD +SF IVL E++
Sbjct: 178 KRYTVVGNPYWMAPEM-----ING---RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 241 AAYAAAFK-NVRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 298
+ + + N P I C DP RP+F ++ L +A P
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289
Query: 299 MIPH 302
+ P
Sbjct: 290 LGPQ 293
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 1e-88
Identities = 68/314 (21%), Positives = 127/314 (40%), Gaps = 53/314 (16%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
K + + +IG+G + +V+ GK++ + VA+K+ E + E+
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQT 85
Query: 79 SRVQHRNLVKFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++H N++ FI A + + ++T+ G+L YL + LD + A
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYS 142
Query: 134 IARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---- 181
+ LH+ I HRDLK +N+L+ ++ T +AD GLA +
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDI 201
Query: 182 -MTAETGTYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL----------HN 229
GT R+M PE L ++ + D YSF ++LWE+
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQ---SYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 230 KLPFEGMSNLQAAY-----AAAFKNVRPS------AENVPEELSIILTSCWKEDPNARPN 278
+LP+ + +Y K +RPS ++ ++ ++T CW +P +R
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 279 FTQIIQMLLNYLSA 292
++ + L +
Sbjct: 319 ALRVKKTLAKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 5e-86
Identities = 68/302 (22%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH 83
+ + + +G+G + +V+ G ++ + VA+KI + +K E+ ++H
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRH 61
Query: 84 RNLVKFIGAC-----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
N++ FI + + ++T G+L YL + LD + L IA +
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGL 118
Query: 139 ECLHS--------HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-----TAE 185
LH I HRDLK +N+L+ ++ +AD GLA S +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL----------HNKLPFEG 235
GT R+MAPE+ Q + +VD ++F +VLWE+ K PF
Sbjct: 178 VGTKRYMAPEVLDETI--QVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235
Query: 236 MSNLQAAY-----AAAFKNVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ ++ RP+ ++ L+ ++ CW ++P+AR +I +
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
Query: 285 ML 286
L
Sbjct: 296 TL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 2e-83
Identities = 69/308 (22%), Positives = 122/308 (39%), Gaps = 53/308 (17%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+ + + IG+G +V+ GK++ + VA+KI E ++ E+
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------ERSWFREAEIYQT 90
Query: 79 SRVQHRNLVKFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++H N++ FI A + +V++ G+L YL + V I AL
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALS 147
Query: 134 IARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLADFGLAREES-----LTE 180
A + LH I HRDLK +N+L+ ++ T +AD GLA +
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDI 206
Query: 181 MMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL----------HN 229
GT R+MAPE L ++ ++ E + D Y+ +V WE+
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFE---SFKRADIYAMGLVFWEIARRCSIGGIHEDY 263
Query: 230 KLPFEGMSNLQAAY-----AAAFKNVRPSAEN------VPEELSIILTSCWKEDPNARPN 278
+LP+ + + + +RP+ N ++ I+ CW + AR
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 279 FTQIIQML 286
+I + L
Sbjct: 324 ALRIKKTL 331
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 2e-78
Identities = 73/335 (21%), Positives = 120/335 (35%), Gaps = 66/335 (19%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAM- 77
+D +L + IG G + VY+G + VA+K+ F E +
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN--------RQNFINEKNIY 59
Query: 78 -LSRVQHRNLVKFIGACKEPVMV------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
+ ++H N+ +FI + +V E G+L KYL D +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRL 116
Query: 131 ALDIARAMECLHS---------HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
A + R + LH+ I HRDL N+L+ D T ++DFGL+ + +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRL 175
Query: 182 ---------MTAETGTYRWMAPE-LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH--- 228
+E GT R+MAPE L V LR E +VD Y+ ++ WE+
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE--SALKQVDMYALGLIYWEIFMRCT 233
Query: 229 NKLPFEGMSNLQAAYAA---------------AFKNVRP-------SAENVPEELSIILT 266
+ P E + Q A+ + + RP L +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 267 SCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 301
CW +D AR + + + + + P
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-74
Identities = 73/308 (23%), Positives = 115/308 (37%), Gaps = 53/308 (17%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
L + G V++ + N+ VA+KI + K+ + EV L
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD------KQSWQNEYEVYSL 72
Query: 79 SRVQHRNLVKFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++H N+++FIGA K + ++T G+L +L + + A
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAET 129
Query: 134 IARAMECLHSH----------GIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTE 180
+AR + LH I HRD+K +N+LL +L T +ADFGLA
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSAG 188
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-----------HN 229
+ GT R+MAPE+ Q + ++D Y+ +VLWEL
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRD---AFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 230 KLPFEGM-----SNLQAAYAAAFKNVRPSAEN------VPEELSIILTSCWKEDPNARPN 278
LPFE S K RP + L + CW D AR +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 279 FTQIIQML 286
+ + +
Sbjct: 306 AGCVGERI 313
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 3e-69
Identities = 76/287 (26%), Positives = 136/287 (47%), Gaps = 37/287 (12%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ W ++ K L + IG+G V G Y+ VA+K + T + F E
Sbjct: 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-------FLAEA 65
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+++++++H NLV+ +G ++ + IVTE ++ G+L YL + L + F+LD
Sbjct: 66 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ AME L + +HRDL N+L++ED K++DFGL +E S + + +
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS-----STQDTGKLPVK 179
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKN 249
W APE LR+ ++ K D +SF I+LWE+ ++P+ +
Sbjct: 180 WTAPE-----ALREK---KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPR 226
Query: 250 VR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291
V + + P + ++ +CW D RP+F Q+ + L + +
Sbjct: 227 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 1e-68
Identities = 75/282 (26%), Positives = 134/282 (47%), Gaps = 29/282 (10%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ W ++ K L + IG+G V G Y+ VA+K + T + F E
Sbjct: 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-------FLAEA 237
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+++++++H NLV+ +G ++ + IVTE ++ G+L YL + L + F+LD
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 297
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ AME L + +HRDL N+L++ED K++DFGL +E S + + +
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS-----STQDTGKLPVK 351
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKN 249
W APE +K ++ K D +SF I+LWE+ ++P+ + K
Sbjct: 352 WTAPEALR--------EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVEKG 402
Query: 250 VR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290
+ + + P + ++ +CW D RP F Q+ + L +
Sbjct: 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-67
Identities = 87/295 (29%), Positives = 143/295 (48%), Gaps = 36/295 (12%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVA 76
+W + + L + R+G G +V+ G Y T VA+K + +G + F E
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD------AFLAEAN 60
Query: 77 MLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
++ ++QH+ LV+ +EP+ I+TE + G+L +L L + + A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWM 192
M + IHRDL+ N+L+++ L + K+ADFGLAR E TA G +W
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNE-YTAREGAKFPIKWT 177
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR 251
APE + G + K D +SF I+L E++ H ++P+ GM+N + +N+
Sbjct: 178 APE-----AINYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNLE 224
Query: 252 -----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP---PEP 298
+N PEEL ++ CWKE P RP F + +L ++ +A P+P
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-67
Identities = 89/282 (31%), Positives = 135/282 (47%), Gaps = 33/282 (11%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT--VAIKIVHKGETPEEIAKKESRFAREV 75
KW+++ + L +G +IG G +V+ G+ + VA+K + P+ AK F +E
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK----FLQEA 163
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+L + H N+V+ IG C K+P+ IV EL+ GG +L R L V + D
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGD 221
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
A ME L S IHRDL N L+TE +K++DFG++REE+ + +
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKN 249
W APE L G Y+ + D +SF I+LWE P+ +SN Q +
Sbjct: 281 WTAPE-----ALNYG---RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREF 327
Query: 250 VR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
V P E P+ + ++ CW +P RP+F+ I Q L
Sbjct: 328 VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-66
Identities = 81/286 (28%), Positives = 131/286 (45%), Gaps = 23/286 (8%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFARE 74
W I + L + ++G+G +V+ G + T VAIK + G E F +E
Sbjct: 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE------AFLQE 229
Query: 75 VAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ +++H LV+ +EP+ IVTE +S G+L +L + L + + A
Sbjct: 230 AQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 191
IA M + +HRDL+ N+L+ E+L K+ADFGLAR E + +W
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNV 250
APE + K D +SF I+L EL ++P+ GM N + +
Sbjct: 348 TAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGY 398
Query: 251 R-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295
R P PE L ++ CW+++P RP F + L +Y ++ P
Sbjct: 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 6e-66
Identities = 80/290 (27%), Positives = 140/290 (48%), Gaps = 35/290 (12%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT--VAIKIVHKGETPEEIAKKESRFAR 73
KW ++ + + ++G G + +VYEG +K + VA+K + + E F +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------EFLK 58
Query: 74 EVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
E A++ ++H NLV+ +G C + P I+TE ++ G L YL + + V + A
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--- 188
I+ AME L IHRDL N L+ E+ +K+ADFGL+R + + TA G
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFP 175
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 247
+W APE +L ++ K D ++F ++LWE+ + P+ G+ Q +
Sbjct: 176 IKWTAPE-----SLAYN---KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VY 222
Query: 248 KNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
+ + E PE++ ++ +CW+ +P+ RP+F +I Q
Sbjct: 223 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-65
Identities = 81/286 (28%), Positives = 131/286 (45%), Gaps = 23/286 (8%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFARE 74
W I + L + ++G+G +V+ G + T VAIK + G E F +E
Sbjct: 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE------AFLQE 312
Query: 75 VAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ +++H LV+ +EP+ IVTE +S G+L +L + L + + A
Sbjct: 313 AQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 191
IA M + +HRDL+ N+L+ E+L K+ADFGLAR E + +W
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNV 250
APE + K D +SF I+L EL ++P+ GM N + +
Sbjct: 431 TAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGY 481
Query: 251 R-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295
R P PE L ++ CW+++P RP F + L +Y ++ P
Sbjct: 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 5e-65
Identities = 83/290 (28%), Positives = 132/290 (45%), Gaps = 39/290 (13%)
Query: 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREV 75
KW+IDP L IG G V+ G + N+ VAIK + +G EE F E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE------DFIEEA 54
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ ++ H LV+ G C + P+ +VTE + G L YL R +G LD
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLD 112
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ M L +IHRDL N L+ E+ IK++DFG+ R + T+ TGT +
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQY-TSSTGTKFPVK 170
Query: 191 WMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 247
W +PE +S Y+ K D +SF +++WE+ K+P+E SN +
Sbjct: 171 WASPEVFSFSR----------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----V 215
Query: 248 KNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
+++ + I+ CW+E P RP F+++++ L +
Sbjct: 216 EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 6e-65
Identities = 92/293 (31%), Positives = 136/293 (46%), Gaps = 25/293 (8%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFARE 74
W I + L + ++G G +V+ Y T VA+K + G E F E
Sbjct: 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE------AFLAE 233
Query: 75 VAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ +QH LVK KEP+ I+TE ++ G+L +L + + I F+
Sbjct: 234 ANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
IA M + IHRDL+ N+L++ L K+ADFGLAR E TA G +
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNE-YTAREGAKFPIK 350
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKN 249
W APE + + K D +SF I+L E++ + ++P+ GMSN + A +
Sbjct: 351 WTAPEAIN--------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALERG 401
Query: 250 VR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 301
R P EN PEEL I+ CWK P RP F I +L ++ +A IP
Sbjct: 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-64
Identities = 79/289 (27%), Positives = 126/289 (43%), Gaps = 39/289 (13%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVA 76
+ + + + +G G V GK+K Q VA+K++ +G E+ F +E
Sbjct: 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED------EFFQEAQ 55
Query: 77 MLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
+ ++ H LVKF G C + P+ IVTE +S G L YL + L+ + D+
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIY-IVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDV 113
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRW 191
M L SH IHRDL N L+ DL +K++DFG+ R + + GT +W
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKW 171
Query: 192 MAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFK 248
APE Y Y+ K D ++F I++WE+ K+P++ +N +
Sbjct: 172 SAPEVFHYFK----------YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVL 216
Query: 249 NVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
V + + I+ SCW E P RP F Q++ +
Sbjct: 217 KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-64
Identities = 82/288 (28%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREV 75
W IDPK L +G G V GK++ Q VAIK++ +G E+ F E
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED------EFIEEA 70
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ + H LV+ G C + P+ I+TE ++ G L YL MR R + D
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIF-IITEYMANGCLLNYLREMRHR-FQTQQLLEMCKD 128
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ AME L S +HRDL N L+ + +K++DFGL+R E T+ G+ R
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEY-TSSVGSKFPVR 186
Query: 191 WMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 247
W PE +YS ++ K D ++F +++WE+ K+P+E +N +
Sbjct: 187 WSPPEVLMYSK----------FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----A 231
Query: 248 KNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290
+++ E++ I+ SCW E + RP F ++ +L+ +
Sbjct: 232 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 3e-64
Identities = 82/286 (28%), Positives = 140/286 (48%), Gaps = 27/286 (9%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAR 73
KW ++ + + ++G G + +VYEG +K TVA+K + + E F +
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------EFLK 265
Query: 74 EVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
E A++ ++H NLV+ +G C + P I+TE ++ G L YL + + V + A
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--- 188
I+ AME L IHR+L N L+ E+ +K+ADFGL+R + + TA G
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFP 382
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 247
+W APE + ++ K D ++F ++LWE+ + P+ G+ Q Y
Sbjct: 383 IKWTAPESLA--------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE 433
Query: 248 KNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
K+ R E PE++ ++ +CW+ +P+ RP+F +I Q
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 8e-64
Identities = 81/291 (27%), Positives = 129/291 (44%), Gaps = 38/291 (13%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ-----TVAIKIVHKGETPEEIAKKESRFA 72
+ I + + +G IGEG V++G Y + VAIK + K F
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK----FL 64
Query: 73 REVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
+E + + H ++VK IG + PV I+ EL + G LR +L + LD+ I +A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLASLILYA 122
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-- 189
++ A+ L S +HRD+ N+L++ + +KL DFGL+R + A G
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPI 181
Query: 190 RWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAA 246
+WMAPE + + + D + F + +WE+L H PF+G+ N
Sbjct: 182 KWMAPESINF----------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----V 226
Query: 247 FKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
+ P N P L ++T CW DP+ RP FT++ L L
Sbjct: 227 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 7e-63
Identities = 86/337 (25%), Positives = 152/337 (45%), Gaps = 51/337 (15%)
Query: 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGE 59
++ A ++ + +W + + + + +G+G+ VYEG K VAIK V++
Sbjct: 8 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 67
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNM 117
+ E + F E +++ ++V+ +G +P +VI EL++ G L+ YL ++
Sbjct: 68 SMRERIE----FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI-MELMTRGDLKSYLRSL 122
Query: 118 RPRC--------LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169
RP + I A +IA M L+++ +HRDL N ++ ED T+K+ D
Sbjct: 123 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGD 181
Query: 170 FGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226
FG+ R+ T+ RWM+PE +L+ G + D +SF +VLWE+
Sbjct: 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPE-----SLKDGV---FTTYSDVWSFGVVLWEI 233
Query: 227 L-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFT 280
+ P++G+SN Q + V +N P+ L ++ CW+ +P RP+F
Sbjct: 234 ATLAEQPYQGLSNEQV-----LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL 288
Query: 281 QIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESP 317
+II + + EP F PE
Sbjct: 289 EIISSIKEEM------EPGFREVSFYYSEENKLPEPE 319
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-62
Identities = 90/321 (28%), Positives = 143/321 (44%), Gaps = 54/321 (16%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN---------QTVAIKIVHKGETPE 62
EL D KW L +G +GEGA +V + TVA+K++ T +
Sbjct: 23 ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRP 119
+++ E+ M+ + +H+N++ +GAC P+ VI E S G LR+YL RP
Sbjct: 83 DLSD----LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRP 137
Query: 120 RCLDVCVA--------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
++ + +AR ME L S IHRDL N+L+TE+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VM 196
Query: 166 KLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 222
K+ADFGLAR+ + + T +WMAPE L Y H+ D +SF ++
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPE-----ALFDRV---YTHQSDVWSFGVL 248
Query: 223 LWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNAR 276
+WE+ P+ G+ + FK ++ N EL +++ CW P+ R
Sbjct: 249 MWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303
Query: 277 PNFTQIIQMLLNYLSAIAPPE 297
P F Q+++ L L+ E
Sbjct: 304 PTFKQLVEDLDRILTLTTNEE 324
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-62
Identities = 65/290 (22%), Positives = 123/290 (42%), Gaps = 33/290 (11%)
Query: 16 DAKW-LIDPKHLFVGPRIGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKE 68
A ++ +G GA VY+G + + VAIK + + +P+ +
Sbjct: 6 QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-- 63
Query: 69 SRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
E +++ V + ++ + +G C V ++T+L+ G L Y+ + +
Sbjct: 64 --ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYL 119
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
+ + + IA+ M L ++HRDL N+L+ +K+ DFGLA+ E G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEG 178
Query: 188 T---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQA 241
+WMA E L+ Y H+ D +S+ + +WEL+ P++G+ +
Sbjct: 179 GKVPIKWMALESILHRI----------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE- 227
Query: 242 AYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290
+ K R P ++ +I+ CW D ++RP F ++I
Sbjct: 228 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-62
Identities = 80/291 (27%), Positives = 126/291 (43%), Gaps = 38/291 (13%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-----VAIKIVHKGETPEEIAKKESRFA 72
++ I + + + +GEG +VYEG Y N VA+K K T + K F
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK----FM 61
Query: 73 REVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
E ++ + H ++VK IG +EP I+ EL G L YL + L V + ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS-LKVLTLVLYS 119
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-- 189
L I +AM L S +HRD+ N+L+ +KL DFGL+R + A
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPI 178
Query: 190 RWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAA 246
+WM+PE + + D + FA+ +WE+L K PF + N
Sbjct: 179 KWMSPESINFRR----------FTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----V 223
Query: 247 FKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
+ P + P L ++T CW DP+ RP FT+++ L +
Sbjct: 224 IGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 4e-62
Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-----VAIKIVHKGETPEEIAKKESRFA 72
LI K L + ++G+G+ V G++ + VA+K + + A + F
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD--FI 69
Query: 73 REVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
REV + + HRNL++ G P+ +VTEL G+L L + + +A
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYA 127
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT-- 188
+ +A M L S IHRDL NLLL +K+ DFGL R + +
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 189 -YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYA 244
+ W APE T ++H D++ F + LWE+ + + P+ G++ Q +
Sbjct: 187 PFAWCAPESLKTRT----------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236
Query: 245 AAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297
+ R P E+ P+++ ++ CW P RP F L ++L P +
Sbjct: 237 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA----LRDFLLEAQPTD 286
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-61
Identities = 81/295 (27%), Positives = 130/295 (44%), Gaps = 34/295 (11%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ-----TVAIKIVHKGETPEEIAK 66
+ + I + + +G IGEG V++G Y + VAIK + K
Sbjct: 378 TMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK 437
Query: 67 KESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVC 125
F +E + + H ++VK IG + PV I+ EL + G LR +L + LD+
Sbjct: 438 ----FLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFS-LDLA 491
Query: 126 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE 185
I +A ++ A+ L S +HRD+ N+L++ + +KL DFGL+R + A
Sbjct: 492 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKAS 550
Query: 186 TGTY--RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAA 242
G +WMAPE ++ + D + F + +WE+L H PF+G+ N
Sbjct: 551 KGKLPIKWMAPE-----SINFR---RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-- 600
Query: 243 YAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
+ P N P L ++T CW DP+ RP FT++ L L
Sbjct: 601 ---VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-61
Identities = 77/318 (24%), Positives = 131/318 (41%), Gaps = 32/318 (10%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIA 65
+ + LI + +G +G+G V E + K VA+K++
Sbjct: 10 ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI 69
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGAC-------KEPVMVIVTELLSGGTLRKYLLNMR 118
++ F RE A + H ++ K +G + P+ +++ + G L +LL R
Sbjct: 70 EE---FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 119 P----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
L + + F +DIA ME L S IHRDL N +L ED+ T+ +ADFGL+R
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCVADFGLSR 185
Query: 175 EESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNK 230
+ + + +W+A E +L Y D ++F + +WE++ +
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALE-----SLADNL---YTVHSDVWAFGVTMWEIMTRGQ 237
Query: 231 LPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290
P+ G+ N + N EE+ ++ CW DP RP+FT + L N L
Sbjct: 238 TPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297
Query: 291 SAIAPPEPMIPHRIFNSE 308
++ N E
Sbjct: 298 GHLSVLSTSQDPLYINIE 315
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-61
Identities = 83/321 (25%), Positives = 140/321 (43%), Gaps = 45/321 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT------VAIKIVHKGETPEEIAKKESRF 71
I P + IG G +VY+G K + VAIK + G T ++ F
Sbjct: 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD----F 93
Query: 72 AREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG 129
E ++ + H N+++ G +P+M I+TE + G L K+L V +G
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMM-IITEYMENGALDKFLREKDGE-FSVLQLVG 151
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT 188
IA M+ L + +HRDL N+L+ +L K++DFGL+R E E +G
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 189 ---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAA 242
RW APE Y + + D +SF IV+WE++ + + P+ +SN +
Sbjct: 211 KIPIRWTAPEAISY----------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV- 259
Query: 243 YAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297
K + P+ + P + ++ CW+++ RP F I+ +L + A P+
Sbjct: 260 ----MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA---PD 312
Query: 298 PMIPHRIFNSENTILPPESPG 318
+ F+ +I P + G
Sbjct: 313 SLKTLADFDPRVSIRLPSTSG 333
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 94/346 (27%), Positives = 151/346 (43%), Gaps = 59/346 (17%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN---------QTVAIKIVHKGETPE 62
EL D +W + L +G +GEGA +V + VA+K++ T +
Sbjct: 57 ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 116
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRP 119
+++ E+ M+ + +H+N++ +GAC P+ VI E S G LR+YL RP
Sbjct: 117 DLSD----LISEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLQARRP 171
Query: 120 RCLDVCVA--------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
L+ + A +AR ME L S IHRDL N+L+TED +
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VM 230
Query: 166 KLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 222
K+ADFGLAR+ + T +WMAPE L Y H+ D +SF ++
Sbjct: 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE-----ALFDRI---YTHQSDVWSFGVL 282
Query: 223 LWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNAR 276
LWE+ P+ G+ + FK ++ N EL +++ CW P+ R
Sbjct: 283 LWEIFTLGGSPYPGVPVEEL-----FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 337
Query: 277 PNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSL 322
P F Q+++ L ++ + E + + + P T +L
Sbjct: 338 PTFKQLVEDLDRIVALTSNQE-----MGYYHHHHHHDYDIPTTENL 378
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-61
Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 41/300 (13%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFA 72
+ID L +G +GEG V EG K VA+K + + + ++ F
Sbjct: 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE---FL 84
Query: 73 REVAMLSRVQHRNLVKFIGAC------KEPVMVIVTELLSGGTLRKYLLNMRPRC----L 122
E A + H N+++ +G C P +++ + G L YLL R +
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 123 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM 182
+ + F +DIA ME L + +HRDL N +L +D+ T+ +ADFGL+++ +
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYY 203
Query: 183 TAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSN 238
+W+A E +L Y K D ++F + +WE+ P+ G+ N
Sbjct: 204 RQGRIAKMPVKWIAIE-----SLADRV---YTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255
Query: 239 LQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293
+ + + E+ +EL I+ SCW+ DP RP F+ + L L ++
Sbjct: 256 HE-----MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-61
Identities = 89/321 (27%), Positives = 142/321 (44%), Gaps = 54/321 (16%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN---------QTVAIKIVHKGETPE 62
EL D KW L +G +GEG +V + TVA+K++ T +
Sbjct: 69 ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 128
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRP 119
+++ E+ M+ + +H+N++ +GAC P+ VI E S G LR+YL RP
Sbjct: 129 DLSD----LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRP 183
Query: 120 RCLDVCVA--------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
++ + +AR ME L S IHRDL N+L+TE+ +
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VM 242
Query: 166 KLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 222
K+ADFGLAR+ + + T +WMAPE L Y H+ D +SF ++
Sbjct: 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPE-----ALFDRV---YTHQSDVWSFGVL 294
Query: 223 LWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNAR 276
+WE+ P+ G+ + FK ++ N EL +++ CW P+ R
Sbjct: 295 MWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349
Query: 277 PNFTQIIQMLLNYLSAIAPPE 297
P F Q+++ L L+ E
Sbjct: 350 PTFKQLVEDLDRILTLTTNEE 370
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-61
Identities = 78/311 (25%), Positives = 129/311 (41%), Gaps = 40/311 (12%)
Query: 8 YLADELKLDAK-WLI--DPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGE 59
L L + K LI + IG+G VY G+Y AIK + +
Sbjct: 2 DLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT 61
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNM 117
+++ F RE ++ + H N++ IG E + ++ + G L +++ +
Sbjct: 62 EMQQVEA----FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP 117
Query: 118 RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177
+ V I F L +AR ME L +HRDL N +L E T+K+ADFGLAR+
Sbjct: 118 QRN-PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDIL 175
Query: 178 LTEMMTAETGTY-----RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKL 231
E + + + +W A E +L+ + K D +SF ++LWELL
Sbjct: 176 DREYYSVQQHRHARLPVKWTALE-----SLQTYR---FTTKSDVWSFGVLLWELLTRGAP 227
Query: 232 PFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
P+ + + P E P+ L ++ CW+ DP RP F ++ +
Sbjct: 228 PYRHIDPFDL-----THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282
Query: 287 LNYLSAIAPPE 297
+SA+
Sbjct: 283 EQIVSALLGDH 293
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-61
Identities = 80/320 (25%), Positives = 140/320 (43%), Gaps = 59/320 (18%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEI 64
++ D KW K+L +G +GEG KV + + TVA+K++ + +P E+
Sbjct: 11 KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70
Query: 65 AKKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCL 122
E +L +V H +++K GAC P+++IV E G+LR +L R
Sbjct: 71 RD----LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGP 125
Query: 123 DVCVA----------------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160
+ I FA I++ M+ L ++HRDL N+L+ E
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE 185
Query: 161 DLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSY 217
+K++DFGL+R+ + + +WMA E +L Y + D +
Sbjct: 186 GR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE-----SLFDHI---YTTQSDVW 236
Query: 218 SFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKE 271
SF ++LWE++ P+ G+ + F ++ +N EE+ ++ CWK+
Sbjct: 237 SFGVLLWEIVTLGGNPYPGIPPERL-----FNLLKTGHRMERPDNCSEEMYRLMLQCWKQ 291
Query: 272 DPNARPNFTQIIQMLLNYLS 291
+P+ RP F I + L +
Sbjct: 292 EPDKRPVFADISKDLEKMMV 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-61
Identities = 75/300 (25%), Positives = 125/300 (41%), Gaps = 39/300 (13%)
Query: 18 KWLIDPKHLFV--GPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESR 70
+I P L V IG G VY G + A+K +++ E+++
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ---- 72
Query: 71 FAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAI 128
F E ++ H N++ +G C E ++V + G LR ++ N V I
Sbjct: 73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLI 131
Query: 129 GFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188
GF L +A+ M+ L S +HRDL N +L E T+K+ADFGLAR+ E + T
Sbjct: 132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKT 190
Query: 189 Y-----RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAA 242
+WMA E +L+ + + K D +SF ++LWEL+ P+ ++
Sbjct: 191 GAKLPVKWMALE-----SLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI- 241
Query: 243 YAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297
+ E P+ L ++ CW RP+F++++ + S
Sbjct: 242 ----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-61
Identities = 64/327 (19%), Positives = 122/327 (37%), Gaps = 36/327 (11%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKESRF 71
+ L +G G V++G + + V IK++ +
Sbjct: 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA----V 62
Query: 72 AREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
+ + + H ++V+ +G C + +VT+ L G+L ++ R L + + +
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNW 120
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT-- 188
+ IA+ M L HG++HR+L N+LL +++ADFG+A + +
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 189 -YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAA 246
+WMA E Y H+ D +S+ + +WEL+ P+ G+ +
Sbjct: 180 PIKWMALESIHF--------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLL 230
Query: 247 FKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIF 305
K R + ++ +++ CW D N RP F ++ P R
Sbjct: 231 EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD--------PPRYL 282
Query: 306 NSENTILPPESPGTSSLMTVRDDIGET 332
+ P +PG + E
Sbjct: 283 VIKRESGPGIAPGPEPHGLTNKKLEEV 309
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-60
Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 32/294 (10%)
Query: 16 DAKWLIDPKHL-FVGPRIGEGAHAKVYEGKYKNQT----VAIKIVHKGETPEEIAKKESR 70
D K + +L +G G V +G Y+ + VAIK++ +G + +
Sbjct: 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE---- 56
Query: 71 FAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG 129
RE ++ ++ + +V+ IG C E +M +V E+ GG L K+L+ R + V
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAE 114
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-TAETGT 188
++ M+ L +HRDL N+LL K++DFGL++ + TA +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAG 173
Query: 189 ---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAA 242
+W APE + ++ + D +S+ + +WE L + + P++ M +
Sbjct: 174 KWPLKWYAPECINFRK----------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-V 222
Query: 243 YAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295
A + R P EL +++ CW RP+F + Q + ++A
Sbjct: 223 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-60
Identities = 90/312 (28%), Positives = 128/312 (41%), Gaps = 45/312 (14%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEI 64
+L D KW L G +G GA KV E TVA+K++ E
Sbjct: 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70
Query: 65 AKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRC 121
E+ +LS + H N+V +GAC P +VI TE G L +L R
Sbjct: 71 EA----LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI-TEYCCYGDLLNFLRRKRDSF 125
Query: 122 LDVCVA----------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
+ + + F+ +A+ M L S IHRDL N+LLT
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-IT 184
Query: 166 KLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 222
K+ DFGLAR+ + +WMAPE ++ Y + D +S+ I
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPE-----SIFNCV---YTFESDVWSYGIF 236
Query: 223 LWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFT 280
LWEL P+ GM Y + R S E+ P E+ I+ +CW DP RP F
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 281 QIIQMLLNYLSA 292
QI+Q++ +S
Sbjct: 297 QIVQLIEKQISE 308
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-60
Identities = 80/323 (24%), Positives = 136/323 (42%), Gaps = 51/323 (15%)
Query: 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGE 59
+ + + K++ + +G GA +VYEG+ VA+K + +
Sbjct: 13 CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNM 117
+ ++ F E ++S+ H+N+V+ IG P I+ EL++GG L+ +L
Sbjct: 73 SEQDELD----FLMEALIISKFNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRET 127
Query: 118 RPRC-----LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLAD 169
RPR L + + A DIA + L + IHRD+ N LLT K+ D
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGD 186
Query: 170 FGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226
FG+AR+ +WM PE +G + K D++SF ++LWE+
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPE-----AFMEG---IFTSKTDTWSFGVLLWEI 238
Query: 227 L-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFT 280
+P+ SN + + V +N P + I+T CW+ P RPNF
Sbjct: 239 FSLGYMPYPSKSNQEV-----LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 293
Query: 281 QIIQMLL------NYLSAIAPPE 297
I++ + + ++ P E
Sbjct: 294 IILERIEYCTQDPDVINTALPIE 316
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-60
Identities = 80/323 (24%), Positives = 136/323 (42%), Gaps = 51/323 (15%)
Query: 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGE 59
+ + + K++ + +G GA +VYEG+ VA+K + +
Sbjct: 54 CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 113
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNM 117
+ ++ F E ++S+ H+N+V+ IG P I+ EL++GG L+ +L
Sbjct: 114 SEQDELD----FLMEALIISKFNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRET 168
Query: 118 RPRC-----LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLAD 169
RPR L + + A DIA + L + IHRD+ N LLT K+ D
Sbjct: 169 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGD 227
Query: 170 FGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226
FG+AR+ +WM PE +G + K D++SF ++LWE+
Sbjct: 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPE-----AFMEGI---FTSKTDTWSFGVLLWEI 279
Query: 227 L-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFT 280
+P+ SN + + V +N P + I+T CW+ P RPNF
Sbjct: 280 FSLGYMPYPSKSNQEV-----LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 334
Query: 281 QIIQMLL------NYLSAIAPPE 297
I++ + + ++ P E
Sbjct: 335 IILERIEYCTQDPDVINTALPIE 357
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-60
Identities = 75/306 (24%), Positives = 128/306 (41%), Gaps = 40/306 (13%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIA 65
I+ + + IG G +V G+ + + VAIK + G T +
Sbjct: 36 GRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR 95
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLD 123
F E +++ + H N+++ G M IVTE + G+L +L +
Sbjct: 96 D----FLSEASIMGQFDHPNIIRLEGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQ-FT 149
Query: 124 VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMM 182
+ +G + M L G +HRDL N+L+ +L K++DFGL+R E +
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAA 208
Query: 183 TAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSN 238
TG RW APE + ++ D +SF +V+WE+L + + P+ M+N
Sbjct: 209 YTTTGGKIPIRWTAPE-----AIAFR---TFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260
Query: 239 LQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293
+V P+ P L ++ CW +D RP F+QI+ +L + +
Sbjct: 261 RD-----VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS- 314
Query: 294 APPEPM 299
PE +
Sbjct: 315 --PESL 318
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-60
Identities = 71/327 (21%), Positives = 135/327 (41%), Gaps = 36/327 (11%)
Query: 16 DAKW-LIDPKHLFVGPRIGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKE 68
A ++ +G GA VY+G + + VAIK + + +P+ +
Sbjct: 6 QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-- 63
Query: 69 SRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
E +++ V + ++ + +G C V ++T+L+ G L Y+ + +
Sbjct: 64 --ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYL 119
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
+ + + IA+ M L ++HRDL N+L+ +K+ DFGLA+ E G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEG 178
Query: 188 T---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQA 241
+WMA E L+ Y H+ D +S+ + +WEL+ P++G+ +
Sbjct: 179 GKVPIKWMALESILHRI----------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE- 227
Query: 242 AYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300
+ K R P ++ +I+ CW D ++RP F ++I P+ +
Sbjct: 228 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD---PQRYL 284
Query: 301 PHRIFNSENTILPPESPGTSSLMTVRD 327
+ + P +S +LM D
Sbjct: 285 VIQGDERMHLPSPTDSNFYRALMDEED 311
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-60
Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 37/300 (12%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESR 70
+ IG G VY G + A+K +++ E+++
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ---- 136
Query: 71 FAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAI 128
F E ++ H N++ +G C E ++V + G LR ++ N V I
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLI 195
Query: 129 GFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188
GF L +A+ M+ L S +HRDL N +L E T+K+ADFGLAR+ E + T
Sbjct: 196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKT 254
Query: 189 Y-----RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAA 242
+WMA E +L+ + + K D +SF ++LWEL+ P+ ++
Sbjct: 255 GAKLPVKWMALE-----SLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI- 305
Query: 243 YAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297
+ E P+ L ++ CW RP+F++++ + S
Sbjct: 306 ----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-60
Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 33/298 (11%)
Query: 11 DELKLDAKWLIDPKHL-FVGPRIGEGAHAKVYEGKYKNQ----TVAIKIVHKGETPEEIA 65
+E++ + +D K L +G G V +G Y+ + TVA+KI+ +
Sbjct: 4 EEIRPK-EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 62
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
+ E ++ ++ + +V+ IG C E M +V E+ G L KYL R +
Sbjct: 63 DE---LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRH--VKD 116
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMT 183
I ++ M+ L +HRDL N+LL K++DFGL++ +
Sbjct: 117 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYK 175
Query: 184 AETGT---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMS 237
A+T +W APE Y ++ K D +SF +++WE + + P+ GM
Sbjct: 176 AQTHGKWPVKWYAPECINYYK----------FSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
Query: 238 NLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294
+ A K R P E+ ++ CW D RP F + L NY +
Sbjct: 226 GSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 6e-60
Identities = 83/316 (26%), Positives = 128/316 (40%), Gaps = 50/316 (15%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEI 64
E + D KW ++L G +G GA KV VA+K++ + E
Sbjct: 33 EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 92
Query: 65 AKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRC 121
E+ M++++ H N+V +GAC P+ +I E G L YL + R +
Sbjct: 93 EA----LMSELKMMTQLGSHENIVNLLGACTLSGPIYLI-FEYCCYGDLLNYLRSKREKF 147
Query: 122 LDVCVA---------------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160
+ + + FA +A+ ME L +HRDL N+L+T
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207
Query: 161 DLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSY 217
K +K+ DFGLAR+ +WMAPE +L +G Y K D +
Sbjct: 208 G-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE-----SLFEGI---YTIKSDVW 258
Query: 218 SFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNA 275
S+ I+LWE+ P+ G+ Y + EE+ II+ SCW D
Sbjct: 259 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 318
Query: 276 RPNFTQIIQMLLNYLS 291
RP+F + L L+
Sbjct: 319 RPSFPNLTSFLGCQLA 334
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-59
Identities = 79/307 (25%), Positives = 131/307 (42%), Gaps = 56/307 (18%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN----QTVAIKIVHKGETPEEIAKKESRFAR 73
++D + IGEG +V + + K AIK + + + ++ FA
Sbjct: 19 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD----FAG 74
Query: 74 EVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--- 127
E+ +L ++ H N++ +GAC + + + E G L +L R D A
Sbjct: 75 ELEVLCKLGHHPNIINLLGACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 128 -----------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176
+ FA D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R +
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQ 192
Query: 177 SLTEMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNK 230
E+ +T RWMA E YS Y D +S+ ++LWE++
Sbjct: 193 ---EVYVKKTMGRLPVRWMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGG 239
Query: 231 LPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285
P+ GM+ + ++ + N +E+ ++ CW+E P RP+F QI+
Sbjct: 240 TPYCGMTCAE-----LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294
Query: 286 LLNYLSA 292
L L
Sbjct: 295 LNRMLEE 301
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-59
Identities = 78/309 (25%), Positives = 131/309 (42%), Gaps = 56/309 (18%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESR 70
I + + + +GEGA KV+ + N VA+K + K T
Sbjct: 9 VQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAA----RKD 63
Query: 71 FAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA- 127
F RE +L+ +QH ++VKF G C +P++ +V E + G L K+L P + +
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 128 -------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
+ A IA M L S +HRDL N L+ +L +K+ DFG++R
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSR 181
Query: 175 EESLTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-H 228
+ T+ T RWM PE +Y + + D +SF ++LWE+ +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRK----------FTTESDVWSFGVILWEIFTY 231
Query: 229 NKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQII 283
K P+ +SN + + + P+E+ ++ CW+ +P R N +I
Sbjct: 232 GKQPWFQLSNTEV-----IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIY 286
Query: 284 QMLLNYLSA 292
++L A
Sbjct: 287 KILHALGKA 295
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-59
Identities = 74/303 (24%), Positives = 121/303 (39%), Gaps = 51/303 (16%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRF 71
I + +GE KVY+G Q VAIK + + F
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE----F 59
Query: 72 AREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA-- 127
E + +R+QH N+V +G +P+ ++ S G L ++L+ P
Sbjct: 60 RHEAMLRARLQHPNVVCLLGVVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 128 ------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175
+ IA ME L SH ++H+DL N+L+ + L +K++D GL RE
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL-NVKISDLGLFRE 177
Query: 176 ESLTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKL 231
+ + RWMAPE + G ++ D +S+ +VLWE+ +
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPE-----AIMYG---KFSIDSDIWSYGVVLWEVFSYGLQ 229
Query: 232 PFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
P+ G SN + +R P ++ P + ++ CW E P+ RP F I L
Sbjct: 230 PYCGYSNQDV-----VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
Query: 287 LNY 289
+
Sbjct: 285 RAW 287
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-59
Identities = 74/324 (22%), Positives = 133/324 (41%), Gaps = 59/324 (18%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKE 68
++ IGEGA +V++ + VA+K++ + + + A
Sbjct: 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-- 96
Query: 69 SRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV 126
F RE A+++ + N+VK +G C +P+ ++ E ++ G L ++L +M P +
Sbjct: 97 --FQREAALMAEFDNPNIVKLLGVCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 127 A----------------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164
+ A +A M L +HRDL N L+ E++
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-V 212
Query: 165 IKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAI 221
+K+ADFGL+R + A+ RWM PE ++ Y + D +++ +
Sbjct: 213 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE-----SIFYNR---YTTESDVWAYGV 264
Query: 222 VLWELL-HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNA 275
VLWE+ + P+ GM++ + VR EN P EL ++ CW + P
Sbjct: 265 VLWEIFSYGLQPYYGMAHEEV-----IYYVRDGNILACPENCPLELYNLMRLCWSKLPAD 319
Query: 276 RPNFTQIIQMLLNYLSAIAPPEPM 299
RP+F I ++L +
Sbjct: 320 RPSFCSIHRILQRMCERAEGTVGV 343
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-59
Identities = 84/322 (26%), Positives = 136/322 (42%), Gaps = 47/322 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFA 72
+D ++ + +G G +V G+ K +VAIK + G T ++ F
Sbjct: 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD----FL 94
Query: 73 REVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
E +++ + H N+++ G +PVM IVTE + G+L +L + V +G
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQ-FTVIQLVGM 152
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT- 188
IA M+ L G +HRDL N+L+ +L K++DFGL R E E G
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 189 --YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAY 243
RW +PE Y + + D +S+ IVLWE++ + + P+ MSN
Sbjct: 212 IPIRWTSPEAIAY----------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-- 259
Query: 244 AAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY------LSA 292
K V P + P L ++ CW++D N RP F QI+ +L L
Sbjct: 260 ---IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKI 316
Query: 293 IAPPEPMIPHRIFNSENTILPP 314
I + + + N +
Sbjct: 317 ITSAAARPSNLLLDQSNVDITT 338
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 4e-59
Identities = 72/306 (23%), Positives = 127/306 (41%), Gaps = 51/306 (16%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESR 70
I + + + +GEGA KV+ + N VA+K + K +
Sbjct: 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQD---- 89
Query: 71 FAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA- 127
F RE +L+ +QH+++V+F G C P++++ E + G L ++L + P +
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGE 148
Query: 128 ------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175
+ A +A M L +HRDL N L+ + L +K+ DFG++R+
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRD 207
Query: 176 ESLTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKL 231
T+ T RWM PE ++ + + + D +SF +VLWE+ + K
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPE-----SILYRK---FTTESDVWSFGVVLWEIFTYGKQ 259
Query: 232 PFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
P+ +SN +A + P E+ I+ CW+ +P R + + L
Sbjct: 260 PWYQLSNTEA-----IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314
Query: 287 LNYLSA 292
A
Sbjct: 315 QALAQA 320
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-58
Identities = 81/314 (25%), Positives = 124/314 (39%), Gaps = 51/314 (16%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEE 63
+L + KW +L G +G GA KV E VA+K++ +E
Sbjct: 33 TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 92
Query: 64 IAKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPR 120
E+ ++S + QH N+V +GAC PV+VI TE G L +L
Sbjct: 93 KEA----LMSELKIMSHLGQHENIVNLLGACTHGGPVLVI-TEYCCYGDLLNFLRRKSRV 147
Query: 121 CLDVCVA------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168
+ F+ +A+ M L S IHRD+ N+LLT K+
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIG 206
Query: 169 DFGLAREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 225
DFGLAR+ + +WMAPE ++ Y + D +S+ I+LWE
Sbjct: 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPE-----SIFDCV---YTVQSDVWSYGILLWE 258
Query: 226 LL-HNKLPFEG-MSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPN 278
+ P+ G + N + +K V+ P+ + I+ +CW +P RP
Sbjct: 259 IFSLGLNPYPGILVNSK-----FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 313
Query: 279 FTQIIQMLLNYLSA 292
F QI L
Sbjct: 314 FQQICSFLQEQAQE 327
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-58
Identities = 86/310 (27%), Positives = 135/310 (43%), Gaps = 44/310 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESR 70
KW L +G +G GA +V E +TVA+K++ +G T E
Sbjct: 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA---- 76
Query: 71 FAREVAMLSRV-QHRNLVKFIGAC---KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV 126
E+ +L + H N+V +GAC P+MVI E G L YL + R + V
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI-VEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 127 A--------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172
A I ++ +A+ ME L S IHRDL N+LL+E +K+ DFGL
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGL 194
Query: 173 AREESLTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-H 228
AR+ + +WMAPE T+ Y + D +SF ++LWE+
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPE-----TIFDRV---YTIQSDVWSFGVLLWEIFSL 246
Query: 229 NKLPFEGMSNLQAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287
P+ G+ + + R + + E+ + CW +P+ RP F+++++ L
Sbjct: 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306
Query: 288 NYLSAIAPPE 297
N L A A +
Sbjct: 307 NLLQANAQQD 316
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-58
Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 60/314 (19%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRF 71
+ +HL ++G+G V +Y + VA+K + + T E + F
Sbjct: 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRD----F 58
Query: 72 AREVAMLSRVQHRNLVKFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
RE+ +L +QH N+VK+ G C + + ++ E L G+LR YL + R +D
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER-IDHIKL 116
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET 186
+ + I + ME L + IHRDL N+L+ + +K+ DFGL + E +
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 187 GT---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-------------- 227
W APE S ++ D +SF +VL+EL
Sbjct: 176 PGESPIFWYAPESLTESK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEFM 225
Query: 228 --HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFT 280
M + ++ P + P+E+ +I+T CW + N RP+F
Sbjct: 226 RMIGNDKQGQMIVFH-----LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR 280
Query: 281 QIIQMLLNYLSAIA 294
+ + +A
Sbjct: 281 DLALRVDQIRDNMA 294
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-58
Identities = 68/305 (22%), Positives = 123/305 (40%), Gaps = 58/305 (19%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRF 71
+ + L +GEG KV +Y + VA+K + IA
Sbjct: 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD----L 70
Query: 72 AREVAMLSRVQHRNLVKFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
+E+ +L + H N+VK+ G C + ++ E L G+L++YL + + +++
Sbjct: 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYLPKNKNK-INLKQQ 128
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET 186
+ +A+ I + M+ L S +HRDL N+L+ + +K+ DFGL + E+ E T +
Sbjct: 129 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKD 187
Query: 187 GT---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-------------- 227
W APE + S + D +SF + L ELL
Sbjct: 188 DRDSPVFWYAPECLMQSK----------FYIASDVWSFGVTLHELLTYCDSDSSPMALFL 237
Query: 228 -HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQ 281
M+ + ++ P N P+E+ ++ CW+ P+ R +F
Sbjct: 238 KMIGPTHGQMTVTR-----LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQN 292
Query: 282 IIQML 286
+I+
Sbjct: 293 LIEGF 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-58
Identities = 70/317 (22%), Positives = 120/317 (37%), Gaps = 60/317 (18%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN------QTVAIKIVHKGETPEEIAKKESRF 71
+ ++L +GEG KV Y + VA+K + P+ + +
Sbjct: 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG----W 80
Query: 72 AREVAMLSRVQHRNLVKFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
+E+ +L + H +++K+ G C + +V E + G+LR YL + +
Sbjct: 81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQ-LVMEYVPLGSLRDYL---PRHSIGLAQL 136
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET 186
+ FA I M LH+ IHRDL N+LL D +K+ DFGLA+ E
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVRE 195
Query: 187 GT---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-------------- 227
W APE + + D +SF + L+ELL
Sbjct: 196 DGDSPVFWYAPECLKEYK----------FYYASDVWSFGVTLYELLTHCDSSQSPPTKFL 245
Query: 228 -HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQ 281
+ M+ L+ + + P + P E+ ++ +CW+ + + RP F
Sbjct: 246 ELIGIAQGQMTVLR-----LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFEN 300
Query: 282 IIQMLLNYLSAIAPPEP 298
+I +L P
Sbjct: 301 LIPILKTVHEKYQGQAP 317
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-58
Identities = 73/314 (23%), Positives = 125/314 (39%), Gaps = 60/314 (19%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRF 71
+ +HL ++G+G V +Y + VA+K + + T E + F
Sbjct: 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRD----F 89
Query: 72 AREVAMLSRVQHRNLVKFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
RE+ +L +QH N+VK+ G C + + ++ E L G+LR YL + R +D
Sbjct: 90 EREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER-IDHIKL 147
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET 186
+ + I + ME L + IHRDL N+L+ + +K+ DFGL + E +
Sbjct: 148 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKE 206
Query: 187 GT---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-------------- 227
W APE S ++ D +SF +VL+EL
Sbjct: 207 PGESPIFWYAPESLTESK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEFM 256
Query: 228 --HNKLPFEGMSNLQAAYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFT 280
M + ++ P + P+E+ +I+T CW + N RP+F
Sbjct: 257 RMIGNDKQGQMIVFH-----LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR 311
Query: 281 QIIQMLLNYLSAIA 294
+ + +A
Sbjct: 312 DLALRVDQIRDQMA 325
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-56
Identities = 68/312 (21%), Positives = 117/312 (37%), Gaps = 49/312 (15%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRF 71
+ + +HL ++G+G V +Y VA+K + ++ F
Sbjct: 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-----DQQRDF 71
Query: 72 AREVAMLSRVQHRNLVKFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
RE+ +L + +VK+ G ++ + +V E L G LR +L R R LD
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRAR-LDASRL 129
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET 186
+ ++ I + ME L S +HRDL N+L+ + +K+ADFGLA+ +
Sbjct: 130 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLPLDKDYYVVRE 188
Query: 187 GT---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQ 240
W APE + ++ + D +SF +VL+EL + +
Sbjct: 189 PGQSPIFWYAPESLSDNI----------FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL 238
Query: 241 AAYAAAFKNVR--------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
P+ P E+ ++ CW P RP+F+ + L
Sbjct: 239 RMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
Query: 287 LNYLSAIAPPEP 298
S E
Sbjct: 299 DMLWSGSRGCET 310
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-55
Identities = 62/300 (20%), Positives = 118/300 (39%), Gaps = 54/300 (18%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ---------TVAIKIVHKGETPEEIAKKES 69
I + L +G+G K+++G + V +K++ K +
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES---- 58
Query: 70 RFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
F +M+S++ H++LV G C + + +V E + G+L YL + +++
Sbjct: 59 -FFEAASMMSKLSHKHLVLNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNC-INILWK 115
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-------TIKLADFGLAREESLTE 180
+ A +A AM L + +IH ++ +N+LL + IKL+D G++
Sbjct: 116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT----- 170
Query: 181 MMTAETGTY----RWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPF 233
W+ PE K+ N D +SF LWE+ P
Sbjct: 171 --VLPKDILQERIPWVPPECIENP---------KNLNLATDKWSFGTTLWEICSGGDKPL 219
Query: 234 EGMSNLQA--AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291
+ + + Y + P EL+ ++ +C +P+ RP+F II+ L + +
Sbjct: 220 SALDSQRKLQFYEDRHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-55
Identities = 64/281 (22%), Positives = 108/281 (38%), Gaps = 23/281 (8%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+GA A V+ G++K AIK+ + + RE +L ++ H+N
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLNHKN 68
Query: 86 LVK---FIGACKEPVMVIVTELLSGGTLRKYLL-NMRPRCLDVCVAIGFALDIARAMECL 141
+VK V++ E G+L L L + D+ M L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 142 HSHGIIHRDLKPENLLLTEDL---KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
+GI+HR++KP N++ KL DFG ARE E + GT ++ P++Y
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG----------MSNLQAAYAAAFK 248
LR+ +K Y VD +S + + LPF M + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 249 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289
+ AEN P + S + + T ++ +L
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 1e-54
Identities = 68/297 (22%), Positives = 129/297 (43%), Gaps = 29/297 (9%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT----VAIKIVHKGETPEEIAK 66
+ELK +L L +G G V +G Y+ + VAIK++ +G + +
Sbjct: 323 EELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE 382
Query: 67 KESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV 126
RE ++ ++ + +V+ IG C+ +++V E+ GG L K+L+ R + V
Sbjct: 383 ----MMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSN 437
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-TAE 185
++ M+ L +HR+L N+LL K++DFGL++ + TA
Sbjct: 438 VAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTAR 496
Query: 186 TGT---YRWMAPE--LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNL 239
+ +W APE + ++ + D +S+ + +WE L + + P++ M
Sbjct: 497 SAGKWPLKWYAPECINFRK----------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546
Query: 240 QAAYAAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295
+ A + R P EL +++ CW RP+F + Q + ++A
Sbjct: 547 E-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-54
Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 42/275 (15%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG G +V++ K++ +T IK + + REV L+++ H N+V
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIK---------RVKYNNEKAEREVKALAKLDHVNIVH 68
Query: 89 FIGA-----------------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
+ G K + I E GTL +++ R LD +A+
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
I + ++ +HS +I+RDLKP N+ L + K +K+ DFGL T GT R+
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251
M+PE + Y +VD Y+ ++L ELLH S + +
Sbjct: 188 MSPEQI--------SSQDYGKEVDLYALGLILAELLHVCDTAFETSKF---FTDLRDGII 236
Query: 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
++ +L + P RPN ++I++ L
Sbjct: 237 SD--IFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-53
Identities = 67/304 (22%), Positives = 114/304 (37%), Gaps = 27/304 (8%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+GA A V+ G++K AIK+ + + RE +L ++ H+N
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLNHKN 68
Query: 86 LVK---FIGACKEPVMVIVTELLSGGTLRKYLL-NMRPRCLDVCVAIGFALDIARAMECL 141
+VK V++ E G+L L L + D+ M L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 142 HSHGIIHRDLKPENLLLTEDL---KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
+GI+HR++KP N++ KL DFG ARE E + GT ++ P++Y
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG----------MSNLQAAYAAAFK 248
LR+ +K Y VD +S + + LPF M + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248
Query: 249 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSE 308
+ AEN P + S + + T ++ +L + + F
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE----ADQEKCWGFDQFFAET 304
Query: 309 NTIL 312
+ IL
Sbjct: 305 SDIL 308
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 8e-53
Identities = 67/291 (23%), Positives = 117/291 (40%), Gaps = 51/291 (17%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G+GA +V + + ++ AIK + E +K S EV +L+ + H+
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE------EKLSTILSEVMLLASLNHQY 63
Query: 86 LVKFIGA--------------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
+V++ A K+ + I E GTL + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLF 122
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---------------EE 176
I A+ +HS GIIHRDLKP N+ + E + +K+ DFGLA+
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 236
++ +T+ GT ++A E+ HYN K+D YS I+ +E+++ GM
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLD-------GTGHYNEKIDMYSLGIIFFEMIY--PFSTGM 232
Query: 237 SN---LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
L+ + + + +N + I+ DPN RP ++
Sbjct: 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-51
Identities = 72/271 (26%), Positives = 127/271 (46%), Gaps = 30/271 (11%)
Query: 29 GPRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
IG G+ VY+G VA + + + + RF E ML +QH N+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS---ERQRFKEEAEMLKGLQHPNI 87
Query: 87 VKFIGAC-----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
V+F + + +V+VTEL++ GTL+ YL R + + + V + I + ++ L
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 142 HSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
H+ IIHRDLK +N+ +T ++K+ D GLA + + GT +MAPE+Y
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMY-- 202
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA--ENV 257
++ Y+ VD Y+F + + E+ ++ P+ N Y V+P++ +
Sbjct: 203 -------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255
Query: 258 PEELSIILTSCWKEDPNARPNFTQIIQMLLN 288
E+ I+ C +++ + R + LLN
Sbjct: 256 IPEVKEIIEGCIRQNKDERYSIKD----LLN 282
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 5e-51
Identities = 70/288 (24%), Positives = 109/288 (37%), Gaps = 54/288 (18%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G V+E K K + AIK + + REV L++++H +V+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE----LAREKVMREVKALAKLEHPGIVR 67
Query: 89 FIGACKE-------------PVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDI 134
+ A E + I +L L+ ++ + V + L I
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-------------EESLTEM 181
A A+E LHS G++HRDLKP N+ T D +K+ DFGL
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 241
T + GT +M+PE Y+HKVD +S ++L+ELL+ PF
Sbjct: 187 HTGQVGTKLYMSPEQI--------HGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235
Query: 242 AYAAAFKNVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+VR P +++ P RP II+
Sbjct: 236 TL----TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-50
Identities = 78/300 (26%), Positives = 139/300 (46%), Gaps = 22/300 (7%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IGEG+ K K + IK ++ + ++ESR REVA+L+ ++H N+V++
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESR--REVAVLANMKHPNIVQY 88
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ +E + IV + GG L K + + + + + I A++ +H I+H
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 149 RDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
RD+K +N+ LT+D T++L DFG+AR S E+ A GT +++PE+ E
Sbjct: 149 RDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC--------EN 199
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 267
K YN+K D ++ VL+EL K FE S + P + + +L +++
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259
Query: 268 CWKEDPNARPNFTQIIQM------LLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 321
+K +P RP+ I++ + +LS E + +P + P +
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQ 319
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-49
Identities = 68/299 (22%), Positives = 122/299 (40%), Gaps = 36/299 (12%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
ID KH ++GEG + V + A+K + E+ ++E++ RE M
Sbjct: 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC---HEQQDREEAQ--READMH 80
Query: 79 SRVQHRNLVKFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPR--CLDVCVAIGFA 131
H N+++ + C ++ GTL + ++ + L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----------EESLTEM 181
L I R +E +H+ G HRDLKP N+LL ++ L D G + +
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 241
A+ T + APEL +++ + + D +S VL+ ++ + P++ +
Sbjct: 200 WAAQRCTISYRAPEL---FSVQSHCV--IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
Query: 242 AYAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 298
+ A A +N P + L +L S DP+ RP+ + L+ L A+ PP P
Sbjct: 255 SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL----LSQLEALQPPAP 309
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-49
Identities = 61/272 (22%), Positives = 119/272 (43%), Gaps = 26/272 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+ +IG G +KV++ + Q AIK V+ E + + E+A L+++Q +
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---SYRNEIAYLNKLQQHSD 88
Query: 87 --VKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
++ + +V E L +L + +D + ++ A+ +H
Sbjct: 89 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQ 145
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPEL---Y 197
HGI+H DLKP N L+ + +KL DFG+A ++ + + ++ GT +M PE
Sbjct: 146 HGIVHSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA--- 254
S+ K + K D +S +L+ + + K PF+ + N + + P+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPNHEIE 260
Query: 255 --ENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ ++L +L C K DP R + +++
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-49
Identities = 62/272 (22%), Positives = 119/272 (43%), Gaps = 26/272 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+ +IG G +KV++ + Q AIK V+ E + + E+A L+++Q +
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---SYRNEIAYLNKLQQHSD 69
Query: 87 --VKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
++ + +V E L +L + +D + ++ A+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQ 126
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPEL---Y 197
HGI+H DLKP N L+ + +KL DFG+A + + T + ++ GT +M PE
Sbjct: 127 HGIVHSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA--- 254
S+ K + K D +S +L+ + + K PF+ + N + + P+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---QISKLHAIIDPNHEIE 241
Query: 255 --ENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ ++L +L C K DP R + +++
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-48
Identities = 61/272 (22%), Positives = 118/272 (43%), Gaps = 26/272 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+ +IG G +KV++ + Q AIK V+ E + + E+A L+++Q +
Sbjct: 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQQHSD 116
Query: 87 --VKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
++ + +V E L +L + +D + ++ A+ +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQ 173
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPEL---Y 197
HGI+H DLKP N L+ + +KL DFG+A + + T + ++ G +M PE
Sbjct: 174 HGIVHSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA--- 254
S+ K + K D +S +L+ + + K PF+ + N + + P+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPNHEIE 288
Query: 255 --ENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ ++L +L C K DP R + +++
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-47
Identities = 65/259 (25%), Positives = 105/259 (40%), Gaps = 21/259 (8%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLV 87
R+G G++ +V++ + K + A+K P K +R EV +V QH V
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMS---PFRGPKDRARKLAEVGSHEKVGQHPCCV 120
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+ A +E ++ + TEL G +L+++ L G+ D A+ LHS G+
Sbjct: 121 RLEQAWEEGGILYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQGL 178
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
+H D+KP N+ L KL DFGL E + G R+MAPEL L+
Sbjct: 179 VHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-----LQGS- 231
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 266
Y D +S + + E+ N G Q + + EL +L
Sbjct: 232 ---YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTA--GLSSELRSVLV 286
Query: 267 SCWKEDPNARPNFTQIIQM 285
+ DP R ++ +
Sbjct: 287 MMLEPDPKLRATAEALLAL 305
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 167 bits (423), Expect = 1e-46
Identities = 68/279 (24%), Positives = 107/279 (38%), Gaps = 29/279 (10%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ R+G G V ++ + VAIK + E K R+ E+ ++ ++ H N
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ----ELSPKNRERWCLEIQIMKKLNHPN 73
Query: 86 LVKFI-------GACKEPVMVIVTELLSGGTLRKYLLNM-RPRCLDVCVAIGFALDIARA 137
+V + ++ E GG LRKYL L DI+ A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 138 MECLHSHGIIHRDLKPENLLL--TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
+ LH + IIHRDLKPEN++L K+ D G A+E E+ T GT +++APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 255
L E+K Y VD +SF + +E + PF + +
Sbjct: 194 LL--------EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245
Query: 256 NVPEELSIILTSCWKEDPNARPNFTQI-----IQMLLNY 289
+ + S PN +Q +L +
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW 284
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-46
Identities = 79/315 (25%), Positives = 140/315 (44%), Gaps = 43/315 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES---RFARE---VAMLS 79
+G +G G ++V+ + ++ VA+K++ ++A+ S RF RE A L+
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLR-----ADLARDPSFYLRFRREAQNAAALN 70
Query: 80 RVQHRNLVK-----FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
H +V P+ IV E + G TLR + P + AI D
Sbjct: 71 ---HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADA 125
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET----GTYR 190
+A+ H +GIIHRD+KP N++++ +K+ DFG+AR + + +T GT +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250
+++PE Q + + D YS VL+E+L + PF G S + AY ++
Sbjct: 185 YLSPE--------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 251 -RPSAEN--VPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSAIAPPEPMIPHRIFN 306
PSA + + +L ++ ++P R ++ L+ + P P + +
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLT---D 293
Query: 307 SENTILPPESPGTSS 321
+E T L + G S
Sbjct: 294 AERTSLLSSAAGNLS 308
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-45
Identities = 69/265 (26%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG G ++VY VA+K V + + A+ + +E+ +L ++ H N++K+
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQLNHPNVIKY 97
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGI 146
+ E + IV EL G L + + + + R + + + + A+E +HS +
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQG 205
+HRD+KP N+ +T +KL D GL R S T + GT +M+PE
Sbjct: 158 MHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-------- 208
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP-----EE 260
+ YN K D +S +L+E+ + PF G + Y+ K + +P EE
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEE 266
Query: 261 LSIILTSCWKEDPNARPNFTQIIQM 285
L ++ C DP RP+ T + +
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-45
Identities = 79/286 (27%), Positives = 132/286 (46%), Gaps = 29/286 (10%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES---RFAREVAMLSRVQ 82
+ ++G G + VY + N VAIK + +KE RF REV S++
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-----IPPREKEETLKRFEREVHNSSQLS 69
Query: 83 HRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
H+N+V I +E +V E + G TL +Y+ + P L V AI F I ++
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHA 127
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYST 199
H I+HRD+KP+N+L+ + KT+K+ DFG+A+ S T + GT ++ +PE
Sbjct: 128 HDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE---- 182
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSAEN- 256
Q + + + D YS IVL+E+L + PF G + + A +V +
Sbjct: 183 ----QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK 238
Query: 257 -VPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSAIAPPEPMI 300
+P+ LS ++ ++D R ++ L + L E +
Sbjct: 239 DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVY 284
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-44
Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 25/268 (9%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG G++ + + + K + + K + G E K+ EV +L ++H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLV--SEVNLLRELKHPNIVR 69
Query: 89 FIGACKEP---VMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHS 143
+ + + IV E GG L + + LD + + A++ H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 144 -----HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELY 197
H ++HRDLKP N+ L + +KL DFGLAR T GT +M+PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257
+ YN K D +S +L+EL PF S + A R
Sbjct: 189 --------NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 258 PEELSIILTSCWKEDPNARPNFTQIIQM 285
+EL+ I+T RP+ +I++
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 44/330 (13%), Positives = 108/330 (32%), Gaps = 61/330 (18%)
Query: 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETP------------------- 61
P+ L G +G+ E + ++ + + + E P
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 62 ----EEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVM---VIVTELLSG--GTLRK 112
++ AK RF ++ Q + +++ ++ + + + T +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 113 YLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170
LL+ + L + L + R + LH +G++H L+P +++L + + L F
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGF 250
Query: 171 GLAREESLTEMMTAETGTYRWMAPEL---YSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 227
+ + + + PEL +T++ + + D+++ +V++ +
Sbjct: 251 EHLVRDG---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 228 HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287
LP F++ + N+P+ + +L + R Q ++
Sbjct: 308 CADLPITK-DAALGGSEWIFRSCK----NIPQPVRALLEGFLRYPKEDRLLPLQAME--- 359
Query: 288 NYLSAIAPPEPMIPHRIFNSENTILPPESP 317
+ T L P
Sbjct: 360 --------------TPEYEQLRTELSAALP 375
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-44
Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 21/263 (7%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKK--ESRFAREVAMLSRVQH 83
VG +G+G+ A VY + VAIK++ K + + K R EV + +++H
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDK----KAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 84 RNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
++++ ++ V +V E+ G + +YL N R + A F I M LH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLH 129
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPELYSTVT 201
SHGI+HRDL NLLLT ++ IK+ADFGLA + + E GT +++PE+ +
Sbjct: 130 SHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT--- 185
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 261
+ + + D +S + + LL + PF+ ++ + E
Sbjct: 186 -----RSAHGLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLNKVVLADYEMPSFLSIEA 239
Query: 262 SIILTSCWKEDPNARPNFTQIIQ 284
++ + +P R + + ++
Sbjct: 240 KDLIHQLLRRNPADRLSLSSVLD 262
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-44
Identities = 84/309 (27%), Positives = 139/309 (44%), Gaps = 28/309 (9%)
Query: 20 LIDPKHL---FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKK--ESRFA 72
L+DP+ G +G+G AK +E + A KIV K + K + +
Sbjct: 34 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPK----SLLLKPHQREKMS 89
Query: 73 REVAMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
E+++ + H+++V F G ++ V +V EL +L + R + L A +
Sbjct: 90 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYL 147
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA-REESLTEMMTAETGTYR 190
I + LH + +IHRDLK NL L EDL +K+ DFGLA + E E GT
Sbjct: 148 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPN 206
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250
++APE+ S KK ++ +VD +S +++ LL K PFE S L+ Y KN
Sbjct: 207 YIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNE 257
Query: 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRIFNS 307
+++ + ++ + DP ARP +++ Y+ A P + F+
Sbjct: 258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSI 317
Query: 308 ENTILPPES 316
+ L P +
Sbjct: 318 APSSLDPSN 326
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-44
Identities = 81/289 (28%), Positives = 132/289 (45%), Gaps = 28/289 (9%)
Query: 20 LIDPKHL---FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKK--ESRFA 72
L+DP+ G +G+G AK +E + A KIV K + K + +
Sbjct: 8 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPK----SLLLKPHQREKMS 63
Query: 73 REVAMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
E+++ + H+++V F G ++ V +V EL +L + R + L A +
Sbjct: 64 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYL 121
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA-REESLTEMMTAETGTYR 190
I + LH + +IHRDLK NL L EDL +K+ DFGLA + E E GT
Sbjct: 122 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPN 180
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250
++APE+ S KK ++ +VD +S +++ LL K PFE S L+ Y KN
Sbjct: 181 YIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNE 231
Query: 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPP 296
+++ + ++ + DP ARP +++ Y+ A P
Sbjct: 232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPI 280
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-43
Identities = 69/327 (21%), Positives = 115/327 (35%), Gaps = 42/327 (12%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+ L V + EG A VYE + + A+K + E +K +EV +
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-----EKNRAIIQEVCFM 79
Query: 79 SRVQ-HRNLVKFIGACKEPVM--------VIVTELLSGGTLRKYLLNMRPR-CLDVCVAI 128
++ H N+V+F A ++ L G L ++L M R L +
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL 139
Query: 129 GFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAR------------ 174
RA++ +H IIHRDLK ENLLL+ TIKL DFG A
Sbjct: 140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSA 198
Query: 175 -EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
+L E T + PE+ + K D ++ +L+ L + PF
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYS-----NFPIGEKQDIWALGCILYLLCFRQHPF 253
Query: 234 EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293
E + P + ++ + + +P R + +++ L ++A
Sbjct: 254 ED-GAKLRIVNGKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE-IAAA 309
Query: 294 APPEPMIPHRIFNSENTILPPESPGTS 320
P P +N +
Sbjct: 310 RNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-42
Identities = 48/232 (20%), Positives = 94/232 (40%), Gaps = 28/232 (12%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHK------------GETPEEIAKKESRFAREVAMLS 79
+ +G K+ + N+ A+K K I K F E+ +++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 80 RVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLN------MRPRCLDVCVAIGFAL 132
+++ + G V I+ E + ++ K+ + + V
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 133 DIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
+ + +H+ I HRD+KP N+L+ ++ +KL+DFG + ++ + GTY +
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSR-GTYEF 216
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 243
M PE +S E + KVD +S I L+ + +N +PF +L +
Sbjct: 217 MPPEFFS------NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 5e-42
Identities = 67/264 (25%), Positives = 121/264 (45%), Gaps = 26/264 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKK--ESRFAREVAMLSRVQH 83
+G +G+G VY + K +A+K++ K ++ K E + REV + S ++H
Sbjct: 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFK----AQLEKAGVEHQLRREVEIQSHLRH 68
Query: 84 RNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
N+++ G + V ++ E GT+ + L + D + ++A A+ H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 126
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTV 200
S +IHRD+KPENLLL +K+ADFG + GT ++ PE+
Sbjct: 127 SKRVIHRDIKPENLLLGSAG-ELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI--- 179
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260
E + ++ KVD +S ++ +E L K PFE + Q Y + + V E
Sbjct: 180 -----EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFTFPDFVTEG 233
Query: 261 LSIILTSCWKEDPNARPNFTQIIQ 284
+++ K +P+ RP ++++
Sbjct: 234 ARDLISRLLKHNPSQRPMLREVLE 257
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 59/281 (20%), Positives = 116/281 (41%), Gaps = 25/281 (8%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKK--ESRFAREVAMLSRVQH 83
+G +G+G VY + K +A+K++ K ++ K+ E + RE+ + S ++H
Sbjct: 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFK----SQLEKEGVEHQLRREIEIQSHLRH 73
Query: 84 RNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
N+++ + + ++ E G L K L + D + F ++A A+ H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCH 131
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 202
+IHRD+KPENLL+ +K+ADFG + T GT ++ PE+
Sbjct: 132 ERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMI----- 184
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELS 262
E K ++ KVD + ++ +E L PF+ + + + +
Sbjct: 185 ---EGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDLKFPPFLSDGSK 240
Query: 263 IILTSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMI 300
+++ + P R +++ + N + P
Sbjct: 241 DLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 149 bits (376), Expect = 2e-41
Identities = 42/335 (12%), Positives = 103/335 (30%), Gaps = 45/335 (13%)
Query: 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE----------------- 63
P+ L G +G+ E + ++ + + + E P
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 64 ------IAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELL-----SGGTLRK 112
AK RF ++ Q + +++ ++ ++ L + T +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 113 YLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170
LL+ + L + L + R + LH +G++H L+P +++L + + L F
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGF 255
Query: 171 GLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 228
+ + + A + Q D+++ + ++ +
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPF---GQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 229 NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ--ML 286
LP F++ + N+P+ + +L + R Q ++
Sbjct: 313 ADLPNTD-DAALGGSEWIFRSCK----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 367
Query: 287 LNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 321
+ ++ P+ + PP
Sbjct: 368 EQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPD 402
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 34/303 (11%), Positives = 83/303 (27%), Gaps = 52/303 (17%)
Query: 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR 80
+ L + + G + V+ + + A+K+ G + R +R
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR--SELERLHEATFAAAR 118
Query: 81 VQHRNLVKFIGACK------------EPVMVIVTELLSGGTLRKYLLNM----------- 117
+ + + + +P ++ + YLL M
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 118 --------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169
+ + R L S G++H P+NL + D + L D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGD 237
Query: 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 229
+ A + + E + H ++++ + ++ +
Sbjct: 238 VSALWKVG--TRGPASSVPVTYAPRE------FLNASTATFTHALNAWQLGLSIYRVWCL 289
Query: 230 KLPFEGMSNLQAAYAAAFKNVRPSAE--------NVPEELSIILTSCWKEDPNARPNFTQ 281
LPF ++ P + +P+ + ++ D R +
Sbjct: 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349
Query: 282 IIQ 284
++
Sbjct: 350 AME 352
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 69/264 (26%), Positives = 114/264 (43%), Gaps = 34/264 (12%)
Query: 28 VGPRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKES---RFAREVAMLSRVQ 82
+ +G G VYE + + + VA+K++ E ++ R RE R+Q
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMS-----ETLSSDPVFRTRMQREARTAGRLQ 92
Query: 83 HRNLVKF--IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
++V G + + + L++G L L P L A+ I A++
Sbjct: 93 EPHVVPIHDFGE-IDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDA 149
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELY 197
H+ G HRD+KPEN+L++ D L DFG+A +E LT++ GT +MAPE
Sbjct: 150 AHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNT-VGTLYYMAPE-- 205
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RPSAEN 256
+ + H ++ D Y+ VL+E L P++G L A + + RPS
Sbjct: 206 ------RFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVR 258
Query: 257 --VPEEL-SIILTSCWKEDPNARP 277
+P ++I K +P R
Sbjct: 259 PGIPVAFDAVIARGMAK-NPEDRY 281
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 36/284 (12%)
Query: 31 RIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHRNLVKF 89
++GEG VY+G N TVA+K + K++ F +E+ ++++ QH NLV+
Sbjct: 38 KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ--FDQEIKVMAKCQHENLVEL 95
Query: 90 IGACKEPV-MVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGII 147
+G + + +V + G+L L + L + A A + LH + I
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
HRD+K N+LL E T K++DFGLAR + + T M + GT +MAPE
Sbjct: 156 HRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALR----- 208
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFE---GMSNLQAAYAAAFKN--------VRPS 253
G K D YSF +VL E++ + L ++ +
Sbjct: 209 G---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIEDEEKTIEDYIDKK 264
Query: 254 AENVPEE-----LSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
+ S+ C E N RP+ ++ Q+L ++
Sbjct: 265 MNDADSTSVEAMYSVAS-QCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 4e-41
Identities = 55/302 (18%), Positives = 104/302 (34%), Gaps = 42/302 (13%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEE 63
+K ++ + K ++V +GEGA A+VYE + Q +K+ P E
Sbjct: 52 PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWE 110
Query: 64 IAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--- 119
+ + L +KF A V+V EL S GTL + +
Sbjct: 111 FYIGT----QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166
Query: 120 RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL----------KTIKLAD 169
+ + + I FA+ + +E +H IIH D+KP+N +L + L D
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226
Query: 170 FGLAREESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226
G + + L + TA+ T + E+ K +N+++D + A ++ +
Sbjct: 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEML--------SNKPWNYQIDYFGVAATVYCM 278
Query: 227 LHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
L + F+ + + +++
Sbjct: 279 LFGTYMKVKNEGGECKPEGLFRR-----LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333
Query: 287 LN 288
L
Sbjct: 334 LK 335
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK---GETPEEIAKKESRFAREVAMLSRVQ 82
+ +G GA +V + + VAI+I+ K A E+ +L ++
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 83 HRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
H ++K IV EL+ GG L ++ + L + + A++ LH
Sbjct: 199 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH 256
Query: 143 SHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
+GIIHRDLKPEN+LL+ E+ IK+ DFG ++ T +M GT ++APE+
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV---- 312
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
L YN VD +S ++L+ L PF
Sbjct: 313 -LVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 68/259 (26%), Positives = 117/259 (45%), Gaps = 30/259 (11%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G + VY G +AIK + PE ++ E+A+ ++H+N+V++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEI-----PERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIG-FALDIARAMECLHSHGII 147
+G+ E + I E + GG+L L + D IG + I ++ LH + I+
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
HRD+K +N+L+ +K++DFG ++ + TGT ++MAPE+
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII------DKG 198
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK----NVRPSAENVPEELS 262
+ Y D +S + E+ K PF L AA FK V P +PE +S
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMFKVHPE---IPESMS 252
Query: 263 II----LTSCWKEDPNARP 277
+ C++ DP+ R
Sbjct: 253 AEAKAFILKCFEPDPDKRA 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 66/289 (22%), Positives = 112/289 (38%), Gaps = 32/289 (11%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVG-PRIGEGAHAKVYEGKYKN--QTVAIKIVHK 57
E L ++LK + H PR+G G+ +V+ K K A+K V
Sbjct: 34 TEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL 93
Query: 58 GETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLN 116
E E+ + + +V GA +E V I ELL GG+L + +
Sbjct: 94 EVFRVE----------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ 143
Query: 117 MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG----L 172
M L A+ + +E LH+ I+H D+K +N+LL+ D L DFG L
Sbjct: 144 MGC--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201
Query: 173 AREESLTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK 230
+ ++T + GT MAPE V + + + KVD +S ++ +L+
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPE----VVMGKP----CDAKVDIWSSCCMMLHMLNGC 253
Query: 231 LPFEGMSNLQAAY--AAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 277
P+ A+ +R + + + +++P R
Sbjct: 254 HPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-40
Identities = 52/279 (18%), Positives = 99/279 (35%), Gaps = 42/279 (15%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLV 87
+IG G V++ + AIK K P + E REV + + QH ++V
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKK---PLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLL--NMRPRCLDVCVAIGFALDIARAMECLHSH 144
++ A E M+I E +GG+L + L + R + +HS
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 145 GIIHRDLKPENLLLTED------------------LKTIKLADFGLAREESLTEMMTAET 186
++H D+KP N+ ++ K+ D G ++ E
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--RISSPQV-EE 191
Query: 187 GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA 246
G R++A E+ E + K D ++ A+ + + +
Sbjct: 192 GDSRFLANEVLQ-------ENYTHLPKADIFALALTVVCAAGAEPLPRNGD----QWHEI 240
Query: 247 FKNVRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ P + + +E + +L DP RP+ +++
Sbjct: 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 59/283 (20%), Positives = 109/283 (38%), Gaps = 40/283 (14%)
Query: 32 IGEGAHAKV-YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89
+G G+ V ++G ++ + VA+K + E+ +L+ H N++++
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLI--------DFCDIALMEIKLLTESDDHPNVIRY 74
Query: 90 IGACKEPVMV-IVTELLSGGTL-----RKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
+ + I EL L K + + + I IA + LHS
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 144 HGIIHRDLKPENLLLTEDLKT------------IKLADFGLAR-----EESLTEMMTAET 186
IIHRDLKP+N+L++ + I ++DFGL + + S + +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 187 GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAA 245
GT W APEL Q K+ +D +S V + +L K PF + ++
Sbjct: 194 GTSGWRAPELLEESNNLQT-KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 246 AFKNVRPSAENVPEELSI----ILTSCWKEDPNARPNFTQIIQ 284
++ L +++ DP RP ++++
Sbjct: 253 GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 63/271 (23%), Positives = 107/271 (39%), Gaps = 37/271 (13%)
Query: 32 IGEGAHAK-VYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89
+G GA VY G + N+ VA+K + + S REV +L +H N++++
Sbjct: 32 LGHGAEGTIVYRGMFDNRDVAVKRILP--------ECFSFADREVQLLRESDEHPNVIRY 83
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
K+ I EL TL++Y+ + I + LHS I+H
Sbjct: 84 FCTEKDRQFQYIAIELC-AATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141
Query: 149 RDLKPENLLLTEDLKT----IKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTV 200
RDLKP N+L++ ++DFGL + + GT W+APE+
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM---- 197
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259
L + K++ + VD +S V + ++ PF Q A S + +
Sbjct: 198 -LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANILLGACSLDCLHP 252
Query: 260 ELSI------ILTSCWKEDPNARPNFTQIIQ 284
E ++ DP RP+ +++
Sbjct: 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 75/284 (26%), Positives = 117/284 (41%), Gaps = 49/284 (17%)
Query: 32 IGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESR-----FAREVAMLSRVQHRN 85
IG G KVY+G ++ VA+K ES F E+ LS +H +
Sbjct: 47 IGHGVFGKVYKGVLRDGAKVALKR----------RTPESSQGIEEFETEIETLSFCRHPH 96
Query: 86 LVKFIGACKEPV-MVIVTELLSGGTLRKYLL--NMRPRCLDVCVAIGFALDIARAMECLH 142
LV IG C E M+++ + + G L+++L ++ + + + AR + LH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYST 199
+ IIHRD+K N+LL E+ K+ DFG+++ E T + T GT ++ PE +
Sbjct: 157 TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF-----EGMSNLQAAYAAAFKNVRPSA 254
K D YSF +VL+E+L + M NL A +A N
Sbjct: 216 --------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL-AEWAVESHNNGQLE 266
Query: 255 ENV---------PEELSIILT---SCWKEDPNARPNFTQIIQML 286
+ V PE L C RP+ ++ L
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-39
Identities = 64/285 (22%), Positives = 102/285 (35%), Gaps = 39/285 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYKN---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
V I G +Y +N + V +K + E A E L+ V H
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQA----MAMAERQFLAEVVHP 139
Query: 85 NLVK------FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
++V+ +PV IV E + G +L++ + L V AI + L+I A+
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPAL 195
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
LHS G+++ DLKPEN++LTE+ +KL D G + + GT + APE+
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVR 250
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258
T D Y+ L L + G Y
Sbjct: 251 T---------GPTVATDIYTVGRTLAALTLDLPTRNG------RYVDGL-PEDDPVLKTY 294
Query: 259 EELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSAIAPPEPMIPH 302
+ +L DP R ++ L L + + +P
Sbjct: 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPR 339
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-38
Identities = 71/275 (25%), Positives = 130/275 (47%), Gaps = 27/275 (9%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP ++ + +G+GA KVY+ K K A K++ + ++ + E+ +L
Sbjct: 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-----ETKSEEELEDYIVEIEIL 70
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLD-VCVAIGFALDIAR 136
+ H +VK +GA + + I+ E GG + ++ R L + + +
Sbjct: 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLE 128
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AET--GTYRWMA 193
A+ LHS IIHRDLK N+L+T + I+LADFG++ + + + ++ GT WMA
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMA 185
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253
PE+ V + Y++K D +S I L E+ + P ++ ++ A K+ P+
Sbjct: 186 PEV---VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPPT 241
Query: 254 AENVPEELSII----LTSCWKEDPNARPNFTQIIQ 284
P + S+ L ++P RP+ Q+++
Sbjct: 242 LLT-PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 70/257 (27%), Positives = 105/257 (40%), Gaps = 43/257 (16%)
Query: 2 ESRSRFYLADELKLDAKWLIDPK------HLFVGPRIGEGAHAKVYEGKYK--NQTVAIK 53
R Y +L+ I K ++G GA+ +V + K + AIK
Sbjct: 9 SGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK 68
Query: 54 IVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRK 112
I+ K S+ EVA+L + H N++K ++ +V E GG L
Sbjct: 69 IIRKTSVS---TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL-- 123
Query: 113 YLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRDLKPENLLLT--ED 161
D + A I + + LH H I+HRDLKPENLLL E
Sbjct: 124 ---------FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174
Query: 162 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAI 221
IK+ DFGL+ + M GT ++APE+ +K Y+ K D +S +
Sbjct: 175 DALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL---------RKKYDEKCDVWSIGV 225
Query: 222 VLWELLHNKLPFEGMSN 238
+L+ LL PF G ++
Sbjct: 226 ILFILLAGYPPFGGQTD 242
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-38
Identities = 83/304 (27%), Positives = 141/304 (46%), Gaps = 39/304 (12%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVH- 56
M S S DE+ L A L DP +F + +G G + +VY+G++ Q AIK++
Sbjct: 2 MASDSPARSLDEIDLSA--LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV 59
Query: 57 KGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA-------CKEPVMVIVTELLSGG 108
G+ EEI + E+ ML + HRN+ + GA + + +V E G
Sbjct: 60 TGDEEEEIKQ-------EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG 112
Query: 109 TLRKYLLNMRPRCLD-VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167
++ + N + L +A +I R + LH H +IHRD+K +N+LLTE+ + +KL
Sbjct: 113 SVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKL 170
Query: 168 ADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224
DFG++ + L + GT WMAPE+ + + Y+ K D +S I
Sbjct: 171 VDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEV---IACDENPDATYDFKSDLWSLGITAI 225
Query: 225 ELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSII----LTSCWKEDPNARPNFT 280
E+ P M ++A + +N P + ++ S + SC ++ + RP
Sbjct: 226 EMAEGAPPLCDMHPMRALFLIP-RNPAPRLK--SKKWSKKFQSFIESCLVKNHSQRPATE 282
Query: 281 QIIQ 284
Q+++
Sbjct: 283 QLMK 286
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-38
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK---GETPEEIAKKESRFAREVAMLSRVQ 82
+ +G GA +V + + VAIKI+ K A E+ +L ++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 83 HRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
H ++K IV EL+ GG L ++ + L + + A++ LH
Sbjct: 74 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH 131
Query: 143 SHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
+GIIHRDLKPEN+LL+ E+ IK+ DFG ++ T +M GT ++APE+
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV---- 187
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
L YN VD +S ++L+ L PF
Sbjct: 188 -LVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-38
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
++G GA V+ + + IK ++K + + E+ +L + H N
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINK----DRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTL--RKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
++K ++ + IV E GG L R R + L + A+ H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 143 SHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
S ++H+DLKPEN+L IK+ DFGLA E T GT +MAPE++
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF--- 198
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
K+ K D +S +V++ LL LPF G
Sbjct: 199 ------KRDVTFKCDIWSAGVVMYFLLTGCLPFTG 227
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 65/287 (22%), Positives = 124/287 (43%), Gaps = 41/287 (14%)
Query: 28 VGPRIGEGAHAKVYEGK--YKNQTVAIKIVHK---------------------GETPEEI 64
+ IG+G++ V N A+K++ K +
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 65 AKKESRFAREVAMLSRVQHRNLVKF---IGACKEPVMVIVTELLSGGTLRKYLLNMRPRC 121
+ +E+A+L ++ H N+VK + E + +V EL++ G + +
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP--- 133
Query: 122 LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
L A + D+ + +E LH IIHRD+KP NLL+ ED IK+ADFG++ E ++
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDA 192
Query: 182 MTAET-GTYRWMAPELYSTVTLRQGEKKHYN-HKVDSYSFAIVLWELLHNKLPFEGMSNL 239
+ + T GT +MAPE S +K ++ +D ++ + L+ + + PF +
Sbjct: 193 LLSNTVGTPAFMAPESLS------ETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERI 245
Query: 240 QAAYAAAFK-NVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
++ + P ++ E+L ++T ++P +R +I
Sbjct: 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 77/280 (27%), Positives = 125/280 (44%), Gaps = 44/280 (15%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
P+ +F V ++GEG++ VY+ +K Q VAIK V +EI K E++++
Sbjct: 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-------EISIM 78
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFA 131
+ ++VK+ G+ K + IV E G++ ++ +R + L +
Sbjct: 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATIL------ 131
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GT 188
+ +E LH IHRD+K N+LL + KLADFG+A + LT+ M GT
Sbjct: 132 QSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQ--LTDTMAKRNTVIGT 188
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248
WMAPE+ + YN D +S I E+ K P+ + ++A +
Sbjct: 189 PFWMAPEVIQ--------EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-T 239
Query: 249 NVRPSAENVPEELSII----LTSCWKEDPNARPNFTQIIQ 284
N P+ PE S + C + P R TQ++Q
Sbjct: 240 NPPPTFRK-PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 42/299 (14%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G+G+ +V K K Q A+K++ K + ++ K+ REV +L ++ H N
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQLDHPN 87
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
++K ++ +V E+ +GG L D ++ A I R
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGEL-----------FDEIISRKRFSEVDAARIIRQVL 136
Query: 137 -AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
+ +H + I+HRDLKPENLLL I++ DFGL+ ++ M + GT ++A
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNV 250
PE+ Y+ K D +S ++L+ LL PF G + L+ +
Sbjct: 197 PEVL---------HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE 247
Query: 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRIFN 306
P + V E ++ P+ R + + + I+ P + + I N
Sbjct: 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILN 306
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 73/292 (25%), Positives = 126/292 (43%), Gaps = 38/292 (13%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKE 68
E W I+ + IG GA A V + VAIK ++ + +
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM---- 57
Query: 69 SRFAREVAMLSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
+E+ +S+ H N+V + + + + +V +LLSGG++ + ++ +
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 128 -----IGFAL-DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG----LAREES 177
I L ++ +E LH +G IHRD+K N+LL ED ++++ADFG LA
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGD 176
Query: 178 LTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+T +T GT WMAPE+ + + Y+ K D +SF I EL P+
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVME-------QVRGYDFKADIWSFGITAIELATGAAPYHK 229
Query: 236 MSNLQAAYAAAFKNVRPSAENVPEELSII----------LTSCWKEDPNARP 277
++ +N PS E ++ ++ ++ C ++DP RP
Sbjct: 230 YPPMKVLMLTL-QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-37
Identities = 69/274 (25%), Positives = 116/274 (42%), Gaps = 40/274 (14%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+G+ +V + K + Q A+K+++K K S REV +L ++ H N
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA---KNKDTSTILREVELLKKLDHPN 82
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
++K ++ IV EL +GG L D + A I +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGEL-----------FDEIIKRKRFSEHDAARIIKQVF 131
Query: 137 -AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
+ +H H I+HRDLKPEN+LL E IK+ DFGL+ M GT ++A
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNV 250
PE+ + Y+ K D +S ++L+ LL PF G + L+ +
Sbjct: 192 PEVL---------RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD 242
Query: 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
P + ++ ++ P+ R TQ ++
Sbjct: 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-37
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 37/222 (16%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+G+ +V + K + Q A+K+++K K S REV +L ++ H N
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA---KNKDTSTILREVELLKKLDHPN 82
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
++K ++ IV EL +GG L D + A I +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGEL-----------FDEIIKRKRFSEHDAARIIKQVF 131
Query: 137 -AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
+ +H H I+HRDLKPEN+LL E IK+ DFGL+ M GT ++A
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
PE+ + Y+ K D +S ++L+ LL PF G
Sbjct: 192 PEVL---------RGTYDEKCDVWSAGVILYILLSGTPPFYG 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-37
Identities = 66/326 (20%), Positives = 107/326 (32%), Gaps = 83/326 (25%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIV--HKGETPEEIAKKESR---------------- 70
+G G V+E K K + AIK + E E +E +
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 71 -----------------------------------FAREVAMLSRVQHRNLVKFIGACKE 95
+ ++ + +N V +
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 96 PVMV-IVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKP 153
V + I +L L+ ++ + V + + IA A+E LHS G++HRDLKP
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192
Query: 154 ENLLLTEDLKTIKLADFGLAR-------------EESLTEMMTAETGTYRWMAPELYSTV 200
N+ T D +K+ DFGL T + GT +M+PE
Sbjct: 193 SNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE----- 246
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPE 259
Q +Y+HKVD +S ++L+ELL+ F P
Sbjct: 247 ---QIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYP 300
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQM 285
+ +++ P RP T II+
Sbjct: 301 QEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK--------GETPEEIAKKESRFAREVAM 77
++G GA+ +V K K + AIK++ K + + I K E+++
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 78 LSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----A 131
L + H N++K ++ +VTE GG L + + A
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-----------FEQIINRHKFDECDA 148
Query: 132 LDIAR----AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAE 185
+I + + LH H I+HRD+KPEN+LL L IK+ DFGL+ S +
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208
Query: 186 TGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 238
GT ++APE+ KK YN K D +S ++++ LL PF G ++
Sbjct: 209 LGTAYYIAPEVL---------KKKYNEKCDVWSCGVIMYILLCGYPPFGGQND 252
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 81/265 (30%), Positives = 128/265 (48%), Gaps = 29/265 (10%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF +IG+G+ +V++G + VAIKI+ E +EI +E+ +L
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI----EDIQQEITVL 74
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIAR 136
S+ + K+ G+ K+ + I+ E L GG+ + P LD I L +I +
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL---LEPGPLDE-TQIATILREILK 130
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMA 193
++ LHS IHRD+K N+LL+E +KLADFG+A LT+ GT WMA
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMA 187
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253
PE V + Y+ K D +S I EL + P + ++ + KN P+
Sbjct: 188 PE----VIKQSA----YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPT 238
Query: 254 AE-NVPEELSIILTSCWKEDPNARP 277
E N + L + +C ++P+ RP
Sbjct: 239 LEGNYSKPLKEFVEACLNKEPSFRP 263
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 32/290 (11%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +GEG++ KV E A+KI+ K + I E+ +E+ +L R++H+N
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 86 LVKF---IGACKEPVMVIVTELLSGGT--LRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
+++ + ++ M +V E G + + R VC A G+ + +E
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDGLEY 124
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPELY 197
LHS GI+H+D+KP NLLLT T+K++ G+A T T G+ + PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257
+ G KVD +S + L+ + PFEG N+ + +N+ + +
Sbjct: 184 N------GLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLF----ENIGKGSYAI 232
Query: 258 PEELSI----ILTSCWKEDPNARPNFTQIIQM--LLNYLSAIAPPEPMIP 301
P + +L + +P R + QI Q P P+ P
Sbjct: 233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPP 282
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 44/273 (16%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA VY Q VAI+ + + K+ E+ ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-----NLQQQPKKELIINEILVM 71
Query: 79 SRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFA 131
++ N+V ++ + + +V E L+GG+L + C+D VC
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVC------ 122
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GT 188
+ +A+E LHS+ +IHRD+K +N+LL D ++KL DFG + +T + + GT
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQ--ITPEQSKRSTMVGT 179
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248
WMAPE+ + +K Y KVD +S I+ E++ + P+ + L+A Y A
Sbjct: 180 PYWMAPEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-T 230
Query: 249 NVRPSAENVPEELSIILTS----CWKEDPNARP 277
N P +N PE+LS I C + D R
Sbjct: 231 NGTPELQN-PEKLSAIFRDFLNRCLEMDVEKRG 262
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 65/307 (21%), Positives = 115/307 (37%), Gaps = 56/307 (18%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ IG+G++ V AIKI++K + + K R EV ++ ++ H N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTL------RKYLLNMRPRCLDVCV------------ 126
+ + ++ + +V EL GG L + V
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 127 --------------------AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-TI 165
I A+ LH+ GI HRD+KPEN L + + I
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 166 KLADFGLAR-----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFA 220
KL DFGL++ MT + GT ++APE+ L + Y K D++S
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV-----LN-TTNESYGPKCDAWSAG 263
Query: 221 IVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARP 277
++L LL +PF G+++ + P+ + +L++ + + R
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323
Query: 278 NFTQIIQ 284
+ + +Q
Sbjct: 324 DAMRALQ 330
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-36
Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 39/222 (17%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ IG G+ +V K A K + K + RF +E+ ++ + H N
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-----VEDVDRFKQEIEIMKSLDHPN 67
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
+++ ++ + +V EL +GG L + V A I +
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGEL-----------FERVVHKRVFRESDAARIMKDVL 116
Query: 137 -AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
A+ H + HRDLKPEN L +KL DFGLA +MM + GT +++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
P++ + Y + D +S ++++ LL PF
Sbjct: 177 PQVL---------EGLYGPECDEWSAGVMMYVLLCGYPPFSA 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 71/281 (25%), Positives = 118/281 (41%), Gaps = 27/281 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +GEGA+ +V + + VA+KIV + +E+ + + H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNHEN 66
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+VKF G +E + + E SGG L + + A F + + LH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI 124
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLA---REESLTEMMTAETGTYRWMAPELYSTVT 201
GI HRD+KPENLLL E +K++DFGLA R + ++ GT ++APEL
Sbjct: 125 GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--- 180
Query: 202 LRQGEKKHYN-HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVP 258
++ ++ VD +S IVL +L +LP++ S+ Y+ + + +
Sbjct: 181 -----RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 259 EELSIILTSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPP 296
+L E+P+AR I + P
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 77/279 (27%), Positives = 122/279 (43%), Gaps = 40/279 (14%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF IG G+ VY + ++ VAIK + ++ +EV L
Sbjct: 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD--IIKEVRFL 108
Query: 79 SRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFA 131
+++H N +++ G +E +V E G LL + + L V
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVT------ 160
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTY 189
+ + LHSH +IHRD+K N+LL+E +KL DFG A + M A + GT
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSA-----SIMAPANSFVGTP 214
Query: 190 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249
WMAPE+ + ++ Y+ KVD +S I EL K P M+ + A Y A +N
Sbjct: 215 YWMAPEV-----ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QN 268
Query: 250 VRPSAENVPEELSII----LTSCWKEDPNARPNFTQIIQ 284
P+ + S + SC ++ P RP +++
Sbjct: 269 ESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 75/300 (25%), Positives = 131/300 (43%), Gaps = 50/300 (16%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ L +IGEG+ V + K + VA+K++ ++ EV ++
Sbjct: 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-----DLRKQQRRELLFNEVVIM 96
Query: 79 SRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFA 131
QH N+V+ + + ++ E L GG L + L+ VC
Sbjct: 97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQVRLNEEQIATVC------ 147
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GT 188
+ +A+ LH+ G+IHRD+K +++LLT D +KL+DFG +++ + GT
Sbjct: 148 EAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFC--AQISKDVPKRKSLVGT 204
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248
WMAPE+ S + Y +VD +S I++ E++ + P+ S +QA
Sbjct: 205 PYWMAPEVIS--------RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-D 255
Query: 249 NVRPSAENVPEELSII----LTSCWKEDPNARPNFTQIIQMLLN--YLSAIAPPEPMIPH 302
+ P +N ++S + L DP R + LL+ +L PE ++P
Sbjct: 256 SPPPKLKN-SHKVSPVLRDFLERMLVRDPQERATAQE----LLDHPFLLQTGLPECLVPL 310
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 31/223 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK----GETPEEIAKKESRFAREVAMLSRV 81
+G G + V +K + A+KI+ + EE+ + +EV +L +V
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 82 -QHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDI 134
H N+++ + +V +L+ G L D I
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-----------FDYLTEKVTLSEKETRKI 129
Query: 135 AR----AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
R + LH I+HRDLKPEN+LL +D+ IKL DFG + + E + GT
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 188
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
++APE+ Y +VD +S ++++ LL PF
Sbjct: 189 YLAPEIIECSM--NDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 73/274 (26%), Positives = 120/274 (43%), Gaps = 22/274 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G AKV ++ + VAIKI+ K + + REV ++ + H N+VK
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNP---TSLQKLFREVRIMKILNHPNIVKL 79
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + ++ E SGG + YL + + A I A++ H I+H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKRIVH 137
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK 208
RDLK ENLLL D+ IK+ADFG + E ++ + A G + APEL+ K
Sbjct: 138 RDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ--------GK 188
Query: 209 HYN-HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 267
Y+ +VD +S ++L+ L+ LPF+G NL+ + + + +L
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFYMSTDCENLLKR 247
Query: 268 CWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEP 298
+P R QI++ + + P
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFV 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-35
Identities = 46/256 (17%), Positives = 101/256 (39%), Gaps = 26/256 (10%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLF-VGPRIGEGAH--AKVYEGKYK--NQTVAIKIV 55
M ++ + + + + IG+G V +YK + V ++ +
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI 60
Query: 56 HKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYL 114
+ E+ E+ + H N+V + + + +VT ++ G+ + +
Sbjct: 61 NLEACSNEMVT---FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI 117
Query: 115 LNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
++ +AI + L + +A++ +H G +HR +K ++L++ D + L+
Sbjct: 118 CTHFMDGMNE-LAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSN 175
Query: 174 --------REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 225
R+ + + W++PE+ L+Q + Y+ K D YS I E
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEV-----LQQ-NLQGYDAKSDIYSVGITACE 229
Query: 226 LLHNKLPFEGMSNLQA 241
L + +PF+ M Q
Sbjct: 230 LANGHVPFKDMPATQM 245
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 36/222 (16%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
V +G+GA + V +K A KI++ + A+ + RE + ++QH N
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPN 66
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIG---------FALDIA 135
+V+ + +E +V +L++GG L + VA I
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGEL-----------FEDIVAREFYSEADASHCIQQIL 115
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMA 193
++ HS+GI+HR+LKPENLLL K +KLADFGLA E + +E GT +++
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 175
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
PE+ L+ K Y+ VD ++ ++L+ LL PF
Sbjct: 176 PEV-----LK---KDPYSKPVDIWACGVILYILLVGYPPFWD 209
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 75/284 (26%), Positives = 120/284 (42%), Gaps = 44/284 (15%)
Query: 32 IGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90
+G G KVY+G+ + VA+K + + T E +F EV M+S HRNL++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLR 93
Query: 91 GACKEPVM-VIVTELLSGGTLRKYLLNMRPRCL----DVCVAIGFALDIARAMECLHSHG 145
G C P ++V ++ G++ L I AL AR + LH H
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI--ALGSARGLAYLHDHC 151
Query: 146 ---IIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPELYSTV 200
IIHRD+K N+LL E+ + DFGLA+ + T + TA GT +APE ST
Sbjct: 152 DPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST- 209
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN---- 256
G + K D + + ++L EL+ + F+ V+ +
Sbjct: 210 ----G---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262
Query: 257 -----------VPEELSIILT---SCWKEDPNARPNFTQIIQML 286
EE+ ++ C + P RP +++++ML
Sbjct: 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 72/301 (23%), Positives = 121/301 (40%), Gaps = 27/301 (8%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +GEGA+ +V + + VA+KIV + +E+ + + H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNHEN 66
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+VKF G +E + + E SGG L + + A F + + LH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI 124
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLA---REESLTEMMTAETGTYRWMAPELYSTVT 201
GI HRD+KPENLLL E +K++DFGLA R + ++ GT ++APEL
Sbjct: 125 GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--- 180
Query: 202 LRQGEKKHYN-HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVP 258
++ ++ VD +S IVL +L +LP++ S+ Y+ + + +
Sbjct: 181 -----RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 235
Query: 259 EELSIILTSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRIFNSENTILPPE 315
+L E+P+AR I + P + +
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQ 295
Query: 316 S 316
S
Sbjct: 296 S 296
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 30/222 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK---GETPEEIAKKESRFAREVAMLSRV- 81
IG G + V ++ A+KI+ +PE++ + RE +L +V
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 82 QHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------A 131
H +++ I + + + +V +L+ G L D
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGEL-----------FDYLTEKVALSEKETRSIM 206
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
+ A+ LH++ I+HRDLKPEN+LL ++++ I+L+DFG + E + GT +
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQ-IRLSDFGFSCHLEPGEKLRELCGTPGY 265
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
+APE+ Y +VD ++ ++L+ LL PF
Sbjct: 266 LAPEILKCSM--DETHPGYGKEVDLWACGVILFTLLAGSPPF 305
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 51/204 (25%), Positives = 79/204 (38%), Gaps = 35/204 (17%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGE-TPEEIAKKESRFAREVAMLSRVQHR 84
+G +G G A V + + K + A K + K + REV +L ++H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 85 NLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDI 134
N++ + +V++ EL+SGG L D A F I
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGEL-----------FDFLAEKESLTEDEATQFLKQI 117
Query: 135 ARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
+ LHS I H DLKPEN++L IKL DFG+A + GT +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177
Query: 192 MAPELYSTVTLRQGEKKHYNHKVD 215
+APE+ + + + D
Sbjct: 178 VAPEI-----VNY---EPLGLEAD 193
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-34
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 39/222 (17%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G GA ++V+ K + + A+K + K A ++S E+A+L +++H N
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-----SPAFRDSSLENEIAVLKKIKHEN 67
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIA 135
+V + +V +L+SGG L D + G +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL-----------FDRILERGVYTEKDASLVIQQVL 116
Query: 136 RAMECLHSHGIIHRDLKPENLLL--TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
A++ LH +GI+HRDLKPENLL E+ I + DFGL++ E +M+ GT ++A
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVA 175
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
PE+ +K Y+ VD +S ++ + LL PF
Sbjct: 176 PEVL--------AQKPYSKAVDCWSIGVITYILLCGYPPFYE 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-34
Identities = 68/232 (29%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
V +G GA + VY K K + A+K++ K + E+ +L R+ H N
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKK-------TVDKKIVRTEIGVLLRLSHPN 109
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
++K + P + +V EL++GG L D V G+ A D +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL-----------FDRIVEKGYYSERDAADAVKQIL 158
Query: 137 -AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
A+ LH +GI+HRDLKPENLL +K+ADFGL++ +M GT + A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 245
PE+ LR Y +VD +S I+ + LL PF Q +
Sbjct: 219 PEI-----LR---GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-34
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 37/225 (16%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK--GETPEEIAKKESRFAREVAMLSRVQH 83
+G +G G A V + + K A K + K +E REV++L +V H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-IEREVSILRQVLH 74
Query: 84 RNLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALD 133
N++ + +V++ EL+SGG L D A F
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGEL-----------FDFLAQKESLSEEEATSFIKQ 123
Query: 134 IARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
I + LH+ I H DLKPEN++L + IKL DFGLA E GT
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
++APE+ + + + D +S ++ + LL PF G
Sbjct: 184 FVAPEI-----VNY---EPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-34
Identities = 62/265 (23%), Positives = 103/265 (38%), Gaps = 26/265 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHR 84
VGP +G G VY G N VAIK V K + +R EV +L +V
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 85 --NLVKFIGACKEPVM-VIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
+++ + + P V++ E L ++ L +A F + A+
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRH 164
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
H+ G++HRD+K EN+L+ + +KL DFG T + GT + PE
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR-- 221
Query: 201 TLRQGEKKHYN-HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259
Y+ +S I+L++++ +PFE + + V
Sbjct: 222 ------YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG-----QVFFRQ--RVSS 268
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQ 284
E ++ C P+ RP F +I
Sbjct: 269 ECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-34
Identities = 56/224 (25%), Positives = 87/224 (38%), Gaps = 35/224 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK-GETPEEIAKKESRFAREVAMLSRVQHR 84
G +G G A V + + K A K + K REV++L +QH
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 85 NLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDI 134
N++ + ++++ EL++GG L D A F I
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGEL-----------FDFLAEKESLTEEEATEFLKQI 123
Query: 135 ARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
+ LHS I H DLKPEN++L IK+ DFGLA + GT +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+APE+ + + + D +S ++ + LL PF G
Sbjct: 184 VAPEI-----VNY---EPLGLEADMWSIGVITYILLSGASPFLG 219
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 61/264 (23%), Positives = 115/264 (43%), Gaps = 21/264 (7%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM-LSRVQHRNLV 87
+G GA+ V + ++ Q +A+K + +E R ++ + + V V
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ----KRLLMDLDISMRTVDCPFTV 69
Query: 88 KFIGAC-KEPVMVIVTELLSGGTLRKY-LLNMRPRCLDVCVAIGFALDIARAMECLHS-H 144
F GA +E + I EL+ + Y + + + + + A+ I +A+E LHS
Sbjct: 70 TFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTL 202
+IHRD+KP N+L+ +K+ DFG++ L + + + G +MAPE
Sbjct: 130 SVIHRDVKPSNVLINAL-GQVKMCDFGISGY--LVDDVAKDIDAGCKPYMAPE----RIN 182
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--AENVPEE 260
+ +K Y+ K D +S I + EL + P++ + P A+ E
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAE 242
Query: 261 LSIILTSCWKEDPNARPNFTQIIQ 284
+ C K++ RP + +++Q
Sbjct: 243 FVDFTSQCLKKNSKERPTYPELMQ 266
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 16/216 (7%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ IG+G + V + Q A+KIV + RE ++ ++H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLH 142
+V+ + M+ +V E + G L ++ VA + I A+ H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 143 SHGIIHRDLKPENLLLT--EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYST 199
+ IIHRD+KP +LL E+ +KL FG+A + + GT +MAPE+
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV--- 204
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
++ ++ Y VD + ++L+ LL LPF G
Sbjct: 205 --VK---REPYGKPVDVWGCGVILFILLSGCLPFYG 235
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 59/224 (26%), Positives = 89/224 (39%), Gaps = 35/224 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK-GETPEEIAKKESRFAREVAMLSRVQHR 84
+G +G G A V + + K A K + K REV++L +V H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 85 NLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDI 134
N++ + +V++ EL+SGG L D A F I
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGEL-----------FDFLAQKESLSEEEATSFIKQI 124
Query: 135 ARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
+ LH+ I H DLKPEN++L + IKL DFGLA E GT +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+APE+ + + + D +S ++ + LL PF G
Sbjct: 185 VAPEI-----VNY---EPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 52/262 (19%), Positives = 102/262 (38%), Gaps = 18/262 (6%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR-VQHRNLV 87
+G G +V++ +++ +A+K + + EE R ++ ++ + +V
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN----KRILMDLDVVLKSHDCPYIV 87
Query: 88 KFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HG 145
+ G + I EL+ + + + + I +A+ L HG
Sbjct: 88 QCFGTFITNTDVFIAMELMGTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 205
+IHRD+KP N+LL E + IKL DFG++ + G +MAPE +
Sbjct: 146 VIHRDVKPSNILLDERGQ-IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP---EELS 262
Y+ + D +S I L EL + P++ + P +
Sbjct: 205 ---DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261
Query: 263 IILTSCWKEDPNARPNFTQIIQ 284
+ C +D RP + ++++
Sbjct: 262 SFVKDCLTKDHRKRPKYNKLLE 283
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 67/230 (29%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVK 88
+GEGAHA+V +Q A+KI+ K SR REV ML + Q HRN+++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLE 75
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIARAM 138
I +E +V E + GG++ L D+A A+
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSI-----------LSHIHKRRHFNELEASVVVQDVASAL 124
Query: 139 ECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAR--------EESLTEMMTAETGT 188
+ LH+ GI HRDLKPEN+L + +K+ DF L T + G+
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 238
+MAPE+ V E Y+ + D +S ++L+ LL PF G
Sbjct: 185 AEYMAPEV---VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 48/218 (22%), Positives = 95/218 (43%), Gaps = 30/218 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G GA V+ K + K ++ + E+++++++ H
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPK 109
Query: 86 LVKFIGACKEPV-MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAM 138
L+ A ++ MV++ E LSGG L Y ++ I + +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA-------EVINYMRQACEGL 162
Query: 139 ECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 197
+ +H H I+H D+KPEN++ T+ ++K+ DFGLA + + E++ T T + APE+
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 222
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+++ D ++ ++ + LL PF G
Sbjct: 223 --------DREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 66/292 (22%), Positives = 107/292 (36%), Gaps = 39/292 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
IG G + K + VA+K + +G + RE+ ++H N
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA------AIDENVQREIINHRSLRHPN 77
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V+F P + I+ E SGG L + + N R A F + + HS
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICN-AGR-FSEDEARFFFQQLLSGVSYCHSM 135
Query: 145 GIIHRDLKPENLLLTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 203
I HRDLK EN LL +K+ DFG ++ L + GT ++APE+
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----- 190
Query: 204 QGEKKHYN-HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR------PSAEN 256
++ Y+ D +S + L+ +L PFE Y + + P
Sbjct: 191 ---RQEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPRDYRKTIQRILSVKYSIPDDIR 246
Query: 257 VPEE----LSIILTSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIP 301
+ E +S I + DP R + +I L N + +
Sbjct: 247 ISPECCHLISRIFVA----DPATRISIPEIKTHSWFLKNLPADLMNESNTGS 294
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 30/219 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
V +G+GA + V +K A KI++ + A+ + RE + ++QH N
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPN 89
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAM 138
+V+ + +E +V +L++GG L R++ A I ++
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--------DASHCIQQILESI 141
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
HS+GI+HR+LKPENLLL K +KLADFGLA E + +E GT +++PE+
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 201
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
L+ K Y+ VD ++ ++L+ LL PF
Sbjct: 202 -----LK---KDPYSKPVDIWACGVILYILLVGYPPFWD 232
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-33
Identities = 64/281 (22%), Positives = 117/281 (41%), Gaps = 21/281 (7%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73
+ W + L IG GA+ V + +K Q +A+K + +E +
Sbjct: 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ----KQLLM 69
Query: 74 EVA-MLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLR--KYLLNMRPRCLDVCVAIG 129
++ ++ +V+F GA +E I EL+S + KY+ ++ + +
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 130 FALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188
L +A+ L IIHRD+KP N+LL IKL DFG++ + + T + G
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGC 188
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248
+MAPE ++ Y+ + D +S I L+EL + P+ +++ K
Sbjct: 189 RPYMAPE----RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
Query: 249 NVRPSAENVPE-----ELSIILTSCWKEDPNARPNFTQIIQ 284
P N E + C +D + RP + ++++
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-33
Identities = 70/265 (26%), Positives = 114/265 (43%), Gaps = 26/265 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK---GETPEEIAKKESRFAREVAMLSRVQ 82
+G GA V+ K N+ V +K + K E K + E+A+LSRV+
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 83 HRNLVKFIGACKEPVMV-IVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
H N++K + + +V E SG L ++ PR LD +A + A+
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPR-LDEPLASYIFRQLVSAVGY 145
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
L IIHRD+K EN+++ ED TIKL DFG A ++ GT + APE+
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM-- 202
Query: 201 TLRQGEKKHYN-HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259
Y +++ +S + L+ L+ + PF L+ AA P V +
Sbjct: 203 ------GNPYRGPELEMWSLGVTLYTLVFEENPFC---ELEETVEAAIHP--PY--LVSK 249
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQ 284
EL +++ + P R +++
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 63/292 (21%), Positives = 110/292 (37%), Gaps = 41/292 (14%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIA-KKESRFAREVAMLSRV--- 81
+GP +G+G V+ G VAIK++ + EVA+L +V
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 82 -QHRNLVKFIGACKEPVM-VIVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
H +++ + + ++V E L L Y+ L + F + A+
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEGPSRCFFGQVVAAI 152
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
+ HS G++HRD+K EN+L+ KL DFG + GT + PE S
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS 211
Query: 199 TVTLRQGEKKHYN-HKVDSYSFAIVLWELLHNKLPFEGMSN-LQAAYAAAFKNVRPSAEN 256
+ Y+ +S I+L++++ +PFE L+A +
Sbjct: 212 --------RHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL------------H 251
Query: 257 VPEELSI----ILTSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIP 301
P +S ++ C P++RP+ +I+ M P P
Sbjct: 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGP 303
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-33
Identities = 72/267 (26%), Positives = 123/267 (46%), Gaps = 30/267 (11%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKE--SRFAREVAMLSRVQH 83
+G +G G KV G+++ VA+KI+++ ++I + + RE+ L +H
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR----QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 84 RNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+++K P +V E +SGG L Y+ ++ A I A++ H
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCH 128
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 202
H ++HRDLKPEN+LL + K+ADFGL+ S E + G+ + APE+ S
Sbjct: 129 RHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS---- 183
Query: 203 RQGEKKHYN-HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 261
+ Y +VD +S ++L+ LL LPF+ ++ + K +R +PE L
Sbjct: 184 ----GRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLF----KKIRGGVFYIPEYL 234
Query: 262 SI----ILTSCWKEDPNARPNFTQIIQ 284
+ +L + DP R I +
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIRE 261
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-33
Identities = 46/218 (21%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G G V+ +T K V + +E+++L+ +HRN
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRN 62
Query: 86 LVKFIGACKEPV-MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAM 138
++ + + +V++ E +SG + + LN R + + + A+
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER-------EIVSYVHQVCEAL 115
Query: 139 ECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 197
+ LHSH I H D++PEN++ T TIK+ +FG AR+ + + APE+
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV- 174
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+ + D +S +++ LL PF
Sbjct: 175 ----HQH---DVVSTATDMWSLGTLVYVLLSGINPFLA 205
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-33
Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 18/212 (8%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G GA V+ + A K V + +E+ +S ++H
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPT 215
Query: 86 LVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV A ++ MV++ E +SGG L + + + + + A+ + + + + +H +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHEN 274
Query: 145 GIIHRDLKPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 203
+H DLKPEN++ T+ +KL DFGL + + TGT + APE+
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA------ 328
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
E K + D +S ++ + LL PF G
Sbjct: 329 --EGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G G +V++ + +A KI+ K + E+++++++ H NL++
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGM-----KDKEEVKNEISVMNQLDHANLIQL 151
Query: 90 IGACKEPV-MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
A + +V+V E + GG L Y L I F I + +H
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL-------DTILFMKQICEGIRHMH 204
Query: 143 SHGIIHRDLKPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 201
I+H DLKPEN+L D K IK+ DFGLAR E + GT ++APE+ +
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN--- 261
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+ D +S ++ + LL PF G
Sbjct: 262 -----YDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 30/230 (13%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVK 88
+G G + KV E ++ Q A+K++ + +EV + ++V
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLL----------YDSPKARQEVDHHWQASGGPHIVC 86
Query: 89 FIGACKEPVMV-----IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
+ + I+ E + GG L + + A DI A++ LHS
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 144 HGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 201
H I HRD+KPENLL T E +KL DFG A+E + + T T ++APE+
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL---- 201
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251
+ Y+ D +S ++++ LL PF + QA + +R
Sbjct: 202 ----GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG-QAISPGMKRRIR 246
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 30/288 (10%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +GEG+ KV + Q VA+K + + + R RE++ L ++H +
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS--DMHMRVEREISYLKLLRHPH 70
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
++K P + +V E +GG L Y++ + + F I A+E H H
Sbjct: 71 IIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRH 127
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
I+HRDLKPENLLL ++L +K+ADFGL+ + + G+ + APE+ +
Sbjct: 128 KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN------ 180
Query: 205 GEKKHYN-HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 263
K Y +VD +S IVL+ +L +LPF+ + + K V +P+ LS
Sbjct: 181 --GKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLF----KKVNSCVYVMPDFLSP 233
Query: 264 ----ILTSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRI 304
++ DP R +I + +N + P E +
Sbjct: 234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYA 281
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
IG+G+ KV + + A+K ++K + + + E R +E+ ++ ++H LV
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC---VERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 89 FIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ ++ M +V +LL GG LR Y L + F ++ A++ L + II
Sbjct: 80 LWYSFQDEEDMFMVVDLLLGGDLR-YHLQ-QNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
HRD+KP+N+LL E + + DF +A +T GT +MAPE+ +
Sbjct: 138 HRDMKPDNILLDEH-GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEM-----FSSRKG 191
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 238
Y+ VD +S + +ELL + P+ S+
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 43/223 (19%)
Query: 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRN 85
+GEG+ + + +K NQ A+KI+ K + E+ +E+ L + H N
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK--------RMEANTQKEITALKLCEGHPN 67
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIA 135
+VK + + +V ELL+GG L + +
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGEL-----------FERIKKKKHFSETEASYIMRKLV 116
Query: 136 RAMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWM 192
A+ +H G++HRDLKPENLL T D IK+ DFG AR + + T +
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
APEL L + Y+ D +S ++L+ +L ++PF+
Sbjct: 177 APEL-----LN---QNGYDESCDLWSLGVILYTMLSGQVPFQS 211
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 14/170 (8%)
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
I ++ +A+ ME L S IHRDL N+LL+E +K+ DFGLAR+ +
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGD 254
Query: 188 T---YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAY 243
+WMAPE + Y + D +SF ++LWE+ P+ G+ +
Sbjct: 255 ARLPLKWMAPE--------TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 244 AAAFKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
+ R + + E+ + CW +P+ RP F+++++ L N L A
Sbjct: 307 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 46/163 (28%), Positives = 65/163 (39%), Gaps = 23/163 (14%)
Query: 10 ADELKLDA-KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETP 61
+ L DA KW L +G +G GA +V E +TVA+K++ +G T
Sbjct: 7 CERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 66
Query: 62 EEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC---KEPVMVIVTELLSGGTLRKYLLNM 117
E E+ +L + H N+V +GAC P+MVIV E G L YL +
Sbjct: 67 SEHRA----LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSK 121
Query: 118 RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160
R + AR + G I DLK +T
Sbjct: 122 RNEFVPYKT------KGARFRQGKDYVGAIPVDLKRRLDSITS 158
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 45/228 (19%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR-VQHR 84
V IG G+++ +K N A+KI I K + E+ +L R QH
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKI---------IDKSKRDPTEEIEILLRYGQHP 76
Query: 85 NLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDI 134
N++ + V +VTEL+ GG L LD + F I
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL-----------LDKILRQKFFSEREASAVLFTI 125
Query: 135 ARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLARE-ESLTEMMTAETGTYR 190
+ +E LH+ G++HRDLKP N+L + ++I++ DFG A++ + ++ T
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 238
++APE V RQG Y+ D +S ++L+ +L PF +
Sbjct: 186 FVAPE----VLERQG----YDAACDIWSLGVLLYTMLTGYTPFANGPD 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 73/292 (25%), Positives = 126/292 (43%), Gaps = 29/292 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +G G KV GK++ VA+KI+++ + + RE+ L +H +
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSL--DVVGKIRREIQNLKLFRHPH 77
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
++K P + +V E +SGG L Y+ LD + I ++ H H
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRH 135
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
++HRDLKPEN+LL + K+ADFGL+ S E + G+ + APE+ S
Sbjct: 136 MVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS------ 188
Query: 205 GEKKHYN-HKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 263
+ Y +VD +S ++L+ LL LPF+ ++ + K + P+ L+
Sbjct: 189 --GRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLF----KKICDGIFYTPQYLNP 241
Query: 264 ----ILTSCWKEDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIPHRIFNSE 308
+L + DP R I + + + P +P + + E
Sbjct: 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDE 293
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 55/274 (20%), Positives = 105/274 (38%), Gaps = 25/274 (9%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G V++ +K +A K++H P ++ RE+ +L +V
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNSPYIVG 95
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGI 146
F GA + + I E + GG+L + L + + ++ + + + L H I
Sbjct: 96 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV--SIAVIKGLTYLREKHKI 153
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQ 204
+HRD+KP N+L+ IKL DFG++ + L + M A + GT +M+PE
Sbjct: 154 MHRDVKPSNILVNSR-GEIKLCDFGVSGQ--LIDSM-ANSFVGTRSYMSPERLQ------ 203
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPF-EGMSNLQAAYAAAFKNVRPSAENVPEELSI 263
HY+ + D +S + L E+ + P + +
Sbjct: 204 --GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 264 ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297
+ + D +++ ++N P
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 43/195 (22%), Positives = 74/195 (37%), Gaps = 17/195 (8%)
Query: 27 FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+G G A V + K Q A K + K + E+A+L +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK---RRRGQDCRAEILHEIAVLELAKSC 88
Query: 85 -NLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
++ + ++++ E +GG + L + I I + LH
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 143 SHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
+ I+H DLKP+N+LL+ L IK+ DFG++R+ + GT ++APE+
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI---- 204
Query: 201 TLRQGEKKHYNHKVD 215
L D
Sbjct: 205 -LNY---DPITTATD 215
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+GA + V Q A I++ + A+ + RE + ++H N
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS---ARDHQKLEREARICRLLKHPN 71
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
+V+ + E ++ +L++GG L + VA + A +
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGEL-----------FEDIVAREYYSEADASHCIQQIL 120
Query: 137 -AMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLARE-ESLTEMMTAETGTYRWM 192
A+ H G++HR+LKPENLLL LK +KLADFGLA E E + GT ++
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+PE+ LR K Y VD ++ ++L+ LL PF
Sbjct: 181 SPEV-----LR---KDPYGKPVDLWACGVILYILLVGYPPFWD 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 28/221 (12%)
Query: 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRN 85
+G G + KV + K + A+K++ + + REV + R +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRASQCPH 116
Query: 86 LVKFIGACKEPVMV-----IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
+V+ + + IV E L GG L + + + A I A++
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 141 LHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
LHS I HRD+KPENLL T +KL DFG A+E + +T T ++APE+
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL- 235
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
+ Y+ D +S ++++ LL PF L
Sbjct: 236 -------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG++ V++ + + Q VAIK + E I + RE+ ML +++H NLV
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI---KKIALREIRMLKQLKHPNLVN 66
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + + + +V E T+ L + R + + +A+ H H I
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQ 204
HRD+KPEN+L+T+ IKL DFG AR + ++ E T YR +PEL +
Sbjct: 125 HRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELL----VGD 177
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
Y VD ++ V ELL + G S++
Sbjct: 178 ---TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG+ + V + ++ AIKI+ K +E K RE ++SR+ H VK
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKE--NKVPYVTRERDVMSRLDHPFFVKL 95
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
++ + G L KY+ + D + +I A+E LH GIIH
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGKGIIH 153
Query: 149 RDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
RDLKPEN+LL ED+ I++ DFG A+ ++ A + GT ++++PEL
Sbjct: 154 RDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL-------- 204
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+K D ++ ++++L+ PF
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPFRA 234
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 57/181 (31%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+GEG++ V + + K + VAIK + + + + + RE+ +L +++H NLV
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV---KKIAMREIKLLKQLRHENLVN 88
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ CK + +V E + T+ L + P LD V + I + HSH II
Sbjct: 89 LLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNII 146
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPEL------YS 198
HRD+KPEN+L+++ +KL DFG AR + E+ E T YR APEL Y
Sbjct: 147 HRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYG 203
Query: 199 T 199
Sbjct: 204 K 204
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 40/282 (14%), Positives = 86/282 (30%), Gaps = 56/282 (19%)
Query: 31 RIGEGAHAKVYEGK--YKNQTVAIKIVH--KGETPEEIAKKESRFAREVAMLSRVQHRNL 86
G + ++ ++ VA+ V + + LSR+ +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQ----ETLSRTLRLSRIDKPGV 93
Query: 87 VKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
+ + ++V E + GG+L++ + + P AI +A A + H G
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQE-VADTSP---SPVGAIRAMQSLAAAADAAHRAG 149
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 205
+ P + ++ D + LA + +
Sbjct: 150 VALSIDHPSRVRVSID-GDVVLAYPATMPDAN---------------------------- 180
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG---MSNLQAAYAAAFKN-VRPSAEN--VPE 259
+ D L+ LL N+ P S L A + P+ + +P
Sbjct: 181 ------PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 301
++S + + D R + L+ +A+A ++
Sbjct: 235 QISAVAARSVQGDGGIRS--ASTLLNLMQQATAVADRTEVLG 274
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 14/210 (6%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
IG GA +V + K ++ A+KI++K E + + E+ R E +L + +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEM---LKRAETACFREERDVLVNGDSKWITT 138
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A ++ + +V + GG L LL+ L +A + ++ A++ +H +
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
HRD+KP+N+L+ + I+LADFG + + + GT +++PE+ + +G
Sbjct: 198 HRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI---LQAMEG 253
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
K Y + D +S + ++E+L+ + PF
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYA 283
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 18/218 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
IG GA +V ++K + A+K++ K E I + +S F E +++ +V+
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM---IKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A ++ + +V E + GG L + N + A + ++ A++ +HS G I
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
HRD+KP+N+LL + +KLADFG + + M+ +T GT +++PE V QG
Sbjct: 191 HRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE----VLKSQG 245
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 243
+Y + D +S + L+E+L PF +L Y
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTY 282
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 60/253 (23%), Positives = 111/253 (43%), Gaps = 21/253 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G+G +V + + + A K + K +K A E +L +V R +V
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + + +V L++GG L+ ++ +M A+ +A +I +E LH I+
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
+RDLKPEN+LL + I+++D GLA + + GT +MAPE+ +
Sbjct: 309 YRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--------KN 359
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI---- 263
+ Y D ++ +L+E++ + PF+ + + V+ E E S
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFSPQARS 418
Query: 264 ILTSCWKEDPNAR 276
+ + +DP R
Sbjct: 419 LCSQLLCKDPAER 431
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 69/223 (30%), Positives = 94/223 (42%), Gaps = 25/223 (11%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA---MLSRVQHRN 85
IG GA+ VY+ + VA+K V REVA L +H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 86 LVKFI------GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
+V+ + +E + +V E + LR YL P L R ++
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRWMAPELY 197
LH++ I+HRDLKPEN+L+T T+KLADFGLAR S +T T YR APE+
Sbjct: 135 FLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTPVVVTLWYR--APEVL 191
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
L Y VD +S + E+ K F G S
Sbjct: 192 ----L--QST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
IG GA ++V K K Q A+KI++K + + + E R E +L R + +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM---LKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A ++ + +V E GG L LL+ + +A + +I A++ +H G +
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLL-TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
HRD+KP+N+LL I+LADFG + + + GT +++PE+ V G
Sbjct: 185 HRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
Y + D ++ + +E+ + + PF
Sbjct: 244 TGS-YGPECDWWALGVFAYEMFYGQTPFYA 272
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 50/218 (22%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLV 87
++G G +++V+E N+ V +KI+ P K+ + RE+ +L ++ N++
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILK----PV----KKKKIKREIKILENLRGGPNII 94
Query: 88 KFIGACKEPVM---VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
K+PV +V E ++ ++ + D+ + +I +A++ HS
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD--YDIRF---YMYEILKALDYCHSM 149
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM-APELYSTVTLR 203
GI+HRD+KP N+++ + + ++L D+GLA + + R+ PEL
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELLVDY--- 205
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNLQ 240
+ Y++ +D +S +L ++ K P F G N
Sbjct: 206 ----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
IG G+ VY+ K + VAIK V ++ RF RE+ ++ ++ H N+V+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCNIVR 111
Query: 89 FI-------GACKEPVMVIVTELLSGGTLRKYL--LNMRPRCLDVCVAIGFALDIARAME 139
E + +V + + T+ + + + L V + + R++
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRWMAPELY 197
+HS GI HRD+KP+NLLL D +KL DFG A++ E + + YR APEL
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELI 228
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
T Y +D +S VL ELL + F G S +
Sbjct: 229 FGAT-------DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 33/222 (14%)
Query: 32 IGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVKF 89
IG G+ V++ K + VAIK V ++ RF RE+ ++ V+H N+V
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKV----------LQDKRFKNRELQIMRIVKHPNVVDL 97
Query: 90 I-------GACKEPVMVIVTELLSGGTLRKYL--LNMRPRCLDVCVAIGFALDIARAMEC 140
E + +V E + T+ + + + + + + + R++
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE--TGTYRWMAPELYS 198
+HS GI HRD+KP+NLLL +KL DFG A+ E + + YR APEL
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--APELIF 214
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
T +Y +D +S V+ EL+ + F G S +
Sbjct: 215 GAT-------NYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 20/162 (12%)
Query: 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV 81
+ +G G + KV + K + A+K++ + + REV + R
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRA 67
Query: 82 -QHRNLVKFIGACKEPVMV-----IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
Q ++V+ + + IV E L GG L + + + A I
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 136 RAMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLARE 175
A++ LHS I HRD+KPENLL T +KL DFG A+E
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 64/265 (24%), Positives = 114/265 (43%), Gaps = 36/265 (13%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G G +V+ + K + A K ++K +K + A E +L++V R +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRL---KKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHG 145
A + + +V +++GG +R ++ N+ AI + I +E LH
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 203
II+RDLKPEN+LL +D ++++D GLA E + GT +MAPEL
Sbjct: 310 IIYRDLKPENVLLDDD-GNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELL------ 361
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 263
+ Y+ VD ++ + L+E++ + PF + + V A P++ S
Sbjct: 362 --LGEEYDFSVDYFALGVTLYEMIAARGPFRA-RGEKVENKELKQRVLEQAVTYPDKFS- 417
Query: 264 ILTSCWKEDPNARPNFTQIIQMLLN 288
P ++ + LL
Sbjct: 418 ---------PASK----DFCEALLQ 429
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G G+ +V K+K A+KI+ K + + K+ E +L V LVK
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKV---VKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ K+ + +V E ++GG + +L R A +A I E LHS +I
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
+RDLKPENLL+ + I++ DFG A+ T GT +APE + L +G
Sbjct: 164 YRDLKPENLLIDQQ-GYIQVTDFGFAKRVK----GRTWTLCGTPEALAPE----IILSKG 214
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
YN VD ++ ++++E+ PF
Sbjct: 215 ----YNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-26
Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 31 RIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
++GEG + VY+ K + VA+K + E I S RE+++L + H N+V
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIP---STAIREISLLKELHHPNIVSL 84
Query: 90 IGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
I E + +V E + L+K L + L + + R + H H I+H
Sbjct: 85 IDVIHSERCLTLVFEFMEKD-LKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQG 205
RDLKP+NLL+ D +KLADFGLAR + T E T YR AP++ L
Sbjct: 143 RDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDV-----LMGS 194
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
K Y+ VD +S + E++ K F G+++
Sbjct: 195 --KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 31 RIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
+IGEG + VY+ + +T A+K + + E I RE+++L ++H N+VK
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVK 64
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ +V+V E L L+K L L+ A F L + + H ++
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQ 204
HRDLKP+NLL+ + +K+ADFGLAR + T E T YR AP++ L
Sbjct: 123 HRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDV-----LMG 174
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
K Y+ +D +S + E+++ F G+S
Sbjct: 175 S--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 5e-26
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 36/216 (16%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-------MLSRVQ 82
+G G+ +V+ + + + A+K++ K E + + ++V MLS V
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKK----EIVVRL-----KQVEHTNDERLMLSIVT 64
Query: 83 HRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
H +++ G ++ + ++ + + GG L L + + VA +A ++ A+E L
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYST 199
HS II+RDLKPEN+LL ++ IK+ DFG A+ T GT ++APE
Sbjct: 123 HSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVP----DVTYTLCGTPDYIAPE---- 173
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
V + YN +D +SF I+++E+L PF
Sbjct: 174 VVSTKP----YNKSIDWWSFGILIYEMLAGYTPFYD 205
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + V++ K + ++ VA+K V + E + S RE+ +L ++H+N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVR 65
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + +V E L+KY + LD + F + + + HS ++
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPELYSTVTLRQ 204
HRDLKP+NLL+ + +KLA+FGLAR + +AE T YR P++ L
Sbjct: 124 HRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDV-----LFG 175
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNLQ 240
K Y+ +D +S + EL + P F G
Sbjct: 176 A--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 69/229 (30%), Positives = 102/229 (44%), Gaps = 39/229 (17%)
Query: 31 RIGEGAHAKVYEG---KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML---SRVQHR 84
IGEGA+ KV++ K + VA+K V E + REVA+L +H
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHP 74
Query: 85 NLVKFI------GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
N+V+ +E + +V E + L YL + + + R +
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRWMAPEL 196
+ LHSH ++HRDLKP+N+L+T IKLADFGLAR S +T+ T YR APE+
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYR--APEV 190
Query: 197 -----YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
Y+T VD +S + E+ K F G S++
Sbjct: 191 LLQSSYAT-------------PVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 58/274 (21%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH----RN 85
IG G++AKV + K ++ A+K+V K E + E + ++
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKK----ELVNDDE-----------DIDWVQTEKH 61
Query: 86 LVKFIGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+ F A P +V V E ++GG L ++ R R L A ++
Sbjct: 62 V--FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSA 117
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYR 190
+I+ A+ LH GII+RDLK +N+LL + IKL D+G+ +E L T T GT
Sbjct: 118 EISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPN 175
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA---- 246
++APE + + Y VD ++ ++++E++ + PF+ + +
Sbjct: 176 YIAPE----ILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227
Query: 247 FKNVRPSAENVPEELSI----ILTSCWKEDPNAR 276
F+ + +P LS+ +L S +DP R
Sbjct: 228 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G+G KV + K + A+KI+ K IAK E E +L +H L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVI---IAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + + V E +GG L +L R R A + +I A+E LHS ++
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
+RD+K ENL+L +D IK+ DFGL +E +++ T +T GT ++APE V
Sbjct: 128 YRDIKLENLMLDKD-GHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPE----VLEDND 181
Query: 206 EKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
Y VD + +V++E++ +LPF
Sbjct: 182 ----YGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 71/219 (32%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES--RFA-REVAMLSRVQHRN 85
+GEG A VY+ + K NQ VAIK + G E K+ R A RE+ +L + H N
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA---KDGINRTALREIKLLQELSHPN 73
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
++ + A + + +V + + L + + L + L + +E LH H
Sbjct: 74 IIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLV-LTPSHIKAYMLMTLQGLEYLHQH 131
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPELYSTVT 201
I+HRDLKP NLLL E+ +KLADFGLA+ T + T YR APEL
Sbjct: 132 WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYR--APEL----- 183
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
L + Y VD ++ +L ELL G S+L
Sbjct: 184 LFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 58/274 (21%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH----RN 85
IG G++AKV + K ++ A+++V K E + E + ++
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKK----ELVNDDE-----------DIDWVQTEKH 104
Query: 86 LVKFIGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+ F A P +V V E ++GG L ++ R R L A ++
Sbjct: 105 V--FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSA 160
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYR 190
+I+ A+ LH GII+RDLK +N+LL + IKL D+G+ +E L T T GT
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPN 218
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA----AA 246
++APE + + Y VD ++ ++++E++ + PF+ + +
Sbjct: 219 YIAPE----ILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270
Query: 247 FKNVRPSAENVPEELSI----ILTSCWKEDPNAR 276
F+ + +P LS+ +L S +DP R
Sbjct: 271 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 50/225 (22%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH----RN 85
+G+G+ KV+ ++K NQ AIK + K + + + V+ +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKK----DVVLMDD-----------DVECTMVEKR 69
Query: 86 LVKFIGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+ A + P + V E L+GG L ++ D+ A +A
Sbjct: 70 V--LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 125
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYR 190
+I ++ LHS GI++RDLK +N+LL +D IK+ADFG+ +E + T GT
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKEN-MLGDAKTNTFCGTPD 183
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
++APE+ + YNH VD +SF ++L+E+L + PF G
Sbjct: 184 YIAPEIL--------LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLV 87
++GEG + +VY+ N+TVAIK + E + A REV++L +QHRN++
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV----PGTAIREVSLLKELQHRNII 96
Query: 88 KFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+ + ++ E L+KY+ + + V F + + HS
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRC 153
Query: 147 IHRDLKPENLLLTEDLKT----IKLADFGLAREESL-TEMMTAETGT--YRWMAPELYST 199
+HRDLKP+NLLL+ + +K+ DFGLAR + T E T YR PE+
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR--PPEIL-- 209
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
L G +HY+ VD +S A + E+L F G S +
Sbjct: 210 --L--GS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID 245
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 60/255 (23%), Positives = 97/255 (38%), Gaps = 30/255 (11%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGE 59
M+++ + D + + + I G++ V G VAIK V
Sbjct: 2 MQAKGEAAMRDLIA--ELHAMQSPYTVQRF-ISSGSYGAVCAGVDSEGIPVAIKRVFNTV 58
Query: 60 TPEEIAKKES------RFAREVAMLSRVQHRNLVKFIGACKEPVMV------IVTELLSG 107
+ S R RE+ +L+ H N++ +VTEL+
Sbjct: 59 SDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-R 117
Query: 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167
L + + + R + F I + LH G++HRDL P N+LL ++ I +
Sbjct: 118 TDLAQVIHDQRIVISPQHIQY-FMYHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITI 175
Query: 168 ADFGLAREESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 225
DF LARE++ T YR APEL + K + VD +S V+ E
Sbjct: 176 CDFNLAREDTADANKTHYVTHRWYR--APELV-------MQFKGFTKLVDMWSAGCVMAE 226
Query: 226 LLHNKLPFEGMSNLQ 240
+ + K F G +
Sbjct: 227 MFNRKALFRGSTFYN 241
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 65/261 (24%), Positives = 115/261 (44%), Gaps = 30/261 (11%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKESRFAR---EVAMLSRVQH 83
+G GA+ KV+ G + A+K++ K I +K E +L ++
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKK----ATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 84 RN-LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
LV A + + ++ + ++GG L +L + + +I A+E L
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVGEIVLALEHL 175
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYST 199
H GII+RD+K EN+LL + + L DFGL++E E A GT +MAP++
Sbjct: 176 HKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV-- 232
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259
+G ++ VD +S ++++ELL PF + + A + + S P+
Sbjct: 233 ----RGGDSGHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQAEISRRILKSEPPYPQ 287
Query: 260 ELSI----ILTSCWKEDPNAR 276
E+S ++ +DP R
Sbjct: 288 EMSALAKDLIQRLLMKDPKKR 308
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-24
Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+G+G+ KV+ G Q A+K++ K + R E +L V H +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVEVNHPFI 88
Query: 87 VKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
VK A + + ++ + L GG L L + + ++A A++ LHS G
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 203
II+RDLKPEN+LL E+ IKL DFGL++ ES+ A + GT +MAPE V R
Sbjct: 147 IIYRDLKPENILLDEE-GHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE----VVNR 200
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+G + D +SF ++++E+L LPF+G
Sbjct: 201 RG----HTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-24
Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 37/226 (16%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE------IAKKESRFAREVAMLSRVQ 82
++G G +A VY+G K VA+K V EE I RE++++ ++
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAI--------REISLMKELK 61
Query: 83 HRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYL----LNMRPRCLDVCVAIGFALDIARA 137
H N+V+ E + +V E + L+KY+ + PR L++ + F + +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAP 194
+ H + I+HRDLKP+NLL+ + +KL DFGLAR + ++E T YR AP
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--AP 177
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
++ + G + Y+ +D +S +L E++ K F G ++ +
Sbjct: 178 DVL----M--GS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 35/219 (15%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVA-------MLS 79
+G+G + KV+ G + A+K++ K I + ++ A +L
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKK----AMIVRNA----KDTAHTKAERNILE 76
Query: 80 RVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
V+H +V I A + + ++ E LSGG L L R A + +I+ A+
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMAL 134
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
LH GII+RDLKPEN++L +KL DFGL + ES+ + T GT +MAPE
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPE- 191
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+ +R G +N VD +S +++++L PF G
Sbjct: 192 ---ILMRSG----HNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-23
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKE---SRFAREVAMLSRVQHRN 85
++GEG +A VY+GK K + VA+K + + +E REV++L ++H N
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V E + +V E L L++YL + +++ F + R + H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPELYSTVT 201
++HRDLKP+NLL+ E +KLADFGLAR +S+ T+ E T YR P++
Sbjct: 120 KVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDI----- 171
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
L Y+ ++D + + +E+ + F G + +
Sbjct: 172 LLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 50/225 (22%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH----RN 85
+G+G+ KV + K A+K++ K + I + + V+ +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKK----DVILQDD-----------DVECTMTEKR 75
Query: 86 LVKFIGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+ A P + V E ++GG L ++ + R D A +A
Sbjct: 76 I--LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAA 131
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYR 190
+I A+ LH GII+RDLK +N+LL + KLADFG+ +E + +T T GT
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEG-ICNGVTTATFCGTPD 189
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
++APE + Y VD ++ ++L+E+L PFE
Sbjct: 190 YIAPE----ILQEML----YGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 37/236 (15%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73
D+ + + ++ + P IG GA V ++ VAIK + + + AK R R
Sbjct: 55 DSTFTVLKRYQNLKP-IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYR 110
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMV-------IVTELLS---GGTLRKYLLNMRPRCLD 123
E+ ++ V H+N++ + + +V EL+ ++ L + R
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-- 168
Query: 124 VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT 183
+ ++ LHS GIIHRDLKP N+++ D +K+ DFGLAR + MMT
Sbjct: 169 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMT 221
Query: 184 AETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237
T YR APE+ Y VD +S ++ E++ +K+ F G
Sbjct: 222 PYVVTRYYR--APEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73
D+ + + ++ + P IG GA V + VAIK + + + AK R R
Sbjct: 18 DSTFTVLKRYQNLKP-IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYR 73
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMV-------IVTELLS---GGTLRKYLLNMRPRCLD 123
E+ ++ V H+N++ + + IV EL+ ++ L + R
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-- 131
Query: 124 VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT 183
+ ++ LHS GIIHRDLKP N+++ D +K+ DFGLAR + MMT
Sbjct: 132 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMT 184
Query: 184 AETGTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237
T R+ APE+ Y VD +S ++ E++ + F G
Sbjct: 185 PYVVT-RYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRV---QHRN 85
IG G +VY + + A+K + K K+ A E MLS V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI---KMKQGETLALNERIMLSLVSTGDCPF 253
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V A P + + +L++GG L +L +A +I +E +H+
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR 311
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
+++RDLKP N+LL E ++++D GLA + S + + GT+ +MAPE+
Sbjct: 312 FVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ------ 363
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
+ Y+ D +S +L++LL PF
Sbjct: 364 -KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 34/217 (15%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA--------MLSRV 81
IG+G+ KV ++K A+K++ K + I KK +E +L V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQK----KAILKK-----KEEKHIMSERNVLLKNV 96
Query: 82 QHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
+H LV + + + V + ++GG L +L R RC A +A +IA A+
Sbjct: 97 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGY 154
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYS 198
LHS I++RDLKPEN+LL I L DFGL +E + T T GT ++APE
Sbjct: 155 LHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKEN-IEHNSTTSTFCGTPEYLAPE--- 209
Query: 199 TVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
V +Q Y+ VD + VL+E+L+ PF
Sbjct: 210 -VLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYS 241
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 42/221 (19%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ KV + K ++ A+KI+ K + + + + +V V+ R L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKK----DVVIQDD-----DVECT-MVEKRVLAL- 76
Query: 90 IGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
K P + V E ++GG L ++ + A+ +A +IA
Sbjct: 77 --PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAI 132
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAP 194
+ L S GII+RDLK +N++L + IK+ADFG+ + E++ + +T +T GT ++AP
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAP 190
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
E + Q Y VD ++F ++L+E+L + PFEG
Sbjct: 191 E----IIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA----REVAMLSRVQHRN 85
G+G V GK K +VAIK V + + RF + + L+ + H N
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQ----------DPRFRNRELQIMQDLAVLHHPN 80
Query: 86 LVKFI--------GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLD-----VCVAIGFAL 132
+V+ ++ + +V E + TL + N R + + V F
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKV---FLF 136
Query: 133 DIARAMECLH--SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT-- 188
+ R++ CLH S + HRD+KP N+L+ E T+KL DFG A++ S +E A +
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239
YR APEL HY VD +S + E++ + F G ++
Sbjct: 197 YR--APELIFGNQ-------HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 42/221 (19%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ KV + K ++ A+KI+ K + + + + +V V+ R L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKK----DVVIQDD-----DVECT-MVEKRVLAL- 397
Query: 90 IGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
K P + V E ++GG L ++ + A+ +A +IA
Sbjct: 398 --PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAI 453
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAP 194
+ L S GII+RDLK +N++L + IK+ADFG+ +E + + +T +T GT ++AP
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIAP 511
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
E + Q Y VD ++F ++L+E+L + PFEG
Sbjct: 512 E----IIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 7e-23
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G+G KV K K + A+KI+ K +AK E E +L +H L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVI---VAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGI 146
+ + + V E +GG L +L R R A + +I A++ LHS +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNV 270
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQ 204
++RDLK ENL+L +D IK+ DFGL +E + + T +T GT ++APE+
Sbjct: 271 VYRDLKLENLMLDKD-GHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEVL------- 321
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
E Y VD + +V++E++ +LPF
Sbjct: 322 -EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 36/238 (15%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73
W + ++ +G GA+ V K + VAIK + + E AK R R
Sbjct: 17 KTAWELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---RAYR 72
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMV-------IVTELLS---GGTLRKYLLNMRPRCLD 123
E+ +L +QH N++ + + +V + + + +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-- 130
Query: 124 VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT 183
+ + ++ +HS G++HRDLKP NL + ED + +K+ DFGLAR MT
Sbjct: 131 ------LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHAD--AEMT 181
Query: 184 AETGTYRW-MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
T RW APE+ HYN VD +S ++ E+L K F+G L
Sbjct: 182 GYVVT-RWYRAPEVI-------LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 65/232 (28%), Positives = 102/232 (43%), Gaps = 29/232 (12%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA 76
W + ++ + P +G GA+ V VA+K + + AK R RE+
Sbjct: 25 WEVPERYQNLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELR 80
Query: 77 MLSRVQHRNLVKFIGACKEPVMV-------IVTELLSGGTLRKYLLNMRPRCLDVCVAIG 129
+L ++H N++ + + +VT L+ G L ++ + L
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI---VKCQKLTDDHVQF 136
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
I R ++ +HS IIHRDLKP NL + ED + +K+ DFGLAR + MT T
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR--HTADEMTGYVAT- 192
Query: 190 RW-MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
RW APE+ HYN VD +S ++ ELL + F G ++
Sbjct: 193 RWYRAPEIMLNW-------MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 55/254 (21%), Positives = 88/254 (34%), Gaps = 64/254 (25%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
+G G+ V E + A+K V + + R+ RE+ ++ + H N++K
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ----------DPRYKNRELDIMKVLDHVNIIK 64
Query: 89 ---FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD------------ 133
+ + L + V V
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 134 -------------------------IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168
+ RA+ +HS GI HRD+KP+NLL+ T+KL
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 169 DFGLAREESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226
DFG A++ +E A + YR APEL T Y +D +S V EL
Sbjct: 185 DFGSAKKLIPSEPSVAYICSRFYR--APELMLGAT-------EYTPSIDLWSIGCVFGEL 235
Query: 227 LHNKLPFEGMSNLQ 240
+ K F G +++
Sbjct: 236 ILGKPLFSGETSID 249
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-22
Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 29/235 (12%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73
W + + + P +G GA+ V VAIK +++ E AK R R
Sbjct: 18 KTAWEVRAVYRDLQP-VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYR 73
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMV-------IVTELLSGGTLRKYLLNMRPRCLDVCV 126
E+ +L ++H N++ + + +V + G L K + + L
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDR 129
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET 186
+ + + +H+ GIIHRDLKP NL + ED + +K+ DFGLAR+ MT
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQAD--SEMTGYV 186
Query: 187 GTYRWM-APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
T RW APE+ Y VD +S ++ E++ K F+G +L
Sbjct: 187 VT-RWYRAPEVI-------LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 51/237 (21%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI---AKKESRFAREVAMLSRVQHRN 85
+IG+G +V++ +++ Q VA+K V E A RE+ +L ++H N
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA------LREIKILQLLKHEN 77
Query: 86 LVKFIGACKEPVMVIVTELLSGGT---------------LRKYLLNMRPRCLDVCVAIGF 130
+V I + T+ L L N+ + +
Sbjct: 78 VVNLIE-------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV 129
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-----ESLTEMMTAE 185
+ + +H + I+HRD+K N+L+T D +KLADFGLAR S T
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 186 TGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
T YR PEL L GE + Y +D + ++ E+ +G +
Sbjct: 189 VVTLWYR--PPELL----L--GE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-21
Identities = 68/236 (28%), Positives = 102/236 (43%), Gaps = 33/236 (13%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA 76
+ + P++ + IGEGA+ V VAIK + E + R RE+
Sbjct: 23 FDVGPRYTNLSY-IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQ---RTLREIK 77
Query: 77 MLSRVQHRNLVKFIGACKEPVMV------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
+L R +H N++ + P + IV +L+ L K L + + L F
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL---KTQHLSNDHICYF 133
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAET 186
I R ++ +HS ++HRDLKP NLLL +K+ DFGLAR + T +T
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYV 192
Query: 187 GT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
T YR APE+ K Y +D +S +L E+L N+ F G L
Sbjct: 193 ATRWYR--APEIM-------LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 9e-21
Identities = 52/236 (22%), Positives = 93/236 (39%), Gaps = 44/236 (18%)
Query: 27 FVGPRIGEGAHAKVYEGKYK----NQTVAIKIVHK-GETPEEIAKKESRFAREVAMLSRV 81
+ G ++G G + VY+ K K ++ A+K + G + RE+A+L +
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC--------REIALLREL 75
Query: 82 QHRNLVKFIGACKEPVM---VIVTELLSGGTLRKYLLNMRPRCLDVCVAI-------GFA 131
+H N++ ++ + L + R +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLARE-----ESLTEMMT 183
I + LH++ ++HRDLKP N+L+ + +K+AD G AR + L + +
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LD 193
Query: 184 AETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237
T YR APEL L G +HY +D ++ + ELL ++ F
Sbjct: 194 PVVVTFWYR--APELL----L--GA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-20
Identities = 54/243 (22%), Positives = 96/243 (39%), Gaps = 36/243 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIK-IVHKGETPEEIAKKESRFARE 74
+ + +++ + P +G G + V+ ++ VAIK IV K RE
Sbjct: 6 GFDLGSRYMDLKP-LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVK---HALRE 58
Query: 75 VAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG----- 129
+ ++ R+ H N+VK + ++ S L + D+ +
Sbjct: 59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL 118
Query: 130 ------FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLT 179
F + R ++ +HS ++HRDLKP NL + + +K+ DFGLAR S
Sbjct: 119 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 180 EMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237
++ T YR +P L +Y +D ++ + E+L K F G
Sbjct: 179 GHLSEGLVTKWYR--SPRLL-------LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
Query: 238 NLQ 240
L+
Sbjct: 230 ELE 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 7e-20
Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 34/231 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
W I ++ IG G++ V E K + VAIK + + K R RE+
Sbjct: 48 DWQIPDRYEIRHL-IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK---RILREI 103
Query: 76 AMLSRVQHRNLVKFIGACKEPVMV------IVTELLSGGT-LRKYLLNMRPRCLD-VCVA 127
A+L+R+ H ++VK + + +V E+ + +K +
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKT- 160
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
++ ++ +HS GI+HRDLKP N L+ +D ++K+ DFGLAR E ++
Sbjct: 161 --LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLP 217
Query: 188 TYRWMAPELYSTVTLRQGEKKHYNHKV--------------DSYSFAIVLW 224
T + K+ V ++Y+ AI +W
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW 268
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 61/244 (25%), Positives = 93/244 (38%), Gaps = 46/244 (18%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ I +GEGA+ V +K + VAIK + + P A R RE+
Sbjct: 6 VYNISSDFQLKSL-LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-AL---RTLREI 60
Query: 76 AMLSRVQHRNLVKFIGACKEPVMV------IVTELLSGGTLRKYLLNMRPRCLD---VCV 126
+L +H N++ + I+ EL+ L + + + L +
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLSDDHIQY 116
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----------E 175
F RA++ LH +IHRDLKP NLL+ + +K+ DFGLAR
Sbjct: 117 ---FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEP 172
Query: 176 ESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
M T YR APE+ Y+ +D +S +L EL + F
Sbjct: 173 TGQQSGMVEFVATRWYR--APEVM-------LTSAKYSRAMDVWSCGCILAELFLRRPIF 223
Query: 234 EGMS 237
G
Sbjct: 224 PGRD 227
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-18
Identities = 68/288 (23%), Positives = 113/288 (39%), Gaps = 50/288 (17%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-R 84
+G +IG G+ +Y G + VAIK+ E + K + E + +Q
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL-------ECVKTKHPQLHIESKIYKMMQGGV 65
Query: 85 NLVKFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ E VMV+ ELL G +L + L N R + + A + +E +
Sbjct: 66 GIPTIRWCGAEGDYNVMVM--ELL-GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 142 HSHGIIHRDLKPENLLL--TEDLKTIKLADFGLARE--ESLTEMMTAE------TGTYRW 191
HS IHRD+KP+N L+ + + + DFGLA++ ++ T TGT R+
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 192 MAPELYSTVTLRQGEKKHYNH----KVDSYSFAIVLWELLHNKLPFEGM--SNLQAAYA- 244
S T H + D S VL LP++G+ + + Y
Sbjct: 182 A-----SINT-------HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 229
Query: 245 -AAFKNVRPSAE---NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288
+ K P P E + L C + +P+++ + Q+ N
Sbjct: 230 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 59/256 (23%), Positives = 97/256 (37%), Gaps = 76/256 (29%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ ++ IG G++ VY K + VAIK V++ K R RE+
Sbjct: 21 NVHVPDNYIIKHL-IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREI 76
Query: 76 AMLSRVQHRNLVKFIGACKEPVMV------IVTELL---------SGGTL----RKYLLN 116
+L+R++ +++ ++ IV E+ + L K +L
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL- 135
Query: 117 MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-- 174
++ +H GIIHRDLKP N LL +D +K+ DFGLAR
Sbjct: 136 ---------------YNLLLGENFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTI 179
Query: 175 ---------------------EESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYN 211
++L + +T+ T YR APEL +++Y
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR--APELILL-------QENYT 230
Query: 212 HKVDSYSFAIVLWELL 227
+D +S + ELL
Sbjct: 231 KSIDIWSTGCIFAELL 246
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-17
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G+ +V + +Q VA+K+V + A +E R + + N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 90 IGA-------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+ C + ELLS L + + + + + + FA I + ++ LH
Sbjct: 165 LENFTFRNHIC------MTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 143 SHGIIHRDLKPENLLLTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 201
+ IIH DLKPEN+LL + ++ IK+ DFG + E ++ YR APE V
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APE----VI 271
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
L Y +D +S +L ELL G
Sbjct: 272 LGAR----YGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 64/290 (22%), Positives = 111/290 (38%), Gaps = 52/290 (17%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-R 84
VG RIGEG+ ++EG NQ VAIK E + E +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF-------EPRRSDAPQLRDEYRTYKLLAGCT 66
Query: 85 NLVKFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ +E V+VI +LL G +L + LL++ R V A + ++ +
Sbjct: 67 GIPNVYYFGQEGLHNVLVI--DLL-GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 142 HSHGIIHRDLKPENLLL----TEDLKTIKLADFGLARE--ESLTEMMTAE------TGTY 189
H +++RD+KP+N L+ +++ I + DFG+ + + +T+ +GT
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 190 RWMAPELYSTVTLRQGEKKHYNH----KVDSYSFAIVLWELLHNKLPFEGM--SNLQAAY 243
R+M S T H + D + V L LP++G+ + + Y
Sbjct: 183 RYM-----SINT-------HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230
Query: 244 A--AAFKNVRPSAE---NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288
K P E PEE + +A P++ + +
Sbjct: 231 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 15/155 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
VG +IG G ++ GK N+ VAIK+ ++ E RF +++ +
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM-KSRAPQLHLEYRFYKQLGSGDGIPQ-- 69
Query: 86 LVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
V + G C + MV+ ELL G +L + L ++ R + + A+ + ME +HS
Sbjct: 70 -VYYFGPCGKYNAMVL--ELL-GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 145 GIIHRDLKPENLLL----TEDLKTIKLADFGLARE 175
+I+RD+KPEN L+ + + I + DF LA+E
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 43/229 (18%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ------- 82
+G G + V+ K N VA+KIV + E A+ E + +L RV
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE------IKLLQRVNDADNTKE 80
Query: 83 ----HRNLVK------FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+++K G +V+V E+L G L + R + + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVH-VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 133 DIARAMECLHSH-GIIHRDLKPENLLLT-----EDLKTIKLADFGLAREESLTEMMTAET 186
+ ++ +H GIIH D+KPEN+L+ E+L IK+AD G A + +T
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 187 GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEG 235
YR +PE V L + D +S A +++EL+ FE
Sbjct: 199 REYR--SPE----VLLGAP----WGCGADIWSTACLIFELITGDFLFEP 237
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 56/262 (21%), Positives = 100/262 (38%), Gaps = 72/262 (27%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ K+ V +G+GA+ V++ + + VA+K + A+ R RE+
Sbjct: 4 DRHVLRKYELVKK-LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREI 59
Query: 76 AMLSRVQ-HRNLVKFIGACKEPVMV---IVTEL--------LSGGTL----RKYLLNMRP 119
+L+ + H N+V + + +V + + L ++Y
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY------ 113
Query: 120 RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----- 174
+ + ++ LHS G++HRD+KP N+LL + +K+ADFGL+R
Sbjct: 114 ----------VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNI 162
Query: 175 -----------------EESLTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNHKVD 215
+ ++T T YR APE+ Y +D
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYR--APEILLGS-------TKYTKGID 213
Query: 216 SYSFAIVLWELLHNKLPFEGMS 237
+S +L E+L K F G S
Sbjct: 214 MWSLGCILGEILCGKPIFPGSS 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 64/290 (22%), Positives = 113/290 (38%), Gaps = 54/290 (18%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +IG G+ ++Y G N+ VAIK+ E + K + E + +Q
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLLYESKIYRILQGGT 63
Query: 86 LV-KFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ E V+V+ +LL G +L + L N R L + + A + +E +
Sbjct: 64 GIPNVRWFGVEGDYNVLVM--DLL-GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 142 HSHGIIHRDLKPENLLL--TEDLKTIKLADFGLAREESLTEMMTAE----------TGTY 189
HS +HRD+KP+N L+ + + DFGLA++ + T + TGT
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--YRDTSTHQHIPYRENKNLTGTA 177
Query: 190 RWMAPELYSTVTLRQGEKKHYNH----KVDSYSFAIVLWELLHNKLPFEGM--SNLQAAY 243
R+ S T H + D S VL L LP++G+ + Y
Sbjct: 178 RYA-----SVNT-------HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225
Query: 244 A--AAFKNVRPSAE---NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288
+ K P E + C + +P+++ + ++ +
Sbjct: 226 EKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 29/221 (13%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G+ +V + + + VAIKI+ + A+ E R + +V
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 90 IGA-------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
C +V E+LS L L N R + + + FA + A+ L
Sbjct: 122 KRHFMFRNHLC------LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 143 SH--GIIHRDLKPENLLLTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
+ IIH DLKPEN+LL ++ IK+ DFG + + ++ YR +PE
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPE---- 228
Query: 200 VTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
V L Y+ +D +S +L E+ + F G + +
Sbjct: 229 VLLGMP----YDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 52/307 (16%), Positives = 95/307 (30%), Gaps = 61/307 (19%)
Query: 28 VGPRIGEGAHAKVYEGKYKNQT-------VAIKIVHKGETPEEIAKKESRFAREVAMLSR 80
VG IG+G +Y + +K+ P E +F + A +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP---LFTELKFYQRAAKPEQ 95
Query: 81 VQHRNLVKFIGACKEPVM--------------VIVTELLSGGTLRKYLLNMRPRCLDVCV 126
+Q + + P ++ + G L+K + +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSRKT 153
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLARE----ESLTEM 181
+ +L I +E +H H +H D+K NLLL ++ + L D+GLA
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213
Query: 182 MTAE----TGTYRWMAPELYSTVTLRQGEKKHYNH----KVDSYSFAIVLWELLHNKLPF 233
GT + S H + D + + L LP+
Sbjct: 214 AADPKRCHDGTIEFT-----SIDA-------HNGVAPSRRGDLEILGYCMIQWLTGHLPW 261
Query: 234 EGM--SNLQAAYA--------AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQII 283
E + A+ + A N P E++ + + D +P + +
Sbjct: 262 EDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLR 321
Query: 284 QMLLNYL 290
+LL L
Sbjct: 322 DILLQGL 328
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 30/166 (18%), Positives = 56/166 (33%), Gaps = 19/166 (11%)
Query: 28 VGPRIGEGAHAKVYEG----------KYKNQTVAIKIVHKGETPEEIAKKESRFAR--EV 75
+ +YE + Q ++K+ K R A+ +V
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 76 AMLSRVQHRNL-----VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
++ L G ++ +V L G +L+ L L +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQV 164
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLARE 175
A + A+E LH + +H ++ EN+ + ED + LA +G A
Sbjct: 165 ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 59/247 (23%), Positives = 87/247 (35%), Gaps = 65/247 (26%)
Query: 32 IGEGAHAKVYEG---KYKNQTVAIKIVHKGETPEEIAKKESRFAR----EVAMLSRVQHR 84
+GEGA KV E K + VA+KIV K R+ E+ +L +
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIV----------KNVDRYCEAARSEIQVLEHLNTT 71
Query: 85 ------NLVKFIGA-------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
V+ + C IV ELL G + ++ + A
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHIC------IVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKT------------------IKLADFGLA 173
I +++ LHS+ + H DLKPEN+L + T IK+ DFG A
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
+ T YR APE V L G ++ D +S +L E F
Sbjct: 185 TYDDEHHSTLVSTRHYR--APE----VILALG----WSQPCDVWSIGCILIEYYLGFTVF 234
Query: 234 EGMSNLQ 240
+ +
Sbjct: 235 PTHDSKE 241
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 51/247 (20%), Positives = 82/247 (33%), Gaps = 65/247 (26%)
Query: 32 IGEGAHAKV---YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAR----EVAMLSRVQHR 84
+GEG KV + VA+KI+ + ++ E+ +L +++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKII----------RNVGKYREAARLEINVLKKIKEK 76
Query: 85 ------NLVKFIGA-------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
V C I ELL G ++L + + A
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMC------IAFELL-GKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKT------------------IKLADFGLA 173
+ A+ LH + + H DLKPEN+L I++ADFG A
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233
+ T YR PE V L G + D +S +L+E F
Sbjct: 190 TFDHEHHTTIVATRHYR--PPE----VILELG----WAQPCDVWSIGCILFEYYRGFTLF 239
Query: 234 EGMSNLQ 240
+ N +
Sbjct: 240 QTHENRE 246
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 35/171 (20%), Positives = 63/171 (36%), Gaps = 32/171 (18%)
Query: 28 VGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +IG G +Y K + A +V K E ++ E+ RV ++
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVV-KVE-----YQENGPLFSELKFYQRVAKKD 94
Query: 86 LVKFIGACKEPVM--------------------VIVTELLSGGTLRKYLLNMRPRCLDVC 125
+K K+ +V E L G L+K
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV 153
Query: 126 VAIGFALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLARE 175
+ + + + +E +H + +H D+K NLLL ++ + LAD+GL+
Sbjct: 154 LQL--GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 57/253 (22%), Positives = 95/253 (37%), Gaps = 73/253 (28%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAR----EVAMLSRVQHR- 84
+G+G +V + A+K+V + ++ R E +L ++Q+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVV----------RNIKKYTRSAKIEADILKKIQNDD 92
Query: 85 ----NLVKFIGA-------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
N+VK+ G C ++ E L G +L + + + + ++
Sbjct: 93 INNNNIVKYHGKFMYYDHMC------LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKT------------------------IKLAD 169
I +A+ L + H DLKPEN+LL + IKL D
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 170 FGLAREESLTEMMTA--ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 227
FG A +S + + T YR APE V L G ++ D +SF VL EL
Sbjct: 206 FGCATFKS--DYHGSIINTRQYR--APE----VILNLG----WDVSSDMWSFGCVLAELY 253
Query: 228 HNKLPFEGMSNLQ 240
L F +++
Sbjct: 254 TGSLLFRTHEHME 266
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 1e-11
Identities = 35/188 (18%), Positives = 58/188 (30%), Gaps = 48/188 (25%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVH---------KGETPEEIAKKESRFAREVAMLS--- 79
IGEG +V++ + VAIKI+ + E E ++E+++LS
Sbjct: 28 IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87
Query: 80 RVQHRNLVKFIGAC-------------------------------KEPVMVIVTELLSGG 108
+ + K+ + IV E GG
Sbjct: 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147
Query: 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLKTIKL 167
L MR + + A + ++ S HRDL N+LL + KL
Sbjct: 148 ID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT-SLKKL 203
Query: 168 ADFGLARE 175
+
Sbjct: 204 HYTLNGKS 211
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 55/273 (20%), Positives = 93/273 (34%), Gaps = 81/273 (29%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ------- 82
+G G + V+ + VA+K+V E E A E+ +L V+
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL------DEIRLLKSVRNSDPNDP 98
Query: 83 -HRNLVKFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+V+ + K + +V E+L G L K+++ + L + + +
Sbjct: 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 137 AMECLHSH-GIIHRDLKPENLLLT------------------------------------ 159
++ LH+ IIH D+KPEN+LL+
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 160 ------------EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
+ +K+AD G A +T YR + E V + G
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR--SLE----VLIGSG-- 269
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240
YN D +S A + +EL FE S +
Sbjct: 270 --YNTPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 23/184 (12%)
Query: 4 RSRFYLADELKLDAKWLIDPKHLFVGPR---IGEGAHAKVYEGKYKNQTVAIKI-VHKGE 59
+ D + + W+ + K IG+GA A + Y + V IK V KG
Sbjct: 316 IPNYRT-DMV--EVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGY 372
Query: 60 TPEEIAKK--ESRFAREVAMLSRVQHRNL-VKFIGACKEPVMVIVTELLSGGTLRKYLLN 116
E + + +SR ARE L+ V+ + +I I+ ++G + + +
Sbjct: 373 RDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED 432
Query: 117 MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176
+ +G LH + +IH DL N + +DL I DFGL +
Sbjct: 433 NLDIAYKIGEIVG----------KLHKNDVIHNDLTTSNFIFDKDLYII---DFGLGKIS 479
Query: 177 SLTE 180
+L E
Sbjct: 480 NLDE 483
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 5e-07
Identities = 53/379 (13%), Positives = 110/379 (29%), Gaps = 93/379 (24%)
Query: 2 ESRSRFYLADE------LKLDAKWLIDPKHL--F-VGPRI-----GEGAHAKVYEGKYKN 47
++ R L + L L + K F + +I + + +
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQ--NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH 288
Query: 48 QTVAIKIVHKGETPEEIAKKESRFAR----EVAMLSRVQHRNLVKFIGACK-EPVMV-IV 101
+++ TP+E +S + L R P + I+
Sbjct: 289 --ISLDHHSMTLTPDE---VKSLLLKYLDCRPQDLPRE----------VLTTNPRRLSII 333
Query: 102 TELLSGGTLR----KYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK-PEN 155
E + G K++ + ++ + L+ A + + P
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLN---VLEPAEYRKMFDRLSVFPPSAHIPTI 390
Query: 156 LL-------LTEDLKTI--KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
LL + D+ + KL + L ++ + T P +Y + E
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP-------KESTIS--IPSIYL-ELKVKLE 440
Query: 207 KKHYNHK--VDSYSFAIVLWELLHNKLPFEGMSNLQA-AYAAAF-----KNVRPSAENVP 258
++ H+ VD Y+ + + + Y + KN+ E +
Sbjct: 441 NEYALHRSIVDHYN--------IPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEH-PERMT 491
Query: 259 EELSIILTSCWKE--------DPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENT 310
+ L + E NA + +Q L Y I +P R+ N+
Sbjct: 492 LFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDP-KYERLVNAILD 550
Query: 311 ILPPESPGTSSLMTVRDDI 329
LP + + + D+
Sbjct: 551 FLP--KIEENLICSKYTDL 567
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 32/158 (20%), Positives = 56/158 (35%), Gaps = 22/158 (13%)
Query: 27 FVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKES------RFAREVAMLSR 80
+G +GEG + V+ + + HK KE F+ +R
Sbjct: 93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 152
Query: 81 VQHRNLVKFIGA-CKEPVM----VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
+ R L K G + ++ EL+ L + + LD I
Sbjct: 153 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLD---------MIL 203
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
+ + GI+H DL N+L++E+ I + DF +
Sbjct: 204 EEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQS 239
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 6e-06
Identities = 34/163 (20%), Positives = 57/163 (34%), Gaps = 27/163 (16%)
Query: 28 VGPRIGEGAHAKVYEGK----YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH 83
+G I G A V+ K +A+KI ++ ET E E + E + R+
Sbjct: 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKI-YRIETSEFDKMDEYLYGDERFDMRRISP 109
Query: 84 RNLVKFIGACKE------------PV--------MVIVTELLSGGTLRKYLLNMRPRCLD 123
+ V I KE V V++ E + L L R L
Sbjct: 110 KEKVF-IWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 124 VCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTI 165
G D+ ++ L+ ++H DL N++ + + I
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDKVYFI 211
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 352 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.49 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.14 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.0 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.78 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.88 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.85 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.74 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.58 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.19 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.14 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.98 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.58 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.4 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.65 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.76 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.8 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 85.66 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.25 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-63 Score=448.62 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=222.2
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
+..|+-.-++|++++.||+|+||+||+|+++ |+.||||++....... ....++.+|++++++|+|||||++++++
T Consensus 16 en~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIV~~~~~~ 92 (350)
T 4b9d_A 16 ENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS---KEREESRREVAVLANMKHPNIVQYRESF 92 (350)
T ss_dssp CCCBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH---HHHHHHHHHHHHHHHCCCCCCCcEEEEE
Confidence 3334444579999999999999999999985 8999999998765443 2345789999999999999999999999
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
.+ +.+|+|||||+||+|.+++...+...+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 93 ~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGl 171 (350)
T 4b9d_A 93 EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGI 171 (350)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT-CCEEECSTTE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CCEEEccccc
Confidence 75 579999999999999999987766668999999999999999999999999999999999999998 7999999999
Q ss_pred ccccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 173 AREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 173 a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
|+..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~--------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~ 243 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICEN--------KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred ceeecCCcccccccCCCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence 9865443 23345679999999999864 67899999999999999999999999998877777777666666
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+.+..+|+++.+||.+||+.||.+|||++++++|.|
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 778899999999999999999999999999999844
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=431.11 Aligned_cols=267 Identities=30% Similarity=0.535 Sum_probs=221.9
Q ss_pred ccccceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
....|.|+.+++++++.||+|+||+||+|++++ .||||+++...... .....|.+|++++++++|||||++++++.
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~---~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTP---EQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 345699999999999999999999999998765 59999997654433 33457999999999999999999999998
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
++.+++|||||+||+|.+++..... .+++..++.|+.|++.||+|||+++|+||||||+|||++++ +.+||+|||+|+
T Consensus 103 ~~~~~iVmEy~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~ 180 (307)
T 3omv_A 103 KDNLAIVTQWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLAT 180 (307)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCB
T ss_pred CCeEEEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCce
Confidence 8889999999999999999976543 49999999999999999999999999999999999999998 799999999997
Q ss_pred cccc---ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-
Q 018656 175 EESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV- 250 (352)
Q Consensus 175 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~- 250 (352)
.... ........||+.|+|||++.+. ....|+.++|||||||++|||++|+.||.+.+.............
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~-----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~ 255 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQ-----DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA 255 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC
T ss_pred ecccCCcceeecccccCCCccCHHHhhcc-----CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC
Confidence 5432 2233456899999999998541 124689999999999999999999999998776655544443322
Q ss_pred CC----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 251 RP----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 251 ~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.| .+..+|+++.+++.+||+.||.+|||+.+++++|+.....
T Consensus 256 ~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 256 SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 22 2567899999999999999999999999999998766443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-61 Score=420.06 Aligned_cols=250 Identities=28% Similarity=0.404 Sum_probs=199.4
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
.+|++++.||+|+||+||+|+++ |+.||||++........ ....++.+|++++++++||||+++++++.+ +.+|+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS--DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCH--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47999999999999999999984 89999999976543322 334568999999999999999999999985 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||| +|+|.+++.+++. +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 91 vmEy~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-CCEEECCSSCC-------
T ss_pred EEeCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-CCEEEeecCCCeecCCCC
Confidence 99999 6799999987654 9999999999999999999999999999999999999988 799999999998766555
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
...+.+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+... ..........+.+..+|++
T Consensus 167 ~~~~~~GT~~Y~APE~~~~-------~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-~~~~i~~~~~~~p~~~s~~ 238 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGVYTLPKFLSPG 238 (275)
T ss_dssp --------CTTSCHHHHSS-------SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCCTTSCHH
T ss_pred ccCCeeECcccCChhhhcC-------CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCHH
Confidence 5667789999999999865 2234679999999999999999999999865543 3344444455567789999
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+.++|.+||+.||.+|||++++++|.|
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 999999999999999999999999843
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-60 Score=423.91 Aligned_cols=260 Identities=29% Similarity=0.516 Sum_probs=223.6
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
+.|++++|.+++.||+|+||+||+|++. ++.||||++..... .....|.+|++++++++|||||++++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-----~~~~~f~~E~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-----NARKDFHREAELLTNLQHEHIVKFYG 82 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh-----HHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 5688999999999999999999999863 67899999875432 23456999999999999999999999
Q ss_pred eeec-CceEEEEEcCCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe
Q 018656 92 ACKE-PVMVIVTELLSGGTLRKYLLNMR-----------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (352)
Q Consensus 92 ~~~~-~~~~lv~e~~~~~sL~~~l~~~~-----------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~ 159 (352)
++.+ +.+++|||||++|+|.+++.++. ...+++.+++.|+.|+++||+|||+++|+||||||+|||++
T Consensus 83 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~ 162 (299)
T 4asz_A 83 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 162 (299)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC
Confidence 9975 47999999999999999997643 34699999999999999999999999999999999999999
Q ss_pred CCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 018656 160 EDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEG 235 (352)
Q Consensus 160 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~ 235 (352)
.+ +.+||+|||+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+
T Consensus 163 ~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 163 EN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp GG-GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CC-CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 88 799999999997543322 2223468999999999865 678999999999999999998 8999999
Q ss_pred CChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 236 MSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.+..+...........+.+..+|+++.+++.+||+.||.+|||+.++.+.|+...+.
T Consensus 234 ~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 234 LSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp SCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 887776666666666667889999999999999999999999999999998877654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-61 Score=428.17 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=214.4
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
..+++|++++.||+|+||+||+|+++ |+.||||++....... ......+.+|++++++++|||||++++++.+ +.
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 106 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 106 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 34568999999999999999999985 8999999987532111 1224568899999999999999999999985 47
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+|+|||||+||+|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLS 183 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC-CCEEEEEcCCceecC
Confidence 9999999999999999987654 9999999999999999999999999999999999999998 899999999998643
Q ss_pred c---ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 178 L---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 178 ~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
. .....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+. ......+
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-~~~~~~p 254 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII-KLEYDFP 254 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHH--------SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCCC
T ss_pred CCCCcccccCcccCcccCCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence 2 223456789999999999865 678999999999999999999999999876655444443 3334556
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+++++++||.+||+.||.+|||+++++.+
T Consensus 255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 255 EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred cccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 7899999999999999999999999987554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=423.97 Aligned_cols=266 Identities=27% Similarity=0.487 Sum_probs=221.5
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 85 (352)
+.....+.|+++++.+.+.||+|+||+||+|++. ++.||||++.... . .....|.+|++++++++|||
T Consensus 30 ~~~~~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~---~~~~~f~~E~~il~~l~Hpn 104 (329)
T 4aoj_A 30 FSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--E---SARQDFQREAELLTMLQHQH 104 (329)
T ss_dssp ---CCSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--H---HHHHHHHHHHHHHTTCCCTT
T ss_pred cchhhhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--H---HHHHHHHHHHHHHHhCCCCC
Confidence 3444567889999999999999999999999863 6789999987532 1 23456999999999999999
Q ss_pred eeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 018656 86 LVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP-------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDL 151 (352)
Q Consensus 86 iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Di 151 (352)
||++++++.+ +.+++|||||++|+|.+++.+... ..+++.+++.|+.|+++||+|||+++|+||||
T Consensus 105 IV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDL 184 (329)
T 4aoj_A 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDL 184 (329)
T ss_dssp BCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccc
Confidence 9999999985 479999999999999999986532 35899999999999999999999999999999
Q ss_pred CCCCeEEeCCCCceEEecCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh
Q 018656 152 KPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH 228 (352)
Q Consensus 152 kp~Nili~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~ 228 (352)
||+|||++++ +.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 185 Kp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~~sDvwS~Gvvl~Ellt 255 (329)
T 4aoj_A 185 ATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDVWSFGVVLWEIFT 255 (329)
T ss_dssp CGGGEEEETT-TEEEECCCC----------------CCCCGGGCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHT
T ss_pred cHhhEEECCC-CcEEEcccccceeccCCCcceecCcccccccccChhhhcC--------CCCCccccccchHHHHHHHHc
Confidence 9999999998 79999999999854322 22334579999999999864 678999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 229 -NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 229 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
|+.||.+.+..+...........+.+..+|+++.+++.+||+.||.+|||+.+++++|+...+.
T Consensus 256 ~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 256 YGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 8999999887766666555555666788999999999999999999999999999999887654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-61 Score=431.28 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=216.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.+.|++.+.||+|+||+||+|+++ |+.||||++....... ...+.+|++++++++|||||++++++.+ +.+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356999999999999999999985 8999999997543322 2347899999999999999999999974 5899
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL- 178 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~- 178 (352)
+|||||+||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 148 ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC-CCEEEecCcCceecCCC
Confidence 999999999999999763 39999999999999999999999999999999999999998 8999999999986543
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--CCCCCC
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSAEN 256 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 256 (352)
.....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+..... .+.+..
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 295 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK 295 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGG
T ss_pred CCcccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcccc
Confidence 334566789999999999854 6789999999999999999999999998776655544443322 223457
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
+|+++.+||.+||+.||.+|||+.++++| .|++...
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~H--p~~~~~~ 331 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAG 331 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGGCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhcCCC
Confidence 89999999999999999999999999998 5565443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-60 Score=427.02 Aligned_cols=258 Identities=23% Similarity=0.282 Sum_probs=217.9
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.+..+.+.|.+.++||+|+||+||+|+++ |+.||||+++.... ..+|+.++++++|||||++++++.+
T Consensus 52 ~~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~ 121 (336)
T 4g3f_A 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVRE 121 (336)
T ss_dssp BCCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred hhhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 35556678999999999999999999985 89999999976433 2479999999999999999999975
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+.+|+|||||+||+|.+++.+.+. +++..++.++.|++.||+|||++||+||||||+||||+.++..+||+|||+|+
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred CCEEEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 579999999999999999987654 99999999999999999999999999999999999999884479999999998
Q ss_pred ccccccc------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 175 EESLTEM------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 175 ~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 271 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMG--------KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE 271 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS
T ss_pred EccCCCcccceecCCccccCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC
Confidence 6433221 223579999999999865 67899999999999999999999999886654444444333
Q ss_pred cC--CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 249 NV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 249 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
.. ...+..+|+++.++|.+||+.||.+|||+.|+++++...+.....
T Consensus 272 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 22 224678999999999999999999999999999999988876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-60 Score=417.27 Aligned_cols=248 Identities=28% Similarity=0.521 Sum_probs=211.1
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
++-|++.+.||+|+||+||+|.++ ++.||+|++....... ....++.+|++++++++|||||++++++.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK---SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence 344588899999999999999985 7899999997654433 234578999999999999999999999853
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+.+|+|||||+||+|.+++.+... +++..++.|+.||+.||+|||++| |+||||||+|||++...+.+||+|||+|
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 358999999999999999987654 999999999999999999999999 9999999999999853379999999999
Q ss_pred cccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-
Q 018656 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP- 252 (352)
Q Consensus 174 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~- 252 (352)
+.... ....+.+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+................|
T Consensus 180 ~~~~~-~~~~~~~GTp~YmAPE~~~---------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~ 249 (290)
T 3fpq_A 180 TLKRA-SFAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249 (290)
T ss_dssp GGCCT-TSBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred EeCCC-CccCCcccCccccCHHHcC---------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC
Confidence 75433 3345678999999999874 348999999999999999999999998877666665555544433
Q ss_pred -CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 -SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 245678999999999999999999999999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-61 Score=425.65 Aligned_cols=255 Identities=28% Similarity=0.396 Sum_probs=211.2
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEE-----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
+....+++++|++++.||+|+||+||+|++ +++.||||++........ ...++.+|++++++++|||||+++
T Consensus 16 ~~~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~ 92 (304)
T 3ubd_A 16 EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---DRVRTKMERDILVEVNHPFIVKLH 92 (304)
T ss_dssp TTCCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE---ECC------CCCCCCCCTTEECEE
T ss_pred hccccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH---HHHHHHHHHHHHHHCCCCCCCeEE
Confidence 344567889999999999999999999987 267899999875432211 112477899999999999999999
Q ss_pred eeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 91 GACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 91 ~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
+++.+ +.+|+|||||+||+|.+++.+.+. +++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus 93 ~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~D 169 (304)
T 3ubd_A 93 YAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTD 169 (304)
T ss_dssp EEEEETTEEEEEECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-SCEEEES
T ss_pred EEEEECCEEEEEEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC-CCEEecc
Confidence 99974 589999999999999999987654 9999999999999999999999999999999999999998 8999999
Q ss_pred CCCcccccc-ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 170 FGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 170 fg~a~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
||+|+.... .....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+. .
T Consensus 170 FGla~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-~ 240 (304)
T 3ubd_A 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL-K 240 (304)
T ss_dssp SEEEEC-----CCCCSCCCCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-H
T ss_pred cccceeccCCCccccccccCcccCCHHHhcc--------CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH-c
Confidence 999985432 334456789999999999854 678999999999999999999999999877655544443 3
Q ss_pred cCCCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018656 249 NVRPSAENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 285 (352)
Q Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~i~~~ 285 (352)
...+.+..+|+++.+||.+||+.||.+||| ++++++|
T Consensus 241 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 241 AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 445567789999999999999999999998 5788888
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=418.96 Aligned_cols=259 Identities=27% Similarity=0.480 Sum_probs=223.2
Q ss_pred cceecCCceeeeccccCCCceEEEEEEE-------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
-+.|+..++++.+.||+|+||+||+|.+ +++.||||++....... ....|.+|+.++++++|||||+++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~----~~~~f~~E~~il~~l~HpNIV~l~ 95 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP----LREEFRHEAMLRARLQHPNVVCLL 95 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-----CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH----HHHHHHHHHHHHHhCCCCCCCCcc
Confidence 3568888999999999999999999986 35789999997654322 234689999999999999999999
Q ss_pred eeeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q 018656 91 GACKE-PVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 155 (352)
Q Consensus 91 ~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~N 155 (352)
+++.+ +.+++|||||++|+|.+++..+. ...+++..++.|+.|+++||+|||+++|+||||||+|
T Consensus 96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N 175 (308)
T 4gt4_A 96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN 175 (308)
T ss_dssp EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence 99975 57899999999999999997543 1358999999999999999999999999999999999
Q ss_pred eEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCC
Q 018656 156 LLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKL 231 (352)
Q Consensus 156 ili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~ 231 (352)
|||+++ +.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..
T Consensus 176 ILl~~~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~~s~ksDVwSfGvvl~El~t~g~~ 246 (308)
T 4gt4_A 176 VLVYDK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--------GKFSIDSDIWSYGVVLWEVFSYGLQ 246 (308)
T ss_dssp EEECGG-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEECCC-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--------CCCCccchhhhHHHHHHHHHhCCCC
Confidence 999988 799999999998543322 2344579999999999865 678999999999999999998 899
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 232 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
||.+.+..+...........+.+..+|+++.+++.+||+.||.+|||+.+|+++|+.+
T Consensus 247 Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 247 PYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9999887776666666666677889999999999999999999999999999998765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=433.08 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=217.4
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.+.|++++.||+|+||+||+|+++ |+.||||++....... ...+.+|+.+|+.++|||||++++++.+ +.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence 367999999999999999999985 8999999997654322 2357899999999999999999999874 5899
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
||||||+||+|.+++... .+++.+++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+.....
T Consensus 225 iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT-CCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEecCccceECCCC
Confidence 999999999999999753 39999999999999999999999999999999999999998 89999999999865433
Q ss_pred -cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--CCCCCC
Q 018656 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSAEN 256 (352)
Q Consensus 180 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 256 (352)
....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+..... .+.+..
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 372 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK 372 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTS
T ss_pred CccccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccccc
Confidence 34456789999999999854 6789999999999999999999999998776665554443322 233567
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
+|+++.+||.+||+.||.+|||+.++++| .|+....
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~H--p~~~~~~ 408 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKAG 408 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGGCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC--HHhcCCC
Confidence 99999999999999999999999999998 5665543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-59 Score=421.35 Aligned_cols=263 Identities=29% Similarity=0.548 Sum_probs=223.0
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEECC-------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC-CCeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVK 88 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~ 88 (352)
++|.|++++|++++.||+|+||+||+|.+.+ +.||||++....... ....+.+|+++++++.| ||||+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~----~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----EHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH----HHHHHHHHHHHHHHcCCCCcEEE
Confidence 4699999999999999999999999998743 579999997655433 24568999999999965 89999
Q ss_pred eeeeeec--CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 018656 89 FIGACKE--PVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (352)
Q Consensus 89 l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dik 152 (352)
++++|.+ ..+++|||||++|+|.+++.+.. ...+++..++.++.|+++||+|||+++|+|||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK 212 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 212 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence 9999864 36899999999999999997642 2348999999999999999999999999999999
Q ss_pred CCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-
Q 018656 153 PENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 228 (352)
Q Consensus 153 p~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~- 228 (352)
|+|||++++ +.+||+|||+|+...... ......||+.|+|||++.+ ..|+.++|||||||++|||++
T Consensus 213 ~~NILl~~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~y~~ksDVwS~Gv~l~El~t~ 283 (353)
T 4ase_A 213 ARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSL 283 (353)
T ss_dssp GGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTT
T ss_pred ccceeeCCC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--------CCCCCcccEeehHHHHHHHHhC
Confidence 999999988 799999999998543222 2234568999999999865 678999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhc-cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 229 NKLPFEGMSNLQAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
|+.||.+............. ...+.+..+|+++.+++.+||+.||.+|||+.+++++|..+++.
T Consensus 284 G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 284 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 99999987654444444333 34455778999999999999999999999999999999988764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-56 Score=409.53 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=213.7
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
+++|++++.||+|+||+||+|+++ |+.||||++....... ....++.+|+++|+.++|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV---TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH---HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch---HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 468999999999999999999985 8999999997655433 234568899999999999999999998752
Q ss_pred --CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 96 --~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+.+|+|||||+ |+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla 205 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMA 205 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC-CCEEEeeccee
Confidence 46899999995 68999998654 49999999999999999999999999999999999999998 89999999999
Q ss_pred ccccc-----ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 174 REESL-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 174 ~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
+.... .....+.+||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~-------~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLS-------LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred eecccCccccccccccceeChHhcCHHHhcC-------CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 85422 223456689999999999865 245789999999999999999999999998776666555433
Q ss_pred cCCCC------------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 249 NVRPS------------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 249 ~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
...+. ...+++++.+||.+||+.||.+|||+.++++| .|++..
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H--p~f~~~ 351 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH--PFLAKY 351 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS--GGGTTT
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC--HhhCcC
Confidence 22221 13568899999999999999999999999999 566554
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=399.72 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=194.4
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-----
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP----- 96 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 96 (352)
++|++++.||+|+||+||+|+++ |+.||||++...... ....++.+|++++++|+|||||++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE----LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 35899999999999999999985 899999999765543 2345688999999999999999999998532
Q ss_pred --------ceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 97 --------VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 97 --------~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
.+|+|||||+||+|.+++..... ...++..++.|+.||++||+|||++||+||||||+|||++.+ +.+||
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~-~~vKl 159 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKV 159 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEE
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC-CcEEE
Confidence 37999999999999999987543 224567788999999999999999999999999999999998 79999
Q ss_pred ecCCCcccccccc-------------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCC
Q 018656 168 ADFGLAREESLTE-------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234 (352)
Q Consensus 168 ~Dfg~a~~~~~~~-------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 234 (352)
+|||+|+...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++ ||.
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--------NSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC--------CCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 9999998543321 1233579999999999854 678999999999999999996 786
Q ss_pred CCChHHHHHHHHhc-cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 235 GMSNLQAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
+............. ...+.....++.+.++|.+||+.||.+|||+.++++| .|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h--~~~~~~ 286 (299)
T 4g31_A 229 TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN--AVFEDL 286 (299)
T ss_dssp SHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGCCC
T ss_pred CccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhCCC
Confidence 53322222222222 2222233456778899999999999999999999997 555544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=395.46 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=201.3
Q ss_pred CCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~- 95 (352)
.++|++++.||+|+||+||+|+++ ++.||||++...... .++.+|+++++.+ +||||+++++++.+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP-------IRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH-------HHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH-------HHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 357999999999999999999863 678999998665432 2477899999988 69999999999974
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+.+|+||||++|++|.+++.. +++.+++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 589999999999999999842 899999999999999999999999999999999999988767999999999974
Q ss_pred cccc-----------------------------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHH
Q 018656 176 ESLT-----------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226 (352)
Q Consensus 176 ~~~~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~l 226 (352)
.... ....+.+||+.|+|||++.+ ...++.++||||+||++|+|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-------CPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHH
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCCccchhhhHHHHHHH
Confidence 3221 11234579999999999864 24588999999999999999
Q ss_pred HhCCCCCCCCChHH-HHHHHHhc-----------------------------------------------------cCCC
Q 018656 227 LHNKLPFEGMSNLQ-AAYAAAFK-----------------------------------------------------NVRP 252 (352)
Q Consensus 227 l~g~~p~~~~~~~~-~~~~~~~~-----------------------------------------------------~~~~ 252 (352)
++|+.||...+... ....+... ....
T Consensus 241 l~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 320 (361)
T 4f9c_A 241 LSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLE 320 (361)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------------------
T ss_pred HHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccc
Confidence 99999996544322 22111100 0011
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
....+|+++.+||.+||+.||.+|||++|+++| .|++++
T Consensus 321 ~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H--p~f~~i 359 (361)
T 4f9c_A 321 GWNEVPDEAYDLLDKLLDLNPASRITAEEALLH--PFFKDM 359 (361)
T ss_dssp -CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS--GGGTTC
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC--cccCCC
Confidence 234678999999999999999999999999998 555543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=388.31 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=197.9
Q ss_pred CceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-----ce
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-----VM 98 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 98 (352)
++|.+.+.||+|+||+||+|+++|+.||||++..... ......+|+..+.+++|||||++++++.++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~------~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch------hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999999999999999865321 112234577777889999999999998642 47
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCCeEEeCCCCceEEecC
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--------~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
++|||||++|+|.+++.+.. +++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DF 152 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCC
T ss_pred EEEecCCCCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeC
Confidence 99999999999999998643 89999999999999999999987 99999999999999998 79999999
Q ss_pred CCcccccccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC--------
Q 018656 171 GLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS-------- 237 (352)
Q Consensus 171 g~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~-------- 237 (352)
|+++...... ......||+.|+|||++.+.. ......++.++|||||||++|||++|..||....
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~--~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI--NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCS--CTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccc--cccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 9997543222 122457999999999986411 0112357889999999999999999976553211
Q ss_pred ------hHHHHHHHH-hccCCCCCC------CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 238 ------NLQAAYAAA-FKNVRPSAE------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 238 ------~~~~~~~~~-~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
......... .....|..+ ..+..+.+++.+||+.||.+|||+.++++.|..+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 112222222 222223211 2345789999999999999999999999999877653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-54 Score=413.76 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=210.8
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHH-HHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-C
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE-IAKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 96 (352)
+.-++|.++++||+|+||+||+|+++ |+.||||++.+...... .........+++.+++.++|||||++++++++ +
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 44568999999999999999999985 89999999865321110 01111223345778888999999999999985 4
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.+|+|||||+||+|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+||||+.+ |.+||+|||+|...
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~-G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC-CCEEecccceeeec
Confidence 79999999999999999988654 9999999999999999999999999999999999999998 89999999999865
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhccCCCCC
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN--LQAAYAAAFKNVRPSA 254 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~ 254 (352)
.... ..+.+||+.|+|||++.. +..|+.++|||||||++|+|++|..||.+.+. ...............+
T Consensus 343 ~~~~-~~t~~GTp~YmAPEvl~~-------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p 414 (689)
T 3v5w_A 343 SKKK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414 (689)
T ss_dssp SSCC-CCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC
T ss_pred CCCC-CCCccCCcCccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC
Confidence 4332 345689999999999853 25689999999999999999999999976432 2233444445555667
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPN-----FTQIIQML 286 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps-----~~~i~~~l 286 (352)
..+|+++.+||.+||+.||.+|++ ++++++|.
T Consensus 415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 889999999999999999999998 79999983
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=410.99 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=218.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++++.||+|+||+||+|.++ |+.||+|++..... .....+.+|+++|+.++||||+++++++.+ ..+|+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-----hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999985 89999999876442 224568899999999999999999999985 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC-CCceEEecCCCccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLT 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~-~~~vkl~Dfg~a~~~~~~ 179 (352)
|||||+||+|.+++.+.. ..+++.++..++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++.....
T Consensus 232 v~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999999997543 349999999999999999999999999999999999999754 368999999999977666
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC---CCCC
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---SAEN 256 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 256 (352)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+....+....... .+..
T Consensus 311 ~~~~~~~GT~~y~APEv~~~--------~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 382 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTT
T ss_pred CceeeeEECccccCHHHhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccC
Confidence 66667789999999999865 678999999999999999999999999987766665555443322 2467
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
+|+++.+||.+||+.||.+|||+.++++| .|++.
T Consensus 383 ~s~~~~dli~~~L~~dp~~R~t~~e~l~H--pw~~~ 416 (573)
T 3uto_A 383 ISEDGKDFIRKLLLADPNTRMTIHQALEH--PWLTP 416 (573)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS--TTTSC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC--cCcCC
Confidence 89999999999999999999999999998 45443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=367.68 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=216.8
Q ss_pred CCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
-.+|++.+.||+|+||.||+|.+ +|+.||||++....... ....++.+|+++++.++||||+++++++.. +..+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP---TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 45799999999999999999998 48999999997654332 234568899999999999999999999974 5799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||++|++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC-CCEEEeeccCceecCCC
Confidence 99999999999999987654 9999999999999999999999999999999999999988 79999999999876655
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
.......||+.|+|||++.+ ....+.++|||||||++|+|++|+.||.+.+........ .......+..+++
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~~p~~~s~ 239 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQG-------KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-LRGKYRIPFYMST 239 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHT-------CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCCCCCTTSCH
T ss_pred CccccccCCcceeCcccccC-------CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCCCCCCH
Confidence 55667789999999999865 123357899999999999999999999987655444333 3334455667899
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
++.++|++||..||.+|||+.++++| .|+.
T Consensus 240 ~~~~li~~~L~~dP~~R~t~~eil~h--~~~~ 269 (328)
T 3fe3_A 240 DCENLLKRFLVLNPIKRGTLEQIMKD--RWIN 269 (328)
T ss_dssp HHHHHHHHHCCSSTTTSCCHHHHTTC--TTTT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC--Hhhc
Confidence 99999999999999999999999998 4443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=365.63 Aligned_cols=271 Identities=33% Similarity=0.579 Sum_probs=217.0
Q ss_pred cccccceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
-....|.+...+|++.+.||+|+||+||+|+++|+.||||++....... .....+.+|++++++++||||+++++++
T Consensus 27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA---ERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp -----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSH---HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3445688999999999999999999999999999999999997765443 2345688999999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeCCCCceEEec
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
.+ +..++||||+++++|.+++.+... ..+++..++.++.|++.||+|||++| |+||||||+||+++.+ +.+||+|
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~D 182 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCD 182 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECC
Confidence 75 478999999999999999986432 23899999999999999999999999 9999999999999988 7999999
Q ss_pred CCCccccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 170 FGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 170 fg~a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
||++...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+...........
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~ 254 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRD--------EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254 (309)
T ss_dssp CC-----------------CCTTSCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS
T ss_pred CCCCccccccccccccCCCCccccChhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 9999753332 22344579999999999854 56788999999999999999999999987766555444333
Q ss_pred -cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 018656 249 -NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 296 (352)
Q Consensus 249 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~ 296 (352)
.....+..+++++.++|.+||+.||.+|||+.++++.|+.+++...++
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 334456789999999999999999999999999999999988765443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=368.42 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=213.0
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
+..++|++.+.||+|+||+||+|+++ |+.||+|++....... ......+.+|+++++.++||||+++++++.+ +.
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 79 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh--hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE
Confidence 34578999999999999999999985 8999999986531100 1223457899999999999999999999985 57
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc-
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE- 176 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~- 176 (352)
+++||||++|++|.+++.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC-CCEEEeeccchhhcc
Confidence 9999999999999999987654 9999999999999999999999999999999999999988 79999999999753
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCC
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 256 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 256 (352)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....... ........+..
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-i~~~~~~~p~~ 227 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-ILMEEIRFPRT 227 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHCCCCCCTT
T ss_pred cCCCcccccccChhhCChhhhcC--------CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCCC
Confidence 22334456679999999999854 5688999999999999999999999988665443333 33334445678
Q ss_pred CcHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
+++++.++|.+||+.||.+|| ++.++++|.
T Consensus 228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 999999999999999999999 899999984
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=354.20 Aligned_cols=261 Identities=30% Similarity=0.568 Sum_probs=223.0
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEE-CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
+.+|.+++++|++.+.||+|+||+||+|.+ .++.||+|++....... ..+.+|++++++++||||+++++++.
T Consensus 2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp ---CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH------HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH------HHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 568999999999999999999999999998 47889999998654432 24889999999999999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ +..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~ 153 (269)
T 4hcu_A 76 EQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMT 153 (269)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGG
T ss_pred cCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEecccccc
Confidence 5 47899999999999999997644 348999999999999999999999999999999999999888 79999999999
Q ss_pred ccccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 018656 174 REESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 174 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~ 225 (269)
T 4hcu_A 154 RFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR 225 (269)
T ss_dssp GGBCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred ccccccccccccCcccccccCCHHHhcC--------CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc
Confidence 7543322 2233456788999999854 568899999999999999999 9999998777666555555545
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
...+..+++++.+++.+||+.||.+|||+.+++++|....+.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 556777899999999999999999999999999999887653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=368.37 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=207.5
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC 93 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~ 93 (352)
..-.+..++|++.+.||+|+||+||+|+++ |+.||||++....... ......+.+|..+++.+ +||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~--~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ--DDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp -------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--HTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcc--hhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 334466789999999999999999999985 8899999987532111 12345577899999988 799999999999
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
.+ ..+++||||++|++|.+++.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-g~ikL~DFG~ 170 (353)
T 3txo_A 94 QTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGM 170 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTT
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC-CCEEEccccc
Confidence 85 479999999999999999987654 9999999999999999999999999999999999999998 8999999999
Q ss_pred ccccc-cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 173 AREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 173 a~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
++... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+ .....
T Consensus 171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i-~~~~~ 241 (353)
T 3txo_A 171 CKEGICNGVTTATFCGTPDYIAPEILQE--------MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI-LNDEV 241 (353)
T ss_dssp CBCSCC---------CCGGGCCHHHHHH--------HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCC
T ss_pred eeecccCCccccccCCCcCeEChhhcCC--------CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH-HcCCC
Confidence 98532 2333455679999999999854 56789999999999999999999999987665444443 33444
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCH------HHHHHHH
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNF------TQIIQML 286 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~i~~~l 286 (352)
..+..++.++.++|++||+.||.+||++ .++++|.
T Consensus 242 ~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 242 VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 5566799999999999999999999998 8899883
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=366.33 Aligned_cols=268 Identities=31% Similarity=0.565 Sum_probs=226.0
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-C
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (352)
+.....|.+..++|.+++.||+|+||.||+|++. +..||||++...... .....+.+|+++++++ +
T Consensus 70 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~~ 145 (370)
T 2psq_A 70 LPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE----KDLSDLVSEMEMMKMIGK 145 (370)
T ss_dssp CCCCTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH----HHHHHHHHHHHHHHHSCC
T ss_pred ccccccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH----HHHHHHHHHHHHHHHhcC
Confidence 3445678999999999999999999999999863 356999999765432 3345688999999999 8
Q ss_pred CCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 018656 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGII 147 (352)
Q Consensus 83 hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~iv 147 (352)
||||+++++++.+ +.+++||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+
T Consensus 146 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 225 (370)
T 2psq_A 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 225 (370)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9999999999874 579999999999999999987542 3489999999999999999999999999
Q ss_pred cCCCCCCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHH
Q 018656 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224 (352)
Q Consensus 148 H~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 224 (352)
||||||+|||++.+ +.+||+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|
T Consensus 226 HrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 226 HRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp CSCCCGGGEEECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHH
T ss_pred ccccchhhEEECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcC--------CCCCcHHHHHHHHHHHH
Confidence 99999999999988 799999999997543322 2233457889999998854 56889999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 225 ELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 225 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
+|++ |..||.+................+.+..++.++.++|.+||+.||.+||++.+++++|...+...
T Consensus 297 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 297 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 9999 99999987765555444444445567789999999999999999999999999999999887643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=371.08 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=212.4
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 94 (352)
...+..++|+++++||+|+||+||+|+++ ++.||+|++........ .....+.+|..+++++ +||||+++++++.
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~--~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD--EDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH--HHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 35567789999999999999999999985 78999999976533221 2234577889988876 8999999999998
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ +.+++||||++|++|.+++.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFGla 200 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMC 200 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC-CCEEEeeccee
Confidence 5 479999999999999999987654 9999999999999999999999999999999999999998 89999999999
Q ss_pred cc-cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC--------hHHHHHH
Q 018656 174 RE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--------NLQAAYA 244 (352)
Q Consensus 174 ~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--------~~~~~~~ 244 (352)
+. ...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......
T Consensus 201 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~ 272 (396)
T 4dc2_A 201 KEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272 (396)
T ss_dssp BCCCCTTCCBCCCCBCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH
T ss_pred eecccCCCccccccCCcccCCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH
Confidence 85 333444556789999999999865 568899999999999999999999996432 2233444
Q ss_pred HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCH------HHHHHHH
Q 018656 245 AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNF------TQIIQML 286 (352)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~i~~~l 286 (352)
.........+..++.++.++|++||+.||.+||++ .++++|.
T Consensus 273 ~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 273 VILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred HHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 44455556677899999999999999999999985 7888873
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=376.89 Aligned_cols=263 Identities=30% Similarity=0.523 Sum_probs=228.0
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
.+.|.+..++|.+.+.||+|+||+||+|.++ ++.||||++...... ...+.+|++++++++||||+++++++.
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~ 253 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS------VEAFLAEANVMKTLQHDKLVKLHAVVT 253 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc------HHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 4669999999999999999999999999986 788999999764422 335889999999999999999999998
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+...++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~ 332 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLAR 332 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CCEEECSTTGGG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-CcEEEeeCCCce
Confidence 8889999999999999999986543358999999999999999999999999999999999999988 799999999998
Q ss_pred ccccccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCC
Q 018656 175 EESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 175 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
....... .....++..|+|||++.. ..++.++||||||+++|+|++ |+.||.+.+..+...........
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 404 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM 404 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC
T ss_pred EcCCCceeccCCCcccccccCHHHhcc--------CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 6433221 223346789999999854 568899999999999999999 99999988776666555555556
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
+.+..+|+++.++|.+||..||.+|||+.++++.|+.+....
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 667889999999999999999999999999999998876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=357.89 Aligned_cols=262 Identities=26% Similarity=0.498 Sum_probs=222.7
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
.+.+..++|++.+.||+|+||+||+|.+. +..||||++....... ....+.+|+.++++++||||++++++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER----QRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH----HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH----HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 46788899999999999999999999984 3459999997654432 34568899999999999999999999
Q ss_pred eec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 93 CKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 93 ~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
+.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg 196 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFG 196 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCS
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-CCEEECCCC
Confidence 975 47899999999999999997643 349999999999999999999999999999999999999988 799999999
Q ss_pred Ccccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 018656 172 LAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 172 ~a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 246 (352)
++....... ......+|..|+|||++.+ ..++.++||||||+++|+|++ |..||.+...........
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 268 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF--------RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcC--------CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 998543321 1223346778999999854 567889999999999999999 999999887776666666
Q ss_pred hccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 247 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
.....+.+..++.++.++|.+||..||.+|||+.++++.|..++...
T Consensus 269 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 269 EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 66566777889999999999999999999999999999999887653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=351.21 Aligned_cols=262 Identities=29% Similarity=0.518 Sum_probs=214.9
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
..|.+..++|++++.||+|+||.||+|.+. +..||+|++...... .....+.+|+.++++++||||+++++
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD----SVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCccceEEE
Confidence 458899999999999999999999999874 456999998764432 33456889999999999999999999
Q ss_pred eeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 92 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 92 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
++.++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg 161 (281)
T 1mp8_A 84 VITENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFG 161 (281)
T ss_dssp EECSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC--
T ss_pred EEccCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECccc
Confidence 998888999999999999999998653 349999999999999999999999999999999999999988 799999999
Q ss_pred Cccccccccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 018656 172 LAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 172 ~a~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 248 (352)
++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~ 233 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 233 (281)
T ss_dssp -----------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred cccccCcccccccccCCCcccccChhhccc--------CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC
Confidence 9976433322 223356789999999854 567889999999999999996 99999987766655555555
Q ss_pred cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 249 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
...+.+..+|+++.+++.+||+.||.+|||+.++++.|...++.
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 55666788999999999999999999999999999999887653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=352.68 Aligned_cols=265 Identities=28% Similarity=0.521 Sum_probs=225.6
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
++.|.+..++|++.+.||+|+||.||+|.+. ++.||+|++...... ...+.+|++++++++||||+++++++.
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc------HHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 4679999999999999999999999999986 568999998765432 235889999999999999999999998
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
++..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLAR 157 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CCEEECCCcccc
Confidence 8889999999999999999976543349999999999999999999999999999999999999988 799999999997
Q ss_pred cccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCC
Q 018656 175 EESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 175 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
...... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+................
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM 229 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred cccCcccccccCCCCccCccChhhhcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC
Confidence 643322 1223456789999999854 567889999999999999999 99999987766555444444444
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
..+..++.++.+++.+||..||.+|||+.++++.|..++.....
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 55678999999999999999999999999999999998876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=363.80 Aligned_cols=272 Identities=32% Similarity=0.563 Sum_probs=231.4
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-C
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (352)
+.....|.+..++|.+++.||+|+||+||+|.+. +..||+|++...... ....++.+|+++++++ +
T Consensus 58 ~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~~ 133 (382)
T 3tt0_A 58 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE----KDLSDLISEMEMMKMIGK 133 (382)
T ss_dssp CCCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH----HHHHHHHHHHHHHHHHCC
T ss_pred cccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH----HHHHHHHHHHHHHHHhcC
Confidence 5566789999999999999999999999999873 257999999766443 2345688999999999 9
Q ss_pred CCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 018656 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGII 147 (352)
Q Consensus 83 hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~iv 147 (352)
||||+++++++.+ +..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++||+
T Consensus 134 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 213 (382)
T 3tt0_A 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 213 (382)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 9999999999874 478999999999999999987542 3599999999999999999999999999
Q ss_pred cCCCCCCCeEEeCCCCceEEecCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHH
Q 018656 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224 (352)
Q Consensus 148 H~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 224 (352)
||||||+|||++.+ +.+||+|||++...... .......+++.|+|||++.+ ..++.++||||||+++|
T Consensus 214 H~Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 214 HRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLW 284 (382)
T ss_dssp CSCCCGGGEEECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--------CCCCHHHHHHHHHHHHH
T ss_pred cCCCCcceEEEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--------CCCCchhHHHHHHHHHH
Confidence 99999999999988 79999999999854332 22234457889999999854 66889999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 225 ELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 225 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
+|++ |..||.+..................+..++.++.++|.+||+.||.+|||+.+++++|+..........
T Consensus 285 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 285 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 9999 999999877665555555554555677899999999999999999999999999999999887655444
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=372.93 Aligned_cols=259 Identities=29% Similarity=0.544 Sum_probs=223.6
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
...|.++.++|++.+.||+|+||.||+|.++|+.||||++..... ...+.+|++++++++||||+++++++.+
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT-------SHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH-------HHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 356999999999999999999999999999999999999976542 2348899999999999999999999764
Q ss_pred C--ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 96 P--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 96 ~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
. ..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.+ +.+||+|||++
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a 336 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLT 336 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-SCEEECCCTTC
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-CCEEEeeCCCc
Confidence 3 68999999999999999998766568999999999999999999999999999999999999988 79999999999
Q ss_pred cccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 018656 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 174 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
+..... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+..+...........+
T Consensus 337 ~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 406 (450)
T 1k9a_A 337 KEASST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 406 (450)
T ss_dssp EECC--------CCCTTTSCHHHHHS--------SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC
T ss_pred cccccc--ccCCCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 854322 223367889999999854 568899999999999999998 999999877665555554444556
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.+..+|+++.++|.+||..||.+|||+.++++.|+.+...
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 6788999999999999999999999999999999887653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=349.69 Aligned_cols=261 Identities=30% Similarity=0.554 Sum_probs=221.8
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
...|.++.++|++.+.||+|+||+||+|.+. +..||+|++....... ..+.+|++++++++||||+++++++.
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE------DEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH------HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH------HHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 3679999999999999999999999999986 5689999998654432 34789999999999999999999997
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ +..++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~ 167 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLS 167 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-SCEEECSTTGG
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-CCEEEcccccc
Confidence 5 478999999999999999986432 39999999999999999999999999999999999999988 79999999999
Q ss_pred cccccccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 018656 174 REESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 174 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |+.||.................
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (283)
T 3gen_A 168 RYVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 239 (283)
T ss_dssp GGBCCHHHHSTTSTTSCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred ccccccccccccCCccCcccCCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC
Confidence 75433221 223356788999999864 567899999999999999998 9999998777666665555555
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
...+..+++.+.+++.+||+.||.+|||+.+++++|.+.+..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 566778899999999999999999999999999999987754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=367.56 Aligned_cols=262 Identities=31% Similarity=0.576 Sum_probs=223.6
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
.+.|.++.++|.+++.||+|+||.||+|.+. |+.||||++...... .....+.+|++++++++||||+++++++
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~ 181 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP----DLKAKFLQEARILKQYSHPNIVRLIGVC 181 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH----HHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH----HHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4579999999999999999999999999995 889999998765432 2344688999999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
.+ +..++||||+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+
T Consensus 182 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~ 259 (377)
T 3cbl_A 182 TQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGM 259 (377)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGG
T ss_pred ecCCCcEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-CcEEECcCCC
Confidence 75 478999999999999999986542 38999999999999999999999999999999999999988 7999999999
Q ss_pred cccccccccc---ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 018656 173 AREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 173 a~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 248 (352)
++........ ....++..|+|||++.. ..++.++||||||+++|+|++ |..||.+.............
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 331 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNY--------GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG 331 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 8754332211 11235678999999854 567889999999999999998 99999987776655555555
Q ss_pred cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 249 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
...+.+..+|+++.++|.+||+.||.+|||+.++++.|..+.+
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 5556677899999999999999999999999999999987754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=363.85 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=213.9
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHH-HHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
.++|.+++.||+|+||+||+|.++ |+.||+|++......... ......+.+|+.++++++||||+++++++.+ ...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999985 899999999875432210 0113458899999999999999999999985 479
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC---ceEEecCCCccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLARE 175 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~---~vkl~Dfg~a~~ 175 (352)
++||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+.. .+||+|||++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999997644 4999999999999999999999999999999999999987632 799999999987
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 253 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 253 (352)
...........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+................
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 240 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred cCCCCccccCCCCccEECchHHcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence 655555566789999999999854 5688999999999999999999999998766554444433322221
Q ss_pred -CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 254 -AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 254 -~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+..+++++.++|.+||..||.+|||+.++++|.|
T Consensus 241 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 3578999999999999999999999999999843
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=353.10 Aligned_cols=246 Identities=28% Similarity=0.464 Sum_probs=211.0
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
.++|++.+.||+|+||+||+|.+. |+.||||++....... ...+.+|+.++++++||||+++++++. .+..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-----HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence 568999999999999999999874 8999999987544322 235789999999999999999999987 45799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||++|++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCST
T ss_pred EEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC-CCEEEeeCCCceecCCc
Confidence 999999999999999864 38999999999999999999999999999999999999988 79999999998754332
Q ss_pred -cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--CCCCCC
Q 018656 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSAEN 256 (352)
Q Consensus 180 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 256 (352)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+............... ...+..
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHC--------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGG
T ss_pred ccccCCccCCcCccChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence 22345579999999999854 5678999999999999999999999998776655554443332 233567
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
++..+.++|.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 89999999999999999999999999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=349.27 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=212.8
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
..++|++.+.||+|+||.||+|++. ++.||+|++........ ....++.+|+.++++++||||+++++++.+ +..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE--ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH--HHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 3578999999999999999999985 88999999866544332 345678999999999999999999999875 478
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||++|++|.+++.+... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCSSSTTC--
T ss_pred EEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEEeCCCcccccc
Confidence 999999999999999987654 9999999999999999999999999999999999999988 7999999999976433
Q ss_pred cc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC----
Q 018656 179 TE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---- 252 (352)
Q Consensus 179 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---- 252 (352)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.................
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKG--------EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTD 235 (294)
T ss_dssp -----------CCSSCCHHHHHT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHH
T ss_pred ccccccCccccCccccCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchh
Confidence 32 2234568999999999854 567889999999999999999999999877665554444433222
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhhc
Q 018656 253 SAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSA 292 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~i~~~l~~~~~~ 292 (352)
....+|+.+.++|.+||+.||.+|| +++++.+.+..++..
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 2467899999999999999999998 888888887766543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=348.06 Aligned_cols=268 Identities=24% Similarity=0.503 Sum_probs=227.4
Q ss_pred cccceecCCceeeec-cccCCCceEEEEEEE----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 16 DAKWLIDPKHLFVGP-RIGEGAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~-~lG~G~~g~Vy~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
+..|.+.+++|.+.. .||+|+||.||+|.+ ++..||+|++...... .....+.+|++++++++||||++++
T Consensus 1 d~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~ 76 (287)
T 1u59_A 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK----ADTEEMMREAQIMHQLDNPYIVRLI 76 (287)
T ss_dssp -CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH----HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch----hHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 356889999999987 999999999999975 3778999999875432 2345688999999999999999999
Q ss_pred eeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 91 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 91 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
+++..+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+||
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Df 154 (287)
T 1u59_A 77 GVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDF 154 (287)
T ss_dssp EEEESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCC
T ss_pred EEecCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcc
Confidence 9998888999999999999999997543 349999999999999999999999999999999999999988 79999999
Q ss_pred CCccccccccc----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 018656 171 GLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAA 245 (352)
Q Consensus 171 g~a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 245 (352)
|++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |+.||.+..........
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i 226 (287)
T 1u59_A 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226 (287)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred cceeeeccCcceeeccccccccccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 99975432221 223356889999999854 557889999999999999998 99999987766555555
Q ss_pred HhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 246 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
......+.+..+|+++.++|.+||..||.+||++.+++++|+..+.....+.
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 227 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 4444455677899999999999999999999999999999999987655544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=356.71 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=213.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|++++.||+|+||+||+|.+. |+.+|+|++..... ....+.+|+.+++.++||||+++++++.+ +..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT------DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc------cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 478999999999999999999985 78999999875431 23457899999999999999999999875 5799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC-CCceEEecCCCcccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESL 178 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~-~~~vkl~Dfg~a~~~~~ 178 (352)
+||||++|++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.+ .+.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999999997643 349999999999999999999999999999999999999862 37899999999987655
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---CC
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---AE 255 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 255 (352)
........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+................ ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCccccccCChhhcCcHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc
Confidence 555556679999999999854 4578899999999999999999999998776555544444333222 35
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+|.++.++|.+||..||.+|||+.++++|.|
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 78999999999999999999999999999954
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=367.76 Aligned_cols=263 Identities=22% Similarity=0.333 Sum_probs=215.8
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.+.+..++|.+.+.||+|+||+||+|+++ |+.||+|++....... ......+.+|+.+++.++||||+++++++.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh--hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 35677889999999999999999999985 7899999986421100 0112237789999999999999999999985
Q ss_pred C-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 ~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+ .+++||||++||+|.+++.+. .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFG~a~ 216 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCM 216 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC-CCEEEeccceeE
Confidence 4 799999999999999999763 38999999999999999999999999999999999999988 799999999997
Q ss_pred cccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---c
Q 018656 175 EESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---N 249 (352)
Q Consensus 175 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~ 249 (352)
...... ......||+.|+|||++... .....++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTT----TTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred eeccCCcccccCCcCCccccCHHHhhcc----CCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence 644332 23456899999999998641 11123788999999999999999999999987765554444332 2
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHHHHhhhc
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~i~~~l~~~~~~ 292 (352)
..|....++.++.++|.+||+.+|.+ ||+++++++| .|++.
T Consensus 293 ~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H--p~f~~ 335 (410)
T 3v8s_A 293 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH--LFFKN 335 (410)
T ss_dssp CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS--GGGCC
T ss_pred cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC--ccccC
Confidence 34455689999999999999999988 9999999999 44443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=346.27 Aligned_cols=258 Identities=28% Similarity=0.518 Sum_probs=221.6
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
.|.+..++|++.+.||+|+||+||+|.+. +..||+|++....... ..+.+|++++++++||||+++++++.+
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE------DEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH------HHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH------HHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 57788999999999999999999999987 5689999997655432 247899999999999999999999875
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRY 153 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT-CCEEECCTTCEEE
T ss_pred CceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC-CCEEEccCcccee
Confidence 47899999999999999998753 248999999999999999999999999999999999999988 7999999999975
Q ss_pred cccccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCC
Q 018656 176 ESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 176 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
...... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...................
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHY--------FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY 225 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHH--------SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cchhhhhcccCCCcCcccCCHHHHhc--------cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC
Confidence 433322 223346778999999854 567889999999999999998 999999877776666666555556
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
.+..+++.+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 677889999999999999999999999999999877643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=352.79 Aligned_cols=267 Identities=28% Similarity=0.539 Sum_probs=225.5
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 85 (352)
.-.+..|.+..++|.+++.||+|+||.||+|.+. ++.||+|++...... .....+.+|++++++++|||
T Consensus 12 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~ 87 (314)
T 2ivs_A 12 ILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP----SELRDLLSEFNVLKQVNHPH 87 (314)
T ss_dssp --CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH----HHHHHHHHHHHHHTTCCCTT
T ss_pred ccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH----HHHHHHHHHHHHHhhCCCCc
Confidence 3456789999999999999999999999999872 478999999765443 23456889999999999999
Q ss_pred eeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 018656 86 LVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP----------------------RCLDVCVAIGFALDIARAMECLH 142 (352)
Q Consensus 86 iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~~L~~lH 142 (352)
|+++++++.+ +..++||||+++++|.+++..... ..+++..++.++.|++.||+|||
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 167 (314)
T 2ivs_A 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167 (314)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred eeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence 9999999874 479999999999999999987543 24899999999999999999999
Q ss_pred hCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhH
Q 018656 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 219 (352)
Q Consensus 143 ~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 219 (352)
++|++||||||+||+++.+ +.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||
T Consensus 168 ~~~ivH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~sl 238 (314)
T 2ivs_A 168 EMKLVHRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--------HIYTTQSDVWSF 238 (314)
T ss_dssp HTTEECCCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--------CEECHHHHHHHH
T ss_pred HCCCcccccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC--------CCcCchhhHHHH
Confidence 9999999999999999988 799999999987543222 1233457889999998854 567889999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 220 AIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 220 G~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
|+++|+|++ |..||.+................+.+..+++++.+++.+||+.||.+||++.+++++|...+..
T Consensus 239 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 239 GVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 999999999 9999998776555544444444556778999999999999999999999999999999887754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=372.60 Aligned_cols=265 Identities=29% Similarity=0.522 Sum_probs=223.8
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
...|.+..++|++.+.||+|+||.||+|.++ +..||||++...... ...+.+|++++++++||||+++++++.
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~ 249 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVS 249 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 4569999999999999999999999999997 467999999765432 235889999999999999999999998
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
++..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++
T Consensus 250 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~ 328 (452)
T 1fmk_A 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLAR 328 (452)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC
T ss_pred CCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CCEEECCCccce
Confidence 8889999999999999999976544459999999999999999999999999999999999999987 799999999998
Q ss_pred cccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCC
Q 018656 175 EESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 175 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
...... ......++..|+|||++.. ..++.++||||||+++|+|++ |+.||.+....+...........
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 400 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 400 (452)
T ss_dssp --------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ecCCCceecccCCcccccccCHhHHhc--------CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 643322 1223356789999998854 568899999999999999999 99999988776665555555555
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
+.+..+|+.+.++|.+||+.||.+|||+.++++.|..++....+
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 66788999999999999999999999999999999888765443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=362.18 Aligned_cols=252 Identities=27% Similarity=0.357 Sum_probs=203.1
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHH-HhcCCCCCeeeeeeeeec-
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM-LSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~iv~l~~~~~~- 95 (352)
.+..++|++.+.||+|+||.||+|+++ ++.||||++........ .....+.+|..+ ++.++||||+++++++.+
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~--~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK--KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh--HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 355678999999999999999999985 78899999976543221 223446677776 577899999999999985
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+.+|+||||++|++|.+++.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKE 188 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCBCGG
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEeeCccccc
Confidence 579999999999999999987554 8999999999999999999999999999999999999988 7999999999975
Q ss_pred c-ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 176 E-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 176 ~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
. ..........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+ .......+
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i-~~~~~~~~ 259 (373)
T 2r5t_A 189 NIEHNSTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI-LNKPLQLK 259 (373)
T ss_dssp GBCCCCCCCSBSCCCCCCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH-HHSCCCCC
T ss_pred cccCCCccccccCCccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HhcccCCC
Confidence 3 22334456689999999999854 56889999999999999999999999886654443333 33344456
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCH----HHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNF----TQIIQM 285 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~----~~i~~~ 285 (352)
..++.++.++|.+||+.||.+||++ .++++|
T Consensus 260 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 260 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 7899999999999999999999987 466665
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=360.47 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=213.4
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||.||+|.++ |+.||+|++....... .....+.+|+.++++++||||+++++++.+ +..++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 47999999999999999999985 8999999998765433 234568899999999999999999999885 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCCcccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREESL 178 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~a~~~~~ 178 (352)
||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+.+||+|||++.....
T Consensus 106 v~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999999997654 39999999999999999999999999999999999999764 24699999999987655
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC---CCCC
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSAE 255 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 255 (352)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.............. +...
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 255 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 255 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGG
T ss_pred CcccccCCCCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence 544556689999999999854 56889999999999999999999999987665444444333222 2235
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+++++.++|.+||+.||.+||++.+++++.|
T Consensus 256 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 256 TVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp GSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 68999999999999999999999999999854
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=363.10 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=217.9
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.+.+.-++|++.+.||+|+||.||+|.+. |+.||+|++....... ......+.+|+++++.++||||+++++++.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE--RNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45677789999999999999999999985 7889999986532111 1223568899999999999999999999985
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
...++||||+.|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.+ +.++|+|||++.
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~ 163 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIAA 163 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC-CCEEEeccceee
Confidence 479999999999999999987543 9999999999999999999999999999999999999988 799999999998
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhccCCC
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NLQAAYAAAFKNVRP 252 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~ 252 (352)
............||+.|+|||++... .+..++.++|||||||++|+|++|+.||.... ...............
T Consensus 164 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T 4fr4_A 164 MLPRETQITTMAGTKPYMAPEMFSSR-----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT 238 (384)
T ss_dssp ECCTTCCBCCCCSCGGGCCGGGTCCC-----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC
T ss_pred eccCCCceeccCCCccccCCeeeccC-----CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC
Confidence 76555556677899999999998541 13457899999999999999999999997543 233334444455556
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCC-HHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPN-FTQIIQML 286 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps-~~~i~~~l 286 (352)
.+..++.++.++|.+||+.||.+||+ ++++++|.
T Consensus 239 ~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp 273 (384)
T 4fr4_A 239 YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273 (384)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence 67789999999999999999999998 88888763
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=343.74 Aligned_cols=259 Identities=30% Similarity=0.572 Sum_probs=220.9
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.+|.+++++|++.+.||+|+||.||+|.+. ++.||+|++....... ..+.+|++++++++||||+++++++.+
T Consensus 1 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp --CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 369999999999999999999999999985 7889999998654332 357899999999999999999999874
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~ 152 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTR 152 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-GCEEECCTTGGG
T ss_pred CCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-CCEEEccccccc
Confidence 47999999999999999998753 348999999999999999999999999999999999999887 799999999987
Q ss_pred cccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCC
Q 018656 175 EESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 175 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
...... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||..................
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~ 224 (267)
T 3t9t_A 153 FVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 224 (267)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccccccccccChhhhcC--------CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC
Confidence 543322 2233457789999999854 567889999999999999999 89999987766555554444444
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
..+..++..+.+++.+||+.||.+||++.+++++|....+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5567789999999999999999999999999999988765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=348.56 Aligned_cols=265 Identities=32% Similarity=0.594 Sum_probs=211.8
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
-+.|.|..++|++.+.||+|+||+||+|.+.+ .+|+|++....... .....+.+|++++++++||||++++++...
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP---QQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCH---HHHHHHHHHHHHHHhCCCCcEEEEEeeccC
Confidence 34588999999999999999999999998766 49999997765543 334568899999999999999999998888
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NTVKIGDFGLATE 169 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC----
T ss_pred CccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CCEEEccceeccc
Confidence 88999999999999999997643 349999999999999999999999999999999999999998 7999999999875
Q ss_pred ccc---ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-
Q 018656 176 ESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR- 251 (352)
Q Consensus 176 ~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~- 251 (352)
... ........|++.|+|||++... ....++.++||||||+++|+|++|+.||.+................
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQ-----DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244 (289)
T ss_dssp --------------CCCTTCCHHHHC---------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC
T ss_pred cccccccccccccCCCccccCchhhccc-----CCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC
Confidence 432 2223345789999999988521 1356788999999999999999999999887665555444433222
Q ss_pred C----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 252 P----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 252 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
+ ....+|+++.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 2 235789999999999999999999999999999987653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=343.84 Aligned_cols=261 Identities=25% Similarity=0.449 Sum_probs=221.3
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
..+.++.++|++.+.||+|+||+||+|.++|+.||+|++........ ....+.+|+.++++++||||+++++++.+
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR---KSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp -CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHH---HHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CcCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHH---HHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 45778899999999999999999999999999999999987654432 34568899999999999999999999874
Q ss_pred --CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeCCCCceEEecCC
Q 018656 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 96 --~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
+..++||||+++++|.+++.......+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~ 158 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMAD 158 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGG
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEecc
Confidence 46899999999999999998866556999999999999999999999999 9999999999999988 789999888
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV- 250 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~- 250 (352)
++..... ....||+.|+|||++.+.. ...++.++||||||+++|+|++|+.||.+...............
T Consensus 159 ~~~~~~~----~~~~~t~~y~aPE~~~~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 229 (271)
T 3kmu_A 159 VKFSFQS----PGRMYAPAWVAPEALQKKP-----EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR 229 (271)
T ss_dssp SCCTTSC----TTCBSCGGGSCHHHHHSCG-----GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC
T ss_pred ceeeecc----cCccCCccccChhhhccCC-----CCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC
Confidence 7654222 2346899999999986411 13344589999999999999999999998777665555544433
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
...+..+++++.+++.+||+.||.+|||+.++++.|....
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 3446789999999999999999999999999999987754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=366.26 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=212.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|++++.||+|+||+||+|.+. |+.+|+|++....... .....+.+|++++++++||||+++++++.+ +..+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA---RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH---HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 457999999999999999999984 8999999998765543 234568899999999999999999999985 4789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCCccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREES 177 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~a~~~~ 177 (352)
+||||++|++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||++....
T Consensus 87 lv~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999999987654 9999999999999999999999999999999999999742 3689999999997644
Q ss_pred cc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC---CCC
Q 018656 178 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV---RPS 253 (352)
Q Consensus 178 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~ 253 (352)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+............. .+.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRK--------DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred CCCceeecccCCcccCCHHHhcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence 33 22345679999999999854 5688999999999999999999999998776555544444332 233
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
...+++++.++|.+||+.||.+|||+.++++|.|
T Consensus 237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 4678999999999999999999999999999843
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=346.30 Aligned_cols=262 Identities=29% Similarity=0.524 Sum_probs=221.8
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
...|-+..++|.+.+.||+|+||+||+|.+. +..||+|++....... ...++.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD----NKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH----HHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred CccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch----HHHHHHHHHHHHHhCCCCCcceEE
Confidence 3568899999999999999999999999864 2359999987654432 345688999999999999999999
Q ss_pred eeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 91 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 91 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
+++.++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+||
T Consensus 80 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Df 157 (281)
T 3cc6_A 80 GIIEEEPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDF 157 (281)
T ss_dssp EEECSSSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCC
T ss_pred EEEcCCCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCcc
Confidence 9998888899999999999999998754 348999999999999999999999999999999999999988 79999999
Q ss_pred CCcccccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 018656 171 GLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 171 g~a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 247 (352)
|++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |+.||..............
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~ 229 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESINF--------RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH
T ss_pred CCCcccccccccccccCCCCcceeCchhhcc--------CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc
Confidence 9987543322 1233457889999998854 567889999999999999998 9999987666655555555
Q ss_pred ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 248 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
....+.+..+++.+.+++.+||..||.+||++.+++++|.....
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 55566677899999999999999999999999999999987764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=350.35 Aligned_cols=274 Identities=32% Similarity=0.534 Sum_probs=229.5
Q ss_pred ccccccccccccceecCCceeeeccccCCCceEEEEEEE-------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHh
Q 018656 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79 (352)
Q Consensus 7 ~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~ 79 (352)
|+=+..+..+..|.+..++|++++.||+|+||.||+|.+ .++.||+|++....... ....+.+|+++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~ 81 (313)
T 1t46_A 6 YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT----EREALMSELKVLS 81 (313)
T ss_dssp CCCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH----HHHHHHHHHHHHH
T ss_pred EeccccCCCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH----HHHHHHHHHHHHh
Confidence 334445778888999999999999999999999999986 25789999997654432 3456889999999
Q ss_pred cC-CCCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 018656 80 RV-QHRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPR----------------CLDVCVAIGFALDIARAMECL 141 (352)
Q Consensus 80 ~l-~hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~----------------~~~~~~~~~i~~qi~~~L~~l 141 (352)
++ +||||+++++++.+ +..++||||+++++|.+++...... .+++..++.++.|++.||+||
T Consensus 82 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l 161 (313)
T 1t46_A 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (313)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred hcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 99 99999999999874 5789999999999999999875432 489999999999999999999
Q ss_pred HhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhh
Q 018656 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 218 (352)
Q Consensus 142 H~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Diws 218 (352)
|++|++||||||+||+++.+ +.+||+|||++........ .....+++.|+|||++.+ ..++.++||||
T Consensus 162 H~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s 232 (313)
T 1t46_A 162 ASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWS 232 (313)
T ss_dssp HHTTCCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHHH
T ss_pred HHCCeecCCCccceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcC--------CCCChHHHHHH
Confidence 99999999999999999988 7999999999975443321 223456789999998854 56889999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 219 FAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 219 lG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
||+++|+|++ |..||.+.............. ....+..++.++.+++.+||+.||.+|||+.+++++|...+...
T Consensus 233 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 9999999998 999998876544444443333 33446779999999999999999999999999999999888654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=356.23 Aligned_cols=263 Identities=28% Similarity=0.515 Sum_probs=222.6
Q ss_pred cceecCCceeeeccccCCCceEEEEEEECC-------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
.|.+..++|++.+.||+|+||.||+|++.+ +.||||++...... .....+.+|+.++++++||||++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~ 116 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA----DMQADFQREAALMAEFDNPNIVKLL 116 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH----HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH----HHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 367888999999999999999999999853 78999999765442 2345688999999999999999999
Q ss_pred eeeec-CceEEEEEcCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 018656 91 GACKE-PVMVIVTELLSGGTLRKYLLNMRP----------------------RCLDVCVAIGFALDIARAMECLHSHGII 147 (352)
Q Consensus 91 ~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~~L~~lH~~~iv 147 (352)
+++.+ +..++||||+++++|.+++..... ..+++..++.++.|+++||.|||++||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv 196 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 196 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99874 578999999999999999987531 4599999999999999999999999999
Q ss_pred cCCCCCCCeEEeCCCCceEEecCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHH
Q 018656 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224 (352)
Q Consensus 148 H~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 224 (352)
||||||+||+++.+ +.+||+|||++...... .......+++.|+|||++.+ ..++.++||||||+++|
T Consensus 197 H~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 267 (343)
T 1luf_A 197 HRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLW 267 (343)
T ss_dssp CSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred cCCCCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc--------CCcCcccccHHHHHHHH
Confidence 99999999999988 79999999998753322 12234467899999998854 56889999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 225 ELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 225 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
+|++ |..||.+................+.+..++.++.+++.+||+.||.+||++.+++++|....+..
T Consensus 268 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 268 EIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 9999 99999987776655555555555667789999999999999999999999999999998876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=355.50 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=211.9
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-C
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-P 96 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~ 96 (352)
+..++|++.+.||+|+||.||+|+++ |+.||+|++........ .....+.+|..+++++ +||||+++++++.+ .
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD--EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH--HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch--HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 44578999999999999999999985 88999999976543222 3345688899999887 89999999999975 5
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.+++||||++|++|.+++.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCGGGCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEEeccccccc
Confidence 79999999999999999987654 9999999999999999999999999999999999999988 79999999999753
Q ss_pred -ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHh
Q 018656 177 -SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--------NLQAAYAAAF 247 (352)
Q Consensus 177 -~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--------~~~~~~~~~~ 247 (352)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..........
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~ 232 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred cCCCCcccccCCCccccCccccCC--------CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence 23334456689999999999854 567899999999999999999999997521 1222333333
Q ss_pred ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCH------HHHHHHH
Q 018656 248 KNVRPSAENVPEELSIILTSCWKEDPNARPNF------TQIIQML 286 (352)
Q Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~i~~~l 286 (352)
......+..++.++.++|.+||+.||.+||++ .++++|.
T Consensus 233 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 233 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred cCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 44445567899999999999999999999985 7888873
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=360.41 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=210.2
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 95 (352)
..+..++|.+.+.||+|+||.||+|+++ |+.||||++....... ......+.+|..+++.+ +||||+++++++.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh--hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 3466789999999999999999999985 8999999987532100 11234567888888876 99999999999985
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
..+++||||++|++|.+++.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~ 166 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCK 166 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCB
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC-CCEEEeEChhhh
Confidence 479999999999999999987654 9999999999999999999999999999999999999988 799999999997
Q ss_pred cccc-ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 018656 175 EESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253 (352)
Q Consensus 175 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (352)
.... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+........ .......
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-~~~~~~~ 237 (345)
T 1xjd_A 167 ENMLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMDNPFY 237 (345)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCCCC
T ss_pred hcccCCCcccCCCCCcccCChhhhcC--------CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HhCCCCC
Confidence 5322 233455689999999999854 56889999999999999999999999986655444333 3333445
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHH-HHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFT-QIIQML 286 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~-~i~~~l 286 (352)
+..+++++.++|.+||..||.+||++. ++++|.
T Consensus 238 p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 238 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 667999999999999999999999997 888773
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=353.81 Aligned_cols=266 Identities=29% Similarity=0.441 Sum_probs=216.3
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
..+.+..++|++++.||+|+||+||+|.+. |+.||+|++..... .....+.+|++++++++||||+++++++.
T Consensus 3 p~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 77 (310)
T 3s95_A 3 PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-----ETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77 (310)
T ss_dssp CCEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence 357788999999999999999999999985 89999998854321 33456889999999999999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ +..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~ 155 (310)
T 3s95_A 78 KDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-KNVVVADFGLA 155 (310)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-SCEEECCCTTC
T ss_pred cCCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-CCEEEeecccc
Confidence 4 57999999999999999998743 349999999999999999999999999999999999999988 79999999999
Q ss_pred ccccccccc---------------ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh
Q 018656 174 REESLTEMM---------------TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN 238 (352)
Q Consensus 174 ~~~~~~~~~---------------~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~ 238 (352)
......... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--------RSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 754322211 14579999999999854 6688999999999999999999999875332
Q ss_pred HHHHH--HHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 239 LQAAY--AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 239 ~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
..... ..........+..+|+.+.+++.+||+.||.+|||+.++++.|+.....+....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 228 RTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288 (310)
T ss_dssp BCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred hHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence 11000 000000112346788999999999999999999999999999988876654433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=358.18 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=211.2
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 94 (352)
.-.+..++|.+.+.||+|+||.||+|+++ |+.||||++....... ......+.+|..+++.+ +||+|+++++++.
T Consensus 14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ--DDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp -----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred cCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc--chHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 34566789999999999999999999996 6889999987532111 12234577899999988 8999999999998
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ +.+|+||||++|++|.+++.+... +++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a 168 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMC 168 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC-CcEEEEeCCcc
Confidence 5 579999999999999999987654 9999999999999999999999999999999999999988 79999999999
Q ss_pred cccc-cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 018656 174 REES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 174 ~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+ ......
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i-~~~~~~ 239 (353)
T 2i0e_A 169 KENIWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI-MEHNVA 239 (353)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCCC
T ss_pred cccccCCcccccccCCccccChhhhcC--------CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH-HhCCCC
Confidence 8532 2333456689999999999854 56789999999999999999999999986655444333 333444
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPN-----FTQIIQML 286 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~i~~~l 286 (352)
.+..++.++.++|.+||..||.+||+ +.++++|.
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 56789999999999999999999995 68888873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=355.92 Aligned_cols=260 Identities=23% Similarity=0.475 Sum_probs=214.2
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--Cce----EEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQT----VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~----vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
-.+..++|++.+.||+|+||+||+|.+. |+. ||+|.+..... ......+.+|+.++++++||||++++++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 85 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS----PKANKEILDEAYVMASVDNPHVCRLLGI 85 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC----HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 3466789999999999999999999874 443 57777754332 1234568899999999999999999999
Q ss_pred eecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 93 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 93 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
+.++..++|+||+.+++|.+++.... ..+++..++.|+.|++.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~ 163 (327)
T 3poz_A 86 CLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGL 163 (327)
T ss_dssp EESSSEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTH
T ss_pred EecCCeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCcc
Confidence 99888999999999999999998754 349999999999999999999999999999999999999988 7999999999
Q ss_pred cccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 018656 173 AREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 173 a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 248 (352)
++...... ......+|..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.............
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 235 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred eeEccCCcccccccCCCccccccChHHhcc--------CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC
Confidence 97533222 1223456889999999864 668899999999999999999 99999987766555555555
Q ss_pred cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 249 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
...+.+..++.++.+++.+||+.||.+||++.+++++|......
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 55666788999999999999999999999999999999877653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=351.00 Aligned_cols=258 Identities=27% Similarity=0.371 Sum_probs=208.2
Q ss_pred cCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
..++|++.+.||+|+||+||+|++. |+.||+|++....... .....+.+|++++++++||||+++++++.+ ...+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE---GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc---hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 4578999999999999999999984 8999999987653322 223567899999999999999999999874 4799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||+++ +|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 96 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEETTSC
T ss_pred EEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC-CCEEEccCcCceecCCC
Confidence 99999975 8988887644 349999999999999999999999999999999999999988 79999999999864322
Q ss_pred -cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC-----
Q 018656 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS----- 253 (352)
Q Consensus 180 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----- 253 (352)
.......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+....+...........+.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMG-------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred cccccCCcccCCcCCHHHhcC-------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 23344578999999998854 24578899999999999999999999988666554444332211111
Q ss_pred ------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 254 ------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 254 ------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
...+++++.++|.+||+.||.+|||+.++++| .|++.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~~~ 308 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH--PYFKDLD 308 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS--GGGTTSC
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC--cccccCC
Confidence 23467899999999999999999999999998 5665543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=359.41 Aligned_cols=266 Identities=28% Similarity=0.488 Sum_probs=223.2
Q ss_pred ccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCee
Q 018656 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87 (352)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 87 (352)
....+.+..++|++++.||+|+||+||+|.+. ++.||||++....... ....+.+|+.++++++||||+
T Consensus 62 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv 137 (367)
T 3l9p_A 62 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ----DELDFLMEALIISKFNHQNIV 137 (367)
T ss_dssp GGGSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH----HHHHHHHHHHHHHHCCCTTBC
T ss_pred CcchhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh----hHHHHHHHHHHHHhCCCCCCC
Confidence 34557788899999999999999999999843 5689999987544433 234588999999999999999
Q ss_pred eeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC
Q 018656 88 KFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161 (352)
Q Consensus 88 ~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~ 161 (352)
++++++.+ ...++||||++|++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 138 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 217 (367)
T 3l9p_A 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP 217 (367)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred eEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecC
Confidence 99999875 478999999999999999987542 358999999999999999999999999999999999999854
Q ss_pred --CCceEEecCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 018656 162 --LKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEG 235 (352)
Q Consensus 162 --~~~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~ 235 (352)
...+||+|||+++..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 218 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~ellt~g~~pf~~ 289 (367)
T 3l9p_A 218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289 (367)
T ss_dssp STTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 135999999999743221 22233467899999998854 568899999999999999998 9999998
Q ss_pred CChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 236 MSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
................+.+..++..+.+++.+||+.||.+|||+.+++++++.....
T Consensus 290 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 290 KSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 777666555555555566778999999999999999999999999999999887764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=350.84 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=211.5
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
..++|++.+.||+|+||+||+|+++ |+.||+|++....... ......+.+|+.+++.++||||+++++++.+ ..+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 4578999999999999999999985 8999999986532111 1223457789999999999999999999985 479
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||++|++|.+++.+... +++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS
T ss_pred EEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC-CCEEEeecCcceecCC
Confidence 999999999999999987544 9999999999999999999999999999999999999988 7999999999976432
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCc
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (352)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+......... ......+..++
T Consensus 159 --~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~p~~~~ 227 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL-NAELRFPPFFN 227 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-HCCCCCCTTSC
T ss_pred --ccccccCCccccCHhHhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCCCCCC
Confidence 2345679999999999854 568899999999999999999999998866554444333 33344567899
Q ss_pred HHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
+++.++|.+||..||.+|| +++++++|.
T Consensus 228 ~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 9999999999999999999 899999983
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=351.75 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=207.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 96 (352)
.++|++.+.||+|+||.||+|++. |+.||||++........ ....++.+|+.++++++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP--SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH--HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH--HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 568999999999999999999984 89999999977544332 3455788999999999999999999997632
Q ss_pred -ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..++||||++|++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++..
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-SCEEECCCSCC--
T ss_pred cccEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC-CCEEEeeccCccc
Confidence 35999999999999999987654 9999999999999999999999999999999999999988 7999999999975
Q ss_pred cccc----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 176 ESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 176 ~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
.... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+................
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 237 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237 (311)
T ss_dssp ----------------CCTTCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence 4322 12233468999999999854 56888999999999999999999999987776655555444333
Q ss_pred CC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 252 PS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 252 ~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
+. ...++.++.++|.+||+.||.+||+..+++.+.+..
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 238 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 32 457899999999999999999999888887774433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=362.49 Aligned_cols=270 Identities=17% Similarity=0.313 Sum_probs=217.3
Q ss_pred ccccccceecCCceeeeccccCC--CceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEG--AHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G--~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 88 (352)
-+..+.++.+.++|++++.||+| +||+||+|++. |+.||||++....... .....+.+|+.++++++||||++
T Consensus 14 ~~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~ 90 (389)
T 3gni_B 14 FQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN---EMVTFLQGELHVSKLFNHPNIVP 90 (389)
T ss_dssp CC--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH---HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh---HHHHHHHHHHHHHHhCCCCCCCc
Confidence 34566789999999999999999 99999999985 8999999998754433 34456889999999999999999
Q ss_pred eeeeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 89 FIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 89 l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
+++++.+ +..++||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~kl 169 (389)
T 3gni_B 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYL 169 (389)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEE
T ss_pred EeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEE
Confidence 9999874 579999999999999999988755669999999999999999999999999999999999999988 79999
Q ss_pred ecCCCccccccc--------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH
Q 018656 168 ADFGLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239 (352)
Q Consensus 168 ~Dfg~a~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 239 (352)
+|||.+...... .......||+.|+|||++.+ ....++.++|||||||++|+|++|+.||.+....
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST------TSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred cccccceeeccccccccccccccccccccccccCHHHHhc------cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 999987632211 11223478999999999854 1256889999999999999999999999875544
Q ss_pred HHHHHHHhcc---------------------------------------------CCCCCCCCcHHHHHHHHHhhccCCC
Q 018656 240 QAAYAAAFKN---------------------------------------------VRPSAENVPEELSIILTSCWKEDPN 274 (352)
Q Consensus 240 ~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~ 274 (352)
.......... ..+.+..+++++.+||.+||+.||.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 323 (389)
T 3gni_B 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323 (389)
T ss_dssp THHHHC--------------------------------------------------------CCHHHHHHHHHHTCSCTT
T ss_pred HHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcc
Confidence 3332211100 0122456789999999999999999
Q ss_pred CCCCHHHHHHHHHHhhhccC
Q 018656 275 ARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 275 ~Rps~~~i~~~l~~~~~~~~ 294 (352)
+|||+.++++| .|++...
T Consensus 324 ~Rpta~ell~h--p~f~~~~ 341 (389)
T 3gni_B 324 ARPSASTLLNH--SFFKQIK 341 (389)
T ss_dssp TSCCHHHHTTS--GGGGGC-
T ss_pred cCCCHHHHhcC--HHHHHHh
Confidence 99999999998 5555443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=346.73 Aligned_cols=263 Identities=25% Similarity=0.470 Sum_probs=219.8
Q ss_pred ccceecCCceeeec-cccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 17 AKWLIDPKHLFVGP-RIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 17 ~~~~i~~~~y~~~~-~lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
..+.++.++|.+.+ .||+|+||+||+|.+. ++.||||++....... .....+.+|+++++.++||||+++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP---ALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C---HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH---HHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45788999999998 9999999999999652 6889999987654322 23456889999999999999999999
Q ss_pred eeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 92 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 92 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
++..+..++||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg 162 (291)
T 1xbb_A 86 ICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFG 162 (291)
T ss_dssp EEESSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCT
T ss_pred EECCCCcEEEEEeCCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCC
Confidence 9988889999999999999999987543 9999999999999999999999999999999999999988 799999999
Q ss_pred Cccccccccc----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 018656 172 LAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 172 ~a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 246 (352)
++........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 234 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhcc--------CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9875433221 222346789999999854 457889999999999999999 999999877665555554
Q ss_pred hccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 247 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
.....+.+..+++++.++|.+||+.||.+||++.++++.|..++...
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 235 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 44445557789999999999999999999999999999999888654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=354.73 Aligned_cols=250 Identities=25% Similarity=0.301 Sum_probs=212.8
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
...++|++.+.||+|+||.||+|++. |+.||||++....... ......+.+|+++++.++||||+++++++.+ ..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 44578999999999999999999985 8999999986532111 1224568899999999999999999999985 47
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+++||||++|++|.+++.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred EEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC-CCEEEcccccceecc
Confidence 9999999999999999987654 9999999999999999999999999999999999999988 799999999998643
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (352)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+......... ......+..+
T Consensus 193 ~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~-~~~~~~p~~~ 261 (350)
T 1rdq_E 193 GR--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV-SGKVRFPSHF 261 (350)
T ss_dssp SC--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCCCCCTTC
T ss_pred CC--cccccCCccccCHHHhcC--------CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence 32 234579999999999854 567899999999999999999999999866554444333 3344556789
Q ss_pred cHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPN-----FTQIIQML 286 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps-----~~~i~~~l 286 (352)
+.++.++|.+||+.||.+||+ ++++++|.
T Consensus 262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 999999999999999999998 99999984
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=365.04 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=213.4
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
+.+..++|++.+.||+|+||+||+|+++ |+.||||++....... ......+.+|..++..++||||+++++++.+
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~--~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK--RGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--HGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhh--HHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 4567889999999999999999999985 8999999986421111 1123347789999999999999999999985
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+.+|+||||++|++|.+++.+.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-g~vkL~DFGla~~ 211 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSCLK 211 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC-CCEEEeechhhee
Confidence 479999999999999999987542 49999999999999999999999999999999999999998 7999999999976
Q ss_pred cccccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---cC
Q 018656 176 ESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---NV 250 (352)
Q Consensus 176 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~~ 250 (352)
...... .....||+.|+|||++..... ......++.++|||||||++|+|++|+.||.+.+.......+... ..
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGG-GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHT-CTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhccc-CcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 443322 234579999999999863110 001246789999999999999999999999987765554444321 11
Q ss_pred CC-CCCCCcHHHHHHHHHhhccCCCCC---CCHHHHHHHHHHhhhc
Q 018656 251 RP-SAENVPEELSIILTSCWKEDPNAR---PNFTQIIQMLLNYLSA 292 (352)
Q Consensus 251 ~~-~~~~~~~~l~~li~~~l~~~p~~R---ps~~~i~~~l~~~~~~ 292 (352)
.| ....+|+++.++|++||. +|.+| |+++++++| .|+..
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H--pff~~ 333 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH--PFFFG 333 (412)
T ss_dssp CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS--GGGTT
T ss_pred CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC--CCcCC
Confidence 22 246799999999999999 99988 699999998 44443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=351.31 Aligned_cols=257 Identities=26% Similarity=0.358 Sum_probs=205.3
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEE-----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
....+..++|++.+.||+|+||.||+|++ +|+.||+|++........ ......+.+|+.+++.++||||+++++
T Consensus 10 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp ---CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh-hhHHHHHHHHHHHHHhCCCCCccceeE
Confidence 34567788999999999999999999987 478999999976532211 123445788999999999999999999
Q ss_pred eeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 92 ACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 92 ~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
++.+ +..++||||++|++|.+++..... +++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~Df 165 (327)
T 3a62_A 89 AFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDF 165 (327)
T ss_dssp EEECSSCEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-SCEEECCC
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-CcEEEEeC
Confidence 9875 589999999999999999987654 8999999999999999999999999999999999999988 79999999
Q ss_pred CCcccccc-ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 171 GLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 171 g~a~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
|++..... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+........ ...
T Consensus 166 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i-~~~ 236 (327)
T 3a62_A 166 GLCKESIHDGTVTHTFCGTIEYMAPEILMR--------SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI-LKC 236 (327)
T ss_dssp SCC----------CTTSSCCTTSCHHHHTT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHT
T ss_pred CcccccccCCccccccCCCcCccCHhhCcC--------CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH-HhC
Confidence 99875322 223345679999999999854 56788999999999999999999999986655444333 333
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
....+..++.++.++|.+||..||.+|| ++.++++|.
T Consensus 237 ~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 237 KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 4455678999999999999999999999 888999983
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=356.02 Aligned_cols=250 Identities=28% Similarity=0.379 Sum_probs=205.7
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 99 (352)
-++|++.+.||+|+||+||+|.+. ++.||||++....... ....+.+|+.+++.++||||+++++++.++ ..+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc----hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 368999999999999999999985 8999999987654322 234578999999999999999999999854 789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL- 178 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~- 178 (352)
+||||++|++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEET
T ss_pred EEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC-CCEEEEEeeccceeccC
Confidence 99999999999999876443 9999999999999999999999999999999999999988 7999999999975432
Q ss_pred --ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--cCCCCC
Q 018656 179 --TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK--NVRPSA 254 (352)
Q Consensus 179 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~ 254 (352)
........||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+............. ...+..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHC-------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTG
T ss_pred CcccccCCCccCcCccCcHHhcc-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCcc
Confidence 222345679999999999854 233477899999999999999999999876554333322222 222334
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..++.++.++|.+||+.||.+|||+.+++++.
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 67899999999999999999999999999983
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=346.86 Aligned_cols=261 Identities=29% Similarity=0.551 Sum_probs=225.4
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
+.|.+..++|++.+.||+|+||+||+|.+. ++.||+|++...... ...+.+|++++++++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME------VEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH------HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 468999999999999999999999999986 789999998764432 345889999999999999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ +..++||||++|++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~ 158 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLS 158 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-GCEEECCCCGG
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-CCEEEccCccc
Confidence 4 478999999999999999988666679999999999999999999999999999999999999888 79999999999
Q ss_pred ccccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 018656 174 REESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 174 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
....... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+...............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~ 230 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 230 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred eeccCCccccccCCccccCcCChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC
Confidence 7543322 2223356788999999854 567899999999999999999 9999988776555555544445
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.+.+..+|+.+.+++.+||..||.+|||+.++++.|..++..
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 566778999999999999999999999999999999887764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=352.24 Aligned_cols=271 Identities=31% Similarity=0.565 Sum_probs=227.7
Q ss_pred cccccccceecCCceeeeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-
Q 018656 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV- 81 (352)
Q Consensus 12 ~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 81 (352)
++.....|.+..++|++++.||+|+||.||+|.+. ++.||+|++...... .....+.+|+++++++
T Consensus 23 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~ 98 (334)
T 2pvf_A 23 ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE----KDLSDLVSEMEMMKMIG 98 (334)
T ss_dssp CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH----HHHHHHHHHHHHHHHHC
T ss_pred cCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH----HHHHHHHHHHHHHHHhh
Confidence 35667889999999999999999999999999873 567999999765443 2345688999999999
Q ss_pred CCCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 018656 82 QHRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGI 146 (352)
Q Consensus 82 ~hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~i 146 (352)
+||||+++++++.+ +..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++||
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 178 (334)
T 2pvf_A 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC 178 (334)
T ss_dssp CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 89999999999874 478999999999999999987542 248999999999999999999999999
Q ss_pred ccCCCCCCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHH
Q 018656 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVL 223 (352)
Q Consensus 147 vH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 223 (352)
+||||||+||+++.+ +.+||+|||++....... ......+++.|+|||++.+ ..++.++||||||+++
T Consensus 179 vH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 249 (334)
T 2pvf_A 179 IHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLM 249 (334)
T ss_dssp ECSCCSGGGEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHH
T ss_pred eCCCCccceEEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcC--------CCcChHHHHHHHHHHH
Confidence 999999999999988 799999999997543322 1233456789999998854 5578899999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 224 WELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 224 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
|+|++ |..||.+................+.+..++.++.++|.+||..||.+|||+.+++++|...+.....
T Consensus 250 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 250 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 99999 9999998776555444444444556678999999999999999999999999999999988875444
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=358.18 Aligned_cols=265 Identities=29% Similarity=0.545 Sum_probs=221.4
Q ss_pred ccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCe
Q 018656 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNL 86 (352)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i 86 (352)
....|.+..++|++++.||+|+||.||+|++. ++.||||++....... ....+.+|+++++++ +||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----EHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHCCCTTB
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH----HHHHHHHHHHHHHhhcCCcce
Confidence 34569999999999999999999999999852 4789999997654433 245688999999999 79999
Q ss_pred eeeeeeeecC--ceEEEEEcCCCCCHHHHHHhcCC---------------------------------------------
Q 018656 87 VKFIGACKEP--VMVIVTELLSGGTLRKYLLNMRP--------------------------------------------- 119 (352)
Q Consensus 87 v~l~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------- 119 (352)
+++++++.+. ..++||||+++++|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 9999998753 58999999999999999986532
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 120 -------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 120 -------------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCT
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecccc
Confidence 128999999999999999999999999999999999999987 79999999999754222
Q ss_pred --cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh-ccCCCCCC
Q 018656 180 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF-KNVRPSAE 255 (352)
Q Consensus 180 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 255 (352)
.......||+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+............ ....+.+.
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 319 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 319 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT
T ss_pred cchhccccCCCceeEChhhhcC--------CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCC
Confidence 12234467889999998854 568899999999999999998 9999988765444443333 33445567
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.+++++.+++.+||+.||.+|||+.+++++|...+++
T Consensus 320 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 320 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 8999999999999999999999999999999988764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=354.82 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=211.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHH-HHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
++|.+.+.||+|+||.||+|.+. |+.||+|++......... ......+.+|+.++++++||||+++++++.+ ...+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56999999999999999999985 899999999765432110 0113458899999999999999999999885 4799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC----ceEEecCCCccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK----TIKLADFGLARE 175 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~----~vkl~Dfg~a~~ 175 (352)
+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.+ + .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~-~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR-NVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCS-SSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecC-CCCCCCEEEEECCCCeE
Confidence 9999999999999997644 49999999999999999999999999999999999999876 4 799999999987
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 253 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 253 (352)
...........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+..................
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (326)
T 2y0a_A 168 IDFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 239 (326)
T ss_dssp CCTTSCCCCCCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred CCCCCccccccCCcCcCCceeecC--------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcc
Confidence 654444556689999999999854 5678999999999999999999999988766554444433322221
Q ss_pred -CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 254 -AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 254 -~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
...++..+.++|.+||+.||.+|||+.++++|.
T Consensus 240 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 240 YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 357889999999999999999999999999983
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=347.24 Aligned_cols=260 Identities=25% Similarity=0.476 Sum_probs=211.3
Q ss_pred ceecCCceeeeccccCCCceEEEEEEE------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
..+..++|++.+.||+|+||+||+|++ +|+.||||++..... .....+.+|++++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 79 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-----EHLRDFEREIEILKSLQHDNIVKYKGV 79 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH-----HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 467789999999999999999999984 478999999875432 234568899999999999999999999
Q ss_pred eec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 93 CKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 93 ~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
+.. ...++||||+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~D 157 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGD 157 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEcc
Confidence 853 468999999999999999987543 48999999999999999999999999999999999999988 7999999
Q ss_pred CCCcccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH------
Q 018656 170 FGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL------ 239 (352)
Q Consensus 170 fg~a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~------ 239 (352)
||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 229 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHC
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcC--------CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhc
Confidence 99998543321 2233457788999999864 56889999999999999999999998653211
Q ss_pred ----------HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 240 ----------QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 240 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
............+.+..+|+++.+++.+||+.||.+|||+.++++.|..+.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 230 NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 011112222344557789999999999999999999999999999999887664
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=345.41 Aligned_cols=261 Identities=32% Similarity=0.623 Sum_probs=212.5
Q ss_pred ceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCce
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVM 98 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 98 (352)
..++.++|++.+.||+|+||+||+|.++++.||+|++.... ....+.+|++++++++||||+++++++.+ ..
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 74 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES-------ERKAFIVELRQLSRVNHPNIVKLYGACLN-PV 74 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT-------HHHHHHHHHHHHHHCCCTTBCCEEEBCTT-TT
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh-------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc
Confidence 46788999999999999999999999999999999986432 23458899999999999999999998875 47
Q ss_pred EEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 99 VIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHS---HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
++||||+++++|.+++..... ..+++..++.++.|+++||+|||+ +||+||||||+||+++.++..+||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 999999999999999986543 247899999999999999999999 8999999999999999874458999999987
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH--HHHHHHhccCCC
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ--AAYAAAFKNVRP 252 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~ 252 (352)
..... .....|++.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ...........+
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (307)
T 2eva_A 155 DIQTH--MTNNKGSAAWMAPEVFEG--------SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224 (307)
T ss_dssp ------------CCTTSSCHHHHTC--------CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC
T ss_pred ccccc--cccCCCCCceEChhhhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC
Confidence 54322 234468999999999854 568899999999999999999999998643322 222333333445
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
....+|..+.+++.+||+.||.+|||+.++++.|....+......
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 567899999999999999999999999999999998877655443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=346.21 Aligned_cols=260 Identities=29% Similarity=0.541 Sum_probs=214.3
Q ss_pred ccccceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
....|.++.++|++.+.||+|+||.||+|.++|+.||+|++..... ...+.+|++++++++||||+++++++.
T Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (278)
T 1byg_A 12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSNLVQLLGVIV 84 (278)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred hhccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH-------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3456899999999999999999999999999999999999876432 235889999999999999999999865
Q ss_pred c--CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 95 E--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 95 ~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
+ +..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~ 163 (278)
T 1byg_A 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGL 163 (278)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC
T ss_pred cCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC-CcEEEeeccc
Confidence 3 378999999999999999987644448899999999999999999999999999999999999988 7999999999
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCC
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
+...... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||..................
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~ 233 (278)
T 1byg_A 164 TKEASST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 233 (278)
T ss_dssp --------------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC
T ss_pred ccccccc--ccCCCccccccCHHHhCC--------CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 8754332 223467889999999854 567889999999999999998 99999887665544444433344
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
..+..+++.+.++|.+||..||.+|||+.++++.|+.....
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 55678999999999999999999999999999999877543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=351.97 Aligned_cols=255 Identities=29% Similarity=0.360 Sum_probs=206.0
Q ss_pred ecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC---CCCCeeeeeeeeec
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE 95 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~ 95 (352)
+..++|++.+.||+|+||+||+|++ +|+.||||++...............+.+|+++++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4467899999999999999999997 489999999875432110000112345666666665 59999999999864
Q ss_pred C------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 96 P------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 96 ~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
. ..+++|||+. ++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~D 163 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLAD 163 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT-SCEEECS
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEEee
Confidence 3 4799999996 599999988766669999999999999999999999999999999999999988 7999999
Q ss_pred CCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 170 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+............
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHT--------SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred CccccccCCCcccCCccccccccCchHHcC--------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999987655555566689999999999854 568899999999999999999999999877666555443322
Q ss_pred CCCC--------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 250 VRPS--------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 250 ~~~~--------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+. ...+++++.++|.+||+.||.+|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1111 13578999999999999999999999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=360.91 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=207.5
Q ss_pred CceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
.+|.+.+.||+|+||+||+|.+ +|+.||+|++....... .....++.+|+.+++.++||||+++++++.. ...++
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK--SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc--hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 5799999999999999999998 48999999986421110 1112458899999999999999999999975 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+ +|+|.+++..... +++..++.++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-CCEEEEEeccceeccCCc
Confidence 99999 7899999987654 9999999999999999999999999999999999999988 799999999998766665
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
......||+.|+|||++.+ ....+.++||||||+++|+|++|..||.+...... ...........+..++++
T Consensus 163 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~i~~~~~~~p~~~s~~ 234 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVING-------KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-FKKVNSCVYVMPDFLSPG 234 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCC-------SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-BCCCCSSCCCCCTTSCHH
T ss_pred ccccccCCcCcCCHHHHcC-------CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-HHHHHcCCCCCcccCCHH
Confidence 5667789999999999864 12236899999999999999999999987432211 111111223345678999
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+.++|++||+.||.+|||+.+++++.|
T Consensus 235 ~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 235 AQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 999999999999999999999999954
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=341.97 Aligned_cols=256 Identities=33% Similarity=0.648 Sum_probs=205.4
Q ss_pred eecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
.++.++|++.+.||+|+||.||+|.++|+.||+|++........ ......+.+|+++++.++||||+++++++.+ +..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDI-SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccH-HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 35678999999999999999999999999999999876543221 2234568899999999999999999999874 478
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCCeEEeCC-------CCceEEe
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPENLLLTED-------LKTIKLA 168 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dikp~Nili~~~-------~~~vkl~ 168 (352)
++||||+++++|.+++.. ..+++..++.++.|++.||+|||++| ++||||||+||+++.+ .+.++|+
T Consensus 82 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999999864 24999999999999999999999999 8999999999999862 3689999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
|||++....... .....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.............
T Consensus 159 Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (271)
T 3dtc_A 159 DFGLAREWHRTT-KMSAAGAYAWMAPEVIRA--------SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229 (271)
T ss_dssp CCCC--------------CCGGGSCHHHHHH--------CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred cCCccccccccc-ccCCCCccceeCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence 999997543332 234578999999998854 56789999999999999999999999987766655554444
Q ss_pred cC-CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 249 NV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 249 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
.. .+.+..+++.+.+++.+||+.||.+|||+.+++++|..
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 33 34567899999999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=350.09 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=214.2
Q ss_pred eecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE- 95 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~- 95 (352)
.+..++|++++.||+|+||+||+|.+ +|+.||||++....... .+.+|+.+++++ +||||+++++++.+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 77 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-------QLHLEYRFYKQLGSGDGIPQVYYFGPCG 77 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSC-------CHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchH-------HHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence 34568999999999999999999997 48999999987654332 377899999999 99999999999875
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCc-----eEEecC
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT-----IKLADF 170 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~-----vkl~Df 170 (352)
...++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +. ++|+||
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~-~~~~~~~~kl~DF 154 (330)
T 2izr_A 78 KYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP-GNKTQQVIHIIDF 154 (330)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTCTTSEEECCC
T ss_pred CccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC-CCCCCceEEEEEc
Confidence 4789999999 999999998753 359999999999999999999999999999999999999887 55 999999
Q ss_pred CCccccccccc--------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH--
Q 018656 171 GLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ-- 240 (352)
Q Consensus 171 g~a~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-- 240 (352)
|++........ .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.....
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~ 226 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--------KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcC--------CCCCchhHHHHHHHHHHHHhcCCCCccccccccHH
Confidence 99985433221 235679999999999854 667899999999999999999999998754321
Q ss_pred H-HHHHHhcc-CCCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCCCcc
Q 018656 241 A-AYAAAFKN-VRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 303 (352)
Q Consensus 241 ~-~~~~~~~~-~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~~~~~~ 303 (352)
. ........ ..+. ...+| ++.+++..||+.||.+||++.++.+.+...............+|
T Consensus 227 ~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 227 ERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp HHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred HHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 1 11111111 1111 23466 99999999999999999999999999998888776655444344
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=350.74 Aligned_cols=268 Identities=28% Similarity=0.468 Sum_probs=210.8
Q ss_pred ccccceecCCceeeeccccCCCceEEEEEEEC--Cc---eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeee
Q 018656 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQ---TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89 (352)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~---~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l 89 (352)
.-..+.+..++|++++.||+|+||+||+|.+. ++ .||||++....... .....+.+|++++++++||||+++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~ 90 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS---SDIEEFLREAACMKEFDHPHVAKL 90 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C---HHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH---HHHHHHHHHHHHHHHCCCCceehh
Confidence 44568899999999999999999999999875 22 79999987653322 234568899999999999999999
Q ss_pred eeeeecC-c------eEEEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEE
Q 018656 90 IGACKEP-V------MVIVTELLSGGTLRKYLLNMRP----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 158 (352)
Q Consensus 90 ~~~~~~~-~------~~lv~e~~~~~sL~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili 158 (352)
++++... . .++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||++
T Consensus 91 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli 170 (323)
T 3qup_A 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML 170 (323)
T ss_dssp CEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE
Confidence 9998643 2 3899999999999999975431 248999999999999999999999999999999999999
Q ss_pred eCCCCceEEecCCCccccccccc---cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCC
Q 018656 159 TEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFE 234 (352)
Q Consensus 159 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~ 234 (352)
+.+ +.+||+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 171 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~ 241 (323)
T 3qup_A 171 AED-MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD--------NLYTVHSDVWAFGVTMWEIMTRGQTPYA 241 (323)
T ss_dssp CTT-SCEEECCCCC-----------------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCC-CCEEEeeccccccccccccccccccccCcccccCchhhcC--------CCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 988 7999999999975433222 223356789999999854 568899999999999999999 999999
Q ss_pred CCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 235 GMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
+................+.+..+++++.+++.+||+.||.+|||+.++++.++..+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 242 GIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 877766666665555566678899999999999999999999999999999999887643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=354.85 Aligned_cols=267 Identities=29% Similarity=0.501 Sum_probs=219.7
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEE-------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCC
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHR 84 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 84 (352)
+..+..|.+..++|.+++.||+|+||.||+|.+ .++.||+|++...... .....+.+|+.+++++ +||
T Consensus 34 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~~hp 109 (344)
T 1rjb_A 34 YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS----SEREALMSELKMMTQLGSHE 109 (344)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCT
T ss_pred cccCcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH----HHHHHHHHHHHHHHhhcCCC
Confidence 445667999999999999999999999999987 2567999999754322 2345688999999999 899
Q ss_pred Ceeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 018656 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP---------------------RCLDVCVAIGFALDIARAMECLH 142 (352)
Q Consensus 85 ~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~~L~~lH 142 (352)
||+++++++.. +..++||||+++++|.+++..... ..+++..++.++.|++.||+|||
T Consensus 110 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 189 (344)
T 1rjb_A 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 189 (344)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred CeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 99999999874 579999999999999999987542 23789999999999999999999
Q ss_pred hCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhH
Q 018656 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 219 (352)
Q Consensus 143 ~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 219 (352)
++||+||||||+||+++.+ +.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||
T Consensus 190 ~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~sl 260 (344)
T 1rjb_A 190 FKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSY 260 (344)
T ss_dssp HTTEEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHH
T ss_pred hCCcccCCCChhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--------CCCChhHhHHHH
Confidence 9999999999999999988 799999999997543322 1223456789999998854 568899999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 220 AIVLWELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 220 G~il~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
|+++|+|++ |..||.+.............. ..+.+..+++++.++|.+||..||.+|||+.+++++|+..+..
T Consensus 261 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 261 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 999999998 999998876554444443333 3344667899999999999999999999999999999887654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=355.42 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=198.2
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
...+.++|++.+.||+|+||+||+|++. |+.||||++....... ..+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID------ENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp CCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC------HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc------HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 4567889999999999999999999985 8999999997654332 247799999999999999999999875
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC-CceEEecCCCcc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL-KTIKLADFGLAR 174 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~-~~vkl~Dfg~a~ 174 (352)
+..++||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+. +.+||+|||+++
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 479999999999999999987654 99999999999999999999999999999999999998652 359999999998
Q ss_pred ccccccccccCCCcccccccccccccccccccccCC-CcccchhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHh--c
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAYAAAF--K 248 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~~~~~~--~ 248 (352)
............||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.... ........ .
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 238 (361)
T 3uc3_A 167 SSVLHSQPKSTVGTPAYIAPEVLLR--------QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK 238 (361)
T ss_dssp --------------CTTSCHHHHHC--------SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC
T ss_pred cccccCCCCCCcCCCCcCChhhhcC--------CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC
Confidence 5444444456679999999999854 333 44599999999999999999999874432 11112111 1
Q ss_pred cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 249 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
...+....+++++.++|.+||+.||.+|||+.++++|.|
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 223344578999999999999999999999999999944
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=349.17 Aligned_cols=265 Identities=27% Similarity=0.524 Sum_probs=224.3
Q ss_pred cccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018656 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86 (352)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 86 (352)
...+.|.+..++|++.+.||+|+||.||+|.+. ++.||+|++...... .....+.+|+.+++.++||||
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM----RERIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH----HHHHHHHHHHHHGGGCCCTTB
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH----HHHHHHHHHHHHHHhcCCCCE
Confidence 345579999999999999999999999999764 578999999765443 234468899999999999999
Q ss_pred eeeeeeeec-CceEEEEEcCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeE
Q 018656 87 VKFIGACKE-PVMVIVTELLSGGTLRKYLLNMR--------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157 (352)
Q Consensus 87 v~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nil 157 (352)
+++++++.+ +..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 170 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence 999999875 47899999999999999997642 134799999999999999999999999999999999999
Q ss_pred EeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCC
Q 018656 158 LTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPF 233 (352)
Q Consensus 158 i~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~ 233 (352)
++.+ +.+||+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||
T Consensus 171 i~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~ 241 (322)
T 1p4o_A 171 VAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPY 241 (322)
T ss_dssp ECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred EcCC-CeEEECcCccccccccccccccccCCCCCCCccChhhhcc--------CCCCchhhHHHHHHHHHHHHhcCCCcc
Confidence 9988 799999999987543322 2233456889999999854 567899999999999999999 89999
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 234 EGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
.+................+.+..++..+.++|.+||+.||.+|||+.+++++|+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 242 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 9877666555555555556678899999999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=351.80 Aligned_cols=267 Identities=25% Similarity=0.345 Sum_probs=212.7
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
-.....|.++..+|++++.||+|+||+||+|++.|+.||||++.... .......+|+.++++++||||++++++
T Consensus 13 ~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~ 86 (322)
T 3soc_A 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD------KQSWQNEYEVYSLPGMKHENILQFIGA 86 (322)
T ss_dssp -CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred ccCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc------hHHHHHHHHHHHHhcCCCCCchhhcce
Confidence 34566799999999999999999999999999999999999986532 122345669999999999999999999
Q ss_pred eecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCccCCCCCCCeE
Q 018656 93 CKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH----------GIIHRDLKPENLL 157 (352)
Q Consensus 93 ~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~----------~ivH~Dikp~Nil 157 (352)
+.++ .+++||||+++++|.+++.... +++..++.++.|++.||+|||+. ||+||||||+|||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nil 163 (322)
T 3soc_A 87 EKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL 163 (322)
T ss_dssp EEEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEE
T ss_pred eccCCCCCceEEEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEE
Confidence 8743 3799999999999999997643 99999999999999999999999 9999999999999
Q ss_pred EeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCC
Q 018656 158 LTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234 (352)
Q Consensus 158 i~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 234 (352)
++.+ +.+||+|||++....... ......||+.|+|||++.+... ....++.++|||||||++|+|++|+.||.
T Consensus 164 l~~~-~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~il~el~tg~~pf~ 239 (322)
T 3soc_A 164 LKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN---FQRDAFLRIDMYAMGLVLWELASRCTAAD 239 (322)
T ss_dssp ECTT-CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCC---CCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred ECCC-CeEEEccCCcccccccccCccccccCccCccccCHhhcccccc---cCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 9988 799999999997543222 2233578999999999864110 01356678999999999999999999997
Q ss_pred CCCh---------------HHHHHH-HHhccCCCCCC------CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 235 GMSN---------------LQAAYA-AAFKNVRPSAE------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 235 ~~~~---------------~~~~~~-~~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
+... ...... .......+... ..++++.++|.+||+.||.+|||+.++++.|+.+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 6422 111111 11122222211 2346699999999999999999999999999887654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=357.22 Aligned_cols=261 Identities=28% Similarity=0.513 Sum_probs=211.7
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
...++.++|.+.+.||+|+||.||+|++. +..||||++...... .....+.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE----KQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH----HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH----HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 45677889999999999999999999864 677999999765432 234568999999999999999999999
Q ss_pred eec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 93 CKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 93 ~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
+.+ +..++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg 192 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFG 192 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-CCEEECcCc
Confidence 975 47899999999999999998653 349999999999999999999999999999999999999988 799999999
Q ss_pred Cccccccccc----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 018656 172 LAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 172 ~a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 246 (352)
++........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+...........
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~ 264 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264 (373)
T ss_dssp ---------------------CTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH
T ss_pred cccccccCCccceeccCCCcCCCccChhhhcc--------CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9975433211 112235678999999854 568899999999999999997 999999877766555555
Q ss_pred hccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 247 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.....+.+..++..+.+++.+||+.||.+||++.++++.|...+..
T Consensus 265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 5545566778999999999999999999999999999999988765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=367.13 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=214.3
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
..++|.+++.||+|+||.||+|.+. |+.||||++....... ......+.+|+++++.++||||+++++++.. +..
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS--LDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH--TTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3468999999999999999999985 8999999986532111 1224568899999999999999999999875 479
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||++|++|.+++.+... +++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSS--CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT-CCEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC-CCeEEEeccchhhccc
Confidence 999999999999999976543 9999999999999999999999999999999999999988 7999999999987655
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCc
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (352)
........||+.|+|||++.+ ....+.++|||||||++|+|++|..||.+......... ........+..++
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~-i~~~~~~~p~~~s 240 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK-ICDGIFYTPQYLN 240 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH-HHTTCCCCCTTCC
T ss_pred cccccccCCCcCeEChhhccC-------CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH-HhcCCcCCCccCC
Confidence 555566789999999999864 12346899999999999999999999988665444333 3333445567789
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+++.++|.+||+.||.+|||+.++++|.+
T Consensus 241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 241 PSVISLLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence 99999999999999999999999999844
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=374.83 Aligned_cols=265 Identities=29% Similarity=0.522 Sum_probs=227.6
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
...|.|..++|++.+.||+|+||.||+|.++ +..||||++...... ...+.+|++++++++||||+++++++.
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4569999999999999999999999999997 467999999765432 235889999999999999999999998
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 95 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
++..++||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 333 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~ 411 (535)
T 2h8h_A 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLAR 411 (535)
T ss_dssp SSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCTTSTT
T ss_pred eccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-CcEEEcccccce
Confidence 8889999999999999999976544458999999999999999999999999999999999999987 799999999998
Q ss_pred ccccccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCC
Q 018656 175 EESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 175 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
....... .....++..|+|||++.. ..++.++||||||+++|+|++ |+.||.+....+...........
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 483 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 483 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ecCCCceecccCCcCcccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 6543221 223356789999998854 568899999999999999999 99999988776665555555455
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
+.+..++.++.++|.+||+.||.+|||+.++++.|+.++....+
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 66778999999999999999999999999999999887755433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=353.54 Aligned_cols=259 Identities=23% Similarity=0.485 Sum_probs=214.1
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--Cce----EEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQT----VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~----vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
.+..++|++.+.||+|+||+||+|.+. ++. |++|.+....... ....+.+|+.++++++||||+++++++
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK----ANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC----CHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH----HHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 466789999999999999999999984 554 4777665433222 234588999999999999999999999
Q ss_pred ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 94 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
..+..+++++|+.+++|.+++..... .+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 87 ~~~~~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a 164 (327)
T 3lzb_A 87 LTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLA 164 (327)
T ss_dssp ESSSEEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC-
T ss_pred ecCCceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCcce
Confidence 98889999999999999999987543 49999999999999999999999999999999999999988 79999999999
Q ss_pred ccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc
Q 018656 174 REESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 174 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 249 (352)
....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+..............
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 236 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236 (327)
T ss_dssp ---------------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred eEccCccccccccCCCccccccCHHHHcC--------CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 7543322 2223456789999999864 668899999999999999999 999999877766555555555
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
..+.+..++.++.++|.+||..||.+||++.++++.|......
T Consensus 237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 6667788999999999999999999999999999999887643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=358.23 Aligned_cols=260 Identities=22% Similarity=0.445 Sum_probs=215.4
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--Cce----EEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQT----VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~----vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
-.+..++|++.+.||+|+||+||+|.+. |+. ||+|++....... ....+.+|+.++++++||||++++++
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~ 83 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ----SFQAVTDHMLAIGSLDHAHIVRLLGL 83 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS----CBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH----HHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 3466789999999999999999999984 444 7778775433211 12236789999999999999999999
Q ss_pred eecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 93 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 93 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
+.++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~ 161 (325)
T 3kex_A 84 CPGSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGV 161 (325)
T ss_dssp ECBSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-SCEEECSCSG
T ss_pred EcCCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-CeEEECCCCc
Confidence 98888999999999999999998643 248999999999999999999999999999999999999988 7999999999
Q ss_pred cccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 018656 173 AREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 173 a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 248 (352)
+....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.............
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 233 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHF--------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT
T ss_pred ccccCcccccccccCCCCcccccChHHhcc--------CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 98643322 2234467889999999854 568899999999999999999 99999987766555555555
Q ss_pred cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 249 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
...+.+..++.++.+++.+||..||.+||++.+++++|......
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 55566777899999999999999999999999999999887653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=343.84 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=204.9
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||+||+|.+. |+.||+|++........ ....+.+|+.++++++||||+++++++.+ +..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCC---cchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 57999999999999999999985 88999999986654332 23457899999999999999999999874 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
||||+++ +|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 79 v~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCSCC
T ss_pred EEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecCCcc
Confidence 9999965 6666665533 349999999999999999999999999999999999999988 79999999999754322
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHhccCCC------
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF-EGMSNLQAAYAAAFKNVRP------ 252 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~-~~~~~~~~~~~~~~~~~~~------ 252 (352)
.......||+.|+|||++.+ ...++.++|||||||++|+|++|..|| .+.+..............+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred ccccCCccccCCcChHHHcC-------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 23345578999999999854 234789999999999999999888775 4443333333322211111
Q ss_pred ----------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 253 ----------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 253 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
....+++++.++|.+||+.||.+|||++++++| .|+....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~~~ 290 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH--PYFSDFC 290 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTTC-
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC--cccccCC
Confidence 123578999999999999999999999999998 5555443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=365.88 Aligned_cols=265 Identities=21% Similarity=0.314 Sum_probs=214.5
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
+.+..++|+++++||+|+||+||+|+++ ++.||+|++....... ......+.+|..+++.++||||+++++++.+
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK--RAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH--TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 4567789999999999999999999985 7899999986421100 0112237789999999999999999999985
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+.+++||||++||+|.+++.+.. ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~-g~vkL~DFGla~~ 224 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLK 224 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC-CCEEEcchhhhhh
Confidence 47999999999999999998743 349999999999999999999999999999999999999988 7999999999975
Q ss_pred ccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc----c
Q 018656 176 ESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK----N 249 (352)
Q Consensus 176 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~----~ 249 (352)
..... ......||+.|+|||++.... .....++.++|||||||++|+|++|+.||.+.+..+....+... .
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 301 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAME---GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHH---TSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred cccCCCcccccccCCcCeeChHHHhhcc---cCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence 43322 223457999999999985311 01256789999999999999999999999987766555444322 1
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHHHHhhhc
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNA--RPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~i~~~l~~~~~~ 292 (352)
.......+++++.++|++||..+|.+ ||+++++++| .|+..
T Consensus 302 ~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H--pff~~ 344 (437)
T 4aw2_A 302 FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH--PFFSG 344 (437)
T ss_dssp CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS--GGGTT
T ss_pred CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC--CccCC
Confidence 22223568999999999999888887 9999999999 45543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=370.04 Aligned_cols=260 Identities=29% Similarity=0.550 Sum_probs=223.6
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
..|.+..++|++.+.||+|+||.||+|.++ +..||||++...... ...+.+|+.++++++||||+++++++.
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~ 286 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME------VEEFLKEAAVMKEIKHPNLVQLLGVCT 286 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc------hHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 569999999999999999999999999986 789999999765432 235889999999999999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ +.+++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a 365 (495)
T 1opk_A 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLS 365 (495)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCE
T ss_pred cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-CcEEEeecccc
Confidence 4 479999999999999999987666669999999999999999999999999999999999999987 79999999999
Q ss_pred ccccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 018656 174 REESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 174 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
+...... ......++..|+|||++.. ..++.++||||||+++|+|++ |..||.+.+.............
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~ 437 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 437 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhc--------CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 8643322 1223346789999999854 567889999999999999999 9999998776655444444444
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
.+.+..+|+++.++|.+||+.||.+|||+.++++.|+.++.
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 55677899999999999999999999999999999887653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=339.88 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=214.5
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 99 (352)
.++|++.+.||+|+||.||+|.+. |+.||+|++....... .....+.+|++++++++||||+++++++.++ ..+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH---HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 578999999999999999999985 8899999997654433 2345688999999999999999999998754 789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC--CceEEecCCCccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLAREES 177 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~--~~vkl~Dfg~a~~~~ 177 (352)
+||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+. +.++|+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999999999987654 99999999999999999999999999999999999997651 349999999998665
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC---CCCC
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV---RPSA 254 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~ 254 (352)
.........|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+............... .+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 231 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred cCccccCCCCCcCCcCchhhcC--------CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh
Confidence 5555556789999999999854 5678899999999999999999999988766555444443322 2234
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
..+++++.++|.+||+.||.+|||+.+++++.+
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 232 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 578999999999999999999999999999843
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=353.23 Aligned_cols=263 Identities=29% Similarity=0.381 Sum_probs=206.7
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|++++.||+|+||.||+|.+. |+.||||++...............+.+|++++++++||||+++++++.+ +..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 468999999999999999999985 8999999997654333222223467899999999999999999999874 5799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL- 178 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~- 178 (352)
+||||+++ +|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-CCEEEEecccceeccCC
Confidence 99999975 8999887643 348899999999999999999999999999999999999988 7999999999986433
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC-----
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS----- 253 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----- 253 (352)
........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+...........+.
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred cccCCcccccccccCchHhhC-------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 223345678999999998854 24578899999999999999999999998776655554433221111
Q ss_pred ----------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 254 ----------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 254 ----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
...++.++.++|.+||..||.+|||+.+++++ .|+.....+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--~~f~~~~~~~ 302 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRPGPT 302 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSSSCCC
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC--hhhhcCCCCC
Confidence 14567899999999999999999999999998 5665544433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=357.54 Aligned_cols=249 Identities=20% Similarity=0.344 Sum_probs=212.1
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||+||+|.+. |+.||+|++..... .....+.+|+.+++.++||||+++++++.+ ...++
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-----hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 57999999999999999999985 88999999876542 223468899999999999999999999875 47999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC-CCceEEecCCCccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLT 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~-~~~vkl~Dfg~a~~~~~~ 179 (352)
||||++|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||++......
T Consensus 126 v~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999999997643 349999999999999999999999999999999999999743 367999999999876555
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC---CCCCC
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSAEN 256 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 256 (352)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.............. .....
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 276 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred cceeeeccCCCccCchhccC--------CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccc
Confidence 44455679999999999854 56788999999999999999999999987765555444433322 22457
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+++++.++|.+||+.||.+|||+.+++++.
T Consensus 277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 899999999999999999999999999983
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=355.73 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=207.0
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
+..++|++.+.||+|+||+||+|.++ |+.||||++...............+.+|+.+++.++||||+++++++.+ +.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34568999999999999999999985 8999999986421100000013458899999999999999999999874 57
Q ss_pred eEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC--CceEEecCCCc
Q 018656 98 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLA 173 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~--~~vkl~Dfg~a 173 (352)
.++||||++|++|.+++.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999999888654 233589999999999999999999999999999999999997652 34999999999
Q ss_pred ccccccc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 018656 174 REESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 174 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ..............
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKR--------EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcC--------CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC
Confidence 7654332 2345579999999999854 567899999999999999999999998743 22222222222221
Q ss_pred C---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 253 S---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 253 ~---~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
. ...++.++.++|.+||+.||.+|||+.++++|.|
T Consensus 252 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 252 NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 1 2578999999999999999999999999999854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=343.57 Aligned_cols=249 Identities=28% Similarity=0.397 Sum_probs=203.0
Q ss_pred CceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
++|++.+.||+|+||+||+|++. |+.||+|++........ ....+.+|++++++++||||+++++++.+ +..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG---IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC---CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccc---cchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 57999999999999999999985 89999999876543221 12357799999999999999999999875 579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-c
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~-~ 180 (352)
|||+++ +|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---
T ss_pred EEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEeECccccccCcccc
Confidence 999975 9999997643 349999999999999999999999999999999999999988 79999999998754322 2
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC--------
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-------- 252 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------- 252 (352)
......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+...........+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp ------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccccccccccccCchheeC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhh
Confidence 2334578999999998854 2457899999999999999999999999877655544433211110
Q ss_pred --------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 --------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
....+++++.++|.+||+.||.+|||+.++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 123578999999999999999999999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=344.78 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=205.2
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHH---------------------HHHHHHHHHHHHH
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE---------------------IAKKESRFAREVA 76 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~---------------------~~~~~~~~~~E~~ 76 (352)
.+.-++|++.+.||+|+||.||+|.+. |+.||||++........ .......+.+|++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 345578999999999999999999984 88999999876542211 0112356889999
Q ss_pred HHhcCCCCCeeeeeeeeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 018656 77 MLSRVQHRNLVKFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 153 (352)
Q Consensus 77 ~l~~l~hp~iv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp 153 (352)
++++++||||+++++++.+ ...++||||+++++|.+++.. ..+++..++.++.|++.||+|||++||+||||||
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 9999999999999999874 468999999999999886543 3499999999999999999999999999999999
Q ss_pred CCeEEeCCCCceEEecCCCccccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCC
Q 018656 154 ENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 232 (352)
Q Consensus 154 ~Nili~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (352)
+||+++.+ +.+||+|||++...... .......||+.|+|||++.+.. ...++.++||||||+++|+|++|+.|
T Consensus 166 ~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 166 SNLLVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR-----KIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp GGEEECTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC-----CCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred HHEEECCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCC-----CCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 99999988 79999999999764332 2334567999999999985411 11247789999999999999999999
Q ss_pred CCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 233 FEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
|.+.............. ..+....+++++.++|.+||+.||.+|||+.++++|.|
T Consensus 240 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 240 FMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred CCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 98866544333333222 22345678999999999999999999999999998843
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=345.22 Aligned_cols=263 Identities=28% Similarity=0.496 Sum_probs=216.7
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
-.+.+++++|.+.+.||+|+||.||+|.+. +..||+|++...... .....+.+|++++++++||||++++
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~ 112 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE----KQRVDFLGEAGIMGQFSHHNIIRLE 112 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH----HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH----HHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 346789999999999999999999999874 235999998765432 2344688999999999999999999
Q ss_pred eeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 91 GACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 91 ~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
+++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|
T Consensus 113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~D 190 (333)
T 1mqb_A 113 GVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSD 190 (333)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECC
T ss_pred EEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-CcEEECC
Confidence 99875 57999999999999999998643 349999999999999999999999999999999999999988 7999999
Q ss_pred CCCcccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 018656 170 FGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYA 244 (352)
Q Consensus 170 fg~a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~ 244 (352)
||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 262 (333)
T 1mqb_A 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 262 (333)
T ss_dssp CCC-----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CCcchhhccccccccccCCCCccccccCchhccc--------CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 99997543321 1122346788999999854 567889999999999999998 9999988776655555
Q ss_pred HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 245 AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
.......+.+..++..+.+++.+||+.||.+||++.++++.|+..+...
T Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 263 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 5444455667789999999999999999999999999999999887653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=364.45 Aligned_cols=254 Identities=26% Similarity=0.342 Sum_probs=204.8
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.+.+..++|++.+.||+|+||.||+|.+. |+.||||++....... ......+.+|+.+++.++||||+++++++.+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA--KDEVAHTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC---------------CCCCCSCTTSCCEEEEEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh--hHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 35566788999999999999999999985 8899999987531111 1223457789999999999999999999874
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+.+++||||++|++|.+++.+... +++..++.++.||+.||+|||+ +||+||||||+|||++.+ +.+||+|||++
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~-~~~kl~DFG~a 296 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLC 296 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS-SCEEECCCCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC-CCEEEccCCCc
Confidence 579999999999999999987654 9999999999999999999998 999999999999999988 79999999999
Q ss_pred cccc-cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 018656 174 REES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 174 ~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+........ ......
T Consensus 297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-~~~~~~ 367 (446)
T 4ejn_A 297 KEGIKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-LMEEIR 367 (446)
T ss_dssp CTTCC-----CCSSSCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCCC
T ss_pred eeccCCCcccccccCCccccCHhhcCC--------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH-HhCCCC
Confidence 7532 2333456689999999999854 66899999999999999999999999886654443333 333445
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 285 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~i~~~ 285 (352)
.+..+++++.++|.+||+.||.+|| ++.++++|
T Consensus 368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 5678999999999999999999999 99999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=351.74 Aligned_cols=265 Identities=24% Similarity=0.380 Sum_probs=211.9
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 96 (352)
.+..++|++.+.||+|+||+||+|.+. |+.||||++....... ....+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR----PVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS----CHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc----hHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 355788999999999999999999986 8999999987543222 133577999999999999999999998643
Q ss_pred --ceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEE----eCCCCceEEec
Q 018656 97 --VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL----TEDLKTIKLAD 169 (352)
Q Consensus 97 --~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili----~~~~~~vkl~D 169 (352)
..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.+ +.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~D 159 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTD 159 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSC-EEEEECC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCC-ceEEEcc
Confidence 68999999999999999987543 349999999999999999999999999999999999998 444 6799999
Q ss_pred CCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh----HHHHHHH
Q 018656 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN----LQAAYAA 245 (352)
Q Consensus 170 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~----~~~~~~~ 245 (352)
||++.............||+.|+|||++............++.++|||||||++|+|++|..||..... .......
T Consensus 160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 999987655555556689999999998864322222246788999999999999999999999975332 2222222
Q ss_pred HhccCC--------------------CC----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 246 AFKNVR--------------------PS----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 246 ~~~~~~--------------------~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
...... +. ...++..+.++|++||+.||.+|||+++++++..+-
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 222111 11 123457789999999999999999999999997654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=354.80 Aligned_cols=273 Identities=18% Similarity=0.237 Sum_probs=213.3
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHH------HHHHHHHHHHHhcCCCCCee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKK------ESRFAREVAMLSRVQHRNLV 87 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~------~~~~~~E~~~l~~l~hp~iv 87 (352)
+..++|++++.||+|+||+||+|.+. ++.||||++.........+.. .....+|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 56789999999999999999999884 478999998765432111100 11234566778889999999
Q ss_pred eeeeeeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe--C
Q 018656 88 KFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT--E 160 (352)
Q Consensus 88 ~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~--~ 160 (352)
++++++.. ...++||||+ |++|.+++.... ..+++..++.|+.|++.||+|||++||+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 99999753 3589999999 999999998753 3499999999999999999999999999999999999998 6
Q ss_pred CCCceEEecCCCccccccccc--------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCC
Q 018656 161 DLKTIKLADFGLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 232 (352)
Q Consensus 161 ~~~~vkl~Dfg~a~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (352)
+ +.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 190 ~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 190 P-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--------VAPSRRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp T-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred C-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--------CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 6 7999999999975433221 123459999999999854 5689999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcc---C-------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCCCc
Q 018656 233 FEGMSNLQAAYAAAFKN---V-------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 302 (352)
Q Consensus 233 ~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~~~~~ 302 (352)
|.+.............. . ......+|.++.+++..||..||.+||++.++++.|...+............
T Consensus 261 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d 340 (364)
T 3op5_A 261 WEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLD 340 (364)
T ss_dssp TGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCC
T ss_pred ccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccc
Confidence 98633222111111100 0 0113578999999999999999999999999999999999887777665555
Q ss_pred cc
Q 018656 303 RI 304 (352)
Q Consensus 303 ~~ 304 (352)
+.
T Consensus 341 w~ 342 (364)
T 3op5_A 341 LS 342 (364)
T ss_dssp C-
T ss_pred eE
Confidence 44
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=343.60 Aligned_cols=267 Identities=28% Similarity=0.511 Sum_probs=215.9
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
-..+.++.++|.+++.||+|+||.||+|.+. ++.||+|++....... .....+.+|+.++++++||||++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~ 102 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ---REIEEFLSEAACMKDFSHPNVIRLL 102 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH---HHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch---hHHHHHHHHHHHHhcCCCCCeeeee
Confidence 3458889999999999999999999999763 3579999997665433 2345688999999999999999999
Q ss_pred eeeecC------ceEEEEEcCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC
Q 018656 91 GACKEP------VMVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (352)
Q Consensus 91 ~~~~~~------~~~lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~ 160 (352)
+++.+. ..++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence 998643 459999999999999999542 2345999999999999999999999999999999999999998
Q ss_pred CCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 018656 161 DLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM 236 (352)
Q Consensus 161 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~ 236 (352)
+ +.+||+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.
T Consensus 183 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 183 D-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp T-SCEEECSCSCC----------------CCGGGSCHHHHHS--------SCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred C-CcEEEeecCcceecccccccCcccccCCCccccCchhhcC--------CCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 8 799999999987543322 2233457889999999854 568899999999999999999 99999887
Q ss_pred ChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 237 SNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
...............+.+..+++++.++|.+||..||.+|||+.+++++|...++.++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 254 QNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp CGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 7665555555554556677899999999999999999999999999999999887654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=339.78 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=215.4
Q ss_pred cceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 94 (352)
.-.+..++|++++.||+|+||+||+|.+ +|+.||||++....... .+.+|+.+++.+ +|+|++++++++.
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp --CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-------CHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred cCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccH-------HHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 3456678999999999999999999997 48999999987654333 367899999999 7999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCc-----eEEe
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT-----IKLA 168 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~-----vkl~ 168 (352)
+ ...++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +. ++|+
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~~~~~~kl~ 153 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP-NSKNANMIYVV 153 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCS-SSTTTTCEEEC
T ss_pred CCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccC-CCCCCCeEEEE
Confidence 5 4789999999 999999998753 349999999999999999999999999999999999999866 33 9999
Q ss_pred cCCCcccccccc--------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh--
Q 018656 169 DFGLAREESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN-- 238 (352)
Q Consensus 169 Dfg~a~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-- 238 (352)
|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 225 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 225 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcC--------CCCChHHHHHHHHHHHHHHHcCCCCcchhhccc
Confidence 999997543321 1244569999999999854 5678999999999999999999999987432
Q ss_pred -HHHHHHHHhccC-C---CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 018656 239 -LQAAYAAAFKNV-R---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300 (352)
Q Consensus 239 -~~~~~~~~~~~~-~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~~~ 300 (352)
............ . .....+|+++.+++.+||+.||.+||++.++++.|..............
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~ 292 (298)
T 1csn_A 226 NKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 292 (298)
T ss_dssp HHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSC
T ss_pred cHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCc
Confidence 221111111111 1 1235789999999999999999999999999999999998776655443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=337.60 Aligned_cols=260 Identities=30% Similarity=0.530 Sum_probs=213.7
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHH--HHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIA--KKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
.-.+..++|++.+.||+|+||+||+|.+. ++.||+|++.......... .....+.+|+.++++++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 34567889999999999999999999984 8999999987654432211 1125688999999999999999999998
Q ss_pred ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeCCCCc-----eE
Q 018656 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKT-----IK 166 (352)
Q Consensus 94 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~~~~~-----vk 166 (352)
.+.. ++||||+++++|.+++.... ..+++..++.++.|++.||+|||++| ++||||||+||+++.+ +. ++
T Consensus 93 ~~~~-~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~k 169 (287)
T 4f0f_A 93 HNPP-RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAK 169 (287)
T ss_dssp TTTT-EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEE
T ss_pred cCCC-eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEE
Confidence 7654 79999999999999987643 35999999999999999999999999 9999999999999876 44 99
Q ss_pred EecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH--HH
Q 018656 167 LADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA--YA 244 (352)
Q Consensus 167 l~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--~~ 244 (352)
|+|||++..... ......|++.|+|||++.. ....++.++||||||+++|+|++|+.||......... ..
T Consensus 170 l~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 170 VADFGLSQQSVH--SVSGLLGNFQWMAPETIGA------EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp ECCCTTCBCCSS--CEECCCCCCTTSCGGGSSC------SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred eCCCCccccccc--cccccCCCccccCchhhcc------CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 999999975433 2345679999999998843 2356788999999999999999999999876544332 22
Q ss_pred HHhc-cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 245 AAFK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 245 ~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
.... .....+..+|+++.++|.+||+.||.+|||+.++++.|..
T Consensus 242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 2222 2334467899999999999999999999999999998864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=339.85 Aligned_cols=252 Identities=25% Similarity=0.420 Sum_probs=209.2
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-c
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~ 97 (352)
+.-++|++++.||+|+||+||+|.+. ++.||+|++....... ......+.+|+.++++++||||+++++++.+. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK--AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--HTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch--hhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 34578999999999999999999986 6789999986532111 12245688999999999999999999999854 7
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP 160 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT-SCEEECSCCEESCC-
T ss_pred EEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC-CCEEEEeccccccCC
Confidence 8999999999999999987654 9999999999999999999999999999999999999988 799999999986543
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (352)
.. ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... .........+..+
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 230 (279)
T 3fdn_A 161 SS-RRTDLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-RISRVEFTFPDFV 230 (279)
T ss_dssp --------CCCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HHHHTCCCCCTTS
T ss_pred cc-cccccCCCCCccCHhHhcc--------CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH-HHHhCCCCCCCcC
Confidence 22 2244578999999999854 567889999999999999999999999866544333 3333444556779
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+.++.++|.+||+.||.+|||+.++++|.+
T Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 231 TEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 999999999999999999999999999943
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=346.24 Aligned_cols=262 Identities=29% Similarity=0.491 Sum_probs=215.6
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--Cce--EEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQT--VAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~--vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 95 (352)
++.++|++.+.||+|+||.||+|++. |.. +|+|.+...... .....+.+|+++++++ +||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch----HHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 56689999999999999999999874 554 489988753322 2344588999999999 89999999999874
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~ 160 (352)
+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 57999999999999999998653 235999999999999999999999999999999999999998
Q ss_pred CCCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChH
Q 018656 161 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNL 239 (352)
Q Consensus 161 ~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~ 239 (352)
+ +.+||+|||++.............+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....
T Consensus 178 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 178 N-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp G-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred C-CeEEEcccCcCccccccccccCCCCCccccChhhhcc--------ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 7 7999999999875443333344567889999998854 557889999999999999998 99999987765
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 240 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
..............+..+++++.++|.+||..||.+|||+.+++++|...+.....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 249 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 54444433334455678999999999999999999999999999999998876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=352.29 Aligned_cols=246 Identities=28% Similarity=0.383 Sum_probs=193.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|.+.+.||+|+||+||+|.+. ++.||||++..... ...+.+|+.++++++||||+++++++.+ ...+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 467999999999999999999995 68899999876432 2347789999999999999999999985 4789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC--CCCceEEecCCCccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAREES 177 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~--~~~~vkl~Dfg~a~~~~ 177 (352)
+||||+++++|.+++..... +++..++.++.|++.||.|||++||+||||||+||+++. +.+.+||+|||++....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999999976543 899999999999999999999999999999999999975 23789999999998655
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC----CCC
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV----RPS 253 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~----~~~ 253 (352)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+............... .+.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 274 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRG--------CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274 (349)
T ss_dssp ----------CGGGSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTT
T ss_pred cccccccccCCCCccCHHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCch
Confidence 5444456679999999999854 5688999999999999999999999987666554443333222 223
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...++.++.++|.+||+.||.+|||+.+++++
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 46789999999999999999999999999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=343.12 Aligned_cols=256 Identities=27% Similarity=0.379 Sum_probs=206.8
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||+||+|.+. |+.||+|++....... .....+.+|++++++++||||+++++++.+ +..++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP---VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 57999999999999999999985 8999999987665433 234567899999999999999999999875 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-c
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-T 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~ 179 (352)
||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++..... .
T Consensus 80 v~e~~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCcc
Confidence 9999999999998876543 9999999999999999999999999999999999999988 7999999999976432 2
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC---------
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--------- 250 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--------- 250 (352)
.......|+..|+|||++.+ ...++.++||||||+++|+|++|..||.+....+..........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVG-------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ---------GGGCCHHHHHT-------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cccCCCcCCccccChHHHhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 23345578999999998854 25678899999999999999999999998776554443322110
Q ss_pred -----------CCC----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 251 -----------RPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 251 -----------~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
.+. ...++.++.++|.+||+.||.+|||+.++++| .|+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~~~ 292 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH--PYFENIR 292 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS--GGGTTCC
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC--hHHHhcc
Confidence 000 14688899999999999999999999999998 5655543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=371.21 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=216.6
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
+..++|.+.+.||+|+||.||+|++. |+.||+|++....... ......+.+|+++++.++||||+++++++.+ ..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 67789999999999999999999984 8999999986532111 1123457899999999999999999999875 47
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+++||||++||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC-CCeEEEecccceecc
Confidence 9999999999999999987665669999999999999999999999999999999999999988 799999999998765
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccCCCCC
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVRPSA 254 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~ 254 (352)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...............+
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~--------~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p 409 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTT--------CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC
T ss_pred cCccccccCCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC
Confidence 5545556689999999999854 5678999999999999999999999987542 2333333334444456
Q ss_pred CCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
..+++++.++|.+||+.||.+|| ++.++++|.
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 78999999999999999999999 789999983
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=355.79 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=199.1
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeec---C
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE---P 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~---~ 96 (352)
.++|++.+.||+|+||+||+|.+. |+.||||++....... ....++.+|+.+++.+. ||||+++++++.. .
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS---TDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH---HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh---HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 368999999999999999999985 8999999986543333 23456789999999997 9999999999863 2
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.+++||||++ ++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSF 159 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEES
T ss_pred EEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC-CCEEecCCcccccc
Confidence 6899999996 5999999763 38999999999999999999999999999999999999998 79999999999743
Q ss_pred cc----------------------ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCC
Q 018656 177 SL----------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234 (352)
Q Consensus 177 ~~----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 234 (352)
.. ........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-------STKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-------CCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 21 112334579999999999854 2568899999999999999999999999
Q ss_pred CCChHHHHHHHHhccCCCC----------------------------------------------CCCCcHHHHHHHHHh
Q 018656 235 GMSNLQAAYAAAFKNVRPS----------------------------------------------AENVPEELSIILTSC 268 (352)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~l~~li~~~ 268 (352)
+.+..............|. ...+++++.+||.+|
T Consensus 233 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 8776665544433222211 126788999999999
Q ss_pred hccCCCCCCCHHHHHHHHHHhhhc
Q 018656 269 WKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 269 l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
|+.||.+|||+.++++| .|+..
T Consensus 313 L~~dP~~R~t~~e~l~H--p~~~~ 334 (388)
T 3oz6_A 313 LQFNPNKRISANDALKH--PFVSI 334 (388)
T ss_dssp CCSSGGGSCCHHHHTTS--TTTTT
T ss_pred hccCcccCCCHHHHhCC--HHHHH
Confidence 99999999999999998 44443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=346.24 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=196.0
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
..++|++.+.||+|+||+||+|.+. |+.||+|++....... ....+.+|++++++++||||+++++++.+ +..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG----TPSTAIREISLMKELKHENIVRLYDVIHTENKL 78 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTC----SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc----cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence 4578999999999999999999875 8999999987654322 12347789999999999999999999875 479
Q ss_pred EEEEEcCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 99 VIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
++||||++ ++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLAR 156 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCSSCE
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC-CCEEECcCccce
Confidence 99999997 59999987642 2358999999999999999999999999999999999999988 799999999997
Q ss_pred ccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC-
Q 018656 175 EESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP- 252 (352)
Q Consensus 175 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~- 252 (352)
..... .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..............+
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMG-------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred ecCCCcccCCCCcccccccCchHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 64322 23345578999999999854 2457889999999999999999999999877655444332211110
Q ss_pred --------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 253 --------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 253 --------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
....++.++.++|.+||+.||.+|||+.+++++ .|+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h--p~f~~~ 300 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH--PWFAEY 300 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGGGG
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC--hhhhcc
Confidence 123578899999999999999999999999998 555543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=347.65 Aligned_cols=269 Identities=28% Similarity=0.493 Sum_probs=223.4
Q ss_pred ccccccccceecCCceeeeccccCCCceEEEEEEEC--C-----ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-C
Q 018656 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--N-----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (352)
Q Consensus 11 ~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~-----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (352)
..+.....|.+..++|.+++.||+|+||.||+|.+. + ..||+|++....... ....+.+|+++++++ +
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~~ 108 (333)
T 2i1m_A 33 TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD----EKEALMSELKIMSHLGQ 108 (333)
T ss_dssp TSSCCCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH----HHHHHHHHHHHHHHHCC
T ss_pred ccccccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH----HHHHHHHHHHHHHhhcC
Confidence 345666789999999999999999999999999985 2 379999997655432 345688999999999 8
Q ss_pred CCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 018656 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMR------------PRCLDVCVAIGFALDIARAMECLHSHGIIHR 149 (352)
Q Consensus 83 hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~ 149 (352)
||||+++++++.+ +..++||||+++++|.+++.... ...+++..++.++.|++.||+|||++||+||
T Consensus 109 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 188 (333)
T 2i1m_A 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188 (333)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence 9999999999874 47999999999999999997642 2348999999999999999999999999999
Q ss_pred CCCCCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHH
Q 018656 150 DLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226 (352)
Q Consensus 150 Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~l 226 (352)
||||+||+++.+ +.++|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 189 Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 189 DVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp CCSGGGCEEEGG-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred CcccceEEECCC-CeEEECccccccccccccceeecCCCCCCccccCHHHhcc--------CCCChHHHHHHHHHHHHHH
Confidence 999999999988 799999999997543222 1223456789999998854 5688999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 227 LH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 227 l~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
++ |..||.+.............. ..+.+..++..+.+++.+||+.||.+|||+.+++++|......
T Consensus 260 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 260 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp TTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 98 999998866544444433333 3344667899999999999999999999999999999877643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=338.20 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=213.2
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
..++|.+++.||+|+||.||+|.+. ++.+|+|++........ .....+.+|+.+++.++||||+++++++.+ +..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP--HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCH--HHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 3578999999999999999999986 78999999876433221 334568899999999999999999999875 478
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-CCEEEEeccCceeccc
Confidence 999999999999999987654 9999999999999999999999999999999999999988 7999999999875432
Q ss_pred -ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 018656 179 -TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257 (352)
Q Consensus 179 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (352)
........|++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+.... ........+..+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-IKKNEYSIPKHI 238 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HHTTCCCCCTTS
T ss_pred CccccccccCCCCcCCcchhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhhccCCCcccc
Confidence 223344578999999999854 5578899999999999999999999988665443333 333344556788
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+..+.+++.+||+.||.+|||+.+++++.+
T Consensus 239 ~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 239 NPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 999999999999999999999999999843
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=364.01 Aligned_cols=265 Identities=27% Similarity=0.388 Sum_probs=216.3
Q ss_pred ccccccccccceecCC------ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhc
Q 018656 9 LADELKLDAKWLIDPK------HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR 80 (352)
Q Consensus 9 ~~~~~~~~~~~~i~~~------~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~ 80 (352)
+..++.....|.+... +|++++.||+|+||+||+|+++ ++.||+|++........ ....+.+|+.+++.
T Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~ 92 (494)
T 3lij_A 16 FQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS---SNSKLLEEVAVLKL 92 (494)
T ss_dssp CGGGCCCCGGGGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C---TTHHHHHHHHHHTT
T ss_pred ccceeccchhheeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHh
Confidence 3344555555555544 6999999999999999999985 78999999876532221 13458899999999
Q ss_pred CCCCCeeeeeeeeecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe
Q 018656 81 VQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (352)
Q Consensus 81 l~hp~iv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~ 159 (352)
++||||+++++++.+. ..++||||++|++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 93 l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 170 (494)
T 3lij_A 93 LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170 (494)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEe
Confidence 9999999999999854 78999999999999999987654 99999999999999999999999999999999999997
Q ss_pred CC--CCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC
Q 018656 160 ED--LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS 237 (352)
Q Consensus 160 ~~--~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 237 (352)
.. .+.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+
T Consensus 171 ~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 171 SKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR---------KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp CSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc---------ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 64 2459999999998766555556678999999999873 357889999999999999999999999877
Q ss_pred hHHHHHHHHhccCC---CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 238 NLQAAYAAAFKNVR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 238 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.............. +....+++++.++|.+||+.||.+|||+.++++|.|
T Consensus 242 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 242 DQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp HHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred HHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence 66555544443332 224678999999999999999999999999999854
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=346.22 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=214.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 99 (352)
.++|.+++.||+|+||.||++.+. ++.+|+|++........ .....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP--HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 578999999999999999999985 78999999876433221 3345688999999999999999999998854 789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL- 178 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~- 178 (352)
+||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++.....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-CCEEEeeccCceecccC
Confidence 99999999999999987544 9999999999999999999999999999999999999988 7999999999975432
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCc
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (352)
........|+..|+|||++.+ ..++.++||||||+++|+|++|+.||............ .......+..++
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~ 265 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIPKHIN 265 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HHTCCCCCTTSC
T ss_pred cccccccCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-hcCCCCCCccCC
Confidence 223344578999999999854 55788999999999999999999999886654443333 333344566889
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.++.++|.+||+.||.+|||+.+++++ .|+..
T Consensus 266 ~~~~~li~~~l~~dp~~Rps~~ell~~--~~~~~ 297 (335)
T 2owb_A 266 PVAASLIQKMLQTDPTARPTINELLND--EFFTS 297 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGS--HHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcC--ccccC
Confidence 999999999999999999999999998 44444
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=369.90 Aligned_cols=267 Identities=23% Similarity=0.496 Sum_probs=223.7
Q ss_pred ccceecCCceeeec-cccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 17 AKWLIDPKHLFVGP-RIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 17 ~~~~i~~~~y~~~~-~lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
..|.+.+.++.+.. .||+|+||.||+|.+. +..||||++....... ....+.+|++++++++||||+++++
T Consensus 328 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~E~~il~~l~hpniv~l~~ 403 (613)
T 2ozo_A 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA----DTEEMMREAQIMHQLDNPYIVRLIG 403 (613)
T ss_dssp CCSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST----THHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH----HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 45788888888887 8999999999999763 5679999997654322 2345889999999999999999999
Q ss_pred eeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 92 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 92 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
++.++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 404 ~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkL~DFG 481 (613)
T 2ozo_A 404 VCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISDFG 481 (613)
T ss_dssp EEESSSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCS
T ss_pred EeccCCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-CcEEEeecc
Confidence 999888999999999999999997643 359999999999999999999999999999999999999988 799999999
Q ss_pred Cccccccccc----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 018656 172 LAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 172 ~a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 246 (352)
+++....... .....+++.|+|||++.. ..++.++||||||+++|+|++ |+.||.+.+..+......
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 553 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 9986433221 122345689999999854 578999999999999999998 999999988776665555
Q ss_pred hccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 247 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
.....+.+..+|+++.++|.+||..||.+||++.++++.|..+........
T Consensus 554 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 554 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 555556677899999999999999999999999999999998887655544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=337.03 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=211.4
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 99 (352)
.++|++.+.||+|+||.||+|.+. +..+|+|++....... ...+.+|++++++++||||+++++++.++ ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-----VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 357999999999999999999986 6789999987643322 34588999999999999999999999854 789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEE---eCCCCceEEecCCCcccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREE 176 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili---~~~~~~vkl~Dfg~a~~~ 176 (352)
+||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||++ +.+ +.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARF 159 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCEEC
T ss_pred EEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccceec
Confidence 99999999999999987654 8999999999999999999999999999999999999 555 78999999999876
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 253 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--- 253 (352)
..........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+..................
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (277)
T 3f3z_A 160 KPGKMMRTKVGTPYYVSPQVLEG---------LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD 230 (277)
T ss_dssp CTTSCBCCCCSCTTTCCHHHHTT---------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred cCccchhccCCCCCccChHHhcc---------cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh
Confidence 55555566789999999998743 378899999999999999999999998776655554444333322
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
...+++.+.++|.+||+.||.+|||+.+++++.+
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 2378999999999999999999999999999843
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=365.42 Aligned_cols=249 Identities=26% Similarity=0.340 Sum_probs=201.1
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC---
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--- 96 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 96 (352)
..++|++.+.||+|+||+||+|.+. |+.||||++....... ....++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh---HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 3578999999999999999999985 8999999997643222 3345688999999999999999999998532
Q ss_pred ----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 97 ----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 97 ----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
..++||||+++ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~-~~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC-CCEEEEEEEe
Confidence 46999999965 67777743 28999999999999999999999999999999999999998 7999999999
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......|
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred eeecCCCcccCCCcccccccCHHHHcC--------CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 987665555566789999999999865 568899999999999999999999999977666555443322221
Q ss_pred CC--------------------CC---------------------CcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 253 SA--------------------EN---------------------VPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 253 ~~--------------------~~---------------------~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+ .. .++++.+||.+||..||.+|||++++++|.+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 10 00 1567999999999999999999999999943
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=337.03 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=203.4
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|.+.+.||+|+||+||+|.+. |+.+|+|++........ ...+.+|++++++++||||+++++++.+ ...+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP----MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh----HHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 367999999999999999999985 78999999876543221 3458899999999999999999999985 4789
Q ss_pred EEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCCccc
Q 018656 100 IVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 175 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~a~~ 175 (352)
+||||+++++|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.+ .+.++|+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999998653 23459999999999999999999999999999999999999532 26899999999986
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--CC
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PS 253 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~ 253 (352)
...........|++.|+|||++. ..++.++||||||+++|+|++|..||.+................ ..
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFK---------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE 247 (285)
T ss_dssp ----------CTTGGGCCHHHHT---------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-
T ss_pred cCCcccCcCcccccCcCChHHhc---------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc
Confidence 55555555667999999999873 35788999999999999999999999987665544444333222 22
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...+++++.++|.+||+.||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 34588999999999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=376.12 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=211.8
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 94 (352)
...+..++|.+++.||+|+||.||+|++. ++.||||++....... ......+.+|..++..+ +||+|+++++++.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ--DDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH--TTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 45567789999999999999999999985 7889999987521111 12234577899999988 7999999999998
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ +.+|+||||++|++|.+++.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~-g~ikL~DFGla 489 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMC 489 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS-SCEEECCCTTC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC-CcEEEeeccee
Confidence 5 579999999999999999987654 9999999999999999999999999999999999999998 79999999999
Q ss_pred cccc-cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 018656 174 REES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 174 ~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
+... .........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+... ........
T Consensus 490 ~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~-~i~~~~~~ 560 (674)
T 3pfq_A 490 KENIWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ-SIMEHNVA 560 (674)
T ss_dssp EECCCTTCCBCCCCSCSSSCCHHHHTC--------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHSSCCC
T ss_pred eccccCCcccccccCCCcccCHhhhcC--------CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH-HHHhCCCC
Confidence 8532 2334456689999999999854 678999999999999999999999999866554444 34444455
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNF-----TQIIQM 285 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~i~~~ 285 (352)
.+..++.++.+||++||+.||.+||++ ++|++|
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 667899999999999999999999997 888887
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=346.50 Aligned_cols=254 Identities=28% Similarity=0.389 Sum_probs=201.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|++.+.||+|+||+||+|.+. |+.||||++....... .....+.+|++++++++||||+++++++.+ ...+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE---GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc---ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 458999999999999999999885 8999999997654432 233457799999999999999999999875 4799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC----CCceEEecCCCccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED----LKTIKLADFGLARE 175 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~----~~~vkl~Dfg~a~~ 175 (352)
+||||++ ++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||++..
T Consensus 110 lv~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999997 499999987654 9999999999999999999999999999999999999533 24699999999975
Q ss_pred cccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 176 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 176 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
.... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+....+...........+..
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLG-------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp HC-----------CCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred cCCcccccCCCcCCccccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 4322 23344578999999999854 245789999999999999999999999987776665554433222211
Q ss_pred -----------------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 255 -----------------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 255 -----------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
..+++++.++|.+||+.||.+|||+.++++| .|+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~ 323 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH--PYFS 323 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGS
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC--cccC
Confidence 1167899999999999999999999999998 4443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=351.52 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=203.6
Q ss_pred eeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEE
Q 018656 27 FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTE 103 (352)
Q Consensus 27 ~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e 103 (352)
...+.||+|+||.||+|.+. |+.||+|++..... .....+.+|++++++++||||+++++++.+ +..++|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-----KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 33678999999999999984 89999999876442 234568899999999999999999999985 47899999
Q ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC-CCCceEEecCCCcccccccccc
Q 018656 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAREESLTEMM 182 (352)
Q Consensus 104 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~-~~~~vkl~Dfg~a~~~~~~~~~ 182 (352)
|+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++. +.+.+||+|||++.........
T Consensus 167 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 167 YVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp CCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred CCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 999999999987643 24899999999999999999999999999999999999942 3368999999999876555555
Q ss_pred ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---CCCCcH
Q 018656 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---AENVPE 259 (352)
Q Consensus 183 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 259 (352)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+................ ...+++
T Consensus 246 ~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNY--------DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp CCCCSSCTTCCHHHHTT--------CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred ccccCCCcEeChhhccC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 56679999999998854 5678899999999999999999999998776655555444333222 357899
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
++.++|.+||+.||.+|||+.+++++.+
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPW 345 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence 9999999999999999999999999844
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=373.02 Aligned_cols=263 Identities=25% Similarity=0.467 Sum_probs=221.3
Q ss_pred ccceecCCceeeec-cccCCCceEEEEEEE----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 17 AKWLIDPKHLFVGP-RIGEGAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 17 ~~~~i~~~~y~~~~-~lG~G~~g~Vy~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
..|.++.+.+.+.. .||+|+||+||+|.+ .++.||||++....... .....+.+|++++++++||||+++++
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~ 437 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP---ALKDELLAEANVMQQLDNPYIVRMIG 437 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG---GGHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 45788888888765 899999999999965 25789999987643322 22346889999999999999999999
Q ss_pred eeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 92 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 92 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
++.++..++||||+++++|.+++..... +++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 438 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFG 514 (635)
T 4fl3_A 438 ICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFG 514 (635)
T ss_dssp EEESSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTT
T ss_pred EEecCCEEEEEEccCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcC
Confidence 9988889999999999999999986543 9999999999999999999999999999999999999988 799999999
Q ss_pred Ccccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 018656 172 LAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 172 ~a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~ 246 (352)
+++...... ......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+...........
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 586 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred CccccccCccccccccCCCCceeeeChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 997543322 1223346788999999854 668999999999999999998 999999988776666555
Q ss_pred hccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 247 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
.....+.+..+|.++.++|..||+.||.+||++.++++.|.+++..+
T Consensus 587 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 587 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 55556667889999999999999999999999999999999887654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=363.58 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=211.7
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 99 (352)
.++|++.+.||+|+||+||+|.+. |+.||||++....... .....+.+|++++++++||||+++++++.++ ..+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 467999999999999999999985 8999999986421111 1134588999999999999999999999854 789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCCccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREES 177 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~a~~~~ 177 (352)
+||||+.|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.. .+.+||+|||++....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999999999987654 9999999999999999999999999999999999999542 2579999999998765
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC---CCC
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSA 254 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 254 (352)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.............. +.+
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRG---------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGS---------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG
T ss_pred CCCccCCCcCCCCCCCHHHhCC---------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 5555566789999999999843 4789999999999999999999999987766555544443322 234
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
..+|+++.++|.+||+.||.+|||+.++++|. |+...
T Consensus 247 ~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp--~~~~~ 283 (486)
T 3mwu_A 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHP--WIQKY 283 (486)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH--HHHHT
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH--hhccC
Confidence 57899999999999999999999999999994 44443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=355.27 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=194.4
Q ss_pred Cceeee-ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHH-hcCCCCCeeeeeeeeec----
Q 018656 24 KHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML-SRVQHRNLVKFIGACKE---- 95 (352)
Q Consensus 24 ~~y~~~-~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~l~~~~~~---- 95 (352)
++|.+. +.||+|+||+||+|.+. |+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 356665 78999999999999985 889999998632 1356788776 44589999999998753
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCC
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGL 172 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~ 172 (352)
..+++||||++|++|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||++.+ .+.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 368999999999999999987655569999999999999999999999999999999999999872 27899999999
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHhc
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ----AAYAAAFK 248 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~----~~~~~~~~ 248 (352)
+.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ........
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~ 282 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282 (400)
T ss_dssp CEECC-----------CTTCCGGGSCC--------CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCC--------CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC
Confidence 986554444556688999999999854 678899999999999999999999997654321 11111111
Q ss_pred c---CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 249 N---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 249 ~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
. ..+....++.++.++|++||..||.+|||+.++++|.|-.
T Consensus 283 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 1 1223467999999999999999999999999999996543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=346.29 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=211.3
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHH-HHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
.++|++++.||+|+||.||+|.+. |+.||+|++......... ......+.+|+.++++++||||+++++++.+ ...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 357999999999999999999985 889999999765432210 0113458899999999999999999999875 479
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC---ceEEecCCCccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLARE 175 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~---~vkl~Dfg~a~~ 175 (352)
++||||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++. .++|+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 99999999999999998644 4999999999999999999999999999999999999988722 799999999986
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 253 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 253 (352)
...........|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+..................
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 240 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred cCccccccccCCCCCccCcccccC--------CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh
Confidence 555444456679999999999854 5678899999999999999999999988766554444333222211
Q ss_pred -CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 -AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 -~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...++..+.++|.+||..||.+|||+.++++|
T Consensus 241 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 241 FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 25788999999999999999999999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=347.53 Aligned_cols=257 Identities=25% Similarity=0.324 Sum_probs=206.9
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 96 (352)
|.+ .++|++.+.||+|+||.||+|.+. |+.||||++....... ....++.+|+++++.++||||+++++++...
T Consensus 21 ~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 21 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE---LFAKRAYRELRLLKHMRHENVIGLLDVFTPD 96 (367)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH---HHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred eee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH---HHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence 444 578999999999999999999984 8999999987654433 3345688999999999999999999998643
Q ss_pred -------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 97 -------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 97 -------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
.+++||||+ +++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~D 171 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILD 171 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECC
T ss_pred CccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC-CCEEEEe
Confidence 369999999 88999999763 38999999999999999999999999999999999999998 7999999
Q ss_pred CCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 170 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
||+++.... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.........
T Consensus 172 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 242 (367)
T 1cm8_A 172 FGLARQADS--EMTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242 (367)
T ss_dssp CTTCEECCS--SCCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred eeccccccc--ccCcCcCCCCcCCHHHHhC-------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999986432 2345678999999998754 2468899999999999999999999999877655544433221
Q ss_pred CCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 250 VRP------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 250 ~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
..+ ....+++++.++|.+||..||.+|||+.++++| .|+.....
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h--p~f~~~~~ 316 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--PYFESLHD 316 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGTTTC-
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC--hHHHhhcC
Confidence 111 124678999999999999999999999999998 56655433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=341.24 Aligned_cols=245 Identities=27% Similarity=0.384 Sum_probs=206.6
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIV 101 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~lv 101 (352)
.|...+.||+|+||.||+|++. |+.||||++....... ...+.+|+.++++++||||+++++++. .+..++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR-----RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS-----HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 4777889999999999999985 8999999987654322 335789999999999999999999987 4579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-c
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~-~ 180 (352)
|||++|++|.+++.+. .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++...... .
T Consensus 121 ~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CcEEEeeeeeeeecccCcc
Confidence 9999999999998653 39999999999999999999999999999999999999988 79999999998754332 2
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--CCCCCCc
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSAENVP 258 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 258 (352)
......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+................ .....++
T Consensus 197 ~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISR--------SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS 268 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSC
T ss_pred ccccccCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCC
Confidence 2345679999999999854 56788999999999999999999999887665544433332221 1234688
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+++.++|.+||+.||.+|||+.+++++.
T Consensus 269 ~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 269 PVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 9999999999999999999999999983
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=366.35 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=215.0
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-C
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 96 (352)
.+..++|++.+.||+|+||+||+|.+. |+.||||++........ .....+.+|+.++++++||||+++++++.+ +
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK--TDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS--SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 344578999999999999999999985 89999999866433211 123458899999999999999999999985 4
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe---CCCCceEEecCCCc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLA 173 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~---~~~~~vkl~Dfg~a 173 (352)
..++||||+.|++|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++ .+ +.+||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~-~~~kl~Dfg~a 176 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKD-ANIRIIDFGLS 176 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTT-CCEEECCTTHH
T ss_pred EEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCC-CcEEEEeeeee
Confidence 79999999999999999986544 99999999999999999999999999999999999994 34 78999999999
Q ss_pred cccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--
Q 018656 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-- 251 (352)
Q Consensus 174 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-- 251 (352)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..............
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 177 THFEASKKMKDKIGTAYYIAPEVLH---------GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE 247 (484)
T ss_dssp HHBCCCCSHHHHTTGGGTCCHHHHH---------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEcccccccccCCCCccccCceeec---------CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 8665555555668999999999874 35788999999999999999999999987766655555444332
Q ss_pred -CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 252 -PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 252 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+.+..+|+++.++|.+||+.||.+|||+.++++|.|
T Consensus 248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 224578999999999999999999999999999954
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=362.43 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=211.0
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHH--------HHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE--------IAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
.++|++++.||+|+||+||+|.++ ++.||+|++........ .......+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 468999999999999999999985 78999999876432210 11224568899999999999999999999
Q ss_pred eecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC--ceEEec
Q 018656 93 CKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLAD 169 (352)
Q Consensus 93 ~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~--~vkl~D 169 (352)
+.++ ..++|||||+|++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 9854 78999999999999999987654 999999999999999999999999999999999999987632 699999
Q ss_pred CCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 170 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+............
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK---------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhc---------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 99998766555556678999999999874 357889999999999999999999999877665555444433
Q ss_pred CCCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 250 VRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 250 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.... +..+|+++.++|++||+.||.+|||+.++++|.|
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 2222 3678999999999999999999999999999944
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=335.87 Aligned_cols=264 Identities=27% Similarity=0.472 Sum_probs=216.7
Q ss_pred cceec--CCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 18 KWLID--PKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 18 ~~~i~--~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
.+.+. ..+|++.+.||+|+||+||+|.+. +..+|+|.+...... .....+.+|+.++++++||||++++
T Consensus 17 ~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~ 92 (298)
T 3f66_A 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEGIIMKDFSHPNVLSLL 92 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH----HHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred heecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH----HHHHHHHHHHHHHHhCCCCCEeeee
Confidence 34444 456888999999999999999864 235899988764443 2345688999999999999999999
Q ss_pred eeee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 91 GACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 91 ~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
+++. ++..++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+
T Consensus 93 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~ 170 (298)
T 3f66_A 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-FTVKVA 170 (298)
T ss_dssp EEECCSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEEC
T ss_pred eEEEcCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-CCEEEC
Confidence 9864 347899999999999999997643 348999999999999999999999999999999999999988 799999
Q ss_pred cCCCcccccccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 018656 169 DFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 242 (352)
Q Consensus 169 Dfg~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 242 (352)
|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||.+.......
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~ 242 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH
Confidence 999997543322 1223457789999999854 567899999999999999999 67778776665555
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 243 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
...........+..+|..+.+++.+||+.||.+|||+.++++.|...+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 243 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 55555555566778999999999999999999999999999999998876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=345.87 Aligned_cols=264 Identities=26% Similarity=0.433 Sum_probs=213.5
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEE------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l 89 (352)
...-+++.++|++.+.||+|+||.||+|++ +++.||||++..... .....+.+|++++++++||||+++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~ 89 (327)
T 3lxl_A 15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-----DQQRDFQREIQILKALHSDFIVKY 89 (327)
T ss_dssp --CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-----HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-----HHHHHHHHHHHHHHhcCCCceeEE
Confidence 334568889999999999999999999984 378999999876432 234568899999999999999999
Q ss_pred eeeee---cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceE
Q 018656 90 IGACK---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (352)
Q Consensus 90 ~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vk 166 (352)
++++. ....++||||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~k 167 (327)
T 3lxl_A 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVK 167 (327)
T ss_dssp EEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEE
T ss_pred EEEEecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEE
Confidence 99875 3468999999999999999987433 38999999999999999999999999999999999999988 7999
Q ss_pred EecCCCcccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH---
Q 018656 167 LADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL--- 239 (352)
Q Consensus 167 l~Dfg~a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--- 239 (352)
|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 239 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--------NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhcc--------CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh
Confidence 99999997543222 2233467888999999854 55788999999999999999999998653221
Q ss_pred -----------HHHH-HHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 240 -----------QAAY-AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 240 -----------~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
.... ........+.+..+++++.++|.+||+.||.+|||+.+++++|+.......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 240 MMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 1111 122223345567899999999999999999999999999999988766543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=335.34 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=203.7
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
+..++|++++.||+|+||.||+|.+. |+.||||++...... .......+.+|+.+++.++||||+++++++.+ +.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR--SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc--chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 44578999999999999999999985 899999998642111 11224468899999999999999999999875 47
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++||||+++++|.+++..... +++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT-SCEEECCCCGGGCCC
T ss_pred EEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC-CCEEEeecccccccC
Confidence 8999999999999999987654 8999999999999999999999999999999999999988 799999999998765
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (352)
.........+++.|+|||.+.+ ....+.++||||||+++|+|++|..||........ ...........+..+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (276)
T 2h6d_A 163 DGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL-FKKIRGGVFYIPEYL 234 (276)
T ss_dssp C-------------CCTGGGTT-------SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTS
T ss_pred CCcceecccCCccccCHHHHcC-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhcCcccCchhc
Confidence 5544455678999999999854 12336799999999999999999999988654433 333333444556778
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
+.++.++|.+||+.||.+|||+.+++++.
T Consensus 235 ~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 235 NRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 99999999999999999999999999984
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=344.19 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=211.1
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
+.|.+.+.||+|+||+||+|++. |+.||||++........ .....+.+|++++++++||||+++++++.+ +..++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 56999999999999999999974 89999999976544332 344568899999999999999999999874 57899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+. |+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 132 v~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB-
T ss_pred EEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEeeccCceecCCC-
Confidence 999996 58888886543 349999999999999999999999999999999999999988 79999999999764332
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-CCCCCCcH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 259 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 259 (352)
....||+.|+|||++.+. ....++.++|||||||++|+|++|..||.+.+.............. .....+++
T Consensus 208 --~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 280 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTT-----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred --CcccCCcceeCHhhhccc-----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCH
Confidence 345799999999987531 1356788999999999999999999999887766555544443332 23567899
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+.++|.+||+.||.+|||+.+++++.+
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 9999999999999999999999999854
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=359.27 Aligned_cols=257 Identities=26% Similarity=0.354 Sum_probs=200.5
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCCh---HHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETP---EEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 97 (352)
.++|.+.+.||+|+||+||+|.+. ++.||||++...... .........+.+|++++++++||||+++++++..+.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 213 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence 578999999999999999999985 789999998754211 111122334789999999999999999999998888
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCCccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 175 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~a~~ 175 (352)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.+ ...+||+|||++..
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred eEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 999999999999999887654 39999999999999999999999999999999999999754 13599999999987
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 253 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 253 (352)
...........||+.|+|||++.+. ....++.++|||||||++|+|++|..||....................
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp CC-----------CTTCCTTTTC---------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred cCCCccccccCCCCCccCceeeecC-----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 6655555667899999999998531 125678899999999999999999999987544322222222222111
Q ss_pred --CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 254 --AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 254 --~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
...+++.+.++|.+||+.||.+|||+.++++|.
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 356899999999999999999999999999983
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=342.68 Aligned_cols=263 Identities=30% Similarity=0.560 Sum_probs=219.8
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEE-------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVK 88 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~ 88 (352)
..|.+..++|++++.||+|+||+||+|.+ +++.||||++....... ....+.+|+++++++ +||||++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----EHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH----HHHHHHHHHHHHHhcccCCCeee
Confidence 45899999999999999999999999985 25789999997655432 334688999999999 7999999
Q ss_pred eeeeeecC--ceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 018656 89 FIGACKEP--VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (352)
Q Consensus 89 l~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dik 152 (352)
+++++... ..++||||+++++|.+++..... ..+++..++.++.|+++||.|||++|++|||||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dik 175 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 175 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence 99998643 58999999999999999987543 128999999999999999999999999999999
Q ss_pred CCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-
Q 018656 153 PENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 228 (352)
Q Consensus 153 p~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~- 228 (352)
|+||+++.+ +.+||+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 176 p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 176 ARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp GGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTT
T ss_pred cceEEECCC-CCEEECCCccccccccCccceeccCCCcceeecCchhhcc--------ccccchhHHHHHHHHHHHHHhC
Confidence 999999987 799999999997543221 1223457889999999854 567899999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHh-ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 229 NKLPFEGMSNLQAAYAAAF-KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
|..||.+............ ....+.+..+++++.+++.+||+.||.+|||+.+++++|...++.
T Consensus 247 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 9999988665444333333 333445667899999999999999999999999999999988765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=350.66 Aligned_cols=249 Identities=25% Similarity=0.330 Sum_probs=205.3
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec--
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-- 95 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-- 95 (352)
....++|++++.||+|+||+||+|.+. |+.||||++...... ..+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTG 73 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecC
Confidence 456789999999999999999999984 899999998754322 3479999999999999999998732
Q ss_pred -------------------------------------CceEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHH
Q 018656 96 -------------------------------------PVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIAR 136 (352)
Q Consensus 96 -------------------------------------~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi~~ 136 (352)
..+++||||++ ++|.+.+.. .....+++..++.++.||+.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 23889999997 588887764 23345999999999999999
Q ss_pred HHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccch
Q 018656 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDS 216 (352)
Q Consensus 137 ~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 216 (352)
||+|||++||+||||||+||+++...+.+||+|||++.............+|+.|+|||++.+ ...++.++||
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di 225 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG-------ATEYTPSIDL 225 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT-------CSSCCTHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC-------CCCCCcchhh
Confidence 999999999999999999999985447999999999986655555566788999999998754 2458899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC----------------------------CCCCCcHHHHHHHHHh
Q 018656 217 YSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP----------------------------SAENVPEELSIILTSC 268 (352)
Q Consensus 217 wslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~ 268 (352)
|||||++|+|++|+.||.+.+..+...........| .+..+|+++.++|.+|
T Consensus 226 wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 226 WSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 999999999999999999987766655544322211 1345789999999999
Q ss_pred hccCCCCCCCHHHHHHH
Q 018656 269 WKEDPNARPNFTQIIQM 285 (352)
Q Consensus 269 l~~~p~~Rps~~~i~~~ 285 (352)
|+.||.+|||+.++++|
T Consensus 306 L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CCSSGGGSCCHHHHHTS
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99999999999999998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=342.70 Aligned_cols=264 Identities=26% Similarity=0.457 Sum_probs=214.5
Q ss_pred ceecCCceeeeccccCCCceEEEEEEE------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
-.++.+.|++.+.||+|+||+||++.+ +|+.||||++...... .....+.+|++++++++||||++++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP----QHRSGWKQEIDILRTLYHEHIIKYKGC 101 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH----HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh----HHHHHHHHHHHHHHhCCCcchhhEEEE
Confidence 445666679999999999999998864 4789999999865442 234568899999999999999999999
Q ss_pred eec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 93 CKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 93 ~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
+.+ ..+++||||+++++|.+++.... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~-~~~kl~D 177 (318)
T 3lxp_A 102 CEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGD 177 (318)
T ss_dssp EEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECC
T ss_pred EecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC-CCEEECC
Confidence 875 36899999999999999997643 8999999999999999999999999999999999999988 7999999
Q ss_pred CCCcccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH-----
Q 018656 170 FGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ----- 240 (352)
Q Consensus 170 fg~a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~----- 240 (352)
||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~ 249 (318)
T 3lxp_A 178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE--------YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249 (318)
T ss_dssp GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC
T ss_pred ccccccccccccccccccCCCCCceeeChHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhc
Confidence 99998643322 2334467889999999864 557789999999999999999999997532210
Q ss_pred ----------HHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 018656 241 ----------AAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 298 (352)
Q Consensus 241 ----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~ 298 (352)
...........+.+..++.++.++|.+||+.||.+|||+.++++.|..+.+....+.|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 250 IAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp SCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred ccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 0111122233455778999999999999999999999999999999988876655443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=349.73 Aligned_cols=258 Identities=26% Similarity=0.362 Sum_probs=206.3
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 99 (352)
.++|++.+.||+|+||+||+|.+. ++.||+|++...............+.+|++++++++||||+++++++.+. ..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 578999999999999999999985 78999999865321111123345688999999999999999999999854 789
Q ss_pred EEEEcCCCCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 018656 100 IVTELLSGGTLRKYLLNMR--------------------------------------PRCLDVCVAIGFALDIARAMECL 141 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~--------------------------------------~~~~~~~~~~~i~~qi~~~L~~l 141 (352)
+||||++|++|.+++.... ...+++..++.++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999985211 11246788999999999999999
Q ss_pred HhCCCccCCCCCCCeEEeCCC-CceEEecCCCcccccccc-----ccccCCCcccccccccccccccccccccCCCcccc
Q 018656 142 HSHGIIHRDLKPENLLLTEDL-KTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVD 215 (352)
Q Consensus 142 H~~~ivH~Dikp~Nili~~~~-~~vkl~Dfg~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~D 215 (352)
|++||+||||||+||+++.+. ..+||+|||++....... ......||+.|+|||++.+ ....++.++|
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~D 258 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT------TNESYGPKCD 258 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC------SSSCCCTHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc------CCCCCCcHHH
Confidence 999999999999999998662 289999999997532211 2345579999999999853 2356888999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 216 SYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 216 iwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
|||||+++|+|++|+.||.+....+............. ...+++++.++|.+||+.||.+||++.+++++.
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 99999999999999999998777665555544433222 335889999999999999999999999999983
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=334.89 Aligned_cols=251 Identities=28% Similarity=0.516 Sum_probs=210.8
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec--
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-- 95 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-- 95 (352)
..+...|++.+.||+|+||+||+|.+. +..||+|++....... .....+.+|+.++++++||||+++++++..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK---SERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH---HHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 345677999999999999999999985 7889999987654433 234568899999999999999999998753
Q ss_pred ---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeCCCCceEEecC
Q 018656 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 96 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
..+++||||+++++|.+++..... +++..++.++.|++.||.|||++| ++||||||+||+++.+.+.++|+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred CCCceEEEEEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 358999999999999999987654 899999999999999999999999 9999999999999843379999999
Q ss_pred CCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 018656 171 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 171 g~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
|++...... ......|++.|+|||++. ..++.++||||||+++|+|++|+.||.................
T Consensus 177 g~~~~~~~~-~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (290)
T 1t4h_A 177 GLATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 246 (290)
T ss_dssp TGGGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred CCccccccc-ccccccCCcCcCCHHHHh---------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC
Confidence 998754332 234457999999999874 3478899999999999999999999988666655555544433
Q ss_pred CC--CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 251 RP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 251 ~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+ .+...++++.++|.+||+.||.+|||+.++++|
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 32 245677899999999999999999999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=335.40 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=212.8
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
...+..++|.+.+.||+|+||.||+|.+. ++.||+|++....... ......+.+|+.++++++||||+++++++.+
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK--EGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch--HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 44566678999999999999999999985 7889999986422111 1123468899999999999999999999875
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+..++||||+++++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-GELKIADFGWSV 162 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC-CCEEEecccccc
Confidence 578999999999999999987654 9999999999999999999999999999999999999988 799999999986
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
..... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||............ .......+
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~ 232 (284)
T 2vgo_A 163 HAPSL-RRRTMCGTLDYLPPEMIEG--------KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI-VNVDLKFP 232 (284)
T ss_dssp ECSSS-CBCCCCSCGGGCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-HTTCCCCC
T ss_pred cCccc-ccccccCCCCcCCHHHhcc--------CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH-hccccCCC
Confidence 54322 2345578999999999854 56788999999999999999999999886655443333 33334456
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
..++.++.++|.+||..||.+||++.++++|.+
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 778999999999999999999999999999844
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=341.47 Aligned_cols=267 Identities=28% Similarity=0.487 Sum_probs=219.0
Q ss_pred cccccceecCCceeeeccccCCCceEEEEEEE-------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018656 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86 (352)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 86 (352)
.....+.+..++|++++.||+|+||.||+|.+ +++.||||++....... ...++.+|+.++++++||||
T Consensus 20 s~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i 95 (327)
T 2yfx_A 20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ----DELDFLMEALIISKFNHQNI 95 (327)
T ss_dssp CGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHH----HHHHHHHHHHHHHHCCCTTB
T ss_pred chhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchh----hHHHHHHHHHHHhhCCCCCC
Confidence 34455678899999999999999999999983 36789999997544332 34468899999999999999
Q ss_pred eeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC
Q 018656 87 VKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (352)
Q Consensus 87 v~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~ 160 (352)
+++++++.+ ...++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 96 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~ 175 (327)
T 2yfx_A 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 175 (327)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred CeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEec
Confidence 999999875 478999999999999999987642 34899999999999999999999999999999999999984
Q ss_pred C--CCceEEecCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCC
Q 018656 161 D--LKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFE 234 (352)
Q Consensus 161 ~--~~~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~ 234 (352)
+ ...++|+|||++...... .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 176 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~ 247 (327)
T 2yfx_A 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFSLGYMPYP 247 (327)
T ss_dssp SSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC--------CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 3 246999999998743221 12233467889999998854 567899999999999999998 999999
Q ss_pred CCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 235 GMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
+..................+..++..+.++|.+||+.||.+||++.+++++++.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 248 SKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 8776655555554445556778999999999999999999999999999999887654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=335.94 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=198.6
Q ss_pred ceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
|.+..++|++.+.||+|+||+||+|.+ +|+.||+|++........ ....+.++...++.++||||+++++++.+
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLDISMRTVDCPFTVTFYGALFRE 78 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH---HHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence 567889999999999999999999998 589999999976544332 23345556666888999999999999874
Q ss_pred CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 96 PVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
+..++||||++ ++|.+++... ....+++..++.++.|++.||+|||++ |++||||||+||+++.+ +.++|+|||+
T Consensus 79 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~ 156 (290)
T 3fme_A 79 GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGI 156 (290)
T ss_dssp SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT-CCEEBCCC--
T ss_pred CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecCC
Confidence 47999999996 4988887642 334599999999999999999999998 99999999999999988 7999999999
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-- 250 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-- 250 (352)
+.............|++.|+|||++... .....++.++||||||+++|+|++|..||.................
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPE----LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232 (290)
T ss_dssp -------------CCCCCCSCHHHHSCC----TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC
T ss_pred cccccccccccccCCCccccChhhcChh----hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC
Confidence 9865555444555799999999996321 1235678899999999999999999999987444333333322222
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
......+++++.+++.+||+.||.+|||+.++++|.+
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 2234578999999999999999999999999999854
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=342.72 Aligned_cols=261 Identities=23% Similarity=0.391 Sum_probs=206.4
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC--CCeeeeeeeeec-
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACKE- 95 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~- 95 (352)
.+..++|++.+.||+|+||.||+|.+. ++.||||++....... .....+.+|+.++++++| |||+++++++.+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN---QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch---HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 467889999999999999999999885 7889999997665433 234568899999999976 999999999875
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
...++|||+ .+++|.+++..... +++..++.++.|++.||+|||++||+||||||+|||+++ +.+||+|||++..
T Consensus 82 ~~~~lv~e~-~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~--~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 82 QYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQ 156 (343)
T ss_dssp SEEEEEECC-CSEEHHHHHHHSCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCC
T ss_pred CEEEEEEeC-CCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--CcEEEeecccccc
Confidence 478999995 58899999987544 999999999999999999999999999999999999985 5899999999986
Q ss_pred ccccc---ccccCCCcccccccccccccccccc---cccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-
Q 018656 176 ESLTE---MMTAETGTYRWMAPELYSTVTLRQG---EKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK- 248 (352)
Q Consensus 176 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~---~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~- 248 (352)
..... ......||+.|+|||++.+...... ....++.++|||||||++|+|++|+.||...............
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 43322 2235579999999999854221110 1256888999999999999999999999875544333332222
Q ss_pred -cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 249 -NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 249 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
.....+...+.++.++|.+||+.||.+|||+.++++|.|-
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 2223456678899999999999999999999999999654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=344.43 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=202.8
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||+||+|.+. |+.||+|++....... ....+.+|++++++++||||+++++++.+ +..++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc----cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 57999999999999999999985 8899999987543211 11235579999999999999999999874 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
||||++ ++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT-CCEEECSSSEEECC----
T ss_pred Eecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC-CCEEEccCcccccccCCc
Confidence 999996 59999988754 349999999999999999999999999999999999999988 79999999998754322
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC------
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS------ 253 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------ 253 (352)
.......||+.|+|||++.+ ...++.++||||||+++|+|++|+.||.+.+..+...........+.
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp --------CGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccCcccccChhhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence 23344578999999998754 24578899999999999999999999998776655544433222111
Q ss_pred -----------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 254 -----------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 254 -----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
...+++++.++|.+||+.||.+|||+.++++| .|+....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~~~ 289 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH--PFFLSLG 289 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGGGGC
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC--hhhhhcc
Confidence 23568899999999999999999999999998 5555543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=345.59 Aligned_cols=247 Identities=24% Similarity=0.401 Sum_probs=202.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeecC-ce
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VM 98 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~ 98 (352)
.++|++.+.||+|+||+||+|.++ |+.||||++...... ..+|++++.++ +||||+++++++.++ ..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 567999999999999999999985 889999999765432 34677777777 799999999999854 78
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC---CceEEecCCCccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL---KTIKLADFGLARE 175 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~---~~vkl~Dfg~a~~ 175 (352)
++||||++|++|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||+.++. +.+||+|||++..
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999999998754 399999999999999999999999999999999999985442 2599999999985
Q ss_pred cccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC--hHHHHHH-HHhccCC
Q 018656 176 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NLQAAYA-AAFKNVR 251 (352)
Q Consensus 176 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--~~~~~~~-~~~~~~~ 251 (352)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ....... .......
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLER--------QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHH--------HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred CcCCCCceeccCCCccccCHHHhcC--------CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence 4332 23445678999999999854 457889999999999999999999998632 2222222 2222221
Q ss_pred ---CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 252 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 252 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
..+..+++++.++|++||..||.+||++.++++|.|-
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 1246789999999999999999999999999999653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=341.37 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=210.6
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
.+.+.++.++|++.+.||+|+||.||+|.+ +|+.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (317)
T 2buj_A 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-----QDREEAQREADMHRLFNHPNILRLVAYC 95 (317)
T ss_dssp EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH-----HHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH-----HHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345889999999999999999999999997 489999999865332 3345688999999999999999999998
Q ss_pred e-----cCceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceE
Q 018656 94 K-----EPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (352)
Q Consensus 94 ~-----~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vk 166 (352)
. ....++||||+++++|.+++... ....+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~-~~~k 174 (317)
T 2buj_A 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPV 174 (317)
T ss_dssp EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEE
T ss_pred EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-CCEE
Confidence 5 22689999999999999999763 23459999999999999999999999999999999999999988 7999
Q ss_pred EecCCCcccccccc----------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 018656 167 LADFGLAREESLTE----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 236 (352)
Q Consensus 167 l~Dfg~a~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 236 (352)
|+|||++....... ......|++.|+|||++.+. ....++.++||||||+++|+|++|+.||...
T Consensus 175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 249 (317)
T 2buj_A 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ-----SHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249 (317)
T ss_dssp ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC-----SEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred EEecCcchhcccccccccccccccccccccCCcccCCHhHhccC-----CCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence 99999987532211 11233579999999998541 1134688999999999999999999999541
Q ss_pred Ch--HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 237 SN--LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 237 ~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
.. .............+....++.++.++|.+||+.||.+|||+.+++++|+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 250 FQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11 0111112222334455688999999999999999999999999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=337.45 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=204.0
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~ 99 (352)
-++|++.+.||+|+||.||+|.+. ++.||+|++....... ......+.+|+.++++++||||+++++++. ++..+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD--PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC--HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 468999999999999999999985 8899999987643322 233467889999999999999999999987 45789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC-CCEEEecCccCcccccc
Confidence 99999999999999987654 9999999999999999999999999999999999999988 79999999998754332
Q ss_pred c--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC---CCC
Q 018656 180 E--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSA 254 (352)
Q Consensus 180 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 254 (352)
. ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.... ........... ..+
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 258 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSE--------SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVR 258 (309)
T ss_dssp ---------CCGGGCCGGGTCC------------CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTS
T ss_pred ccccccccCCCcCccCHHHHcC--------CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccC
Confidence 2 2234578999999999854 56788999999999999999999999875543 22222222211 235
Q ss_pred CCCcHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhhcc
Q 018656 255 ENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSAI 293 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rp-s~~~i~~~l~~~~~~~ 293 (352)
..+|.++.++|.+||..||.+|| +++++++.|...+...
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 67899999999999999999999 9999999988876554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=338.10 Aligned_cols=258 Identities=24% Similarity=0.447 Sum_probs=209.7
Q ss_pred ceecCCceeeeccccCCCceEEEEEEE------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
..+..++|++.+.||+|+||.||+|++ +|+.||+|++....... ....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN----HIADLKKEIEILRNLYHENIVKYKGI 91 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C----CHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch----hHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 456677899999999999999999984 48899999987644322 23468899999999999999999999
Q ss_pred eec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 93 CKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 93 ~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
+.+ ...++||||+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~D 169 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGD 169 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECC
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECc
Confidence 864 468999999999999999976543 39999999999999999999999999999999999999988 7999999
Q ss_pred CCCcccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCC---------
Q 018656 170 FGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM--------- 236 (352)
Q Consensus 170 fg~a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~--------- 236 (352)
||++....... ......+|..|+|||++.+ ..++.++||||||+++|+|++|..|+...
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 241 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--------SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecC--------CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccC
Confidence 99997543322 2334568888999998855 56778999999999999999999876431
Q ss_pred -----ChHHHHH-HHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 237 -----SNLQAAY-AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 237 -----~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
....... ........+.+..+++++.++|.+||+.||.+|||+.++++.|..++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp SCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111111 22223344556789999999999999999999999999999998765
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=355.48 Aligned_cols=256 Identities=25% Similarity=0.337 Sum_probs=192.3
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
.++|++++.||+|+||+||+|.+. |+.||||++....... ....++.+|++++++++||||+++++++..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL---IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSH---HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCH---HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 478999999999999999999885 8999999987644332 234568899999999999999999999842
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
..+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCB
T ss_pred CceEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC-CCEeecccccch
Confidence 3689999998 579999998654 49999999999999999999999999999999999999998 799999999997
Q ss_pred ccccc----------------------------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHH
Q 018656 175 EESLT----------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226 (352)
Q Consensus 175 ~~~~~----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~l 226 (352)
..... ......+||+.|+|||++.. ...++.++|||||||++|+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-------QENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHH
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC-------CCCCCcHhHHHHHHHHHHHH
Confidence 54321 12234578999999997643 35689999999999999999
Q ss_pred Hh-----------CCCCCCCCCh--------------------HHHHHHHHhccCC------------------------
Q 018656 227 LH-----------NKLPFEGMSN--------------------LQAAYAAAFKNVR------------------------ 251 (352)
Q Consensus 227 l~-----------g~~p~~~~~~--------------------~~~~~~~~~~~~~------------------------ 251 (352)
++ |+++|.+... .+....+......
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 98 6777766431 1111111100000
Q ss_pred ------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 252 ------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 252 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
.....+++++.+||.+||..||.+|||++++++| .|++...
T Consensus 358 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H--p~f~~~~ 404 (458)
T 3rp9_A 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH--PFFKEVR 404 (458)
T ss_dssp CCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGTTTC
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC--HhhhhcC
Confidence 0124568999999999999999999999999999 6665543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=345.98 Aligned_cols=246 Identities=27% Similarity=0.395 Sum_probs=196.6
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-----
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP----- 96 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~----- 96 (352)
++|++.+.||+|+||.||+|++. |+.||||++....... ....+.+|++++++++||||+++++++.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL----AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTT----HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 47999999999999999999985 8999999997654332 234688999999999999999999987432
Q ss_pred -----------------------------------------------------ceEEEEEcCCCCCHHHHHHhcCC-CCC
Q 018656 97 -----------------------------------------------------VMVIVTELLSGGTLRKYLLNMRP-RCL 122 (352)
Q Consensus 97 -----------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~-~~~ 122 (352)
..++||||+++++|.+++..... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 27999999999999999987543 235
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc-------------ccccCCCcc
Q 018656 123 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-------------MMTAETGTY 189 (352)
Q Consensus 123 ~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~g~~ 189 (352)
++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++....... ......||+
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 666789999999999999999999999999999999988 799999999997544321 223456999
Q ss_pred cccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHh
Q 018656 190 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSC 268 (352)
Q Consensus 190 ~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~ 268 (352)
.|+|||++.+ ..++.++||||||+++|+|++|..|+.. ........... ........++++.++|.+|
T Consensus 241 ~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 241 LYMSPEQIHG--------NNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp GGSCHHHHHC--------CCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHH
T ss_pred CccChHHhcC--------CCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccccCChhHHHHHHHH
Confidence 9999999854 5678999999999999999998776532 11111111111 1112335667889999999
Q ss_pred hccCCCCCCCHHHHHHH
Q 018656 269 WKEDPNARPNFTQIIQM 285 (352)
Q Consensus 269 l~~~p~~Rps~~~i~~~ 285 (352)
|+.||.+|||+.+++++
T Consensus 310 l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 310 LSPSPTERPEATDIIEN 326 (332)
T ss_dssp HCSSGGGSCCHHHHHHS
T ss_pred ccCCCCcCCCHHHHhhc
Confidence 99999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=344.09 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=214.7
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCC---hHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-C
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGET---PEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-P 96 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~ 96 (352)
++|.+.+.||+|+||.||+|.+. |+.||||++..... ..........+.+|+.+++++ +||||+++++++.. +
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 57999999999999999999985 89999999876542 233334456788999999999 89999999999874 5
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
..++||||++|++|.+++..... +++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEecCccccc
Confidence 79999999999999999987544 9999999999999999999999999999999999999988 79999999999866
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC---C
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---S 253 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~ 253 (352)
..........||+.|+|||++.+.. ......++.++|||||||++|+|++|..||.+................. .
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSM--DETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTT--CTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CCCcccccCCCCCCccChhhccccc--cccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 5555555678999999999885421 0112457889999999999999999999998866554444333332222 1
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...++.++.++|.+||+.||.+|||+.+++++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 35788999999999999999999999999998
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=362.82 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=212.4
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
+..++|.+.+.||+|+||.||+|+++ |+.||||++....... ......+.+|++++++++||||+++++++.+ ..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK--RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh--hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 55688999999999999999999984 8999999986532111 1223568899999999999999999999875 47
Q ss_pred eEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+++||||++|++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~-g~vkL~DFGla~~ 338 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAVE 338 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC-CCEEEeecceeee
Confidence 999999999999999998654 3459999999999999999999999999999999999999998 7999999999986
Q ss_pred cccccc-cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhccCC
Q 018656 176 ESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN---LQAAYAAAFKNVR 251 (352)
Q Consensus 176 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~---~~~~~~~~~~~~~ 251 (352)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+... .............
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~ 410 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLG--------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred ccCCCcccccccCCccccChhhhcC--------CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence 543332 334589999999999854 5688999999999999999999999987532 2333344444445
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNF-----TQIIQM 285 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~i~~~ 285 (352)
..+..++.++.++|.+||+.||.+||++ +++++|
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 5567899999999999999999999964 788887
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=335.74 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=210.3
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee---cCce
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK---EPVM 98 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~---~~~~ 98 (352)
++|++++.||+|+||.||+|.+. ++.||+|++........ ......+.+|++++++++||||+++++++. ....
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI-PNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc-chhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 67999999999999999999984 78999999865321110 123456889999999999999999999974 2478
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||++++ |.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC-CcEEeeccccccccCc
Confidence 9999999765 8888887666679999999999999999999999999999999999999988 7999999999875432
Q ss_pred ---ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 179 ---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 179 ---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
........|++.|+|||++.+ ....++.++||||||+++|+|++|..||.+....... ........+.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~i~~~~~~~~~ 234 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANG------LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF-ENIGKGSYAIPG 234 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTC------CSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHCCCCCCS
T ss_pred cccccccccCCCCCCCcChhhccC------cccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-HHHhcCCCCCCC
Confidence 222345578999999998854 1233477999999999999999999999986654433 333334445567
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
.+++.+.++|.+||..||.+|||+.+++++ .++...
T Consensus 235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--~~~~~~ 270 (305)
T 2wtk_C 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH--SWFRKK 270 (305)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS--HHHHSC
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcC--cccccC
Confidence 899999999999999999999999999998 445443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=351.76 Aligned_cols=257 Identities=27% Similarity=0.349 Sum_probs=202.1
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
.++|++.+.||+|+||+||+|.+. |+.||||++....... ....++.+|++++++++||||+++++++..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL---IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSH---HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcCh---HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 678999999999999999999985 7899999997654332 334568899999999999999999999863
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
...|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~kL~DFGla~ 177 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSVKVCDFGLAR 177 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred CCeEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCEEEccCCCcc
Confidence 35899999995 59999998654 39999999999999999999999999999999999999998 799999999998
Q ss_pred cccccc-----------------------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC--
Q 018656 175 EESLTE-----------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-- 229 (352)
Q Consensus 175 ~~~~~~-----------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g-- 229 (352)
...... .....+||+.|+|||++.. ...++.++|||||||++|+|++|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-------QENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc-------CCCCCcccccchHHHHHHHHHhccc
Confidence 543321 2355689999999998643 35689999999999999999984
Q ss_pred ---------CCCCCCCCh-----------------HHHHHHHHhccCCC-----------------------C-------
Q 018656 230 ---------KLPFEGMSN-----------------LQAAYAAAFKNVRP-----------------------S------- 253 (352)
Q Consensus 230 ---------~~p~~~~~~-----------------~~~~~~~~~~~~~~-----------------------~------- 253 (352)
.++|.+.+. .+....+......| .
T Consensus 251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (432)
T 3n9x_A 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330 (432)
T ss_dssp TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH
Confidence 444444321 11111111100000 0
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
...+++++.+||.+||+.||.+|||++++++| .|++....
T Consensus 331 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H--p~f~~~~~ 370 (432)
T 3n9x_A 331 YPSISDDGINLLESMLKFNPNKRITIDQALDH--PYLKDVRK 370 (432)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC--GGGTTTCC
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC--hhhhhccC
Confidence 14689999999999999999999999999999 66665443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=344.86 Aligned_cols=255 Identities=22% Similarity=0.346 Sum_probs=208.2
Q ss_pred Cceeee-ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-Cce
Q 018656 24 KHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 24 ~~y~~~-~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~ 98 (352)
.+|.+. +.||+|+||+||+|.+. |+.||+|++........ ....+.+|+.+++.+ .||||+++++++.+ +..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD---CRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE---CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH---HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 456666 88999999999999985 89999999876443321 233578999999999 56999999999985 478
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC---CCCceEEecCCCccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFGLARE 175 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~---~~~~vkl~Dfg~a~~ 175 (352)
++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++. + +.+||+|||++..
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~-~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPL-GDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTB-CCEEECCGGGCEE
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCC-CcEEEeeCccccc
Confidence 99999999999999987655556999999999999999999999999999999999999987 4 7899999999987
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC---C
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---P 252 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~ 252 (352)
...........|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+................ +
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNY--------DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp C---------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cCCccccccccCCcCccCCeeecC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 655555556689999999999854 56789999999999999999999999987766555444433322 2
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
....++..+.++|.+||+.||.+|||+.+++++ .|++.
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h--~~~~~ 293 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH--SWLQQ 293 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC--GGGCC
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC--Hhhcc
Confidence 345789999999999999999999999999998 45544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=332.62 Aligned_cols=270 Identities=29% Similarity=0.464 Sum_probs=219.9
Q ss_pred cccccceecCCc--eeeeccccCCCceEEEEEEEC--C---ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe
Q 018656 14 KLDAKWLIDPKH--LFVGPRIGEGAHAKVYEGKYK--N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86 (352)
Q Consensus 14 ~~~~~~~i~~~~--y~~~~~lG~G~~g~Vy~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 86 (352)
.....+++..++ |.+++.||+|+||+||+|.+. + ..+|+|++...... .....+.+|+.++++++||||
T Consensus 9 ~~~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i 84 (298)
T 3pls_A 9 AEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM----QQVEAFLREGLLMRGLNHPNV 84 (298)
T ss_dssp HHTGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH----HHHHHHHHHHHHHHTCCCTTB
T ss_pred hhhhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH----HHHHHHHHHHHHHHhCCCCCe
Confidence 334556666554 456799999999999999863 2 37999998764432 234568899999999999999
Q ss_pred eeeeeeeecC--ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCc
Q 018656 87 VKFIGACKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (352)
Q Consensus 87 v~l~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~ 164 (352)
+++++++.+. ..+++|||+.+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.
T Consensus 85 v~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~-~~ 162 (298)
T 3pls_A 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-FT 162 (298)
T ss_dssp CCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CC
T ss_pred eeEEEEEecCCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-Cc
Confidence 9999998643 4589999999999999998643 458999999999999999999999999999999999999988 79
Q ss_pred eEEecCCCcccccccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCCh
Q 018656 165 IKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSN 238 (352)
Q Consensus 165 vkl~Dfg~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~ 238 (352)
++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |.+||...+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~ 234 (298)
T 3pls_A 163 VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT--------YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234 (298)
T ss_dssp EEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred EEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc--------CCCChhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence 9999999997543221 2233467899999999854 567899999999999999999 5555666555
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 239 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
.............+.+..+++.+.+++.+||+.||.+|||+.++++.|...+..+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 235 FDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred HHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 55555555555566677899999999999999999999999999999999988765443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=336.61 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=212.0
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee---cCc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK---EPV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~---~~~ 97 (352)
.++|++.+.||+|+||.||+|.+. |+.||+|++....... .....+.+|+.++++++||||+++++++. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE---AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH---HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 468999999999999999999985 8999999998765433 23456889999999999999999999874 347
Q ss_pred eEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCCeEEeCCCCceEEecC
Q 018656 98 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHG-----IIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~-----ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~df 160 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 160 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecC
Confidence 899999999999999997642 335999999999999999999999999 9999999999999988 79999999
Q ss_pred CCcccccccc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 171 GLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 171 g~a~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
|++....... ......|+..|+|||++.+ ..++.++||||||+++|+|++|..||................
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~ 232 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHC--------C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred chheeeccccccccccCCCccccChHHhcc--------CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence 9987543322 2234468999999999854 567889999999999999999999999877655544444444
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
....+..++.++.++|.+||+.||.+||++.+++++++
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 45566789999999999999999999999999999743
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=346.10 Aligned_cols=265 Identities=28% Similarity=0.481 Sum_probs=209.9
Q ss_pred cceecCC--ceeeeccccCCCceEEEEEEEC---C--ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 18 KWLIDPK--HLFVGPRIGEGAHAKVYEGKYK---N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 18 ~~~i~~~--~y~~~~~lG~G~~g~Vy~~~~~---~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
.|.+.++ .|.+.+.||+|+||+||+|.+. + ..||+|.+....... ...++.+|+.++++++||||++++
T Consensus 81 ~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~~~ 156 (373)
T 3c1x_A 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG----EVSQFLTEGIIMKDFSHPNVLSLL 156 (373)
T ss_dssp TTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSH----HHHHHHHHHTTSTTCCCTTBCCCC
T ss_pred ccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHH----HHHHHHHHHHHHHhCCCCCcceEE
Confidence 4555544 4778999999999999999863 2 368999987544332 345688999999999999999999
Q ss_pred eeee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 91 GACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 91 ~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
+++. ++..++||||+++++|.+++.+.. ..+++..++.++.|+++||+|||++||+||||||+|||++.+ +.+||+
T Consensus 157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~ 234 (373)
T 3c1x_A 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVA 234 (373)
T ss_dssp EEECCCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEEC
T ss_pred EEEEcCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-CCEEEe
Confidence 9864 347899999999999999997643 348999999999999999999999999999999999999988 799999
Q ss_pred cCCCcccccccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 018656 169 DFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAA 242 (352)
Q Consensus 169 Dfg~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~ 242 (352)
|||+++...... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |.+||.+....+..
T Consensus 235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~ 306 (373)
T 3c1x_A 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 306 (373)
T ss_dssp CC---------------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH
T ss_pred eccccccccccccccccccCCCCCcccccChHHhcC--------CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH
Confidence 999997543221 1123356789999999854 568899999999999999999 78888876655544
Q ss_pred HHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 018656 243 YAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 296 (352)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~ 296 (352)
...........+..+|..+.+++.+||..||.+|||+.++++.|...+......
T Consensus 307 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 307 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 444444445556789999999999999999999999999999999988765543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=351.45 Aligned_cols=252 Identities=25% Similarity=0.313 Sum_probs=205.3
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
..+|.+.+.||+|+||+||+|.+. |+.||||++...... ..+|+++++.++||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---------HHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 347999999999999999999984 899999998654321 3479999999999999999998742
Q ss_pred --CceEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 96 --PVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 96 --~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
.++++||||+++ +|.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 147899999965 77776653 2334599999999999999999999999999999999999999765678999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
+++............||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+...........
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~ 275 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 275 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHcC-------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9986555544556689999999998854 246889999999999999999999999987766555444332111
Q ss_pred C----------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 252 P----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 252 ~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
+ ....+++++.+||.+||+.||.+||++.++++| .|+..+
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h--p~f~~~ 343 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH--SFFDEL 343 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGGGG
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC--Hhhccc
Confidence 1 123568999999999999999999999999998 455443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=335.82 Aligned_cols=261 Identities=29% Similarity=0.540 Sum_probs=208.2
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC---Cc--eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK---NQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~--~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
...+..++|++++.||+|+||+||+|.+. ++ .||+|++....... ......+.+|++++++++||||++++++
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ--PEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 46778899999999999999999999863 23 68999987643222 1334568899999999999999999999
Q ss_pred eecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 93 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 93 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
+.++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||+
T Consensus 90 ~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~ 167 (291)
T 1u46_A 90 VLTPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGL 167 (291)
T ss_dssp ECSSSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTT
T ss_pred EccCCceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEccccc
Confidence 98888999999999999999998753 238999999999999999999999999999999999999988 7999999999
Q ss_pred cccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 018656 173 AREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 173 a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 247 (352)
+....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.+............
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 239 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred cccccccccchhhhccCCCCceeeCchhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc
Confidence 87543322 1233457889999999854 457889999999999999999 9999998776555444433
Q ss_pred cc-CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 248 KN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 248 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
.. ..+.+..++.++.++|.+||..||.+|||+.+++++|....
T Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 32 33456789999999999999999999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=337.08 Aligned_cols=244 Identities=25% Similarity=0.345 Sum_probs=195.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhc-CCCCCeeeeeeeeec-Cce
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR-VQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~-~~~ 98 (352)
.++|++.+.||+|+||+||+|.+. |+.||||++........ ...+..+|+..+.+ .+||||+++++++.+ +..
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK---DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH---HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 368999999999999999999985 89999999876544332 22234455555444 499999999999975 579
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEECCCTTCEECC-
T ss_pred EEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEccceeeeeccc
Confidence 9999999 779999988754 349999999999999999999999999999999999999988 7999999999987655
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC--CCCC
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--SAEN 256 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 256 (352)
........||+.|+|||++.+ .++.++||||||+++|+|++|..|+.+... .........+ .+..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~ 276 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQG---------SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLRQGYLPPEFTAG 276 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT---------CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTTTCCCHHHHTT
T ss_pred CCCCcccCCCccccCHhHhcC---------CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhccCCCcccccC
Confidence 555556679999999998742 578899999999999999999776654222 1111111111 2457
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+++++.++|.+||+.||.+|||+.+++++
T Consensus 277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 277 LSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 89999999999999999999999999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=338.43 Aligned_cols=255 Identities=24% Similarity=0.473 Sum_probs=207.0
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--C-------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--N-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~-------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l 89 (352)
+.+..++|.+.+.||+|+||+||+|.+. + ..||+|++..... .....+.+|+.++++++||||+++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-----NYSESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-----GGHHHHHHHHHHHHTSCCTTBCCE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-----HHHHHHHHHHHHHHhCCCCCEeEE
Confidence 3567889999999999999999999875 3 4699999865332 223468899999999999999999
Q ss_pred eeeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCc----
Q 018656 90 IGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT---- 164 (352)
Q Consensus 90 ~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~---- 164 (352)
++++.+ +..++||||+++++|.+++.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~ 155 (289)
T 4fvq_A 78 YGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE-EDRKTG 155 (289)
T ss_dssp EEEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC-CBGGGT
T ss_pred EEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC-Cccccc
Confidence 999874 47899999999999999998753 348999999999999999999999999999999999999887 44
Q ss_pred ----eEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC-CCCCCCCChH
Q 018656 165 ----IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNL 239 (352)
Q Consensus 165 ----vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~ 239 (352)
++|+|||++...... ....++..|+|||++.+ ...++.++||||||+++|+|++| ..||......
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~ 225 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK---DILQERIPWVPPECIEN-------PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHC-------GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ccceeeeccCcccccccCc---cccCCcCcccCHHHhCC-------CCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence 999999998754332 22357889999998853 24578899999999999999995 5555554433
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 240 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.. .. ........+...+.++.+++.+||+.||.+|||+.+++++|..++..
T Consensus 226 ~~-~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 226 RK-LQ-FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HH-HH-HHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HH-HH-HhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 22 22 22233444556788999999999999999999999999999877653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=334.47 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=207.4
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHH-HHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
.++|++++.||+|+||.||+|.+. |+.||+|++......... ......+.+|+.++++++||||+++++++.+ ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999985 889999998765432110 0113458899999999999999999999875 478
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC---CceEEecCCCccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL---KTIKLADFGLARE 175 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~---~~vkl~Dfg~a~~ 175 (352)
++||||+++++|.+++.+... +++..++.++.|++.||.|||++|++||||||+||+++.+. ..++|+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 999999999999999987544 99999999999999999999999999999999999998762 2799999999986
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC--
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS-- 253 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 253 (352)
...........|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+..................
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE 233 (283)
T ss_dssp CC--------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH
T ss_pred ccCCCcccccCCCcCccCcceecC--------CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch
Confidence 555444455679999999998854 5678899999999999999999999998766544443333222211
Q ss_pred -CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 254 -AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 254 -~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
...++..+.+++.+||..||.+||++.+++++.+
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 268 (283)
T 3bhy_A 234 YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268 (283)
T ss_dssp HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence 2578899999999999999999999999999843
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=346.93 Aligned_cols=249 Identities=26% Similarity=0.323 Sum_probs=196.1
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC---
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--- 96 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--- 96 (352)
..++|++.+.||+|+||.||+|.+. |+.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSH---HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCCh---HHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 3578999999999999999999985 8899999997654333 2345688999999999999999999998632
Q ss_pred ----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 97 ----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 97 ----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
..++||||++ ++|.+++.. .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~ 173 (371)
T 2xrw_A 100 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 173 (371)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC
T ss_pred ccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEEEeec
Confidence 5799999996 488888863 28999999999999999999999999999999999999988 7999999999
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (352)
+.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..............+
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245 (371)
T ss_dssp ----------------CTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred ccccccccccCCceecCCccCHHHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 986655444456689999999999864 567899999999999999999999999877655444433221111
Q ss_pred C--------------------C---------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 253 S--------------------A---------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 253 ~--------------------~---------------------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
. . ...+.++.+||.+||+.||.+|||++++++|.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 0 0 012578999999999999999999999999944
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=333.67 Aligned_cols=266 Identities=25% Similarity=0.404 Sum_probs=203.6
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~ 97 (352)
..-.+|++.+.||+|+||.||+|.+. |+.||+|++........ .....+.+|+.++++++||||+++++++. ++.
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA--KARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 34568999999999999999999984 89999999876433222 34556889999999999999999999987 457
Q ss_pred eEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 98 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
.++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCC-----
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC-CCEEEEeccceee
Confidence 99999999999999999753 23458999999999999999999999999999999999999988 7999999999875
Q ss_pred cccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH-HH-HHHHhccCCC
Q 018656 176 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ-AA-YAAAFKNVRP 252 (352)
Q Consensus 176 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~-~~~~~~~~~~ 252 (352)
.... .......|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+..... .. .........+
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 257 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 257 (310)
T ss_dssp -------------CCSSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC
T ss_pred ecCCCccccccCCCeeEeChHHhCC--------CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC
Confidence 4332 22234568999999998854 567889999999999999999999997643222 22 2222222222
Q ss_pred C-CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 253 S-AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 253 ~-~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
. ...++.++.+++.+||..||.+|||+.++++.++.+......+.
T Consensus 258 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 2 36789999999999999999999999999999998877655554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=345.57 Aligned_cols=262 Identities=23% Similarity=0.386 Sum_probs=206.9
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC--CCCeeeeeeeeec
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGACKE 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~ 95 (352)
..+...+|++++.||+|+||+||+|.+. ++.||||++....... .....+.+|++++++++ ||||+++++++..
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN---QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccH---HHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 4556778999999999999999999885 8899999997655433 33456889999999996 5999999999874
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+.+++||| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++.
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~kl~DFG~a~ 202 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIAN 202 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--SCEEECCCSSSC
T ss_pred CCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--CeEEEEecCccc
Confidence 57899999 55889999998755 4899999999999999999999999999999999999964 689999999998
Q ss_pred cccccc---ccccCCCccccccccccccccccc---ccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 175 EESLTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 175 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~---~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
...... ......||+.|+|||++.+..... .....++.++|||||||++|+|++|..||...............
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 643322 234557999999999986421110 01246889999999999999999999999876544333322222
Q ss_pred -c-CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 249 -N-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 249 -~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
. ..+.+...+.++.++|.+||+.||.+|||+.+++++.+-
T Consensus 283 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 1 223355668899999999999999999999999999553
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=344.81 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=206.1
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHH---HHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-C
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI---AKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 96 (352)
.++|++.+.||+|+||+||+|.+. |+.||||++......... ......+.+|+.++++++||||+++++++.+ +
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 368999999999999999999884 889999999775422110 0012236689999999999999999999985 4
Q ss_pred ceEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 97 VMVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 97 ~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..++||||+.++ +|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-CcEEEeecccceE
Confidence 789999999766 99999987544 9999999999999999999999999999999999999988 7999999999986
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
...........||+.|+|||++.+ ...++.++||||||+++|+|++|..||..... ........+.
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~~~~~ 245 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMG-------NPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVEAAIHPPY 245 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTTTCCCCSS
T ss_pred CCCCCceeccCCCccccChhhhcC-------CCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHhhccCCCc
Confidence 655555556679999999999854 12347899999999999999999999976322 1122334456
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.+++++.++|.+||+.||.+|||+.+++++.
T Consensus 246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 7899999999999999999999999999983
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=340.48 Aligned_cols=238 Identities=28% Similarity=0.423 Sum_probs=179.0
Q ss_pred ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeecC-ceEEEEEcC
Q 018656 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~-~~~lv~e~~ 105 (352)
+.||+|+||+||+|.+. |+.||||++... ....+.+|+.+++.+. ||||+++++++.++ ..++||||+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 77999999999999985 899999998642 1234678999999996 99999999999854 789999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC--CceEEecCCCccccccc-ccc
Q 018656 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLAREESLT-EMM 182 (352)
Q Consensus 106 ~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~--~~vkl~Dfg~a~~~~~~-~~~ 182 (352)
+|++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.++ ..+||+|||++...... ...
T Consensus 89 ~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 89 NGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp CSCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 99999999987543 99999999999999999999999999999999999998752 27999999999754332 233
Q ss_pred ccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH------HHHHHHHhccCCCC---
Q 018656 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL------QAAYAAAFKNVRPS--- 253 (352)
Q Consensus 183 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~--- 253 (352)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.... ..............
T Consensus 167 ~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQ--------NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp -------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred cccCCCcCccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 45578999999999854 56889999999999999999999999864331 12222222222111
Q ss_pred -CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 -AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 -~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
...+++++.++|.+||..||.+|||+.+++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 13689999999999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=336.91 Aligned_cols=253 Identities=28% Similarity=0.402 Sum_probs=198.4
Q ss_pred CCceeee-ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-Cc
Q 018656 23 PKHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PV 97 (352)
Q Consensus 23 ~~~y~~~-~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~ 97 (352)
.++|++. +.||+|+||+||+|.+. |+.||||++....... ...+.+|+++++++ +||||+++++++.+ +.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI-----RSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC-----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh-----HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 4678884 78999999999999874 8999999997654322 33578999999885 79999999999874 57
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC--ceEEecCCCccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLARE 175 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~--~vkl~Dfg~a~~ 175 (352)
.++||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+.. .+||+|||++..
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999999999987654 899999999999999999999999999999999999987622 399999999875
Q ss_pred cccc--------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH--------
Q 018656 176 ESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL-------- 239 (352)
Q Consensus 176 ~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-------- 239 (352)
.... .......||+.|+|||++..... ....++.++|||||||++|+|++|+.||.+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE---EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSH---HHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccc---cccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 3221 11223469999999999853110 0134688999999999999999999999875421
Q ss_pred ------HHHHHHHhccCCCC----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 240 ------QAAYAAAFKNVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 240 ------~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.............. ...++.++.++|.+||+.||.+|||+.++++|
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11222222222222 24688999999999999999999999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=332.18 Aligned_cols=259 Identities=23% Similarity=0.349 Sum_probs=215.7
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCC----ChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeee
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGE----TPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACK 94 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~----~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~ 94 (352)
..++|++.+.||+|+||.||+|.++ |+.||||++.... ...........+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999984 7899999997654 22233344567889999999995 999999999997
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ +..++||||+++++|.+++..... +++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC-CcEEEecccch
Confidence 5 478999999999999999987644 9999999999999999999999999999999999999988 79999999999
Q ss_pred cccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--
Q 018656 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-- 251 (352)
Q Consensus 174 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-- 251 (352)
.............+++.|+|||++.+... .....++.++||||||+++|+|++|..||.+................
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred hhcCCCcccccccCCccccCHHHhccccc--cccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 86555555556679999999998753211 11345788999999999999999999999887655444443333222
Q ss_pred -CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 -PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+....++..+.++|.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 2235689999999999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=333.78 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=207.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|.+.+.||+|+||.||+|++. |+.||+|++...... ....+.+|+.++++++||||+++++++.+ +..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-----RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-----chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 467999999999999999999985 899999999764321 22457899999999999999999999875 4789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEE---eCCCCceEEecCCCcccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREE 176 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili---~~~~~~vkl~Dfg~a~~~ 176 (352)
+||||+++++|.+++..... +++..++.++.|++.||.|||++|++||||||+||++ +.+ +.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKME 159 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCC
T ss_pred EEEEcCCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC-CCEEEccCCcceec
Confidence 99999999999999987654 8999999999999999999999999999999999999 455 78999999998754
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC---CCC
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV---RPS 253 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~ 253 (352)
... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+............... .+.
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (304)
T 2jam_A 160 QNG-IMSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF 230 (304)
T ss_dssp CCB-TTHHHHSCCCBCCTTTBSS--------CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTT
T ss_pred CCC-ccccccCCCCccChHHhcc--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 332 2234468999999999854 5678999999999999999999999988766544444333322 233
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
...++.++.++|.+||..||.+|||+.+++++.+
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 4678999999999999999999999999999843
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=342.04 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=208.2
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec----
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---- 95 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---- 95 (352)
..++|++.+.||+|+||+||+|++. |+.||+|++........ ....+.+|+++++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS---SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc---chHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 3578999999999999999999984 89999999866544331 12346789999999999999999999864
Q ss_pred -----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 96 -----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 96 -----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
+..++||||+++ +|.+.+..... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Df 168 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADF 168 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCC
T ss_pred cccCCceEEEEEeccCC-CHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CCEEEccc
Confidence 258999999965 88888876433 49999999999999999999999999999999999999988 79999999
Q ss_pred CCcccccc-----ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 018656 171 GLAREESL-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 245 (352)
Q Consensus 171 g~a~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 245 (352)
|++..... ........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+..........
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 241 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcC-------CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99975432 222344578999999998854 245789999999999999999999999987766554444
Q ss_pred HhccCCCCC---CC----------------------------CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 246 AFKNVRPSA---EN----------------------------VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 246 ~~~~~~~~~---~~----------------------------~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
......+.+ .. .++++.++|.+||+.||.+|||+.++++| .|+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~~~ 319 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH--DFFWSDP 319 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGGSSS
T ss_pred HHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC--CCcCCCC
Confidence 332222111 11 26779999999999999999999999998 5555433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=343.30 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=208.6
Q ss_pred cCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
..++|.+.+.||+|+||.||+|.+. |+.||||++...... ....+.+|+.+++.++||||+++++++.+ +..+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-----GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS-----HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 4578999999999999999999985 899999998765432 23458899999999999999999999874 5789
Q ss_pred EEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGISKKGT 190 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT-CCEEECCCTTCEECS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC-CCEEEeecccccccc
Confidence 99999999999999876432 358999999999999999999999999999999999999988 799999999987532
Q ss_pred cc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH------HHHHHHhc
Q 018656 178 LT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ------AAYAAAFK 248 (352)
Q Consensus 178 ~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~------~~~~~~~~ 248 (352)
.. .......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+..... ........
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIK--------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHH--------CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred cccccccccccCCCccccCHHHhcC--------CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence 21 22233458999999999854 567899999999999999999999997643211 10111111
Q ss_pred cC-----C-----CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 249 NV-----R-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 249 ~~-----~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.. . ......+..+.+++.+||+.||.+|||+.+++++|+..++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 00 0 11233567899999999999999999999999999987753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=341.57 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=209.1
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
...+...-++|++.+.||+|+||.||+|++. |+.||+|++....... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 93 (331)
T 4aaa_A 17 ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK---MVKKIAMREIKLLKQLRHENLVNLLEVC 93 (331)
T ss_dssp --CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch---HHHHHHHHHHHHHhhCCCCCEeeEEEEe
Confidence 3346667789999999999999999999986 8899999987665443 2344578999999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
.+ +..++||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~ 170 (331)
T 4aaa_A 94 KKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGF 170 (331)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCTT
T ss_pred ecCCEEEEEEecCCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC-CcEEEEeCCC
Confidence 75 478999999999999888765443 9999999999999999999999999999999999999988 7999999999
Q ss_pred cccccc-ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 173 AREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 173 a~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
+..... ........|++.|+|||++.+ ...++.++||||||+++|+|++|+.||.+....+...........
T Consensus 171 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (331)
T 4aaa_A 171 ARTLAAPGEVYDDEVATRWYRAPELLVG-------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243 (331)
T ss_dssp C------------CCCCCTTCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred ceeecCCccccCCCcCCccccCcccccC-------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 975433 233345578999999998854 236788999999999999999999999987765544433221110
Q ss_pred --------------------CC----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 252 --------------------PS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 252 --------------------~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+. ...+++++.++|.+||+.||.+|||+.++++|.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp CCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred CChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00 2367899999999999999999999999999844
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=336.38 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=197.7
Q ss_pred ecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhc--CCCCCeeeeeeeeec---
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR--VQHRNLVKFIGACKE--- 95 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~l~~~~~~--- 95 (352)
+..++|++.+.||+|+||+||+|.++|+.||||++.... ...+.+|.+++.. ++||||+++++++.+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD--------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG--------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc--------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 346789999999999999999999999999999986532 1224455555554 899999999998642
Q ss_pred --CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCCCeEEeCCCCce
Q 018656 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--------SHGIIHRDLKPENLLLTEDLKTI 165 (352)
Q Consensus 96 --~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH--------~~~ivH~Dikp~Nili~~~~~~v 165 (352)
...++||||+++++|.+++... .+++..++.++.|++.||+||| ++||+||||||+|||++.+ +.+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~ 152 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQC 152 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT-SCE
T ss_pred CCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC-CCE
Confidence 2589999999999999999643 4999999999999999999999 9999999999999999988 799
Q ss_pred EEecCCCccccccccc-----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC----------C
Q 018656 166 KLADFGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN----------K 230 (352)
Q Consensus 166 kl~Dfg~a~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g----------~ 230 (352)
||+|||++........ .....||+.|+|||++.+... .....++.++||||||+++|+|++| .
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ--VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCC--TTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCC--CCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 9999999874332211 233479999999999865110 0001456799999999999999999 8
Q ss_pred CCCCCCCh----HHHHHHHHh-ccCCCCC------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 231 LPFEGMSN----LQAAYAAAF-KNVRPSA------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 231 ~p~~~~~~----~~~~~~~~~-~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
.||..... ......... ....+.. ..++.++.+++.+||+.||.+|||+.++++.|...
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 88865322 122222221 1122221 23567899999999999999999999999998753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=333.72 Aligned_cols=251 Identities=27% Similarity=0.437 Sum_probs=214.1
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
..+.|++.+.||+|+||.||+|.+. |+.||||++........ ...+.+|+.++++++||||+++++++.+ ...
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH----HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 3567999999999999999999885 88999999976544322 3458899999999999999999999874 578
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECBT
T ss_pred EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC-CCEEEeecccceecCc
Confidence 999999999999999965 249999999999999999999999999999999999999988 7999999999975433
Q ss_pred cc-ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 018656 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257 (352)
Q Consensus 179 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (352)
.. ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.......................+
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY 243 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSC
T ss_pred cccccCccCCCcCccCHHHHhc--------CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCcccc
Confidence 32 2344578999999999854 56788999999999999999999999887766555444444444556789
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
+..+.++|.+||..||.+|||+.+++++.+-
T Consensus 244 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence 9999999999999999999999999998653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=345.30 Aligned_cols=258 Identities=17% Similarity=0.194 Sum_probs=209.3
Q ss_pred CCceeeeccccCCCceEEEEEEEC----------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeee----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK----------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK---- 88 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~---- 88 (352)
.++|++++.||+|+||.||+|.+. ++.||+|++.... .+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~----------~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG----------RLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS----------THHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc----------hHHHHHHHHHHhcccchhhhhhh
Confidence 689999999999999999999884 6789999987542 3778999999999999987
Q ss_pred -----------eeeeee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q 018656 89 -----------FIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 155 (352)
Q Consensus 89 -----------l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~N 155 (352)
+++++. +...++||||+ +++|.+++.......+++..++.++.|++.||+|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 455554 45789999999 9999999987644459999999999999999999999999999999999
Q ss_pred eEEeCCCC--ceEEecCCCccccccccc--------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHH
Q 018656 156 LLLTEDLK--TIKLADFGLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 225 (352)
Q Consensus 156 ili~~~~~--~vkl~Dfg~a~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ 225 (352)
|+++.+ + .++|+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+
T Consensus 190 Il~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~e 260 (352)
T 2jii_A 190 IFVDPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--------CGPSRRSDLQSLGYCMLK 260 (352)
T ss_dssp EEEETT-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHH
T ss_pred EEEcCC-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--------CCCCchhhHHHHHHHHHH
Confidence 999987 6 899999999975433221 133478999999998854 568899999999999999
Q ss_pred HHhCCCCCCCCC-hHHHHHHHHh---ccCCCC------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 018656 226 LLHNKLPFEGMS-NLQAAYAAAF---KNVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295 (352)
Q Consensus 226 ll~g~~p~~~~~-~~~~~~~~~~---~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~ 295 (352)
|++|+.||.+.. .......... ...... ...++.++.++|.+||+.||.+|||+.++++.|...+.....
T Consensus 261 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 261 WLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp HHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 999999998754 2222222111 111111 135789999999999999999999999999999999887665
Q ss_pred CCCCC
Q 018656 296 PEPMI 300 (352)
Q Consensus 296 ~~~~~ 300 (352)
.....
T Consensus 341 ~~~~~ 345 (352)
T 2jii_A 341 SPYDP 345 (352)
T ss_dssp CTTSC
T ss_pred CcCcc
Confidence 54433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=331.43 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=210.6
Q ss_pred cCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee--cCc
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--EPV 97 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~ 97 (352)
..++|++++.||+|+||.||+|++ +|+.||||++....... .+.+|+.+++.++|++++..+..+. ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC-------HHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh-------HHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence 357899999999999999999997 48999999987654433 3778999999999988777766653 457
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe---CCCCceEEecCCCcc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLAR 174 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~---~~~~~vkl~Dfg~a~ 174 (352)
.++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++ .+ +.+||+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAK 156 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT-TCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCC-CeEEEeeCCCcc
Confidence 89999999 899999997543 3499999999999999999999999999999999999995 44 789999999997
Q ss_pred ccccccc--------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH---HHHH
Q 018656 175 EESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAY 243 (352)
Q Consensus 175 ~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~~ 243 (352)
....... .....|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred cccccccccccccccccccccccccCChhhhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence 5433221 234579999999999854 56889999999999999999999999864321 1111
Q ss_pred HHHhcc-CC---CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 018656 244 AAAFKN-VR---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300 (352)
Q Consensus 244 ~~~~~~-~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~~~ 300 (352)
...... .. .....+|+++.+++.+||+.||.+|||+.++++.|.........+....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~ 289 (296)
T 3uzp_A 229 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 289 (296)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCC
T ss_pred hhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccc
Confidence 111111 11 1236789999999999999999999999999999999988776654433
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=339.01 Aligned_cols=257 Identities=26% Similarity=0.355 Sum_probs=204.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChH---HHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecCc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPE---EIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 97 (352)
.++|.+.+.||+|+||.||+|.+. |+.||||++....... ........+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 357999999999999999999985 7899999987643211 11122345789999999999999999999998878
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC--CceEEecCCCccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLARE 175 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~--~~vkl~Dfg~a~~ 175 (352)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.+. ..+||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 999999999999999997644 499999999999999999999999999999999999998652 2499999999986
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC---
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP--- 252 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--- 252 (352)
...........|++.|+|||++... ....++.++||||||+++|+|++|..||...................
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHT-----TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred cccccccccccCCcCccCchhhccC-----CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence 5544444455789999999987421 13567889999999999999999999997654332222222221111
Q ss_pred -CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 253 -SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 253 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
....++.++.++|.+||..||.+||++.+++++.
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 1356889999999999999999999999999873
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=335.38 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=186.8
Q ss_pred CceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||.||+|.+ +|+.||+|++....... .....++.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK--AGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh--hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 5799999999999999999998 48999999986422111 1123568899999999999999999999875 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT-CCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEEeecceeeccCCC
Confidence 999999999999998643 349999999999999999999999999999999999999988 79999999998754322
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcH
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPE 259 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (352)
.......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||............ .......+..++.
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATR--------SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV-VLADYEMPSFLSI 237 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C-CSSCCCCCTTSCH
T ss_pred CcceeccCCCCcCCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH-hhcccCCccccCH
Confidence 22234568999999998854 56788999999999999999999999875543322221 1222234567899
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
++.++|.+||..||.+|||+.+++++
T Consensus 238 ~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 238 EAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 99999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=339.90 Aligned_cols=252 Identities=29% Similarity=0.342 Sum_probs=208.1
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
..+|++.+.||+|+||.||+|.+. ++.||||++...... .....+.+|++++++++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc----HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 578999999999999999999985 789999998754432 234568899999999999999999999853
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
...++||||++ ++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++.
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLAR 176 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred cceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC-CCEEEEeCcceE
Confidence 25899999996 5999999763 39999999999999999999999999999999999999988 799999999998
Q ss_pred ccccccc----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 018656 175 EESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 175 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
....... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+....+..........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 249 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHT-------BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcC-------CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence 5443321 234579999999998743 24578999999999999999999999988765544433322111
Q ss_pred CCC------------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 251 RPS------------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 251 ~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.+. ...+++++.++|.+||+.||.+|||+.++++| .|+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~~~~ 319 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH--PYLEQ 319 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGTT
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC--cchhh
Confidence 110 24678999999999999999999999999998 55544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=342.80 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=204.9
Q ss_pred ceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-----CCCeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-----HRNLVKFIG 91 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~l~~ 91 (352)
..+..++|++.+.||+|+||+||+|++ +|+.||||++.... .....+.+|+.+++.+. ||||+++++
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK------KYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH------HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch------hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 445578999999999999999999998 48899999986421 22345677888888886 999999999
Q ss_pred eeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC----------
Q 018656 92 ACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---------- 160 (352)
Q Consensus 92 ~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~---------- 160 (352)
++.. +..++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 9874 5799999999 899999998876666999999999999999999999999999999999999975
Q ss_pred --------------CCCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHH
Q 018656 161 --------------DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWEL 226 (352)
Q Consensus 161 --------------~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~l 226 (352)
..+.+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN--------LGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHHH
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC--------CCCCCccchHHHHHHHHHH
Confidence 137899999999975432 2345678999999999864 5688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHhccCCCC---------------------------------------------CCCCcHHH
Q 018656 227 LHNKLPFEGMSNLQAAYAAAFKNVRPS---------------------------------------------AENVPEEL 261 (352)
Q Consensus 227 l~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~l 261 (352)
++|+.||.+....+............. ....++.+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 999999988665544333222111100 00123678
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHH
Q 018656 262 SIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 262 ~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.++|.+||+.||.+|||+.++++|
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhcCChhhCCCHHHHhcC
Confidence 899999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=336.44 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=206.8
Q ss_pred ceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~ 95 (352)
+....++|++.+.||+|+||.||+|.+ +|+.||||++....... ..+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT------HHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH------HHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 445678999999999999999999999 48999999987654322 3477899999998 89999999999863
Q ss_pred -------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 96 -------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 96 -------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
...++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~kl~ 171 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLV 171 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEEC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC-CCEEEe
Confidence 468999999999999999987654569999999999999999999999999999999999999988 799999
Q ss_pred cCCCccccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 018656 169 DFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 169 Dfg~a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 247 (352)
|||++...... .......|++.|+|||++.... .....++.++||||||+++|+|++|..||.+............
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC-----------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred eCcCceecCcCccccccccCCccccChhhhcccc---ccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 99998754332 2233457899999999985311 1135678899999999999999999999988776554444333
Q ss_pred ccC-CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 248 KNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 248 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
... ......++..+.++|.+||..||.+||++.+++++.
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 249 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 322 223567899999999999999999999999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=341.45 Aligned_cols=253 Identities=21% Similarity=0.347 Sum_probs=209.4
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
..+..++|++.+.||+|+||+||+|.+. |+.||+|++...... .....+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP----AIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH----HHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 4567889999999999999999999996 899999999876432 234568899999999999999999999874
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+..++||||++|++|.+++..... +++..++.++.|++.||+|||++ ||+||||||+||+++.+ +.++|+|||++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSG 180 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC-CCEEEEECCCCc
Confidence 579999999999999999987654 99999999999999999999996 99999999999999988 799999999986
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH---------
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA--------- 245 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~--------- 245 (352)
.... .......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||............
T Consensus 181 ~~~~-~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3eqc_A 181 QLID-SMANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251 (360)
T ss_dssp HHHH-HC----CCCCTTCCHHHHTT--------CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------
T ss_pred cccc-ccccCCCCCCCeECHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCC
Confidence 5322 22344579999999999854 56889999999999999999999999875543321110
Q ss_pred --------------------------------HhccC--CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 246 --------------------------------AFKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 246 --------------------------------~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
..... ......++.++.++|.+||+.||.+|||+.++++|.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 01111 1113457899999999999999999999999999954
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=345.07 Aligned_cols=257 Identities=26% Similarity=0.330 Sum_probs=194.2
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.|.+. ++|++.+.||+|+||.||+|.+. |+.||||++....... ....++.+|+++++.++||||+++++++..
T Consensus 24 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 99 (367)
T 2fst_X 24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI---IHAKRTYRELRLLKHMKHENVIGLLDVFTP 99 (367)
T ss_dssp EEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred ccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 35554 78999999999999999999884 8999999987654332 234568899999999999999999999853
Q ss_pred -------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 96 -------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 96 -------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
...++++|++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+
T Consensus 100 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kL~ 174 (367)
T 2fst_X 100 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKIL 174 (367)
T ss_dssp CSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEEC
T ss_pred CCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC-CCEEEe
Confidence 3579999999 7899999875 239999999999999999999999999999999999999988 799999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
|||+++.... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+........
T Consensus 175 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~ 245 (367)
T 2fst_X 175 DFGLARHTAD--EMTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245 (367)
T ss_dssp C-----------------CCCTTCCHHHHTT-------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eccccccccc--cCCCcCcCcCccChHHHcC-------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999976432 2345678999999998854 256789999999999999999999999987765554433322
Q ss_pred cCCCC------------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 249 NVRPS------------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 249 ~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
...|. ....++++.+||.+||..||.+|||+.++++| .|+....
T Consensus 246 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h--p~~~~~~ 319 (367)
T 2fst_X 246 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQYH 319 (367)
T ss_dssp HCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTTTC
T ss_pred hCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC--hhhhhcc
Confidence 11110 13567899999999999999999999999998 5555443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=363.33 Aligned_cols=263 Identities=29% Similarity=0.515 Sum_probs=222.6
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
...|.+..++|++++.||+|+||.||+|.+. +..||+|++...... .....+.+|+.++++++||||++++
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~ 457 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD----SVREKFLQEALTMRQFDHPHIVKLI 457 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH----HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH----HHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3457888999999999999999999999874 356999998764432 2345688999999999999999999
Q ss_pred eeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 91 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 91 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
+++.++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 458 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~vkL~DF 535 (656)
T 2j0j_A 458 GVITENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDF 535 (656)
T ss_dssp EEECSSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCC
T ss_pred EEEecCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CCEEEEec
Confidence 9998888999999999999999998653 348999999999999999999999999999999999999988 79999999
Q ss_pred CCccccccccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 018656 171 GLAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 171 g~a~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 247 (352)
|++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+.......
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~ 607 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcC--------CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Confidence 99986433322 223456789999999854 568899999999999999997 9999998777666655555
Q ss_pred ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 248 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
....+.+..+|+.+.++|.+||..||.+|||+.++++.|...+..
T Consensus 608 ~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 608 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 555667788999999999999999999999999999999887653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=331.78 Aligned_cols=247 Identities=27% Similarity=0.429 Sum_probs=208.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
..+|++.+.||+|+||.||+|.+. |+.||+|++..... .+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG---------GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH---------HHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 457999999999999999999985 89999999876431 36689999999999999999998742
Q ss_pred ------------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC
Q 018656 96 ------------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (352)
Q Consensus 96 ------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~ 163 (352)
...++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~ 159 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-K 159 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-T
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-C
Confidence 358999999999999999987655569999999999999999999999999999999999999988 7
Q ss_pred ceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 018656 164 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 243 (352)
Q Consensus 164 ~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 243 (352)
.++|+|||++.............|++.|+|||++.+ ..++.++||||||+++|+|++|..|+... ....
T Consensus 160 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~ 228 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS--------QDYGKEVDLYALGLILAELLHVCDTAFET---SKFF 228 (284)
T ss_dssp EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC--------SCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHH
T ss_pred CEEECcchhheeccccccccccCCcccccChhhhcc--------CCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHH
Confidence 999999999886555444455679999999999854 56789999999999999999999887531 1111
Q ss_pred HHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 244 AAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.... ....+..++..+.++|.+||..||.+|||+.+++++++.+...
T Consensus 229 ~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 229 TDLR--DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHH--TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHhh--cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1111 1233467899999999999999999999999999999887654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=337.32 Aligned_cols=252 Identities=20% Similarity=0.309 Sum_probs=206.2
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeec
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~ 95 (352)
-....++|++++.||+|+||+||+|.+. |+.||||++.... ...+.+|++++++++ ||||+++++++.+
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 3445789999999999999999999884 8999999987432 234789999999997 9999999999875
Q ss_pred ---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 96 ---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
...++||||+++++|.+++.. +++..++.++.|++.||+|||++||+||||||+|||++.+...++|+|||+
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred CCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 368999999999999998854 899999999999999999999999999999999999997745899999999
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHh----
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA-AYAAAF---- 247 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~~~~~~---- 247 (352)
+.............++..|+|||++.+ ...++.++|||||||++|+|++|..||........ ......
T Consensus 178 a~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~ 250 (330)
T 3nsz_A 178 AEFYHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250 (330)
T ss_dssp CEECCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred ceEcCCCCccccccccccccChhhhcC-------CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCC
Confidence 986555555556689999999998753 25678999999999999999999999955433221 111100
Q ss_pred --------ccC------------------------CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 248 --------KNV------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 248 --------~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
... ......+++++.++|.+||+.||.+|||++++++| .|+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h--p~f~~ 325 (330)
T 3nsz_A 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH--PYFYT 325 (330)
T ss_dssp HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC--ccHhh
Confidence 000 00112378999999999999999999999999998 45443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=349.42 Aligned_cols=245 Identities=24% Similarity=0.301 Sum_probs=201.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC------CCCCeeeeeeeee
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV------QHRNLVKFIGACK 94 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~l~~~~~ 94 (352)
..+|++.+.||+|+||+||+|.+. ++.||||++.... .....+.+|+++++.+ +|+||+++++++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK------RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc------chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 457999999999999999999985 7899999987532 1223455666666655 6789999999987
Q ss_pred -cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCc--eEEecCC
Q 018656 95 -EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT--IKLADFG 171 (352)
Q Consensus 95 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~--vkl~Dfg 171 (352)
....++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ +. +||+|||
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~-~~~~vkL~DFG 247 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFG 247 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST-TSCCEEECCCT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC-CCcceEEeecc
Confidence 457999999995 699999988766669999999999999999999999999999999999999987 45 9999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...........
T Consensus 248 ~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~ 317 (429)
T 3kvw_A 248 SSCYEHQ--RVYTYIQSRFYRAPEVILG--------ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317 (429)
T ss_dssp TCEETTC--CCCSSCSCGGGCCHHHHHT--------BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cceecCC--cccccCCCCCccChHHHhC--------CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9875432 2345679999999999865 56899999999999999999999999987765554433322111
Q ss_pred CC----------------------------------------------------------CCCCcHHHHHHHHHhhccCC
Q 018656 252 PS----------------------------------------------------------AENVPEELSIILTSCWKEDP 273 (352)
Q Consensus 252 ~~----------------------------------------------------------~~~~~~~l~~li~~~l~~~p 273 (352)
+. ....++++.+||.+||+.||
T Consensus 318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP 397 (429)
T 3kvw_A 318 PSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP 397 (429)
T ss_dssp CCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSST
T ss_pred CCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCCh
Confidence 10 11237889999999999999
Q ss_pred CCCCCHHHHHHH
Q 018656 274 NARPNFTQIIQM 285 (352)
Q Consensus 274 ~~Rps~~~i~~~ 285 (352)
.+|||+.++++|
T Consensus 398 ~~Rpta~e~L~H 409 (429)
T 3kvw_A 398 AVRMTPGQALRH 409 (429)
T ss_dssp TTSCCHHHHHTS
T ss_pred hhCCCHHHHhCC
Confidence 999999999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=331.67 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=206.1
Q ss_pred cCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee--cCc
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--EPV 97 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~ 97 (352)
..++|++.+.||+|+||+||+|.+ +++.||||++....... .+.+|+.+++.++|++++..+..+. ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC-------CHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch-------HHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 357899999999999999999997 48999999876543322 3778999999999888887777653 457
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEE---eCCCCceEEecCCCcc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAR 174 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili---~~~~~~vkl~Dfg~a~ 174 (352)
.++||||+ +++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||++ +.+ +.+||+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAK 156 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT-TCEEECCCTTCE
T ss_pred eEEEEEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC-CeEEEecCccce
Confidence 89999999 9999999986433 49999999999999999999999999999999999999 555 789999999997
Q ss_pred cccccc--------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH---HHHH
Q 018656 175 EESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAY 243 (352)
Q Consensus 175 ~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~~ 243 (352)
...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcC--------CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence 543322 1234578999999999864 56789999999999999999999999864321 1111
Q ss_pred HHHhc-cCCC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 018656 244 AAAFK-NVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 300 (352)
Q Consensus 244 ~~~~~-~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~~~ 300 (352)
..... ...+ ....+|+++.+++.+||+.||.+|||+.++++.+...+..........
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~ 289 (296)
T 4hgt_A 229 RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 289 (296)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCC
T ss_pred hhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCc
Confidence 11111 1111 135789999999999999999999999999999999998776555433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=335.88 Aligned_cols=268 Identities=25% Similarity=0.460 Sum_probs=212.3
Q ss_pred cccccccccceecCCceeeeccccCCCceEEEEEEE------CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC
Q 018656 10 ADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH 83 (352)
Q Consensus 10 ~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 83 (352)
+..+...+...+..++|++.+.||+|+||.||+|++ +|+.||+|++..... .....+.+|++++++++|
T Consensus 27 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h 101 (326)
T 2w1i_A 27 GSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-----EHLRDFEREIEILKSLQH 101 (326)
T ss_dssp ----------CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-----HHHHHHHHHHHHHHTCCC
T ss_pred HHHhcccCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCC
Confidence 344445555677889999999999999999999984 478999999876433 234568899999999999
Q ss_pred CCeeeeeeeeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC
Q 018656 84 RNLVKFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (352)
Q Consensus 84 p~iv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~ 160 (352)
|||+++++++.. ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus 102 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~ 180 (326)
T 2w1i_A 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN 180 (326)
T ss_dssp TTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE
T ss_pred CCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcC
Confidence 999999998753 26899999999999999998754 34999999999999999999999999999999999999998
Q ss_pred CCCceEEecCCCccccccccc----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 018656 161 DLKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGM 236 (352)
Q Consensus 161 ~~~~vkl~Dfg~a~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 236 (352)
+ +.++|+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 181 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 181 E-NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp T-TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred C-CcEEEecCcchhhccccccccccccCCCCceeEECchhhcC--------CCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 8 7999999999975433221 223457788999999854 45788999999999999999999988642
Q ss_pred ChH-----------H----HHHHH-HhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 237 SNL-----------Q----AAYAA-AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 237 ~~~-----------~----~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
... . ..... ......+.+..+|.++.++|.+||+.||.+|||+.++++.|......
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 252 PAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 110 0 01111 11223455678999999999999999999999999999999887654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=331.52 Aligned_cols=258 Identities=26% Similarity=0.355 Sum_probs=204.1
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
+..+.......++|.+.+.||+|+||.||+|.+. |+.||+|++...... ..+.+|+.++++++||||++++
T Consensus 18 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~ 90 (314)
T 3com_A 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-------QEIIKEISIMQQCDSPHVVKYY 90 (314)
T ss_dssp ------------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC-------HHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCchhhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH-------HHHHHHHHHHHhCCCCCCccEE
Confidence 3334444556789999999999999999999986 899999999765432 2478899999999999999999
Q ss_pred eeee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 91 GACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 91 ~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
+++. ++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~d 168 (314)
T 3com_A 91 GSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLAD 168 (314)
T ss_dssp EEEEETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECC
T ss_pred EEEEeCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC-CCEEEee
Confidence 9987 457899999999999999997543 349999999999999999999999999999999999999988 7999999
Q ss_pred CCCccccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 170 FGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 170 fg~a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
||++...... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||...............
T Consensus 169 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 240 (314)
T 3com_A 169 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--------IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN 240 (314)
T ss_dssp CTTCEECBTTBSCBCCCCSCGGGCCHHHHSS--------SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred cccchhhhhhccccCccCCCCCccChhhcCC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence 9998754332 22334578999999999854 56788999999999999999999999887665544433322
Q ss_pred cC--CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 249 NV--RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 249 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.. ...+..++..+.++|.+||..||.+|||+.+++++.+
T Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 241 PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 21 1224567899999999999999999999999999843
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=341.06 Aligned_cols=257 Identities=17% Similarity=0.235 Sum_probs=199.2
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHH------HHHHHHHHHHHHhcCCCCCeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAK------KESRFAREVAMLSRVQHRNLVKF 89 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~l 89 (352)
+..++|++++.||+|+||+||+|.+. +..+|+|+..........+. ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 45789999999999999999999984 57899999887654321111 11235678899999999999999
Q ss_pred eeeeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC-
Q 018656 90 IGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK- 163 (352)
Q Consensus 90 ~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~- 163 (352)
++++.. ...++||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-ST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CC
Confidence 999764 3789999999 999999998765 49999999999999999999999999999999999999876 4
Q ss_pred -ceEEecCCCcccccccc--------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCC
Q 018656 164 -TIKLADFGLAREESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234 (352)
Q Consensus 164 -~vkl~Dfg~a~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 234 (352)
.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--------VALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 89999999997543221 1244579999999999854 568999999999999999999999996
Q ss_pred CCChHHH-HHHHHh--ccCCC-------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 235 GMSNLQA-AYAAAF--KNVRP-------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 235 ~~~~~~~-~~~~~~--~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
+...... ...... ....+ ....+|+++.++|..||+.||.+||++.++++.|+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 262 QNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp GGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred ccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 5322111 111111 11111 1227899999999999999999999999999998654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=350.56 Aligned_cols=267 Identities=25% Similarity=0.388 Sum_probs=212.2
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC--
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-- 96 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-- 96 (352)
+..++|++.+.||+|+||+||+|++. |+.||||++....... ....+.+|++++++++||||+++++++.+.
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR----PVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS----CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc----hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 45678999999999999999999986 8999999987533222 134577899999999999999999998743
Q ss_pred -ceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEE----eCCCCceEEecC
Q 018656 97 -VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL----TEDLKTIKLADF 170 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili----~~~~~~vkl~Df 170 (352)
..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.+ +.+||+||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~DF 160 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDF 160 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSC-EEEEECCG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCc-eeEEEecC
Confidence 67999999999999999976532 349999999999999999999999999999999999998 444 67999999
Q ss_pred CCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHH
Q 018656 171 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS----NLQAAYAAA 246 (352)
Q Consensus 171 g~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~----~~~~~~~~~ 246 (352)
|++.............||+.|+|||++............++.++|||||||++|+|++|+.||.... .........
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 9998765555555678999999999875422111112457889999999999999999999996432 222333322
Q ss_pred hccCC--------------------CC----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 247 FKNVR--------------------PS----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 247 ~~~~~--------------------~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
..... +. ...++..+.++|++||+.||.+||++.++++.+...+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 22111 11 123557788999999999999999999999999887764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=329.83 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=205.5
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++.+.||+|+||.||+|.+. |+.||+|++....... ....+.+|+.+++.++||||+++++++.+ +..++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh----hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 57999999999999999999985 8999999987544322 23458899999999999999999999875 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
||||+++++|.+++.... .+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETT
T ss_pred EEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC-CCEEEeeCCCccccCCCc
Confidence 999999999999987543 39999999999999999999999999999999999999988 79999999998754322
Q ss_pred --cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--cCCCCCC
Q 018656 180 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK--NVRPSAE 255 (352)
Q Consensus 180 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~ 255 (352)
.......|++.|+|||++.+ ...++.++||||||+++|+|++|..||.+............. ...+...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTC-------SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGG
T ss_pred chhcccCCccccCccChHHHhc-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchh
Confidence 22345578999999999854 123477899999999999999999999876543322222222 1223345
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.++..+.++|.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 789999999999999999999999999887
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=355.31 Aligned_cols=258 Identities=16% Similarity=0.268 Sum_probs=197.2
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHH---HHHhcCCCCCeeeee-
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV---AMLSRVQHRNLVKFI- 90 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hp~iv~l~- 90 (352)
..|....++|++++.||+|+||+||+|.+. |+.||||++........ .....+.+|+ +.+++++||||++++
T Consensus 66 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~l~hpniv~~~~ 143 (377)
T 3byv_A 66 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS--NAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143 (377)
T ss_dssp ESSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT--THHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred eecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch--HHHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence 445556789999999999999999999864 89999999975432221 2334688999 556666899999998
Q ss_pred ------eeeecC------------------ceEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHH
Q 018656 91 ------GACKEP------------------VMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECL 141 (352)
Q Consensus 91 ------~~~~~~------------------~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~l 141 (352)
+++.++ ..+++|||+ +|+|.+++..... ..+++..++.|+.|++.||+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 555433 378999999 6799999986532 1133488888999999999999
Q ss_pred HhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCCCcccccccccccccc---cccccccCCCcccchhh
Q 018656 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT---LRQGEKKHYNHKVDSYS 218 (352)
Q Consensus 142 H~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~~~~~~~Diws 218 (352)
|++||+||||||+|||++.+ +.+||+|||++..... ......| +.|+|||++.+.. ........++.++||||
T Consensus 223 H~~~ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 223 HHYGLVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp HHTTEECSCCCGGGEEECTT-CCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred HhCCeecCCCCHHHEEEcCC-CCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 99999999999999999988 7999999999986332 3345567 9999999986520 00001126889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 219 FAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 219 lG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
|||++|+|++|+.||.+...... ..........+|+++.++|.+||+.||.+|||+.+++++.
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 361 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGG-----SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP 361 (377)
T ss_dssp HHHHHHHHHHSSCCC------CC-----SGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred HHHHHHHHHHCCCCCcccccccc-----hhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence 99999999999999976442211 1111223468899999999999999999999999999973
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=333.89 Aligned_cols=258 Identities=28% Similarity=0.392 Sum_probs=209.3
Q ss_pred cCCceeeeccccCCCceEEEEEEEC---CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC---CCCCeeeeeeeee-
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACK- 94 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~- 94 (352)
..++|++.+.||+|+||.||+|++. |+.||+|++......... ...+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC---CchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3578999999999999999999983 788999998754322110 11244666666555 8999999999875
Q ss_pred -----cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 95 -----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 95 -----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
....++||||++ ++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~-~~~kl~D 163 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLAD 163 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECS
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-CCEEEec
Confidence 236899999997 599999988766669999999999999999999999999999999999999988 7999999
Q ss_pred CCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 170 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
||++.............|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.+..............
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CcccccccCCCCccccccccceeCHHHHhc--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence 999987655555556689999999999854 567889999999999999999999999877655544433211
Q ss_pred CC--------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 250 VR--------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 250 ~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
.. .....++..+.++|.+||..||.+|||+.++++| .++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~~~~~~ 304 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH--PYFQDLE 304 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS--GGGTTCC
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC--ccccccc
Confidence 11 0124688999999999999999999999999998 5555443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=343.40 Aligned_cols=254 Identities=23% Similarity=0.296 Sum_probs=204.3
Q ss_pred cCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC----
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 96 (352)
...+|++.+.||+|+||+||+|++. +..+|+|.+...... ..+|+++++.++||||+++++++...
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 3567999999999999999999985 556888887654322 23699999999999999999998421
Q ss_pred ---ceEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 97 ---VMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 97 ---~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
.+++||||+++ +|.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++...+.+||+|||
T Consensus 109 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 37899999976 44444332 1234599999999999999999999999999999999999999433899999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
+++............||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+...........
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 260 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIFG-------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CcccccCCCCCcccccCcCccCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9987655555566789999999998854 245889999999999999999999999998766655544332111
Q ss_pred C----------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 252 P----------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 252 ~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
+ ....+++++.++|.+||+.||.+|||+.++++| .|++.+.
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~~~ 329 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH--PFFDELR 329 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS--GGGSTTT
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC--hhhhhhc
Confidence 1 123478999999999999999999999999998 5665543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=336.40 Aligned_cols=267 Identities=25% Similarity=0.357 Sum_probs=199.1
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGA 92 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~ 92 (352)
...+.+...+|++.+.||+|+||.||+|.+ +|+.||||++..... .....+.+|+.+++++. ||||++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-----EKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-----HHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-----HHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 345788899999999999999999999998 589999999865432 23456889999999995 9999999998
Q ss_pred ee---------cCceEEEEEcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeC
Q 018656 93 CK---------EPVMVIVTELLSGGTLRKYLLNM-RPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTE 160 (352)
Q Consensus 93 ~~---------~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~ 160 (352)
+. ...++++|||+. ++|.+++... ....+++..++.++.|++.||+|||++| |+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT
T ss_pred ccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC
Confidence 83 124899999995 6999998753 2345999999999999999999999999 999999999999998
Q ss_pred CCCceEEecCCCccccccccc-------------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHH
Q 018656 161 DLKTIKLADFGLAREESLTEM-------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 227 (352)
Q Consensus 161 ~~~~vkl~Dfg~a~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll 227 (352)
+ +.+||+|||++........ .....|++.|+|||++... ....++.++||||||+++|+|+
T Consensus 174 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~~Dv~slG~il~el~ 247 (337)
T 3ll6_A 174 Q-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-----SNFPIGEKQDIWALGCILYLLC 247 (337)
T ss_dssp T-SCEEBCCCTTCBCCSSCC-------------------------------CC-----TTSCSSHHHHHHHHHHHHHHHH
T ss_pred C-CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-----ccCCCChHHhHHHHHHHHHHHH
Confidence 8 7999999999975433211 1134589999999987321 2356788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 228 HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 228 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
+|+.||......... ......+.....+..+.++|.+||+.||.+|||+.+++++|+.+........
T Consensus 248 ~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 248 FRQHPFEDGAKLRIV---NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp HSSCCC---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred hCCCCCcchhHHHhh---cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 999999764432211 1122334456778889999999999999999999999999998887654443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=346.33 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=207.9
Q ss_pred eecCCceeeeccccCCCceEEEEEEE-----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeee
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC 93 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~ 93 (352)
.+..++|++++.||+|+||.||+|++ +|+.||||++........ ......+.+|+++++.+ +||||+++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh-hhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 34457999999999999999999988 589999999865321000 00112366789999999 799999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
.+ ...++||||+++++|.+++..... +++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~ 205 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGL 205 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CcEEEeeCCC
Confidence 74 578999999999999999987654 9999999999999999999999999999999999999988 7999999999
Q ss_pred ccccccc--cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHh
Q 018656 173 AREESLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS---NLQAAYAAAF 247 (352)
Q Consensus 173 a~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~---~~~~~~~~~~ 247 (352)
+...... .......||+.|+|||++.+ ....++.++|||||||++|+|++|+.||.... ..........
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred CeecccCCCCcccCcccCcCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 9754322 22334579999999999854 12457889999999999999999999997532 2223333333
Q ss_pred ccCCCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q 018656 248 KNVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQMLL 287 (352)
Q Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~i~~~l~ 287 (352)
....+.+..++..+.++|.+||..||.+|| ++.+++++.+
T Consensus 280 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 280 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 445566778999999999999999999999 9999999843
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=350.76 Aligned_cols=257 Identities=22% Similarity=0.311 Sum_probs=205.4
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCee-eeeeeee-cCc
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV-KFIGACK-EPV 97 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~l~~~~~-~~~ 97 (352)
..++|++++.||+|+||.||+|.+. |+.||||++....... .+.+|+++++.+.|++++ .+..++. ...
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-------CHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-------HHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 4578999999999999999999985 8999999987654433 367899999999875554 4444444 457
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe---CCCCceEEecCCCcc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLAR 174 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~---~~~~~vkl~Dfg~a~ 174 (352)
.++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+||||+ .+ +.+||+|||++.
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~ 154 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAK 154 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGT-TCEEECCCTTCE
T ss_pred EEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCC-CeEEEEeCCcce
Confidence 89999999 999999998643 3499999999999999999999999999999999999994 55 789999999997
Q ss_pred ccccccc--------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH---HHHH
Q 018656 175 EESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QAAY 243 (352)
Q Consensus 175 ~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~~ 243 (352)
....... .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 226 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH
Confidence 5433221 125579999999999865 56889999999999999999999999875431 1111
Q ss_pred HHHhccC----CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 018656 244 AAAFKNV----RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 296 (352)
Q Consensus 244 ~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~ 296 (352)
....... ......+|.++.++|..||..||.+||++.+|++.|+..+.....+
T Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 227 KISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp HHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 1111111 1113578999999999999999999999999999999887755443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=335.89 Aligned_cols=257 Identities=25% Similarity=0.444 Sum_probs=192.6
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEE--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
..|.+..++|++.+.||+|+||.||+|.+ +|+.||||++...... .....+.+|+.++++++||||+++++++.
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 83 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQCHHPNIVSYYTSFV 83 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEE
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc----hhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence 34889999999999999999999999987 5899999998654322 23446889999999999999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNM------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~------~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
. +..++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl 162 (303)
T 2vwi_A 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQI 162 (303)
T ss_dssp SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEE
T ss_pred ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-CCEEE
Confidence 4 5799999999999999999742 23358999999999999999999999999999999999999988 79999
Q ss_pred ecCCCccccccc------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 018656 168 ADFGLAREESLT------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 241 (352)
Q Consensus 168 ~Dfg~a~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 241 (352)
+|||++...... .......|++.|+|||++.+ ...++.++||||||+++|+|++|..||........
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 235 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ-------VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHH-------HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhcc-------ccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence 999998643322 12234568999999998753 13578899999999999999999999988766554
Q ss_pred HHHHHhccCC---------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 242 AYAAAFKNVR---------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 242 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.......... .....++.++.++|.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 4433332221 1135688999999999999999999999999997
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=328.71 Aligned_cols=246 Identities=20% Similarity=0.281 Sum_probs=203.6
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee-cCceE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK-EPVMV 99 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~-~~~~~ 99 (352)
++|++.+.||+|+||+||+|.+. ++.||+|++........ ....+.+|+..+..+ +||||+++++++. ++..+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV---DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH---HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH---HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 57999999999999999999985 89999999986544332 234577899999998 9999999999987 45789
Q ss_pred EEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC----------------
Q 018656 100 IVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---------------- 161 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~---------------- 161 (352)
+||||+++++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999999986521 348999999999999999999999999999999999999743
Q ss_pred --CCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH
Q 018656 162 --LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL 239 (352)
Q Consensus 162 --~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 239 (352)
...++|+|||++...... ....|++.|+|||++.+ ...++.++||||||+++|+|++|..|+....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-- 235 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQE-------NYTHLPKADIFALALTVVCAAGAEPLPRNGD-- 235 (289)
T ss_dssp --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTT-------CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--
T ss_pred CCceEEEEcccccccccCCc---cccCCCccccChhHhcC-------CCCCCchhhHHHHHHHHHHHhcCCCCCcchh--
Confidence 247999999998765432 23468999999999854 2356689999999999999999988775432
Q ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 240 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.............+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 222333333445567899999999999999999999999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=328.69 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=208.5
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|++.+.||+|+||.||+|.+. ++.||+|++....... .....+.+|++++++++||||+++++++.+ +..+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 358999999999999999999984 8999999986543221 123458899999999999999999999875 4789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC--CceEEecCCCccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLAREES 177 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~--~~vkl~Dfg~a~~~~ 177 (352)
+||||+++++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+. +.++|+|||++....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999977554 99999999999999999999999999999999999997642 379999999988654
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC---CCC
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSA 254 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 254 (352)
.........+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.............. +..
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRG---------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTT---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred CCCccccccCcccccChHHhcC---------CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhh
Confidence 4443344468899999998743 4788999999999999999999999987665544443333222 223
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
..++.++.++|.+||..||.+|||+.+++++.
T Consensus 247 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred hhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 57899999999999999999999999999983
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=334.83 Aligned_cols=253 Identities=26% Similarity=0.331 Sum_probs=205.9
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
.++|++.+.||+|+||.||+|.+. |+.||||++...... ....++.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP----LFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH----HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc----hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 578999999999999999999986 899999999654432 234457899999999999999999998753
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
...++||||+. ++|.+++... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLAR 160 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred cceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC-CcEEEEeccccc
Confidence 46899999996 5999999763 39999999999999999999999999999999999999988 799999999997
Q ss_pred cccccc-----------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 018656 175 EESLTE-----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY 243 (352)
Q Consensus 175 ~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~ 243 (352)
...... ......||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 233 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHS-------CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeecc-------CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 543221 1223468999999998743 2567889999999999999999999999876554433
Q ss_pred HHHhccCCC-------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 244 AAAFKNVRP-------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 244 ~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
........+ ....+++++.++|.+||..||.+|||+.++++| .|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~~ 311 (353)
T 2b9h_A 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH--PYLQT 311 (353)
T ss_dssp HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC--ccccc
Confidence 322111110 024688999999999999999999999999998 55544
Q ss_pred c
Q 018656 293 I 293 (352)
Q Consensus 293 ~ 293 (352)
.
T Consensus 312 ~ 312 (353)
T 2b9h_A 312 Y 312 (353)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=335.81 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=206.4
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.|.+. ++|.+.+.||+|+||.||+|.+. |+.||||++....... ....++.+|+.+++.++||||+++++++..
T Consensus 37 ~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 112 (371)
T 4exu_A 37 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE---IFAKRAYRELLLLKHMQHENVIGLLDVFTP 112 (371)
T ss_dssp EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred eeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch---hHHHHHHHHHHHHHhcCCCCchhhhhheec
Confidence 46554 68999999999999999999985 8999999997655443 334568899999999999999999999874
Q ss_pred C-c------eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 96 P-V------MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 96 ~-~------~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
. . .++||||+. ++|.+++.. .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+
T Consensus 113 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~ 186 (371)
T 4exu_A 113 ASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKIL 186 (371)
T ss_dssp CSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEEC
T ss_pred cCCcccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC-CCEEEE
Confidence 3 2 399999996 688887743 39999999999999999999999999999999999999988 799999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
|||++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+........
T Consensus 187 Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 257 (371)
T 4exu_A 187 DFGLARHADA--EMTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 257 (371)
T ss_dssp STTCC----------CTTCCCTTSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ecCccccccc--CcCCcccCccccCHHHhcC-------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999975432 2345578999999998854 256788999999999999999999999987765544443321
Q ss_pred cCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 249 NVRP------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 249 ~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
...+ ....+++++.++|.+||+.||.+|||+.++++| .|++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~~ 330 (371)
T 4exu_A 258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH--PFFEPF 330 (371)
T ss_dssp HCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS--GGGTTT
T ss_pred hCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC--cccccC
Confidence 1111 024578999999999999999999999999998 555543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=337.64 Aligned_cols=272 Identities=27% Similarity=0.495 Sum_probs=215.0
Q ss_pred cccccceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
.....|.++.++|++++.||+|+||.||+|.+.+ .+|+|++........ ....+.+|+.++++++||||+++++++
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNED---QLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCC---CCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHH---HHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 3456799999999999999999999999999876 499999876433221 122367899999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
.+ +..++||||++|++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||++++ +.++|+|||+
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~--~~~~l~Dfg~ 175 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGL 175 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSC
T ss_pred ecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC--CCEEEeecCC
Confidence 75 47999999999999999997643 34899999999999999999999999999999999999984 6899999999
Q ss_pred cccccc------ccccccCCCccccccccccccccccc-ccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 018656 173 AREESL------TEMMTAETGTYRWMAPELYSTVTLRQ-GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 245 (352)
Q Consensus 173 a~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 245 (352)
+..... ........|++.|+|||++....... .....++.++||||||+++|+|++|..||.+..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 764321 12223346899999999986422110 11245788999999999999999999999987765554444
Q ss_pred HhccCCC-CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 246 AFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 246 ~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
....... ....++.++.+++.+||..||.+|||+.++++.|......
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 3332222 2346889999999999999999999999999998876654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=331.11 Aligned_cols=254 Identities=23% Similarity=0.303 Sum_probs=200.6
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-----
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK----- 94 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~----- 94 (352)
..++|++.+.||+|+||.||+|.+. |+.||+|++..... .....+.+|++++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH-----HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh-----HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 4678999999999999999999986 89999999875431 33456889999999999999999999863
Q ss_pred ----------cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCc
Q 018656 95 ----------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (352)
Q Consensus 95 ----------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~ 164 (352)
....++||||++ ++|.+++.+ ..+++..++.++.|++.||+|||++|++||||||+||+++.+.+.
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence 246899999997 599999965 248999999999999999999999999999999999999855479
Q ss_pred eEEecCCCccccccc----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH
Q 018656 165 IKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ 240 (352)
Q Consensus 165 vkl~Dfg~a~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~ 240 (352)
+||+|||++...... .......++..|+|||.+.. ...++.++||||||+++|+|++|+.||.+.....
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 232 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-------TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcC-------cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999854322 12233457899999998743 2567889999999999999999999999877654
Q ss_pred HHHHHHhccCC-----------------------C------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 241 AAYAAAFKNVR-----------------------P------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 241 ~~~~~~~~~~~-----------------------~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
........... + ....++.++.++|.+||+.||.+|||+.++++| .|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~ 310 (320)
T 2i6l_A 233 QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH--PYMS 310 (320)
T ss_dssp HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS--HHHH
T ss_pred HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC--cccc
Confidence 43332221110 0 124689999999999999999999999999998 4454
Q ss_pred cc
Q 018656 292 AI 293 (352)
Q Consensus 292 ~~ 293 (352)
..
T Consensus 311 ~~ 312 (320)
T 2i6l_A 311 IY 312 (320)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=332.07 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=206.9
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
.+...++|++.+.||+|+||.||+|.+. |+.||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-----ELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C-----CHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-----HHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 3445688999999999999999999996 889999998754322 23458899999999999999999999874
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAK 166 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-SCEEECCCHHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC-CCEEEEECCCCcc
Confidence 57999999999999999987643 349999999999999999999999999999999999999988 7999999998753
Q ss_pred ccc-ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC--C
Q 018656 176 ESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--P 252 (352)
Q Consensus 176 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~ 252 (352)
... ........|++.|+|||++.... .....++.++||||||+++|+|++|..||...+.............. .
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T 2j7t_A 167 NLKTLQKRDSFIGTPYWMAPEVVMCET---MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL 243 (302)
T ss_dssp HHHHHHC-----CCGGGCCHHHHHHHH---TTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS
T ss_pred ccccccccccccCChhhcCCeeecccc---CCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccC
Confidence 221 12223457899999999874211 01356788999999999999999999999987765554444333222 2
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+..++.++.++|.+||..||.+|||+.++++|
T Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 346788999999999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=337.47 Aligned_cols=255 Identities=20% Similarity=0.316 Sum_probs=209.1
Q ss_pred cCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHH------------HHHHHHHHHHHHHHhcCCCCCeeee
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI------------AKKESRFAREVAMLSRVQHRNLVKF 89 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~------------~~~~~~~~~E~~~l~~l~hp~iv~l 89 (352)
..++|++++.||+|+||.||+|.++|+.||+|++......... ......+.+|++++++++||||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 3568999999999999999999999999999998643211000 0001468899999999999999999
Q ss_pred eeeeec-CceEEEEEcCCCCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCC
Q 018656 90 IGACKE-PVMVIVTELLSGGTLRKY------LLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTED 161 (352)
Q Consensus 90 ~~~~~~-~~~~lv~e~~~~~sL~~~------l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~ 161 (352)
++++.+ +..++||||+++++|.++ +.......+++..++.++.|++.||.|||+ +|++||||||+||+++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 999875 479999999999999998 665435569999999999999999999999 999999999999999988
Q ss_pred CCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCc-ccchhhHHHHHHHHHhCCCCCCCCChHH
Q 018656 162 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH-KVDSYSFAIVLWELLHNKLPFEGMSNLQ 240 (352)
Q Consensus 162 ~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~-~~DiwslG~il~~ll~g~~p~~~~~~~~ 240 (352)
+.++|+|||++...... ......|+..|+|||++.+ ...++. ++||||||+++|+|++|..||.+.....
T Consensus 189 -~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 189 -GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN-------ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp -SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS-------CCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred -CcEEEeccccccccccc-cccCCCCCcCccCchhhcC-------CCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 79999999999764333 3345679999999999864 114445 9999999999999999999998876633
Q ss_pred HHHHHHhccCCCCC-------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 241 AAYAAAFKNVRPSA-------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 241 ~~~~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.............+ ..++.++.++|.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 33333333322222 5789999999999999999999999999997
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=333.13 Aligned_cols=258 Identities=27% Similarity=0.405 Sum_probs=206.2
Q ss_pred cCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
....|..++.||+|+||+||+|.++++.||+|++........ ......+.+|+.++++++||||+++++++.+ +..++
T Consensus 29 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 107 (307)
T 2nru_A 29 ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCL 107 (307)
T ss_dssp CSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT-TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcch-HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEE
Confidence 344566678999999999999999999999999875432111 1234568899999999999999999999874 57899
Q ss_pred EEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 101 VTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARASEKF 186 (307)
T ss_dssp EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCSC
T ss_pred EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-CcEEEeecccccccccc
Confidence 999999999999997543 3459999999999999999999999999999999999999988 79999999998754322
Q ss_pred ---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHhc-----
Q 018656 180 ---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA---AYAAAFK----- 248 (352)
Q Consensus 180 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~---~~~~~~~----- 248 (352)
.......|++.|+|||++.+ .++.++||||||+++|+|++|..||........ .......
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 257 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG---------EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTI 257 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT---------EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCH
T ss_pred cccccccccCCCcCcCChHHhcC---------CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhh
Confidence 12234578999999998743 468899999999999999999999986443211 1111100
Q ss_pred ------cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 249 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 249 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
.........+..+.+++.+||..||.+|||+.+++++|+.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 258 EDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111123345678999999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=332.70 Aligned_cols=265 Identities=23% Similarity=0.384 Sum_probs=190.5
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHH-HHhcCCCCCeeee
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKF 89 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~l 89 (352)
+..+..|.+..++|++.+.||+|+||.||+|.++ |+.||||++........ ..++.+|+. +++.++||||+++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~~~~~~~h~niv~~ 86 (327)
T 3aln_A 11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE----QKQLLMDLDVVMRSSDCPYIVQF 86 (327)
T ss_dssp CCCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH----HHHHHHHHHHHHSSCCCTTBCCE
T ss_pred CChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH----HHHHHHHHHHHHHcCCCCcEeee
Confidence 4456679999999999999999999999999986 89999999987654332 223445555 7788899999999
Q ss_pred eeeeec-CceEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCc
Q 018656 90 IGACKE-PVMVIVTELLSGGTLRKYLLN---MRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKT 164 (352)
Q Consensus 90 ~~~~~~-~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~ 164 (352)
++++.+ +..++||||+++ +|.+++.. .....+++..++.++.|++.||.|||++ |++||||||+||+++.+ +.
T Consensus 87 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~-~~ 164 (327)
T 3aln_A 87 YGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GN 164 (327)
T ss_dssp EEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-TE
T ss_pred eeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-CC
Confidence 999874 578999999975 88888763 1234599999999999999999999999 99999999999999988 79
Q ss_pred eEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 018656 165 IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA 244 (352)
Q Consensus 165 vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~ 244 (352)
+||+|||++.............|++.|+|||++... .....++.++||||||+++|+|++|..||.+.........
T Consensus 165 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 240 (327)
T 3aln_A 165 IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS----ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240 (327)
T ss_dssp EEECCCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C
T ss_pred EEEccCCCceecccccccccCCCCccccCceeeccc----cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH
Confidence 999999999865444444445799999999998431 1135678899999999999999999999987543222211
Q ss_pred HHhccCCCC-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 245 AAFKNVRPS-----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 245 ~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.......+. ...+++.+.++|.+||+.||.+|||+.+++++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 111111111 2468999999999999999999999999999854
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=338.42 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=203.5
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChH------HHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPE------EIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
...++|++.+.||+|+||.||+|.+. |+.||||++....... .......++.+|++++++++||||+++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45688999999999999999999875 8999999986543321 1122345689999999999999999999987
Q ss_pred ec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 94 KE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 94 ~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
.. ..+++||||++ ++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.+ +.++|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl 175 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN-NDITI 175 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEE
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC-CCEEE
Confidence 42 25899999996 68998887543 359999999999999999999999999999999999999988 79999
Q ss_pred ecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 018656 168 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 247 (352)
+|||++.............+++.|+|||++.+ ...++.++|||||||++|+|++|+.||.+............
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQ-------FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EecCcccccccccccceecccceecCcHHhcC-------CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999986555555556678999999998754 24578999999999999999999999998765544443322
Q ss_pred ccCCC-------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 248 KNVRP-------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 248 ~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
....+ ....+++.+.++|.+||+.||.+|||+.++++| .|++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~~~~ 324 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH--PYFESLF 324 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGTTTC
T ss_pred HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC--chhhhcc
Confidence 11111 124568899999999999999999999999998 5665543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=344.73 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=187.1
Q ss_pred Cceee-eccccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee---c
Q 018656 24 KHLFV-GPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK---E 95 (352)
Q Consensus 24 ~~y~~-~~~lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~---~ 95 (352)
+.|.+ +++||+|+||+||+|++. ++.||||++....... .+.+|+.++++++||||+++++++. +
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM-------SACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH-------HHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH-------HHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 34665 568999999999999964 6889999997654433 3678999999999999999999984 3
Q ss_pred CceEEEEEcCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEE----eCCCCc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL----TEDLKT 164 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili----~~~~~~ 164 (352)
...++||||+. ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.+ +.
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~ 170 (405)
T 3rgf_A 93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GR 170 (405)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT-TC
T ss_pred CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC-Cc
Confidence 47899999995 58888886432 1249999999999999999999999999999999999999 444 78
Q ss_pred eEEecCCCccccccc----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH-
Q 018656 165 IKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL- 239 (352)
Q Consensus 165 vkl~Dfg~a~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~- 239 (352)
+||+|||++...... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 243 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTT-------CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcC-------CCcccchhhhHHHHHHHHHHHhCCCCCCCccccc
Confidence 999999999854322 22344578999999999854 245889999999999999999999999765431
Q ss_pred --------HHHHHHHhccCCCCC-------------------------------------CCCcHHHHHHHHHhhccCCC
Q 018656 240 --------QAAYAAAFKNVRPSA-------------------------------------ENVPEELSIILTSCWKEDPN 274 (352)
Q Consensus 240 --------~~~~~~~~~~~~~~~-------------------------------------~~~~~~l~~li~~~l~~~p~ 274 (352)
+...........+.. ...++.+.+||.+||+.||.
T Consensus 244 ~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~ 323 (405)
T 3rgf_A 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323 (405)
T ss_dssp ---CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGG
T ss_pred cccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcc
Confidence 222222211111111 12267889999999999999
Q ss_pred CCCCHHHHHHHHHHhhhccC
Q 018656 275 ARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 275 ~Rps~~~i~~~l~~~~~~~~ 294 (352)
+|||+.++++| .|+...+
T Consensus 324 ~R~ta~e~L~h--p~f~~~~ 341 (405)
T 3rgf_A 324 KRITSEQAMQD--PYFLEDP 341 (405)
T ss_dssp GSCCHHHHHTS--GGGTSSS
T ss_pred cCCCHHHHhcC--hhhccCC
Confidence 99999999999 6665443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=331.30 Aligned_cols=257 Identities=27% Similarity=0.489 Sum_probs=197.4
Q ss_pred CCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhc--CCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR--VQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~l~~~~~~----- 95 (352)
.++|++.+.||+|+||.||+|+++|+.||||++.... .....+|.+++.. ++||||+++++++.+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE--------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG--------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc--------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3689999999999999999999999999999986432 1123445555554 499999999999764
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCCeEEeCCCCceEE
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--------~ivH~Dikp~Nili~~~~~~vkl 167 (352)
...++||||+++++|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++.+ +.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCEEE
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCEEE
Confidence 4689999999999999999764 399999999999999999999999 99999999999999988 79999
Q ss_pred ecCCCccccccccc-----cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC----------CCC
Q 018656 168 ADFGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN----------KLP 232 (352)
Q Consensus 168 ~Dfg~a~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g----------~~p 232 (352)
+|||++........ .....||+.|+|||++.+.... .....+.++|||||||++|+|++| ..|
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR--NHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCT--TCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCC--ccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999975432221 1245799999999998651100 001111249999999999999999 777
Q ss_pred CCCCCh----HHHHHHHH-hccCCCCC------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 233 FEGMSN----LQAAYAAA-FKNVRPSA------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 233 ~~~~~~----~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
|..... ........ .....+.. ..+++++.+++.+||+.||.+|||+.+++++|....+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 765322 11122211 12222221 256788999999999999999999999999999887654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=337.84 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=207.9
Q ss_pred cccccceecCCceeeeccccCCCceEEEEEE-----E--CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC---C
Q 018656 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGK-----Y--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---H 83 (352)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~-----~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h 83 (352)
.....+.+..++|.+.+.||+|+||+||+|. + .++.||||++..... ..+.+|+++++++. |
T Consensus 55 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~e~~~~~~l~~~~~ 126 (365)
T 3e7e_A 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP--------WEFYIGTQLMERLKPSMQ 126 (365)
T ss_dssp CSSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH--------HHHHHHHHHHHHSCGGGG
T ss_pred ccceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh--------hHHHHHHHHHHHhhhhhh
Confidence 3445677889999999999999999999993 2 489999999876432 13566777777775 9
Q ss_pred CCeeeeeeeee-cCceEEEEEcCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe
Q 018656 84 RNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNM---RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (352)
Q Consensus 84 p~iv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~ 159 (352)
+||+++++++. ++..++||||+++++|.+++... ....+++..++.|+.|++.||+|||++||+||||||+|||++
T Consensus 127 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~ 206 (365)
T 3e7e_A 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206 (365)
T ss_dssp GGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC
T ss_pred hhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEec
Confidence 99999999987 45799999999999999999753 234599999999999999999999999999999999999998
Q ss_pred C-----------CCCceEEecCCCcccc---ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHH
Q 018656 160 E-----------DLKTIKLADFGLAREE---SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWE 225 (352)
Q Consensus 160 ~-----------~~~~vkl~Dfg~a~~~---~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ 225 (352)
. + +.+||+|||++... ..........||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 207 ~~~~~~~~~~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 277 (365)
T 3e7e_A 207 NGFLEQDDEDDLS-AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--------KPWNYQIDYFGVAATVYC 277 (365)
T ss_dssp GGGTCC------C-TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--------CCBSTHHHHHHHHHHHHH
T ss_pred ccccCcccccccc-CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--------CCCCccccHHHHHHHHHH
Confidence 7 5 79999999999643 23334456679999999999865 568999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHhhhcc
Q 018656 226 LLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNAR-PNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 226 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-ps~~~i~~~l~~~~~~~ 293 (352)
|++|+.||........ ...........++.+.+++..||+.+|.+| |++.++.+.+..++...
T Consensus 278 lltg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 278 MLFGTYMKVKNEGGEC-----KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp HHHSSCCCEEEETTEE-----EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHhCCCccccCCCCce-----eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 9999999965322100 000111122457889999999999999998 57888888888887663
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=334.64 Aligned_cols=257 Identities=28% Similarity=0.426 Sum_probs=204.8
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-C
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 96 (352)
+.+..++|++.+.||+|+||.||+|++. |+.||||++....... ....+.+|+++++.++||||+++++++.+ +
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch----HHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 5667889999999999999999999874 8999999987644322 12247899999999999999999999874 4
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSH---GIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++ |++||||||+|||++.+ +.++|+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg 179 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFG 179 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEEECCCS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEEeccCc
Confidence 78999999999999999987543 3499999999999999999999999 99999999999999988 799999999
Q ss_pred Ccccccc--ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC----hHHHHHHH
Q 018656 172 LAREESL--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS----NLQAAYAA 245 (352)
Q Consensus 172 ~a~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~----~~~~~~~~ 245 (352)
++..... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.... ........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHH--------SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred cccccCcccccccccccCCcCccCHHHhcc--------CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9975432 222344569999999999854 557889999999999999999999995210 00000011
Q ss_pred HhccCC--------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 246 AFKNVR--------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 246 ~~~~~~--------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
...... ......+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 100000 0112234779999999999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=323.92 Aligned_cols=256 Identities=24% Similarity=0.399 Sum_probs=205.8
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 95 (352)
|.....+|.....||+|+||.||+|.+. ++.||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 91 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-----RYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-----HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence 4444455556668999999999999984 78999999876543 223458899999999999999999999874
Q ss_pred CceEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+||+++...+.++|+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 57899999999999999998753 23477999999999999999999999999999999999999743799999999987
Q ss_pred ccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHH-HHH-HhccCC
Q 018656 175 EESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA-YAA-AFKNVR 251 (352)
Q Consensus 175 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-~~~-~~~~~~ 251 (352)
..... .......|++.|+|||++.+. ...++.++||||||+++|+|++|+.||......... ... ......
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 2clq_A 172 RLAGINPCTETFTGTLQYMAPEIIDKG------PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 245 (295)
T ss_dssp ESCC-----CCCCCCGGGCCHHHHHHG------GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC
T ss_pred ccCCCCCcccccCCCccccChhhhcCC------CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccc
Confidence 54332 223445789999999998541 134788999999999999999999999765433322 222 222233
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+..++.++.++|.+||+.||.+||++.+++++
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 4467899999999999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=336.56 Aligned_cols=261 Identities=25% Similarity=0.304 Sum_probs=197.5
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-C
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~ 96 (352)
...-++|++.+.||+|+||+||+|.+. |+.||||++....... .+..++++.++.++||||+++++++.. +
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR------NRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC------CHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc------HHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 344568999999999999999999985 8899999886543322 135567788888899999999999842 1
Q ss_pred -------ceEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCCeEEeCCCCce
Q 018656 97 -------VMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLH--SHGIIHRDLKPENLLLTEDLKTI 165 (352)
Q Consensus 97 -------~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dikp~Nili~~~~~~v 165 (352)
..++||||+++ +|.+.+.. .....+++..++.++.|++.||.||| ++||+||||||+|||++...+.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 27899999976 66555543 13345899999999999999999999 99999999999999999733899
Q ss_pred EEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 018656 166 KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA 245 (352)
Q Consensus 166 kl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~ 245 (352)
||+|||++.............||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+........
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG-------NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 9999999987665555556678999999998854 245789999999999999999999999987765554444
Q ss_pred HhccCCC-------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 246 AFKNVRP-------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 246 ~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
......+ .....+.++.++|.+||+.||.+|||+.++++| .|+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~f~~~~ 322 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH--PYFDELH 322 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS--GGGGGGG
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC--ccccccC
Confidence 3221111 122367899999999999999999999999998 6665544
Q ss_pred CC
Q 018656 295 PP 296 (352)
Q Consensus 295 ~~ 296 (352)
.+
T Consensus 323 ~~ 324 (360)
T 3e3p_A 323 DP 324 (360)
T ss_dssp CT
T ss_pred Cc
Confidence 33
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=331.81 Aligned_cols=266 Identities=23% Similarity=0.368 Sum_probs=199.4
Q ss_pred cceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec--
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-- 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-- 95 (352)
.+.++.++|++++.||+|+||+||+|+++|+.||||++....... .....|+..++.++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~------~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQN------FINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHH------HHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhh------HHHHHHHHHHHhccCcchhhheecccccc
Confidence 466788999999999999999999999999999999986532111 112234444556899999999975431
Q ss_pred ----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCCCeEEeCCC
Q 018656 96 ----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---------GIIHRDLKPENLLLTEDL 162 (352)
Q Consensus 96 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---------~ivH~Dikp~Nili~~~~ 162 (352)
..+++||||+++++|.+++.... .++..++.++.|++.||+|||++ ||+||||||+|||++.+
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~- 156 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND- 156 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-
Confidence 25789999999999999997644 68999999999999999999999 99999999999999988
Q ss_pred CceEEecCCCccccccc---------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCC
Q 018656 163 KTIKLADFGLAREESLT---------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233 (352)
Q Consensus 163 ~~vkl~Dfg~a~~~~~~---------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 233 (352)
+.+||+|||++...... .......||+.|+|||++.+... ......++.++|||||||++|+|++|..||
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN-LRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCC-GGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcc-cccccccccccchHHHHHHHHHHHhcCCcC
Confidence 79999999999754321 12234469999999999864210 001135667899999999999999997665
Q ss_pred CCCCh-----------------HHHHHHH-HhccCCCC-C------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 234 EGMSN-----------------LQAAYAA-AFKNVRPS-A------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 234 ~~~~~-----------------~~~~~~~-~~~~~~~~-~------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
..... ....... ......+. + ..+++++.++|.+||+.||.+|||+.++++.|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 33211 0111111 11111111 1 2255689999999999999999999999999998
Q ss_pred hhhccC
Q 018656 289 YLSAIA 294 (352)
Q Consensus 289 ~~~~~~ 294 (352)
++....
T Consensus 316 ll~~~~ 321 (336)
T 3g2f_A 316 LMMIWE 321 (336)
T ss_dssp HHHCCC
T ss_pred HHHHHH
Confidence 886543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=344.58 Aligned_cols=258 Identities=13% Similarity=0.140 Sum_probs=190.3
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHH---HHHHhcCCCCCeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFARE---VAMLSRVQHRNLVKFI 90 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~hp~iv~l~ 90 (352)
.+.|-....+|++.+.||+|+||+||+|.+. |+.||||++........ .....+.+| ++.++. +||||++++
T Consensus 54 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~~~~l~~-~hp~iv~~~ 130 (371)
T 3q60_A 54 DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR--SELERLHEATFAAARLLG-ESPEEARDR 130 (371)
T ss_dssp EETTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHH--HHHHHHHHHHHHHHHHHC----------
T ss_pred EecCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccc--cHHHHHHHHHHHHHHhcc-cChhhhhhc
Confidence 3444455667999999999999999999985 88999999988665332 334567777 455565 799988755
Q ss_pred -------eeeec------------------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHH
Q 018656 91 -------GACKE------------------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA------IGFALDIARAME 139 (352)
Q Consensus 91 -------~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~------~~i~~qi~~~L~ 139 (352)
+++.. ...++||||++ ++|.+++..... .+++..+ +.++.||+.||+
T Consensus 131 ~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~ 208 (371)
T 3q60_A 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAA 208 (371)
T ss_dssp -CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHH
Confidence 33321 23799999997 799999987532 2455555 677899999999
Q ss_pred HHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhH
Q 018656 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSF 219 (352)
Q Consensus 140 ~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 219 (352)
|||++||+||||||+|||++.+ +.+||+|||++....... ....+|+.|+|||++.+ ....++.++|||||
T Consensus 209 ~LH~~~ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~------~~~~~~~~~DiwSl 279 (371)
T 3q60_A 209 NLQSKGLVHGHFTPDNLFIMPD-GRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNA------STATFTHALNAWQL 279 (371)
T ss_dssp HHHHTTEEETTCSGGGEEECTT-SCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTC------SEEECCHHHHHHHH
T ss_pred HHHHCCCccCcCCHHHEEECCC-CCEEEEecceeeecCCCc--cCccCCcCCcChhhccC------CCCCcCccccHHHH
Confidence 9999999999999999999988 799999999998654322 24456799999999843 12567899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHH--------HhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 220 AIVLWELLHNKLPFEGMSNLQAAYAA--------AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 220 G~il~~ll~g~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
||++|+|++|+.||.+.......... ......+....+++.+.++|.+||+.||.+|||+.++++|.+
T Consensus 280 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 280 GLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp HHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred HHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 99999999999999876432110000 001111223578999999999999999999999999998743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=332.89 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=204.1
Q ss_pred CCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhc--CCCCCeeeeeeeeecC----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR--VQHRNLVKFIGACKEP---- 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~l~~~~~~~---- 96 (352)
.++|++.+.||+|+||.||+|.++|+.||||++.... ...+.+|.++++. ++||||+++++++...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE--------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG--------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh--------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 3689999999999999999999999999999986421 2346678888776 7999999999998743
Q ss_pred -ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCCCeEEeCCCCceEE
Q 018656 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--------SHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH--------~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
..++||||+++++|.+++.+. .+++..++.++.|++.||+||| ++|++||||||+||+++.+ +.+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~-~~~kL 188 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCI 188 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT-SCEEE
T ss_pred ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC-CCEEE
Confidence 689999999999999999764 3999999999999999999999 8999999999999999988 79999
Q ss_pred ecCCCcccccccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC----------CCC
Q 018656 168 ADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN----------KLP 232 (352)
Q Consensus 168 ~Dfg~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g----------~~p 232 (352)
+|||++....... ......||+.|+|||++.+.... ....++.++||||||+++|+|++| ..|
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM--KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT--TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccc--cccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 9999987543322 22445799999999998641100 001344789999999999999999 789
Q ss_pred CCCCCh----HHHHHHHH-hccCCCCC------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 233 FEGMSN----LQAAYAAA-FKNVRPSA------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 233 ~~~~~~----~~~~~~~~-~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
|..... ........ .....+.. ..++..+.+++.+||+.||.+|||+.+++++|+.+.+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 876432 12222222 22222221 234568999999999999999999999999999887653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=331.37 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=205.3
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
.|.+ .++|.+.+.||+|+||.||+|.+. |+.||||++....... ....++.+|+.+++.++||||+++++++..
T Consensus 19 ~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 94 (353)
T 3coi_A 19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE---IFAKRAYRELLLLKHMQHENVIGLLDVFTP 94 (353)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred cccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch---HHHHHHHHHHHHHHhcCCCCcccHhheEec
Confidence 3544 468999999999999999999985 8999999997654433 234568899999999999999999999874
Q ss_pred C-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 96 P-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 96 ~-------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
. ..++||||+. ++|.+++.. .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+
T Consensus 95 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~ 168 (353)
T 3coi_A 95 ASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKIL 168 (353)
T ss_dssp CSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-CCEEEC
T ss_pred ccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC-CcEEEe
Confidence 3 2599999996 588887642 38999999999999999999999999999999999999988 799999
Q ss_pred cCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 248 (352)
|||++...... .....+++.|+|||++.+ ...++.++||||||+++|+|++|..||.+.+..+........
T Consensus 169 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~ 239 (353)
T 3coi_A 169 DFGLARHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239 (353)
T ss_dssp STTCTTC----------CCSBCCSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHH
T ss_pred ecccccCCCCC--ccccccCcCcCCHHHHhC-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999764322 334578999999998753 246788999999999999999999999987655443332221
Q ss_pred c------------------------------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 249 N------------------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 249 ~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
. .......+++++.++|.+||..||.+|||+.++++| .|+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h--p~f~~~ 312 (353)
T 3coi_A 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH--PFFEPF 312 (353)
T ss_dssp HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS--GGGTTT
T ss_pred hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC--cchhhc
Confidence 0 111234678999999999999999999999999998 555443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=324.08 Aligned_cols=262 Identities=21% Similarity=0.381 Sum_probs=194.2
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
..|.+..++|++.+.||+|+||.||+|.+. |+.||||++........ ....+.++..+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE---NKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH---HHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH---HHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 457888899999999999999999999985 89999999987654432 2233555666788899999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
+ +..++||||+ ++.+..+..... ..+++..++.++.|++.||.|||++ |++|+||||+||+++.+ +.++|+|||+
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~ 171 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GQIKLCDFGI 171 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-SCEEECCCTT
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-CCEEEEECCC
Confidence 5 5789999999 666766665433 3499999999999999999999996 99999999999999988 7999999999
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR- 251 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~- 251 (352)
+.............+++.|+|||++.... .....++.++||||||+++|+|++|+.||..................
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPD---PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP 248 (318)
T ss_dssp C--------------CCTTCCHHHHC-----------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC
T ss_pred chhccCCccccccCCCccccChhhccccc---ccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC
Confidence 97654444445567999999999985311 01356788999999999999999999999875444333333333222
Q ss_pred --CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 252 --PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 252 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
+....++.++.++|.+||+.||.+||++.+++++.+
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 249 LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 223468999999999999999999999999999843
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=322.35 Aligned_cols=263 Identities=23% Similarity=0.391 Sum_probs=206.2
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC--CCCeeeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGAC 93 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~ 93 (352)
+...+..++|++.+.||+|+||.||+|.+. |+.||+|++....... .....+.+|++++++++ ||||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN---QTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH---HHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc---cchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 346677889999999999999999999885 7899999997655433 23456889999999997 59999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
.+ +..++|||+ .+++|.+++..... +++..++.++.|+++||.|||++|++||||||+||++++ +.+||+|||+
T Consensus 98 ~~~~~~~lv~e~-~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~kL~Dfg~ 172 (313)
T 3cek_A 98 ITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGI 172 (313)
T ss_dssp ECSSEEEEEECC-CSEEHHHHHHHCSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSS
T ss_pred ecCCEEEEEEec-CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--CeEEEeeccc
Confidence 74 478999994 58899999987543 899999999999999999999999999999999999975 6899999999
Q ss_pred cccccccc---ccccCCCccccccccccccccccc---ccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 018656 173 AREESLTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 173 a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~---~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 246 (352)
+....... ......|++.|+|||++.+..... .....++.++||||||+++|+|++|..||.............
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 97543322 123456899999999986421110 012467889999999999999999999998765443333322
Q ss_pred hc-c-CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 247 FK-N-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 247 ~~-~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.. . ....+...+.++.++|.+||+.||.+||++.+++++.+
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 22 1 22335667899999999999999999999999999854
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=329.98 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=181.6
Q ss_pred cccceecCCceeee-ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 16 DAKWLIDPKHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 16 ~~~~~i~~~~y~~~-~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
+.......++|++. +.||+|+||+||+|.+. |+.||||++.... .. ..+....++.+.||||++++++
T Consensus 20 ~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~---~~e~~~~~~~~~h~~i~~~~~~ 90 (336)
T 3fhr_A 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KA---RQEVDHHWQASGGPHIVCILDV 90 (336)
T ss_dssp CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HH---HHHHHHHHHHTTSTTBCCEEEE
T ss_pred CCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HH---HHHHHHHHHhcCCCChHHHHHH
Confidence 33444556778885 56999999999999986 8999999986521 11 1122334566799999999999
Q ss_pred eec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCce
Q 018656 93 CKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTI 165 (352)
Q Consensus 93 ~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~v 165 (352)
+.. ...++||||++|++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.+ .+.+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred HhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceE
Confidence 863 258999999999999999998766679999999999999999999999999999999999999764 2469
Q ss_pred EEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHH-
Q 018656 166 KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA- 244 (352)
Q Consensus 166 kl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~- 244 (352)
+|+|||++...... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........
T Consensus 171 kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 241 (336)
T 3fhr_A 171 KLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241 (336)
T ss_dssp EECCCTTCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred EEeccccceecccc-ccccCCCCcCccChhhhCC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH
Confidence 99999999754322 2345578999999999854 5678899999999999999999999976544322111
Q ss_pred ------HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 245 ------AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 245 ------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
.......+....++.++.++|.+||+.||.+|||+.+++++.|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 242 KRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred HHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 01111223346789999999999999999999999999998543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=337.59 Aligned_cols=248 Identities=22% Similarity=0.272 Sum_probs=198.3
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC--------CCCeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--------HRNLVKFI 90 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hp~iv~l~ 90 (352)
+..++|++.+.||+|+||+||+|++. |+.||||++.... .....+.+|+.+++.++ |+||++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE------HYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC------cchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 34578999999999999999999885 8899999986431 23445788999998885 78899999
Q ss_pred eeee-----cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEeCCC--
Q 018656 91 GACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDL-- 162 (352)
Q Consensus 91 ~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~~~~-- 162 (352)
+++. ....++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9886 23689999999 67888877765555699999999999999999999999 999999999999998762
Q ss_pred ----------------------------------------------CceEEecCCCccccccccccccCCCccccccccc
Q 018656 163 ----------------------------------------------KTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196 (352)
Q Consensus 163 ----------------------------------------------~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~ 196 (352)
..++|+|||++...... .....||+.|+|||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHH
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChh
Confidence 27999999999764332 345579999999999
Q ss_pred ccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhccCC-------------------
Q 018656 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSN------LQAAYAAAFKNVR------------------- 251 (352)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~------~~~~~~~~~~~~~------------------- 251 (352)
+.+ ..++.++|||||||++|+|++|+.||.+.+. .............
T Consensus 265 ~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 265 LIG--------SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp HHT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred hcC--------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence 865 5688999999999999999999999986542 1111111110000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 ----------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
......+.++.+||.+||+.||.+|||+.++++|
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0112345678999999999999999999999998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=323.25 Aligned_cols=248 Identities=22% Similarity=0.255 Sum_probs=201.8
Q ss_pred ecCCceeeeccccCCCceEEEEEEE---CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCC------Ceeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKY---KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR------NLVKFIG 91 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------~iv~l~~ 91 (352)
+..++|++.+.||+|+||+||+|.+ .|+.||||++.... .....+.+|+++++.++|+ +++++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD------RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH------HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC------chhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 4467899999999999999999987 37899999986431 2234577888888887655 5999999
Q ss_pred eee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC---------
Q 018656 92 ACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--------- 161 (352)
Q Consensus 92 ~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--------- 161 (352)
++. ++..++||||+ +++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 987 45899999999 8899999988765669999999999999999999999999999999999999863
Q ss_pred ---------CCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCC
Q 018656 162 ---------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 232 (352)
Q Consensus 162 ---------~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (352)
.+.++|+|||++..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA--------LGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT--------SCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC--------CCCCcchhhHHHHHHHHHHHhCCCC
Confidence 25799999999875432 2345578999999999854 5688999999999999999999999
Q ss_pred CCCCChHHHHHHHHhccC-------------------------------------------CCCCCCCcHHHHHHHHHhh
Q 018656 233 FEGMSNLQAAYAAAFKNV-------------------------------------------RPSAENVPEELSIILTSCW 269 (352)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~l~~li~~~l 269 (352)
|.+.+............. .......++++.++|.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 988765443322211110 0112234678999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 018656 270 KEDPNARPNFTQIIQM 285 (352)
Q Consensus 270 ~~~p~~Rps~~~i~~~ 285 (352)
..||.+|||+.+++++
T Consensus 314 ~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 314 EYDPAKRITLREALKH 329 (339)
T ss_dssp CSSTTTSCCHHHHTTS
T ss_pred CcCcccccCHHHHhcC
Confidence 9999999999999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=322.40 Aligned_cols=244 Identities=27% Similarity=0.400 Sum_probs=193.2
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec------
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------ 95 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 95 (352)
++|++.+.||+|+||.||+|++. |+.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 57999999999999999999984 899999998642 1234568899999999999999999998742
Q ss_pred --------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 96 --------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 96 --------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~-~~~kl 157 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKI 157 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC-CCEEE
Confidence 36899999999999999998643 348889999999999999999999999999999999999988 79999
Q ss_pred ecCCCccccccc---------------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCC
Q 018656 168 ADFGLAREESLT---------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP 232 (352)
Q Consensus 168 ~Dfg~a~~~~~~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (352)
+|||++...... .......|++.|+|||++.+ ...++.++||||||+++|+|++ |
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-------TGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTS-------CSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC-------CCCCcchhhHHHHHHHHHHHHh---c
Confidence 999998754321 12234568999999999854 2357889999999999999998 6
Q ss_pred CCCCChHHHHHHHHhccC----CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 233 FEGMSNLQAAYAAAFKNV----RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
|................. .......+..+.++|.+||+.||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 228 FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp CSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 654222222222222211 12245677889999999999999999999999997
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=325.84 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=201.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC--C-ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC------eeeeeeee
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--N-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN------LVKFIGAC 93 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~------iv~l~~~~ 93 (352)
.++|++.+.||+|+||+||+|.+. + +.||+|++.... .....+.+|+.+++.++|++ ++.+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG------KYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc------cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 679999999999999999999985 4 689999986431 23345778888888886655 88888888
Q ss_pred e-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEE--------------
Q 018656 94 K-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL-------------- 158 (352)
Q Consensus 94 ~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili-------------- 158 (352)
. .+..++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 7 45899999999 6788888877665569999999999999999999999999999999999999
Q ss_pred -----eCCCCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCC
Q 018656 159 -----TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPF 233 (352)
Q Consensus 159 -----~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 233 (352)
+.+ +.+||+|||++..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 171 ~~~~~~~~-~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 171 CEEKSVKN-TSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE--------LGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp CCEEEESC-CCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccCC-CcEEEeecCccccccc--cccCCcCCCcccCCeeeec--------CCCCCccchHHHHHHHHHHHhCCCCC
Confidence 444 7899999999975332 2345579999999999854 56889999999999999999999999
Q ss_pred CCCChHHHHHHHHhccCC-------------------------------------------CCCCCCcHHHHHHHHHhhc
Q 018656 234 EGMSNLQAAYAAAFKNVR-------------------------------------------PSAENVPEELSIILTSCWK 270 (352)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~l~~li~~~l~ 270 (352)
.+................ ......+.++.++|.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 987655433322211110 0111235689999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhcc
Q 018656 271 EDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 271 ~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
.||.+|||+.++++| .|+...
T Consensus 320 ~dP~~Rpt~~e~l~h--p~f~~~ 340 (355)
T 2eu9_A 320 FDPAQRITLAEALLH--PFFAGL 340 (355)
T ss_dssp SSTTTSCCHHHHTTS--GGGGGC
T ss_pred CChhhCcCHHHHhcC--hhhcCC
Confidence 999999999999998 555543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=330.67 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=201.0
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-----------CCC
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-----------HRN 85 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~ 85 (352)
..+...+|++.+.||+|+||+||+|.+. |+.||||++.... .....+.+|++++++++ |||
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK------VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc------cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 3456789999999999999999999984 8999999986422 22345778888888875 899
Q ss_pred eeeeeeeeecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCCeEEe
Q 018656 86 LVKFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLT 159 (352)
Q Consensus 86 iv~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dikp~Nili~ 159 (352)
|+++++++... ..+++||++ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 99999998632 689999999 88999999886666699999999999999999999998 999999999999995
Q ss_pred CC-----CCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCC
Q 018656 160 ED-----LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234 (352)
Q Consensus 160 ~~-----~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 234 (352)
.+ .+.+||+|||++..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhC--------CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 32 24799999999976433 2344578999999999864 567899999999999999999999998
Q ss_pred CCChH------HHHHHHHhc-----------------------------------------cCCCCCCCCcHHHHHHHHH
Q 018656 235 GMSNL------QAAYAAAFK-----------------------------------------NVRPSAENVPEELSIILTS 267 (352)
Q Consensus 235 ~~~~~------~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~li~~ 267 (352)
+.... ......... .....+..++.++.++|.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 316 (373)
T 1q8y_A 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316 (373)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHH
Confidence 65421 111111110 0011123456789999999
Q ss_pred hhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 268 CWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 268 ~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
||+.||.+|||+.++++| .|+..
T Consensus 317 ~L~~dP~~Rpt~~ell~h--p~f~~ 339 (373)
T 1q8y_A 317 MLQLDPRKRADAGGLVNH--PWLKD 339 (373)
T ss_dssp GGCSSTTTCBCHHHHHTC--GGGTT
T ss_pred HhccCccccCCHHHHhhC--hhhhc
Confidence 999999999999999998 55554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=331.90 Aligned_cols=246 Identities=23% Similarity=0.275 Sum_probs=198.0
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CC-----Ceeeeeeeee
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HR-----NLVKFIGACK 94 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~iv~l~~~~~ 94 (352)
.++|++.+.||+|+||+||+|.+. |+.||||++.... .....+.+|+.+++.++ |+ +|+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH------HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 478999999999999999999985 7899999987432 22344667777777774 44 4999999887
Q ss_pred -cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCCeEEeC-CCCceEEecC
Q 018656 95 -EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--SHGIIHRDLKPENLLLTE-DLKTIKLADF 170 (352)
Q Consensus 95 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dikp~Nili~~-~~~~vkl~Df 170 (352)
.+..++||||++ ++|.+++.......+++..++.++.|++.||.||| +.||+||||||+|||++. +.+.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 458999999995 59999998876556999999999999999999999 579999999999999964 2368999999
Q ss_pred CCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 018656 171 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 171 g~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
|++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..........
T Consensus 206 G~a~~~~~--~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 206 GSSCQLGQ--RIYQYIQSRFYRSPEVLLG--------MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp TTCEETTC--CCCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cCceeccc--ccccccCCccccChHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99976532 2345679999999999865 5688999999999999999999999998776655444332211
Q ss_pred CCC--------------------------------------CCC-------------------------CcHHHHHHHHH
Q 018656 251 RPS--------------------------------------AEN-------------------------VPEELSIILTS 267 (352)
Q Consensus 251 ~~~--------------------------------------~~~-------------------------~~~~l~~li~~ 267 (352)
.+. ... .++++.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 110 000 01478999999
Q ss_pred hhccCCCCCCCHHHHHHH
Q 018656 268 CWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 268 ~l~~~p~~Rps~~~i~~~ 285 (352)
||+.||.+|||+.++++|
T Consensus 356 mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HTCSCTTTSCCHHHHTTS
T ss_pred hcCCChhhCCCHHHHhcC
Confidence 999999999999999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=339.39 Aligned_cols=271 Identities=23% Similarity=0.325 Sum_probs=195.1
Q ss_pred CCCCCcccccccccccccceecCCceeeeccccCCCceEE-EEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHh
Q 018656 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKV-YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79 (352)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V-y~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~ 79 (352)
|.+....-..+.-...+.+.+...+|.+.+.||+|+||+| |++..+|+.||||++...... .+.+|+++++
T Consensus 1 M~ss~s~~~~~~~~~~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~--------~~~~E~~~l~ 72 (432)
T 3p23_A 1 MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS--------FADREVQLLR 72 (432)
T ss_dssp -----------------CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE--------ECHHHHHHHH
T ss_pred CCCCcccccCcCcccCCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH--------HHHHHHHHHH
Confidence 4433333333444556678899999999999999999985 455667999999998654332 2457999999
Q ss_pred cC-CCCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeE
Q 018656 80 RV-QHRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157 (352)
Q Consensus 80 ~l-~hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nil 157 (352)
.+ +||||+++++++.+ ...++||||+. ++|.+++..... .+.+..++.++.||+.||+|||++||+||||||+|||
T Consensus 73 ~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIl 150 (432)
T 3p23_A 73 ESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNIL 150 (432)
T ss_dssp HSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEE
T ss_pred hccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEE
Confidence 99 89999999999875 47899999995 599999987543 2555567789999999999999999999999999999
Q ss_pred EeCC----CCceEEecCCCccccccc----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-
Q 018656 158 LTED----LKTIKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH- 228 (352)
Q Consensus 158 i~~~----~~~vkl~Dfg~a~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~- 228 (352)
++.+ ...++|+|||++...... .......||+.|+|||++.+. ....++.++|||||||++|+|++
T Consensus 151 l~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~t~~~DiwSlG~il~ellt~ 225 (432)
T 3p23_A 151 ISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED-----CKENPTYTVDIFSAGCVFYYVISE 225 (432)
T ss_dssp ECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC--------CCCTHHHHHHHHHHHHHHHTT
T ss_pred EecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcc-----cccCCCcHHHHHHHHHHHHHHHcC
Confidence 9532 125789999999764432 223445799999999998531 12456789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhccCC--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 229 NKLPFEGMSNLQAAYAAAFKNVR--PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 229 g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
|..||.................. ......+..+.++|.+||+.||.+|||+.++++|.
T Consensus 226 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 226 GSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp SCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred CCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 99999765443332221111111 11233456789999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=324.34 Aligned_cols=265 Identities=24% Similarity=0.353 Sum_probs=205.6
Q ss_pred ccccccccccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHH-HHHHHHHHHHHHHHhcCC--C
Q 018656 9 LADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQ--H 83 (352)
Q Consensus 9 ~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~--h 83 (352)
-+..+.....+....++|++++.||+|+||.||+|.+. |+.||||++......... .....++.+|+.+++++. |
T Consensus 28 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 107 (320)
T 3a99_A 28 HATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107 (320)
T ss_dssp ------------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSS
T ss_pred hhhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCC
Confidence 33445555566777899999999999999999999984 889999998764321100 001123567899999986 5
Q ss_pred CCeeeeeeeeec-CceEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC
Q 018656 84 RNLVKFIGACKE-PVMVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161 (352)
Q Consensus 84 p~iv~l~~~~~~-~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~ 161 (352)
|||+++++++.+ +..++|+|++.+ ++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+
T Consensus 108 ~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN 185 (320)
T ss_dssp CSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred CCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC
Confidence 999999999985 478999999976 899999987654 8999999999999999999999999999999999999944
Q ss_pred CCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH
Q 018656 162 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA 241 (352)
Q Consensus 162 ~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 241 (352)
.+.+||+|||++...... ......||+.|+|||++.+ ....+.++||||||+++|+|++|+.||....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~---- 253 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 253 (320)
T ss_dssp TTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred CCCEEEeeCccccccccc-cccCCCCCccCCChHHhcc-------CCCCCccchHHhHHHHHHHHHHCCCCCCChh----
Confidence 379999999998765432 2344579999999998854 2334778999999999999999999997632
Q ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 242 AYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.........+..+++++.++|.+||+.||.+|||+.+++++ .++..
T Consensus 254 ---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h--p~~~~ 299 (320)
T 3a99_A 254 ---EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH--PWMQD 299 (320)
T ss_dssp ---HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGSS
T ss_pred ---hhhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC--HhhcC
Confidence 11122334456889999999999999999999999999998 44443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=322.93 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=196.1
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHH-HHHHHHHHHHHHHHhcC----CCCCeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRV----QHRNLVKFIG 91 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l----~hp~iv~l~~ 91 (352)
.....++|++++.||+|+||.||+|.+. |+.||||++......... ......+.+|+.+++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4455788999999999999999999884 889999999765432211 11223456788888888 8999999999
Q ss_pred eee-cCceEEEEEc-CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 92 ACK-EPVMVIVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 92 ~~~-~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
++. ++..++|+|+ +.+++|.+++.+... +++..++.++.|++.||+|||++|++||||||+||+++.+.+.++|+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 987 4578999999 789999999987654 999999999999999999999999999999999999993338999999
Q ss_pred CCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 170 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
||++...... ......|+..|+|||++.+ ....+.++||||||+++|+|++|+.||..... ....
T Consensus 184 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~ 248 (312)
T 2iwi_A 184 FGSGALLHDE-PYTDFDGTRVYSPPEWISR-------HQYHALPATVWSLGILLYDMVCGDIPFERDQE-------ILEA 248 (312)
T ss_dssp CSSCEECCSS-CBCCCCSCTTTSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHT
T ss_pred cchhhhcccC-cccccCCcccccCceeeec-------CCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------Hhhh
Confidence 9998765433 2345578999999998754 12335589999999999999999999975311 1122
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
....+..++.++.++|.+||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 334456789999999999999999999999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.68 Aligned_cols=230 Identities=15% Similarity=0.155 Sum_probs=187.2
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
+..++|++.+.||+|+||.||+|.+. |+.||||++........ .....+.+|+..+++++||||+++++++.+ +.
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 105 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD--DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG 105 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCH--HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence 34578999999999999999999996 89999999987654332 334568899999999999999999999874 57
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++||||++|++|.+++... ....++..++.|++.||+|||++||+||||||+|||++.+ +.++|+++|..
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~-g~~kl~~~~~~---- 176 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPATM---- 176 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT-SCEEECSCCCC----
T ss_pred EEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC-CCEEEEecccc----
Confidence 99999999999999999542 4556788999999999999999999999999999999988 78999855432
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH---HHHhccCC---
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY---AAAFKNVR--- 251 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~---~~~~~~~~--- 251 (352)
+ .++.++|||||||++|+|++|+.||.+.+...... ........
T Consensus 177 ---------------~---------------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T 3uqc_A 177 ---------------P---------------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226 (286)
T ss_dssp ---------------T---------------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH
T ss_pred ---------------C---------------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh
Confidence 2 24678999999999999999999998755422110 00000011
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.....+|+++.++|.+||+.||.+| |+.++++.|......
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 1135789999999999999999999 999999999877643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=308.63 Aligned_cols=226 Identities=26% Similarity=0.392 Sum_probs=180.4
Q ss_pred Cceeee-ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHH-hcCCCCCeeeeeeeeec----
Q 018656 24 KHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML-SRVQHRNLVKFIGACKE---- 95 (352)
Q Consensus 24 ~~y~~~-~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~l~~~~~~---- 95 (352)
.+|.+. +.||+|+||.||+|.+. |+.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 346665 88999999999999984 889999998642 1356788877 66699999999998764
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCC
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGL 172 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~ 172 (352)
...++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ .+.++|+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 468999999999999999998766679999999999999999999999999999999999999872 26899999998
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc---
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--- 249 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--- 249 (352)
+.... ...++.++|||||||++|+|++|..||.+..............
T Consensus 167 a~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 217 (299)
T 3m2w_A 167 AKETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217 (299)
T ss_dssp CEECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred ccccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence 85421 1345779999999999999999999997644322111000000
Q ss_pred CCCC----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 250 VRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 250 ~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
.... ...+++++.++|.+||+.||.+|||+.++++|.+-
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 0011 15689999999999999999999999999998543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=329.47 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=187.9
Q ss_pred CCceeeeccccCCCceEEEEE-EECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEG-KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~-~~~~ 99 (352)
.+.|.+.+.||+|+||+||.+ ..+|+.||||++.... ...+.+|+++++++ +||||+++++++.+ +..+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 456677899999999999765 4469999999986522 22467899999876 89999999999875 4789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC------------C
Q 018656 100 IVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED------------L 162 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~-----~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~------------~ 162 (352)
+||||++ ++|.+++....... .++..++.++.|++.||+|||++||+||||||+|||++.+ .
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999995 59999998654311 1333467899999999999999999999999999999753 2
Q ss_pred CceEEecCCCcccccccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 018656 163 KTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGM 236 (352)
Q Consensus 163 ~~vkl~Dfg~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~ 236 (352)
..+||+|||++....... ......||+.|+|||++.+.... .....++.++|||||||++|+|++ |..||...
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL-QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTT-SCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccc-ccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 479999999998644322 12345799999999998542110 113568899999999999999998 99999875
Q ss_pred ChHHHHHHHHhccCCCC----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 237 SNLQAAYAAAFKNVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 237 ~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
................. ...++.++.++|.+||+.||.+|||+.++++|.+
T Consensus 244 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp TTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 54432221111111111 1235688999999999999999999999998743
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=323.56 Aligned_cols=255 Identities=16% Similarity=0.233 Sum_probs=189.9
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC-CCee--------
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLV-------- 87 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv-------- 87 (352)
+-....+|.+++.||+|+||+||+|.+. |+.||||++........ .....+.+|+.+++.+.| +|..
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS--NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH--HHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 3345567999999999999999999986 99999999875443322 234568899999999977 2211
Q ss_pred -------------eeeeeee------cCceEEEEEcCCCCCHHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 018656 88 -------------KFIGACK------EPVMVIVTELLSGGTLRKYLLN-----MRPRCLDVCVAIGFALDIARAMECLHS 143 (352)
Q Consensus 88 -------------~l~~~~~------~~~~~lv~e~~~~~sL~~~l~~-----~~~~~~~~~~~~~i~~qi~~~L~~lH~ 143 (352)
.+..++. ....+++|+.+ +++|.+++.. .....+++..++.++.|+++||+|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 1111111 11367778877 6799999852 223347888999999999999999999
Q ss_pred CCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCCCcccccccccccccc--cccccccCCCcccchhhHHH
Q 018656 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHKVDSYSFAI 221 (352)
Q Consensus 144 ~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~~~~~~~DiwslG~ 221 (352)
+||+||||||+|||++.+ +.+||+|||+++..... .....| +.|+|||++.... ........++.++|||||||
T Consensus 230 ~~iiHrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TTEECSCCCGGGEEECTT-CCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CCcccCCcccceEEEecC-CeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999998 78999999998764433 345567 9999999984311 00002356788999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 222 VLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 222 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
++|+|++|+.||.+....... .........+|+++.++|.+||+.||.+||++.+++++
T Consensus 306 il~elltg~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGS-----EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCS-----GGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHCCCCCCCcchhhhH-----HHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999999875432211 11122234789999999999999999999999888775
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=339.13 Aligned_cols=250 Identities=27% Similarity=0.353 Sum_probs=197.2
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec------
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------ 95 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 95 (352)
++|++.+.||+|+||+||+|.+. |+.||||++...... .....+.+|++++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP----KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH----HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH----HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 68999999999999999999874 899999998765432 334568899999999999999999998643
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC--ceEEecCC
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFG 171 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~--~vkl~Dfg 171 (352)
+..++||||++|++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+||+++.+++ .++|+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 367999999999999999987542 25899999999999999999999999999999999999987622 38999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHH--------
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY-------- 243 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~-------- 243 (352)
++.............|++.|+|||++.+ ..++.++||||||+++|+|++|..||.+........
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQ--------KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCC--------SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred cccccccccccccccCCcccCChHHhcc--------CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 9987665555566789999999999854 678899999999999999999999997643221100
Q ss_pred HH-Hhc----------cCCCC----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 244 AA-AFK----------NVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 244 ~~-~~~----------~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.. ... ...+. ...+++.+.++|.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 00 000 00011 22367899999999999999999999885543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.84 Aligned_cols=238 Identities=25% Similarity=0.283 Sum_probs=191.1
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC---CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~- 96 (352)
+..++|++.+.||+|+||+||+|.+. |+.||||++...... .....+.+|+.++++++||||+++++++.+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA----EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH----HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 34589999999999999999999984 789999998765432 2344688999999999999999999998643
Q ss_pred c-----eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 97 V-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 97 ~-----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
. .|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG 226 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLG 226 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCT
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecc
Confidence 3 6999999999999998754 39999999999999999999999999999999999999875 79999999
Q ss_pred CccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 172 ~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
++...... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... ..
T Consensus 227 ~a~~~~~~---~~~~gt~~y~aPE~~~~---------~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~ 284 (681)
T 2pzi_A 227 AVSRINSF---GYLYGTPGFQAPEIVRT---------GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GL 284 (681)
T ss_dssp TCEETTCC---SCCCCCTTTSCTTHHHH---------CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SC
T ss_pred cchhcccC---CccCCCccccCHHHHcC---------CCCCceehhhhHHHHHHHHhCCCCCcccccc----------cc
Confidence 99764333 44579999999998753 2478999999999999999999888752110 00
Q ss_pred CC---CCCCcHHHHHHHHHhhccCCCCCCCH-HHHHHHHHHhh
Q 018656 252 PS---AENVPEELSIILTSCWKEDPNARPNF-TQIIQMLLNYL 290 (352)
Q Consensus 252 ~~---~~~~~~~l~~li~~~l~~~p~~Rps~-~~i~~~l~~~~ 290 (352)
+. ....++.+.++|.+||+.||.+||+. +++...+...+
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 11 11245789999999999999999964 44554454443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=307.00 Aligned_cols=243 Identities=16% Similarity=0.195 Sum_probs=183.6
Q ss_pred ecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChH---HHHHHHHHHHHHHHHHhcCC---------CCCeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPE---EIAKKESRFAREVAMLSRVQ---------HRNLVK 88 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~---------hp~iv~ 88 (352)
+..++|++++.||+|+||+||+|+++|+.||||++....... ........+.+|+.+++.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 456789999999999999999999999999999998754210 00011234667777777664 777777
Q ss_pred eeeeee-------------------------------cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q 018656 89 FIGACK-------------------------------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137 (352)
Q Consensus 89 l~~~~~-------------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~ 137 (352)
+.+++. ++..++||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 766532 4689999999999976666643 348999999999999999
Q ss_pred HHHHH-hCCCccCCCCCCCeEEeCCCC--------------------ceEEecCCCccccccccccccCCCccccccccc
Q 018656 138 MECLH-SHGIIHRDLKPENLLLTEDLK--------------------TIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196 (352)
Q Consensus 138 L~~lH-~~~ivH~Dikp~Nili~~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~ 196 (352)
|+||| ++||+||||||+|||++.+ + .+||+|||+++..... ...||+.|+|||+
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhh
Confidence 99999 9999999999999999887 4 8999999999864332 3479999999999
Q ss_pred ccccccccccccCCCcccchhhHHHH-HHHHHhCCCCCCCCChHHHHHHHHh-c-cCCCC-----CCCCcHHHHHHHHHh
Q 018656 197 YSTVTLRQGEKKHYNHKVDSYSFAIV-LWELLHNKLPFEGMSNLQAAYAAAF-K-NVRPS-----AENVPEELSIILTSC 268 (352)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~DiwslG~i-l~~ll~g~~p~~~~~~~~~~~~~~~-~-~~~~~-----~~~~~~~l~~li~~~ 268 (352)
+.+ .. +.++|||||+++ .++++.|..||.+............ . ..... +..+++++.+||++|
T Consensus 249 ~~g--------~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 249 FTG--------DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp GCC--------CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred hcC--------CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 864 22 779999998777 6778889999854211011111111 1 11111 235788999999999
Q ss_pred hccCCCCCCCHHHHH-HH
Q 018656 269 WKEDPNARPNFTQII-QM 285 (352)
Q Consensus 269 l~~~p~~Rps~~~i~-~~ 285 (352)
|+.| |+.+++ +|
T Consensus 320 L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 320 LNFS-----SATDLLCQH 332 (336)
T ss_dssp GGSS-----SHHHHHHHC
T ss_pred hccC-----CHHHHHhcC
Confidence 9976 999999 77
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=273.22 Aligned_cols=184 Identities=17% Similarity=0.177 Sum_probs=130.1
Q ss_pred cccCCCceEEEEEEE--CCceEEEEEcccCC-----ChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeeecC-ceEEE
Q 018656 31 RIGEGAHAKVYEGKY--KNQTVAIKIVHKGE-----TPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIV 101 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~-~~~lv 101 (352)
..+.|++|.+..++. .|+.+++|++.... ..........++.+|+++|+++ .|+||++++++++++ ..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467788887777655 59999999997653 2223334456799999999999 799999999999854 79999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-c
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~-~ 180 (352)
|||++|++|.++|.+.+. +++. .|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... .
T Consensus 321 MEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-SCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC-CCEEEeecccCeeCCCCCc
Confidence 999999999999987554 6665 478999999999999999999999999999998 89999999999854332 3
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 229 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g 229 (352)
...+.+||+.|+|||++.+ .+..++|+||+|++++++.++
T Consensus 395 ~~~t~vGTp~YmAPE~l~g---------~~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE---------NKSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp CSHHHHHHHHHHHHHHC--------------------------CCCCTT
T ss_pred cccCceechhhccHHHhCC---------CCCCcccccccccchhhhccc
Confidence 3445679999999999854 356789999999998877554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=248.12 Aligned_cols=186 Identities=22% Similarity=0.302 Sum_probs=145.1
Q ss_pred eccccCCCceEEEEEEECCceEEEEEcccCCChH---HHHHHHHHHHHHHHHHhcCCCCCee--eeeeeeecCceEEEEE
Q 018656 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPE---EIAKKESRFAREVAMLSRVQHRNLV--KFIGACKEPVMVIVTE 103 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv--~l~~~~~~~~~~lv~e 103 (352)
.+.||+|+||+||+|...++.+++|......... .......++.+|++++++++||||+ .+++. .....++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-DLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-ETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-eCCccEEEEE
Confidence 6789999999999998889999999876543321 1122356789999999999999999 44444 3456799999
Q ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccccc--
Q 018656 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-- 181 (352)
Q Consensus 104 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~-- 181 (352)
|++|++|.+++.. ++.++.|+++||+|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCccccc
Confidence 9999999999875 4579999999999999999999999999999987 799999999986544321
Q ss_pred ------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCC
Q 018656 182 ------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234 (352)
Q Consensus 182 ------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 234 (352)
.....||+.|+|||++... ...|+..+|+|+..+-..+-..++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~------~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERF------LEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHH------HHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHH------HHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2355799999999998642 1456778999999988888887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=200.89 Aligned_cols=150 Identities=19% Similarity=0.166 Sum_probs=118.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChH-------------HHHHHHHHHHHHHHHHhcCCCCCeee
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPE-------------EIAKKESRFAREVAMLSRVQHRNLVK 88 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~hp~iv~ 88 (352)
...|.+++.||+|+||.||+|.+. |+.||||++....... ........+.+|++++++++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 445567799999999999999984 8999999986543211 01123456889999999998 5 67
Q ss_pred eeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEe
Q 018656 89 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (352)
Q Consensus 89 l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~ 168 (352)
+.+++..+..++||||++|++|.+ +. .+ ....++.|++.||.|||++||+||||||+|||++ + +.++|+
T Consensus 166 v~~~~~~~~~~lvmE~~~g~~L~~-l~------~~--~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~ 234 (282)
T 1zar_A 166 VPKVYAWEGNAVLMELIDAKELYR-VR------VE--NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWII 234 (282)
T ss_dssp SCCEEEEETTEEEEECCCCEEGGG-CC------CS--CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEEC
T ss_pred cCeEEeccceEEEEEecCCCcHHH-cc------hh--hHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEE
Confidence 777666677899999999999998 42 11 2446899999999999999999999999999999 6 899999
Q ss_pred cCCCccccccccccccCCCccccccccccc
Q 018656 169 DFGLAREESLTEMMTAETGTYRWMAPELYS 198 (352)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~ 198 (352)
|||++.. +..+.|||.+.
T Consensus 235 DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE------------TTSTTHHHHHH
T ss_pred ECCCCeE------------CCCCCHHHHHH
Confidence 9999864 33567888763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.6e-23 Score=178.78 Aligned_cols=142 Identities=19% Similarity=0.188 Sum_probs=108.7
Q ss_pred CceeeeccccCCCceEEEEEEE--CCce--EEEEEcccCCChHH-------------------HHHHHHHHHHHHHHHhc
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKY--KNQT--VAIKIVHKGETPEE-------------------IAKKESRFAREVAMLSR 80 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~--vaiK~~~~~~~~~~-------------------~~~~~~~~~~E~~~l~~ 80 (352)
.-|.+.+.||+|+||.||+|.+ +|+. ||||+++....... .......+.+|+..+++
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3478899999999999999988 6888 99999765421100 11223457889999999
Q ss_pred CCCCCe--eeeeeeeecCceEEEEEcCCC-C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCC
Q 018656 81 VQHRNL--VKFIGACKEPVMVIVTELLSG-G----TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLK 152 (352)
Q Consensus 81 l~hp~i--v~l~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH-~~~ivH~Dik 152 (352)
+.|+++ +..++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.||+|||||
T Consensus 127 l~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HHhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 988764 333432 357899999942 3 78776543 234567789999999999999 9999999999
Q ss_pred CCCeEEeCCCCceEEecCCCcccc
Q 018656 153 PENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 153 p~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS---SEEECCCTTCEET
T ss_pred HHHEEEcC---cEEEEECcccccC
Confidence 99999987 7999999998753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.7e-20 Score=168.05 Aligned_cols=143 Identities=19% Similarity=0.220 Sum_probs=100.1
Q ss_pred ceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCCh-----------------HHHHHHHHHHHHHHHHHhcCCCCCe
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETP-----------------EEIAKKESRFAREVAMLSRVQHRNL 86 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~-----------------~~~~~~~~~~~~E~~~l~~l~hp~i 86 (352)
-|.++..||+|++|.||+|.+. |+.||||+++..... ...........+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4899999999999999999984 899999987642110 0000111112356677777754443
Q ss_pred eeeeeeeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCC---
Q 018656 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--- 163 (352)
Q Consensus 87 v~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~--- 163 (352)
. ....+.....++||||++|.+|.++.. .+ ....++.|++.+|.+||+.|||||||||.|||+++++.
T Consensus 176 ~-vp~p~~~~~~~LVME~i~G~~L~~l~~------~~--~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 176 P-VPEPIAQSRHTIVMSLVDALPMRQVSS------VP--DPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp S-CCCEEEEETTEEEEECCSCEEGGGCCC------CS--CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred C-CCeeeeccCceEEEEecCCccHhhhcc------cH--HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 2 222222223479999999988865421 22 24567899999999999999999999999999987621
Q ss_pred ------ceEEecCCCcccc
Q 018656 164 ------TIKLADFGLAREE 176 (352)
Q Consensus 164 ------~vkl~Dfg~a~~~ 176 (352)
.+.|+||+.+...
T Consensus 247 ~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECCCTTCEET
T ss_pred ccccccceEEEEeCCcccC
Confidence 3889999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=1.3e-13 Score=120.07 Aligned_cols=138 Identities=16% Similarity=0.103 Sum_probs=107.0
Q ss_pred ceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeec-CceEEEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE-PVMVIVT 102 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~-~~~~lv~ 102 (352)
.|++...+|.|+.+.||++...|+.+++|+........ ...+.+|.++++.+. +..+.++++++.+ +..|+||
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 48888889999999999998888999999986521110 113678888888874 6678888888764 5789999
Q ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 018656 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS--------------------------------------- 143 (352)
Q Consensus 103 e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~--------------------------------------- 143 (352)
|+++|.+|.+.+. +......++.+++++|..||+
T Consensus 90 e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 90 SEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp ECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 9999999987632 112234678899999999998
Q ss_pred --------------------CCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 144 --------------------HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 144 --------------------~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..++|+|++|.||+++++ +.+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhccc
Confidence 348999999999999875 4566999997643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=2e-11 Score=105.76 Aligned_cols=132 Identities=17% Similarity=0.116 Sum_probs=94.4
Q ss_pred ceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC--eeeeeeeeec-CceEE
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN--LVKFIGACKE-PVMVI 100 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~l~~~~~~-~~~~l 100 (352)
.+.+....+.|..+.||++... |+.+++|+...... ..+.+|+++++.+.+.+ +.+++++..+ +..++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~--------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc--------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 3444444456677999999764 67899999765411 13667888888775434 5567777664 46899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG----------------------------------- 145 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~----------------------------------- 145 (352)
||||++|.+|. ... .+. ..++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999998884 211 222 246777888888888754
Q ss_pred -----------------------CccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 146 -----------------------IIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 146 -----------------------ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
++|+|++|.||+++++ +.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence 8999999999999876 4566999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.5e-11 Score=112.03 Aligned_cols=141 Identities=15% Similarity=0.249 Sum_probs=105.4
Q ss_pred eeeccccCCCceEEEEEEECCceEEEEEcc--cCCChHHHHHHHHHHHHHHHHHhcCC--CCCeeeeeeeeecC----ce
Q 018656 27 FVGPRIGEGAHAKVYEGKYKNQTVAIKIVH--KGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGACKEP----VM 98 (352)
Q Consensus 27 ~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~----~~ 98 (352)
.-.+.|+.|.++.||+....+..+++|+.. ..... .....+.+|.++++.+. +..+++++.++.+. ..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~----~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL----PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC----CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 345678999999999998888899999876 32211 11234778999988886 45578888887643 47
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS----------------------------------- 143 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~----------------------------------- 143 (352)
++||||++|..+.+.. ...++......++.+++++|..||+
T Consensus 117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999999998875411 1237788888999999999999997
Q ss_pred -----------------------CCCccCCCCCCCeEEeCCCC-ceEEecCCCccc
Q 018656 144 -----------------------HGIIHRDLKPENLLLTEDLK-TIKLADFGLARE 175 (352)
Q Consensus 144 -----------------------~~ivH~Dikp~Nili~~~~~-~vkl~Dfg~a~~ 175 (352)
..++|+|++|.||+++.+.+ .+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987633 358999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.14 E-value=5.3e-11 Score=105.79 Aligned_cols=191 Identities=20% Similarity=0.226 Sum_probs=120.7
Q ss_pred eccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCC--eeeeeeeeecC----ceEEE
Q 018656 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRN--LVKFIGACKEP----VMVIV 101 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~--iv~l~~~~~~~----~~~lv 101 (352)
.+.++.|....||+. ++.+++|+.... .....+.+|.++++.+ .+.. +.+++...... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v---~~~~vlR~~~~~-------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI---NRDFIFKFPKHS-------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEES---TTSEEEEEESSH-------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEE---CCEEEEEecCCc-------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 345899999999986 367999986432 2234578899988877 3322 34555443322 35899
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-------------------------------------- 143 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-------------------------------------- 143 (352)
|++++|.+|.+.... .++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999988764332 27788888889999999999996
Q ss_pred --------------------CCCccCCCCCCCeEEeCC-CCceEEecCCCccccccccccccCCCcccccccccccccc-
Q 018656 144 --------------------HGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT- 201 (352)
Q Consensus 144 --------------------~~ivH~Dikp~Nili~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~- 201 (352)
..++|+|++|.||+++.+ .+.+.|+||+.+.................-..|+.....-
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 136999999999999984 2567899999986432221111100000001222111000
Q ss_pred ccccc-----ccCCCcccchhhHHHHHHHHHhCCCCC
Q 018656 202 LRQGE-----KKHYNHKVDSYSFAIVLWELLHNKLPF 233 (352)
Q Consensus 202 ~~~~~-----~~~~~~~~DiwslG~il~~ll~g~~p~ 233 (352)
..... ........+.|+++.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00000 001112358999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=8.3e-08 Score=85.14 Aligned_cols=133 Identities=20% Similarity=0.225 Sum_probs=93.7
Q ss_pred eccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCC---Ceeeeeeeee--cCceEEEEE
Q 018656 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR---NLVKFIGACK--EPVMVIVTE 103 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~l~~~~~--~~~~~lv~e 103 (352)
...++.|....||+. |+.+++|+... . .....+.+|.++++.+.+. .|.+++.+.. ++..++|||
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~---~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS---Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS---H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC---c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 345789999999988 78899998532 1 2234688999999988642 3556666653 346789999
Q ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 018656 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------------------------------------- 144 (352)
Q Consensus 104 ~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--------------------------------------- 144 (352)
+++|.+|.+..-. .++......++.++.+.|..||+.
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999888764221 145555556666666666666643
Q ss_pred ---------------------CCccCCCCCCCeEEeC---CCCceEEecCCCccc
Q 018656 145 ---------------------GIIHRDLKPENLLLTE---DLKTIKLADFGLARE 175 (352)
Q Consensus 145 ---------------------~ivH~Dikp~Nili~~---~~~~vkl~Dfg~a~~ 175 (352)
.++|+|++|.||+++. +...+.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3489999999999987 323458999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.9e-07 Score=79.88 Aligned_cols=129 Identities=19% Similarity=0.142 Sum_probs=90.7
Q ss_pred ccCCCce-EEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeee-cCceEEEEEcCC
Q 018656 32 IGEGAHA-KVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACK-EPVMVIVTELLS 106 (352)
Q Consensus 32 lG~G~~g-~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~-~~~~~lv~e~~~ 106 (352)
+..|..+ .||+.... +..+++|+-... ....+.+|...++.+. +--|.+++.++. .+..++|||+++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 3344444 68987654 568999986532 2234778888887773 333667777776 457899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH------------------------------------------ 144 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~------------------------------------------ 144 (352)
|.++.+...... .....+..++...|..||+.
T Consensus 104 G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 104 GKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp SEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred CccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 999888765421 12334667777888888841
Q ss_pred ----------------CCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 145 ----------------GIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 145 ----------------~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
.++|+|+.+.||+++.+ +.+-|+||+.+..
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~ 223 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence 16899999999999976 5566999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=3.6e-07 Score=82.72 Aligned_cols=82 Identities=9% Similarity=0.062 Sum_probs=53.5
Q ss_pred eeeeccc-cCCCceEEEEEEEC--------CceEEEEEcccCCC--hHHHHHHHHHHHHHHHHHhcCC-C--CCeeeeee
Q 018656 26 LFVGPRI-GEGAHAKVYEGKYK--------NQTVAIKIVHKGET--PEEIAKKESRFAREVAMLSRVQ-H--RNLVKFIG 91 (352)
Q Consensus 26 y~~~~~l-G~G~~g~Vy~~~~~--------~~~vaiK~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~-h--p~iv~l~~ 91 (352)
....+.| +.|....+|+.... ++.+++|+...... ... ...+.+|..+++.+. + -.+.+++.
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~----~~~~~~E~~~l~~L~~~~~vpvP~v~~ 97 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP----TYRLDHQFEVIRLVGELTDVPVPRVRW 97 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS----CCCHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc----hhHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 3445678 88999999988764 77899998654220 000 012556777777663 2 34667777
Q ss_pred eeecC----ceEEEEEcCCCCCHH
Q 018656 92 ACKEP----VMVIVTELLSGGTLR 111 (352)
Q Consensus 92 ~~~~~----~~~lv~e~~~~~sL~ 111 (352)
+..+. ..++|||+++|.++.
T Consensus 98 ~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 98 IETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp EECSSTTTSSCEEEEECCCCBCCC
T ss_pred EccCCCccCCceEEEEecCCCChh
Confidence 76543 468999999986654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=6e-07 Score=82.57 Aligned_cols=80 Identities=20% Similarity=0.101 Sum_probs=48.2
Q ss_pred eeccccCCCceEEEEEEE--CCceEEEEEcccCCC-hHHH-HHHHHHHHHHHHHHhcCCC--C-CeeeeeeeeecCceEE
Q 018656 28 VGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGET-PEEI-AKKESRFAREVAMLSRVQH--R-NLVKFIGACKEPVMVI 100 (352)
Q Consensus 28 ~~~~lG~G~~g~Vy~~~~--~~~~vaiK~~~~~~~-~~~~-~~~~~~~~~E~~~l~~l~h--p-~iv~l~~~~~~~~~~l 100 (352)
-.+.||.|..+.||++.. .++.+++|....... .... .....++.+|.++++.+.. | .+.+++.+ .....++
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~l 112 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVT 112 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEE
Confidence 356799999999999964 468899998653211 0000 0012245667777776632 3 34455544 4455789
Q ss_pred EEEcCCCC
Q 018656 101 VTELLSGG 108 (352)
Q Consensus 101 v~e~~~~~ 108 (352)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=2.5e-05 Score=69.84 Aligned_cols=31 Identities=26% Similarity=0.333 Sum_probs=26.9
Q ss_pred CCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 144 ~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..++|+|+++.||+++.+ +.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGG-GCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCC-CcEEEEehhhccc
Confidence 579999999999999766 6799999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.98 E-value=0.00013 Score=60.00 Aligned_cols=142 Identities=13% Similarity=0.102 Sum_probs=93.6
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecCCCccccccccccccCC
Q 018656 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET 186 (352)
Q Consensus 108 ~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 186 (352)
.||.+.+...+ .+++++++|.++.|.+.+|..+-. +.-..+=+.|..|++..+ |.|.+.+ +.+. .
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-G~V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-GAVTLAP-AADD-----------A 98 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-SCEEECC-C---------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-Cceeccc-cccc-----------c
Confidence 48999988765 459999999999999999888622 221233345688899888 7776664 1111 1
Q ss_pred CcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHH
Q 018656 187 GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 266 (352)
Q Consensus 187 g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 266 (352)
....+.|||... ...+.+.=|||||+++|..+-=..|- .....+|+.|.+||.
T Consensus 99 ~~~~~~~pe~~~---------~~~te~~~IysLG~tLY~ALDygL~e------------------~eE~eLS~~LE~LL~ 151 (229)
T 2yle_A 99 GEPPPVAGKLGY---------SQCMETEVIESLGIIIYKALDYGLKE------------------NEERELSPPLEQLID 151 (229)
T ss_dssp --------CCSS---------SSSCHHHHHHHHHHHHHHHHTTTCCT------------------TEEECCCHHHHHHHH
T ss_pred cccCCCChhhcc---------ccchHHHHHHHHHHHHHHHhhcCCCc------------------ccchhhCHHHHHHHH
Confidence 233556888652 23467889999999999887533321 112478899999999
Q ss_pred Hhhcc-------------------------CCCCCCCHHHHHHHHHHhh
Q 018656 267 SCWKE-------------------------DPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 267 ~~l~~-------------------------~p~~Rps~~~i~~~l~~~~ 290 (352)
.|..- .+..|+++++|++.....+
T Consensus 152 ~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl 200 (229)
T 2yle_A 152 HMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHL 200 (229)
T ss_dssp HHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTS
T ss_pred HHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhc
Confidence 99765 2457889999988765544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.93 E-value=5.1e-05 Score=67.12 Aligned_cols=75 Identities=19% Similarity=0.166 Sum_probs=56.8
Q ss_pred eeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC---CCCeeeeeeeee-cCceEEEEE
Q 018656 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRNLVKFIGACK-EPVMVIVTE 103 (352)
Q Consensus 28 ~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~-~~~~~lv~e 103 (352)
-.+.|+.|....+|+....++.+++|+..... ...+.+|.+.++.|. ...+++++.+.. .+..++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~--------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERSY--------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGGG--------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCccc--------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 35678999999999998778899999875421 234677888777773 356778887765 357899999
Q ss_pred cCCCCCH
Q 018656 104 LLSGGTL 110 (352)
Q Consensus 104 ~~~~~sL 110 (352)
+++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.88 E-value=0.00012 Score=67.71 Aligned_cols=34 Identities=21% Similarity=0.383 Sum_probs=28.8
Q ss_pred HhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 142 H~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
+...++|+|++|.|||++.+ + +.++||+.+....
T Consensus 230 ~~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYGP 263 (420)
T ss_dssp BCCEEECSCCSGGGEEECSS-C-EEECCCTTCEEEC
T ss_pred CCCeEEecCCCCCcEEEeCC-C-CEEEeCcccccCc
Confidence 45679999999999999876 4 9999999987543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.85 E-value=4.4e-05 Score=67.18 Aligned_cols=72 Identities=15% Similarity=0.147 Sum_probs=43.9
Q ss_pred eccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe-eeeeeeeecCceEEEEEcC-C
Q 018656 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL-VKFIGACKEPVMVIVTELL-S 106 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~lv~e~~-~ 106 (352)
.+.|+.|....+|+. +.+++|+........ ....+|..+++.+...++ .+++... ...-++++||+ +
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~~~~~-~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY------INRANEAVAAREAAKAGVSPEVLHVD-PATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C------CCHHHHHHHHHHHHHTTSSCCEEEEC-TTTCCEEEECCTT
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce------eCHHHHHHHHHHHHHcCCCCceEEEE-CCCCEEEEeecCC
Confidence 677999999999998 678999876531110 012346666655532222 4555443 33457899999 7
Q ss_pred CCCHH
Q 018656 107 GGTLR 111 (352)
Q Consensus 107 ~~sL~ 111 (352)
|.+|.
T Consensus 92 g~~l~ 96 (301)
T 3dxq_A 92 AQTMS 96 (301)
T ss_dssp CEECC
T ss_pred CccCC
Confidence 65553
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00011 Score=65.13 Aligned_cols=141 Identities=18% Similarity=0.145 Sum_probs=75.8
Q ss_pred eeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-----CCCeeeee-e---eeecCc
Q 018656 27 FVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-----HRNLVKFI-G---ACKEPV 97 (352)
Q Consensus 27 ~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~iv~l~-~---~~~~~~ 97 (352)
.-.+.|+.|....+|+....+..+++|+........ .+..|..+++.|. -|.++... + ....+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~-------~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKN-------DLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEESSCCEEEEEECC---CC-------HHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEeCCccEEEEEeCCCCCHH-------HHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 345667889999999998776689999987532211 2344555555442 23333211 0 012346
Q ss_pred eEEEEEcCCCCCHHH-----------H---HHhc-CC--CC----CCHHHHHHH---------------HHHHHHHHHHH
Q 018656 98 MVIVTELLSGGTLRK-----------Y---LLNM-RP--RC----LDVCVAIGF---------------ALDIARAMECL 141 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~-----------~---l~~~-~~--~~----~~~~~~~~i---------------~~qi~~~L~~l 141 (352)
.++++++++|..+.. . +... .. .. ......... ...+...++.+
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 789999998865311 0 1111 00 00 111100000 01133344455
Q ss_pred Hh-------CCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 142 HS-------HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 142 H~-------~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
++ .+++|+|+.+.||+++.+ +.+.++||+.+..
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 42 368999999999999876 4557999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00013 Score=65.12 Aligned_cols=138 Identities=13% Similarity=0.087 Sum_probs=70.8
Q ss_pred ccccCCCceE-EEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC--CCCeeeeeeeeecCceEEEEEcC
Q 018656 30 PRIGEGAHAK-VYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGACKEPVMVIVTELL 105 (352)
Q Consensus 30 ~~lG~G~~g~-Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~lv~e~~ 105 (352)
+.|+.|+... +|+.... |+.+++|........ .+..|+.+++.+. .-.+.+++.+..+. -+++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~--------~~~~e~~~l~~L~~~g~~vP~v~~~d~~~-g~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGG--------DTQPFVDLAQYLRNLDISAPEIYAEEHAR-GLLLIEDL 94 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTTC--------CSHHHHHHHHHHHHTTCBCCCEEEEETTT-TEEEECCC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCc--------cccHHHHHHHHHHhCCCCCCceeeecCCC-CEEEEeeC
Confidence 4566665554 6677664 777888875443211 1234555555442 12345566553333 37899999
Q ss_pred CCCCHHHHHHhcCC------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHH
Q 018656 106 SGGTLRKYLLNMRP------------------------RCLDVCVAI-------GFA-------------LDIARAMECL 141 (352)
Q Consensus 106 ~~~sL~~~l~~~~~------------------------~~~~~~~~~-------~i~-------------~qi~~~L~~l 141 (352)
.+..+.+++..... ..++..... .+. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 87777665532100 012221110 000 0111122222
Q ss_pred ------HhCCCccCCCCCCCeEEeCC---CCceEEecCCCcccc
Q 018656 142 ------HSHGIIHRDLKPENLLLTED---LKTIKLADFGLAREE 176 (352)
Q Consensus 142 ------H~~~ivH~Dikp~Nili~~~---~~~vkl~Dfg~a~~~ 176 (352)
+...++|+|+.+.|||++.+ .+.+.|+||+.+...
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 23469999999999999863 147899999988643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00021 Score=62.31 Aligned_cols=79 Identities=10% Similarity=0.109 Sum_probs=53.4
Q ss_pred CCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC---CCeeeeeeeeecCce
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH---RNLVKFIGACKEPVM 98 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---p~iv~l~~~~~~~~~ 98 (352)
+..+.-.+.+|.|..+.||+.... |+.|++|+........ ...+.+|.+.|+.|.. --+++++.+ +.-
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL-----DGLFRAEALGLDWLGRSFGSPVPQVAGW---DDR 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC-----TTHHHHHHHHHHHHTCSTTCCSCCEEEE---ETT
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch-----hhHHHHHHHHHHHHHhhCCCCcceEEec---cCc
Confidence 345566778999999999999874 8999999876443221 1136678888777732 223444443 234
Q ss_pred EEEEEcCCCCC
Q 018656 99 VIVTELLSGGT 109 (352)
Q Consensus 99 ~lv~e~~~~~s 109 (352)
++||||++++.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 78999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00014 Score=67.30 Aligned_cols=73 Identities=18% Similarity=0.268 Sum_probs=48.0
Q ss_pred eeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe-eeeeeeeecCc
Q 018656 28 VGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL-VKFIGACKEPV 97 (352)
Q Consensus 28 ~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~ 97 (352)
-.+.|+.|....+|++... ++.+++|+.......+ .+.+|..+++.|...++ .++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~li~E~~~l~~L~~~g~~P~l~~~~~~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETES-------HLVAESVIFTLLSERHLGPKLYGIFSG-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHH-------HHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHH-------HHHHHHHHHHHHHhCCCCCcEEEEeCC--
Confidence 3466888999999999864 4789999984422211 24467777777743333 566666543
Q ss_pred eEEEEEcCCCCCH
Q 018656 98 MVIVTELLSGGTL 110 (352)
Q Consensus 98 ~~lv~e~~~~~sL 110 (352)
.+|+||++|.+|
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00032 Score=63.74 Aligned_cols=142 Identities=15% Similarity=0.182 Sum_probs=79.7
Q ss_pred CceeeeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeee
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGAC 93 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~ 93 (352)
+.+. .+.|..|-...+|++... ++.+++|+....... .....+|.++++.|. +.-..++++.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~------~~~~~rE~~vl~~L~~~gv~P~ll~~~ 123 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG------VDSLVLESVMFAILAERSLGPQLYGVF 123 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC------HHHHHHHHHHHHHHHHTTSSCCEEEEE
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch------HHHHHHHHHHHHHHHhcCCCCeEEEEc
Confidence 3443 345777888899998763 478999986332111 122457888887773 22235666666
Q ss_pred ecCceEEEEEcCCCCCHHH--------------HHHh---cC---CCCCC--HHHHHHHHHHHHH---------------
Q 018656 94 KEPVMVIVTELLSGGTLRK--------------YLLN---MR---PRCLD--VCVAIGFALDIAR--------------- 136 (352)
Q Consensus 94 ~~~~~~lv~e~~~~~sL~~--------------~l~~---~~---~~~~~--~~~~~~i~~qi~~--------------- 136 (352)
.++ +||||++|.+|.. .+.+ .. .+... ..++.++..++-.
T Consensus 124 ~~g---~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 124 PEG---RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp TTE---EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred CCc---cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 543 9999998865431 1111 00 11111 3445555544322
Q ss_pred ----HHHHH----HhC----CCccCCCCCCCeEEeCC---CCceEEecCCCccc
Q 018656 137 ----AMECL----HSH----GIIHRDLKPENLLLTED---LKTIKLADFGLARE 175 (352)
Q Consensus 137 ----~L~~l----H~~----~ivH~Dikp~Nili~~~---~~~vkl~Dfg~a~~ 175 (352)
.+..| ... .++|+|+.+.||+++.+ .+.+.++||..+..
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 12222 222 48999999999999865 35799999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0004 Score=62.85 Aligned_cols=73 Identities=18% Similarity=0.198 Sum_probs=42.0
Q ss_pred eccccCCCceEEEEEEECC----------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCC-eeeeeeeeecCc
Q 018656 29 GPRIGEGAHAKVYEGKYKN----------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACKEPV 97 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~l~~~~~~~~ 97 (352)
...|+.|....+|+....+ +.+++|+...... ... ...+|.++++.+...+ +.++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~----~~~~E~~~l~~L~~~g~~P~~~~~~-~-- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELY----NTISEFEVYKTMSKYKIAPQLLNTF-N-- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTS----CHHHHHHHHHHHHHTTSSCCEEEEE-T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--cee----cHHHHHHHHHHHHhcCCCCceEEec-C--
Confidence 4567888889999988754 6899998754211 100 1245666666663223 34555543 2
Q ss_pred eEEEEEcCCCCCH
Q 018656 98 MVIVTELLSGGTL 110 (352)
Q Consensus 98 ~~lv~e~~~~~sL 110 (352)
-++||||++|.++
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 3789999988543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.002 Score=59.96 Aligned_cols=73 Identities=15% Similarity=0.080 Sum_probs=46.8
Q ss_pred eccccCCCceEEEEEEECC--ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe-eeeeeeeecCceEEEEEcC
Q 018656 29 GPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL-VKFIGACKEPVMVIVTELL 105 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~l~~~~~~~~~~lv~e~~ 105 (352)
.+.|+.|-...+|+....+ ..+++|+........ .. -.+|..+++.|...++ .++++.+.. .+|+||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-----id-R~~E~~vl~~L~~~gl~P~ll~~~~~---G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-----IN-REREKKISCILYNKNIAKKIYVFFTN---GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-----SC-HHHHHHHHHHHTTSSSBCCEEEEETT---EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-----cC-HHHHHHHHHHHHhcCCCCCEEEEeCC---eEEEEee
Confidence 4568889999999998876 889999875432111 00 1467888877754444 566766633 3599999
Q ss_pred CCCCH
Q 018656 106 SGGTL 110 (352)
Q Consensus 106 ~~~sL 110 (352)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0059 Score=53.99 Aligned_cols=135 Identities=13% Similarity=0.162 Sum_probs=73.9
Q ss_pred cccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC--CCeeeeeee------eecCceEEE
Q 018656 31 RIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGA------CKEPVMVIV 101 (352)
Q Consensus 31 ~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~------~~~~~~~lv 101 (352)
.++ |....||+.... |+.+++|+......... .+..|..+++.+.. -.+++++.. ..++..+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~------~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTAD------QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHH------HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHH------HHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 456 888899988764 66899999864322221 24456665555521 123333332 113456889
Q ss_pred EEcCCCCCHH-----H------HH---Hhc-C--C----CCCCHHHH----------------------HHHHHHHHHHH
Q 018656 102 TELLSGGTLR-----K------YL---LNM-R--P----RCLDVCVA----------------------IGFALDIARAM 138 (352)
Q Consensus 102 ~e~~~~~sL~-----~------~l---~~~-~--~----~~~~~~~~----------------------~~i~~qi~~~L 138 (352)
+++++|..+. . .+ ... . . ...+.... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875431 1 11 000 0 0 01111110 11122222223
Q ss_pred HHH----HhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 139 ECL----HSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 139 ~~l----H~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..+ ....++|+|+++.||+++ + .+.++||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 222 234589999999999998 4 689999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0065 Score=54.20 Aligned_cols=31 Identities=19% Similarity=0.340 Sum_probs=26.7
Q ss_pred CCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 144 ~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-ESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGG-GCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCC-CeEEEEECCCCee
Confidence 358999999999999876 5799999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0031 Score=58.07 Aligned_cols=74 Identities=12% Similarity=0.066 Sum_probs=46.2
Q ss_pred eeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeecCc
Q 018656 28 VGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEPV 97 (352)
Q Consensus 28 ~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~ 97 (352)
-.+.+..|-...+|+.... ++.+++|+......... ...+|.++++.+. +.-..++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i------dR~~E~~~l~~L~~~gi~P~l~~~~~--- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY------DSKVELDVFRYLSNINIAPNIIADFP--- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC------CHHHHHHHHHHHHHTTSSCCEEEEET---
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc------CHHHHHHHHHHHHhcCCCCCEEEEcC---
Confidence 3456778889999998875 68899999654321110 1235666666663 222345555332
Q ss_pred eEEEEEcCCCCCH
Q 018656 98 MVIVTELLSGGTL 110 (352)
Q Consensus 98 ~~lv~e~~~~~sL 110 (352)
-++|++|++|..|
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 3789999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.65 E-value=0.067 Score=48.76 Aligned_cols=30 Identities=30% Similarity=0.472 Sum_probs=24.7
Q ss_pred CccCCCCCCCeEEeC-----CCCceEEecCCCccc
Q 018656 146 IIHRDLKPENLLLTE-----DLKTIKLADFGLARE 175 (352)
Q Consensus 146 ivH~Dikp~Nili~~-----~~~~vkl~Dfg~a~~ 175 (352)
++|+|+.+.||++.. +.+.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999943 236799999999864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.76 E-value=0.86 Score=37.30 Aligned_cols=115 Identities=12% Similarity=0.097 Sum_probs=73.3
Q ss_pred CCCCeeeeeeeeecCceEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC
Q 018656 82 QHRNLVKFIGACKEPVMVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (352)
Q Consensus 82 ~hp~iv~l~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~ 160 (352)
.||+++..--.-.++.+.+.++.-+. .++.. +.+ ++....++++.+|+....+++ .-+|--|.|+|++++.
T Consensus 43 ~~~~Fl~~~I~e~eD~v~~~y~~~~~~~~f~~-ik~-----~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDAELTELRDSFQIHYDINDNHTPFDN-IKS-----FTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCEEEEECSSEEEEEECCCTTSEEGGG-GGG-----SCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECT
T ss_pred cCCcccceEEEEcccEEEEEEEcCcccCCHHH-HHh-----cCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcC
Confidence 57888876322234445555554432 23332 332 788899999999988875443 3478889999999999
Q ss_pred CCCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCC
Q 018656 161 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234 (352)
Q Consensus 161 ~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 234 (352)
+ +.+++.--|+-.. ++|.. .+...=+-.+=|++..++.++..|.
T Consensus 115 ~-~~p~i~~RGik~~----------------l~P~~-------------~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 115 D-GLPIAKTRGLQNV----------------VDPLP-------------VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp T-SCEEESCCEETTT----------------BSCCC-------------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred C-CCEEEEEccCccC----------------CCCCC-------------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 8 7888887765322 12221 1222233447788888999887764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.80 E-value=0.082 Score=49.17 Aligned_cols=60 Identities=12% Similarity=0.063 Sum_probs=16.8
Q ss_pred eeeccccCCCceEEEEEEECC--ceEEE------EEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 27 FVGPRIGEGAHAKVYEGKYKN--QTVAI------KIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 27 ~~~~~lG~G~~g~Vy~~~~~~--~~vai------K~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
.+.+.|| ||.||++.+.+ .+||+ |......... +....+.+|..+++.++|||+++.+.+
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~---e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSE---KRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC--------------------------------------CBCCCE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccc---cccccccccccccccccccccCCCcce
Confidence 4566777 99999998864 57888 6544322221 223457788888999999999988765
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=85.66 E-value=5.8 Score=34.71 Aligned_cols=137 Identities=15% Similarity=0.151 Sum_probs=77.5
Q ss_pred eeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee-------------
Q 018656 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA------------- 92 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~------------- 92 (352)
+..++..-.|..|.++... ++..|+||... .. ..+.+-.++...-.+.-|+..-+.-.
T Consensus 71 v~~I~~s~~Gstgvff~~t-d~~~~VVK~s~----~l----~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~ 141 (342)
T 1cja_A 71 FKGIERSEKGTEGLFFVET-ESGVFIVKRST----NI----ESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAA 141 (342)
T ss_dssp EEEEEECCSTTSCEEEEEE-SSCEEEEECCT----TH----HHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHH
T ss_pred eeEEEeccCCCCCeEEEEe-CCCEEEEeCcH----HH----HHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHH
Confidence 6666777777765555444 68889999541 11 12235556666666766664322211
Q ss_pred ----------eecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHH--HHHHHHHHhCC----C-ccCCCCCCC
Q 018656 93 ----------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI--ARAMECLHSHG----I-IHRDLKPEN 155 (352)
Q Consensus 93 ----------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi--~~~L~~lH~~~----i-vH~Dikp~N 155 (352)
..++..+++|+|.+|..|.+.-.......+.+. ...++ +-++..+..++ . -+..-.++|
T Consensus 142 ~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~----~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~N 217 (342)
T 1cja_A 142 IDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKS----TMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDN 217 (342)
T ss_dssp HCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHH----HHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGG
T ss_pred hhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHH----HHHhhchhheehhhhcCCccCcccccCCCChhh
Confidence 012256799999988766542111000012222 23333 34556666653 1 122357899
Q ss_pred eEEeCCCCceEEecCCCccc
Q 018656 156 LLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 156 ili~~~~~~vkl~Dfg~a~~ 175 (352)
||++.+.+.+.++|-+++..
T Consensus 218 IL~~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 218 IMLSERGATVVPIDSKIIPL 237 (342)
T ss_dssp EEEESBTTCEEECSCCCCCC
T ss_pred eEEeCCCCeEEEEcCCcccc
Confidence 99988755689999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.25 E-value=1.5 Score=35.91 Aligned_cols=114 Identities=12% Similarity=0.095 Sum_probs=73.3
Q ss_pred CCCCeeeeeeeeecCceEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCccCCCCCCCeEEe
Q 018656 82 QHRNLVKFIGACKEPVMVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAME-CLHSHGIIHRDLKPENLLLT 159 (352)
Q Consensus 82 ~hp~iv~l~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~-~lH~~~ivH~Dikp~Nili~ 159 (352)
.||++ ..--...++.+.+.++.-+++ ++. .+++ ++....++++.+|+.... ++ ..-+|--|.|+|++++
T Consensus 48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~-~i~~-----~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFA-AIRK-----TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS-EEEEEECSSEEEEEEECCTTCEEHH-HHHT-----SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC-CeEEEEeCCEEEEEEEcCcccCcHH-HHHh-----cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 57877 332223455666666665343 444 3433 788889988888877655 33 4457888999999999
Q ss_pred CCCCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCC
Q 018656 160 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFE 234 (352)
Q Consensus 160 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 234 (352)
.+ +.+++.-.|+-.. ++|.-+ +...=+-++=|++..++.++..|.
T Consensus 119 ~~-~~p~i~hRGi~~~----------------lpP~e~-------------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 119 RA-LEPFFLHVGVKES----------------LPPDEW-------------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp TT-CCEEESCCEETTT----------------BSSCSC-------------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CC-CcEEEEEcCCccc----------------CCCCCC-------------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 88 7899987775322 233322 222223347788888888876663
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 352 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-79 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-69 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-69 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-66 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-62 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-58 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-56 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-55 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-54 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-51 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-51 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-46 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-24 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 7e-79
Identities = 85/277 (30%), Positives = 139/277 (50%), Gaps = 19/277 (6%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAM 77
W I + VG RIG G+ VY+GK+ VA+K+++ + + F EV +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQ---AFKNEVGV 57
Query: 78 LSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
L + +H N++ F+G P + IVT+ G +L +L + + ++ I A A+
Sbjct: 58 LRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQG 116
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAP 194
M+ LH+ IIHRDLK N+ L EDL T+K+ DFGLA S + +G+ WMAP
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254
E+ +R +K Y+ + D Y+F IVL+EL+ +LP+ ++N +
Sbjct: 176 EV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230
Query: 255 -----ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
N P+ + ++ C K+ + RP F QI+ +
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-69
Identities = 77/281 (27%), Positives = 134/281 (47%), Gaps = 19/281 (6%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFARE 74
+ +W + + L + R+G G +V+ G Y + VA+K + +G + F E
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD------AFLAE 58
Query: 75 VAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
++ ++QH+ LV+ + + I+TE + G+L +L L + + A I
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWM 192
A M + IHRDL+ N+L+++ L + K+ADFGLAR E++ +W
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVR 251
APE + + K D +SF I+L E++ H ++P+ GM+N +
Sbjct: 178 APEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM 229
Query: 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
+N PEEL ++ CWKE P RP F + +L ++ +A
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 4e-69
Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 21/271 (7%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
W ++ K L + IG+G V G Y+ VA+K + T + F E +++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ-------AFLAEASVM 54
Query: 79 SRVQHRNLVKFIGACKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
++++H NLV+ +G E + IVTE ++ G+L YL + L + F+LD+
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
AME L + +HRDL N+L++ED K++DFGL +E + +W APE
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEA 171
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAE 255
K ++ K D +SF I+LWE+ ++P+ + + +
Sbjct: 172 LRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223
Query: 256 NVPEELSIILTSCWKEDPNARPNFTQIIQML 286
P + ++ +CW D RP+F Q+ + L
Sbjct: 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-66
Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 21/273 (7%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLS 79
IDPK L +G G V GK++ Q VAIK++ +G E+ F E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED------EFIEEAKVMM 54
Query: 80 RVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
+ H LV+ G C + + I+TE ++ G L YL MR R + D+ AM
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAM 113
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPEL 196
E L S +HRDL N L+ + +K++DFGL+R + RW PE+
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAE 255
++ K D ++F +++WE+ K+P+E +N + A A
Sbjct: 173 LMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 224
Query: 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288
E++ I+ SCW E + RP F ++ +L+
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 7e-66
Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 19/283 (6%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVA 76
W I + L + ++G+G +V+ G + VAIK + G E F +E
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE------AFLQEAQ 64
Query: 77 MLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
++ +++H LV+ E + IVTE +S G+L +L + L + + A IA
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAP 194
M + +HRDL+ N+L+ E+L K+ADFGLAR E++ +W AP
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPS 253
E + K D +SF I+L EL ++P+ GM N + P
Sbjct: 184 EAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
Query: 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 296
PE L ++ CW+++P RP F + L +Y ++ P
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 4e-65
Identities = 72/275 (26%), Positives = 129/275 (46%), Gaps = 26/275 (9%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
D + L IG G+ VY+G VA + + + + RF E ML
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS---ERQRFKEEAEML 62
Query: 79 SRVQHRNLVKFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+QH N+V+F + + V +V+VTEL++ GTL+ YL + + + V +
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQ 120
Query: 134 IARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
I + ++ LH+ IIHRDLK +N+ +T ++K+ D GLA + A GT +
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEF 179
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251
MAPE+Y ++ Y+ VD Y+F + + E+ ++ P+ N Y V+
Sbjct: 180 MAPEMY---------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230
Query: 252 PSA--ENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
P++ + E+ I+ C +++ + R + ++
Sbjct: 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-64
Identities = 67/270 (24%), Positives = 124/270 (45%), Gaps = 20/270 (7%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
+W ++ +G +G+G VY + K +A+K++ K + + E + REV
Sbjct: 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA--GVEHQLRREV 57
Query: 76 AMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
+ S ++H N+++ G + V ++ E GT+ + L + D + ++
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITEL 115
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAP 194
A A+ HS +IHRD+KPENLLL +K+ADFG + + T GT ++ P
Sbjct: 116 ANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTT-LCGTLDYLPP 173
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254
E+ + ++ KVD +S ++ +E L K PFE Q Y +
Sbjct: 174 EMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETYKRISRVEFTFP 224
Query: 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ V E +++ K +P+ RP ++++
Sbjct: 225 DFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 5e-64
Identities = 64/287 (22%), Positives = 124/287 (43%), Gaps = 24/287 (8%)
Query: 18 KWLIDPKHLFVGPR-IGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFA 72
K + +L + +G G V +G Y+ VAIK++ +G +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE----EMM 57
Query: 73 REVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
RE ++ ++ + +V+ IG C+ +++V E+ GG L K+L+ R + V
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLH 116
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGT 188
++ M+ L +HRDL N+LL K++DFGL++ ++S +A
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAF 247
+W APE + + ++ + D +S+ + +WE L + + P++ M +
Sbjct: 176 LKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
Query: 248 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294
P EL +++ CW RP+F + Q + ++A
Sbjct: 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (507), Expect = 1e-62
Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 21/275 (7%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
KW ++ + + ++G G + +VYEG +K + TVA+K + + E F +E
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------EFLKEA 64
Query: 76 AMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
A++ ++H NLV+ +G C +EP I+TE ++ G L YL + + V + A I
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWM 192
+ AME L IHRDL N L+ E+ +K+ADFGL+R +W
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP 252
APE + ++ K D ++F ++LWE+ + +L Y K+ R
Sbjct: 184 APESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235
Query: 253 SA-ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
E PE++ ++ +CW+ +P+ RP+F +I Q
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-62
Identities = 69/271 (25%), Positives = 123/271 (45%), Gaps = 17/271 (6%)
Query: 21 IDPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM 77
++P+ + + +G+GA KVY+ + K + A K++ + ++ + E+ +
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT-----KSEEELEDYMVEIDI 62
Query: 78 LSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
L+ H N+VK + A + I+ E +GG + +L + R L
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLD 121
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPE 195
A+ LH + IIHRDLK N+L T D IKLADFG++ + + + GT WMAPE
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA- 254
+ T + + Y++K D +S I L E+ + P ++ ++ A A
Sbjct: 181 VVMCETSKD---RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 255 -ENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
L C +++ +AR +Q++Q
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (508), Expect = 2e-62
Identities = 71/268 (26%), Positives = 114/268 (42%), Gaps = 18/268 (6%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF IG G+ VY + ++ VAIK + +K +EV L
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFL 69
Query: 79 SRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+++H N +++ G +V E G ++ +P L +
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQG 127
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 197
+ LHSH +IHRD+K N+LL+E +KL DFG A + + GT WMAPE+
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSAS---IMAPANSFVGTPYWMAPEV- 182
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAEN 256
+ ++ Y+ KVD +S I EL K P M+ + A Y A + +
Sbjct: 183 ----ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 257 VPEELSIILTSCWKEDPNARPNFTQIIQ 284
E + SC ++ P RP +++
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-62
Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 20 LIDPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFARE 74
LI K L + ++G+G+ V G++ K +VA+K + + + F RE
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP--EAMDDFIRE 61
Query: 75 VAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
V + + HRNL++ G P M +VTEL G+L L + + +A+ +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQV 120
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYR 190
A M L S IHRDL NLLL +K+ DFGL R + M +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKN 249
W APE T + ++H D++ F + LWE+ + + P+ G++ Q + +
Sbjct: 180 WCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231
Query: 250 VR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287
R P E+ P+++ ++ CW P RP F + LL
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-62
Identities = 67/279 (24%), Positives = 118/279 (42%), Gaps = 24/279 (8%)
Query: 21 IDPKHLFVGPR-IGEGAHAKVYEGKYKN----QTVAIKIVHKGETPEEIAKKESRFAREV 75
+D K L + + +G G V +G Y+ +TVA+KI+ + E
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEA 59
Query: 76 AMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
++ ++ + +V+ IG C+ ++V E+ G L KYL + R + I ++
Sbjct: 60 NVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVS 117
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRW 191
M+ L +HRDL N+LL K++DFGL++ +E+ + T +W
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNV 250
APE + ++ K D +SF +++WE + + P+ GM +
Sbjct: 177 YAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 228
Query: 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289
P E+ ++ CW D RP F + L NY
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-62
Identities = 74/272 (27%), Positives = 114/272 (41%), Gaps = 21/272 (7%)
Query: 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+IDP L IG G V+ G + N VAIK + +G EE F E ++
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE------DFIEEAEVM 54
Query: 79 SRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
++ H LV+ G C E + +V E + G L YL R +G LD+
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEG 113
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPE 195
M L +IHRDL N L+ E+ IK++DFG+ R + T +W +PE
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA- 254
++S Y+ K D +SF +++WE+ + R
Sbjct: 173 VFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224
Query: 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+ I+ CWKE P RP F+++++ L
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 6e-62
Identities = 80/310 (25%), Positives = 122/310 (39%), Gaps = 48/310 (15%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEI 64
E + D KW ++L G +G GA KV VA+K++ + E
Sbjct: 25 EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE- 83
Query: 65 AKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPR-- 120
E+ M++++ H N+V +GAC + ++ E G L YL + R +
Sbjct: 84 ---REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140
Query: 121 -------------------CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161
L + FA +A+ ME L +HRDL N+L+T
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 200
Query: 162 LKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYS 218
K +K+ DFGLAR +S + +WMAPE Y K D +S
Sbjct: 201 -KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWS 251
Query: 219 FAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNAR 276
+ I+LWE+ P+ G+ Y + EE+ II+ SCW D R
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311
Query: 277 PNFTQIIQML 286
P+F + L
Sbjct: 312 PSFPNLTSFL 321
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-60
Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 25/267 (9%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG G++ + + + K + + K + G E ++ EV +L ++H N+V+
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE---AEKQMLVSEVNLLRELKHPNIVR 67
Query: 89 FIGACKEP---VMVIVTELLSGGTLRKYLLNMRPR--CLDVCVAIGFALDIARAMECLH- 142
+ + + IV E GG L + LD + + A++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 143 ----SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELY 197
H ++HRDLKP N+ L + +KL DFGLAR T A GT +M+PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 198 STVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257
+ YN K D +S +L+EL PF S + A R
Sbjct: 187 NR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 258 PEELSIILTSCWKEDPNARPNFTQIIQ 284
+EL+ I+T RP+ +I++
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-60
Identities = 78/276 (28%), Positives = 127/276 (46%), Gaps = 22/276 (7%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFAR 73
+ I + + +G IGEG V++G Y + VAIK + +F +
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV----REKFLQ 57
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
E + + H ++VK IG E + I+ EL + G LR +L + LD+ I +A
Sbjct: 58 EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQ 116
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRW 191
++ A+ L S +HRD+ N+L++ + +KL DFGL+R E+S + +W
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 192 MAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNV 250
MAPE + + + D + F + +WE+L H PF+G+ N
Sbjct: 176 MAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 227
Query: 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
P N P L ++T CW DP+ RP FT++ L
Sbjct: 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 190 bits (484), Expect = 4e-59
Identities = 71/273 (26%), Positives = 117/273 (42%), Gaps = 15/273 (5%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREV 75
ID + + IG G +V G K VAIK + G T ++ F E
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR----DFLSEA 78
Query: 76 AMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
+++ + H N++ G + V I+TE + G+L +L + V +G I
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRGI 137
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAP 194
A M+ L +HRDL N+L+ +L K++DFGL+R T P
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPS 253
++ Q + + D +S+ IV+WE++ + + P+ M+N A P
Sbjct: 197 IRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP 254
Query: 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+ P L ++ CW++D N RP F QI+ L
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-58
Identities = 75/296 (25%), Positives = 130/296 (43%), Gaps = 26/296 (8%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA VY Q VAI+ ++ + K+ E+ ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----QPKKELIINEILVM 71
Query: 79 SRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
++ N+V ++ + + +V E L+GG+L + C+D + +A
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQA 128
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPEL 196
+E LHS+ +IHRD+K +N+LL D ++KL DFG + + + + GT WMAPE+
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 197 YSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--PSA 254
+ K Y KVD +S I+ E++ + P+ + L+A Y A +
Sbjct: 188 VTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENT 310
E + L C D R + +++Q +L P + P E T
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH--QFLKIAKPLSSLTPLIAAAKEAT 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 1e-58
Identities = 89/311 (28%), Positives = 127/311 (40%), Gaps = 43/311 (13%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEE 63
+L D KW L G +G GA KV E TVA+K++ E
Sbjct: 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE 69
Query: 64 IAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRC 121
E+ +LS + H N+V +GAC +++TE G L +L R
Sbjct: 70 ----REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125
Query: 122 ----------------LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
LD+ + F+ +A+ M L S IHRDL N+LLT +
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG-RIT 184
Query: 166 KLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIV 222
K+ DFGLAR +S + +WMAPE Y + D +S+ I
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIF 236
Query: 223 LWELLHNKLP-FEGMSNLQAAYAAAFKNVRP-SAENVPEELSIILTSCWKEDPNARPNFT 280
LWEL + GM Y + R S E+ P E+ I+ +CW DP RP F
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 281 QIIQMLLNYLS 291
QI+Q++ +S
Sbjct: 297 QIVQLIEKQIS 307
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-58
Identities = 75/300 (25%), Positives = 137/300 (45%), Gaps = 33/300 (11%)
Query: 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGE 59
++ A ++ + +W + + + + +G+G+ VYEG K VAIK V++
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR 118
+ E F E +++ ++V+ +G + +++ EL++ G L+ YL ++R
Sbjct: 63 SMRE----RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 118
Query: 119 PRC--------LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170
P + I A +IA M L+++ +HRDL N ++ ED T+K+ DF
Sbjct: 119 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDF 177
Query: 171 GLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELL 227
G+ R E RWM+PE + D +SF +VLWE+
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIA 229
Query: 228 H-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
+ P++G+SN Q + +N P+ L ++ CW+ +P RP+F +II +
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-58
Identities = 69/262 (26%), Positives = 114/262 (43%), Gaps = 22/262 (8%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+GEGA+ +V + + VA+KIV + +E+ + + H N+VK
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNHENVVK 67
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
F G +E + + E SGG L + + A F + + LH GI
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQ 204
HRD+KPENLLL E +K++DFGLA + ++ GT ++APEL
Sbjct: 126 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR----- 179
Query: 205 GEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAENVPEELS 262
++ + VD +S IVL +L +LP++ S+ Y+ + + +
Sbjct: 180 --REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 263 IILTSCWKEDPNARPNFTQIIQ 284
+L E+P+AR I +
Sbjct: 238 ALLHKILVENPSARITIPDIKK 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 189 bits (481), Expect = 5e-58
Identities = 51/261 (19%), Positives = 110/261 (42%), Gaps = 21/261 (8%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G GA V+ K + K ++ + E+++++++ H L+
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINT-----PYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A ++ MV++ E LSGG L + + + I + ++ +H H I+
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHSIV 149
Query: 148 HRDLKPENLLLT-EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
H D+KPEN++ + ++K+ DFGLA + + E++ T T + APE+ +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV--------D 201
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---NVPEELSI 263
++ D ++ ++ + LL PF G +L+ + + +V E
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 264 ILTSCWKEDPNARPNFTQIIQ 284
+ + +++P R ++
Sbjct: 262 FIKNLLQKEPRKRLTVHDALE 282
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (472), Expect = 2e-57
Identities = 73/304 (24%), Positives = 128/304 (42%), Gaps = 47/304 (15%)
Query: 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKES 69
++ IGEGA +V++ + VA+K++ + + + ++
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM----QA 61
Query: 70 RFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRC------- 121
F RE A+++ + N+VK +G C M ++ E ++ G L ++L +M P
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 122 ---------------LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
L + A +A M L +HRDL N L+ E++ +K
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVK 180
Query: 167 LADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVL 223
+ADFGL+R + + RWM PE Y + D +++ +VL
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVL 232
Query: 224 WELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 282
WE+ P+ GM++ + Y N+ EN P EL ++ CW + P RP+F I
Sbjct: 233 WEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
Query: 283 IQML 286
++L
Sbjct: 293 HRIL 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-57
Identities = 78/294 (26%), Positives = 119/294 (40%), Gaps = 29/294 (9%)
Query: 19 WLIDPKHLFV--GPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRF 71
+I P L V IG G VY G K A+K +++ E+ S+F
Sbjct: 20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV----SQF 75
Query: 72 AREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG 129
E ++ H N++ +G C E ++V + G LR ++ V IG
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIG 134
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTA 184
F L +A+ M+ L S +HRDL N +L E T+K+ADFGLAR E T
Sbjct: 135 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTG 193
Query: 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA 244
+WMA E T + + K D +SF ++LWEL+ P N
Sbjct: 194 AKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245
Query: 245 AAFKNVRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297
+ R E P+ L ++ CW RP+F++++ + S
Sbjct: 246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 185 bits (470), Expect = 3e-57
Identities = 60/265 (22%), Positives = 107/265 (40%), Gaps = 16/265 (6%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHK----GETPEEIAKKESRFAREVAMLSRVQ-H 83
+G G + V +K + A+KI+ + EE+ + +EV +L +V H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 84 RNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
N+++ + +V +L+ G L YL L + + LH
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALH 127
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 202
I+HRDLKPEN+LL +D IKL DFG + + E + GT ++APE+
Sbjct: 128 KLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE--CS 184
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSAENVPE 259
Y +VD +S ++++ LL PF + N + P ++ +
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244
Query: 260 ELSIILTSCWKEDPNARPNFTQIIQ 284
+ +++ P R + +
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 187 bits (475), Expect = 4e-57
Identities = 60/292 (20%), Positives = 112/292 (38%), Gaps = 22/292 (7%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G GA V+ + A K V + +E+ +S ++H
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPT 84
Query: 86 LVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV A ++ MV++ E +SGG L + + + + A+ + + + + +H +
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 145 GIIHRDLKPENLLLTEDLK-TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 203
+H DLKPEN++ T +KL DFGL + + TGT + APE+
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG---- 199
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---NVPEE 260
K + D +S ++ + LL PF G ++ + + + E+
Sbjct: 200 ----KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 261 LSIILTSCWKEDPNARPNFTQIIQM-LLNYLSAIAPPEPMIPHRIFNSENTI 311
+ DPN R Q ++ L +A + R ++I
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 307
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 6e-57
Identities = 64/302 (21%), Positives = 122/302 (40%), Gaps = 19/302 (6%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G GA VY+G + + V I + K K E +++ V + ++ +
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHR 149
+G C + ++T+L+ G L Y+ + + + + IA+ M L ++HR
Sbjct: 77 LGICLTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLEDRRLVHR 135
Query: 150 DLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
DL N+L+ +K+ DFGLA+ E +WMA E
Sbjct: 136 DLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH------- 187
Query: 207 KKHYNHKVDSYSFAIVLWELL-HNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIIL 265
+ Y H+ D +S+ + +WEL+ P++G+ + + P ++ +I+
Sbjct: 188 -RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 246
Query: 266 TSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTV 325
CW D ++RP F ++I P+ + + + P +S +LM
Sbjct: 247 VKCWMIDADSRPKFRELIIEFSKMAR---DPQRYLVIQGDERMHLPSPTDSNFYRALMDE 303
Query: 326 RD 327
D
Sbjct: 304 ED 305
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-56
Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 26/278 (9%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT------VAIKIVHKGETPEEIAKKESRFARE 74
I P + IG G +VY+G K + VAIK + G T ++ F E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ----RVDFLGE 59
Query: 75 VAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ + H N+++ G + M+I+TE + G L K+L + V +G
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRG 118
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTY 189
IA M+ L + +HRDL N+L+ +L K++DFGL+R + T +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 190 RWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249
RW APE S + + D +SF IV+WE++ + A
Sbjct: 178 RWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229
Query: 250 VR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 286
R P+ + P + ++ CW+++ RP F I+ +L
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 7e-56
Identities = 76/311 (24%), Positives = 125/311 (40%), Gaps = 34/311 (10%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKN----QTVAIKIVHKGETPEEIAKKESRFAREVA 76
+D + IGEG +V + + K AIK + + + ++ FA E+
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELE 62
Query: 77 MLSRV-QHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRC------------- 121
+L ++ H N++ +GAC+ + + E G L +L R
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 122 -LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
L + FA D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R + +
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYV 181
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNL 239
T RWMA E + Y D +S+ ++LWE++ P+ GM+
Sbjct: 182 KKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233
Query: 240 QAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM 299
+ N +E+ ++ CW+E P RP+F QI+ L L
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 293
Query: 300 IPHRIFNSENT 310
+ F
Sbjct: 294 TLYEKFTYAGI 304
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 1e-55
Identities = 67/272 (24%), Positives = 126/272 (46%), Gaps = 23/272 (8%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
D + ++ +G GA ++V + K + VAIK + K + + KE E+A+L
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK----KALEGKEGSMENEIAVL 61
Query: 79 SRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+++H N+V + + ++ +L+SGG L + + A + A
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDA 119
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
++ LH GI+HRDLKPENLL + I ++DFGL++ E +++ GT ++APE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA---AAFKNVRP 252
+ + K Y+ VD +S ++ + LL PF ++ + A ++ P
Sbjct: 180 VLAQ--------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231
Query: 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+++ + + ++DP R Q +Q
Sbjct: 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-55
Identities = 67/295 (22%), Positives = 116/295 (39%), Gaps = 51/295 (17%)
Query: 31 RIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90
IG+G +V+ GK++ + VA+KI E ++ E+ ++H N++ FI
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFI 63
Query: 91 GACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH- 144
A + + +V++ G+L YL + V I AL A + LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 145 -------GIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWM 192
I HRDLK +N+L+ ++ T +AD GLA +++ GT R+M
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 193 APELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAY--------- 243
APE+ + + + D Y+ +V WE+ + Q Y
Sbjct: 180 APEVLDDSINMKHFE--SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 244 ------AAAFKNVRPSAEN------VPEELSIILTSCWKEDPNARPNFTQIIQML 286
+ +RP+ N ++ I+ CW + AR +I + L
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-55
Identities = 53/272 (19%), Positives = 108/272 (39%), Gaps = 26/272 (9%)
Query: 24 KHLF----VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM 77
K L+ + +G G V+ +T K V T + +E+++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISI 54
Query: 78 LSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
L+ +HRN++ + + +V++ E +SG + + + N L+ + + +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCE 113
Query: 137 AMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
A++ LHSH I H D++PEN++ TIK+ +FG AR+ + + APE
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173
Query: 196 LYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 255
++ + + D +S +++ LL PF +N Q E
Sbjct: 174 VH--------QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE 225
Query: 256 ---NVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ E + ++ +R ++ +Q
Sbjct: 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 7e-55
Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 22/272 (8%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G V++ +K +A K++H P ++ RE+ +L +V
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI----RNQIIRELQVLHECNSPYIVG 68
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGI 146
F GA + I E + GG+L + L + + + ++ + + + L H I
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
+HRD+KP N+L+ IKL DFG++ + M + GT +M+PE
Sbjct: 127 MHRDVKPSNILVNSR-GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQG------- 177
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 266
HY+ + D +S + L E+ + P + + V A P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPP-PDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 267 SCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 298
++RP I ++L ++ P P
Sbjct: 236 PLSSYGMDSRPPM-AIFELLDYIVNEPPPKLP 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-54
Identities = 85/304 (27%), Positives = 135/304 (44%), Gaps = 42/304 (13%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN---------QTVAIKIVHKGETPE 62
EL D +W + L +G +GEGA +V + VA+K++ T +
Sbjct: 1 ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 60
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPR 120
++ S E+ M+ + +H+N++ +GAC + + ++ E S G LR+YL RP
Sbjct: 61 DL----SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 116
Query: 121 C--------------LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
L + A +AR ME L S IHRDL N+L+TED +K
Sbjct: 117 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMK 175
Query: 167 LADFGLAR---EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVL 223
+ADFGLAR + T +WMAPE + Y H+ D +SF ++L
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLL 227
Query: 224 WELLHN-KLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 282
WE+ P+ G+ + + N EL +++ CW P+ RP F Q+
Sbjct: 228 WEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287
Query: 283 IQML 286
++ L
Sbjct: 288 VEDL 291
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-54
Identities = 80/346 (23%), Positives = 140/346 (40%), Gaps = 37/346 (10%)
Query: 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESR 70
L++ +ID + +G G + KV + K + A+K++ + +
Sbjct: 2 LQIKKNAIID-DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPK 50
Query: 71 FAREVAMLSRV-QHRNLVKFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
REV + R Q ++V+ + + ++IV E L GG L + + +
Sbjct: 51 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAREESLTEMM 182
A I A++ LHS I HRD+KPENLL T +KL DFG A+E + +
Sbjct: 111 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
Query: 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAA 242
T T ++APE+ + Y+ D +S ++++ LL PF L +
Sbjct: 171 TTPCYTPYYVAPEVLG--------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 222
Query: 243 YA-------AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 295
++ P V EE+ +++ + K +P R T+ + S P
Sbjct: 223 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282
Query: 296 PEPMIPHRIFNSENTILPP-ESPGTSSLMTVRDDIGETPKAKMGDK 340
P+ R+ + + TS+L T+R D + K+ D
Sbjct: 283 QTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDA 328
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-54
Identities = 67/270 (24%), Positives = 110/270 (40%), Gaps = 20/270 (7%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
P+ G +GEG+ + V + ++ AIKI+ K +E K RE ++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE--NKVPYVTRERDVM 62
Query: 79 SRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
SR+ H VK ++ + G L KY+ + D + +I A
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSA 120
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAP 194
+E LH GIIHRDLKPEN+LL ED I++ DFG A+ ES + GT ++++P
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254
EL + K D ++ ++++L+ PF N + K
Sbjct: 180 ELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEYDFP 230
Query: 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
E + ++ D R ++
Sbjct: 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 8e-52
Identities = 79/303 (26%), Positives = 131/303 (43%), Gaps = 40/303 (13%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESR 70
KW L +G +G GA +V E +TVA+K++ +G T E +
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRAL 63
Query: 71 FAREVAMLSRVQHRNLVKFIGACKEP--VMVIVTELLSGGTLRKYLLNMR---------- 118
+ ++ H N+V +GAC +P ++++ E G L YL + R
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123
Query: 119 ----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
L + I ++ +A+ ME L S IHRDL N+LL+E +K+ DFGLAR
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLAR 182
Query: 175 EESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NK 230
+ + +WMAPE + Y + D +SF ++LWE+
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGA 234
Query: 231 LPFEGMSNLQAAYAAAFKNVRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289
P+ G+ + + R A + E+ + CW +P+ RP F+++++ L N
Sbjct: 235 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
Query: 290 LSA 292
L A
Sbjct: 295 LQA 297
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 8e-52
Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 22/263 (8%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGE-TPEEIAKKESRFAREVAMLSRVQ-- 82
VGP +G G VY G N VAIK V K + +R EV +L +V
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 83 HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+++ + + P V++ E + R L +A F + A+
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHC 126
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 201
H+ G++HRD+K EN+L+ + +KL DFG + T GT + PE
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRY-- 183
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 261
+++ +S I+L++++ +PFE + + + V E
Sbjct: 184 -----HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSSEC 231
Query: 262 SIILTSCWKEDPNARPNFTQIIQ 284
++ C P+ RP F +I
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (433), Expect = 1e-51
Identities = 64/287 (22%), Positives = 117/287 (40%), Gaps = 30/287 (10%)
Query: 23 PKHLF----VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA 76
P HL +G +G G ++V+ + ++ VA+K++ + RF RE
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP--SFYLRFRREAQ 59
Query: 77 MLSRVQHRNLVKFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
+ + H +V + P+ IV E + G TLR + P + AI
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVI 117
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAREESLTEMMTAETGT 188
D +A+ H +GIIHRD+KP N++++ +A + A GT
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 248
++++PE + + D YS VL+E+L + PF G S + AY +
Sbjct: 178 AQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229
Query: 249 NVRPSA---ENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLS 291
+ P + E + +L ++ ++P R ++ L+ +
Sbjct: 230 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-51
Identities = 64/267 (23%), Positives = 102/267 (38%), Gaps = 20/267 (7%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGET-PEEIAKKESRFAREVAMLSRVQHR 84
G +G G A V + + K A K + K T REV++L +QH
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 85 NLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
N++ + ++++ EL++GG L + L A F I + LHS
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 144 HGIIHRDLKPENLLLTED---LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
I H DLKPEN++L + IK+ DFGLA + GT ++APE+
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV--- 188
Query: 201 TLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE---NV 257
+ + D +S ++ + LL PF G + + + N E N
Sbjct: 189 -----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 258 PEELSIILTSCWKEDPNARPNFTQIIQ 284
+ +DP R +Q
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-51
Identities = 69/260 (26%), Positives = 119/260 (45%), Gaps = 17/260 (6%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+G+ KV+ ++K NQ AIK + K + E + + +H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPF 64
Query: 86 LVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
L + + V E L+GG L ++ + D+ A +A +I ++ LHS
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK 122
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPELYSTVTLR 203
GI++RDLK +N+LL +D IK+ADFG+ +E L + GT ++APE+
Sbjct: 123 GIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG---- 177
Query: 204 QGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI 263
+ YNH VD +SF ++L+E+L + PF G + ++ N + +E
Sbjct: 178 ----QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP-RWLEKEAKD 232
Query: 264 ILTSCWKEDPNARPNFTQII 283
+L + +P R I
Sbjct: 233 LLVKLFVREPEKRLGVRGDI 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (421), Expect = 2e-49
Identities = 67/254 (26%), Positives = 117/254 (46%), Gaps = 19/254 (7%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G+ +V+ + + + A+K++ K K+ E MLS V H +++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL--KQVEHTNDERLMLSIVTHPFIIR 68
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
G ++ + ++ + + GG L + + VA +A ++ A+E LHS II
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSL--LRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 126
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
+RDLKPEN+LL ++ IK+ DFG A+ + ++ GT ++APE+ ST
Sbjct: 127 YRDLKPENILLDKNG-HIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVST-------- 175
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 267
K YN +D +SF I+++E+L PF N Y E++ +L+
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKILNAELRFPPFFNEDVKDLLSR 234
Query: 268 CWKEDPNARPNFTQ 281
D + R Q
Sbjct: 235 LITRDLSQRLGNLQ 248
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (412), Expect = 1e-47
Identities = 56/253 (22%), Positives = 102/253 (40%), Gaps = 17/253 (6%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES-RFAREVAMLSRVQHRNLV 87
IG G +VY + + A+K + K + + + ++++S +V
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
A P + + +L++GG L +L A +I +E +H+ +
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--AAEIILGLEHMHNRFV 128
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
++RDLKP N+LL E ++++D GLA + S + A GT+ +MAPE+
Sbjct: 129 VYRDLKPANILLDEH-GHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQK------- 179
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMS--NLQAAYAAAFKNVRPSAENVPEELSII 264
Y+ D +S +L++LL PF + ++ EL +
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239
Query: 265 LTSCWKEDPNARP 277
L + D N R
Sbjct: 240 LEGLLQRDVNRRL 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 4e-47
Identities = 57/284 (20%), Positives = 101/284 (35%), Gaps = 38/284 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +IG G+ +Y G + VAIK+ K + E + +Q
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-------KTKHPQLHIESKIYKMMQGGV 63
Query: 86 LVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
+ I C + V+V ELL + R + + A + +E +HS
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 121
Query: 144 HGIIHRDLKPENLL--LTEDLKTIKLADFGLAR--------EESLTEMMTAETGTYRWMA 193
IHRD+KP+N L L + + + DFGLA+ + TGT R+ +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN---- 249
+ + + D S VL LP++G+ +
Sbjct: 182 INTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233
Query: 250 ---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290
+ + P E + L C + +P+++ + Q+ N
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 158 bits (399), Expect = 2e-46
Identities = 59/284 (20%), Positives = 104/284 (36%), Gaps = 36/284 (12%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
VG RIGEG+ ++EG NQ VAIK + ++ R +L+
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR----DEYRTYKLLAGCTGIP 64
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
V + G V+V +LL G + LL++ R V A + ++ +H
Sbjct: 65 NVYYFGQEGLH-NVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 146 IIHRDLKPENLLLTEDLK----TIKLADFGLAR--------EESLTEMMTAETGTYRWMA 193
+++RD+KP+N L+ I + DFG+ + + +GT R+M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 194 PELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA----AAFKN 249
+ + + + D + V L LP++G+ K
Sbjct: 182 INTH--------LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233
Query: 250 VRPSAE---NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290
P E PEE + +A P++ + + L
Sbjct: 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-46
Identities = 66/252 (26%), Positives = 109/252 (43%), Gaps = 18/252 (7%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G+G KV + K + A+KI+ K + + + E +L +H L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTA 69
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + + V E +GG L +L R R A + +I A+E LHS ++
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
+RD+K ENL+L +D IK+ DFGL +E S M GT ++APE+
Sbjct: 128 YRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED------- 179
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILT 266
Y VD + +V++E++ +LPF + + + +R + E +L
Sbjct: 180 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP-RTLSPEAKSLLA 237
Query: 267 SCWKEDPNARPN 278
K+DP R
Sbjct: 238 GLLKKDPKQRLG 249
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 3e-45
Identities = 69/289 (23%), Positives = 112/289 (38%), Gaps = 45/289 (15%)
Query: 31 RIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
IGEGA+ KV++ + + VA+K V E + R + L +H N+V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 88 KFIGAC------KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ C +E + +V E + YL + + + R ++ L
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 201
HSH ++HRDLKP+N+L+T IKLADFGLAR S +T+ T + APE+
Sbjct: 133 HSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-- 189
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 261
Y VD +S + E+ K F G S++ P E+ P ++
Sbjct: 190 ------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 262 SI--------------------------ILTSCWKEDPNARPNFTQIIQ 284
++ +L C +P R + +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-44
Identities = 80/298 (26%), Positives = 116/298 (38%), Gaps = 43/298 (14%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG A VY+ + K NQ VAIK + G E RE+ +L + H N++
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ A + +V + + N A L + +E LH H I+H
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEYLHQHWILH 123
Query: 149 RDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
RDLKP NLLL E+ +KLADFGLA+ S T + T + APEL
Sbjct: 124 RDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------A 175
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSI---- 263
+ Y VD ++ +L ELL G S+L P+ E P+ S+
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 264 -----------------------ILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 298
++ + +P AR TQ ++M Y S P P
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRPGPTP 291
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-44
Identities = 67/309 (21%), Positives = 111/309 (35%), Gaps = 56/309 (18%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG G+ VY+ K + VAIK V + + RE+ ++ ++ H N+V+
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQ---------DKRFKNRELQIMRKLDHCNIVRL 78
Query: 90 IGACKEP-------VMVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECL 141
+ +V + + R R + L V + + R++ +
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 201
HS GI HRD+KP+NLLL D +KL DFG A++ E + + + APEL
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF--- 195
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE------ 255
Y +D +S VL ELL + F G S + P+ E
Sbjct: 196 ----GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 256 ----------------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293
P E + + + P AR + ++ +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH--SFFDEL 309
Query: 294 APPEPMIPH 302
P +P+
Sbjct: 310 RDPNVKLPN 318
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-42
Identities = 77/304 (25%), Positives = 109/304 (35%), Gaps = 62/304 (20%)
Query: 28 VGPR------IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79
VGPR IGEGA+ V VAIK + E R RE+ +L
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ----RTLREIKILL 61
Query: 80 RVQHRNLVKFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
R +H N++ + P V + L G L K L + + L F I
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQI 118
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYR 190
R ++ +HS ++HRDLKP NLLL +K+ DFGLAR + T +T T
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 191 WMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250
+ APE+ K Y +D +S +L E+L N+ F G L
Sbjct: 178 YRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 251 RPSAE------------------------------NVPEELSIILTSCWKEDPNARPNFT 280
PS E N + +L +P+ R
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290
Query: 281 QIIQ 284
Q +
Sbjct: 291 QALA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 8e-42
Identities = 66/299 (22%), Positives = 117/299 (39%), Gaps = 44/299 (14%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+ + K + VA+K + E + RE+++L + H N+VK
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS---TAIREISLLKELNHPNIVK 65
Query: 89 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + + L+K++ + + + + + + + HSH ++H
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEK 207
RDLKP+NLL+ + IKLADFGLAR + T E T + APE+
Sbjct: 126 RDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL-------GC 177
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE------------ 255
K+Y+ VD +S + E++ + F G S + + P
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 256 ----------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 298
+ E+ +L+ DPN R + + + + P P
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVTKPVP 294
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (368), Expect = 2e-41
Identities = 65/251 (25%), Positives = 106/251 (42%), Gaps = 19/251 (7%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G+ +V K+K A+KI+ K + + K+ E +L V LVK
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL--KQIEHTLNEKRILQAVNFPFLVK 105
Query: 89 FIGACKEPVMVI-VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ K+ + V E ++GG + +L R A +A I E LHS +I
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
+RDLKPENLL+ + I++ DFG A+ GT +APE+ +
Sbjct: 164 YRDLKPENLLIDQQ-GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILS-------- 212
Query: 208 KHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTS 267
K YN VD ++ ++++E+ PF +Q VR + +L +L +
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP-SHFSSDLKDLLRN 271
Query: 268 CWKEDPNARPN 278
+ D R
Sbjct: 272 LLQVDLTKRFG 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (361), Expect = 5e-41
Identities = 64/284 (22%), Positives = 111/284 (39%), Gaps = 42/284 (14%)
Query: 31 RIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+IGEG + VY+ + +T A+K + + E I RE+++L ++H N+VK
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS---TTIREISILKELKHSNIVKL 65
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHR 149
+++ L+K L L+ A F L + + H ++HR
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 150 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW-MAPELYSTVTLRQGEKK 208
DLKP+NLL+ + +K+ADFGLAR + W AP++ K
Sbjct: 125 DLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM-------GSK 176
Query: 209 HYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN------------ 256
Y+ +D +S + E+++ F G+S P+++N
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 257 ----------------VPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ E +L+ K DPN R Q ++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-40
Identities = 55/301 (18%), Positives = 102/301 (33%), Gaps = 60/301 (19%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG+G +V++ +++ Q VA+K V E RE+ +L ++H N+V
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI---TALREIKILQLLKHENVVN 73
Query: 89 FIGACKEPV---------MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
I C+ + +V + + L + + +
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--MQMLLNGLY 131
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAP 194
+H + I+HRD+K N+L+T D +KLADFGLAR SL + T T + P
Sbjct: 132 YIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 195 ELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254
EL ++ Y +D + ++ E+ +G + + +
Sbjct: 191 ELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 255 ENVPEELSI-------------------------------ILTSCWKEDPNARPNFTQII 283
E P + ++ DP R + +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 284 Q 284
Sbjct: 304 N 304
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 139 bits (352), Expect = 3e-39
Identities = 52/300 (17%), Positives = 112/300 (37%), Gaps = 63/300 (21%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HR 84
+ ++G G +++V+E N+ V +KI+ K+ + RE+ +L ++
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIKREIKILENLRGGP 90
Query: 85 NLVKFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
N++ K+PV +V E ++ ++ + L + +I +A++
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYC 145
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 201
HS GI+HRD+KP N+++ + + ++L D+GLA + + + PEL
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV--- 202
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV----------- 250
+ + Y++ +D +S +L ++ K PF + K +
Sbjct: 203 ----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 251 --------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 284
+ V E L + D +R + ++
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-39
Identities = 60/259 (23%), Positives = 112/259 (43%), Gaps = 22/259 (8%)
Query: 31 RIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR- 84
+G GA+ KV+ + + A+K++ K ++ AK E +L ++
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSP 89
Query: 85 NLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
LV A + + ++ + ++GG L +L + +I A+E LH
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHK 147
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPELYSTVT 201
GII+RD+K EN+LL + + L DFGL++E TE GT +MAP++
Sbjct: 148 LGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV---- 202
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSAENVP 258
+G ++ VD +S ++++ELL PF + + + ++ P + +
Sbjct: 203 --RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 259 EELSIILTSCWKEDPNARP 277
++ +DP R
Sbjct: 261 ALAKDLIQRLLMKDPKKRL 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-39
Identities = 60/299 (20%), Positives = 116/299 (38%), Gaps = 48/299 (16%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + V++ K + ++ VA+K V + E + RE+ +L ++H+N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKHKNIVR 65
Query: 89 FIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ +V E + + ++ + + + + HS ++
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCHSRNVL 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGE 206
HRDLKP+NLL+ + +KLA+FGLAR + +AE T + P++
Sbjct: 124 HRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG------- 175
Query: 207 KKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE----------- 255
K Y+ +D +S + EL + P +++ F+ + E
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 256 ------------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 296
+ +L + K +P R + + +Q Y S PP
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH--PYFSDFCPP 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 8e-35
Identities = 68/326 (20%), Positives = 112/326 (34%), Gaps = 60/326 (18%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G GA+ V VAIK +++ E AK R RE+ +L ++H N++
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMRHENVIG 81
Query: 89 FIGACKEP-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ +V + GT L+ L + + + +
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYI 137
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 201
H+ GIIHRDLKP NL + ED + +K+ DFGLAR+ MT T + APE+
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL--- 191
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE------ 255
Y VD +S ++ E++ K F+G +L P AE
Sbjct: 192 ----NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 256 ------------------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291
N +L D R + + Y
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--PYFE 305
Query: 292 AI--APPEPMIPHRIFNSENTILPPE 315
++ EP + + ++ +
Sbjct: 306 SLHDTEDEPQVQKYDDSFDDVDRTLD 331
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-33
Identities = 61/262 (23%), Positives = 104/262 (39%), Gaps = 26/262 (9%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG GA V ++ VAIK + + + AK R RE+ ++ V H+N++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVNHKNIIS 80
Query: 89 FIGACKEPVMV-------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ + +V EL+ + + + + ++ L
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 135
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 201
HS GIIHRDLKP N+++ D T+K+ DFGLAR + MMT T + APE+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL--- 191
Query: 202 LRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEEL 261
Y VD +S ++ E++ +K+ F G + + P E + +
Sbjct: 192 -----GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 262 SIILTSCWKEDPNARPNFTQII 283
+ A F ++
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLF 268
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-33
Identities = 74/325 (22%), Positives = 113/325 (34%), Gaps = 58/325 (17%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G GA+ V VA+K + + AK R RE+ +L ++H N++
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVIG 81
Query: 89 FIGACK------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+ E V + L G L ++ + L I R ++ +H
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 202
S IIHRDLKP NL + ED +K+ DFGLAR + MT T + APE+
Sbjct: 139 SADIIHRDLKPSNLAVNED-CELKILDFGLARHTD--DEMTGYVATRWYRAPEIML---- 191
Query: 203 RQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE------- 255
HYN VD +S ++ ELL + F G ++ P AE
Sbjct: 192 ---NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 256 -----------------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292
+L D + R Q + Y +
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQ 306
Query: 293 IAPP--EPMIPHRIFNSENTILPPE 315
P EP+ + E+ L +
Sbjct: 307 YHDPDDEPVADPYDQSFESRDLLID 331
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (250), Expect = 1e-24
Identities = 49/298 (16%), Positives = 92/298 (30%), Gaps = 35/298 (11%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ ++G G + V+ K N VA+KIV + E E+ +L RV +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE------AAEDEIKLLQRVNDAD 70
Query: 86 LVKFIGACKEPVM---------------VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
K ++ V++ + G L + R + +
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 131 ALDIARAMECLH-SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAET 186
+ + ++ +H GIIH D+KPEN+L+ L +A E T
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 187 GTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA 246
T + +PE+ + D +S A +++EL+ FE
Sbjct: 191 QTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242
Query: 247 FKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRI 304
+ + N+R I ++ L + +
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.8 bits (235), Expect = 8e-24
Identities = 35/199 (17%), Positives = 63/199 (31%), Gaps = 26/199 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAK-----KESRFAREVAMLSRV 81
+G +GEG + V+ + +K G T + K + F+ +R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 82 QHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ R L K G + V L + + + V I +
Sbjct: 64 EFRALQKLQGLA----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY--ST 199
+ GI+H DL N+L++E+ I + DF + E E+
Sbjct: 120 YHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVE------------VGEEGWREILERDV 165
Query: 200 VTLRQGEKKHYNHKVDSYS 218
+ + Y + D S
Sbjct: 166 RNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 352 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.67 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.19 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.98 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.27 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.88 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-60 Score=419.30 Aligned_cols=266 Identities=32% Similarity=0.576 Sum_probs=222.7
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 96 (352)
+.|.|+.++|.+++.||+|+||+||+|++++ .||||+++....... ....+.+|++++++++||||+++++++.++
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 76 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ---QLQAFKNEVGVLRKTRHVNILLFMGYSTAP 76 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTT---HHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHH---HHHHHHHHHHHHHhCCCCCEeeeeEEEecc
Confidence 4699999999999999999999999998765 599999976544332 345688999999999999999999998888
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.+++|||||+||+|.+++..... .+++..++.++.|+++||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVK 154 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SSEEECCCCCSCC-
T ss_pred EEEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CCEEEccccceeec
Confidence 89999999999999999976543 49999999999999999999999999999999999999998 79999999999754
Q ss_pred ccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC-CC
Q 018656 177 SLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV-RP 252 (352)
Q Consensus 177 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~ 252 (352)
... .......||+.|+|||++.+. ....++.++|||||||++|||++|+.||.+.+............. .|
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p 229 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQ-----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC
T ss_pred cccCCcccccccccCcccCCHHHHhcc-----cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 322 233456799999999998541 124578999999999999999999999998776655554444332 22
Q ss_pred ----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 253 ----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 253 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
.+..+|+++.++|.+||+.||.+|||+.+++++|+...+++
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 25678999999999999999999999999999998877654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=409.61 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=215.3
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
+|.+ ++|++++.||+|+||+||+|+++ |+.||+|++....... ......+.+|++++++++||||+++++++.+
T Consensus 2 ~~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 77 (263)
T d2j4za1 2 QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK--AGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77 (263)
T ss_dssp CCCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred Ccch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC--hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence 4655 47999999999999999999985 7899999986432111 1224568899999999999999999999985
Q ss_pred C-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 ~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+ ..++|||||+||+|.+++.+... +++..++.++.||++||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 78 ~~~~~ivmEy~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~~kl~DFG~a~ 154 (263)
T d2j4za1 78 ATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSV 154 (263)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCSCS
T ss_pred CCEEEEEEeecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC-CCEeecccceee
Confidence 4 79999999999999999987654 9999999999999999999999999999999999999988 799999999997
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+... .........+
T Consensus 155 ~~~~~-~~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-~i~~~~~~~p 224 (263)
T d2j4za1 155 HAPSS-RRTTLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-RISRVEFTFP 224 (263)
T ss_dssp CCCCC-CCEETTEEGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HHHTTCCCCC
T ss_pred ecCCC-cccccCCCCcccCHHHHcC--------CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH-HHHcCCCCCC
Confidence 65433 2345679999999999864 568899999999999999999999998866554433 3334444556
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
..+|+++.++|.+||+.||.+|||++++++|.|
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence 789999999999999999999999999999843
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-59 Score=410.38 Aligned_cols=263 Identities=29% Similarity=0.528 Sum_probs=224.4
Q ss_pred ccccceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
.++.|.|++++|++++.||+|+||+||+|.++ ++.||||++....... ..+.+|++++++++||||+++++++
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~------~~~~~E~~~l~~l~HpnIv~~~g~~ 77 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP------DAFLAEANLMKQLQHQRLVRLYAVV 77 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH------HHHHHHHHHHHhCCCCCEeEEEeee
Confidence 35779999999999999999999999999996 5789999987654322 3588999999999999999999999
Q ss_pred ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 94 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
.++..++||||+++|+|.+++.......+++..++.|+.|+++||+|||++||+||||||+||||+++ +.+||+|||+|
T Consensus 78 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla 156 (272)
T d1qpca_ 78 TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLA 156 (272)
T ss_dssp CSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTC
T ss_pred ccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccce
Confidence 88889999999999999998866554459999999999999999999999999999999999999998 79999999999
Q ss_pred ccccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccC
Q 018656 174 REESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 174 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g-~~p~~~~~~~~~~~~~~~~~~ 250 (352)
+...... ......||+.|+|||++.. ..++.++|||||||++|||++| .+||...+..+..........
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~ 228 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred EEccCCccccccccCCcccccChHHHhC--------CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence 8643322 2344578999999999854 5688999999999999999995 555555555444444444444
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.+.+..+|+++.+++.+||+.||.+|||++++++.|++++.+
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 556788999999999999999999999999999999988754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-58 Score=408.85 Aligned_cols=260 Identities=29% Similarity=0.548 Sum_probs=221.0
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 94 (352)
++|.|++++|++.+.||+|+||+||+|.+. |+.||||++...... .+++.+|++++++++||||+++++++.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME------VEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch------HHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 369999999999999999999999999985 889999998765432 235889999999999999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ +.+++|||||++|+|.+++.+.....+++..++.++.|+++||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG~a 162 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLS 162 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCCT
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-CcEEEccccce
Confidence 5 589999999999999999987766679999999999999999999999999999999999999988 79999999999
Q ss_pred ccccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-C
Q 018656 174 REESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN-V 250 (352)
Q Consensus 174 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~-~ 250 (352)
+...... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||................ .
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~ 234 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 234 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred eecCCCCceeeccccccccccChHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC
Confidence 8643322 2233457899999999865 678999999999999999999766655444444444444333 4
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
.+.+..+|+++.++|.+||+.||.+|||++++++.|+.+.+
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 45577899999999999999999999999999998877654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-59 Score=406.56 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=207.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec---Cc
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~---~~ 97 (352)
.++|++.+.||+|+||+||+|+++ |+.||||++......+. ..+.+.+|++++++++||||+++++++.+ +.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA---EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHH---HHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHH---HHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence 367999999999999999999985 88999999987654432 34568899999999999999999998853 46
Q ss_pred eEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCCeEEeCCCCceEEecC
Q 018656 98 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHG-----IIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~-----ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
+|+|||||+||+|.+++.+. ....+++..++.++.|++.||+|||++| |+||||||+|||++.+ +.+||+||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DF 158 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 158 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeec
Confidence 89999999999999998753 2345999999999999999999999976 9999999999999998 79999999
Q ss_pred CCccccccc-cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 171 GLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 171 g~a~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
|+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.........
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcC--------CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 999865433 23455689999999999854 668999999999999999999999999877766555555555
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+.+..+|+++.++|.+||+.||.+|||+.++++|
T Consensus 231 ~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 566678899999999999999999999999999987
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-58 Score=406.49 Aligned_cols=250 Identities=28% Similarity=0.467 Sum_probs=215.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|++.+.||+|+||+||+|.++ |+.||||++....... .+.+.+|++++++++||||+++++++.+ +.+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-----HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 468999999999999999999975 8999999987644322 2458899999999999999999999874 5799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~ 179 (352)
+|||||+||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCST
T ss_pred EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-CcEeeccchhheeeccc
Confidence 999999999999988763 39999999999999999999999999999999999999988 79999999999865433
Q ss_pred -cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--CCCCCC
Q 018656 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSAEN 256 (352)
Q Consensus 180 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 256 (352)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+............. .+.+..
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSS--------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGG
T ss_pred cccccccccCCCccChhhhcC--------CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence 33455679999999999854 6688999999999999999999999998777666555544432 233567
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
+|+++.++|.+||+.||.+|||+.++++| .|++
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~H--p~~~ 274 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH--QFLK 274 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTC--GGGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC--HhhC
Confidence 89999999999999999999999999998 4554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-58 Score=402.74 Aligned_cols=263 Identities=24% Similarity=0.507 Sum_probs=224.6
Q ss_pred cceecCCceeeecc-ccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 18 KWLIDPKHLFVGPR-IGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 18 ~~~i~~~~y~~~~~-lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
+|++.+++|.+.+. ||+|+||+||+|.+. +..||||++....... ...++.+|++++++++||||++++++
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~----~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA----DTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH----HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH----HHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 68899999999985 999999999999764 4579999997654432 34568999999999999999999999
Q ss_pred eecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 93 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 93 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
+.++.+++||||+++|+|.+++.... ..+++..++.++.|+++||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 78 ~~~~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGl 155 (285)
T d1u59a_ 78 CQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGL 155 (285)
T ss_dssp EESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTT
T ss_pred eccCeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cceeeccchh
Confidence 98888999999999999999986543 349999999999999999999999999999999999999988 7999999999
Q ss_pred cccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 018656 173 AREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 173 a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~ 247 (352)
++...... ......||+.|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+.......
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~ 227 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT
T ss_pred hhcccccccccccccccccCccccChHHHhC--------CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 98543322 2234468999999999854 568899999999999999998 9999998777665555555
Q ss_pred ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 248 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
....+.+..+|+++.++|.+||+.||.+|||+.++.+.|+.....+.
T Consensus 228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 55556678999999999999999999999999999998887665443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-59 Score=406.94 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=206.6
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++++.||+|+||+||+|+++ |+.||||++......+ ...++.+|++++++++||||+++++++.+ +..|+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch----HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 57999999999999999999985 8999999997654322 23468899999999999999999999875 47899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
|||||+||+|.+++.+.. .+++..++.++.||++||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 81 vmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC-CCEEEccchhheeeccCC
Confidence 999999999999997544 49999999999999999999999999999999999999988 79999999999854322
Q ss_pred --cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc--CCCCCC
Q 018656 180 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN--VRPSAE 255 (352)
Q Consensus 180 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~ 255 (352)
......+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.............. ..+...
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~-------~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHC-------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGG
T ss_pred ccccccceeeCcCccCHhHhcC-------CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence 23445689999999999854 2334678999999999999999999998765544433333322 223346
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+|+++.++|.+||+.||.+|||++++++|
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 231 KIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 789999999999999999999999999887
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=398.19 Aligned_cols=256 Identities=29% Similarity=0.548 Sum_probs=210.1
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCc
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPV 97 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~ 97 (352)
+|++++|++++.||+|+||+||+|++. ++.||||++....... ..+.+|++++++++||||+++++++. ++.
T Consensus 1 ~idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp CBCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CCChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH------HHHHHHHHHHHhcCCCCcccccceeccCCc
Confidence 478999999999999999999999985 6789999987654332 35889999999999999999999987 458
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~ 177 (352)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+|||++++ +.+||+|||+++...
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVL 152 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-GCEEECSCC------
T ss_pred eEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-CCeEecccchheecc
Confidence 999999999999999987653 348999999999999999999999999999999999999988 799999999998543
Q ss_pred ccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCC
Q 018656 178 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSA 254 (352)
Q Consensus 178 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 254 (352)
... ......||+.|+|||++.+ ..++.++||||||+++|||++ |.+||...+..+...........+.+
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p 224 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP 224 (263)
T ss_dssp ------------CTTSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC
T ss_pred CCCceeecceecCcccCChHHhcC--------CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 332 2233568999999999854 678999999999999999999 56667665555444444444445557
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
..+++++.+++.+||+.||.+|||+++++++|++..+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 7889999999999999999999999999999987754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=398.99 Aligned_cols=248 Identities=28% Similarity=0.528 Sum_probs=210.1
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
++.|++.+.||+|+||+||+|.++ ++.||+|++....... .....+.+|++++++++||||+++++++.+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK---SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 445688889999999999999985 7899999987654433 234568999999999999999999999853
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
..+++||||++||+|.+++.+... +++..++.++.||++||+|||+++ |+||||||+|||++.+.+.+||+|||++
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CEEEEEEeCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 358999999999999999987654 999999999999999999999999 9999999999999754379999999999
Q ss_pred cccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC
Q 018656 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS 253 (352)
Q Consensus 174 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (352)
+..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+................+.
T Consensus 163 ~~~~~~-~~~~~~GT~~Y~aPE~~~---------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 163 TLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 232 (270)
T ss_dssp GGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred eeccCC-ccCCcccCccccCHHHhC---------CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc
Confidence 754332 334668999999999874 3489999999999999999999999988766666555554443332
Q ss_pred --CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 254 --AENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 254 --~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+..+++++.++|.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 45688999999999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=406.86 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=210.2
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
.+++|++++.||+|+||+||+|+++ |+.||||++....... ......+.+|++++++++||||+++++++.+ +.+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC--HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 3568999999999999999999985 8899999986522111 1223568899999999999999999999985 479
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
|+|||||+||+|.+++...+. +++..++.++.|++.||+|||++||+||||||+|||++++ +.+||+|||+|+....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSP 160 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC-
T ss_pred EEEEEccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC-ceEEecccccceeccc
Confidence 999999999999999987655 9999999999999999999999999999999999999998 7999999999986433
Q ss_pred c---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 179 T---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 179 ~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+. ......+.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-~~~~~~p~ 231 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-KLEYDFPE 231 (288)
T ss_dssp ---------CCCCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-TTCCCCCT
T ss_pred CCcccccccccCCccccCceeecc--------CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH-cCCCCCCc
Confidence 2 23345679999999999864 678999999999999999999999999876655444433 33344567
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
.+++++.+||.+||+.||.+|||++|++++
T Consensus 232 ~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 899999999999999999999999997665
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=399.48 Aligned_cols=257 Identities=26% Similarity=0.478 Sum_probs=214.2
Q ss_pred ecCCceeee-ccccCCCceEEEEEEEC----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 21 IDPKHLFVG-PRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 21 i~~~~y~~~-~~lG~G~~g~Vy~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
++++.+.+. +.||+|+||+||+|.+. ++.||||++....... ....++.+|++++++++||||+++++++.+
T Consensus 3 ld~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~g~~~~ 79 (277)
T d1xbba_ 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP---ALKDELLAEANVMQQLDNPYIVRMIGICEA 79 (277)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C---HHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred echhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCH---HHHHHHHHHHHHHHhCCCCCCceEEEEecc
Confidence 455666665 46999999999999763 4679999986543322 334578999999999999999999999988
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+..++||||+++|+|.+++.+... +++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~~kl~DFGla~~ 156 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKA 156 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred CCEEEEEEcCCCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Ccccccchhhhhh
Confidence 888999999999999999987554 9999999999999999999999999999999999999988 7999999999975
Q ss_pred cccc----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC
Q 018656 176 ESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 176 ~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+..........
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~ 228 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 228 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred ccccccccccccccCCCceecCchhhcC--------CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 4322 12233468999999999865 568899999999999999997 8999998777665555555455
Q ss_pred CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 251 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
.+.+..+|+++.++|.+||+.||.+|||++++.+.|..++.
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 56678899999999999999999999999999998887654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=400.90 Aligned_cols=263 Identities=28% Similarity=0.494 Sum_probs=219.0
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 95 (352)
+.|.|+.++|++++.||+|+||+||+|.++ ++.||||++....... +.+.+|+.++++++|||||++++++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~------~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH------HHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 469999999999999999999999999986 5689999987654322 358899999999999999999999988
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
+..++||||+++|+|..++.......+++.+++.++.|++.||+|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARL 162 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC-
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhh
Confidence 889999999999999999876544459999999999999999999999999999999999999988 7999999999985
Q ss_pred ccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHhccCCC
Q 018656 176 ESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNLQAAYAAAFKNVRP 252 (352)
Q Consensus 176 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~ 252 (352)
..... ......||+.|+|||++.. ..++.++||||||+++|+|++|..| +.+....+...........+
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~ 234 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234 (285)
T ss_dssp -------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccCCCceeeccccccccccChHHHhC--------CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 43322 2234568999999999854 6789999999999999999996555 55544444444444444556
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 253 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
.+..+|+++.++|.+||+.||++||+++++++.|..++....
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 788999999999999999999999999999999988876543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-57 Score=400.66 Aligned_cols=260 Identities=27% Similarity=0.485 Sum_probs=213.7
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--C---ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
+.++.++|++++.||+|+||+||+|+++ | ..||||.+....... ....+.+|++++++++|||||++++++
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK----QRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH----HHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 4578899999999999999999999884 3 258888887655433 345689999999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
.+ +.+++|||||++|+|.+++..... .+++.+++.++.|+++||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGl 174 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGL 174 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC--
T ss_pred eeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-CcEEECCccc
Confidence 74 579999999999999999886443 49999999999999999999999999999999999999998 7999999999
Q ss_pred ccccccccc------cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 018656 173 AREESLTEM------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAA 245 (352)
Q Consensus 173 a~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~ 245 (352)
++....... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.....
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i 246 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246 (299)
T ss_dssp ---------------------CGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhc--------CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 985433221 112357899999999854 678999999999999999998 89999988776666655
Q ss_pred HhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 246 AFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
......+.+..+|+++.+++.+||+.||.+|||+.++++.|+.++++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 247 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 55555667788999999999999999999999999999999887764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=408.01 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=215.2
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ce
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~ 98 (352)
.-++|.+++.||+|+||+||+|+++ |+.||||++....... .....++.+|+.++++++||||+++++++.++ .+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC--HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 3457999999999999999999985 8999999987532111 12245688999999999999999999999865 79
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
|+|||||+||+|.+++.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+....
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC
T ss_pred ccceeccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC-CCEEEeeccccccccc
Confidence 999999999999999988665 9999999999999999999999999999999999999998 8999999999986433
Q ss_pred -ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 018656 179 -TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENV 257 (352)
Q Consensus 179 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (352)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.... ...........+..+
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~--------~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~i~~~~~~~p~~~ 228 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIRFPRTL 228 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCCTTS
T ss_pred CCcccccceeCHHHhhhhhccC--------CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-HHHHhcCCCCCCccC
Confidence 334456689999999999865 6789999999999999999999999998765443 344444455667889
Q ss_pred cHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPN-----FTQIIQML 286 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps-----~~~i~~~l 286 (352)
|+++.+||++||+.||.+|++ +.++++|.
T Consensus 229 s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp 262 (337)
T d1o6la_ 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred CHHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence 999999999999999999994 89999983
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-57 Score=406.29 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=196.9
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.+.|++++.||+|+||+||+|+++ |+.||||++....... ....+.+|++++++++||||+++++++.+ +.+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG----KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456999999999999999999985 8899999997654332 23457899999999999999999999985 4799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC--CCCceEEecCCCccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAREES 177 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~--~~~~vkl~Dfg~a~~~~ 177 (352)
+|||||+|++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||+.. +.+.+||+|||+++...
T Consensus 84 lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999999998654 3999999999999999999999999999999999999953 23789999999998766
Q ss_pred cccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC---CCC
Q 018656 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR---PSA 254 (352)
Q Consensus 178 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~---~~~ 254 (352)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+................ +..
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233 (307)
T ss_dssp -----------CTTSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTT
T ss_pred CCCeeeeeeeCccccCcHHHcC--------CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccc
Confidence 6655667789999999999854 56899999999999999999999999987766555544443332 334
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 255 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
..+|+++.++|.+||+.||.+|||+.++++|
T Consensus 234 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 6899999999999999999999999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-57 Score=402.55 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=214.1
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
+.|++.+.||+|+||+||+|++. |+.||||++........ .....+.+|++++++++||||+++++++.+ +..++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCH--HHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 35999999999999999999985 88999999987654432 345678999999999999999999999874 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
|||||++|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 93 v~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp EEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB-
T ss_pred EEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-CCEEEeecccccccCCC-
Confidence 999999999987776544 39999999999999999999999999999999999999988 89999999999864332
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC-CCCCCCcH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR-PSAENVPE 259 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 259 (352)
....||+.|+|||++.+. ....|+.++|||||||++|+|++|..||.+.+..+........... .....+|+
T Consensus 169 --~~~~GT~~Y~APE~~~~~-----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 241 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTT-----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCH
T ss_pred --CccccCccccCHHHHhcc-----CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCH
Confidence 356899999999998542 1246889999999999999999999999987776666555544433 33557899
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 260 ELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 260 ~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
++.+||.+||+.||.+|||++++++|.
T Consensus 242 ~~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 242 YFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence 999999999999999999999999984
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-58 Score=403.15 Aligned_cols=252 Identities=28% Similarity=0.421 Sum_probs=213.9
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeee-cCceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~l 100 (352)
+.|++++.||+|+||+||+|+++ |+.||||++....... ...+.+|++++++++||||+++++++. ++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-----LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG-----GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH-----HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 46899999999999999999985 8899999987654322 345889999999999999999999987 458999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~- 179 (352)
|||||+||+|.+++.+.. ..+++..+..++.||++||+|||++||+||||||+|||++.+ +.+||+|||+|......
T Consensus 87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECHHHH
T ss_pred EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC-CCEEEEechhhhccCCCc
Confidence 999999999999987643 349999999999999999999999999999999999999988 79999999999754332
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC--CCCCCCC
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV--RPSAENV 257 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 257 (352)
.......||+.|+|||++.... .....++.++|||||||++|+|++|+.||.+.+..+.......... .+.+..+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~---~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 241 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCS---TTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGS
T ss_pred ccccccccccccCCHHHHhhcc---cCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccC
Confidence 2334568999999999985421 1246688999999999999999999999998777666655554432 2235678
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 258 PEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
|+++.++|.+||+.||.+|||+.++++|
T Consensus 242 s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999999988
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-57 Score=396.22 Aligned_cols=261 Identities=29% Similarity=0.519 Sum_probs=216.0
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC-----CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
.|.|++++|++++.||+|+||+||+|.+. +..||||.+...... .....+.+|++++++++||||++++++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD----SVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH----HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 38999999999999999999999999874 345888887654432 334568999999999999999999999
Q ss_pred eecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 93 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 93 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
+.++.+++||||+++|+|.+++.... ..+++..++.++.|+++||+|||++|++||||||+||+++.+ +.+||+|||+
T Consensus 77 ~~~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~ 154 (273)
T d1mp8a_ 77 ITENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGL 154 (273)
T ss_dssp ECSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC---
T ss_pred EecCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchh
Confidence 98889999999999999999887644 349999999999999999999999999999999999999998 7999999999
Q ss_pred cccccccc--ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc
Q 018656 173 AREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 173 a~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 249 (352)
++...... ......||+.|+|||++.. ..++.++|||||||++|||++ |.+||.+.+..+.........
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~--------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~ 226 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 226 (273)
T ss_dssp ----------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred heeccCCcceeccceecCcccchhhHhcc--------CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 98643322 2334568999999999864 678999999999999999997 899999887776666666555
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
..+.+..+|+++.++|.+||+.||.+|||+.+++++|...++.
T Consensus 227 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 6677889999999999999999999999999999999877653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=408.11 Aligned_cols=264 Identities=30% Similarity=0.511 Sum_probs=220.0
Q ss_pred ccccccccceecCCceeeeccccCCCceEEEEEEECC-------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-C
Q 018656 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (352)
Q Consensus 11 ~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (352)
.++..+.+|.|++++|++++.||+|+||+||+|++.+ ..||+|++...... .....+.+|+.+++++ +
T Consensus 24 ~~~~~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~~ 99 (325)
T d1rjba_ 24 REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS----SEREALMSELKMMTQLGS 99 (325)
T ss_dssp GGSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCC
T ss_pred hhcCCCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH----HHHHHHHHHHHHHHHhcC
Confidence 3466678899999999999999999999999998742 25899988654332 2344688999999988 8
Q ss_pred CCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHH
Q 018656 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP---------------------RCLDVCVAIGFALDIARAMEC 140 (352)
Q Consensus 83 hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~~L~~ 140 (352)
|||||++++++.+ +.+++|||||++|+|.+++..... ..+++..++.++.|+++||+|
T Consensus 100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 179 (325)
T d1rjba_ 100 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179 (325)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred CCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 9999999999974 579999999999999999976532 248999999999999999999
Q ss_pred HHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchh
Q 018656 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSY 217 (352)
Q Consensus 141 lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Diw 217 (352)
||++||+||||||+||+++.+ +.+||+|||+|+...... ......||+.|+|||++.+ ..++.++|||
T Consensus 180 LH~~~IiHRDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~Diw 250 (325)
T d1rjba_ 180 LEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVW 250 (325)
T ss_dssp HHHTTEEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHH
T ss_pred HHhCCeeeccCchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--------CCCCcceecc
Confidence 999999999999999999998 899999999997543322 2234467999999999854 6789999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccC-CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 218 SFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 218 slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
||||++|||++ |..||.+.+............. .+.+..+|+++.++|.+||+.||++|||+++|+++|.
T Consensus 251 S~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred chhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99999999997 8999998766555555544443 3456789999999999999999999999999999984
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=389.37 Aligned_cols=252 Identities=30% Similarity=0.559 Sum_probs=219.3
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
+|+++|++++.||+|+||+||+|+++ ++.||||+++...... ..+.+|++++++++||||+++++++.+ +.+
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~------~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH------HHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH------HHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence 57899999999999999999999996 6689999998755432 358899999999999999999999874 589
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
++||||+++|+|.+++..... .+++..++.++.|+++||+|||++||+||||||+||+++++ +.+||+|||+++....
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSS
T ss_pred EEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-CcEEECcchhheeccC
Confidence 999999999999999776443 48999999999999999999999999999999999999998 7999999999975433
Q ss_pred ccc--cccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 179 TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 179 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
... .....||+.|+|||.+.. ..++.++||||||+++|||++ |+.||.+.+..+...........+.+.
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~ 224 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 224 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred CCceeecccCCCCCcCCcHHhcC--------CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 222 233568999999999864 668999999999999999998 899999988776666666555566778
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 288 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~ 288 (352)
.+++++.++|.+||+.||++|||+++++++|.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 899999999999999999999999999999854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-57 Score=411.46 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=217.0
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++++.||+|+||+||+|+++ |+.||||++..... .....+.+|+.++++++||||+++++++.+ +.+|+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46999999999999999999985 89999999876542 223468899999999999999999999985 57899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeC-CCCceEEecCCCccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAREESLT 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~-~~~~vkl~Dfg~a~~~~~~ 179 (352)
|||||+||+|.+++.+.. ..+++.+++.|+.||+.||+|||++||+||||||+|||++. +.+.+||+|||+|......
T Consensus 104 vmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999999999886543 34999999999999999999999999999999999999973 2378999999999877666
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC---CCCC
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP---SAEN 256 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 256 (352)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..............+ ....
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 254 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred CceeeccCcccccCHHHHcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 66667789999999999854 668999999999999999999999999977766655555443322 2467
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
+|+++.+||.+||+.||.+|||+.++++| .|++
T Consensus 255 ~s~~~~~li~~~L~~dp~~R~s~~eil~H--p~~~ 287 (352)
T d1koba_ 255 VSPEAKDFIKNLLQKEPRKRLTVHDALEH--PWLK 287 (352)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTS--TTTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC--HhhC
Confidence 99999999999999999999999999998 4444
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-57 Score=400.27 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=217.0
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHH-HHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~ 99 (352)
++|++++.||+|+||+||+|+++ |+.||||++......... ....+.+.+|++++++++||||+++++++.++ .++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999985 899999998764332210 11234688999999999999999999999854 789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCC---CceEEecCCCcccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL---KTIKLADFGLAREE 176 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~---~~vkl~Dfg~a~~~ 176 (352)
+|||||+||+|.+++.+.+. +++..++.++.|++.||+|||++||+||||||+|||++.++ ..+||+|||++...
T Consensus 90 iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 99999999999999987654 99999999999999999999999999999999999998762 25999999999876
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS--- 253 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--- 253 (352)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.............
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred CCCccccccCCCCcccCHHHHcC--------CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 66656667789999999999854 5689999999999999999999999998776665555444333222
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 254 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
+..+|+++.+||++||+.||.+|||++++++| .|++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--p~~~ 275 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH--PWIK 275 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--TTTC
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC--cccC
Confidence 36789999999999999999999999999998 4443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-56 Score=405.56 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=216.3
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++++.||+|+||+||+|++. |+.||||++..... .....+.+|++++++++||||+++++++.+ +.+++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-----HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-----hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 47999999999999999999985 89999999876432 224568899999999999999999999874 58999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC-CCceEEecCCCccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLT 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~-~~~vkl~Dfg~a~~~~~~ 179 (352)
|||||+||+|.+++.+.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.+ .+.+||+|||++......
T Consensus 101 vmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp EECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999999996543 349999999999999999999999999999999999999643 368999999999876666
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---CCC
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---AEN 256 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 256 (352)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+........ ...
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 251 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHT--------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGG
T ss_pred cccceecCcccccCHHHHcC--------CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 66667789999999999854 5678999999999999999999999998776665555544433322 356
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 257 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
+|+++.+||.+||+.||.+|||++++++| .|+.
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~h--p~~~ 284 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALEH--PWLT 284 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHHS--TTTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC--cccC
Confidence 89999999999999999999999999998 4444
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-57 Score=404.26 Aligned_cols=250 Identities=22% Similarity=0.373 Sum_probs=206.8
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cc
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~ 97 (352)
+..++|++.+.||+|+||+||+|++. |+.||+|++....... ...++.+|++++++++|||||++++++.+ +.
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 78 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT----HHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45678999999999999999999985 8999999997654432 23468899999999999999999999985 47
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 98 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
+++||||++||+|.+++.+... +++..++.++.|++.||.|||+ +||+||||||+|||++.+ +.+||+|||+|...
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-CCEEEeeCCCcccc
Confidence 9999999999999999987654 9999999999999999999997 599999999999999988 79999999999854
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHH------------
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYA------------ 244 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~------------ 244 (352)
.. ....+.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......
T Consensus 156 ~~-~~~~~~~GT~~Y~APEvl~~--------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
T d1s9ja_ 156 ID-SMANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226 (322)
T ss_dssp HH-HTC---CCSSCCCCHHHHHC--------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred CC-CccccccCCccccCchHHcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence 33 22345689999999999965 6789999999999999999999999987543221110
Q ss_pred -----------------------------HHhccCCCC--CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 018656 245 -----------------------------AAFKNVRPS--AENVPEELSIILTSCWKEDPNARPNFTQIIQML 286 (352)
Q Consensus 245 -----------------------------~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l 286 (352)
.......+. ...++.++.++|.+||..||.+|||++++++|.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp 299 (322)
T d1s9ja_ 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299 (322)
T ss_dssp -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence 000001111 124678999999999999999999999999984
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=389.92 Aligned_cols=254 Identities=30% Similarity=0.554 Sum_probs=215.2
Q ss_pred ceecCCceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec--C
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--P 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~ 96 (352)
|.|+.++|++++.||+|+||.||+|.++|+.||||+++..... +.+.+|++++++++||||+++++++.+ +
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA-------QAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHH-------HHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 9999999999999999999999999999999999999764432 358899999999999999999998853 4
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccc
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~ 176 (352)
.+++||||+++|+|.+++.+.....+++..++.|+.|++.||.|||+++|+||||||+|||++.+ +.+||+|||+++..
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA 153 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-CCEeecccccceec
Confidence 68999999999999999976554458999999999999999999999999999999999999998 79999999999864
Q ss_pred ccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 177 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
... .....++..|+|||++.+ ..++.++||||||+++|||++ |++||...+..+...........+.+.
T Consensus 154 ~~~--~~~~~~~~~y~aPE~l~~--------~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~ 223 (262)
T d1byga_ 154 SST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223 (262)
T ss_dssp ----------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT
T ss_pred CCC--CccccccccCCChHHHhC--------CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 332 234468899999999854 678999999999999999998 799998877666555555445556677
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
.+++++.++|.+||..||.+|||+.+++++|+...
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 89999999999999999999999999999987754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.1e-56 Score=388.77 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=220.4
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCCh----HHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeec
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETP----EEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~ 95 (352)
.++|++++.||+|+||+||+|++. |+.||||++...... ........++.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999984 899999998765432 223344567889999999996 9999999999985
Q ss_pred C-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 ~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
+ ..|+||||++||+|.+++..+.. +++..++.++.||++||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-CCeEEccchhee
Confidence 4 78999999999999999987654 9999999999999999999999999999999999999988 799999999998
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC---
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--- 251 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--- 251 (352)
............||+.|+|||.+.+... .....++.++||||+||++|+|++|+.||.+.+..............
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~--~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred EccCCCceeeeeccCCCCCHHHhhcccc--ccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 7665555566789999999999865321 12356789999999999999999999999998766655544444332
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 252 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
+....+|+++.++|.+||+.||.+|||++++++|
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2345799999999999999999999999999988
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.2e-56 Score=395.60 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=212.1
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~l 100 (352)
++|++++.||+|+||+||+|+++ |+.||||++....... ......+.+|+.++++++||||+++++++.+ +.+|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC--HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 57999999999999999999985 8999999986532111 1224568899999999999999999999985 57999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
|||||+|++|..++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 82 vmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp EECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS--
T ss_pred EeeecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC-CCEEEecCccceEecc--
Confidence 9999999999999987654 8999999999999999999999999999999999999988 7999999999986533
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......... .....+..+|++
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~--------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-~~~~~p~~~s~~ 227 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-AELRFPPFFNED 227 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-CCCCCCTTSCHH
T ss_pred ccccccCcccccCHHHHcC--------CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc-CCCCCCCCCCHH
Confidence 2345689999999999854 5688999999999999999999999998766555444433 344556789999
Q ss_pred HHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
+.+++.+||..||.+|+ |++++++|.
T Consensus 228 ~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp 258 (316)
T d1fota_ 228 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 258 (316)
T ss_dssp HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHHHHHhhhCHHhccccchhhHHHHHcCc
Confidence 99999999999999996 899999983
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=383.47 Aligned_cols=259 Identities=28% Similarity=0.494 Sum_probs=210.1
Q ss_pred eecCCceeeeccccCCCceEEEEEEECC------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKN------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
.|+++.|.++++||+|+||+||+|.+++ ..||||++....... ....+.+|++++++++|||||++++++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK----QRVDFLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH----HHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH----HHHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence 5788899999999999999999998742 369999987655433 244688999999999999999999998
Q ss_pred ec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCC
Q 018656 94 KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (352)
Q Consensus 94 ~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~ 172 (352)
.+ +..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+||||+.+ +.+||+|||+
T Consensus 79 ~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGl 156 (283)
T d1mqba_ 79 SKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGL 156 (283)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC
T ss_pred ecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-CeEEEcccch
Confidence 74 57999999999999999887644 349999999999999999999999999999999999999998 7999999999
Q ss_pred cccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHh
Q 018656 173 AREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLP-FEGMSNLQAAYAAAF 247 (352)
Q Consensus 173 a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p-~~~~~~~~~~~~~~~ 247 (352)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..| +.+.+..+.......
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~ 228 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228 (283)
T ss_dssp -----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHcc--------CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc
Confidence 98543221 2233468999999998854 6789999999999999999996555 554444443333344
Q ss_pred ccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 248 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
....+.+..+|.++.++|.+||+.||.+|||+.++++.|+..++.
T Consensus 229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 444566778999999999999999999999999999999877653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-56 Score=396.40 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=214.9
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceE
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~ 99 (352)
.++|++++.||+|+||+||+|.++ |+.||||++..... ....+.+|++++++++||||+++++++.+ +.+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT------DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 367999999999999999999985 88999999976532 12357899999999999999999999874 5899
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC-CCceEEecCCCcccccc
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESL 178 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~-~~~vkl~Dfg~a~~~~~ 178 (352)
+|||||+|++|.+++.+.+ ..+++.+++.|+.||+.||+|||++||+||||||+|||++.+ ...++|+|||++.....
T Consensus 78 lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999999997654 249999999999999999999999999999999999999754 35799999999987666
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC---CC
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---AE 255 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 255 (352)
........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....+........ +.
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~--------~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 228 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred CCcccccccccccccchhccC--------CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhcc
Confidence 555566789999999998854 6688999999999999999999999998777665555544433322 34
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.+|+++.+||.+||..||.+|||+.++++|.|
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 78999999999999999999999999999843
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.4e-55 Score=384.38 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=209.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---- 96 (352)
.++|++.+.||+|+||+||+|++. |+.||||++........ ....++.+|+++++.++||||+++++++...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP--SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH--HHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 357999999999999999999985 89999999987554332 3456789999999999999999999998632
Q ss_pred -ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 97 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..|+||||++|++|.+++...+. +++.+++.++.||++||+|||++||+||||||+|||++.+ +.++++|||.+..
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-SCEEECCCTTCEE
T ss_pred ceEEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc-ccceeehhhhhhh
Confidence 48999999999999999987654 9999999999999999999999999999999999999998 7999999999864
Q ss_pred cccc----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC
Q 018656 176 ESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR 251 (352)
Q Consensus 176 ~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 251 (352)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...........
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 232 (277)
T ss_dssp CC----------------TTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred hccccccccccccccCcccccCHHHHcC--------CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC
Confidence 3222 23345579999999999854 56889999999999999999999999987776666555554433
Q ss_pred C---CCCCCcHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHh
Q 018656 252 P---SAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNY 289 (352)
Q Consensus 252 ~---~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~i~~~l~~~ 289 (352)
+ ....+|+++.++|.+||+.||.+|| |+++++..|.+.
T Consensus 233 ~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 2 2567999999999999999999999 788888877654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-55 Score=394.30 Aligned_cols=247 Identities=26% Similarity=0.306 Sum_probs=212.0
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 100 (352)
++|++++.||+|+||+||+|+++ |+.||||++....... .....++.+|+++++.++||||+++++++.+. ..++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC--HHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 57999999999999999999985 8999999986422111 12245688999999999999999999998854 7899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
||||+.||+|.+++.+.+. +++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 119 v~e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSSC-
T ss_pred ccccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC-CCEEeeeceeeeecccc-
Confidence 9999999999999987654 9999999999999999999999999999999999999988 79999999999865432
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCcHH
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVPEE 260 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (352)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+ .......+..+|++
T Consensus 195 -~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-~~~~~~~p~~~s~~ 264 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKVRFPSHFSSD 264 (350)
T ss_dssp -BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCCCCCTTCCHH
T ss_pred -cccccCccccCCHHHHcC--------CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH-hcCCCCCCccCCHH
Confidence 345679999999999865 66889999999999999999999999987655444443 34445556789999
Q ss_pred HHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 018656 261 LSIILTSCWKEDPNARP-----NFTQIIQML 286 (352)
Q Consensus 261 l~~li~~~l~~~p~~Rp-----s~~~i~~~l 286 (352)
+.++|++||..||.+|+ |++++++|.
T Consensus 265 ~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp 295 (350)
T d1rdqe_ 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence 99999999999999994 899999983
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-55 Score=386.91 Aligned_cols=266 Identities=32% Similarity=0.576 Sum_probs=220.9
Q ss_pred ccccccceecCCceeeeccccCCCceEEEEEEECC---------ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-C
Q 018656 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN---------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (352)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (352)
+..+++|.|+.++|.+++.||+|+||.||+|++.+ ..||||++....... ....+.+|...+.++ +
T Consensus 2 ~~~~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~e~~~l~~~~~ 77 (299)
T d1fgka_ 2 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK----DLSDLISEMEMMKMIGK 77 (299)
T ss_dssp CCCCTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH----HHHHHHHHHHHHHHHCC
T ss_pred cCcCCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH----HHHHHHHHHHHHHHhcC
Confidence 56678899999999999999999999999998632 469999998765533 234578888888888 8
Q ss_pred CCCeeeeeeeeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 018656 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGII 147 (352)
Q Consensus 83 hp~iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~L~~lH~~~iv 147 (352)
||||+++++++.+ +..++||||+++|+|.+++..+.. ..+++..++.++.||+.||+|||+++|+
T Consensus 78 HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~iv 157 (299)
T d1fgka_ 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 157 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEE
Confidence 9999999999975 579999999999999999976532 3589999999999999999999999999
Q ss_pred cCCCCCCCeEEeCCCCceEEecCCCcccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHH
Q 018656 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224 (352)
Q Consensus 148 H~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 224 (352)
||||||+|||++.+ +.+||+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|
T Consensus 158 HrDiKp~NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--------~~y~~k~DiwS~Gvvl~ 228 (299)
T d1fgka_ 158 HRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLW 228 (299)
T ss_dssp CSCCSGGGEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred eeeecccceeecCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcC--------CCCCchhhhHHhHHHHH
Confidence 99999999999998 799999999998544332 2334578999999999854 67899999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 225 ELLH-NKLPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 225 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
+|++ |.+||.+.+..............+.+..+|+++.++|.+||+.||.+|||+.++++.|+..+.
T Consensus 229 ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 229 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 9997 799998877655444444444556678899999999999999999999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=391.43 Aligned_cols=258 Identities=29% Similarity=0.371 Sum_probs=204.3
Q ss_pred eeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEEEEc
Q 018656 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTEL 104 (352)
Q Consensus 28 ~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv~e~ 104 (352)
.+++||+|+||+||+|+++ |+.||||++..............++.+|++++++++||||+++++++.+ +.+++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999984 8999999997655433323334568899999999999999999999974 589999999
Q ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-cccc
Q 018656 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMT 183 (352)
Q Consensus 105 ~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~-~~~~ 183 (352)
+.++++..+... ...+++..+..++.||++||+|||++||+||||||+|||++.+ +.+||+|||++...... ....
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-CccccccCccccccCCCccccc
Confidence 988766655543 2348999999999999999999999999999999999999988 79999999999764433 2334
Q ss_pred cCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC----------
Q 018656 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS---------- 253 (352)
Q Consensus 184 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 253 (352)
..+||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 159 ~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ceecChhhccHHHHcc-------CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 5679999999998754 34678999999999999999999999998877666555433211111
Q ss_pred -----------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 018656 254 -----------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 297 (352)
Q Consensus 254 -----------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~ 297 (352)
...+++++.+||.+||+.||.+|||+.|+++| .|++..+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H--p~f~~~p~p~ 290 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRPGPT 290 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSSSCCC
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC--HhhCCCCCCC
Confidence 13567899999999999999999999999998 5666544433
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=393.87 Aligned_cols=248 Identities=29% Similarity=0.427 Sum_probs=208.4
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHh-cCCCCCeeeeeeeeecC-ceE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLS-RVQHRNLVKFIGACKEP-VMV 99 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~l~~~~~~~-~~~ 99 (352)
++|.+++.||+|+||+||+|.++ |+.||||++....... ......+.+|..++. .++||||+++++++.++ .+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~--~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC--hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 57999999999999999999994 8999999986522111 112234556666654 68999999999999854 799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-
Q 018656 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL- 178 (352)
Q Consensus 100 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~- 178 (352)
+||||++||+|.+++..... +++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 80 ivmEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-Cceeccccchhhhcccc
Confidence 99999999999999987665 8999999999999999999999999999999999999988 8999999999985443
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCCCCc
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAENVP 258 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (352)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+......... ......+..+|
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-~~~~~~p~~~s 227 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-MDNPFYPRWLE 227 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCCCCCTTSC
T ss_pred cccccccCCCCCcCCHHHHcC--------CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccCC
Confidence 333445679999999999865 678999999999999999999999999877655444443 34445567899
Q ss_pred HHHHHHHHHhhccCCCCCCCHH-HHHHH
Q 018656 259 EELSIILTSCWKEDPNARPNFT-QIIQM 285 (352)
Q Consensus 259 ~~l~~li~~~l~~~p~~Rps~~-~i~~~ 285 (352)
+++.+||++||+.||.+||++. ++++|
T Consensus 228 ~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 228 KEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 9999999999999999999995 78877
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=384.27 Aligned_cols=259 Identities=29% Similarity=0.541 Sum_probs=209.0
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC---C--ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK---N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~---~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
-+|+.++|++.+.||+|+||+||+|++. + ..||||++........ +...++.+|++++++++||||+++++++
T Consensus 3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP--EAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C--HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3678899999999999999999999863 2 3689999876443222 3445789999999999999999999999
Q ss_pred ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 94 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
.++..++||||+++++|.+++..+.. .+++..++.++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 81 ~~~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~ 158 (273)
T d1u46a_ 81 LTPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLM 158 (273)
T ss_dssp CSSSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTC
T ss_pred eecchheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhh
Confidence 88889999999999999998876543 39999999999999999999999999999999999999998 79999999999
Q ss_pred ccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 018656 174 REESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFK 248 (352)
Q Consensus 174 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~ 248 (352)
+...... ......|+..|+|||++.+ ..++.++||||||+++|||++ |..||.+.+..+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhC--------CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC
Confidence 8543221 2233457889999999865 668899999999999999998 89999988777665555444
Q ss_pred cC-CCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 018656 249 NV-RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 289 (352)
Q Consensus 249 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~ 289 (352)
.. .+.+..+|+++.++|.+||..||++|||+.++.+.|.+.
T Consensus 231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 33 345678999999999999999999999999999888653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-55 Score=388.70 Aligned_cols=263 Identities=29% Similarity=0.541 Sum_probs=209.6
Q ss_pred ccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeee
Q 018656 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVK 88 (352)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~ 88 (352)
++|.|++++|++++.||+|+||+||+|++. ++.||||++....... ....+.+|...+.++ +|+||+.
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~----~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----EHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH----HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH----HHHHHHHHHHHHHhhcCCCeEEE
Confidence 569999999999999999999999999873 3679999987654433 234567777777766 7899999
Q ss_pred eeeeeec--CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 018656 89 FIGACKE--PVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (352)
Q Consensus 89 l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dik 152 (352)
+++++.+ ..+++|||||++|+|.+++.... ...+++..++.++.|+++||+|||++||+|||||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK 161 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 161 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence 9998764 36899999999999999997542 2348999999999999999999999999999999
Q ss_pred CCCeEEeCCCCceEEecCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC
Q 018656 153 PENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN 229 (352)
Q Consensus 153 p~Nili~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g 229 (352)
|+|||++++ +.+||+|||+|+..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 162 p~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gvil~ellt~ 232 (299)
T d1ywna1 162 ARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSL 232 (299)
T ss_dssp GGGEEECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccceeECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhc--------CCCCcccceeehHHHHHHHHhC
Confidence 999999988 79999999999753322 22334579999999999865 6789999999999999999986
Q ss_pred -CCCCCCCChHHHHHHHHhc-cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 230 -KLPFEGMSNLQAAYAAAFK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 230 -~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
..||.+............. ...+.+..+++++.++|.+||+.||.+|||+.+++++|...+++
T Consensus 233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 5688876654444444333 34455678999999999999999999999999999999988754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-55 Score=391.64 Aligned_cols=258 Identities=23% Similarity=0.491 Sum_probs=214.4
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--Cc----eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
++..++|++++.||+|+||+||+|.+. |+ .||+|.+...... .....+.+|++++++++||||+++++++
T Consensus 5 ~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 80 (317)
T d1xkka_ 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP----KANKEILDEAYVMASVDNPHVCRLLGIC 80 (317)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 455678999999999999999999885 43 5888887653322 2244689999999999999999999999
Q ss_pred ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 94 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
.++..++++|++.+++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 81 ~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~~kl~DFGla 158 (317)
T d1xkka_ 81 LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLA 158 (317)
T ss_dssp ESSSEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCCSHH
T ss_pred ecCCeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CCeEeeccccc
Confidence 9888999999999999999987753 359999999999999999999999999999999999999998 79999999999
Q ss_pred ccccccc---ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc
Q 018656 174 REESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLH-NKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 174 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~ 249 (352)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~ 230 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 230 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred eecccccccccccccccCccccChHHHhc--------CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 8543322 2233468999999999865 678999999999999999998 899999877665544444445
Q ss_pred CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 250 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
..+.+..+|+++.+++.+||+.||.+|||+.++++++.....
T Consensus 231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 556678899999999999999999999999999999887654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.6e-55 Score=396.21 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=207.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHH-HHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-Cce
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE-IAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~ 98 (352)
-++|.+++.||+|+||+||+|++. |+.||||++........ ......+..+|+++++.++||||+++++++.+ +.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999985 89999999864321111 01111223345788889999999999999985 479
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~ 178 (352)
|+|||||+||+|.+++.+... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|.....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-SCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC-CcEEEeeeceeeecCC
Confidence 999999999999999987654 8999999999999999999999999999999999999988 7999999999986543
Q ss_pred ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHhccCCCCCCC
Q 018656 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA--AYAAAFKNVRPSAEN 256 (352)
Q Consensus 179 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 256 (352)
.. .....||+.|+|||++.. +..++.++|||||||++|+|++|+.||.+...... ............+..
T Consensus 160 ~~-~~~~~GT~~y~APE~~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (364)
T d1omwa3 160 KK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231 (364)
T ss_dssp SC-CCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSS
T ss_pred Cc-ccccccccccchhHHhhc-------CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCC
Confidence 32 345679999999999853 35688999999999999999999999987554322 222233334445678
Q ss_pred CcHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 018656 257 VPEELSIILTSCWKEDPNARPN-----FTQIIQM 285 (352)
Q Consensus 257 ~~~~l~~li~~~l~~~p~~Rps-----~~~i~~~ 285 (352)
+|+++.++|.+||+.||.+||| ++++++|
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 9999999999999999999999 7999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=383.24 Aligned_cols=261 Identities=27% Similarity=0.432 Sum_probs=212.3
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 100 (352)
++|++++.||+|+||+||+|.+. |+.||||++....... ....++.+|++++++++||||+++++++.++ .+|+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh---HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence 48999999999999999999985 8999999996543221 2245688999999999999999999999854 7999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccc-c
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-T 179 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~-~ 179 (352)
||||+. +++.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .
T Consensus 79 v~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 79 VFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCS
T ss_pred EEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc-CcceeccCCcceeccCCc
Confidence 999995 466666665555669999999999999999999999999999999999999988 7999999999975433 3
Q ss_pred cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC------
Q 018656 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS------ 253 (352)
Q Consensus 180 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------ 253 (352)
.......||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+...........+.
T Consensus 157 ~~~~~~~gt~~y~apE~~~~-------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccceeecccceeeehhhhcc-------ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccc
Confidence 33445579999999998754 24568899999999999999999999998777665554432211111
Q ss_pred ----------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 018656 254 ----------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 298 (352)
Q Consensus 254 ----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~ 298 (352)
...++.++.+||.+||..||.+|||+.++++| .|++++..|.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H--~ff~~~~~p~p 294 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVTKPVP 294 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGTTCCCCCC
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC--HhhccCCCCCC
Confidence 12567899999999999999999999999998 67776655544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-55 Score=392.11 Aligned_cols=246 Identities=27% Similarity=0.411 Sum_probs=202.2
Q ss_pred Cceeee-ccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhc-CCCCCeeeeeeeeec----
Q 018656 24 KHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR-VQHRNLVKFIGACKE---- 95 (352)
Q Consensus 24 ~~y~~~-~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~l~~~~~~---- 95 (352)
++|.+. +.||+|+||+||+|++. |+.||||++... ..+.+|+.++.+ ++||||+++++++.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 468876 56999999999999984 899999998642 236689988654 589999999999863
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCC
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGL 172 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~ 172 (352)
..+|+|||||+||+|.+++.+++...+++.+++.|+.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 468999999999999999988666679999999999999999999999999999999999999753 25799999999
Q ss_pred ccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---c
Q 018656 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK---N 249 (352)
Q Consensus 173 a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~ 249 (352)
++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+........... .
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCG--------GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred eeeccCCCccccccCCcccCCcHHHcC--------CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC
Confidence 987666666667789999999999864 56889999999999999999999999875543322222111 1
Q ss_pred CC--C--CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 018656 250 VR--P--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 287 (352)
Q Consensus 250 ~~--~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~ 287 (352)
.. | ....+|+++.+||++||+.||.+|||+.++++|.|
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 11 1 12357899999999999999999999999999843
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-54 Score=382.27 Aligned_cols=266 Identities=27% Similarity=0.518 Sum_probs=225.1
Q ss_pred cccccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 018656 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84 (352)
Q Consensus 12 ~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 84 (352)
++..-++|.|++++|++++.||+|+||+||+|.++ ++.||||++...... .....+.+|++++++++||
T Consensus 8 ~~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~----~~~~~~~~E~~il~~l~h~ 83 (308)
T d1p4oa_ 8 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM----RERIEFLNEASVMKEFNCH 83 (308)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH----HHHHHHHHHHHHGGGCCCT
T ss_pred cCcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh----HHHHHHHHHHHHHHHcCCC
Confidence 34454579999999999999999999999999874 468999999754432 2345688999999999999
Q ss_pred Ceeeeeeeee-cCceEEEEEcCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCC
Q 018656 85 NLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMR--------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 155 (352)
Q Consensus 85 ~iv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~N 155 (352)
||+++++++. +...++||||+++|+|.+++.... ...+++..+..++.|+++||.|||+++|+||||||+|
T Consensus 84 nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~N 163 (308)
T d1p4oa_ 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163 (308)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred CEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCc
Confidence 9999999987 457999999999999999986542 1247889999999999999999999999999999999
Q ss_pred eEEeCCCCceEEecCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhC-CC
Q 018656 156 LLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHN-KL 231 (352)
Q Consensus 156 ili~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g-~~ 231 (352)
||++.+ +.+||+|||+++..... .......||+.|+|||.+.+ ..++.++||||+|+++|||++| .+
T Consensus 164 iLld~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--------~~~~~~~Dv~S~G~il~El~t~~~~ 234 (308)
T d1p4oa_ 164 CMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQ 234 (308)
T ss_dssp EEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred eeecCC-ceEEEeecccceeccCCcceeeccceecccccCCHHHHcc--------CCCCcccccccHHHHHHHHHhCCCC
Confidence 999988 79999999999754322 22334468999999999854 6788899999999999999998 58
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 232 PFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
||.+.+..+...........+.+..+|+.+.++|.+||+.||.+|||+.+++++|+..+
T Consensus 235 p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 235 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 88887776666655555566667889999999999999999999999999999986654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-53 Score=380.46 Aligned_cols=260 Identities=28% Similarity=0.517 Sum_probs=219.9
Q ss_pred cceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeee
Q 018656 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (352)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 90 (352)
.|.+.+++|++++.||+|+||+||+|++. ++.||||++...... ....++.+|++++++++||||++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA----DMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH----HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh----HHHHHHHHHHHHHHhcCCCCcccce
Confidence 37788899999999999999999999875 368999998765443 2345689999999999999999999
Q ss_pred eeeec-CceEEEEEcCCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q 018656 91 GACKE-PVMVIVTELLSGGTLRKYLLNMR----------------------PRCLDVCVAIGFALDIARAMECLHSHGII 147 (352)
Q Consensus 91 ~~~~~-~~~~lv~e~~~~~sL~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~~L~~lH~~~iv 147 (352)
+++.. +..+++|||+++|+|.+++.... ...+++..++.|+.|++.||+|||+++++
T Consensus 83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv 162 (301)
T d1lufa_ 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 162 (301)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence 99874 57999999999999999997542 12488999999999999999999999999
Q ss_pred cCCCCCCCeEEeCCCCceEEecCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHH
Q 018656 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLW 224 (352)
Q Consensus 148 H~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~ 224 (352)
||||||+|||++.+ +.+||+|||+++..... .......|++.|+|||.+.+ ..++.++|||||||++|
T Consensus 163 HrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~t~ksDVwS~Gvvl~ 233 (301)
T d1lufa_ 163 HRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLW 233 (301)
T ss_dssp CSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred eeEEcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--------CCCChhhhhccchhhHH
Confidence 99999999999988 79999999999743222 22334578899999999865 67899999999999999
Q ss_pred HHHhCC-CCCCCCChHHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 018656 225 ELLHNK-LPFEGMSNLQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 290 (352)
Q Consensus 225 ~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~ 290 (352)
||++|. .||.+.+..+...........+.+..+|+++.++|.+||+.||.+|||+.+|++.|++..
T Consensus 234 ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 234 EIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 999985 678887776666665555555667889999999999999999999999999999987653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-54 Score=381.92 Aligned_cols=261 Identities=29% Similarity=0.495 Sum_probs=215.2
Q ss_pred eecCCceeeeccccCCCceEEEEEEEC--Cc--eEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-CCCCeeeeeeeee
Q 018656 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (352)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~ 94 (352)
.|+-++|++++.||+|+||+||+|.++ |. .||||.+......+ ..+.+.+|+++++++ +||||+++++++.
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD----DHRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH----HHHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 467789999999999999999999874 44 46777765443322 244689999999999 7999999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEe
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~ 159 (352)
+ +.+++||||+++|+|.+++.+.. ...+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 4 57999999999999999997542 24599999999999999999999999999999999999999
Q ss_pred CCCCceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCC-CCCCCCCh
Q 018656 160 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNK-LPFEGMSN 238 (352)
Q Consensus 160 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~-~p~~~~~~ 238 (352)
.+ +.+||+|||+++............||..|+|||.+.. ..++.++||||||+++|+|++|. +||.+.+.
T Consensus 162 ~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 162 EN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp GG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CC-CceEEccccccccccccccccceecCCcccchHHhcc--------CCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 88 7999999999986555544455678999999999854 67899999999999999999965 67877665
Q ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 239 LQAAYAAAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
.+...........+.+..+|+++.++|.+||+.||++|||+.+++++|...++..
T Consensus 233 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 233 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 5544444444445557789999999999999999999999999999999887643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=380.33 Aligned_cols=270 Identities=32% Similarity=0.541 Sum_probs=226.5
Q ss_pred cccccccccceecCCceeeeccccCCCceEEEEEEEC-------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC-
Q 018656 10 ADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV- 81 (352)
Q Consensus 10 ~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 81 (352)
+..+.-+.+|.|++++|++++.||+|+||.||+|++. ++.||||++....... ....+.+|+.+++++
T Consensus 9 ~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~E~~~~~~l~ 84 (311)
T d1t46a_ 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT----EREALMSELKVLSYLG 84 (311)
T ss_dssp TTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHC
T ss_pred cccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH----HHHHHHHHHHHHHhcc
Confidence 3457778899999999999999999999999999863 4689999997655432 344688999999999
Q ss_pred CCCCeeeeeeeeecC-ceEEEEEcCCCCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 018656 82 QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP----------------RCLDVCVAIGFALDIARAMECLHSH 144 (352)
Q Consensus 82 ~hp~iv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~~~i~~qi~~~L~~lH~~ 144 (352)
+||||+++++++.++ ..++|||||++|+|.+++.+... ..+++..++.++.||++||+|||++
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~ 164 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 799999999999754 78999999999999999976532 2589999999999999999999999
Q ss_pred CCccCCCCCCCeEEeCCCCceEEecCCCccccccc---cccccCCCcccccccccccccccccccccCCCcccchhhHHH
Q 018656 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAI 221 (352)
Q Consensus 145 ~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~ 221 (352)
|++||||||+||+++.+ +.++++|||+++..... .......||+.|+|||++.. ..++.++|||||||
T Consensus 165 ~ivHrDLKp~NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DIwS~G~ 235 (311)
T d1t46a_ 165 NCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGI 235 (311)
T ss_dssp TCCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHH
T ss_pred Ceeeccccccccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--------CCCCCcccccchHH
Confidence 99999999999999988 79999999999854332 22234578999999999854 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHHhcc-CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 222 VLWELLH-NKLPFEGMSNLQAAYAAAFKN-VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 222 il~~ll~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
++|+|++ |.+||.+.+............ ....+..+|+++.+||.+||+.||.+|||+.++++.|+..+..
T Consensus 236 ~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 9999998 677777766555444444433 3444678999999999999999999999999999999887654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=379.51 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=205.2
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHH-HHHHHHHHHHHHHHHhcCC--CCCeeeeeeeeec-C
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE-IAKKESRFAREVAMLSRVQ--HRNLVKFIGACKE-P 96 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~-~ 96 (352)
.++|++++.||+|+||+||+|++. |+.||||++........ ......++.+|+.++++++ ||||+++++++.+ +
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999985 89999999875322110 0001123568999999886 8999999999985 4
Q ss_pred ceEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 97 VMVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 97 ~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..++||||+.+ +++.+++.+... +++..++.++.||++||+|||++||+||||||+|||++.+.+.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEEEEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 78999999976 688888887654 999999999999999999999999999999999999986657999999999976
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCCCC
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE 255 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (352)
.... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+ .........+.
T Consensus 161 ~~~~-~~~~~~GT~~y~aPE~~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~~~~~~~ 225 (273)
T d1xwsa_ 161 LKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQVFFRQ 225 (273)
T ss_dssp CCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCCCCCSS
T ss_pred cccc-cccccccCCCcCCHHHHcC-------CCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhcccCCCC
Confidence 4332 3355689999999999865 2345678999999999999999999998622 12223344567
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 256 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.+|+++.++|.+||+.||.+|||++++++| .|++.
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h--p~~~~ 260 (273)
T d1xwsa_ 226 RVSSECQHLIRWCLALRPSDRPTFEEIQNH--PWMQD 260 (273)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGSS
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcC--HhhCC
Confidence 899999999999999999999999999998 45544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=374.84 Aligned_cols=256 Identities=27% Similarity=0.358 Sum_probs=206.6
Q ss_pred CCceeeeccccCCCceEEEEEEEC---CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcC---CCCCeeeeeeeeec-
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~iv~l~~~~~~- 95 (352)
.++|++++.||+|+||+||+|++. ++.||||++......... ...+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH---HHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 368999999999999999999984 567999998654332211 11245666666555 89999999998742
Q ss_pred -----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 96 -----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 96 -----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
..++++|||++++.+..... .....+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~-~~~kl~df 160 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADF 160 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSC
T ss_pred ccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC-CCeeecch
Confidence 36899999998766554443 344569999999999999999999999999999999999999988 79999999
Q ss_pred CCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccC
Q 018656 171 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNV 250 (352)
Q Consensus 171 g~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 250 (352)
|++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..........
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~--------~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 232 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcC--------CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhC
Confidence 99987666666677889999999999854 6789999999999999999999999998876665554432211
Q ss_pred C--------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 018656 251 R--------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 293 (352)
Q Consensus 251 ~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~ 293 (352)
. .....+++++.+||.+||+.||.+|||+.++++| .|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H--pff~~i 299 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH--PYFQDL 299 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS--GGGTTC
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC--hhhcCc
Confidence 1 1134578999999999999999999999999998 555543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-52 Score=370.65 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=202.8
Q ss_pred CceeeeccccCCCceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-CceEEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~lv 101 (352)
++|++.+.||+|+||+||+|+++ |+.||||++....... ....++.+|+.++++++||||+++++++.+ +..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE---GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG---CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh---HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 58999999999999999999986 8999999997654332 223468899999999999999999999874 579999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccccccc-c
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~-~ 180 (352)
||++.++.+..+.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||.+...... .
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC-CCEEecccccceecccCcc
Confidence 9999776666655443 349999999999999999999999999999999999999998 79999999999764332 2
Q ss_pred ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCC--------
Q 018656 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRP-------- 252 (352)
Q Consensus 181 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------- 252 (352)
......+++.|+|||.+.. ...++.++|||||||++|+|++|+.||.+.+..+...........+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp ------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccceecccchhhhHHHHhC-------CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence 2344568999999999854 3567899999999999999999999999877665554433211111
Q ss_pred --------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 018656 253 --------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 285 (352)
Q Consensus 253 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~ 285 (352)
....+++++.+||++||+.||++|||+.|+++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 124568899999999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=375.94 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=207.3
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 96 (352)
|.+ +++|++++.||+|+||+||+|.++ |+.||||++....... ....++.+|+++|++++||||+++++++...
T Consensus 14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE---LFAKRAYRELRLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH---HHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh---HHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence 666 679999999999999999999985 8999999997654433 3345688999999999999999999998643
Q ss_pred -------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEec
Q 018656 97 -------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (352)
Q Consensus 97 -------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~D 169 (352)
.+++||||+ +.+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|++|
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~-~~~kl~D 164 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILD 164 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECC
T ss_pred ccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc-ccccccc
Confidence 479999999 67888877653 39999999999999999999999999999999999999998 7999999
Q ss_pred CCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 018656 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKN 249 (352)
Q Consensus 170 fg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 249 (352)
||+++.... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+............
T Consensus 165 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 235 (346)
T d1cm8a_ 165 FGLARQADS--EMTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235 (346)
T ss_dssp CTTCEECCS--SCCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred ccceeccCC--ccccccccccccCHHHHcC-------CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhcc
Confidence 999986533 2355689999999998854 2457889999999999999999999999876655443322211
Q ss_pred CC------------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 250 VR------------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 250 ~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
.. .....+++++.+||.+||..||.+|||+.++++| .|++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H--p~f~~~~ 308 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--PYFESLH 308 (346)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGTTTC
T ss_pred CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC--hhhCcCC
Confidence 11 1134678999999999999999999999999998 6666544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=365.22 Aligned_cols=259 Identities=29% Similarity=0.475 Sum_probs=207.5
Q ss_pred eecCCcee--eeccccCCCceEEEEEEEC---C--ceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee
Q 018656 20 LIDPKHLF--VGPRIGEGAHAKVYEGKYK---N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (352)
Q Consensus 20 ~i~~~~y~--~~~~lG~G~~g~Vy~~~~~---~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 92 (352)
.+.++... +.++||+|+||+||+|.+. + ..||||.+...... ....++.+|++++++++||||++++++
T Consensus 21 ~~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~ 96 (311)
T d1r0pa_ 21 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEGIIMKDFSHPNVLSLLGI 96 (311)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH----HHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred EeChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH----HHHHHHHHHHHHHHhCCCCCEeEEeEE
Confidence 34444333 3778999999999999874 2 35899998654432 334669999999999999999999998
Q ss_pred ee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 93 CK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 93 ~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
+. ++..++|||||++++|.+++.... ..+++..++.++.|++.||.|||+.+|+||||||+|||++++ +.+||+||
T Consensus 97 ~~~~~~~~~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~-~~~kL~DF 174 (311)
T d1r0pa_ 97 CLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADF 174 (311)
T ss_dssp EEETTTEEEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSS
T ss_pred EEecCCceEEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-CCEEEecc
Confidence 75 357899999999999999987644 348888999999999999999999999999999999999988 79999999
Q ss_pred CCcccccccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHH-HHH
Q 018656 171 GLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQA-AYA 244 (352)
Q Consensus 171 g~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~~~ 244 (352)
|+++...... ......||..|+|||.+.. ..++.++||||||+++|||++|..||........ ...
T Consensus 175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~ 246 (311)
T d1r0pa_ 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246 (311)
T ss_dssp GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH
T ss_pred cchhhccccccccceecccccccccccChHHHhc--------CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 9998543222 2223468999999999854 6789999999999999999998777765433322 233
Q ss_pred HHhccCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 245 AAFKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.......+.+..+++++.++|.+||+.||++||++.+++++|+...+.
T Consensus 247 i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 333334445678899999999999999999999999999999988765
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=374.28 Aligned_cols=252 Identities=25% Similarity=0.293 Sum_probs=205.7
Q ss_pred ceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-------
Q 018656 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------- 95 (352)
Q Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------- 95 (352)
+|+..++||+|+||+||+|++. |+.||||++...... ..+|++++++++||||+++++++..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 6999999999999999999995 899999999765432 3479999999999999999999742
Q ss_pred CceEEEEEcCCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 PVMVIVTELLSGGTLRKYLLN-MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
.++++|||||+++.+..+... .....+++..++.++.||+.||+|||++||+||||||+|||++.+...+||+|||++.
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 247899999976543333221 2344599999999999999999999999999999999999999774589999999998
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCC---
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVR--- 251 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~--- 251 (352)
............|+..|+|||.+.+ ...++.++|||||||++|+|++|+.||.+.+..+...........
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred hccCCcccccccccccccChHHhhc-------ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 7666666667789999999998754 356899999999999999999999999987766554443321110
Q ss_pred -------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 252 -------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 252 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
.....+++++.+||.+||..||.+|||+.|+++| .|++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H--p~f~~~~ 310 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH--SFFDELR 310 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGGGGG
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC--Hhhcccc
Confidence 0123578999999999999999999999999998 5665543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=369.82 Aligned_cols=255 Identities=29% Similarity=0.358 Sum_probs=203.5
Q ss_pred ceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC
Q 018656 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (352)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 96 (352)
|.|.. +|++++.||+|+||+||+|.++ |+.||||++...... ....++.+|+.++++++||||+++++++...
T Consensus 4 ~~i~~-rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 4 FDVGP-RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ----TYCQRTLREIKILLRFRHENIIGINDIIRAP 78 (345)
T ss_dssp CCCCT-TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred cCcCC-CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh----HHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence 44443 5999999999999999999985 899999999764432 3345688999999999999999999998643
Q ss_pred -----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 97 -----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 97 -----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
..+++++|+.|++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++++ +.+||+|||
T Consensus 79 ~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~-~~~kl~DfG 154 (345)
T d1pmea_ 79 TIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFG 154 (345)
T ss_dssp STTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCT
T ss_pred cccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC-CCEEEcccC
Confidence 234555666799999999764 39999999999999999999999999999999999999988 799999999
Q ss_pred Ccccccccc----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 018656 172 LAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 172 ~a~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 247 (352)
++....... ......||+.|+|||++.. ...++.++||||+||++|+|++|+.||.+.+..+.......
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~ 227 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT-------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ceeeccCCCccceeeccccccceechHHHhhc-------CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh
Confidence 997543322 2344579999999998754 35678899999999999999999999988765444333322
Q ss_pred ccCCC------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 018656 248 KNVRP------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 291 (352)
Q Consensus 248 ~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~ 291 (352)
....+ ....+++++.+||.+||+.||.+|||+.++++| .|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h--pf~~ 299 (345)
T d1pmea_ 228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH--PYLE 299 (345)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS--GGGT
T ss_pred hccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC--Hhhc
Confidence 11111 124677899999999999999999999999998 4554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=371.68 Aligned_cols=260 Identities=25% Similarity=0.322 Sum_probs=209.9
Q ss_pred cccceecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeee
Q 018656 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (352)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~ 93 (352)
.+.|.| +++|++++.||+|+||+||+|++. |+.||||++....... ....++.+|++++++++||||+++++++
T Consensus 11 ~~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~h~~iv~~~~~~ 86 (348)
T d2gfsa1 11 KTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI---IHAKRTYRELRLLKHMKHENVIGLLDVF 86 (348)
T ss_dssp SSEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred CccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345776 578999999999999999999985 8999999998655433 2344688999999999999999999998
Q ss_pred ec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEE
Q 018656 94 KE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (352)
Q Consensus 94 ~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl 167 (352)
.. ...+++++|+.|++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|+
T Consensus 87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~-~~~kl 162 (348)
T d2gfsa1 87 TPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKI 162 (348)
T ss_dssp CSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEE
T ss_pred eeccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc-ccccc
Confidence 52 2456777788899999998643 39999999999999999999999999999999999999998 89999
Q ss_pred ecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 018656 168 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAF 247 (352)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~ 247 (352)
+|||++.... .......|++.|+|||.+.+ ...++.++|||||||++|+|++|+.||.+.+..........
T Consensus 163 ~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~-------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~ 233 (348)
T d2gfsa1 163 LDFGLARHTD--DEMTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233 (348)
T ss_dssp CCC----CCT--GGGSSSCHHHHTSCHHHHTT-------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccchhcccC--cccccccccccccCchhhcC-------CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999987643 23345679999999998754 34568899999999999999999999998776554443332
Q ss_pred ccCCCC------------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 248 KNVRPS------------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 248 ~~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
....+. ...+++++.+||.+||..||.+|||+.++++| .|++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H--p~f~~~~ 308 (348)
T d2gfsa1 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQYH 308 (348)
T ss_dssp HHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTTTC
T ss_pred hcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC--HhhCCCC
Confidence 221111 23578999999999999999999999999998 5665543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-51 Score=364.87 Aligned_cols=255 Identities=21% Similarity=0.271 Sum_probs=201.1
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec-----
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----- 95 (352)
-++|++.+.||+|+||+||+|+++ |+.||||++....... ....++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 479999999999999999999985 8999999987654432 223457899999999999999999998743
Q ss_pred ----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 96 ----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 96 ----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
..++++|||+.++.+..+... ...+++..++.++.|+++||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg 162 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFG 162 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCT
T ss_pred cccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC-CcEEeeecc
Confidence 258999999977655544332 3349999999999999999999999999999999999999998 799999999
Q ss_pred Cccccccc-----cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 018656 172 LAREESLT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAA 246 (352)
Q Consensus 172 ~a~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~ 246 (352)
++...... .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcC-------CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 99754322 22234579999999999854 2467899999999999999999999999877655544433
Q ss_pred hccCCCCCC-------------------------------CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 247 FKNVRPSAE-------------------------------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 247 ~~~~~~~~~-------------------------------~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.....+... ..++++.+||.+||+.||++|||++++++| .|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H--pff~~ 310 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH--DFFWS 310 (318)
T ss_dssp HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGSS
T ss_pred HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC--hhhcc
Confidence 322211100 125678899999999999999999999999 45544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.1e-51 Score=368.27 Aligned_cols=249 Identities=20% Similarity=0.329 Sum_probs=204.4
Q ss_pred cCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeeec---
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE--- 95 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~--- 95 (352)
+.++|++++.||+|+||+||+|++. |+.||||++.... ..++.+|+++++.++ ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 4678999999999999999999985 8999999986533 234789999999995 9999999999863
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 96 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..+++||||+.+++|.++. +.+++..++.++.||+.||+|||++||+||||||+|||++.+.+.++|+|||++..
T Consensus 105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 3699999999999987753 23999999999999999999999999999999999999997746799999999987
Q ss_pred cccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------
Q 018656 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK------- 248 (352)
Q Consensus 176 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~------- 248 (352)
...........+|+.|+|||.+.+ ...++.++|||||||++|+|++|+.||...............
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred ccCCCcccccccCccccCcccccC-------CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 666556667789999999998754 245788999999999999999999999765543221111000
Q ss_pred ------c------------------------CCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 249 ------N------------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 249 ------~------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
. ..+....+++++.+||++||..||.+|||++++++| .|+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H--p~F~~ 324 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH--PYFYT 324 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC--cccCC
Confidence 0 000123467899999999999999999999999998 44443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=357.63 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=208.2
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-ceEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~l 100 (352)
++|++++.||+|+||+||+|++. |+.||||+++...... ....++.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST---THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh---HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 48999999999999999999985 7899999997655433 2345688999999999999999999999854 7899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcccccccc
Q 018656 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (352)
Q Consensus 101 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~~~~~~ 180 (352)
+++++.+++|..++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||.+.......
T Consensus 79 v~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSCC
T ss_pred Eeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC-CceeeeecchhhcccCCC
Confidence 999999999888877654 48999999999999999999999999999999999999988 799999999998654432
Q ss_pred -ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH-HhccCCC------
Q 018656 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA-AFKNVRP------ 252 (352)
Q Consensus 181 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~------ 252 (352)
......++..|+|||.+.. ...++.++|||||||++|+|++|+.||....+....... ......+
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred ccceeeccccchhhhhHhcc-------CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence 3334467889999998754 245688999999999999999999986554443333222 2111110
Q ss_pred ----------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 018656 253 ----------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 253 ----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~ 294 (352)
....+++++.+||++||+.||.+|||++|+++| .|++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H--p~f~~~~ 290 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH--PYFSDFC 290 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGSSCS
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC--hhhcCCC
Confidence 123567899999999999999999999999998 5665443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.6e-50 Score=353.88 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=210.9
Q ss_pred ecCCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC-CCeeeeeeeeec-C
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGACKE-P 96 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~-~ 96 (352)
|-+++|++++.||+|+||+||+|++. |+.||||++....... .+.+|++.++.++| +|++.+++++.+ .
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-------CHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH-------HHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 44689999999999999999999985 8999999986654332 36678888888865 899999998874 4
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC----CCceEEecCCC
Q 018656 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED----LKTIKLADFGL 172 (352)
Q Consensus 97 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~----~~~vkl~Dfg~ 172 (352)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.+ .+.++|+|||+
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence 789999999 789999987654 349999999999999999999999999999999999999642 36899999999
Q ss_pred ccccccc--------cccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH---HH
Q 018656 173 AREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL---QA 241 (352)
Q Consensus 173 a~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~ 241 (352)
|+..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.... ..
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~ 224 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcC--------CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH
Confidence 9754321 12334579999999999854 67899999999999999999999999865432 11
Q ss_pred HHHHHhc-cCCC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCC
Q 018656 242 AYAAAFK-NVRP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM 299 (352)
Q Consensus 242 ~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~~~~ 299 (352)
....... ...+ ....+|+++.+++..|+..+|.+||+++.+.+.+.+.++......+.
T Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~ 286 (293)
T d1csna_ 225 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286 (293)
T ss_dssp HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCS
T ss_pred HHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCC
Confidence 1111111 1111 24578999999999999999999999999999998888776555443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-50 Score=355.46 Aligned_cols=257 Identities=22% Similarity=0.287 Sum_probs=201.0
Q ss_pred CCceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeee-ee-cCce
Q 018656 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA-CK-EPVM 98 (352)
Q Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~-~~-~~~~ 98 (352)
+++|++++.||+|+||+||+|++. |+.||||++....... ++.+|+++++.++|++++..+.. +. .+..
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC-------CHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH-------HHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 457999999999999999999985 8999999987654332 36789999999987776655544 44 4578
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCC--CCceEEecCCCcccc
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREE 176 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~--~~~vkl~Dfg~a~~~ 176 (352)
++||||+ +++|.+.+.... ..+++..++.++.|++.||+|||++||+||||||+|||++.. ...++|+|||+|+..
T Consensus 79 ~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 8999999 667877776543 349999999999999999999999999999999999998642 247999999999854
Q ss_pred cccc--------ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHH---
Q 018656 177 SLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAA--- 245 (352)
Q Consensus 177 ~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~--- 245 (352)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~ 228 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--------BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH
T ss_pred cccccccceeccccCCcCCCccccCHHHHhC--------CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh
Confidence 3321 2234579999999999864 66899999999999999999999999875543322211
Q ss_pred Hhc----cCCCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 018656 246 AFK----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 296 (352)
Q Consensus 246 ~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~~~~~ 296 (352)
... ........+|+++.+++..||+.||.+||++.++.+.|+..+......
T Consensus 229 ~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 229 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 111 111124679999999999999999999999999998888776654433
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=358.50 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=197.6
Q ss_pred CceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeecC-----ce
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-----VM 98 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 98 (352)
++|.+.+.||+|+||+||+|+++|+.||||++..... .......|+..++.++||||+++++++.+. .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~------~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch------hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4688999999999999999999999999999864321 112233566667788999999999998632 57
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCccCCCCCCCeEEeCCCCceEEecC
Q 018656 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS--------HGIIHRDLKPENLLLTEDLKTIKLADF 170 (352)
Q Consensus 99 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~--------~~ivH~Dikp~Nili~~~~~~vkl~Df 170 (352)
++||||+++|+|.+++.+. .+++..++.++.|++.||+|+|+ +||+||||||+||||+.+ +.+||+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DF 152 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCC
T ss_pred EEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEec
Confidence 9999999999999999874 38999999999999999999996 599999999999999988 79999999
Q ss_pred CCcccccccc-----ccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCC--------
Q 018656 171 GLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMS-------- 237 (352)
Q Consensus 171 g~a~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~-------- 237 (352)
|+++...... ......||+.|+|||++.+... .....++.++|||||||++|||++|..||....
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhcccccc--ccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 9998543322 2234579999999999865211 112346789999999999999999987764311
Q ss_pred ------hHHHHHHHHh-ccCCCCC------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 238 ------NLQAAYAAAF-KNVRPSA------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 238 ------~~~~~~~~~~-~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
.......... ....|.. ...+..+.+++.+||+.||.+|||+.++++.|.++.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1111222221 2222221 12335689999999999999999999999999887654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=364.79 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=207.2
Q ss_pred ecCCceeeeccccCCCceEEEEEEE-----CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC-CCeeeeeeeee
Q 018656 21 IDPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGACK 94 (352)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~ 94 (352)
+.-++|++++.||+|+||+||+|++ +|+.||||++........ .....++.+|++++++++| |||+++++++.
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 3447899999999999999999987 378999999865321110 0112347789999999976 89999999987
Q ss_pred c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCc
Q 018656 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (352)
Q Consensus 95 ~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a 173 (352)
+ ...+++|||+.+++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a 176 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLS 176 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEE
T ss_pred cCCceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccch
Confidence 5 579999999999999999988765 7899999999999999999999999999999999999998 79999999999
Q ss_pred ccccc--ccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHhc
Q 018656 174 REESL--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQ---AAYAAAFK 248 (352)
Q Consensus 174 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~---~~~~~~~~ 248 (352)
+.... ........|++.|+|||.+.+ ....++.++|||||||++|+|++|+.||.+..... ........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~------~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhHHhhc------CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 75432 223345679999999999854 23457889999999999999999999997754322 23333334
Q ss_pred cCCCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 018656 249 NVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 285 (352)
Q Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~i~~~ 285 (352)
...+.+..+++++.++|.+||.+||.+|| |++|+++|
T Consensus 251 ~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 44555678999999999999999999999 48899987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=365.39 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=193.6
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCeeeeeeeeec------
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------ 95 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~------ 95 (352)
++|++++.||+|+||+||+|+++ |+.||||++....... ....++.+|+.++++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH---HHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 56999999999999999999985 8999999998765443 334568899999999999999999999842
Q ss_pred -CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCCCcc
Q 018656 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (352)
Q Consensus 96 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~ 174 (352)
..+|+||||+.++ |.+.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.++++|||+++
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~-~~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC--
T ss_pred CceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc-cceeeechhhhh
Confidence 4689999999664 444443 238999999999999999999999999999999999999998 789999999988
Q ss_pred ccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChHHHHHHHHhccCCCC-
Q 018656 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPS- 253 (352)
Q Consensus 175 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~- 253 (352)
............+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..............+.
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~--------~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp -------------CCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccccccccccccccccChhhhcC--------CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 7666666667789999999999864 6788999999999999999999999988765544433322111100
Q ss_pred ----------------------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 018656 254 ----------------------------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 292 (352)
Q Consensus 254 ----------------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~i~~~l~~~~~~ 292 (352)
....++++.+||++||..||++|||++++++| .|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H--pw~~~ 316 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH--PYINV 316 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS--TTTGG
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC--cccCC
Confidence 01235778999999999999999999999999 45543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.5e-43 Score=318.36 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=188.5
Q ss_pred CceeeeccccCCCceEEEEEEEC--CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-----------CCCeeeee
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-----------HRNLVKFI 90 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~iv~l~ 90 (352)
.+|++++.||+|+||+||+|++. |+.||||+++... ...+.+.+|+++++.++ |+||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc------cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 46999999999999999999984 8999999987532 12234677888877764 57899999
Q ss_pred eeeec---CceEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCCeEEeCCCC--
Q 018656 91 GACKE---PVMVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK-- 163 (352)
Q Consensus 91 ~~~~~---~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dikp~Nili~~~~~-- 163 (352)
+++.. ...+++++++..+ +............+++..++.++.|++.||+|||+ .||+||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 88753 3455555555444 44444555555669999999999999999999998 89999999999999976521
Q ss_pred ---ceEEecCCCccccccccccccCCCcccccccccccccccccccccCCCcccchhhHHHHHHHHHhCCCCCCCCChH-
Q 018656 164 ---TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDSYSFAIVLWELLHNKLPFEGMSNL- 239 (352)
Q Consensus 164 ---~vkl~Dfg~a~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~- 239 (352)
.++++|||.+..... ......||+.|+|||++.. ..++.++||||+||++++|++|+.||......
T Consensus 167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred ccceeeEeeccccccccc--ccccccccccccChhhccc--------cCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 499999999875432 2345679999999998854 56889999999999999999999999764321
Q ss_pred -----HHHHHHHhcc-----------------------------------------CCCCCCCCcHHHHHHHHHhhccCC
Q 018656 240 -----QAAYAAAFKN-----------------------------------------VRPSAENVPEELSIILTSCWKEDP 273 (352)
Q Consensus 240 -----~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~li~~~l~~~p 273 (352)
.......... ........++++.+||.+||..||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 1111110000 000012346789999999999999
Q ss_pred CCCCCHHHHHHHHHHhhhccC
Q 018656 274 NARPNFTQIIQMLLNYLSAIA 294 (352)
Q Consensus 274 ~~Rps~~~i~~~l~~~~~~~~ 294 (352)
.+|||++++++| .|+++..
T Consensus 317 ~~Rpta~e~L~H--p~f~~~~ 335 (362)
T d1q8ya_ 317 RKRADAGGLVNH--PWLKDTL 335 (362)
T ss_dssp TTCBCHHHHHTC--GGGTTCT
T ss_pred hHCcCHHHHhcC--cccCCCC
Confidence 999999999998 5666443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.6e-27 Score=196.66 Aligned_cols=138 Identities=22% Similarity=0.221 Sum_probs=107.5
Q ss_pred eeeeccccCCCceEEEEEEE-CCceEEEEEcccCCCh-------------HHHHHHHHHHHHHHHHHhcCCCCCeeeeee
Q 018656 26 LFVGPRIGEGAHAKVYEGKY-KNQTVAIKIVHKGETP-------------EEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (352)
Q Consensus 26 y~~~~~lG~G~~g~Vy~~~~-~~~~vaiK~~~~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~ 91 (352)
+.+++.||+|+||+||+|.+ +|+.||||+++..... ...........+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46889999999999999987 4899999987643211 011122334567889999999999998876
Q ss_pred eeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCCeEEeCCCCceEEecCC
Q 018656 92 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (352)
Q Consensus 92 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dikp~Nili~~~~~~vkl~Dfg 171 (352)
+.. .+++|||+++..+.+ ++...+..++.|++++|.|||++||+||||||+|||++++ .++|+|||
T Consensus 82 ~~~---~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG 147 (191)
T d1zara2 82 WEG---NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP 147 (191)
T ss_dssp EET---TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred ecC---CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence 532 379999998765433 4445567889999999999999999999999999999975 58999999
Q ss_pred Cccccc
Q 018656 172 LAREES 177 (352)
Q Consensus 172 ~a~~~~ 177 (352)
+|....
T Consensus 148 ~a~~~~ 153 (191)
T d1zara2 148 QSVEVG 153 (191)
T ss_dssp TCEETT
T ss_pred CcccCC
Confidence 987543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.67 E-value=3.1e-08 Score=83.57 Aligned_cols=139 Identities=15% Similarity=0.110 Sum_probs=92.1
Q ss_pred CceeeeccccCCCceEEEEEEECCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeeeeee-cCceEEE
Q 018656 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACK-EPVMVIV 101 (352)
Q Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~-~~~~~lv 101 (352)
+.|++.+..+.++.+.||+....++.+++|......... ...+.+|...++.+. +--+.+++.+.. ++..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 456666666556667999988778888999875432211 112556777766553 333567777665 4578999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 018656 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-------------------------------------- 143 (352)
Q Consensus 102 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-------------------------------------- 143 (352)
|++++|.++.+..... .. ...++.++.+.+..||+
T Consensus 89 ~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999998887654221 11 22245555566666663
Q ss_pred ---------------------CCCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 144 ---------------------HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 144 ---------------------~~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
..++|+|+.|.||+++++ +.+-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhccc
Confidence 126899999999999976 4556999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.19 E-value=2.3e-06 Score=71.32 Aligned_cols=125 Identities=19% Similarity=0.152 Sum_probs=77.6
Q ss_pred ccCCC-ceEEEEEEEC-CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCC--CCeeeeeeeeec-CceEEEEEcCC
Q 018656 32 IGEGA-HAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACKE-PVMVIVTELLS 106 (352)
Q Consensus 32 lG~G~-~g~Vy~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~l~~~~~~-~~~~lv~e~~~ 106 (352)
+..|. .+.||+.... +..+++|......... +.+|...++.+.. -.+.+++.+..+ +..++||++++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~--------l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNE--------LQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSC--------HHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhH--------HHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 44444 3678988876 5678889876544322 4566666665532 235667776554 47899999998
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 018656 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-------------------------------------------- 142 (352)
Q Consensus 107 ~~sL~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH-------------------------------------------- 142 (352)
|.++.+.. ..... .+.++...|..||
T Consensus 90 G~~~~~~~-------~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 90 GQDLLSSH-------LAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp SEETTTSC-------CCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cccccccc-------ccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 86653310 11111 1223333333333
Q ss_pred -------hC-------CCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 143 -------SH-------GIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 143 -------~~-------~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
++ .++|+|+.|.|||++++ +.+-|+||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~-~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCC-ceEEEEEchhccc
Confidence 21 26999999999999986 4567999998653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.98 E-value=3.4e-06 Score=75.14 Aligned_cols=80 Identities=20% Similarity=0.110 Sum_probs=45.6
Q ss_pred eccccCCCceEEEEEEEC--CceEEEEEcccCC--ChHHHHHHHHHHHHHHHHHhcCC---CCCeeeeeeeeecCceEEE
Q 018656 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGE--TPEEIAKKESRFAREVAMLSRVQ---HRNLVKFIGACKEPVMVIV 101 (352)
Q Consensus 29 ~~~lG~G~~g~Vy~~~~~--~~~vaiK~~~~~~--~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~l~~~~~~~~~~lv 101 (352)
.+.||.|....||+..+. ++.+++|...... ..+.......+...|.+.++.+. ...+++++.+ .....++|
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d~~~~~lv 109 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV 109 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-cCCCCEEE
Confidence 456899999999998753 6789999643210 00000000112445666666552 2345555544 44566899
Q ss_pred EEcCCCCC
Q 018656 102 TELLSGGT 109 (352)
Q Consensus 102 ~e~~~~~s 109 (352)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.27 E-value=0.00034 Score=61.83 Aligned_cols=78 Identities=17% Similarity=0.243 Sum_probs=49.9
Q ss_pred cCCceeeeccccCCCceEEEEEEEC---------CceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCC-CCCeeeeee
Q 018656 22 DPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIG 91 (352)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~ 91 (352)
+.+.+++ +.|+.|-.-.+|++... .+.|++++........ ...+|..+++.+. +.-..++++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~i-------dr~~E~~i~~~ls~~gl~Pkll~ 112 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETES-------HLVAESVIFTLLSERHLGPKLYG 112 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHH-------HHHHHHHHHHHHHHTTSSSCEEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhh-------HHHHHHHHHHHHHhCCCCCeEEE
Confidence 3344444 56888999999998764 3568888865332211 1346777777774 333357777
Q ss_pred eeecCceEEEEEcCCCCCH
Q 018656 92 ACKEPVMVIVTELLSGGTL 110 (352)
Q Consensus 92 ~~~~~~~~lv~e~~~~~sL 110 (352)
++.+ .+|+||++|.+|
T Consensus 113 ~~~~---g~I~efi~g~~l 128 (395)
T d1nw1a_ 113 IFSG---GRLEEYIPSRPL 128 (395)
T ss_dssp EETT---EEEECCCCEEEC
T ss_pred EcCC---ceEEEEeccccC
Confidence 7654 678999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.17 E-value=0.0011 Score=56.78 Aligned_cols=65 Identities=9% Similarity=0.136 Sum_probs=39.3
Q ss_pred ceEEEEEEE-CCceEEEEEcccCCChHHHHHHHHHHHHHHHHHhcCCCCCe--eeeeee------eecCceEEEEEcCCC
Q 018656 37 HAKVYEGKY-KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL--VKFIGA------CKEPVMVIVTELLSG 107 (352)
Q Consensus 37 ~g~Vy~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i--v~l~~~------~~~~~~~lv~e~~~~ 107 (352)
--.||++.. .|+.|++|+.+...-... .+..|.+.+..|...++ +..+.. ..++..+.++++++|
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~------~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTAD------QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHH------HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHH------HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 347999986 588999999876643332 24556666655532111 111111 124568899999976
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.88 E-value=0.0016 Score=55.31 Aligned_cols=30 Identities=37% Similarity=0.558 Sum_probs=26.0
Q ss_pred CCccCCCCCCCeEEeCCCCceEEecCCCccc
Q 018656 145 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (352)
Q Consensus 145 ~ivH~Dikp~Nili~~~~~~vkl~Dfg~a~~ 175 (352)
|+||+|+.++||+++.+ +..-++||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~-~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGD-ELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccc-cceeEeccccccc
Confidence 69999999999999987 5568999998753
|